Citrus Sinensis ID: 008116
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 577 | 2.2.26 [Sep-21-2011] | |||||||
| O61122 | 478 | Serine/threonine-protein | yes | no | 0.461 | 0.556 | 0.634 | 1e-104 | |
| B0LT89 | 431 | Serine/threonine-protein | yes | no | 0.457 | 0.612 | 0.659 | 3e-96 | |
| Q99KH8 | 431 | Serine/threonine-protein | yes | no | 0.457 | 0.612 | 0.655 | 5e-96 | |
| Q9Y6E0 | 443 | Serine/threonine-protein | yes | no | 0.457 | 0.595 | 0.651 | 1e-95 | |
| Q9Z2W1 | 426 | Serine/threonine-protein | no | no | 0.466 | 0.631 | 0.642 | 4e-93 | |
| Q9P289 | 416 | Serine/threonine-protein | no | no | 0.457 | 0.634 | 0.632 | 4e-93 | |
| Q99JT2 | 416 | Serine/threonine-protein | no | no | 0.457 | 0.634 | 0.632 | 7e-93 | |
| Q3SWY6 | 426 | Serine/threonine-protein | no | no | 0.466 | 0.631 | 0.638 | 3e-92 | |
| O00506 | 426 | Serine/threonine-protein | no | no | 0.466 | 0.631 | 0.634 | 1e-91 | |
| Q86IX1 | 737 | Serine/threonine-protein | no | no | 0.457 | 0.358 | 0.539 | 9e-79 |
| >sp|O61122|SVKA_DICDI Serine/threonine-protein kinase svkA OS=Dictyostelium discoideum GN=svkA PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 378 bits (971), Expect = e-104, Method: Compositional matrix adjust.
Identities = 170/268 (63%), Positives = 222/268 (82%), Gaps = 2/268 (0%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
E IG+GSFG+V+K +K+ N+ +AIK IDLE++EDEIEDIQ+EI+VLSQC SP++T+Y+G
Sbjct: 16 EKIGKGSFGEVFKGINKKTNETIAIKTIDLEDAEDEIEDIQQEINVLSQCESPFVTKYFG 75
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
S+L +KLWIIMEY+AGGSV DL++ GP DE IA ILR+LL +EYLH+EGKIHRDIK
Sbjct: 76 SFLKGSKLWIIMEYLAGGSVLDLMKPGP-FDEGYIAIILRELLKGLEYLHSEGKIHRDIK 134
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSL 198
AAN+LL+ +GDVK+ADFGVS QLT +++R TFVGTPFWMAPEVI+ + GY+ KADIWS+
Sbjct: 135 AANVLLSASGDVKLADFGVSGQLTDQMTKRNTFVGTPFWMAPEVIKQT-GYDSKADIWSM 193
Query: 199 GITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258
GIT +EMAKGEPP ADLHPMR LF+IP++ PP L+ +FS+ KEF +LCL K P +RP+A
Sbjct: 194 GITALEMAKGEPPRADLHPMRALFLIPKDPPPTLEGNFSKGFKEFCALCLNKDPNQRPTA 253
Query: 259 KELLRHRFIRNARKSPRLLERIRERPKY 286
K+LL+H+FI+ A+K+ L + I R K+
Sbjct: 254 KDLLKHKFIKAAKKTSSLTDLIERRQKW 281
|
Involved in regulation of actin cytoskeleton organization during cell motility; F-actin fragmenting and capping protein allowing dynamic rearrangements of the actin cytoskeleton. Also part of a regulatory pathway from the centrosome to the midzone, thus regulating the completion of cell division. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|B0LT89|STK24_RAT Serine/threonine-protein kinase 24 OS=Rattus norvegicus GN=Stk24 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 353 bits (905), Expect = 3e-96, Method: Compositional matrix adjust.
Identities = 176/267 (65%), Positives = 219/267 (82%), Gaps = 3/267 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPY+T
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ G PLDE+ IA ILR++L ++YLH+E KIH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDEIQIATILREILKGLDYLHSEKKIH 142
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 201
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP ++LHPM+VLF+IP+ NPP L+ +SR +KEFV CL K P+
Sbjct: 202 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGSYSRPLKEFVEACLNKEPSF 261
Query: 255 RPSAKELLRHRF-IRNARKSPRLLERI 280
RP+AKELL+H+F IRNA+K+ L E I
Sbjct: 262 RPTAKELLKHKFIIRNAKKTSYLTELI 288
|
Serine/threonine-protein kinase that acts on both serine and threonine residues and promotes apoptosis in response to stress stimuli and caspase activation. Mediates oxidative-stress-induced cell death by modulating phosphorylation of JNK1-JNK2 (MAPK8 and MAPK9), p38 (MAPK11, MAPK12, MAPK13 and MAPK14) during oxidative stress. Plays a role in a staurosporine-induced caspase-independent apoptotic pathway by regulating the nuclear translocation of AIFM1 and ENDOG and the DNase activity associated with ENDOG. Phosphorylates STK38L on 'Thr-442' and stimulates its kinase activity. Regulates cellular migration with alteration of PTPN12 activity and PXN phosphorylation: phosphorylates PTPN12 and inhibits its activity and may regulate PXN phosphorylation through PTPN12 (By similarity). Acts as a key regulator of axon regeneration in the adult optic nerve and radial nerve. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q99KH8|STK24_MOUSE Serine/threonine-protein kinase 24 OS=Mus musculus GN=Stk24 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (903), Expect = 5e-96, Method: Compositional matrix adjust.
Identities = 175/267 (65%), Positives = 220/267 (82%), Gaps = 3/267 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPY+T
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ G PLDE+ IA ILR++L ++YLH+E KIH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDEIQIATILREILKGLDYLHSEKKIH 142
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 201
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP ++LHPM+VLF+IP+ NPP L+ ++S+ +KEFV CL K P+
Sbjct: 202 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 261
Query: 255 RPSAKELLRHRF-IRNARKSPRLLERI 280
RP+AKELL+H+F IRNA+K+ L E I
Sbjct: 262 RPTAKELLKHKFIIRNAKKTSYLTELI 288
|
Serine/threonine-protein kinase that acts on both serine and threonine residues and promotes apoptosis in response to stress stimuli and caspase activation. Mediates oxidative-stress-induced cell death by modulating phosphorylation of JNK1-JNK2 (MAPK8 and MAPK9), p38 (MAPK11, MAPK12, MAPK13 and MAPK14) during oxidative stress. Plays a role in a staurosporine-induced caspase-independent apoptotic pathway by regulating the nuclear translocation of AIFM1 and ENDOG and the DNase activity associated with ENDOG. Phosphorylates STK38L on 'Thr-442' and stimulates its kinase activity. Regulates cellular migration with alteration of PTPN12 activity and PXN phosphorylation: phosphorylates PTPN12 and inhibits its activity and may regulate PXN phosphorylation through PTPN12. Acts as a key regulator of axon regeneration in the optic nerve and radial nerve. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y6E0|STK24_HUMAN Serine/threonine-protein kinase 24 OS=Homo sapiens GN=STK24 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 350 bits (899), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 174/267 (65%), Positives = 219/267 (82%), Gaps = 3/267 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPY+T
Sbjct: 36 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 95
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ G PLDE IA ILR++L ++YLH+E KIH
Sbjct: 96 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIH 154
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 155 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 213
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+A+GEPP ++LHPM+VLF+IP+ NPP L+ ++S+ +KEFV CL K P+
Sbjct: 214 IWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 273
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERI 280
RP+AKELL+H+FI RNA+K+ L E I
Sbjct: 274 RPTAKELLKHKFILRNAKKTSYLTELI 300
|
Serine/threonine-protein kinase that acts on both serine and threonine residues and promotes apoptosis in response to stress stimuli and caspase activation. Mediates oxidative-stress-induced cell death by modulating phosphorylation of JNK1-JNK2 (MAPK8 and MAPK9), p38 (MAPK11, MAPK12, MAPK13 and MAPK14) during oxidative stress. Plays a role in a staurosporine-induced caspase-independent apoptotic pathway by regulating the nuclear translocation of AIFM1 and ENDOG and the DNase activity associated with ENDOG. Phosphorylates STK38L on 'Thr-442' and stimulates its kinase activity. Regulates cellular migration with alteration of PTPN12 activity and PXN phosphorylation: phosphorylates PTPN12 and inhibits its activity and may regulate PXN phosphorylation through PTPN12. May act as a key regulator of axon regeneration in the optic nerve and radial nerve. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Z2W1|STK25_MOUSE Serine/threonine-protein kinase 25 OS=Mus musculus GN=Stk25 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 342 bits (878), Expect = 4e-93, Method: Compositional matrix adjust.
Identities = 174/271 (64%), Positives = 211/271 (77%), Gaps = 2/271 (0%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ L+ IG+GSFG+VYK D + VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPYIT
Sbjct: 20 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 79
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
Y+GSYL TKLWIIMEY+ GGS DL++ G PL+E IA ILR++L ++YLH+E KIH
Sbjct: 80 RYFGSYLKSTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSERKIH 138
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 139 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKAD 197
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +DLHPMRVLF+IP+ NPP L+ H S+ KEFV CL K P
Sbjct: 198 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNNPPTLEGHHSKPFKEFVEACLNKDPRF 257
Query: 255 RPSAKELLRHRFIRNARKSPRLLERIRERPK 285
RP+AKELL+H+FI K L + +R K
Sbjct: 258 RPTAKELLKHKFITRYTKKTSFLTELIDRYK 288
|
Oxidant stress-activated serine/threonine kinase that may play a role in the response to environmental stress. Targets to the Golgi apparatus where it appears to regulate protein transport events, cell adhesion, and polarity complexes important for cell migration. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9P289|MST4_HUMAN Serine/threonine-protein kinase MST4 OS=Homo sapiens GN=MST4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 342 bits (878), Expect = 4e-93, Method: Compositional matrix adjust.
Identities = 169/267 (63%), Positives = 214/267 (80%), Gaps = 3/267 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D + VAIK+IDLEE+EDEIEDIQ+EI+VLSQC S Y+T
Sbjct: 24 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 83
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL +KLWIIMEY+ GGS DL+++G P DE IA +L+++L ++YLH+E KIH
Sbjct: 84 KYYGSYLKGSKLWIIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEKKIH 142
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVIQ S Y+ KAD
Sbjct: 143 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKAD 201
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +D+HPMRVLF+IP+ NPP L F++ KEF+ CL K P+
Sbjct: 202 IWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSF 261
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERI 280
RP+AKELL+H+FI +N++K+ L E I
Sbjct: 262 RPTAKELLKHKFIVKNSKKTSYLTELI 288
|
Mediator of cell growth. Modulates apoptosis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q99JT2|MST4_MOUSE Serine/threonine-protein kinase MST4 OS=Mus musculus GN=Mst4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (876), Expect = 7e-93, Method: Compositional matrix adjust.
Identities = 169/267 (63%), Positives = 214/267 (80%), Gaps = 3/267 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D + VAIK+IDLEE+EDEIEDIQ+EI+VLSQC S Y+T
Sbjct: 24 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 83
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL +KLWIIMEY+ GGS DL+++G P DE IA +L+++L ++YLH+E KIH
Sbjct: 84 KYYGSYLKGSKLWIIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEKKIH 142
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVIQ S Y+ KAD
Sbjct: 143 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKAD 201
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +D+HPMRVLF+IP+ NPP L F++ KEF+ CL K P+
Sbjct: 202 IWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLIGDFTKSFKEFIDACLNKDPSF 261
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERI 280
RP+AKELL+H+FI +N++K+ L E I
Sbjct: 262 RPTAKELLKHKFIVKNSKKTSYLTELI 288
|
Mediator of cell growth. Modulates apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3SWY6|STK25_BOVIN Serine/threonine-protein kinase 25 OS=Bos taurus GN=STK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 339 bits (870), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 173/271 (63%), Positives = 211/271 (77%), Gaps = 2/271 (0%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ L+ IG+GSFG+VYK D + VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPYIT
Sbjct: 20 FTKLDRIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 79
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
Y+GSYL TKLWIIMEY+ GGS DL++ G PL+E IA ILR++L ++YLH+E KIH
Sbjct: 80 RYFGSYLKSTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSERKIH 138
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 139 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKAD 197
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +DLHPMRVLF+IP+ +PP L+ H S+ KEFV CL K P
Sbjct: 198 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGHHSKPFKEFVEACLNKDPRF 257
Query: 255 RPSAKELLRHRFIRNARKSPRLLERIRERPK 285
RP+AKELL+H+FI K L + +R K
Sbjct: 258 RPTAKELLKHKFITRYTKKTSFLTELIDRYK 288
|
Oxidant stress-activated serine/threonine kinase that may play a role in the response to environmental stress. Targets to the Golgi apparatus where it appears to regulate protein transport events, cell adhesion, and polarity complexes important for cell migration. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O00506|STK25_HUMAN Serine/threonine-protein kinase 25 OS=Homo sapiens GN=STK25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (865), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 172/271 (63%), Positives = 210/271 (77%), Gaps = 2/271 (0%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ L+ IG+GSFG+VYK D + VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPYIT
Sbjct: 20 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 79
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
Y+GSYL TKLWIIMEY+ GGS DL++ G PL+E IA ILR++L ++YLH+E KIH
Sbjct: 80 RYFGSYLKSTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSERKIH 138
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 139 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKAD 197
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +DLHPMRVLF+IP+ +PP L+ S+ KEFV CL K P
Sbjct: 198 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRF 257
Query: 255 RPSAKELLRHRFIRNARKSPRLLERIRERPK 285
RP+AKELL+H+FI K L + +R K
Sbjct: 258 RPTAKELLKHKFITRYTKKTSFLTELIDRYK 288
|
Oxidant stress-activated serine/threonine kinase that may play a role in the response to environmental stress. Targets to the Golgi apparatus where it appears to regulate protein transport events, cell adhesion, and polarity complexes important for cell migration. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q86IX1|DST1_DICDI Serine/threonine-protein kinase dst1 OS=Dictyostelium discoideum GN=dst1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (754), Expect = 9e-79, Method: Compositional matrix adjust.
Identities = 145/269 (53%), Positives = 191/269 (71%), Gaps = 5/269 (1%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
E +G+GSFG V+KA K VAIK+I L++ E I+D++KEIS+L++C P I +Y+G
Sbjct: 33 ERLGKGSFGQVFKAVHFANGKVVAIKIISLDDQE-AIKDVRKEISILAECNYPNIVQYFG 91
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
SY +LWI+MEY GGSV+DL+Q + E IA I R+ L + YLH KIHRDIK
Sbjct: 92 SYFKDHQLWIVMEYCGGGSVSDLLQVIDTISEDEIALICREALKGLNYLHEFKKIHRDIK 151
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSL 198
NILL + G+VK+ADFGVSAQL T S+R TFVGTP+WMAPEVIQ ++ Y+ KAD+WSL
Sbjct: 152 GGNILLNDRGEVKLADFGVSAQLFNTFSKRNTFVGTPYWMAPEVIQENK-YDGKADVWSL 210
Query: 199 GITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH--FSRLMKEFVSLCLKKVPAERP 256
GIT IEMA+G PP +++HPMRV+F+IPRE P L + +S ++F+S CL K PAERP
Sbjct: 211 GITAIEMAEGLPPNSNVHPMRVIFMIPREESPALTDKSIWSDKFQDFISKCLTKDPAERP 270
Query: 257 SAKELLRHRFIRNARKSPRLLERIRERPK 285
+AKELL H FI+ +K +L + E K
Sbjct: 271 TAKELLNHEFIQ-TKKPLSILSDLVENCK 298
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 577 | ||||||
| 225461512 | 706 | PREDICTED: uncharacterized protein LOC10 | 0.982 | 0.803 | 0.785 | 0.0 | |
| 255584401 | 697 | ATP binding protein, putative [Ricinus c | 0.980 | 0.812 | 0.780 | 0.0 | |
| 224128268 | 703 | predicted protein [Populus trichocarpa] | 0.977 | 0.802 | 0.764 | 0.0 | |
| 356549701 | 695 | PREDICTED: uncharacterized protein LOC10 | 0.977 | 0.811 | 0.739 | 0.0 | |
| 356543342 | 700 | PREDICTED: uncharacterized protein LOC10 | 0.984 | 0.811 | 0.742 | 0.0 | |
| 356517110 | 700 | PREDICTED: uncharacterized protein LOC10 | 0.979 | 0.807 | 0.743 | 0.0 | |
| 356543344 | 709 | PREDICTED: uncharacterized protein LOC10 | 0.984 | 0.801 | 0.728 | 0.0 | |
| 15232528 | 690 | putative protein kinase [Arabidopsis tha | 0.979 | 0.818 | 0.717 | 0.0 | |
| 3819699 | 676 | BnMAP4K alpha2 [Brassica napus] | 0.954 | 0.815 | 0.721 | 0.0 | |
| 297834386 | 692 | hypothetical protein ARALYDRAFT_897796 [ | 0.979 | 0.816 | 0.718 | 0.0 |
| >gi|225461512|ref|XP_002285125.1| PREDICTED: uncharacterized protein LOC100258981 isoform 1 [Vitis vinifera] gi|302142973|emb|CBI20268.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 872 bits (2254), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/570 (78%), Positives = 499/570 (87%), Gaps = 3/570 (0%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
MA+ A + +A GSRFSSLELIGRGSFGDVYK FDKELNKDVAIKVIDLEE+EDEIEDIQK
Sbjct: 1 MAEAAAIMDATGSRFSSLELIGRGSFGDVYKGFDKELNKDVAIKVIDLEEAEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG PLDEMSIACILRDL
Sbjct: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGQPLDEMSIACILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR M
Sbjct: 181 EVIQNSEGYNEKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRPM 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKKVPAERPSAKELL+HRFIRNARKSPRLLERIRERPKY I+++ +TP NG +
Sbjct: 241 KEFVSLCLKKVPAERPSAKELLKHRFIRNARKSPRLLERIRERPKYQIKDDAETPRNGPK 300
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
+GE S TVKV RD R EETV+ SSQG+T+RNAGW+FSLS S TGT+R+ ++PPQ RE+
Sbjct: 301 GIGEGSDTVKVTRDSRGEETVRASSQGKTLRNAGWDFSLSGSQSTGTVRSVIRPPQARER 360
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYYEDDDTS 420
KPE SY Q ++TA+ +NH SASGS +ES + + ARD+Y+D+ QD+ +EDD+ S
Sbjct: 361 KPEVSY-QAPSRKTADSNNHLLSASGSGRYESSEIFLGKEARDAYYDE-QDNSHEDDELS 418
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSARTPR 480
S SGTVV+RSPRG +SS F D+S++SS+TY S EDASTSGTVV R HDDSDS RTP+
Sbjct: 419 VSGSGTVVVRSPRGYQSSIPFSDQSSLSSNTYASLEDASTSGTVVIRSHHDDSDSPRTPK 478
Query: 481 SRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNND-GEYRRREQIT 539
SRLGIQER+S+A EDSA+NLAEAKAA+Q GLRKGNARER LGK+N D E R+ EQIT
Sbjct: 479 SRLGIQERTSTAPPEDSAINLAEAKAAMQGGLRKGNARERSVLGKVNKDEQEKRKTEQIT 538
Query: 540 SSSDSSRDSRDYLDAQRGFSRPRQGSDEEE 569
SSSDSSR SR+Y DA + F+R RQ SD++E
Sbjct: 539 SSSDSSRHSREYYDAPKAFARSRQSSDDDE 568
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584401|ref|XP_002532933.1| ATP binding protein, putative [Ricinus communis] gi|223527297|gb|EEF29449.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2203), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/570 (78%), Positives = 496/570 (87%), Gaps = 4/570 (0%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
M D AGL EAAGSRFSSLELIG+GSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK
Sbjct: 1 MGDAAGLMEAAGSRFSSLELIGKGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCR PYITEYYGSYL+QTKLWIIMEYMAGGSVADL+QSG PLDE+SIACILRDL
Sbjct: 61 EISVLSQCRCPYITEYYGSYLNQTKLWIIMEYMAGGSVADLLQSGHPLDEISIACILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHAIEYLHNEGKIHRDIKAANILL+ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAIEYLHNEGKIHRDIKAANILLSENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR M
Sbjct: 181 EVIQNSEGYNEKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRPM 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKKVPAERPSAKELL+HRFI+NARKSPRLLERIRERPKY I++ +TP NG +
Sbjct: 241 KEFVSLCLKKVPAERPSAKELLKHRFIKNARKSPRLLERIRERPKYQIRDA-ETPRNGPK 299
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
+GEAS TVKV RD R + TV+ S+QG+ ++NAGW+FS+ S +GT+++ ++PPQVREK
Sbjct: 300 PMGEASDTVKVSRDVRDDGTVRASAQGKPLKNAGWDFSIGGSLSSGTVKSVLRPPQVREK 359
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYYEDDDTS 420
K E SYN+ T +RT+E N S SG+ L SPD + ARD D+ D+ ++ DD S
Sbjct: 360 KTENSYNKVT-QRTSESGNFLLSPSGNALQGSPDLLFGKDARDLRPDEHLDNSHDYDDLS 418
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSARTPR 480
S SGTVVIR+PRGS+SS LFRD+S+ SSST S EDASTSGTV++RGQHDD DS +TP+
Sbjct: 419 ISGSGTVVIRTPRGSQSSTLFRDQSSPSSSTVASFEDASTSGTVIFRGQHDDYDSPQTPK 478
Query: 481 SRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDG-EYRRREQIT 539
SRLGI+ER+SSASLEDSAVNLAEAKA I++GLRKGNARER AL K+NNDG E RRREQ+T
Sbjct: 479 SRLGIKERTSSASLEDSAVNLAEAKAVIEAGLRKGNARERSALHKINNDGHENRRREQMT 538
Query: 540 SSSDSSRDSRDYLDAQRGFSRPRQGSDEEE 569
+SS S SRDY DAQR F R RQ SD+EE
Sbjct: 539 NSS-DSSSSRDYFDAQRMFPRSRQVSDDEE 567
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128268|ref|XP_002329122.1| predicted protein [Populus trichocarpa] gi|222869791|gb|EEF06922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 827 bits (2137), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/570 (76%), Positives = 485/570 (85%), Gaps = 6/570 (1%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
MAD AGL EAAG+RFSSLELIGRGSFGDVYKAFDKEL+K+VAIKVIDLEESEDEIEDIQK
Sbjct: 1 MADAAGLMEAAGARFSSLELIGRGSFGDVYKAFDKELDKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVL QCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL+QSGPPLDEMSIACILRDL
Sbjct: 61 EISVLRQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLLQSGPPLDEMSIACILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHAIEYLHNEGKIHRDIKAANILL+ENGDVKVADFGVSAQLT T+SRRKTFVGTPFWMAP
Sbjct: 121 LHAIEYLHNEGKIHRDIKAANILLSENGDVKVADFGVSAQLTGTVSRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYN KADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR M
Sbjct: 181 EVIQNSEGYNVKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRPM 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVS CLKK RP+AKELLRHRFIRNARKSPRLLERIRERP Y I+ + +TP NG
Sbjct: 241 KEFVSFCLKK----RPTAKELLRHRFIRNARKSPRLLERIRERPMYQIK-DAETPRNGPI 295
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
+GE TVKVVRD R++ TV+ S QG+ +NAGW+FS+ S TGTIR+A +PPQVREK
Sbjct: 296 GIGEGFDTVKVVRDLRADGTVRASGQGKPFKNAGWDFSIGGSQTTGTIRSAARPPQVREK 355
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYYEDDDTS 420
K + SYN+ T +R +E NH SASG+ L ES + S + ARD Y DD QD+ Y+DDD S
Sbjct: 356 KTDISYNKDTQRRASESGNHLLSASGNALQESLELSYGKDARDPYHDDHQDNSYDDDDLS 415
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSARTPR 480
S SGTVVIR+P+G +SS LFRD++ SSST TS EDASTSGTVV+RGQHD+SDS RT +
Sbjct: 416 VSGSGTVVIRTPKGYQSSALFRDQNNASSSTSTSFEDASTSGTVVFRGQHDESDSPRTHK 475
Query: 481 SRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDG-EYRRREQIT 539
SRLG+QER+SS+SLEDSA+NLAEA+AA+Q GLRK NARER N G E RRREQ+T
Sbjct: 476 SRLGMQERTSSSSLEDSALNLAEARAALQGGLRKVNARERFVPSNNNRYGLENRRREQLT 535
Query: 540 SSSDSSRDSRDYLDAQRGFSRPRQGSDEEE 569
+SSDSSR SR+Y DA + F R +Q S+ EE
Sbjct: 536 NSSDSSRSSREYFDAPKAFPRSQQASNVEE 565
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549701|ref|XP_003543230.1| PREDICTED: uncharacterized protein LOC100814188 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2100), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/569 (73%), Positives = 482/569 (84%), Gaps = 5/569 (0%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
MAD+AGL EA+GSRFSSLELIG+GSFGDVYKAFD+ELNK VAIKVIDLEESEDEI+DIQK
Sbjct: 1 MADVAGLVEASGSRFSSLELIGQGSFGDVYKAFDRELNKLVAIKVIDLEESEDEIDDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCR PYITEYYGSYL+QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL
Sbjct: 61 EISVLSQCRCPYITEYYGSYLNQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHA++YLH+EGKIHRDIKAANILL+ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAVDYLHSEGKIHRDIKAANILLSENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQN++GYNEKADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLD+HFSR +
Sbjct: 181 EVIQNTDGYNEKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDDHFSRPL 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKKVPAERPSAKELL+ RFIRNARKS +L ERIRERPKY I+E+ +TP NG
Sbjct: 241 KEFVSLCLKKVPAERPSAKELLKDRFIRNARKSSKLSERIRERPKYQIKEDEETPRNGPS 300
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
+GEASGTVKV RD R EE + S QG+T+++AGW+FS+ S GTGT R +PPQ R+K
Sbjct: 301 GMGEASGTVKVARDSRGEENNRPSDQGKTLKSAGWDFSIGGSQGTGTFRNVSRPPQFRDK 360
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYYEDDDTS 420
K E S+NQ T ++ ER G S + S L+ES ++S R R + D+ D++ EDD+ S
Sbjct: 361 KTEVSHNQLTQRKAPERGYQGVSVNRSALNESLESSFGRDLRVPHHDEHLDNHLEDDELS 420
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSARTPR 480
+ SGTVVIRSP+GSRSS FRD+S++SSS+Y S EDAS+SGTVV RGQHD+SDS +TPR
Sbjct: 421 GNGSGTVVIRSPKGSRSSA-FRDQSSLSSSSYASFEDASSSGTVVLRGQHDESDSPQTPR 479
Query: 481 SRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDGEYRRREQITS 540
SRLG+ +R+S+AS+EDSA NLAEAKAAI LRK NARERLA GK+NND + +R+Q S
Sbjct: 480 SRLGLNDRNSNASMEDSAANLAEAKAAI---LRKSNARERLARGKINNDRQESKRDQKAS 536
Query: 541 SSDSSRDSRDYLDAQRGFSRPRQGSDEEE 569
SSDSSR +Y DA + R SD EE
Sbjct: 537 SSDSSRPHGEY-DAHKSMLRSHHASDGEE 564
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543342|ref|XP_003540120.1| PREDICTED: uncharacterized protein LOC100786501 isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 808 bits (2088), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/570 (74%), Positives = 480/570 (84%), Gaps = 2/570 (0%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
MAD+AGL EAAG+RFSSLELIG+GSFGDVYK FDKELNK+VAIKVIDLEESEDEIEDIQK
Sbjct: 1 MADIAGLAEAAGARFSSLELIGQGSFGDVYKGFDKELNKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCRSPYITEYYGS+L+QTKLWIIMEYMAGGSVADL+QSGPPLDEMSIACILRDL
Sbjct: 61 EISVLSQCRSPYITEYYGSFLNQTKLWIIMEYMAGGSVADLLQSGPPLDEMSIACILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHAI+YLHNEGKIHRDIKAANILLT+NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAIDYLHNEGKIHRDIKAANILLTDNGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR M
Sbjct: 181 EVIQNSEGYNEKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRYM 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP+LLERIRERPKY I+E+ TP N R
Sbjct: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPKLLERIRERPKYQIKEDQTTPRNAPR 300
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
+GEAS T+KV +D R +ET Q S QG+T+R++GW+FS+ S GTGT R+ +PPQ R+K
Sbjct: 301 GMGEASDTIKVAKDLRGDETNQPSGQGKTLRSSGWDFSIGGSQGTGTFRSVSRPPQFRDK 360
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYYEDDDTS 420
K E S +Q ++ E G S + S L+E + S + Y D+ D++ E+D+ S
Sbjct: 361 KTEVSDHQLNQRKIPESGYQGESGNKSALNELLETSFGKDLGVPYHDEHPDNHLENDEFS 420
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGT-VVYRGQHDDSDSARTP 479
+ SGTVVIRSP+G + S +FRD+S+ SSS+Y S ED STSGT VV QHDDSDS +TP
Sbjct: 421 GNGSGTVVIRSPKGPQPS-MFRDQSSQSSSSYASFEDVSTSGTVVVLHSQHDDSDSPQTP 479
Query: 480 RSRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDGEYRRREQIT 539
RSRLG+ R+S+ASLEDSA NL EAKAAIQ GLRK N RER ALGK+NND + +R+Q++
Sbjct: 480 RSRLGLNSRNSNASLEDSATNLVEAKAAIQGGLRKVNVRERFALGKLNNDVQDSKRDQMS 539
Query: 540 SSSDSSRDSRDYLDAQRGFSRPRQGSDEEE 569
SSSDSSR SR+Y DA + FSR D+EE
Sbjct: 540 SSSDSSRPSREYFDAPKAFSRSHYSIDDEE 569
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517110|ref|XP_003527233.1| PREDICTED: uncharacterized protein LOC100788857 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2079), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/572 (74%), Positives = 484/572 (84%), Gaps = 7/572 (1%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
MAD+AGL EAAG+RFSSLELIG+GSFGDVYK FD+ELNK+VAIKVIDLEESEDEIEDIQK
Sbjct: 1 MADIAGLAEAAGARFSSLELIGQGSFGDVYKGFDRELNKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCRSPYITEYYGS+L+QTKLWIIMEYMAGGSVADL+QSGPPLDEMSIACILRDL
Sbjct: 61 EISVLSQCRSPYITEYYGSFLNQTKLWIIMEYMAGGSVADLLQSGPPLDEMSIACILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHAI+YLHNEGKIHRDIKAANILLT+NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAIDYLHNEGKIHRDIKAANILLTDNGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYN KADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR M
Sbjct: 181 EVIQNSEGYNVKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRYM 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP+LLERIRERPKY I+E+ TP N R
Sbjct: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPKLLERIRERPKYQIKEDQMTPRNAPR 300
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
+GEAS T+KV +D R +ET Q S QG+++R++GW+FS+ S GTGT R+ +PPQ R+K
Sbjct: 301 GMGEASDTIKVAKDLRGDETNQPSGQGKSLRSSGWDFSIGGSQGTGTFRSVSRPPQFRDK 360
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARD---SYFDDRQDDYYEDD 417
K E S +Q +++ E S + S +ES + T + +D +Y D+ D++ EDD
Sbjct: 361 KIELSNHQLNQRKSPESGYQVGSDNKSAHNESLE---TYFGKDLGVAYHDEHPDNHLEDD 417
Query: 418 DTSASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSAR 477
+ S + SGTVVIRSP+G + S LFRD+S+ SSS+Y S ED STSGTVV R Q++DSDS +
Sbjct: 418 EFSGNGSGTVVIRSPKGPQPS-LFRDQSSRSSSSYASFEDVSTSGTVVLRSQYNDSDSPQ 476
Query: 478 TPRSRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDGEYRRREQ 537
TPRSRLG+ R+S+ASLEDSA NLAEAK AIQ GLRK N RER ALGK+NND + RR Q
Sbjct: 477 TPRSRLGLNSRNSNASLEDSATNLAEAKVAIQGGLRKVNIRERFALGKLNNDVQDSRRGQ 536
Query: 538 ITSSSDSSRDSRDYLDAQRGFSRPRQGSDEEE 569
I+SSSDSSR SR+Y DAQ+GFSR D+EE
Sbjct: 537 ISSSSDSSRPSREYFDAQKGFSRSHYAIDDEE 568
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543344|ref|XP_003540121.1| PREDICTED: uncharacterized protein LOC100786501 isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2071), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/579 (72%), Positives = 480/579 (82%), Gaps = 11/579 (1%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
MAD+AGL EAAG+RFSSLELIG+GSFGDVYK FDKELNK+VAIKVIDLEESEDEIEDIQK
Sbjct: 1 MADIAGLAEAAGARFSSLELIGQGSFGDVYKGFDKELNKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCRSPYITEYYGS+L+QTKLWIIMEYMAGGSVADL+QSGPPLDEMSIACILRDL
Sbjct: 61 EISVLSQCRSPYITEYYGSFLNQTKLWIIMEYMAGGSVADLLQSGPPLDEMSIACILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHAI+YLHNEGKIHRDIKAANILLT+NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAIDYLHNEGKIHRDIKAANILLTDNGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR M
Sbjct: 181 EVIQNSEGYNEKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRYM 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP+LLERIRERPKY I+E+ TP N R
Sbjct: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPKLLERIRERPKYQIKEDQTTPRNAPR 300
Query: 301 AVGEASGTVKVVRDKRSEET---------VQVSSQGQTVRNAGWNFSLSESHGTGTIRTA 351
+GEAS T+KV +D R +ET + S QG+T+R++GW+FS+ S GTGT R+
Sbjct: 301 GMGEASDTIKVAKDLRGDETNHEFSDGQFLNCSGQGKTLRSSGWDFSIGGSQGTGTFRSV 360
Query: 352 VKPPQVREKKPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQD 411
+PPQ R+KK E S +Q ++ E G S + S L+E + S + Y D+ D
Sbjct: 361 SRPPQFRDKKTEVSDHQLNQRKIPESGYQGESGNKSALNELLETSFGKDLGVPYHDEHPD 420
Query: 412 DYYEDDDTSASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGT-VVYRGQH 470
++ E+D+ S + SGTVVIRSP+G + S +FRD+S+ SSS+Y S ED STSGT VV QH
Sbjct: 421 NHLENDEFSGNGSGTVVIRSPKGPQPS-MFRDQSSQSSSSYASFEDVSTSGTVVVLHSQH 479
Query: 471 DDSDSARTPRSRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDG 530
DDSDS +TPRSRLG+ R+S+ASLEDSA NL EAKAAIQ GLRK N RER ALGK+NND
Sbjct: 480 DDSDSPQTPRSRLGLNSRNSNASLEDSATNLVEAKAAIQGGLRKVNVRERFALGKLNNDV 539
Query: 531 EYRRREQITSSSDSSRDSRDYLDAQRGFSRPRQGSDEEE 569
+ +R+Q++SSSDSSR SR+Y DA + FSR D+EE
Sbjct: 540 QDSKRDQMSSSSDSSRPSREYFDAPKAFSRSHYSIDDEE 578
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15232528|ref|NP_188140.1| putative protein kinase [Arabidopsis thaliana] gi|9294249|dbj|BAB02151.1| MAP kinase [Arabidopsis thaliana] gi|22316560|emb|CAD44272.1| map 4 kinase alpha2 [Arabidopsis thaliana] gi|24030319|gb|AAN41328.1| putative MAP kinase [Arabidopsis thaliana] gi|332642112|gb|AEE75633.1| putative protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2069), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/570 (71%), Positives = 473/570 (82%), Gaps = 5/570 (0%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
M D+AGLQEAAG+RFS +ELIGRGSFGDVYKAFDK+LNK+VAIKVIDLEESEDEIEDIQK
Sbjct: 1 MDDVAGLQEAAGARFSQIELIGRGSFGDVYKAFDKDLNKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCR PYITEYYGSYLHQTKLWIIMEYMAGGSVADL+QS PLDE SIACI RDL
Sbjct: 61 EISVLSQCRCPYITEYYGSYLHQTKLWIIMEYMAGGSVADLLQSNNPLDETSIACITRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHA+EYLHNEGKIHRDIKAANILL+ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAVEYLHNEGKIHRDIKAANILLSENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE PPQLDEHFSR +
Sbjct: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRETPPQLDEHFSRQV 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKK PAERPSAKEL++HRFI+NARKSP+LLERIRERPKY ++E+ +TP NG +
Sbjct: 241 KEFVSLCLKKAPAERPSAKELIKHRFIKNARKSPKLLERIRERPKYQVKEDEETPRNGAK 300
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
A E+SGTV++ RD+RS+ S QG TV+NAGW+F++ S GT+R A+KPPQ RE+
Sbjct: 301 APVESSGTVRIARDERSQGAPGYSFQGNTVKNAGWDFTVGGSQSIGTVR-ALKPPQARER 359
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYYEDDDTS 420
+ E S N+ + + T N SA+GST+ E+ + R R + +D +D ++E+DD+S
Sbjct: 360 RQEVSPNRISQRTTRPSGNQWSSATGSTISEASEGGFVR--RHPFQNDHEDGFHEEDDSS 417
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSARTPR 480
S SGTVVIR+PR S+SS +FR+ S+ SS Y + +DAS SGTVV RGQ+DDS S RTP+
Sbjct: 418 LSGSGTVVIRTPRSSQSSSVFREPSSGSSGRYAAFDDASASGTVVVRGQYDDSGSPRTPK 477
Query: 481 SRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDGEY-RRREQIT 539
SRLGIQER+SSAS EDS NLAEAKAA+ +G R+G ARERL +G NNDG+ RRREQ+
Sbjct: 478 SRLGIQERTSSAS-EDSNANLAEAKAALDAGFRRGKARERLGMGNNNNDGKVNRRREQMA 536
Query: 540 SSSDSSRDSRDYLDAQRGFSRPRQGSDEEE 569
SD SR+S D Q+ R Q SDEE+
Sbjct: 537 DDSDYSRNSGDKSSKQKVVPRSEQVSDEED 566
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|3819699|emb|CAA08758.1| BnMAP4K alpha2 [Brassica napus] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2041), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/571 (72%), Positives = 474/571 (83%), Gaps = 20/571 (3%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
M D+AGLQEAAG+RFS +ELIGRGSFGDVYKAFDKELNK+VAIKVIDLEESEDEIEDIQK
Sbjct: 1 MDDVAGLQEAAGARFSQVELIGRGSFGDVYKAFDKELNKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCR PYITEYYGSYLHQTKLWIIMEYMAGGSVADL+QSG PLDE SIACI RDL
Sbjct: 61 EISVLSQCRCPYITEYYGSYLHQTKLWIIMEYMAGGSVADLLQSGHPLDETSIACITRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHA+EYLH+EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAVEYLHSEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR +
Sbjct: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRPL 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKKVPAERPSAKEL++HRFI+NA+KSP+LLERIRERPKY ++E+ +TP NG +
Sbjct: 241 KEFVSLCLKKVPAERPSAKELIKHRFIKNAKKSPKLLERIRERPKYQVKEDEETPRNGPK 300
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
A E+SGTV+VVRD+RS+ T S QG+TV+NAGW+FS+ S G GTIR A+KPP RE+
Sbjct: 301 APFESSGTVRVVRDERSQGTPGSSFQGKTVKNAGWDFSIGASQGIGTIR-ALKPPHARER 359
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYYEDDDTS 420
+ E Q T++R+ ASGS L SP + T +D +D +++++D+S
Sbjct: 360 RQEVPSTQ-----TSQRATR---ASGSQL--SPTSGIT-------VNDYEDGFHDEEDSS 402
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSARTPR 480
S SGTVVIR+P+ S+SS +FR++ + SSS Y S +DAS SGTVV RGQHDD S RTP+
Sbjct: 403 LSGSGTVVIRTPKRSQSSSIFREQISASSSGYASLDDASASGTVVVRGQHDDYASPRTPK 462
Query: 481 SRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDGEY-RRREQIT 539
SRLG Q+R+SSAS EDS NLAEAKAA+ +G R+GNARERL + N DG RRREQ+T
Sbjct: 463 SRLGNQDRTSSAS-EDSLANLAEAKAALDAGFRRGNARERLGMRNNNKDGNVNRRREQMT 521
Query: 540 SSSDSSRDSRDYLDAQRGFSRPRQGSDEEEK 570
SD SR+S D Q+ + +Q SDEEE+
Sbjct: 522 EDSDYSRNSGDKSGKQKALPKSQQVSDEEEE 552
|
Source: Brassica napus Species: Brassica napus Genus: Brassica Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297834386|ref|XP_002885075.1| hypothetical protein ARALYDRAFT_897796 [Arabidopsis lyrata subsp. lyrata] gi|297330915|gb|EFH61334.1| hypothetical protein ARALYDRAFT_897796 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/572 (71%), Positives = 476/572 (83%), Gaps = 7/572 (1%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
M D+AGL+EAAG+RFS +ELIGRGSFGDVYKAFDK+LNK+VAIKVIDLEESEDEIEDIQK
Sbjct: 1 MDDVAGLREAAGARFSHIELIGRGSFGDVYKAFDKDLNKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCR PYITEYYGSYLHQTKLWIIMEYMAGGSVADL+QS PLDE SIACI RDL
Sbjct: 61 EISVLSQCRCPYITEYYGSYLHQTKLWIIMEYMAGGSVADLLQSSNPLDETSIACITRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
L A+EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LLAVEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR +
Sbjct: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRPV 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKKVPAERPSAKEL++HRFI+NARKSP+LLERIRERPKY ++E+ +TP NG +
Sbjct: 241 KEFVSLCLKKVPAERPSAKELIKHRFIKNARKSPKLLERIRERPKYQVKEDEETPRNGPK 300
Query: 301 AVGEASGTVKVVRDKRSEET--VQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVR 358
A ++SGTV+V +D+RS+ T S QG TV+NAGW+FS+ S G +R A+KPPQ R
Sbjct: 301 APVDSSGTVRVAKDERSQGTPGSSYSFQGNTVKNAGWDFSVEGSQSIGAVR-ALKPPQAR 359
Query: 359 EKKPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYYEDDD 418
E++ E S NQ + + T + N S++GST+ E+ + R R + +D +D ++E+DD
Sbjct: 360 ERRHEVSSNQISQQTTRDSGNQWSSSTGSTISEASEGGFVR--RHPFQNDHEDGFHEEDD 417
Query: 419 TSASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSART 478
+S S SGTVVIR+ R S+SS FR++S+VSS Y +DAS SGTV+ RGQ+DDS S RT
Sbjct: 418 SSLSGSGTVVIRASRSSQSSSKFREQSSVSSGRYAPFDDASASGTVIVRGQYDDSGSPRT 477
Query: 479 PRSRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDGEY-RRREQ 537
P+SRLGIQER+SSAS EDS NLAEAKAA+ +G RKGNARERL +GK NNDG+ RRR+Q
Sbjct: 478 PKSRLGIQERTSSAS-EDSNANLAEAKAALDAGFRKGNARERLGMGKNNNDGKVNRRRDQ 536
Query: 538 ITSSSDSSRDSRDYLDAQRGFSRPRQGSDEEE 569
+ SD SR+S D Q+ R Q SDEE+
Sbjct: 537 MADDSDYSRNSGDKSSKQKAVPRSEQVSDEED 568
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 577 | ||||||
| TAIR|locus:2087130 | 690 | AT3G15220 [Arabidopsis thalian | 0.987 | 0.826 | 0.664 | 8.1e-195 | |
| MGI|MGI:2385007 | 431 | Stk24 "serine/threonine kinase | 0.504 | 0.675 | 0.558 | 2.7e-84 | |
| RGD|1561742 | 431 | Stk24 "serine/threonine kinase | 0.504 | 0.675 | 0.558 | 9.1e-84 | |
| UNIPROTKB|H9KVF3 | 419 | Stk24 "Serine/threonine-protei | 0.504 | 0.694 | 0.558 | 9.1e-84 | |
| WB|WBGene00001526 | 653 | gck-1 [Caenorhabditis elegans | 0.473 | 0.418 | 0.554 | 9.3e-84 | |
| UNIPROTKB|Q9Y6E0 | 443 | STK24 "Serine/threonine-protei | 0.504 | 0.656 | 0.552 | 2.4e-83 | |
| UNIPROTKB|F1P0K4 | 419 | STK24 "Uncharacterized protein | 0.504 | 0.694 | 0.555 | 5e-83 | |
| DICTYBASE|DDB_G0286359 | 478 | svkA "severin kinase" [Dictyos | 0.590 | 0.713 | 0.490 | 6.4e-83 | |
| UNIPROTKB|F1N5S6 | 423 | STK24 "Uncharacterized protein | 0.474 | 0.647 | 0.577 | 6.4e-83 | |
| FB|FBgn0086736 | 642 | GckIII "Germinal centre kinase | 0.481 | 0.433 | 0.546 | 1.1e-82 |
| TAIR|locus:2087130 AT3G15220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1887 (669.3 bits), Expect = 8.1e-195, P = 8.1e-195
Identities = 382/575 (66%), Positives = 439/575 (76%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXX 60
M D+AGLQEAAG+RFS +ELIGRGSFGDVYKAFDK+LNK+VAIKV
Sbjct: 1 MDDVAGLQEAAGARFSQIELIGRGSFGDVYKAFDKDLNKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 XXSVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
SVLSQCR PYITEYYGSYLHQTKLWIIMEYMAGGSVADL+QS PLDE SIACI RDL
Sbjct: 61 EISVLSQCRCPYITEYYGSYLHQTKLWIIMEYMAGGSVADLLQSNNPLDETSIACITRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHA+EYLHNEGKIHRDIKAANILL+ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAVEYLHNEGKIHRDIKAANILLSENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE PPQLDEHFSR +
Sbjct: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRETPPQLDEHFSRQV 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKK PAERPSAKEL++HRFI+NARKSP+LLERIRERPKY ++E+ +TP NG +
Sbjct: 241 KEFVSLCLKKAPAERPSAKELIKHRFIKNARKSPKLLERIRERPKYQVKEDEETPRNGAK 300
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
A E+SGTV++ RD+RS+ S QG TV+NAGW+F++ S GT+R A+KPPQ RE+
Sbjct: 301 APVESSGTVRIARDERSQGAPGYSFQGNTVKNAGWDFTVGGSQSIGTVR-ALKPPQARER 359
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSXXXXXXXXXXXXXXTS 420
+ E S N+ + + T N SA+GST+ E+ + R R +S
Sbjct: 360 RQEVSPNRISQRTTRPSGNQWSSATGSTISEASEGGFVR--RHPFQNDHEDGFHEEDDSS 417
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSARTPR 480
S SGTVVIR+PR S+SS +FR+ S+ SS Y + +DAS SGTVV RGQ+DDS S RTP+
Sbjct: 418 LSGSGTVVIRTPRSSQSSSVFREPSSGSSGRYAAFDDASASGTVVVRGQYDDSGSPRTPK 477
Query: 481 SRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDGEY-RRREQIT 539
SRLGIQER+SSAS EDS NLAEAKAA+ +G R+G ARERL +G NNDG+ RRREQ+
Sbjct: 478 SRLGIQERTSSAS-EDSNANLAEAKAALDAGFRRGKARERLGMGNNNNDGKVNRRREQMA 536
Query: 540 XXXXXXXXXXXYLDAQRGFSRPRQGSDEEEKKATE 574
Q+ R Q SDEE+ E
Sbjct: 537 DDSDYSRNSGDKSSKQKVVPRSEQVSDEEDDSIWE 571
|
|
| MGI|MGI:2385007 Stk24 "serine/threonine kinase 24" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 844 (302.2 bits), Expect = 2.7e-84, P = 2.7e-84
Identities = 166/297 (55%), Positives = 216/297 (72%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+ +VLSQC SPY+T
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ GP LDE+ IA ILR++L ++YLH+E KIH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDEIQIATILREILKGLDYLHSEKKIH 142
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 201
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP ++LHPM+VLF+IP+ NPP L+ ++S+ +KEFV CL K P+
Sbjct: 202 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 261
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERIRERPKYPIQ---EEPDTPINGVRAVGEASG 307
RP+AKELL+H+FI RNA+K+ L E I ++ + E+ + + V G+ASG
Sbjct: 262 RPTAKELLKHKFIIRNAKKTSYLTELIDRYKRWKAEQSHEDSSSEDSDVETDGQASG 318
|
|
| RGD|1561742 Stk24 "serine/threonine kinase 24" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 839 (300.4 bits), Expect = 9.1e-84, P = 9.1e-84
Identities = 166/297 (55%), Positives = 214/297 (72%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+ +VLSQC SPY+T
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ GP LDE+ IA ILR++L ++YLH+E KIH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDEIQIATILREILKGLDYLHSEKKIH 142
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 201
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP ++LHPM+VLF+IP+ NPP L+ +SR +KEFV CL K P+
Sbjct: 202 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGSYSRPLKEFVEACLNKEPSF 261
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERIRERPKYPIQ---EEPDTPINGVRAVGEASG 307
RP+AKELL+H+FI RNA+K+ L E I ++ + E+ + + V +ASG
Sbjct: 262 RPTAKELLKHKFIIRNAKKTSYLTELIDRYKRWKAEQSHEDSSSEDSDVETDSQASG 318
|
|
| UNIPROTKB|H9KVF3 Stk24 "Serine/threonine-protein kinase 24" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 839 (300.4 bits), Expect = 9.1e-84, P = 9.1e-84
Identities = 166/297 (55%), Positives = 214/297 (72%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+ +VLSQC SPY+T
Sbjct: 12 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 71
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ GP LDE+ IA ILR++L ++YLH+E KIH
Sbjct: 72 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDEIQIATILREILKGLDYLHSEKKIH 130
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 131 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 189
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP ++LHPM+VLF+IP+ NPP L+ +SR +KEFV CL K P+
Sbjct: 190 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGSYSRPLKEFVEACLNKEPSF 249
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERIRERPKYPIQ---EEPDTPINGVRAVGEASG 307
RP+AKELL+H+FI RNA+K+ L E I ++ + E+ + + V +ASG
Sbjct: 250 RPTAKELLKHKFIIRNAKKTSYLTELIDRYKRWKAEQSHEDSSSEDSDVETDSQASG 306
|
|
| WB|WBGene00001526 gck-1 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 780 (279.6 bits), Expect = 9.3e-84, Sum P(2) = 9.3e-84
Identities = 153/276 (55%), Positives = 196/276 (71%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ E IGRGSFG+VYK D + VAIK+ VLSQC S Y+T
Sbjct: 34 FTKQERIGRGSFGEVYKGIDNRTGRVVAIKIIDLEQAEDEIEDIQQEIQVLSQCDSQYVT 93
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+Y+GS+L +KLWIIMEY+ GGS DL +SG LDE IA ILR++L +EYLH+E KIH
Sbjct: 94 KYFGSFLKGSKLWIIMEYLGGGSALDLTKSGK-LDESHIAVILREILKGLEYLHSERKIH 152
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+L++E+GDVKVADFGV+ QLT T+ +R TFVG+PFWMAPE+I+ S Y+ KAD
Sbjct: 153 RDIKAANVLVSEHGDVKVADFGVAGQLTETVKKRITFVGSPFWMAPELIKQSS-YDYKAD 211
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD-EHFSRLMKEFVSLCLKKVPA 253
IWSLGIT IE+A GEPP +DLHPMRVLF+IP+ PP L +S+ KEFV +CL K P
Sbjct: 212 IWSLGITAIELANGEPPHSDLHPMRVLFLIPKNPPPVLQGSQWSKPFKEFVEMCLNKDPE 271
Query: 254 ERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQ 289
RPSA LL+H+FI+ A+K+ L++ I +Y ++
Sbjct: 272 NRPSASTLLKHQFIKRAKKNSILVDLIERAAEYRLR 307
|
|
| UNIPROTKB|Q9Y6E0 STK24 "Serine/threonine-protein kinase 24" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 835 (299.0 bits), Expect = 2.4e-83, P = 2.4e-83
Identities = 164/297 (55%), Positives = 214/297 (72%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+ +VLSQC SPY+T
Sbjct: 36 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 95
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ GP LDE IA ILR++L ++YLH+E KIH
Sbjct: 96 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKIH 154
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 155 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 213
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+A+GEPP ++LHPM+VLF+IP+ NPP L+ ++S+ +KEFV CL K P+
Sbjct: 214 IWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 273
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERIRERPKYPIQEEPD---TPINGVRAVGEASG 307
RP+AKELL+H+FI RNA+K+ L E I ++ ++ D + + G+ASG
Sbjct: 274 RPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDSSSEDSDAETDGQASG 330
|
|
| UNIPROTKB|F1P0K4 STK24 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 832 (297.9 bits), Expect = 5.0e-83, P = 5.0e-83
Identities = 165/297 (55%), Positives = 212/297 (71%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+ +VLSQC SPY+T
Sbjct: 12 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 71
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ G LDE IA ILR++L ++YLH+E KIH
Sbjct: 72 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGS-LDETQIATILREILKGLDYLHSEKKIH 130
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 131 RDIKAANVLLSEQGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 189
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP ++LHPM+VLF+IP+ NPP L+ +FS+ +KEFV CL K P+
Sbjct: 190 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNFSKSLKEFVEACLNKDPSF 249
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERIRERPKYPIQEEPD---TPINGVRAVGEASG 307
RP+AKELL+H+FI RNA+K+ L E I ++ ++ D + + G+ASG
Sbjct: 250 RPTAKELLKHKFILRNAKKTSYLTELIDRHKRWKSEQSHDDSSSDDSDTEPDGQASG 306
|
|
| DICTYBASE|DDB_G0286359 svkA "severin kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 831 (297.6 bits), Expect = 6.4e-83, P = 6.4e-83
Identities = 176/359 (49%), Positives = 241/359 (67%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYITEYYG 78
E IG+GSFG+V+K +K+ N+ +AIK +VLSQC SP++T+Y+G
Sbjct: 16 EKIGKGSFGEVFKGINKKTNETIAIKTIDLEDAEDEIEDIQQEINVLSQCESPFVTKYFG 75
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
S+L +KLWIIMEY+AGGSV DL++ GP DE IA ILR+LL +EYLH+EGKIHRDIK
Sbjct: 76 SFLKGSKLWIIMEYLAGGSVLDLMKPGP-FDEGYIAIILRELLKGLEYLHSEGKIHRDIK 134
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSL 198
AAN+LL+ +GDVK+ADFGVS QLT +++R TFVGTPFWMAPEVI+ + GY+ KADIWS+
Sbjct: 135 AANVLLSASGDVKLADFGVSGQLTDQMTKRNTFVGTPFWMAPEVIKQT-GYDSKADIWSM 193
Query: 199 GITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258
GIT +EMAKGEPP ADLHPMR LF+IP++ PP L+ +FS+ KEF +LCL K P +RP+A
Sbjct: 194 GITALEMAKGEPPRADLHPMRALFLIPKDPPPTLEGNFSKGFKEFCALCLNKDPNQRPTA 253
Query: 259 KELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGTVKVVRDKRSE 318
K+LL+H+FI+ A+K+ L + I R K+ +Q +NG A E + RD +S
Sbjct: 254 KDLLKHKFIKAAKKTSSLTDLIERRQKW-LQ------LNGNNADDENDD---LDRDAKSN 303
Query: 319 ETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREKKPEFSYNQYTPKRTAER 377
E + T++ ++ E T T V P ++E++ + Q TP T ++
Sbjct: 304 EE-DFGWEFPTIKQKS-PVAVQEQQQTPQKPTVVSTP-IKEQQQQ---QQPTPVTTPQQ 356
|
|
| UNIPROTKB|F1N5S6 STK24 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 831 (297.6 bits), Expect = 6.4e-83, P = 6.4e-83
Identities = 160/277 (57%), Positives = 206/277 (74%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+ +VLSQC SPY+T
Sbjct: 14 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 73
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ GP LDE IA ILR++L ++YLH+E KIH
Sbjct: 74 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKIH 132
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 133 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 191
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP ++LHPM+VLF+IP+ NPP L+ ++S+ +KEFV CL K P+
Sbjct: 192 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 251
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERIRERPKYPIQE 290
RP+AKELL+H+FI RNA+K+ L E I ++ ++
Sbjct: 252 RPTAKELLKHKFIIRNAKKTSYLTELIDRYKRWKAEQ 288
|
|
| FB|FBgn0086736 GckIII "Germinal centre kinase III" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 1.1e-82, Sum P(2) = 1.1e-82
Identities = 154/282 (54%), Positives = 203/282 (71%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ E IG+GSFG+V+K D + VAIK+ VLSQC SPY+T
Sbjct: 13 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIDDIQQEIMVLSQCDSPYVT 72
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGS+L TKLWIIMEY+ GGS DL+++G +EM I ILR++L ++YLH+E K+H
Sbjct: 73 KYYGSFLKGTKLWIIMEYLGGGSALDLMKAGS-FEEMHIGIILREVLKGLDYLHSERKLH 131
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T S+R TFVGTPFWMAPEVI+ S+ Y+ KAD
Sbjct: 132 RDIKAANVLLSEQGDVKLADFGVAGQLTNTTSKRNTFVGTPFWMAPEVIKQSQ-YDAKAD 190
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP ++LHPMRVLF+IP+ NPPQL +++ K+FV CL K P
Sbjct: 191 IWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGSYTKSFKDFVEACLNKDPEN 250
Query: 255 RPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQ--EEPDT 294
RP+AKELL++ FI+ A+K+ L++ I K+ + +E +T
Sbjct: 251 RPTAKELLKYPFIKKAKKNAYLIDLIDRFKKWKVSKGDESET 292
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00027725001 | SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (706 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | GSVIVG00031451001 | SubName- Full=Chromosome chr11 scaffold_56, whole genome shotgun sequence; (387 aa) | • | 0.483 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 577 | |||
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 0.0 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-130 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-129 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-126 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-122 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-121 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-120 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-115 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-110 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-108 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-108 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-105 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-98 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-98 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-98 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-90 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-87 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-87 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-83 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-83 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-82 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-81 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-80 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-80 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-77 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-76 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-74 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-73 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-72 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-72 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-71 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-70 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-70 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-68 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-66 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-65 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-65 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-64 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-64 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-63 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-61 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-60 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-58 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-58 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-57 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-56 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-56 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-56 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-55 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-55 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-54 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-52 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-51 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-50 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-50 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-49 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-49 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-49 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-49 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-49 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-49 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-49 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-49 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-48 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-48 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-48 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-47 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-47 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-45 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-44 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-44 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-43 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-42 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-42 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-42 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-41 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-39 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-39 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-39 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-39 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-39 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-38 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-38 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-38 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-37 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-37 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-36 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-35 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-35 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-35 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-35 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-34 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-34 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-34 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-34 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-33 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-33 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-33 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-32 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-31 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-31 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-31 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-30 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-30 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-30 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-30 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-30 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-29 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-29 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-29 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-29 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-29 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-29 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-29 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-29 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-29 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-29 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-28 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-28 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-28 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-28 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-28 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-27 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-27 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-27 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-27 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-27 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-27 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-27 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-27 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-26 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-26 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-26 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-26 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-26 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-26 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-25 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-25 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-25 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-25 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-25 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-24 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-24 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-24 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-24 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-24 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-23 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-23 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-23 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-23 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-23 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-23 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-23 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-22 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-22 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-22 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-21 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-21 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-21 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-21 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-21 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-21 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-21 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-21 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-20 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-20 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-20 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-20 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-20 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-19 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-19 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-19 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-18 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-18 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-18 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-18 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-17 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-17 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-17 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-16 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-15 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-14 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-12 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-10 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-08 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 526 bits (1356), Expect = 0.0
Identities = 190/275 (69%), Positives = 224/275 (81%), Gaps = 3/275 (1%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
F+ LE IG+GSFG+VYKA DK N+ VAIKVIDLEE+EDEIEDIQ+EI LSQCRSPY
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
IT+YYGS+L +KLWIIMEY GGS DL++ G LDE IA ILR++L +EYLH EGK
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGK 119
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRDIKAANILL+E GDVK+ADFGVS QLT T+S+R TFVGTPFWMAPEVI+ S GY+EK
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS-GYDEK 178
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH-FSRLMKEFVSLCLKKV 251
ADIWSLGIT IE+AKGEPPL+DLHPMRVLF+IP+ NPP L+ + FS+ K+FVSLCL K
Sbjct: 179 ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKD 238
Query: 252 PAERPSAKELLRHRFIRNARKSPRLLERIRERPKY 286
P ERPSAKELL+H+FI+ A+K+ L I K+
Sbjct: 239 PKERPSAKELLKHKFIKKAKKTSYLTLLIERIKKW 273
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 381 bits (982), Expect = e-130
Identities = 146/256 (57%), Positives = 180/256 (70%), Gaps = 7/256 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F LE +G GS+G VYKA KE + VAIKV+ E+++++I KEIS+L QC SPYI
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIV 61
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+YYGSY T LWI+MEY GSV+D+++ L E IA IL L +EYLH+ KI
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIKA NILL E G K+ADFGVS QLT T+++R T +GTPFWMAPEVIQ GYN KA
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNNKA 180
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGIT IEMA+G+PP +D+HPMR +F+IP + PP L E +S +FV CL K
Sbjct: 181 DIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKD 240
Query: 252 PAERPSAKELLRHRFI 267
P ERPSA +LL+H FI
Sbjct: 241 PEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 377 bits (970), Expect = e-129
Identities = 137/255 (53%), Positives = 182/255 (71%), Gaps = 6/255 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F LE IG+G FG+VYKA K K+VAIKVI LE E + E I EI +L +C+ P I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK-EKIINEIQILKKCKHPNIV 60
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+YYGSYL + +LWI+ME+ +GGS+ DL++S L E IA + ++LL +EYLH+ G I
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGII 120
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIKAANILLT +G+VK+ DFG+SAQL+ T + R T VGTP+WMAPEVI + Y+ KA
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVING-KPYDYKA 178
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGIT IE+A+G+PP ++L PM+ LF I PP L E +S K+F+ CL+K
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKN 238
Query: 252 PAERPSAKELLRHRF 266
P +RP+A++LL+H F
Sbjct: 239 PEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 369 bits (950), Expect = e-126
Identities = 142/261 (54%), Positives = 185/261 (70%), Gaps = 8/261 (3%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ ++ IG G++GDVYKA D + VAIKVI LE D+ E IQ+EIS+L +CR P
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPN 61
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEG 131
I Y+GSYL + KLWI+MEY GGS+ D+ Q PL E+ IA + R+ L + YLH G
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSE--GY 189
KIHRDIK ANILLTE+GDVK+ADFGVSAQLT TI++RK+F+GTP+WMAPEV GY
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY 181
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLD--EHFSRLMKEFVS 245
+ K DIW+LGIT IE+A+ +PP+ DLHPMR LF+I + N PP+L E +S + +F+
Sbjct: 182 DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIK 241
Query: 246 LCLKKVPAERPSAKELLRHRF 266
CL K P +RP+A +LL+H F
Sbjct: 242 KCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 360 bits (925), Expect = e-122
Identities = 173/267 (64%), Positives = 215/267 (80%), Gaps = 3/267 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D + VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPY+T
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL+++G P DE IA +L+++L ++YLH+E KIH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEKKIH 124
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVIQ S Y+ KAD
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKAD 183
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +D+HPMRVLF+IP+ NPP L FS+ KEF+ CL K P+
Sbjct: 184 IWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSF 243
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERI 280
RP+AKELL+H+FI +NA+K+ L E I
Sbjct: 244 RPTAKELLKHKFIVKNAKKTSYLTELI 270
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 359 bits (922), Expect = e-121
Identities = 174/267 (65%), Positives = 218/267 (81%), Gaps = 3/267 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPY+T
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ G PLDE IA ILR++L ++YLH+E KIH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIH 124
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 183
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP ++LHPM+VLF+IP+ NPP L+ ++S+ +KEFV CL K P+
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 243
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERI 280
RP+AKELL+H+FI R A+K+ L E I
Sbjct: 244 RPTAKELLKHKFIVRFAKKTSYLTELI 270
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 356 bits (914), Expect = e-120
Identities = 174/271 (64%), Positives = 211/271 (77%), Gaps = 2/271 (0%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+VYK D + VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPYIT
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
YYGSYL TKLWIIMEY+ GGS DL++ G PL+E IA ILR++L ++YLH+E KIH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSERKIH 124
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKAD 183
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +DLHPMRVLF+IP+ +PP L+ +S+ KEFV CL K P
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRF 243
Query: 255 RPSAKELLRHRFIRNARKSPRLLERIRERPK 285
RP+AKELL+H+FI K L + +R K
Sbjct: 244 RPTAKELLKHKFITRYTKKTSFLTELIDRYK 274
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 342 bits (880), Expect = e-115
Identities = 136/267 (50%), Positives = 193/267 (72%), Gaps = 5/267 (1%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR--- 69
S + LELIGRG++G VY+ + VA+K+I+L+ +D++ DIQ+E+++LSQ R
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ 60
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
P IT+YYGSYL +LWIIMEY GGSV L+++GP + E I+ I+R++L A++Y+H
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVLVALKYIHK 119
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
G IHRDIKAANIL+T G+VK+ DFGV+A L + S+R TFVGTP+WMAPEVI + Y
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-DEHFSRLMKEFVSLCL 248
+ KADIWSLGIT+ EMA G PP +D+ R + +IP+ PP+L D +S+L++EFV+ CL
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACL 239
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPR 275
+ P ER SA+ELL+ ++I+ K+P
Sbjct: 240 DEEPKERLSAEELLKSKWIKAHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 331 bits (850), Expect = e-110
Identities = 124/262 (47%), Positives = 181/262 (69%), Gaps = 12/262 (4%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
+E+IG G+ VY A N+ VAIK IDLE+ + +++++KE+ +SQC P + +YY
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPP---LDEMSIACILRDLLHAIEYLHNEGKIH 134
S++ +LW++M Y++GGS+ D+++S P LDE IA +L+++L +EYLH+ G+IH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIH 125
Query: 135 RDIKAANILLTENGDVKVADFGVSAQL----TRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
RDIKA NILL E+G VK+ADFGVSA L RT RKTFVGTP WMAPEV++ GY+
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH-----FSRLMKEFVS 245
KADIWS GIT IE+A G P + PM+VL + + +PP L+ +S+ ++ +S
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMIS 245
Query: 246 LCLKKVPAERPSAKELLRHRFI 267
LCL+K P++RP+A+ELL+H+F
Sbjct: 246 LCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 326 bits (838), Expect = e-108
Identities = 126/265 (47%), Positives = 177/265 (66%), Gaps = 6/265 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ +LE IG G+ G+VYKA D+ K+VAIK + L + E I EI ++ C+ P I
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIINEILIMKDCKHPNIV 78
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+YY SYL +LW++MEYM GGS+ D+I Q+ ++E IA + R++L +EYLH++ I
Sbjct: 79 DYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI 138
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIK+ NILL+++G VK+ADFG +AQLT+ S+R + VGTP+WMAPEVI+ + Y K
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD-YGPKV 197
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGI IEMA+GEPP P+R LF+I + P L E +S K+F++ CL K
Sbjct: 198 DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKD 257
Query: 252 PAERPSAKELLRHRFIRNARKSPRL 276
P +RPSA+ELL+H F++ A
Sbjct: 258 PEKRPSAEELLQHPFLKKACPKEEF 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 324 bits (832), Expect = e-108
Identities = 130/274 (47%), Positives = 177/274 (64%), Gaps = 19/274 (6%)
Query: 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CR 69
F +E+IG G++G VYKA K+ + VAIK++D+ E DE E+I++E ++L +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSN 61
Query: 70 SPYITEYYGSYL------HQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRD 119
P I +YG+++ + +LW++ME GGSV DL++ G L E IA ILR+
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 120 LLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMA 179
L + YLH IHRDIK NILLT+N +VK+ DFGVSAQL T+ RR TF+GTP+WMA
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181
Query: 180 PEVI----QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--D 233
PEVI Q Y+ ++D+WSLGIT IE+A G+PPL D+HPMR LF IPR PP L
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241
Query: 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
E++S+ +F+S CL K +RP +ELL H FI
Sbjct: 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 317 bits (815), Expect = e-105
Identities = 102/256 (39%), Positives = 148/256 (57%), Gaps = 5/256 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ LE +G GSFG VY A DK+ K VAIKVI ++ + + E I +EI +L + + P I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
Y + + KL+++MEY GG + DL++ L E LR +L A+EYLH++G +H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K NILL E+G VK+ADFG++ QL + TFVGTP +MAPEV+ +GY + D
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEVLL-GKGYGKAVD 178
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH---FSRLMKEFVSLCLKKV 251
IWSLG+ + E+ G+PP + LF + P S K+ + L K
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKD 238
Query: 252 PAERPSAKELLRHRFI 267
P +R +A+E L+H F
Sbjct: 239 PEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 299 bits (769), Expect = 1e-98
Identities = 115/250 (46%), Positives = 159/250 (63%), Gaps = 2/250 (0%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
+LIGRG+FG VYK + E VAIK I LE+ E+ ++ I +EI +L + P I +Y
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
GS L+II+EY GS+ +I+ P E +A + +L + YLH +G IHRDI
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDI 125
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWS 197
KAANIL T++G VK+ADFGV+ +L + VGTP+WMAPEVI+ S G + +DIWS
Sbjct: 126 KAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS-GASTASDIWS 184
Query: 198 LGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPS 257
LG TVIE+ G PP DL+PM LF I +++ P L E S +K+F+ C +K P RP+
Sbjct: 185 LGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPT 244
Query: 258 AKELLRHRFI 267
AK+LL+H +I
Sbjct: 245 AKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 299 bits (768), Expect = 2e-98
Identities = 117/256 (45%), Positives = 164/256 (64%), Gaps = 8/256 (3%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
EL+GRGSFG VY A DK+ + +A+K ++L SE+E+E +++EI +LS + P I YY
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 78 GSYLHQTK--LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
GS + K L I +EY++GGS++ L++ L E I R +L + YLH+ G +HR
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 136 DIKAANILLTENGDVKVADFGVSAQL--TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
DIK ANIL+ +G VK+ADFG + +L T + GTP+WMAPEVI E Y A
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI-RGEEYGRAA 184
Query: 194 DIWSLGITVIEMAKGEPPLADLH-PMRVLF-IIPRENPPQLDEHFSRLMKEFVSLCLKKV 251
DIWSLG TVIEMA G+PP ++L PM L+ I PP++ EH S K+F+ CL++
Sbjct: 185 DIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRD 244
Query: 252 PAERPSAKELLRHRFI 267
P +RP+A ELL+H F+
Sbjct: 245 PKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 299 bits (768), Expect = 3e-98
Identities = 121/269 (44%), Positives = 175/269 (65%), Gaps = 8/269 (2%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G+FG VYKA KE A K+I +E SE+E+ED EI +LS+C+ P I Y +Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 81 LHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKA 139
++ KLWI++E+ GG++ ++ + L E I + R +L A+ +LH+ IHRD+KA
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKA 131
Query: 140 ANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ----NSEGYNEKADI 195
NILLT +GDVK+ADFGVSA+ T+ +R TF+GTP+WMAPEV+ Y+ KADI
Sbjct: 132 GNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADI 191
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE--HFSRLMKEFVSLCLKKVPA 253
WSLGIT+IE+A+ EPP +L+PMRVL I + PP LD+ +S +F+ CL K P
Sbjct: 192 WSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPD 251
Query: 254 ERPSAKELLRHRFIRNARKSPRLLERIRE 282
+RP+A ELL+H F+ + + + + + E
Sbjct: 252 DRPTAAELLKHPFVSDQSDNKAIKDLLAE 280
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 277 bits (711), Expect = 6e-90
Identities = 101/261 (38%), Positives = 149/261 (57%), Gaps = 9/261 (3%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK--EISVLSQCRSPY 72
+ L +G GSFG VYKA K K VA+K++ SE +D EI +L + P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKR-SEKSKKDQTARREIRILRRLSHPN 59
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I ++ + L+++MEY GG + D + G PL E I +L +EYLH+ G
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRD+K NILL ENG VK+ADFG++ +L ++ S TFVGTP++MAPEV+ GY K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF------SRLMKEFVSL 246
D+WSLG+ + E+ G+PP + + + L +I R P L+ S K+ +
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239
Query: 247 CLKKVPAERPSAKELLRHRFI 267
CL K P++RP+A+E+L+H +
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 271 bits (693), Expect = 2e-87
Identities = 128/258 (49%), Positives = 179/258 (69%), Gaps = 7/258 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F ++ IG G++GDVYKA + + AIKVI LE ED +Q+EI ++ C+ I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMMKDCKHSNIV 69
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
Y+GSYL + KLWI ME+ GGS+ D+ PL E IA + R+ L + YLH++GK+H
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMH 129
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV--IQNSEGYNEK 192
RDIK ANILLT+NG VK+ADFGVSAQ+T TI++RK+F+GTP+WMAPEV ++ GYN+
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDE--HFSRLMKEFVSLCL 248
DIW++GIT IE+A+ +PP+ DLHPMR LF++ + N PP+L + +S FV + L
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMAL 249
Query: 249 KKVPAERPSAKELLRHRF 266
K P +RP+A++LL+H F
Sbjct: 250 TKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 269 bits (690), Expect = 9e-87
Identities = 124/258 (48%), Positives = 181/258 (70%), Gaps = 7/258 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ ++ +G G++GDVYKA + + A+K+I LE +D IQ+EI ++ +C+ I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD-FSLIQQEIFMVKECKHCNIV 69
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
Y+GSYL + KLWI MEY GGS+ D+ PL E+ IA + R+ L + YLH++GK+H
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV--IQNSEGYNEK 192
RDIK ANILLT+NGDVK+ADFGV+A++T TI++RK+F+GTP+WMAPEV ++ + GYN+
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQL 189
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDE--HFSRLMKEFVSLCL 248
DIW++GIT IE+A+ +PP+ DLHPMR LF++ + N PP+L + +S FV + L
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISL 249
Query: 249 KKVPAERPSAKELLRHRF 266
K P +RP+A+ LL H F
Sbjct: 250 TKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 1e-83
Identities = 108/263 (41%), Positives = 160/263 (60%), Gaps = 9/263 (3%)
Query: 16 SSLEL---IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
S LE +G+GS G VYK K K A+K I ++ E+ + + +E+ L C SPY
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + YG++ + ++ I++EYM GGS+ADL++ + E +A I R +L ++YLH +
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120
Query: 133 -IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
IHRDIK +N+L+ G+VK+ADFG+S L T+ + TFVGT +M+PE IQ E Y+
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ-GESYSY 179
Query: 192 KADIWSLGITVIEMAKGEPPLADLH---PMRVLFIIPRENPPQL-DEHFSRLMKEFVSLC 247
ADIWSLG+T++E A G+ P ++ I PP L E FS ++F+S C
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239
Query: 248 LKKVPAERPSAKELLRHRFIRNA 270
L+K P +RPSA ELL+H FI+ A
Sbjct: 240 LQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 262 bits (670), Expect = 4e-83
Identities = 127/283 (44%), Positives = 177/283 (62%), Gaps = 12/283 (4%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL--EESEDEIEDIQKEISVLSQCRSP 71
F+ L IG GSFG VY A D N+ VAIK + ++S ++ +DI KE+ L Q R P
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNE 130
EY G YL + W++MEY G S +D+++ PL E+ IA I L + YLH+
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI-QNSEG- 188
+IHRDIKA NILLTE G VK+ADFG SA L +S +FVGTP+WMAPEVI EG
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFG-SASL---VSPANSFVGTPYWMAPEVILAMDEGQ 190
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE-HFSRLMKEFVSLC 247
Y+ K D+WSLGIT IE+A+ +PPL +++ M L+ I + + P L +S + FV C
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC 250
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQE 290
L+K+P +RPS++ELL+HRF+ R +++ I +R K ++E
Sbjct: 251 LQKIPQDRPSSEELLKHRFVLRERPPTVIIDLI-QRTKDAVRE 292
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 257 bits (658), Expect = 1e-82
Identities = 99/246 (40%), Positives = 138/246 (56%), Gaps = 34/246 (13%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G FG VY A DK+ K VAIK+I E+S +E++ +EI +L + P I + YG +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 81 LHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKA 139
+ L+++MEY GGS+ DL++ L E I IL +L +EYLH+ G IHRD+K
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 140 ANILLTE-NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSL 198
NILL NG VK+ADFG+S LT S KT VGTP +MAPEV+ Y+EK+DIWSL
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180
Query: 199 GITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258
G+ + E+ + +K+ + L+K P +RPSA
Sbjct: 181 GVILYELPE--------------------------------LKDLIRKMLQKDPEKRPSA 208
Query: 259 KELLRH 264
KE+L H
Sbjct: 209 KEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 256 bits (656), Expect = 1e-81
Identities = 132/279 (47%), Positives = 185/279 (66%), Gaps = 17/279 (6%)
Query: 3 DLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEI 62
DL+ L++ AG F +E++G G++G VYK + + AIKV+D+ +EDE E+I+ EI
Sbjct: 7 DLSALRDPAGI-FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV--TEDEEEEIKLEI 63
Query: 63 SVLSQ-CRSPYITEYYGSYL------HQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSI 113
++L + I YYG+++ H +LW++ME+ GSV DL+++ G L E I
Sbjct: 64 NMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI 123
Query: 114 ACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
A I R++L + +LH IHRDIK N+LLTEN +VK+ DFGVSAQL RT+ RR TF+G
Sbjct: 124 AYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG 183
Query: 174 TPFWMAPEVIQNSEG----YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP 229
TP+WMAPEVI E Y+ ++DIWSLGIT IEMA+G PPL D+HPMR LF+IPR P
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243
Query: 230 PQL-DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
P+L + +S+ +F+ CL K RPS ++LL+H FI
Sbjct: 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 1e-80
Identities = 99/255 (38%), Positives = 143/255 (56%), Gaps = 6/255 (2%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEY 76
++ IG+GSFG VY K K +K IDL SE E ED E+ +L + P I +Y
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGK 132
Y S+ + KL I+MEY GG ++ I+ G P E I L A++YLH+
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKI 124
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
+HRDIK NI LT NG VK+ DFG+S L+ T+ KT VGTP++++PE+ QN + YN K
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN-KPYNYK 183
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252
+DIWSLG + E+ + P + + + I + P + +S ++ VS L+K P
Sbjct: 184 SDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDP 243
Query: 253 AERPSAKELLRHRFI 267
ERPS ++L+ FI
Sbjct: 244 EERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 251 bits (644), Expect = 5e-80
Identities = 103/254 (40%), Positives = 156/254 (61%), Gaps = 6/254 (2%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDL----EESEDEIEDIQKEISVLSQCRSPYIT 74
EL+G GSFG VY+ + + A+K + L + ++ ++ +++EI++LS+ + P I
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+Y G+ + L+I +E + GGS+A L++ E I R +L +EYLH+ +H
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIK ANIL+ NG VK+ADFG++ Q+ S K+F G+P+WMAPEVI GY AD
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQGGYGLAAD 184
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP-PQLDEHFSRLMKEFVSLCLKKVPA 253
IWSLG TV+EMA G+PP + L + +F I R P + +H S K+F+ CL++ P+
Sbjct: 185 IWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPS 244
Query: 254 ERPSAKELLRHRFI 267
RP+A ELL H F+
Sbjct: 245 LRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 245 bits (626), Expect = 6e-77
Identities = 123/269 (45%), Positives = 174/269 (64%), Gaps = 8/269 (2%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G+FG VYKA +KE A KVI+ +SE+E+ED EI +L+ C PYI + G++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 81 LHQTKLWIIMEYMAGGSV-ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKA 139
KLWI++E+ GG+V A +++ L E I I R +L A++YLH+ IHRD+KA
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138
Query: 140 ANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI----QNSEGYNEKADI 195
N+LLT +GD+K+ADFGVSA+ +T+ RR +F+GTP+WMAPEV+ Y+ KADI
Sbjct: 139 GNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 198
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE--HFSRLMKEFVSLCLKKVPA 253
WSLGIT+IEMA+ EPP +L+PMRVL I + PP L + +S ++F+ L K P
Sbjct: 199 WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPE 258
Query: 254 ERPSAKELLRHRFIRNARKSPRLLERIRE 282
RPSA +LL H F+ + + L E + E
Sbjct: 259 TRPSAAQLLEHPFVSSVTSNRPLRELVAE 287
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 243 bits (620), Expect = 2e-76
Identities = 127/275 (46%), Positives = 183/275 (66%), Gaps = 17/275 (6%)
Query: 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLS 66
L++ AG F +EL+G G++G VYK + + AIKV+D+ + DE E+I++EI++L
Sbjct: 1 LRDPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV--TGDEEEEIKQEINMLK 57
Query: 67 Q-CRSPYITEYYGSYLHQT------KLWIIMEYMAGGSVADLIQS--GPPLDEMSIACIL 117
+ I YYG+++ + +LW++ME+ GSV DLI++ G L E IA I
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117
Query: 118 RDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFW 177
R++L + +LH IHRDIK N+LLTEN +VK+ DFGVSAQL RT+ RR TF+GTP+W
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 177
Query: 178 MAPEVIQNSEG----YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL- 232
MAPEVI E Y+ K+D+WSLGIT IEMA+G PPL D+HPMR LF+IPR P+L
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
+ +S+ + F+ CL K ++RP+ ++L++H FI
Sbjct: 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 237 bits (607), Expect = 4e-74
Identities = 105/263 (39%), Positives = 157/263 (59%), Gaps = 5/263 (1%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
S + IG GS G V A DK + VA+K +DL + + E + E+ ++ + P
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR-ELLFNEVVIMRDYQHPN 77
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I E Y SYL +LW++ME++ GG++ D++ ++E IA + +L A+ +LH +G
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFLHAQGV 136
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRDIK+ +ILLT +G VK++DFG AQ+++ + RRK+ VGTP+WMAPEVI + Y +
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPYGTE 195
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH--FSRLMKEFVSLCLKK 250
DIWSLGI VIEM GEPP + P++ + I PP+L S ++ F+ L +
Sbjct: 196 VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR 255
Query: 251 VPAERPSAKELLRHRFIRNARKS 273
PA+R +A ELL H F+ A
Sbjct: 256 DPAQRATAAELLNHPFLAKAGPP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 234 bits (599), Expect = 5e-73
Identities = 119/266 (44%), Positives = 164/266 (61%), Gaps = 18/266 (6%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVID-LEESEDEIEDIQKEISVLSQCRSPYITEY 76
+E IG+G++G V+K +K+ A+K++D + + ++EIE + LS P + ++
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD--HPNVVKF 80
Query: 77 YGSYLHQT-----KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYL 127
YG Y + +LW+++E GGSV DL++ G ++E IA IL + L +++L
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI---- 183
H IHRD+K NILLT G VK+ DFGVSAQLT T RR T VGTPFWMAPEVI
Sbjct: 141 HVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 200
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMK 241
Q Y+ + D+WSLGIT IE+ G+PPLADLHPMR LF IPR PP L E +S
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFN 260
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFI 267
+F+ CL K +RP+ +LL+H FI
Sbjct: 261 DFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 1e-72
Identities = 119/261 (45%), Positives = 167/261 (63%), Gaps = 8/261 (3%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G+FG VYKA +KE A KVID +SE+E+ED EI +L+ C P I + ++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVID-TKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 81 LHQTKLWIIMEYMAGGSV-ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKA 139
++ LWI++E+ AGG+V A +++ PL E I + + L A+ YLH IHRD+KA
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKA 131
Query: 140 ANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI----QNSEGYNEKADI 195
NIL T +GD+K+ADFGVSA+ TRTI RR +F+GTP+WMAPEV+ Y+ KAD+
Sbjct: 132 GNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADV 191
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE--HFSRLMKEFVSLCLKKVPA 253
WSLGIT+IEMA+ EPP +L+PMRVL I + PP L + +S K+F+ CL+K
Sbjct: 192 WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVD 251
Query: 254 ERPSAKELLRHRFIRNARKSP 274
R + +LL+H F+ P
Sbjct: 252 ARWTTTQLLQHPFVTVNSNKP 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 5e-72
Identities = 105/255 (41%), Positives = 150/255 (58%), Gaps = 11/255 (4%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G+ G V K + K +A+K I LE +E + I +E+ +L +C SPYI +YG++
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKI-HRDIK 138
+ + I MEYM GGS+ +++ + E + I +L + YLH + KI HRD+K
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVK 128
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSL 198
+NIL+ G +K+ DFGVS QL +++ KTFVGT +MAPE IQ Y+ K+DIWSL
Sbjct: 129 PSNILVNSRGQIKLCDFGVSGQLVNSLA--KTFVGTSSYMAPERIQ-GNDYSVKSDIWSL 185
Query: 199 GITVIEMAKGEPPLA-----DLHPMRVLFIIPRENPPQLDEH-FSRLMKEFVSLCLKKVP 252
G+++IE+A G P +L I E PP+L FS ++FV+LCL K P
Sbjct: 186 GLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDP 245
Query: 253 AERPSAKELLRHRFI 267
ERPS KELL H FI
Sbjct: 246 RERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (587), Expect = 2e-71
Identities = 102/258 (39%), Positives = 151/258 (58%), Gaps = 11/258 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE----ESEDEIEDIQKEISVLSQCRSPYIT 74
+L+G+G+FG VY +D + +++A+K + + E++ E+ ++ EI +L + I
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYG L I MEYM GGSV D +++ L E R +L +EYLH+ +H
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTI----SRRKTFVGTPFWMAPEVIQNSEGYN 190
RDIK ANIL G+VK+ DFG S +L +TI + K+ GTP+WM+PEVI + EGY
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRL-QTICSSGTGMKSVTGTPYWMSPEVI-SGEGYG 185
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP-PQLDEHFSRLMKEFVSLCLK 249
KAD+WS+G TV+EM +PP A+ M +F I + PQL H S + F+
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFV 245
Query: 250 KVPAERPSAKELLRHRFI 267
+ +RPSA+ELLRH F+
Sbjct: 246 ENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 228 bits (582), Expect = 2e-70
Identities = 114/260 (43%), Positives = 168/260 (64%), Gaps = 5/260 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+++ E IG+G+ G VY A D ++VAIK ++L++ + E I EI V+ + + P I
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK-ELIINEILVMRENKHPNI 78
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
Y SYL +LW++MEY+AGGS+ D++ + +DE IA + R+ L A+E+LH+ I
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVI 137
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIK+ NILL +G VK+ DFG AQ+T S+R T VGTP+WMAPEV+ Y K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKV 196
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGI IEM +GEPP + +P+R L++I P+L E S + ++F++ CL+
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 256
Query: 252 PAERPSAKELLRHRFIRNAR 271
+R SAKELL+H F++ A+
Sbjct: 257 VEKRGSAKELLQHPFLKIAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 7e-70
Identities = 120/267 (44%), Positives = 160/267 (59%), Gaps = 18/267 (6%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVL-SQCRSPYITEY 76
+E IG+G++G VYK +K+ A+K++D DE +I+ E ++L S P + ++
Sbjct: 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE--EIEAEYNILQSLPNHPNVVKF 84
Query: 77 YGSYLHQTK-----LWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYL 127
YG + K LW+++E GGSV +L++ G LDE I+ IL L +++L
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI---- 183
HN IHRD+K NILLT G VK+ DFGVSAQLT T RR T VGTPFWMAPEVI
Sbjct: 145 HNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMK 241
Q Y+ + D+WSLGIT IE+ G+PPL D+HP++ LF IPR PP L E + R
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFN 264
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIR 268
F+S CL K RPS LL H FI+
Sbjct: 265 HFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 4e-68
Identities = 122/282 (43%), Positives = 173/282 (61%), Gaps = 12/282 (4%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL--EESEDEIEDIQKEISVLSQCRSPY 72
F L IG GSFG VY A + N+ VA+K + +++ ++ +DI KE+ L Q + P
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEG 131
EY G YL + W++MEY G S +DL++ PL E+ IA I L + YLH+
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI-QNSEG-Y 189
IHRDIKA NILLTE G VK+ADFG ++ S +FVGTP+WMAPEVI EG Y
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSAS----KSSPANSFVGTPYWMAPEVILAMDEGQY 197
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH-FSRLMKEFVSLCL 248
+ K D+WSLGIT IE+A+ +PPL +++ M L+ I + + P L + ++ + FV CL
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCL 257
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQE 290
+K+P ERP++ ELLRH F+R R R+L + +R K ++E
Sbjct: 258 QKIPQERPASAELLRHDFVRRDR-PARVLIDLIQRTKDAVRE 298
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 2e-66
Identities = 98/264 (37%), Positives = 158/264 (59%), Gaps = 10/264 (3%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE-IEDIQKEISVLSQCRSPY 72
R+ IG G+FG VY A + + + +A+K I +++++ + I++I E+ VL + P
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ +YYG +H+ K++I MEY +GG++ +L++ G LDE I LL + YLH+ G
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQL----TRTISRRKTFVGTPFWMAPEVI--QNS 186
+HRDIK ANI L NG +K+ DFG + +L T ++ GTP +MAPEVI
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPRENPPQLDEH--FSRLMKEF 243
+G+ ADIWSLG V+EMA G+ P ++L + +++F + + P + + S K+F
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDF 240
Query: 244 VSLCLKKVPAERPSAKELLRHRFI 267
+ CL+ P +RP+A ELL+H F+
Sbjct: 241 LDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 216 bits (550), Expect = 1e-65
Identities = 113/260 (43%), Positives = 169/260 (65%), Gaps = 5/260 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+++ E IG+G+ G VY A D ++VAIK ++L++ + E I EI V+ + ++P I
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK-ELIINEILVMRENKNPNI 78
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
Y SYL +LW++MEY+AGGS+ D++ + +DE IA + R+ L A+++LH+ I
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALDFLHSNQVI 137
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIK+ NILL +G VK+ DFG AQ+T S+R T VGTP+WMAPEV+ + Y K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYGPKV 196
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGI IEM +GEPP + +P+R L++I P+L E S + ++F++ CL+
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMD 256
Query: 252 PAERPSAKELLRHRFIRNAR 271
R SAKELL+H F++ A+
Sbjct: 257 VDRRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 215 bits (548), Expect = 2e-65
Identities = 113/260 (43%), Positives = 170/260 (65%), Gaps = 5/260 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+++ E IG+G+ G VY A D ++VAI+ ++L++ + E I EI V+ + ++P I
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-ELIINEILVMRENKNPNI 79
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
Y SYL +LW++MEY+AGGS+ D++ + +DE IA + R+ L A+E+LH+ I
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIK+ NILL +G VK+ DFG AQ+T S+R T VGTP+WMAPEV+ + Y K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYGPKV 197
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGI IEM +GEPP + +P+R L++I P+L E S + ++F++ CL
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 252 PAERPSAKELLRHRFIRNAR 271
+R SAKELL+H+F++ A+
Sbjct: 258 VEKRGSAKELLQHQFLKIAK 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 213 bits (543), Expect = 1e-64
Identities = 110/260 (42%), Positives = 169/260 (65%), Gaps = 5/260 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+++ E IG+G+ G V+ A D ++VAIK I+L++ + E I EI V+ + ++P I
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK-ELIINEILVMKELKNPNI 78
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ S+L +L+++MEY+AGGS+ D++ + +DE IA + R+ L A+E+LH I
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVV-TETCMDEAQIAAVCRECLQALEFLHANQVI 137
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIK+ N+LL +G VK+ DFG AQ+T S+R T VGTP+WMAPEV+ + Y K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYGPKV 196
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGI IEM +GEPP + +P+R L++I P+L E S + ++F++ CL+
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMD 256
Query: 252 PAERPSAKELLRHRFIRNAR 271
+R SAKELL+H F++ A+
Sbjct: 257 VEKRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 1e-64
Identities = 117/282 (41%), Positives = 172/282 (60%), Gaps = 12/282 (4%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL--EESEDEIEDIQKEISVLSQCRSPY 72
FS L IG GSFG VY A D ++ VAIK + ++S ++ +DI KE+ L + R P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEG 131
+Y G YL + W++MEY G S +DL++ PL E+ IA + L + YLH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI-QNSEG-Y 189
IHRD+KA NILL+E G VK+ DFG ++ ++ FVGTP+WMAPEVI EG Y
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSAS----IMAPANXFVGTPYWMAPEVILAMDEGQY 191
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE-HFSRLMKEFVSLCL 248
+ K D+WSLGIT IE+A+ +PPL +++ M L+ I + P L H+S + FV CL
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQE 290
+K+P +RP+++ LL+HRF+ R +++ I +R K ++E
Sbjct: 252 QKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI-QRTKDAVRE 292
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 5e-63
Identities = 122/282 (43%), Positives = 172/282 (60%), Gaps = 12/282 (4%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL--EESEDEIEDIQKEISVLSQCRSPY 72
F+ L IG GSFG VY A D N+ VAIK + ++S ++ +DI KE+ L + + P
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEG 131
EY G YL + W++MEY G S +DL++ PL E+ IA I L + YLH+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI-QNSEG-Y 189
IHRDIKA NILLTE G VK+ADFG ++ S +FVGTP+WMAPEVI EG Y
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSAS----IASPANSFVGTPYWMAPEVILAMDEGQY 201
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE-HFSRLMKEFVSLCL 248
+ K D+WSLGIT IE+A+ +PPL +++ M L+ I + P L +S + FV CL
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL 261
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQE 290
+K+P +RP+++ELL+H F+ R L++ I +R K ++E
Sbjct: 262 QKIPQDRPTSEELLKHMFVLRERPETVLIDLI-QRTKDAVRE 302
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 8e-61
Identities = 94/267 (35%), Positives = 134/267 (50%), Gaps = 23/267 (8%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEY 76
LE IG+GSFG V K K K + K ID +E E + + E+++L + + P I Y
Sbjct: 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 77 YGSYL--HQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNE 130
Y + L+I+MEY GG +A LIQ ++E I IL LL A+ HN
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 131 GK-----IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
+HRD+K ANI L N +VK+ DFG++ L S KT+VGTP++M+PE + N
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL-N 183
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPL-----ADLHPMRVLFIIPRENPPQLDEHFSRLM 240
Y+EK+DIWSLG + E+ PP L I ++ +S +
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK-----IKEGKFRRIPYRYSSEL 238
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFI 267
E + L P +RPS +ELL+ I
Sbjct: 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 5e-60
Identities = 100/263 (38%), Positives = 151/263 (57%), Gaps = 17/263 (6%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-----EDEIEDIQKEISVLSQCRSPYI 73
E++G+G++G VY + + +A+K ++L+ S E E E +Q+E+ +L + I
Sbjct: 6 EVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+Y G+ L + I ME++ GGS++ ++ PL E + +L + YLHN +
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 134 HRDIKAANILLTENGDVKVADFG-------VSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
HRDIK N++L NG +K+ DFG V T + + K+ GTP+WMAPEVI N
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS-NMLKSMHGTPYWMAPEVI-NE 182
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP--RENPPQLDEHFSRLMKEFV 244
GY K+DIWS+G TV EMA G+PPLA + + +F I R P+L + FS +FV
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFV 242
Query: 245 SLCLKKVPAERPSAKELLRHRFI 267
+ CL + ERPSA +LLRH F+
Sbjct: 243 TSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 195 bits (499), Expect = 1e-58
Identities = 81/253 (32%), Positives = 138/253 (54%), Gaps = 11/253 (4%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVID--LEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+G+GSFG V K+ K A+KV+ E+E E ++LS+ P+I + +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
++ + KL++++EY GG + + E +++ A+EYLH+ G I+RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSL 198
NILL +G +K+ DFG++ +L+ SR TF GTP ++APEV+ +GY + D WSL
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSL 179
Query: 199 GITVIEMAKGEPPLADLHPMRVLF--IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER- 255
G+ + EM G+PP + ++ I+ ++P + E S ++ +S L+K P +R
Sbjct: 180 GVLLYEMLTGKPPFYA-EDRKEIYEKIL--KDPLRFPEFLSPEARDLISGLLQKDPTKRL 236
Query: 256 --PSAKELLRHRF 266
A+E+ H F
Sbjct: 237 GSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 2e-58
Identities = 102/285 (35%), Positives = 151/285 (52%), Gaps = 26/285 (9%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
L +G G+ G V K K A+K I + + D + I +E+ + C+SPYI
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62
Query: 75 EYYGSYL--HQTKLWIIMEYMAGGSV----ADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
+YYG++L + + I MEY GGS+ + + G + E + I +L + YLH
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
+ IHRDIK +NILLT G VK+ DFGVS +L S TF GT F+MAPE IQ
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN--SLAGTFTGTSFYMAPERIQGKP- 179
Query: 189 YNEKADIWSLGITVIEMA--------KGEPPLADLHPMRVLFIIPRENPPQL-DE----- 234
Y+ +D+WSLG+T++E+A +GEPPL P+ +L I P+L DE
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG---PIELLSYIVNMPNPELKDEPGNGI 236
Query: 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLER 279
+S K+F+ CL+K P RP+ ++L H +I+ K + +
Sbjct: 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAK 281
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 8e-57
Identities = 105/269 (39%), Positives = 165/269 (61%), Gaps = 10/269 (3%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
IG GS G V A +K + VA+K++DL + + E + E+ ++ + + E Y SY
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR-ELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAA 140
L +LW++ME++ GG++ D++ S L+E IA + +L A+ YLH++G IHRDIK+
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV-SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSD 146
Query: 141 NILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGI 200
+ILLT +G VK++DFG AQ+++ + +RK+ VGTP+WMAPEVI + Y + DIWSLGI
Sbjct: 147 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGI 205
Query: 201 TVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKVPAERPSA 258
VIEM GEPP P++ + + PP+L S ++++F+ L + P ER +A
Sbjct: 206 MVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATA 265
Query: 259 KELLRHRFIRNARKSPR----LLERIRER 283
+ELL H F+ P L+++ R+R
Sbjct: 266 QELLDHPFLLQT-GLPECLVPLIQQYRKR 293
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 1e-56
Identities = 100/252 (39%), Positives = 160/252 (63%), Gaps = 5/252 (1%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
IG GS G V A +K K VA+K +DL + + E + E+ ++ + + Y SY
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR-ELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAA 140
L +LW++ME++ GG++ D++ + ++E IA + +L A+ YLHN+G IHRDIK+
Sbjct: 89 LVGDELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 147
Query: 141 NILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGI 200
+ILLT +G +K++DFG AQ+++ + +RK+ VGTP+WMAPEVI Y + DIWSLGI
Sbjct: 148 SILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGI 206
Query: 201 TVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE--HFSRLMKEFVSLCLKKVPAERPSA 258
VIEM GEPP + P++ + I PP++ + S +++ F+ L L + P++R +A
Sbjct: 207 MVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATA 266
Query: 259 KELLRHRFIRNA 270
+ELL+H F++ A
Sbjct: 267 QELLQHPFLKLA 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 3e-56
Identities = 78/263 (29%), Positives = 126/263 (47%), Gaps = 25/263 (9%)
Query: 18 LELIGRGSFGDVYKA---FDKELNK-DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +G G+FG+VYK D E + VA+K + SE+E E+ +E S++ + P I
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
G L+I+ EYM GG + D L + G L + + + +EYL ++
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNF 123
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV---GTPF---WMAPEVIQNS 186
+HRD+ A N L+TEN VK++DFG L+R I + G WMAPE +++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFG----LSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 187 EGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRLMK 241
+ + K+D+WS G+ + E+ GE P + VL ++ P + LM
Sbjct: 180 K-FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELML 238
Query: 242 EFVSLCLKKVPAERPSAKELLRH 264
+ C P +RP+ EL+
Sbjct: 239 Q----CWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 8e-56
Identities = 96/262 (36%), Positives = 148/262 (56%), Gaps = 15/262 (5%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDL----EESEDE----IEDIQKEISVLSQCRSP 71
LIG GSFG VY + + +A+K ++L S+D ++ + +EI++L + +
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
I +Y GS L L I +EY+ GGSVA L+ + +E + +R +L + YLHN G
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQL------TRTISRRKTFVGTPFWMAPEVIQN 185
IHRDIK ANIL+ G +K++DFG+S +L T+T R + G+ FWMAPEV++
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245
+ Y KADIWSLG V+EM G+ P D ++ +F I P++ + S +F+
Sbjct: 187 TS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLE 245
Query: 246 LCLKKVPAERPSAKELLRHRFI 267
+ +RP+A ELL+H F+
Sbjct: 246 KTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 1e-55
Identities = 102/252 (40%), Positives = 154/252 (61%), Gaps = 5/252 (1%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
IG GS G V A K K VA+K +DL + + E + E+ ++ + + E Y SY
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR-ELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAA 140
L +LW++ME++ GG++ D++ + ++E IA + +L A+ LH +G IHRDIK+
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSD 145
Query: 141 NILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGI 200
+ILLT +G VK++DFG AQ+++ + RRK+ VGTP+WMAPE+I Y + DIWSLGI
Sbjct: 146 SILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGI 204
Query: 201 TVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKVPAERPSA 258
VIEM GEPP + P++ + +I PP+L S +K F+ L + PA+R +A
Sbjct: 205 MVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATA 264
Query: 259 KELLRHRFIRNA 270
ELL+H F+ A
Sbjct: 265 AELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 7e-55
Identities = 98/278 (35%), Positives = 153/278 (55%), Gaps = 20/278 (7%)
Query: 14 RFSSLELI---GRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
R LE I G G+ G V K +A KV+ + + I +E+ ++ +CRS
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS 62
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
PYI +YG++L++ + + ME+M GS+ + + G P+ + I ++ + YL+N
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122
Query: 131 GKI-HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+I HRDIK +NIL+ G +K+ DFGVS +L +I+ TFVGT +M+PE IQ Y
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--DTFVGTSTYMSPERIQ-GGKY 179
Query: 190 NEKADIWSLGITVIEMAKGEPPLAD--------LHPMRVLFIIPR---ENPPQL-DEHFS 237
K+D+WSLGI++IE+A G+ P A PM +L ++ + E PP+L F
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239
Query: 238 RLMKEFVSLCLKKVPAERPSAKELLRHR-FIRNARKSP 274
+++FV CL K P ERP+ ++L FI+ R S
Sbjct: 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 2e-54
Identities = 90/263 (34%), Positives = 146/263 (55%), Gaps = 16/263 (6%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
L+ +G+G++G VYK + +A+K I LE E + I E+ +L + SPYI ++Y
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPP---LDEMSIACILRDLLHAIEYLHNEGK-I 133
G++ + +++ MEYM GS+ L G + E + I ++ +++L E I
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG----- 188
HRD+K N+L+ NG VK+ DFGVS L +++ KT +G +MAPE I+ S G
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA--KTNIGCQSYMAPERIK-SGGPNQNP 182
Query: 189 -YNEKADIWSLGITVIEMAKGE---PPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244
Y ++D+WSLG++++EMA G PP + L I +PP L +S ++FV
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFV 242
Query: 245 SLCLKKVPAERPSAKELLRHRFI 267
+ CL K+P RP+ +LL H ++
Sbjct: 243 AKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 3e-53
Identities = 99/305 (32%), Positives = 162/305 (53%), Gaps = 46/305 (15%)
Query: 16 SSLELIGRGSFGD--VYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPY 72
L LIG+ V+ A K N VA+K I+L+ S+++++ +Q+EI Q + P
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYLHNE 130
I Y S++ ++L+++ MA GS DL+++ P L E++IA IL+D+L+A++Y+H++
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP-------FWMAPEVI 183
G IHR +KA++ILL+ +G V ++ S + + R++ P W++PEV+
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 184 -QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL---------- 232
QN +GYNEK+DI+S+GIT E+A G P D+ ++L R P L
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240
Query: 233 ---------DEH--------------FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269
+EH FS +FV LCL++ P RPSA +LL H F +
Sbjct: 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300
Query: 270 ARKSP 274
++
Sbjct: 301 CKRRN 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 1e-52
Identities = 78/263 (29%), Positives = 131/263 (49%), Gaps = 20/263 (7%)
Query: 19 ELIGRGSFGDVYKA-FDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+ +G G+FG+VYK + K +VA+K + + SE+E +D KE V+ + P +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI-LRDLLH-------AIEY 126
G + L++++EYM GG + D L +S P + + L+DLL +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVI 183
L ++ +HRD+ A N L+ E+ VK++DFG+S + RK G WMAPE +
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK-TGGKLPIRWMAPESL 179
Query: 184 QNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVL-FIIPRENPPQLDEHFSRLMK 241
++ + K+D+WS G+ + E G P L VL ++ P+ E+ +
Sbjct: 180 KDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK-PEYCPDELY 237
Query: 242 EFVSLCLKKVPAERPSAKELLRH 264
E + C + P +RP+ EL+
Sbjct: 238 ELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 3e-51
Identities = 95/259 (36%), Positives = 151/259 (58%), Gaps = 15/259 (5%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
E++G G+ G VYKA+ + +A+KVI L+ + + + I E+ +L +C SPYI +Y
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
G++ + ++ I E+M GGS+ D+ + P E + I ++ + YL + +HRD+
Sbjct: 66 GAFFVENRISICTEFMDGGSL-DVYRKIP---EHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWS 197
K +N+L+ G VK+ DFGVS QL +I+ KT+VGT +MAPE I + E Y +D+WS
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVSTQLVNSIA--KTYVGTNAYMAPERI-SGEQYGIHSDVWS 178
Query: 198 LGITVIEMAKGEPPL-------ADLHPMRVLFIIPRENPPQLDEH-FSRLMKEFVSLCLK 249
LGI+ +E+A G P L P+++L I E+PP L FS F++ C++
Sbjct: 179 LGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMR 238
Query: 250 KVPAERPSAKELLRHRFIR 268
K P ERP+ + L+ H FI
Sbjct: 239 KQPKERPAPENLMDHPFIV 257
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-50
Identities = 84/252 (33%), Positives = 135/252 (53%), Gaps = 4/252 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPY 72
+ + ++G+G+FG+ E + V K ++L SE E D EI +LS + P
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNE 130
I YY ++ L I MEY GG++ D I Q G +E + L ++ A+ Y+H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
G +HRDIK NI LT+ G +K+ DFG+S L S +T VGTP++M+PE+ Q + YN
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK-YN 179
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
K+DIW+LG + E+ + +P+ ++ I + N + +S + V L++
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239
Query: 251 VPAERPSAKELL 262
P +RP+A E+L
Sbjct: 240 DPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 3e-50
Identities = 78/268 (29%), Positives = 126/268 (47%), Gaps = 38/268 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +G G+FG+VYK K +VA+K + + SE +IE+ +E ++ + P +
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLH-------AIE 125
+ G + L+I+MEYM GG + L ++ P L L DLL +E
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLS-------LSDLLSFALQIARGME 116
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP-----FWMAP 180
YL ++ IHRD+ A N L+ EN VK++DFG L+R + + WMAP
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFG----LSRDLYDDDYYRKRGGKLPIRWMAP 172
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPREN----PPQLDEH 235
E ++ + + K+D+WS G+ + E+ GE P + VL + PP
Sbjct: 173 ESLKEGK-FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPE 231
Query: 236 FSRLMKEFVSLCLKKVPAERPSAKELLR 263
LM + C + P +RP+ EL+
Sbjct: 232 LYDLMLQ----CWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 5e-50
Identities = 103/263 (39%), Positives = 150/263 (57%), Gaps = 20/263 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE----ESEDEIEDIQKEISVLSQCRSPYIT 74
+L+G+G+FG VY +D + +++A+K + + E+ E+ ++ EI +L I
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 75 EYYGSYL--HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+YYG + L I ME+M GGS+ D ++S L E R +L + YLH+
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTI----SRRKTFVGTPFWMAPEVIQNSEG 188
+HRDIK ANIL G+VK+ DFG S +L +TI + K+ GTP+WM+PEVI + EG
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTGMKSVTGTPYWMSPEVI-SGEG 185
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-IIPRENPPQLDEHFSRLMKEFVSLC 247
Y KADIWS+G TV+EM +PP A+ M +F I + P L H S ++F
Sbjct: 186 YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF---- 241
Query: 248 LKKVPAE---RPSAKELLRHRFI 267
LK++ E RPSA ELLRH F+
Sbjct: 242 LKRIFVEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 1e-49
Identities = 84/264 (31%), Positives = 140/264 (53%), Gaps = 15/264 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVI-----DLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +G G+F Y+A D + +A+K + E E+ +E ++KEI ++++ P+I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
G+ + + +E+MAGGSV+ L+ E I LL + YLH I
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 134 HRDIKAANILLTENG-DVKVADFGVSAQLTRTISR----RKTFVGTPFWMAPEVIQNSEG 188
HRD+K AN+L+ G +++ADFG +A+L + + +GT +MAPEV++ E
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR-GEQ 184
Query: 189 YNEKADIWSLGITVIEMAKGEPPL-ADLHP--MRVLFIIPREN-PPQLDEHFSRLMKEFV 244
Y D+WS+G +IEMA +PP A+ H + ++F I P + EH S +++
Sbjct: 185 YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVT 244
Query: 245 SLCLKKVPAERPSAKELLRHRFIR 268
CL+ P +RP ++ELL+H R
Sbjct: 245 LRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 1e-49
Identities = 90/253 (35%), Positives = 142/253 (56%), Gaps = 6/253 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYI 73
F L IG+GSFG V+K K + A+K IDL + + E E+ E VL++ S YI
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEG 131
YY S+L + KL I+MEY G + L+ Q G PL E + +L + +LH++
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
+HRDIK+ N+ L +VK+ D GV+ L+ + T VGTP++++PE+ ++ YNE
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP-YNE 180
Query: 192 KADIWSLGITVIEMAKGEPPL-ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
K+D+W+LG+ + E G+ P A+ +L II PP + + +S+ + + + CL K
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-VSQMYSQQLAQLIDQCLTK 239
Query: 251 VPAERPSAKELLR 263
+RP +LLR
Sbjct: 240 DYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 100/263 (38%), Positives = 152/263 (57%), Gaps = 20/263 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVI----DLEESEDEIEDIQKEISVLSQCRSPYIT 74
+L+GRG+FG+VY +D + +++A+K + D +E+ E+ ++ EI +L R I
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 75 EYYGSYL--HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+YYG + KL I +EYM GGS+ D +++ L E R +L + YLH+
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR----KTFVGTPFWMAPEVIQNSEG 188
+HRDIK ANIL G+VK+ DFG S ++ +TI K+ GTP+WM+PEVI + EG
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPEVI-SGEG 185
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-IIPRENPPQLDEHFSRLMKEFVSLC 247
Y KAD+WS+ TV+EM +PP A+ M +F I + P L + S ++F
Sbjct: 186 YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF---- 241
Query: 248 LKKVPAE---RPSAKELLRHRFI 267
LK++ E RP+A+ LLRH F+
Sbjct: 242 LKQIFVEEKRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-49
Identities = 79/267 (29%), Positives = 128/267 (47%), Gaps = 35/267 (13%)
Query: 18 LELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +G G+FG+VYK +VA+K + + SE +IE+ +E ++ + P I
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLH-------AIEY 126
+ G + L I+MEYM GG + D ++ P E+S L DLL +EY
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELS----LSDLLSFALQIARGMEY 118
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP-----FWMAPE 181
L ++ IHRD+ A N L+ EN VK++DFG L+R + + WMAPE
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFG----LSRDLYDDDYYKVKGGKLPIRWMAPE 174
Query: 182 VIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPREN----PPQLDEHF 236
++ + + K+D+WS G+ + E+ GE P + VL + + PP
Sbjct: 175 SLKEGK-FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPEL 233
Query: 237 SRLMKEFVSLCLKKVPAERPSAKELLR 263
+LM + C + P +RP+ EL+
Sbjct: 234 YKLMLQ----CWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 102/259 (39%), Positives = 150/259 (57%), Gaps = 14/259 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE----ESEDEIEDIQKEISVLSQCRSPYIT 74
+L+G+G+FG VY +D + +++A K + + E+ E+ ++ EI +L + I
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 75 EYYGSYLHQTK--LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+YYG + + L I MEYM GGSV D +++ L E R +L + YLH+
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTI----SRRKTFVGTPFWMAPEVIQNSEG 188
+HRDIK ANIL G+VK+ DFG S +L +TI + ++ GTP+WM+PEVI + EG
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWMSPEVI-SGEG 185
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-IIPRENPPQLDEHFSRLMKEFVSLC 247
Y KAD+WSLG TV+EM +PP A+ M +F I + PQL H S ++F+ C
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLG-C 244
Query: 248 LKKVPAERPSAKELLRHRF 266
+ RPSA+ELLRH F
Sbjct: 245 IFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 3e-49
Identities = 101/297 (34%), Positives = 151/297 (50%), Gaps = 41/297 (13%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F L +G G+ G V K + +A K+I LE I +E+ VL +C SPYI
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI- 133
+YG++ ++ I ME+M GGS+ +++ + E + I +L + YL + KI
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIM 122
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRD+K +NIL+ G++K+ DFGVS QL +++ +FVGT +M+PE +Q + Y ++
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTH-YTVQS 179
Query: 194 DIWSLGITVIEMAKGE---PP-----LADLH-------------------------PMRV 220
DIWSLG++++EMA G PP L + PM +
Sbjct: 180 DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI 239
Query: 221 ---LFIIPRENPPQL-DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273
L I E PP+L FS ++FV CLKK P ER KEL +H FI+ A
Sbjct: 240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 6e-49
Identities = 87/267 (32%), Positives = 146/267 (54%), Gaps = 19/267 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE---------DEIEDIQKEISVLSQCR 69
ELIG+G++G VY A + + +A+K ++L + D ++ ++ EI L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
I +Y G + L I +EY+ GGS+ +++ +E + +L + YLH+
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI---SRRKTFVGTPFWMAPEVIQN- 185
+G +HRD+KA N+L+ +G K++DFG+S + + I + + G+ FWMAPEVI +
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-----PPQLDEHFSRLM 240
S+GY+ K DIWSLG V+EM G P +D + +F + + PP + + S +
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVA 245
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFI 267
+F++ C P RP+A+ELL+H FI
Sbjct: 246 LDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 8e-49
Identities = 91/261 (34%), Positives = 136/261 (52%), Gaps = 18/261 (6%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPY 72
F L+ +G+GS+G VYK N+ A+K +DL S+ E ED EI +L+ P
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP----PLDEMSIACILRDLLHAIEYLH 128
I Y ++L KL I+MEY G ++ I + E I I LL ++ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
+ +HRD+K+ANILL N VK+ D G+S L + ++ KT +GTP +MAPEV +
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA--KTQIGTPHYMAPEVWKGRP- 177
Query: 189 YNEKADIWSLGITVIEMAKGEPP-----LADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243
Y+ K+DIWSLG + EMA PP + DL +V R P + +S+ ++ F
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-YKVQ----RGKYPPIPPIYSQDLQNF 232
Query: 244 VSLCLKKVPAERPSAKELLRH 264
+ L+ P RP+ ++L
Sbjct: 233 IRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 9e-49
Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 31/280 (11%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSP 71
F ++IG GSF V A +KE NK+ AIK++D + E +++ ++ E VL++ P
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
I + Y ++ + L+ ++EY G + I+ LDE ++L A+EYLH++G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--------------------RRKTF 171
IHRD+K NILL ++ +K+ DFG + L S R +F
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-FIIPRENPP 230
VGT +++PE++ + +D+W+LG + +M G+PP + I+ E
Sbjct: 183 VGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE--Y 239
Query: 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAK----ELLRHRF 266
+F K+ + L P +R EL H F
Sbjct: 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 2e-48
Identities = 94/255 (36%), Positives = 145/255 (56%), Gaps = 8/255 (3%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGS 79
++G+G++G VY A D +AIK I +S ++ + +EI++ S + I +Y GS
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 80 YLHQTKLWIIMEYMAGGSVADLIQS--GPPLD-EMSIACILRDLLHAIEYLHNEGKIHRD 136
I ME + GGS++ L++S GP D E +I + +L ++YLH+ +HRD
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133
Query: 137 IKAANILL-TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI-QNSEGYNEKAD 194
IK N+L+ T +G VK++DFG S +L +TF GT +MAPEVI + GY AD
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPAD 193
Query: 195 IWSLGITVIEMAKGEPPLADL-HPMRVLFIIPR-ENPPQLDEHFSRLMKEFVSLCLKKVP 252
IWSLG T++EMA G+PP +L P +F + + P++ E S K F+ C + P
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDP 253
Query: 253 AERPSAKELLRHRFI 267
+R SA +LL+ F+
Sbjct: 254 DKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 87/268 (32%), Positives = 135/268 (50%), Gaps = 36/268 (13%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI------EDIQKEISVLSQCRSPYIT 74
+G G FG V K N+ A+K + + I E I E +L +C P+I
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV----KKRHIVETGQQEHIFSEKEILEECNHPFIV 56
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDE----MSIACILRDLLHAIEYLHNE 130
+ Y ++ + ++++MEY GG + +++ DE IAC++ A EYLHN
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVL----AFEYLHNR 112
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
G I+RD+K N+LL NG VK+ DFG + +L + TF GTP ++APE+I N +GY+
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG-QKTWTFCGTPEYVAPEIILN-KGYD 170
Query: 191 EKADIWSLGITVIEMAKGEPPLA--DLHPMRVLFIIPREN-----PPQLDEHFSRLMKEF 243
D WSLGI + E+ G PP D PM + I + N P +D+ L+K
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIK-- 228
Query: 244 VSLCLKKVPAER-----PSAKELLRHRF 266
L ++ P ER K++ +H++
Sbjct: 229 -QLL-RRNPEERLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 4e-48
Identities = 91/269 (33%), Positives = 147/269 (54%), Gaps = 9/269 (3%)
Query: 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ 67
A + +L IG G+ G VYK K+ +A+K + +++E + I ++ V+ +
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69
Query: 68 CR-SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEY 126
PYI + YG ++ + ++I ME M+ L + P+ E + + ++ A+ Y
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHY 129
Query: 127 L-HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI-- 183
L G IHRD+K +NILL +G+VK+ DFG+S +L + ++ ++ G +MAPE I
Sbjct: 130 LKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYMAPERIDP 188
Query: 184 QNSEG-YNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQLD--EHFSRL 239
+ Y+ +AD+WSLGI+++E+A G+ P + VL I +E PP L E FS
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248
Query: 240 MKEFVSLCLKKVPAERPSAKELLRHRFIR 268
FV LCL K +RP +ELL+H FIR
Sbjct: 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 171 bits (432), Expect = 8e-48
Identities = 97/294 (32%), Positives = 139/294 (47%), Gaps = 30/294 (10%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSP- 71
+ L +G GSFG+VY A D K VA+KV+ LE E+E +EI +L+ P
Sbjct: 2 YRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLH 128
I + Y + + L+++MEY+ GGS+ DL++ PL E IL +L A+EYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 129 NEGKIHRDIKAANILLTENGD-VKVADFGVSAQLTRTISRR------KTFVGTPFWMAPE 181
++G IHRDIK NILL +G VK+ DFG++ L S T VGTP +MAPE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 182 VI--QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------PRE 227
V+ + + +DIWSLGIT+ E+ G PP
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIR 281
P E S+ + + L K P R S+ L H + + + L +
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
|
Length = 384 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 2e-47
Identities = 87/265 (32%), Positives = 139/265 (52%), Gaps = 19/265 (7%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVI---DLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
I +G++G V+ A K AIKVI D+ +++++ + E +LSQ +SPY+ + Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI-RKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
S+ + L+++MEY+ GG +A L+++ LDE + +++ A+EYLH+ G IHRD+
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 138 KAANILLTENGDVKVADFGVSAQ--------LTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
K NIL+ NG +K+ DFG+S L K VGTP ++APEVI +G+
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI-LGQGH 178
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--IIPRENPPQLDEHFSRLMKEFVSLC 247
++ D WSLG + E G PP P + F I+ + D S + +S
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHGETPEEI-FQNILNGKIEWPEDVEVSDEAIDLISKL 237
Query: 248 LKKVPAERP---SAKELLRHRFIRN 269
L P +R S +E+ H F +
Sbjct: 238 LVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 2e-47
Identities = 89/292 (30%), Positives = 136/292 (46%), Gaps = 49/292 (16%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI--EDIQKEISVLSQCRSPY 72
+ LE +G G++G VYKA DK+ + VA+K I L+ E+ I + +EIS+L + + P
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL-REISLLKELKHPN 59
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQS-GPPLDEMSIACILRDLLHAIEYLH 128
I + + KL+++ EY DL + PL I I+ LL + Y H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---RRKTF-VGTPFWMAPEVIQ 184
+ +HRD+K NIL+ +G +K+ADFG L R R T V T ++ APE++
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFG----LARAFGIPLRTYTHEVVTLWYRAPEILL 171
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPLA------------------------DLHPMRV 220
S+ Y+ DIWS+G EM G+P + +
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231
Query: 221 -LFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRHRFI 267
P+ P L++ RL E + L L K+ PA+R SAKE L+H +
Sbjct: 232 YKPTFPKFPPKDLEKVLPRLDPEGIDL-LSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 3e-45
Identities = 85/258 (32%), Positives = 142/258 (55%), Gaps = 5/258 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPY 72
R+ ++ IG GSFG +Y A K ++ IK IDL + E E +KE+ +L++ + P
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNE 130
I ++ S+ +L+I+MEY GG + I Q G E I + ++++H+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 131 GKIHRDIKAANILLTENGDV-KVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+HRDIK+ NI L++NG V K+ DFG++ QL ++ T VGTP++++PE+ QN Y
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP-Y 179
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249
N K DIWSLG + E+ + P + +++ I + + +FSR ++ +S K
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239
Query: 250 KVPAERPSAKELLRHRFI 267
P +RPS +L+ F+
Sbjct: 240 VSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-44
Identities = 96/268 (35%), Positives = 146/268 (54%), Gaps = 22/268 (8%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVL---SQCRSPYIT 74
L IGRG+FG V K K +A+K I E E + + ++ V+ S C PYI
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC--PYIV 66
Query: 75 EYYGSYLHQTKLWIIMEYMAGG------SVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
++YG+ + WI ME M V ++++S + E + I + A+ YL
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKS--VIPEEILGKIAVATVKALNYLK 124
Query: 129 NEGKI-HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS- 186
E KI HRD+K +NILL NG++K+ DFG+S QL +I++ + G +MAPE I S
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSA 183
Query: 187 -EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV-LFIIPRENPPQL----DEHFSRLM 240
+GY+ ++D+WSLGIT+ E+A G+ P + + L + + +PP L + FS
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF 243
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIR 268
F++LCL K ++RP KELL H FI+
Sbjct: 244 VNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 6e-44
Identities = 95/269 (35%), Positives = 141/269 (52%), Gaps = 17/269 (6%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSPYITE 75
+E +GRG++G V K +A+K I + E + + +IS+ S PY
Sbjct: 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVD-CPYTVT 64
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADL----IQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+YG+ + +WI ME M S+ G + E + I ++ A+EYLH++
Sbjct: 65 FYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123
Query: 132 K-IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF-VGTPFWMAPEVI---QNS 186
IHRD+K +N+L+ NG VK+ DFG+S L +++ KT G +MAPE I N
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAPERINPELNQ 181
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQL-DEHFSRLMKEFV 244
+GY+ K+D+WSLGIT+IE+A G P P + L + E PQL E FS ++FV
Sbjct: 182 KGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFV 241
Query: 245 SLCLKKVPAERPSAKELLRHRFIRNARKS 273
+ CLKK ERP+ ELL+H F
Sbjct: 242 NKCLKKNYKERPNYPELLQHPFFELHLSK 270
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-43
Identities = 82/251 (32%), Positives = 131/251 (52%), Gaps = 10/251 (3%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI--EDIQKEISVLSQCRSPYITEYYG 78
IG+G F VYKA + VA+K + + E D +D KEI +L Q P + +Y
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
S++ +L I++E G ++ +I+ + E +I L A+E++H++ +H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMH 129
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIK AN+ +T G VK+ D G+ + + + VGTP++M+PE I GYN K+D
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-ENGYNFKSD 188
Query: 195 IWSLGITVIEMAKGEPPL-ADLHPMRVLF--IIPRENPPQLDEHFSRLMKEFVSLCLKKV 251
IWSLG + EMA + P D + L I + PP +H+S +++ VS C+
Sbjct: 189 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPD 248
Query: 252 PAERPSAKELL 262
P +RP +L
Sbjct: 249 PEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 85/257 (33%), Positives = 141/257 (54%), Gaps = 4/257 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPY 72
++ ++ IG GSFG KE K IK I++ + S E E+ +KE++VLS + P
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNE 130
I +Y S+ L+I+M+Y GG + I Q G E I + A++++H+
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
+HRDIK+ NI LT++G +K+ DFG++ L T+ +T +GTP++++PE+ +N YN
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP-YN 179
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
K+DIW+LG + EM + + ++ I R + P + H+S ++ VS K+
Sbjct: 180 NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR 239
Query: 251 VPAERPSAKELLRHRFI 267
P +RPS +L FI
Sbjct: 240 NPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 6e-42
Identities = 87/257 (33%), Positives = 145/257 (56%), Gaps = 10/257 (3%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPY 72
++ + ++GRG+FG V+ K K V IK I +E+ ++DE Q E VL P
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
I EYY ++L L I+MEY GG++A+ IQ LDE +I +L A+ ++H +
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 131 GKIHRDIKAANILLTENGDV-KVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+HRD+K NILL ++ V K+ DFG+S L+ + S+ T VGTP +++PE+ + + Y
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVVGTPCYISPELCE-GKPY 178
Query: 190 NEKADIWSLGITVIEMAKGEPPL--ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247
N+K+DIW+LG + E+A + A+L P VL I+ P + + +S +++ +
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAANL-PALVLKIMSGTFAP-ISDRYSPDLRQLILSM 236
Query: 248 LKKVPAERPSAKELLRH 264
L P++RP +++
Sbjct: 237 LNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 6e-42
Identities = 84/286 (29%), Positives = 141/286 (49%), Gaps = 35/286 (12%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIED-IQKEISVLSQCRSPY 72
R+ L IG G+ G V+KA D+E + VA+K + L E I + +EI L C+ PY
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEG 131
+ + + H + ++MEYM ++++++ PL E + +R LL + Y+H G
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF-VGTPFWMAPEVIQNSEGYN 190
+HRD+K AN+L++ +G +K+ADFG++ + R + V T ++ APE++ + Y+
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 191 EKADIWSLGITVIEMAKGEP--------------------PLADLHP-MRVL----FIIP 225
D+W++G E+ G P P + P + L I
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239
Query: 226 RENPPQ-LDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRHRF 266
E+ P L+E F E + L LK + P++R SA E LRH +
Sbjct: 240 PESKPIPLEEIFPDASPEALDL-LKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 7e-41
Identities = 69/215 (32%), Positives = 116/215 (53%), Gaps = 20/215 (9%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F ++ +G GSFG V K K A+K++ + ++E + E +L R P+
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIAC------ILRDLLHAIEY 126
+ YGS+ + L+++MEY+ GG + ++ E +A +L A+EY
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPE-PVARFYAAQVVL-----ALEY 116
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-TRTISRRKTFVGTPFWMAPEVIQN 185
LH+ ++RD+K N+LL +G +K+ DFG + ++ RT T GTP ++APE+I
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT----YTLCGTPEYLAPEIIL- 171
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV 220
S+GY + D W+LGI + EM G PP D +P+++
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 1e-39
Identities = 79/251 (31%), Positives = 133/251 (52%), Gaps = 3/251 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+++ L ++G GSFG ++ A+K I L +S +ED +KE +L++ + P I
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ S+ L+I+MEY GG + I Q G E +I + ++++H +
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
+HRDIK+ NI LT+NG VK+ DFG + LT + T+VGTP+++ PE+ +N YN
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP-YNN 179
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251
K+DIWSLG + E+ + P ++ + + + L H+S ++ + K+
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRN 239
Query: 252 PAERPSAKELL 262
P RPSA +L
Sbjct: 240 PRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 83/261 (31%), Positives = 136/261 (52%), Gaps = 14/261 (5%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVL-SQCRSPYIT 74
L+ I +G+FG VY A + AIKV+ + +++++ +++ E +++ Q SPY+
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+ Y S+ + L+++MEY+ GG A LI++ L E + +++ +E LH G IH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIK N+L+ + G +K+ DFG L+R K FVGTP ++APE I G ++ +D
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFG----LSRNGLENKKFVGTPDYLAPETI-LGVGDDKMSD 175
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKV 251
WSLG + E G PP P V I P ++ E S + ++ L
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
Query: 252 PAERPSAK---ELLRHRFIRN 269
PA+R A E+ H F ++
Sbjct: 236 PAKRLGANGYQEIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 80/287 (27%), Positives = 135/287 (47%), Gaps = 35/287 (12%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCRSPY 72
++ L ++G G++G V K +K + VAIK + E+ ED + +E+ VL Q R
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHNEG 131
I ++ + +L+++ EY ++ +L+++ P L ++ + LL AI Y H+
Sbjct: 62 IVNLKEAFRRKGRLYLVFEY-VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLT-RTISRRKTFVGTPFWMAPEVIQNSEGYN 190
IHRDIK NIL++E+G +K+ DFG + L R S +V T ++ APE++ Y
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180
Query: 191 EKADIWSLGITVIEMAKGEP-------------------PLADLHPMRVL-------FII 224
+ D+W++G + E+ GEP PL H
Sbjct: 181 KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240
Query: 225 PRENPPQLDEH-----FSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
P + P+ E S +F+ CL+ P ER + ELL+H +
Sbjct: 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-39
Identities = 87/262 (33%), Positives = 136/262 (51%), Gaps = 10/262 (3%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL----EESEDEIEDIQKEISVLSQCR 69
R+ + +G+GSFG VY DK+ + +KV+ E + +E +E +LS+
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIE 125
P I +++ S+L + II EY G + ++ +G L E + LL +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
Y+H +HRD+KA NI L N +K+ DFGVS L + TF GTP++M+PE +++
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245
+GY+ K+DIWSLG + EM + + V+ I P L E +SR + +
Sbjct: 180 -QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238
Query: 246 LCLKKVPAERPSAKELLRHRFI 267
L K P+ RPSA E+LR+ FI
Sbjct: 239 SMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 5e-39
Identities = 92/275 (33%), Positives = 142/275 (51%), Gaps = 18/275 (6%)
Query: 5 AGLQEAAGSRFSSLE---LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKE 61
+G +A S LE IG G+ G VYK + + A+KVI + I +E
Sbjct: 63 SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE 122
Query: 62 ISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLL 121
I +L P + + + + H ++ +++E+M GGS ++ DE +A + R +L
Sbjct: 123 IEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS----LEGTHIADEQFLADVARQIL 178
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPE 181
I YLH +HRDIK +N+L+ +VK+ADFGVS L +T+ + VGT +M+PE
Sbjct: 179 SGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPE 238
Query: 182 VIQ---NSEGYNEKA-DIWSLGITVIEMAKGEPPLA-----DLHPMRVLFIIPRENPPQL 232
I N Y+ A DIWSLG++++E G P D + + I PP+
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL--MCAICMSQPPEA 296
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
SR + F+S CL++ PA+R SA +LL+H FI
Sbjct: 297 PATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 81/246 (32%), Positives = 131/246 (53%), Gaps = 12/246 (4%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI--EDIQKEISVLSQCRSPYITEYYG 78
IGRG F +VY+A K VA+K + + E D +D KEI +L Q P + +Y
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 79 SYLHQTKLWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
S++ +L I++E G ++ +I + + E ++ L A+E++H+ +H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH 129
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIK AN+ +T G VK+ D G+ + + + VGTP++M+PE I + GYN K+D
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSD 188
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLKK 250
IWSLG + EMA + P M + + + + PP EH+S ++E VS+C+
Sbjct: 189 IWSLGCLLYEMAALQSPFYG-DKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYP 247
Query: 251 VPAERP 256
P +RP
Sbjct: 248 DPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 78/284 (27%), Positives = 135/284 (47%), Gaps = 49/284 (17%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI---DLEESEDEIEDIQKEISVLSQCR 69
F +++IGRG+FG+V+ DK+ + A+KV+ D+ + +I ++ E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRN-QIAHVRAERDILADAD 59
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
SP+I + Y S+ + L+++MEYM GG + +L+ E + + +L+ A++ +H
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQL---------------------------- 161
G IHRDIK NIL+ +G +K+ADFG+ ++
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 162 -TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV 220
+ R + VGTP ++APEV++ Y + D WSLG+ + EM G PP
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPPFYS------ 232
Query: 221 LFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
L E +++++ SL P P A +L+
Sbjct: 233 ---------DTLQETYNKIINWKESLRFPPDPPVSPEAIDLICR 267
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 3e-38
Identities = 80/299 (26%), Positives = 138/299 (46%), Gaps = 58/299 (19%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ--KEISVLSQCRSPY 72
+ + IG G++G VYKA +K+ + VA+K I +E ++ I +EI +L + R P
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGF-PITAIREIKLLQKLRHPN 59
Query: 73 ITEYYGSYLHQTK--LWIIMEYM----AGGSVADLIQSGP-PLDEMSIACILRDLLHAIE 125
I + K ++++ EYM G L+ S E I C ++ LL ++
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLLEGLQ 114
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF-----VGTPFWMAP 180
YLH+ G +HRDIK +NIL+ +G +K+ADFG L R ++R + V T ++ P
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGVLKLADFG----LARPYTKRNSADYTNRVITLWYRPP 170
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLA---DLHPMRVLFII------------- 224
E++ + Y + D+WS+G + E+ G+P +L + +F +
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230
Query: 225 --PRENPPQLDEHFSRLMKEFVS--------------LCLKKVPAERPSAKELLRHRFI 267
P + + + R ++EF L L P +R SA + L+H +
Sbjct: 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLD--PKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-37
Identities = 92/302 (30%), Positives = 153/302 (50%), Gaps = 49/302 (16%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F + +G G+ G V+K K +A K+I LE I +E+ VL +C SPYI
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI- 133
+YG++ ++ I ME+M GGS+ +++ + E + + ++ + YL + KI
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 126
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRD+K +NIL+ G++K+ DFGVS QL +++ +FVGT +M+PE +Q + Y+ ++
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTH-YSVQS 183
Query: 194 DIWSLGITVIEMA----------------------KGEPPLADLHP-------------- 217
DIWS+G++++EMA +G+P ++ P
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGP 243
Query: 218 --------MRVLFIIPRENPPQLDE-HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268
+L I E PP+L F ++FV+ CL K PAER K+L+ H FI+
Sbjct: 244 DSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK 303
Query: 269 NA 270
+
Sbjct: 304 RS 305
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 79/285 (27%), Positives = 129/285 (45%), Gaps = 34/285 (11%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVLSQCRSPYI 73
+ L IG G++G VYKA DK + VAIK I L + I +EI +L + P I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + H+ L+++ E+M + LI+ L E I L LL + + H+ G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQNSEGYNE 191
+HRD+K N+L+ G +K+ADFG A+ + R T +V T ++ APE++ +GY+
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFG-LARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178
Query: 192 KADIWSLGITVIEMAKGEPPL---ADL----HPMRVL-------------------FIIP 225
DIWS+G E+ P +++ R L F P
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238
Query: 226 RENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFI 267
++ L + F + + L L P +R +A++ L H +
Sbjct: 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 9e-36
Identities = 77/259 (29%), Positives = 130/259 (50%), Gaps = 19/259 (7%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKD-VAIKVI---------DLEESEDEIEDIQKEISV 64
++ LE +G G+FG VYK K ++ +A+K I D E + I DI E+++
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 65 L-SQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRD 119
+ Q R P I YY ++L +L+I+M+ + G + + S E I I
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 120 LLHAIEYLHNEGKI-HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM 178
++ A+ YLH E +I HRD+ NI+L E+ V + DFG++ Q S+ + VGT +
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSVVGTILYS 180
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-IIPRENPPQLDEHFS 237
PE+++N E Y EKAD+W+ G + +M +PP + + + I+ P + +S
Sbjct: 181 CPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239
Query: 238 RLMKEFVSLCLKKVPAERP 256
+ + ++ CL RP
Sbjct: 240 EDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 66/207 (31%), Positives = 113/207 (54%), Gaps = 6/207 (2%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS 70
++ +G G+FG V+ D+ A+KV+ + E + + + E VL +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P+I + + Q L+++MEY+ GG + +++ + +++ A+EYLH++
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
++RD+K NILL + G +K+ DFG + +L R T GTP ++APEVIQ S+G+N
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWTLCGTPEYLAPEVIQ-SKGHN 176
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHP 217
+ D W+LGI + EM G PP D +P
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 62/204 (30%), Positives = 111/204 (54%), Gaps = 14/204 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L +IG+G+FG V ++ K A+K ++ ++ + + ++ E +L + P+
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAIEYLHN 129
+ + S+ + ++++++ + GG DL + E + + +++ A+EYLH+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGG---DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTPFWMAPEVIQNSE 187
+G IHRDIK NILL E G V + DF ++ ++T T GTP +MAPEV+ +
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTSTSGTPGYMAPEVLC-RQ 174
Query: 188 GYNEKADIWSLGITVIEMAKGEPP 211
GY+ D WSLG+T E +G+ P
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 8e-35
Identities = 87/284 (30%), Positives = 140/284 (49%), Gaps = 31/284 (10%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVLSQCRSPY 72
++ +L L+G GS+G V K KE + VAIK E + ++ I +EI +L Q R
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + + +L+++ E++ + DL + LDE + L +L IE+ H+
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNI 121
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRDIK NIL++++G VK+ DFG + L +V T ++ APE++ Y
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRA 181
Query: 193 ADIWSLGITVIEMAKGEPPL---ADL----HPMRVL-FIIPR------ENP-------PQ 231
DIW++G V EM GEP +D+ H ++ L +IPR +NP P+
Sbjct: 182 VDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE 241
Query: 232 LDE---------HFSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
+ E S L+ + CL+ P +RPS+ +LL H F
Sbjct: 242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 93/304 (30%), Positives = 150/304 (49%), Gaps = 51/304 (16%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F + +G G+ G V K K +A K+I LE I +E+ VL +C SPYI
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI- 133
+YG++ ++ I ME+M GGS+ +++ + E + + +L + YL + +I
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIM 126
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRD+K +NIL+ G++K+ DFGVS QL +++ +FVGT +M+PE +Q + Y+ ++
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTH-YSVQS 183
Query: 194 DIWSLGITVIEMAKGEPPLA---------------------------------------- 213
DIWS+G++++E+A G P+
Sbjct: 184 DIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGH 243
Query: 214 --DLHPMRVLF----IIPRENPPQLDEH-FSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
D P +F I E PP+L F+ +EFV+ CL K PAER K L+ H F
Sbjct: 244 GMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303
Query: 267 IRNA 270
I+ +
Sbjct: 304 IKRS 307
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-34
Identities = 76/247 (30%), Positives = 131/247 (53%), Gaps = 14/247 (5%)
Query: 21 IGRGSFGDVYKA---FDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
IGRG F +VY+A D +++ DL +++ D KEI +L Q P + +YY
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHPNVIKYY 68
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPP----LDEMSIACILRDLLHAIEYLHNEGKI 133
S++ +L I++E G ++ +I+ + E ++ L A+E++H+ +
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVM 128
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIK AN+ +T G VK+ D G+ + + + VGTP++M+PE I + GYN K+
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKS 187
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLK 249
DIWSLG + EMA + P M + + + + PP +H+S +++ V++C+
Sbjct: 188 DIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCIN 246
Query: 250 KVPAERP 256
P +RP
Sbjct: 247 PDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 80/296 (27%), Positives = 133/296 (44%), Gaps = 47/296 (15%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ----KEISVLSQCR 69
R+ + +G G++ VYKA DKE + VAIK I L E ++ + I +EI +L + +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSG-PPLDEMSIACILRDLLHAIE 125
P I + H++ + ++ E+M DL I+ L I + L +E
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET----DLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI---SRRKTF-VGTPFWMAPE 181
YLH+ +HRD+K N+L+ +G +K+ADFG L R+ +R+ T V T ++ APE
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFG----LARSFGSPNRKMTHQVVTRWYRAPE 172
Query: 182 VIQNSEGYNEKADIWSLGITVIEMAKGEPPLA---DLHPMRVLFII---PREN------- 228
++ + Y D+WS+G E+ P L D+ + +F P E
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 229 -----------PPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRNA 270
P L + F + + L L P +R +A++ L H + N
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 70/219 (31%), Positives = 117/219 (53%), Gaps = 13/219 (5%)
Query: 9 EAAGSRFSSLEL---IGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEIS 63
+ + + S E+ +G GSFG V A K + AIK + E +++ + +E S
Sbjct: 11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKS 70
Query: 64 VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV-ADLIQSGP-PLDEMSIACILRDLL 121
+L + P+I S+ + +++ ++E++ GG + L ++G P D +L+
Sbjct: 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA--ELV 128
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPE 181
A EYLH++ I+RD+K N+LL G VKV DFG + ++ R T GTP ++APE
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---DRTFTLCGTPEYLAPE 185
Query: 182 VIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV 220
VIQ S+G+ + D W++G+ + E G PP D P R+
Sbjct: 186 VIQ-SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223
|
Length = 329 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 85/326 (26%), Positives = 138/326 (42%), Gaps = 64/326 (19%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI-DLEESEDEIEDIQKEISVLSQCRSPY 72
R+ L+ IG G++G V A DK + VAIK I ++ + + + I +EI +L R
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 73 ITE-----YYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAI 124
I S ++I+ E M DL I+S PL + I L +L +
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELME----TDLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI------SRRKT-FVGTPFW 177
+YLH+ IHRD+K +NIL+ N D+K+ DFG L R + T +V T ++
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFG----LARGVDPDEDEKGFLTEYVVTRWY 172
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP--PLAD-LHPMRVLF------------ 222
APE++ +S Y + DIWS+G E+ +P P D + + ++
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232
Query: 223 IIPREN--------PPQLDEHFSRLMKE-------FVSLCLKKVPAERPSAKELLRHRFI 267
I E P + + S+L + L P +R +A E L H +
Sbjct: 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY- 291
Query: 268 RNARKSPRLLERIRERPKYPIQEEPD 293
L ++ + P+ + P
Sbjct: 292 ---------LAQLHDPEDEPVAKPPF 308
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 76/261 (29%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQC-RSPYITEY 76
++G+GSFG V A K ++ A+KV+ D+ +D++E E VL+ + P++T+
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
+ + + +L+ +MEY+ GG + IQ DE +++ +++LH G I+RD
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
+K N+LL G +K+ADFG+ + TF GTP ++APE++ Y D W
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP-YGPAVDWW 180
Query: 197 SLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC---LKKVPA 253
+LG+ + EM G+ P + LF E+ + S KE S+ L K P
Sbjct: 181 ALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLS---KEAKSILKSFLTKNPE 236
Query: 254 ER-----PSAKELLRHRFIRN 269
+R +++ H F R
Sbjct: 237 KRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 77/254 (30%), Positives = 130/254 (51%), Gaps = 5/254 (1%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEY 76
+ ++G+GS+G+V + K IK ++L S E + ++E +LSQ + P I Y
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 77 YGSYLHQT-KLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
S+ + L+I+M + GG + + Q G L E + + A++YLH + +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL 124
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRD+K N+ LT +KV D G++ L T +GTP++M+PE+ N YN K+
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP-YNYKS 183
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPA 253
D+W+LG V EMA + +++ I P + + +S + E ++ L K P
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPE 243
Query: 254 ERPSAKELLRHRFI 267
+RPS K +LR +I
Sbjct: 244 KRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 81/291 (27%), Positives = 129/291 (44%), Gaps = 60/291 (20%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVI-----DLEE--SEDEIEDIQKEISVLSQCRSPYI 73
+G G+FG VY A +KE + VAIK + EE + E++ ++K L+ P I
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRK----LN--EHPNI 60
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG 131
+ + +L+ + EYM G ++ L++ G P E I I+ +L + ++H G
Sbjct: 61 VKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF---VGTPFWMAPEVIQNSEG 188
HRD+K N+L++ VK+ADFG L R I R + V T ++ APE++ S
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFG----LAREIRSRPPYTDYVSTRWYRAPEILLRSTS 175
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHP-----------MRVL---------------- 221
Y+ DIW+LG + E+ P L P VL
Sbjct: 176 YSSPVDIWALGCIMAELYTLRP----LFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231
Query: 222 ---FIIPRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRF 266
F P+ P L + E + L L+ P +RP+A + L+H +
Sbjct: 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 6/201 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVID--LEESEDEIEDIQKEISVLSQCRSPY 72
F L +G+G +G V+ A K+ + VA+K + L +E+ + E +L+ +S +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + ++ L++ MEY+ GG L+ + L E + ++ A++ LH G
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRD+K N L+ +G +K+ DFG+S ++ + VG+P +MAPEV++ +GY+
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKG---IVTYANSVVGSPDYMAPEVLR-GKGYDFT 178
Query: 193 ADIWSLGITVIEMAKGEPPLA 213
D WSLG + E G PP +
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 89/316 (28%), Positives = 147/316 (46%), Gaps = 60/316 (18%)
Query: 18 LELIGRGSFGD---VYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYI 73
L +IGRG F D V A K + V ++ I+LE + + + +Q E+ V P I
Sbjct: 3 LTVIGRG-FEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNI 61
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG 131
Y +++ +LW++ +MA GS DLI + + E++IA IL+ +L A++Y+H+ G
Sbjct: 62 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-------WMAPEVI- 183
+HR +KA++IL++ +G V ++ + + R + P W++PEV+
Sbjct: 122 YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQ 181
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--------------IIP---- 225
QN +GY+ K+DI+S+GIT E+A G P D+ ++L IP
Sbjct: 182 QNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL 241
Query: 226 ----------------------RENPPQLDEH-----FSRLMKEFVSLCLKKVPAERPSA 258
R + + H FS FV CL++ P RPSA
Sbjct: 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA 301
Query: 259 KELLRHRFIRNARKSP 274
LL H F + ++
Sbjct: 302 STLLNHSFFKQIKRRA 317
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 7e-32
Identities = 87/279 (31%), Positives = 141/279 (50%), Gaps = 7/279 (2%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQC-RSPYITE 75
+++G+GSFG V+ A K N+ AIK + D+ +D++E E VLS P++T
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
Y ++ + L+ +MEY+ GG + IQS D +++ +++LH++G ++R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K NILL +G +K+ADFG+ + ++ TF GTP ++APE++ + YN D
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNTSVDW 179
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255
WS G+ + EM G+ P H LF R + P +R K+ + + P R
Sbjct: 180 WSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERR 238
Query: 256 PSAKELLR-HRFIRNARKSPRLLERIRERPKYPIQEEPD 293
K +R H F R S L ER E P P + +
Sbjct: 239 LGVKGDIRQHPFFREIDWS-ALEEREIEPPFKPKVKSAN 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 81/288 (28%), Positives = 128/288 (44%), Gaps = 44/288 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI-EDIQKEISVLSQCRS---PYI 73
L IG G++G VYKA D + VA+K + + SE+ I +EI++L Q S P I
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 74 TEYY----GSYL-HQTKLWIIMEYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEY 126
G + KL ++ E++ +A + P L +I ++R LL +++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
LH+ +HRD+K NIL+T +G VK+ADFG++ + + V T ++ APEV+ S
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-MALTSVVVTLWYRAPEVLLQS 181
Query: 187 EGYNEKADIWSLGITVIEMAKGEP--------------------PLADLHPMRVLFIIPR 226
Y D+WS+G E+ + P P + P V PR
Sbjct: 182 S-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL--PR 238
Query: 227 EN-PPQLDEHFSRLMKE-------FVSLCLKKVPAERPSAKELLRHRF 266
+ P F + E + L P +R SA E L+H +
Sbjct: 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 66/205 (32%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIE-DIQKEISVLSQCRSP 71
+ F L IG G++G VY+A D + VA+K + ++ D I +EI++L R P
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 72 YITEYY----GSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEY 126
I E G +L ++++MEY +A L+ + P P E + C++ LL ++Y
Sbjct: 67 NIVELKEVVVGKHL--DSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQN 185
LH IHRD+K +N+LLT+ G +K+ADFG+ A+ ++ T V T ++ APE++
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGCLKIADFGL-ARTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 186 SEGYNEKADIWSLGITVIEMAKGEP 210
Y D+W++G + E+ +P
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 80/257 (31%), Positives = 133/257 (51%), Gaps = 14/257 (5%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLS-QCRSPYITEY 76
++G+GSFG V A K N+ AIK + D+ +D++E E VL+ P++T
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
+ ++ + L+ +MEY+ GG + IQS DE +++ +++LH +G I+RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
+K N+LL ++G +K+ADFG+ + + TF GTP ++APE+++ + YNE D W
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK-GQKYNESVDWW 180
Query: 197 SLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----P 252
S G+ + EM G+ P + I + P HF R + + CL K+ P
Sbjct: 181 SFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP-----HFPRWISKEAKDCLSKLFERDP 235
Query: 253 AERPSAKELLR-HRFIR 268
+R +R H F R
Sbjct: 236 TKRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 86/311 (27%), Positives = 136/311 (43%), Gaps = 59/311 (18%)
Query: 21 IGRG--SFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
IGRG + VY A V +++ DLE +E+ ++ +Q E+ + R P I +
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYLHNEGKIHR 135
+ + LW+I +MA GS L+++ P + E I IL L + YLH G IHR
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHR 125
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-------WMAPEVI-QNSE 187
+IKA++IL++ +G V ++ L R + K P W++PE++ Q+
Sbjct: 126 NIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY 185
Query: 188 GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--------------IIPRENPPQLD 233
GYN K+DI+S+GIT E+A G P D+ ++L P E +
Sbjct: 186 GYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKN 245
Query: 234 EH--------------------------------FSRLMKEFVSLCLKKVPAERPSAKEL 261
FS + V LCL++ P +RPSA L
Sbjct: 246 SQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSL 305
Query: 262 LRHRFIRNARK 272
L H F + ++
Sbjct: 306 LSHAFFKQVKE 316
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 9/209 (4%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L+GRG FG+V +K A+KV+ +++ + ++E +LS SP+
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEG 131
I + ++ + L+++MEY GG + L+ + DE L +L+ AI +H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGTPFWMAPEVIQNSEGYN 190
+HRDIK N+L+ G +K+ADFG +A+LT + K VGTP ++APEV+ G
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 191 EKA-----DIWSLGITVIEMAKGEPPLAD 214
+ D WSLG+ EM G P +
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 85/325 (26%), Positives = 139/325 (42%), Gaps = 60/325 (18%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F S+++IGRG+FG+V K+ A+K + E ++++ ++ E +L++ +P+
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + Y S+ + L++IMEY+ GG + L+ E + + + AI+ +H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISR------------------RKTF--- 171
IHRDIK N+LL G +K++DFG+ L ++ K
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 172 -----------------VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD 214
VGTP ++APEV + GYN++ D WSLG+ + EM G PP
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 215 LHPM---------RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHR 265
+P + P E P L L+K C + E+ H
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVP--LSPEAKDLIKRL--CCEAERRLGNNGVNEIKSHP 297
Query: 266 FIRNARKSPRLLERIRERPK-YPIQ 289
F + E IRERP +
Sbjct: 298 FFKGVD-----WEHIRERPAPIIPE 317
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 77/280 (27%), Positives = 125/280 (44%), Gaps = 19/280 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVL---SQCR 69
F L ++GRG FG V A K+ + AIK + + + DE+E + E + + R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS---GPPLDEMSIACILRDLLHAIEY 126
P++ + + + + +MEY AGG + I + P AC++ ++Y
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL----GLQY 116
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
LH ++RD+K N+LL G VK+ADFG+ + R TF GTP ++APEV+ +
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET 176
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246
Y D W LG+ + EM GE P V I + SR +
Sbjct: 177 S-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR-YPRFLSREAISIMRR 234
Query: 247 CLKKVPAER-----PSAKELLRHRFIRNARKSPRLLERIR 281
L++ P R A+++ + F R+ L +I+
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIK 274
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 16/265 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLS-QCRSP 71
F+ L ++G+GSFG V A K ++ AIK++ D+ +D++E E VL+ + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
++T+ + + +L+ +MEY+ GG + IQ E ++ + +LH++G
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
I+RD+K N++L G +K+ADFG+ + +TF GTP ++APE+I + Y +
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY-QPYGK 180
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC---L 248
D W+ G+ + EM G+PP D LF E+ + S+ E VS+C L
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYPKSLSK---EAVSICKGLL 236
Query: 249 KKVPAER----PSAKELLR-HRFIR 268
K PA+R P+ + +R H F R
Sbjct: 237 TKHPAKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 66/196 (33%), Positives = 107/196 (54%), Gaps = 4/196 (2%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRS-PYITE 75
+++G+GSFG V A K ++ AIKV+ D+ +D+++ E +L+ P++T
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
+ + + +L+ +MEY+ GG + IQ DE ++ A+ +LH G I+R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K NILL G K+ADFG+ + TF GTP ++APE++Q E Y D
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE-YGPSVDW 179
Query: 196 WSLGITVIEMAKGEPP 211
W+LG+ + EM G+PP
Sbjct: 180 WALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 90/307 (29%), Positives = 148/307 (48%), Gaps = 34/307 (11%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRS-PYITE 75
++G+GSFG V A KE + A+KV+ D+ +D++E E +LS R+ P++T+
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
Y + +L+ +ME++ GG + IQ DE ++ A+ +LH++G I+R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K N+LL G K+ADFG+ + TF GTP ++APE++Q Y D
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ-EMLYGPSVDW 179
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKVP 252
W++G+ + EM G P + + I + P L + ++K F + K P
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF----MTKNP 235
Query: 253 AERPSA------KELLRHRFIR-------NARK-SPRLLERIRER-------PKYPIQEE 291
R + + +LRH F + N R+ P RI+ R P + I+E+
Sbjct: 236 TMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDF-IKED 294
Query: 292 PD-TPIN 297
P TPI
Sbjct: 295 PVLTPIE 301
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 84/277 (30%), Positives = 142/277 (51%), Gaps = 29/277 (10%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F +++LI G++G VY KE + A+K I+ + ++I+ + E +L+ +P+
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLD-EMSIACILRDLLHAIEYLHNEG 131
+ + S+ + L ++MEY+ GG A L+++ L +M+ +L A+EYLHN G
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLHNYG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVS----------------AQLTRTISRRKTFVGTP 175
+HRD+K N+L+T G +K+ DFG+S + TR ++ GTP
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTP 180
Query: 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--IIPRE-NPPQL 232
++APEVI +GY + D W++GI + E G P P LF +I + P+
Sbjct: 181 EYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIEWPEG 238
Query: 233 DEHFSRLMKEFVSLCLKKVPAER---PSAKELLRHRF 266
DE ++ +S L++ P ER A E+ +HRF
Sbjct: 239 DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 79/305 (25%), Positives = 132/305 (43%), Gaps = 59/305 (19%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQK------------EISVLSQ 67
+G G++G V KA+D K VAIK + + E S D +D Q E+ ++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 68 CRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
+ I Y+ + ++M+ MA + ++ L E + CIL +L+ + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQ-----LTRTISRRKTF---------VG 173
H +HRD+ ANI + G K+ADFG++ + + T+S+ +T V
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV 195
Query: 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP----------------------- 210
T ++ APE++ +E Y+ D+WS+G E+ G+P
Sbjct: 196 TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNE 255
Query: 211 ---PLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVSLCLKKVPAERPSAKELLRH 264
P A P+ F P L F S + + LK P ER SAKE L+H
Sbjct: 256 DNWPQAKKLPLYTEF--TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313
Query: 265 RFIRN 269
+ ++
Sbjct: 314 EYFKS 318
|
Length = 335 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 76/267 (28%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 21 IGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+G+GSFG VY+ K + K VAIK ++ S E + E SV+ + ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDE----MSIACILRDLLHAIE------ 125
G ++ME MA G + ++S P E + + + + A E
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT-PF-WMAPEVI 183
YL + +HRD+ A N ++ E+ VK+ DFG++ + T RK G P WMAPE +
Sbjct: 134 YLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193
Query: 184 QNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL-FIIPR------ENPPQLDEH 235
++ + K+D+WS G+ + EMA E P L VL F+I EN P
Sbjct: 194 KDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPD---- 248
Query: 236 FSRLMKEFVSLCLKKVPAERPSAKELL 262
+ E + +C + P RP+ E++
Sbjct: 249 ---KLLELMRMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 74/293 (25%), Positives = 137/293 (46%), Gaps = 52/293 (17%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE---IEDIQKEISVLSQCRSP 71
+ L I G++G VY+A DK+ + VA+K + +E+ E E I + +EI++L + + P
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSL-REINILLKLQHP 64
Query: 72 YITEY----YGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEY 126
I GS + K++++MEY+ + L+++ P + + C++ LL + +
Sbjct: 65 NIVTVKEVVVGS--NLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
LH+ +HRD+K +N+LL G +K+ DFG++ + + V T ++ APE++ +
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------PREN------------ 228
+ Y+ D+WS+G E+ +P + L I P E
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241
Query: 229 ------PP--QLDEHFSR---------LMKEFVSLCLKKVPAERPSAKELLRH 264
P QL + F L+ ++ PA+R SA++ L+H
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYD----PAKRISAEDALKH 290
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 35/286 (12%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE--IEDIQ-KEISVLSQCRS 70
++ L IG GS+G V+K ++E + VAIK ESED+ I+ I +EI +L Q +
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P + + + KL ++ EY + +L ++ + E I I+ L A+ + H
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
IHRD+K NIL+T+ G +K+ DFG + LT +V T ++ APE++ Y
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179
Query: 191 EKADIWSLGITVIEMAKGEP----------------PLADLHP-----------MRVLFI 223
D+W++G E+ G+P L DL P + L I
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239
Query: 224 IPRENPPQLDEHFSRLMK---EFVSLCLKKVPAERPSAKELLRHRF 266
E L+ F + F+ CL+ P ER S +ELL H +
Sbjct: 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 80/286 (27%), Positives = 139/286 (48%), Gaps = 15/286 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEY 76
+L+G+G+FG V +K K A+K++ E ++DE+ E VL R P++T
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
S+ +L +MEY GG + + E +++ A+ YLH+ ++RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
+K N++L ++G +K+ DFG+ + + KTF GTP ++APEV+++++ Y D W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWW 179
Query: 197 SLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKVPA 253
LG+ + EM G P + ++ +I E P L K ++ LKK P
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE----AKSLLAGLLKKDPK 235
Query: 254 ER-----PSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDT 294
+R AKE++ HRF + + +++ K + E DT
Sbjct: 236 QRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDT 281
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 80/261 (30%), Positives = 127/261 (48%), Gaps = 15/261 (5%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVL---SQCRSPYITE 75
IG+G+FG VY+ K+ + A+KV+ +E ++ E+ E ++L SP+I
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
S+ + L+++ +YM+GG + +Q E + +L+ A+E+LH ++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 136 DIKAANILLTENGDVKVADFGVS-AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
D+K NILL G + + DFG+S A LT TF GT ++APEV+ + +GY + D
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVD 179
Query: 195 IWSLGITVIEMAKGEPPL--ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252
WSLG+ V EM G P D M + P+ S ++FV L + P
Sbjct: 180 FWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK--NVLSDEGRQFVKGLLNRNP 237
Query: 253 AER----PSAKELLRHRFIRN 269
R A EL H F +
Sbjct: 238 QHRLGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 79/282 (28%), Positives = 131/282 (46%), Gaps = 33/282 (11%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVLSQCRSPYI 73
++ +E IG G++G VYK +K+ + VA+K I LE E+ + +EIS+L + + P I
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 74 TEYYGSYLHQTKLWIIMEY--MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ +++L++I E+ M D + G +D + L +L I + H+
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
+HRD+K N+L+ G +K+ADFG++ + V T ++ APEV+ S Y+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------------------------PR 226
DIWS+G EMA +P + LF I P+
Sbjct: 182 PVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPK 241
Query: 227 ENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRH 264
L L ++ + L L+K+ PA+R SAK+ L H
Sbjct: 242 WKKGSLRSAVKNLDEDGLDL-LEKMLIYDPAKRISAKKALNH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 88/295 (29%), Positives = 148/295 (50%), Gaps = 27/295 (9%)
Query: 18 LELIGRGSFGDVY---KAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQCRSP 71
L+++G+G +G V+ K + K A+KV+ + ++ + + E ++L + P
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 72 YITEYYGSYLHQT--KLWIIMEYMAGGSV-ADLIQSGPPLDEMSIACI-LRDLLHAIEYL 127
+I + Y QT KL++I+EY++GG + L + G +++ AC L ++ A+E+L
Sbjct: 61 FIVDLI--YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDT--ACFYLSEISLALEHL 116
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSE 187
H +G I+RD+K NILL G VK+ DFG+ + + TF GT +MAPE++ S
Sbjct: 117 HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS- 175
Query: 188 GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFV 244
G+ + D WSLG + +M G PP + + + I + PP L L+K+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKL- 234
Query: 245 SLCLKKVPAER----PS-AKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDT 294
LK+ P+ R P A E+ H F R+ L ++ K +Q E D
Sbjct: 235 ---LKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDV 286
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 78/268 (29%), Positives = 129/268 (48%), Gaps = 17/268 (6%)
Query: 15 FSSLELIGRGSFGDVY---KAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQC 68
F L ++G G++G V+ K + K A+KV+ + + E + E VL
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 69 R-SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
R P++ + ++ TKL +I++Y+ GG + + E + + +++ A+++L
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQ-LTRTISRRKTFVGTPFWMAPEVIQN- 185
H G I+RDIK NILL G V + DFG+S + L R +F GT +MAPEVI+
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPL----ADLHPMRVLFIIPRENPPQLDEHFSRLMK 241
S G+++ D WSLG+ E+ G P + I + PP + S +
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP-FPKTMSAEAR 240
Query: 242 EFVSLCLKKVPAER---PSAKELLRHRF 266
+F+ L+K P +R A E+ H F
Sbjct: 241 DFIQKLLEKDPKKRLGANGADEIKNHPF 268
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 80/267 (29%), Positives = 127/267 (47%), Gaps = 33/267 (12%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNK-DVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
S + L+ +G G FG V+ K K DVAIK+I E + E +D +E V+ + P
Sbjct: 4 SELTFLKELGSGQFGVVHLG--KWRGKIDVAIKMIR-EGAMSE-DDFIEEAKVMMKLSHP 59
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSI---ACILRDLLHAIEYLH 128
+ + YG Q ++I+ EYMA G + + ++ C D+ A+EYL
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS--DVCEAMEYLE 117
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRRKTFVGTPF---WMAPEVI 183
+ G IHRD+ A N L+ E+ VKV+DFG L R + + + GT F W PEV
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFG----LARYVLDDQYTSSQGTKFPVKWAPPEVF 173
Query: 184 QNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVL------FIIPRENPPQLDEHF 236
S ++ K+D+WS G+ + E+ ++G+ P V+ + + R P
Sbjct: 174 DYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR--PKLAPTEV 230
Query: 237 SRLMKEFVSLCLKKVPAERPSAKELLR 263
+M C + P +RP+ K+LL
Sbjct: 231 YTIMY----SCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 70/232 (30%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS 70
F ++L+G+G G V+ K K A+KV+D +E ++++ + E +L+
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYLH 128
P++ Y S+ +T L ++M+Y GG + L+Q P L E ++L A+EYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 129 NEGKIHRDIKAANILLTENGDVKVADF------------------------GVSAQLTRT 164
G ++RD+K NILL E+G + ++DF V++ + T
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 165 IS-----RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPP 211
S R +FVGT ++APEVI + +G+ D W+LGI + EM G P
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVI-SGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 76/259 (29%), Positives = 135/259 (52%), Gaps = 30/259 (11%)
Query: 18 LELIGRGSFGDVY---KAFDKELNKDVAIKVIDLEESEDEIED---IQKEISVLSQCRSP 71
L+++G+GSFG V+ K + + A+KV L+++ ++ D + E +L++ P
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKV--LKKATLKVRDRVRTKMERDILAEVNHP 58
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+I + + ++ + KL++I++++ GG + + E + L +L A+++LH+ G
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
I+RD+K NILL E G +K+ DFG+S + + +F GT +MAPEV+ N G+ +
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQ 177
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL-MKEFVSLCLKK 250
AD WS G+ + EM G P + +I + ++L M +F+S
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK----------AKLGMPQFLS----- 222
Query: 251 VPAERPSAKELLRHRFIRN 269
P A+ LLR F RN
Sbjct: 223 -----PEAQSLLRALFKRN 236
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 7e-28
Identities = 75/255 (29%), Positives = 132/255 (51%), Gaps = 9/255 (3%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEY 76
+L+G+G+FG V +K K A+K++ E ++DE+ E VL R P++T
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
S+ + +L +MEY+ GG + + E +++ A++YLH+ ++RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
+K N++L ++G +K+ DFG+ + + KTF GTP ++APEV+++++ Y D W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND-YGRAVDWW 179
Query: 197 SLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER- 255
LG+ + EM G P + ++ +I E+ + S K +S L K P +R
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMED-IKFPRTLSADAKSLLSGLLIKDPNKRL 238
Query: 256 ----PSAKELLRHRF 266
AKE++RH F
Sbjct: 239 GGGPDDAKEIMRHSF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 86/312 (27%), Positives = 128/312 (41%), Gaps = 67/312 (21%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDI--QKEISVLSQCRS 70
+ L +G G+FG+VYKA + + VA+K I L +E + I +EI +L + +
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKH 66
Query: 71 PYIT-------EYYGSYLHQTK-LWIIMEYMAGGSVADL--IQSGPP--LDEMSIACILR 118
P + E + ++++ YM DL + P L E I C +
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYM----DHDLSGLLENPSVKLTESQIKCYML 122
Query: 119 DLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR-------------TI 165
LL I YLH +HRDIKAANIL+ G +K+ADFG L R
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG----LARPYDGPPPNPKGGGGG 178
Query: 166 SRRK--TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLA---DLHPMRV 220
RK V T ++ PE++ Y DIW +G EM P L D+ + +
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238
Query: 221 LFII---PREN--------------------PPQLDEHFSRLMKEFVSLC---LKKVPAE 254
+F + P E P L+E F +L E + L L P +
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298
Query: 255 RPSAKELLRHRF 266
R +A + L H +
Sbjct: 299 RLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 84/277 (30%), Positives = 123/277 (44%), Gaps = 50/277 (18%)
Query: 16 SSLEL---IGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
SL+L +G G FG+V+ N VA+K L+ E +E ++ + R
Sbjct: 6 ESLKLERKLGAGQFGEVWMGT---WNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRH 60
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMS--IACILRDLL 121
+ + Y + ++I+ EYM+ GS+ D ++SG P L +M+ IA
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA------- 113
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK--TFVGTPF--- 176
+ YL + IHRD+ A NIL+ EN K+ADFG L R I + G F
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFG----LARLIEDDEYTAREGAKFPIK 169
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVL------FIIPRENP 229
W APE N + K+D+WS GI + E + G P + VL + +PR P
Sbjct: 170 WTAPEAA-NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR--P 226
Query: 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
P E LM + C K P ERP+ E L+
Sbjct: 227 PNCPEELYDLMLQ----CWDKDPEERPTF-EYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 76/260 (29%), Positives = 135/260 (51%), Gaps = 18/260 (6%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEY 76
+L+G+G+FG V +K + A+K++ E ++DE+ E VL R P++T
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI-HR 135
S+ +L +MEY GG + + E +++ A++YLH+E + +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K N++L ++G +K+ DFG+ + + + KTF GTP ++APEV+++++ Y D
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDW 179
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM----KEFVSLCLKKV 251
W LG+ + EM G P + ++ +I E + F R + K +S LKK
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----EIRFPRTLSPEAKSLLSGLLKKD 234
Query: 252 PAER-----PSAKELLRHRF 266
P +R AKE+++H+F
Sbjct: 235 PKQRLGGGPDDAKEIMQHKF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 82/285 (28%), Positives = 140/285 (49%), Gaps = 29/285 (10%)
Query: 15 FSSLELIGRGSFGDVY---KAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQC 68
F L+++G G++G V+ K + K A+KV+ L + +E + E +VL
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 69 R-SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
R SP++ + ++ + KL +I++Y++GG + + E + +++ A+E+L
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQ-LTRTISRRKTFVGTPFWMAPEVIQNS 186
H G ++RDIK NILL G V + DFG+S + L+ R +F GT +MAPE+I+
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246
G+ + D WSLGI + E+ G P F + E Q E R++K
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASP----------FTLEGERNTQ-SEVSRRILK----- 225
Query: 247 CLKKVPAE-RPSAKELLRHRFIRNARK----SPRLLERIRERPKY 286
C P+ P A++LL ++ +K P+ I+E P +
Sbjct: 226 CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 83/286 (29%), Positives = 142/286 (49%), Gaps = 15/286 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEY 76
+L+G+G+FG V +K + A+K++ E ++DE+ E VL R P++T
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
++ +L +MEY GG + + E +++ A+EYLH+ ++RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
IK N++L ++G +K+ DFG+ + + KTF GTP ++APEV+++++ Y D W
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWW 179
Query: 197 SLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKVPA 253
LG+ + EM G P + R+ +I E P L K ++ LKK P
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE----AKSLLAGLLKKDPK 235
Query: 254 ER----PS-AKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDT 294
+R PS AKE++ HRF + + +++ K + E DT
Sbjct: 236 QRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDT 281
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 92/317 (29%), Positives = 144/317 (45%), Gaps = 58/317 (18%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI---DLEESEDEIEDIQKEISVLSQCRSP 71
F SL++IGRG+FG+V K+ A+K++ D+ E E ++ I+ E +L + S
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE-QVGHIRAERDILVEADSL 61
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
++ + + S+ + L++IME++ GG + L+ L E + + + AI+ +H G
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRT----------------------ISRRK 169
IHRDIK N+LL G VK++DFG+ L + S+RK
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 170 -------------TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH 216
+ VGTP ++APEV + GYN+ D WSLG+ + EM G PP
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 217 PM---------RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
P + I P E P + E L+ F ++ A P +E+ + F
Sbjct: 241 PQETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCCEWEHRIGA--PGVEEIKTNPFF 296
Query: 268 RNARKSPRLLERIRERP 284
E IRERP
Sbjct: 297 EGVD-----WEHIRERP 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 76/251 (30%), Positives = 122/251 (48%), Gaps = 7/251 (2%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYG 78
IG+GSFG V + ++ + A+K I S E+ E +VL+Q P+I
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
S+ KL++++ ++ GG + +Q D +LL A+E LH I+RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSL 198
NILL G + + DFG+ + + TF GTP ++APE++ GY + D W+L
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL-GHGYTKAVDWWTL 179
Query: 199 GITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER--- 255
G+ + EM G PP D + + I +E P + + F R K+ + L + P R
Sbjct: 180 GVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFPDGFDRDAKDLLIGLLSRDPTRRLGY 238
Query: 256 PSAKELLRHRF 266
A+E+ H F
Sbjct: 239 NGAQEIKNHPF 249
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 88/317 (27%), Positives = 143/317 (45%), Gaps = 58/317 (18%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI---DLEESEDEIEDIQKEISVLSQCRSP 71
F SL++IGRG+FG+V K+ A+K++ D+ E E ++ I+ E +L +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE-QVAHIRAERDILVEADGA 61
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
++ + + S+ + L++IME++ GG + L+ L E + + + + AI+ +H G
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRT----------------------ISRRK 169
IHRDIK N+LL G VK++DFG+ L + S+RK
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 170 -------------TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH 216
+ VGTP ++APEV + GYN+ D WSLG+ + EM G PP
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 217 PM---------RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
P + + P E P + E L+ F + ++ + +E+ H F
Sbjct: 241 PQETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCTDSENRIGSN--GVEEIKSHPFF 296
Query: 268 RNARKSPRLLERIRERP 284
IRERP
Sbjct: 297 EGVD-----WGHIRERP 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 82/265 (30%), Positives = 136/265 (51%), Gaps = 16/265 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLS-QCRSP 71
F+ L ++G+GSFG V A K ++ AIK++ D+ +D++E E VL+ Q + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
++T+ + + +L+ +MEY+ GG + IQ E ++ + +LH G
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
I+RD+K N++L G +K+ADFG+ + +TF GTP ++APE+I + Y +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA-YQPYGK 180
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC---L 248
D W+ G+ + EM G+PP D LF E+ + S KE VS+C +
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYPKSLS---KEAVSICKGLM 236
Query: 249 KKVPAER----PSAKELLR-HRFIR 268
K P++R P + +R H F R
Sbjct: 237 TKHPSKRLGCGPEGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 72/264 (27%), Positives = 124/264 (46%), Gaps = 20/264 (7%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVID---LEESEDE-IEDIQKEISVLSQCRSPYITEY 76
+G+G FG+V K K A K +D L++ + E + +K+I L + S +I
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58
Query: 77 YGSYLHQTKLWIIMEYMAGGSVA-DLIQSGPP-LDEMSIACILRDLLHAIEYLHNEGKIH 134
++ + L ++M M GG + + G P E ++ +E+LH ++
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K N+LL ++G+V+++D G++ +L + K GTP +MAPEV+Q Y+ D
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPGYMAPEVLQGEV-YDFSVD 176
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRV----LFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
++LG T+ EM G P +V L E + + FS K+ L+K
Sbjct: 177 WFALGCTLYEMIAGRSPFRQ-RKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235
Query: 251 VPAER-----PSAKELLRHRFIRN 269
P +R SA E+ H ++
Sbjct: 236 DPEKRLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 61/186 (32%), Positives = 86/186 (46%), Gaps = 24/186 (12%)
Query: 96 GSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVAD 154
S+AD+++ G PL+E I + L A+ LH R K+ NILLT +G +K+
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELH------RQAKSGNILLTWDGLLKL-- 52
Query: 155 FGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD 214
G A T SR P++MAPEVIQ + Y EKADI+SLGIT+ E E P +
Sbjct: 53 DGSVAFKTPEQSR-----PDPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNE 106
Query: 215 LHPMRVLFIIPRENPPQLDEHFS---------RLMKEFVSLCLKKVPAERPSAKELLRHR 265
+ + I P D R ++F+ LC ++P R +A L H
Sbjct: 107 ERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166
Query: 266 FIRNAR 271
A
Sbjct: 167 RALFAE 172
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 46/278 (16%)
Query: 21 IGRGSFGDVYKA-FDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEY 76
+G G FG V +D + VA+K ++ E D ++EI +L I +Y
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 77 YG-SY-LHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYLHNEG 131
G L +IMEY+ GS+ D +Q D++++ +L + ++YL ++
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTP-----FWMAPEVIQ 184
IHRD+ A NIL+ VK++DFG L + + K + V P FW APE ++
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFG----LAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 185 NSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMR--VLFIIPRENPPQLDEHFSRLMK 241
S+ ++ +D+WS G+T+ E+ G+P P + I + + L+K
Sbjct: 186 TSK-FSSASDVWSFGVTLYELFTYGDP---SQSPPAEFLRMIGIAQGQMIV-TRLLELLK 240
Query: 242 EFVSL----------------CLKKVPAERPSAKELLR 263
E L C + P +RPS +L+
Sbjct: 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 78/255 (30%), Positives = 119/255 (46%), Gaps = 20/255 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
E IG+G+FGDVYK K N +VA+K D +E +L Q P I + G
Sbjct: 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 79 SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ + ++I+ME + GGS+ L + L + + D +EYL ++ IHRD+
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119
Query: 138 KAANILLTENGDVKVADFGVSAQ-----LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
A N L+ EN +K++DFG+S + T + ++ + W APE + N Y +
Sbjct: 120 AARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK---WTAPEAL-NYGRYTSE 175
Query: 193 ADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIP---RENPPQL-DEHFSRLMKEFVSLC 247
+D+WS GI + E + G+ P + + I R PQL E RLM C
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLML----QC 231
Query: 248 LKKVPAERPSAKELL 262
P RPS E+
Sbjct: 232 WAYDPENRPSFSEIY 246
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 75/268 (27%), Positives = 138/268 (51%), Gaps = 16/268 (5%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F +++IGRG+FG+V K + A+K++ E + +E +++ S +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I + + ++ L+++MEYM GG + +L+ S + E +++ A++ +H+ G
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDAIHSMGF 163
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGTPFWMAPEVIQNSEG--- 188
IHRD+K N+LL ++G +K+ADFG ++ + R T VGTP +++PEV+++ G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 189 YNEKADIWSLGITVIEMAKGEPP-LADLHPMRVLFIIPREN----PPQLD--EHFSRLMK 241
Y + D WS+G+ + EM G+ P AD I+ +N P ++ + L+
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLIC 283
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRN 269
F L ++V R E+ H F +N
Sbjct: 284 AF--LTDREVRLGRNGVDEIKSHPFFKN 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 61/197 (30%), Positives = 110/197 (55%), Gaps = 4/197 (2%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLS-QCRSPYITE 75
+++G+GSFG V A K + A+K + D+ +D++E E VL+ +P++T
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
Y ++ + L+ +ME++ GG + IQ D +++ +++LH++G I+R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K N++L +G +K+ADFG+ + +R TF GTP ++APE++Q + Y D
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK-YTFSVDW 179
Query: 196 WSLGITVIEMAKGEPPL 212
WS G+ + EM G+ P
Sbjct: 180 WSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 79/289 (27%), Positives = 139/289 (48%), Gaps = 18/289 (6%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRS-PYITEY 76
+IGRGS+ V K+ ++ A+KV+ +L +++I+ +Q E V Q S P++
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
+ + ++L++++EY+ GG + +Q L E ++ A+ +LH G I+RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
+K N+LL +G +K+ D+G+ + TF GTP ++APE+++ E Y D W
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWW 180
Query: 197 SLGITVIEMAKGEPPL------ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
+LG+ + EM G P D++ LF + E P ++ S + L K
Sbjct: 181 ALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK 240
Query: 251 VPAERPSAK------ELLRHRFIRNARKSPRLLERIRERPKYPIQEEPD 293
P ER + ++ H F R+ LLE+ + P + Q D
Sbjct: 241 DPKERLGCQPQTGFSDIKSHTFFRSIDWD--LLEKKQVTPPFKPQITDD 287
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 90/295 (30%), Positives = 129/295 (43%), Gaps = 56/295 (18%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE------IEDIQKEISVLSQC 68
+ +E IG G++G VYKA DK + VA+K I LE +EDE I +EIS+L +
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLE-TEDEGVPSTAI----REISLLKEL 55
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGP--PLDEMSIACILRDLLHA 123
P I + KL+++ E++ DL + S P LD I L LL
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---RRKTF-VGTPFWMA 179
I Y H+ +HRD+K N+L+ G +K+ADFG L R R T V T ++ A
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFG----LARAFGVPVRTYTHEVVTLWYRA 167
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII--------------- 224
PE++ S Y+ DIWS+G EM P + LF I
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227
Query: 225 ----------PRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRF 266
P+ L + L ++ + L L PA+R SAK L+H +
Sbjct: 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 30/280 (10%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F LE +G G++ VYK ++ + VA+K I L+ E +EIS++ + + I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 75 EYYGSYLHQTKLWIIMEYMAGG--SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + KL ++ EYM D LD ++ LL I + H
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
+HRD+K N+L+ + G++K+ADFG++ ++ V T ++ AP+V+ S Y+
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTS 181
Query: 193 ADIWSLGITVIEMAKGEP--------------------PLADLHPMRVLF--------II 224
DIWS+G + EM G P P P
Sbjct: 182 IDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRY 241
Query: 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
P ++ QL H L + + L+ P R SA + L+H
Sbjct: 242 PPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-26
Identities = 75/265 (28%), Positives = 132/265 (49%), Gaps = 16/265 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLS-QCRSP 71
F+ L ++G+GSFG V A K ++ AIK++ D+ +D++E E VL+ + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
++T+ + + +L+ +MEY+ GG + IQ E ++ + +LH++G
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
I+RD+K N++L G +K+ADFG+ + KTF GTP ++APE+I + Y +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA-YQPYGK 180
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC---L 248
D W+ G+ + EM G+ P + I N + + KE V++C +
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV----AYPKSMSKEAVAICKGLM 236
Query: 249 KKVPAER-----PSAKELLRHRFIR 268
K P +R +++ H F R
Sbjct: 237 TKHPGKRLGCGPEGERDIKEHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 78/261 (29%), Positives = 130/261 (49%), Gaps = 37/261 (14%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK---EISVLSQCRSPYITE 75
IG+G FGDV + + VA+K + +D+ Q E SV++ R P + +
Sbjct: 12 ATIGKGEFGDVMLGDYR--GQKVAVKCL-----KDDSTAAQAFLAEASVMTTLRHPNLVQ 64
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACIL---RDLLHAIEYLHNEG 131
G L L+I+ EYMA GS+ D ++S G + +++A L D+ +EYL +
Sbjct: 65 LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGMEYLEEKN 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVS--AQLTRTISRRKTFVGTPF-WMAPEVIQNSEG 188
+HRD+ A N+L++E+ KV+DFG++ A + + P W APE ++ +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK------LPVKWTAPEALREKK- 175
Query: 189 YNEKADIWSLGITVIEM-AKGEPP-----LADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
++ K+D+WS GI + E+ + G P L D+ P V E P ++MK+
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-HVEKGYRMEAPEGCPPEVYKVMKD 234
Query: 243 FVSLCLKKVPAERPSAKELLR 263
C + PA+RP+ K+L
Sbjct: 235 ----CWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 83/278 (29%), Positives = 140/278 (50%), Gaps = 29/278 (10%)
Query: 15 FSSLELIGRGSFGDVY---KAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQC 68
F L+++G G++G V+ K + K A+KV+ + + E + E VL
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 69 R-SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
R SP++ + ++ TKL +I++Y+ GG + + E + +++ A+E+L
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQ-LTRTISRRKTFVGTPFWMAPEVIQNS 186
H G I+RDIK NILL NG V + DFG+S + + R +F GT +MAP++++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 187 EGYNEKA-DIWSLGITVIEMAKGEPPL---------ADLHPMRVLFIIPRENPPQLDEHF 236
+G ++KA D WS+G+ + E+ G P A++ R+L + PP E
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-SRRIL----KSEPPYPQE-M 235
Query: 237 SRLMKEFVSLCLKKVPAER----PS-AKELLRHRFIRN 269
S L K+ + L K P +R PS A E+ +H F +
Sbjct: 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPYI 73
F +E IG G++G VYKA +K + VA+K I L+ E+E +EIS+L + P I
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADL--IQSGPPLDEMSIACI---LRDLLHAIEYLH 128
+ + KL+++ E++ DL PL + + I L LL + + H
Sbjct: 62 VKLLDVIHTENKLYLVFEFLH----QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
+ +HRD+K N+L+ G +K+ADFG++ + V T ++ APE++ +
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 189 YNEKADIWSLGITVIEM 205
Y+ DIWSLG EM
Sbjct: 178 YSTAVDIWSLGCIFAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 83/295 (28%), Positives = 128/295 (43%), Gaps = 47/295 (15%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVL-SQCRSPY 72
+ LE IG G++G VYKA DK K VA+K LE E+ I +EIS+L S Y
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 73 IT-----EYYGSYLHQTKLWIIMEYMAGG--SVADLIQSGP--PLDEMSIACILRDLLHA 123
I E+ + L+++ EY+ D GP PL +I + LL
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDV-KVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
+ + H G +HRD+K N+L+ + + K+AD G+ + + + T ++ APEV
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEV 182
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLAD-------LHPMRVL-------------- 221
+ S Y+ DIWS+G EM++ +P LH ++L
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL 242
Query: 222 ---FIIPRENP-------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
P+ P P L L+++ L+ PA+R SAK L H +
Sbjct: 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKM----LRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 82/293 (27%), Positives = 145/293 (49%), Gaps = 32/293 (10%)
Query: 3 DLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQK 60
+ LQ A + +++IGRG+FG+V K K A+K++ E + +
Sbjct: 34 KIRKLQMKA-EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
E +++ SP++ + + ++ L+++MEYM GG + +L+ S + E ++
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEV 151
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGTPFWMA 179
+ A++ +H+ G IHRD+K N+LL ++G +K+ADFG ++ T + R T VGTP +++
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYIS 211
Query: 180 PEVIQNSEG---YNEKADIWSLGITVIEMAKGEPPL-ADLHPMRVLFIIPRENPPQLDEH 235
PEV+++ G Y + D WS+G+ + EM G+ P AD L
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD----------------SLVGT 255
Query: 236 FSRLMKEFVSLCLKKVPAERPSAKEL----LRHRFIRNARKSPRLLERIRERP 284
+S++M SL + AK L L R +R R +E I++ P
Sbjct: 256 YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNG---VEEIKQHP 305
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 82/288 (28%), Positives = 137/288 (47%), Gaps = 39/288 (13%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI-EDIQKEISVLSQCRSP 71
+R+ L+ +G G+FG V A D+ ++VAIK I S + + +E+ +L R
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 72 YITEYYGSYLH-QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
I ++ ++ + E + G + L+ S P L++ I L +L ++Y+H+
Sbjct: 70 NIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYVHSA 127
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQNSEGY 189
G +HRD+K +NIL+ EN D+K+ DFG L R + T +V T ++ APE++ + Y
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFG----LARIQDPQMTGYVSTRYYRAPEIMLTWQKY 183
Query: 190 NEKADIWSLGITVIEMAKGEP--P----------LADL---HPMRVL----------FI- 223
+ + DIWS G EM +G+P P + DL P V+ F+
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 224 -IPRENPPQLDEHFSRLMKEFVSLCLKKV---PAERPSAKELLRHRFI 267
+P+ P E F + L K + P +R SA E L H ++
Sbjct: 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 6e-25
Identities = 78/260 (30%), Positives = 130/260 (50%), Gaps = 20/260 (7%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPYITEYYG 78
++G G+ G V A + A+KV+D+E SE + Q E+ L C I + +
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 79 SYLHQTK--------LWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEY 126
+ + + ++++Y G + I+S E + +L A+ +
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHH 158
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR--KTFVGTPFWMAPEVIQ 184
+H++ IHRDIK+ANILL NG VK+ DFG S T+S +TF GTP+++APE I
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE-IW 217
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPL--ADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
+ Y++KAD++SLG+ + E+ + P ++ + + R +P L S M+E
Sbjct: 218 RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP--LPPSISPEMQE 275
Query: 243 FVSLCLKKVPAERPSAKELL 262
V+ L P RPS+ +LL
Sbjct: 276 IVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 76/281 (27%), Positives = 137/281 (48%), Gaps = 38/281 (13%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ 67
R + + +G G+FG V KA L+ VA+K++ + +E ++ D+ E+ ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 68 C-RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACI-------L 117
+ I G + L++++EY A G++ D +++ P
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 118 RDLL-------HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170
+DL+ +E+L ++ IHRD+ A N+L+TE+ +K+ADFG++ + RKT
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 171 FVG-TPF-WMAPEVIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPRE 227
G P WMAPE + Y ++D+WS G+ + E G P + P+ LF + +E
Sbjct: 192 TNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLKE 249
Query: 228 ----NPPQL--DEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
PQ E + LM++ C +VP++RP+ K+L+
Sbjct: 250 GYRMEKPQNCTQELY-HLMRD----CWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 76/271 (28%), Positives = 130/271 (47%), Gaps = 26/271 (9%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRS-PYITEY 76
+IGRGS+ V K+ + A+KVI +L +++I+ +Q E V + P++
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
+ + +++L+ ++E+++GG + +Q L E ++ A+ +LH G I+RD
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRD 121
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
+K N+LL G +K+ D+G+ + R TF GTP ++APE+++ E Y D W
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR-GEDYGFSVDWW 180
Query: 197 SLGITVIEMAKGEPPL--------ADLHPMRVLFIIPREN----PPQLDEHFSRLMKEFV 244
+LG+ + EM G P D + LF + E P L S ++K F
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF- 239
Query: 245 SLCLKKVPAER------PSAKELLRHRFIRN 269
L K P ER +++ H F RN
Sbjct: 240 ---LNKDPKERLGCHPQTGFRDIKSHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 69/256 (26%), Positives = 117/256 (45%), Gaps = 58/256 (22%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE----DEIEDIQKEISVLSQC 68
S F ++ IG G+FG+V + N A+K L +++ ++ ++ E +L++
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKT--LRKADVLMRNQAAHVKAERDILAEA 58
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL-IQSG---PPLDEMSIACILRDLLHAI 124
+ ++ + Y S+ + L+ +M+Y+ GG + L I+ G L IA +L AI
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA----ELTCAI 114
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFG---------------------------- 156
E +H G IHRDIK NIL+ +G +K+ DFG
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 157 -----VSAQLTRTISRRK----------TFVGTPFWMAPEVIQNSEGYNEKADIWSLGIT 201
+ + + RR+ + VGTP ++APEV+ + GY + D WS+G+
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVI 233
Query: 202 VIEMAKGEPPLADLHP 217
+ EM G+PP P
Sbjct: 234 LYEMLVGQPPFLADTP 249
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 73/252 (28%), Positives = 125/252 (49%), Gaps = 21/252 (8%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G +G+VY+ K+ + VA+K L+E E+E+ KE +V+ + + P + + G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
+ +II E+M G++ D ++ ++ + + + + A+EYL + IHRD+
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 131
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGYNE---KAD 194
A N L+ EN VKVADFG+S +T P W APE S YN+ K+D
Sbjct: 132 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE----SLAYNKFSIKSD 187
Query: 195 IWSLGITVIEMAK-GEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLK 249
+W+ G+ + E+A G P + +V ++ + E P LM+ C +
Sbjct: 188 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA----CWQ 243
Query: 250 KVPAERPSAKEL 261
P++RPS E+
Sbjct: 244 WNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 7/216 (3%)
Query: 59 QKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIA 114
+ E+ L+ C I +++ + KL +IMEY +GG + I+ P E +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 115 CILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR--KTFV 172
+ ++ A++ +H+ +HRD+K+ANI L G +K+ DFG S Q + ++S +F
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL 232
GTP+++APE+ + Y++KAD+WSLG+ + E+ P ++ +
Sbjct: 233 GTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268
S MK + L K PA RP+ ++LL F++
Sbjct: 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 78/261 (29%), Positives = 121/261 (46%), Gaps = 24/261 (9%)
Query: 19 ELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
++IG G FG+V + K K DVAIK + S+ + D E S++ Q P I
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 76 YYGSYLHQTKLWIIMEYMAGGSV-ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
G + II EYM GS+ L ++ + +LR + ++YL +H
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVH 129
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-TPF-WMAPEVIQNSEGYNEK 192
RD+ A NIL+ N KV+DFG+S +L + + T G P W APE I + +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-FTSA 188
Query: 193 ADIWSLGITVIE-MAKGEPPLADLHPMRVLFII--------PRENPPQLDEHFSRLMKEF 243
+D+WS GI + E M+ GE P D+ V+ + P + P L +LM +
Sbjct: 189 SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSAL----YQLMLD- 243
Query: 244 VSLCLKKVPAERPSAKELLRH 264
C +K ERP+ +++
Sbjct: 244 ---CWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 8e-24
Identities = 76/266 (28%), Positives = 140/266 (52%), Gaps = 12/266 (4%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
+ +++IGRG+FG+V K K A+K++ E + +E +++ SP+
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + + ++ L+++MEYM GG + +L+ S + E +++ A++ +H+ G
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGF 163
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGTPFWMAPEVIQNSEG--- 188
IHRD+K N+LL ++G +K+ADFG ++ + + R T VGTP +++PEV+++ G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 189 YNEKADIWSLGITVIEMAKGEPPL-ADLHPMRVLFIIPRENPPQL--DEHFSRLMKEFVS 245
Y + D WS+G+ + EM G+ P AD I+ +N D S+ K +
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 283
Query: 246 LCL--KKVPAERPSAKELLRHRFIRN 269
L ++V R +E+ RH F +N
Sbjct: 284 AFLTDREVRLGRNGVEEIKRHLFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 74/276 (26%), Positives = 117/276 (42%), Gaps = 36/276 (13%)
Query: 17 SLELI---GRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQC 68
S+ L+ G G+FG+VY+ + + D VA+K + SE + D E ++S+
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLH------ 122
I G + +I++E MAGG + ++ P E + ++DLL
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 123 -AIEYLHNEGKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTISRRKTFVGTPF-- 176
+YL IHRDI A N LLT G K+ADFG++ + R RK G
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG--GRAMLP 184
Query: 177 --WMAPEVIQNSEG-YNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----EN 228
WM PE +G + K D+WS G+ + E + G P V+ + +
Sbjct: 185 IKWMPPEAFL--DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDP 242
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
P R+M + C + P +RP+ +L
Sbjct: 243 PKGCPGPVYRIMTD----CWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 63/194 (32%), Positives = 98/194 (50%), Gaps = 4/194 (2%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQ-CRSPYITEYY 77
IG+GSFG V A K K A+KV+ + + E + I E +VL + + P++ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
S+ KL+ +++Y+ GG + +Q E ++ A+ YLH+ I+RD+
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWS 197
K NILL G V + DFG+ + TF GTP ++APEV++ Y+ D W
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWC 181
Query: 198 LGITVIEMAKGEPP 211
LG + EM G PP
Sbjct: 182 LGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 75/267 (28%), Positives = 127/267 (47%), Gaps = 18/267 (6%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRS-PYITEY 76
+IGRGS+ V K+ + A+KV+ +L +++I+ +Q E V Q + P++
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
+ + +++L+ ++EY+ GG + +Q L E ++ A+ YLH G I+RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
+K N+LL G +K+ D+G+ + R TF GTP ++APE+++ E Y D W
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR-GEDYGFSVDWW 180
Query: 197 SLGITVIEMAKGEPPL--------ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248
+LG+ + EM G P D + LF + E ++ S + L
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL 240
Query: 249 KKVPAER----PSA--KELLRHRFIRN 269
K P ER P ++ H F RN
Sbjct: 241 NKDPKERLGCHPQTGFADIQGHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 69/262 (26%), Positives = 114/262 (43%), Gaps = 30/262 (11%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+ +G GSFG V + VA+K + ++ D ++D KE +++ +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYLHNEGK 132
YG L L ++ E GS+ D ++ L I+ + + + + YL ++
Sbjct: 61 LYGVVL-THPLMMVTELAPLGSLLDRLRK-DALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLT------RTISRRKTFVGTPF-WMAPEVIQN 185
IHRD+ A NILL + VK+ DFG+ L K PF W APE +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK----VPFAWCAPESL-R 173
Query: 186 SEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPR-----ENPPQLDEHFSRL 239
+ ++ +D+W G+T+ EM GE P A L ++L I + E P + +
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV 233
Query: 240 MKEFVSLCLKKVPAERPSAKEL 261
M + C PA+RP+ L
Sbjct: 234 MLQ----CWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 73/245 (29%), Positives = 126/245 (51%), Gaps = 16/245 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELN-KDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSP 71
F+ + +G GSFG V A K + VAIK + + + +++ + E +L+ P
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILR-DLLHAIEYLH 128
+ YGS+ ++ L++++E++ GG ++ P D + C ++ EYL
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND---VGCFYAAQIVLIFEYLQ 148
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
+ ++RD+K N+LL ++G +K+ DFG A++ T R T GTP ++APE++ N G
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGF-AKVVDT--RTYTLCGTPEYIAPEILLNV-G 204
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---ENPPQLDEHFSRLMKEFVS 245
+ + AD W+LGI + E+ G PP P+ + I P LD + LMK+ +S
Sbjct: 205 HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLS 264
Query: 246 LCLKK 250
L K
Sbjct: 265 HDLTK 269
|
Length = 340 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 20/265 (7%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVID---LEESEDEIEDIQKEI--SVLSQCRSPYIT 74
+IGRG FG+VY + K A+K +D ++ + E + + I S++S P+I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 75 EYYGSYLHQT--KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
SY T KL I++ M GG + + E + +++ +E++HN
Sbjct: 61 CM--SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
++RD+K ANILL E+G V+++D G++ ++ + VGT +MAPEV+Q Y+
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSS 176
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLK 249
AD +SLG + ++ +G P H + I R +L + FS ++ + L+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235
Query: 250 KVPAER-----PSAKELLRHRFIRN 269
+ R A+E+ H F R+
Sbjct: 236 RDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 66/205 (32%), Positives = 109/205 (53%), Gaps = 8/205 (3%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L++IGRG+FG+V K + A+K+++ E E ++E VL +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEG 131
IT + ++ + L+++M+Y GG + L+ L E L +++ AI+ +H G
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQL-TRTISRRKTFVGTPFWMAPEVIQNSEG-- 188
+HRDIK N+LL +NG +++ADFG +L + VGTP +++PE++Q E
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 189 --YNEKADIWSLGITVIEMAKGEPP 211
Y + D WSLG+ + EM GE P
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 72/264 (27%), Positives = 130/264 (49%), Gaps = 20/264 (7%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEISVLSQCRSPYIT 74
+IGRG FG+VY + K A+K +D +++ E + + +S++S P+I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
++ KL I++ M GG + + E + +++ +E++HN ++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K ANILL E+G V+++D G++ ++ + VGT +MAPEV+Q Y+ AD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTAYDSSAD 178
Query: 195 IWSLGITVIEMAKGEPPL-----ADLHPM-RVLFIIPRENP----PQLDEHFSRLMKEFV 244
+SLG + ++ +G P D H + R+ + E P P+L L++ V
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV 238
Query: 245 SLCLKKVPAERPSAKELLRHRFIR 268
S K++ A+E+ H F +
Sbjct: 239 S---KRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 8/206 (3%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L++IGRG+FG+V K +K A+K+++ E E ++E VL + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHNEG 131
IT + ++ + L+++M+Y GG + L+ L E L +++ AI+ +H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF-VGTPFWMAPEVIQNSEG-- 188
+HRDIK NIL+ NG +++ADFG +L + + + VGTP +++PE++Q E
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 189 --YNEKADIWSLGITVIEMAKGEPPL 212
Y + D WSLG+ + EM GE P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 66/283 (23%), Positives = 127/283 (44%), Gaps = 30/283 (10%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI-EDIQKEISVLSQCRSPY 72
++ LE IG G++G V+KA ++E ++ VA+K + L++ ++ + +EI +L + +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I Y KL ++ EY +D + + LL + + H+
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
+HRD+K N+L+ +NG++K+ADFG++ + V T ++ P+V+ ++ Y+
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 180
Query: 193 ADIWSLGITVIEMAKGEPPL---ADLHP-----MRVLFIIPRENPPQLDE--------HF 236
D+WS G E+A PL D+ R+L E+ P + + +
Sbjct: 181 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY 240
Query: 237 SRLM-------------KEFVSLCLKKVPAERPSAKELLRHRF 266
++ + L P +R SA+E L+H +
Sbjct: 241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 5e-23
Identities = 77/253 (30%), Positives = 128/253 (50%), Gaps = 21/253 (8%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
IG G FG V+ + E K VAIK I E ED +E V+ + P + + YG
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTI--REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKA 139
++ + ++ E+M G ++D +++ + ++ + D+ + YL + IHRD+ A
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAA 128
Query: 140 ANILLTENGDVKVADFGVSAQLTRTI--SRRKTFVGTPF---WMAPEVIQNSEGYNEKAD 194
N L+ EN VKV+DFG +TR + + + GT F W +PEV S+ Y+ K+D
Sbjct: 129 RNCLVGENQVVKVSDFG----MTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK-YSSKSD 183
Query: 195 IWSLGITVIEM-AKGEPPLADLHPMRVLFIIP---RENPPQLDEHFSRLMKEFVSLCLKK 250
+WS G+ + E+ ++G+ P + V+ I R P+L S+ + E + C K+
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLA---SQSVYELMQHCWKE 240
Query: 251 VPAERPSAKELLR 263
P +RPS LL
Sbjct: 241 RPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 72/277 (25%), Positives = 119/277 (42%), Gaps = 19/277 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAF---DKELNK-DVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ ++++G G+FG VYK + E K VAIKV+ E S ++I E V++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYL 127
P++ G L + +I + M G + D + + + + + YL
Sbjct: 67 DHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-TPF-WMAPEVIQN 185
+ +HRD+ A N+L+ VK+ DFG++ L G P WMA E I +
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 186 SEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLM 240
Y K+D+WS G+TV E M G P + + + ++ + PP ++
Sbjct: 186 RI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVL 244
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLL 277
+ C RP+ KEL+ F + AR R L
Sbjct: 245 VK----CWMIDAESRPTFKELIN-EFSKMARDPQRYL 276
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 6e-23
Identities = 81/289 (28%), Positives = 129/289 (44%), Gaps = 52/289 (17%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ--KEISVLSQCRSPY 72
F + IG G++G VYKA DK+ + VA+K + L+ +E E I +EI +L Q
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD-NEKEGFPITAIREIKILRQLNHRN 67
Query: 73 ITEYYGSYLHQT---------------KLWIIMEYMAGGSVADLIQSG-PPLDEMSIACI 116
I L + +++ EYM + L++SG E I
Sbjct: 68 IVN-----LKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSF 121
Query: 117 LRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR--KTFVGT 174
++ LL + Y H + +HRDIK +NILL G +K+ADFG+ A+L + R V T
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL-ARLYNSEESRPYTNKVIT 180
Query: 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE 234
++ PE++ E Y D+WS G L +L + +F Q ++
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCI----------LGELFTKKPIF--------QANQ 222
Query: 235 HFSRLMKEFVS-LCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRE 282
++L E +S LC PA P +L ++ ++ R R+RE
Sbjct: 223 ELAQL--ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRR---RLRE 266
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
R+ +L +G G++G V AFD + + VAIK + +S + +E+ +L
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 73 ITEYYGSYLHQTKL------WIIMEYMAGGSVADL--IQSGPPLDEMSIACILRDLLHAI 124
+ + + L +++ M ADL I L + I ++ +L +
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMG----ADLNNIVKCQKLSDDHIQFLVYQILRGL 131
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
+Y+H+ G IHRD+K +NI + E+ ++K+ DFG++ T +V T ++ APE++
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH---TDDEMTGYVATRWYRAPEIML 188
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEP 210
N YN+ DIWS+G + E+ G+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-22
Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 8/206 (3%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F +++IGRG+FG+V K + A+K+++ E E ++E +VL +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEG 131
IT + ++ + L+++M+Y GG + L+ L E + +++ AI +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF-VGTPFWMAPEVIQNSEG-- 188
+HRDIK N+LL NG +++ADFG ++ + + + + VGTP +++PE++Q E
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 189 --YNEKADIWSLGITVIEMAKGEPPL 212
Y + D WSLG+ + EM GE P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 72/259 (27%), Positives = 120/259 (46%), Gaps = 20/259 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
F+ +G G FG+V++ K + VAIK++ + + +D QKE+ L + R +
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILK-SDDLLKQQDFQKEVQALKRLRHKH 63
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
+ + ++II E M GS+ ++S G L S+ + + + YL +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI---SRRKTFVGTPFWMAPEVIQNSE 187
IHRD+ A NIL+ E+ KVADFG++ + + S +K W APE +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK---WTAPEAA-SHG 179
Query: 188 GYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKE 242
++ K+D+WS GI + EM G+ P ++ V I P + + ++M E
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLE 239
Query: 243 FVSLCLKKVPAERPSAKEL 261
C P +RPS K L
Sbjct: 240 ----CWAAEPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 75/265 (28%), Positives = 126/265 (47%), Gaps = 34/265 (12%)
Query: 20 LIGRGSFGDVYKAFDKELNKD------VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+G G+FG+VY+ ++ VA+K + ++ E ++ KE ++S P I
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSV------ADLIQSGPP---LDEMSIACILRDLLHAI 124
+ G L +IIME M GG + A + + GPP L E+ C+ D+
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL--DVAKGC 119
Query: 125 EYLHNEGKIHRDIKAANILLTENGD-----VKVADFGVSAQLTRTISRRKTFVGT-PF-W 177
YL IHRD+ A N L++E G VK+ DFG++ + ++ RK G P W
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQL 232
MAPE + + + + ++D+WS G+ + E + G+ P L+ VL + + P
Sbjct: 180 MAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC 238
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPS 257
+ +LM + C + P+ERP+
Sbjct: 239 PDKIYQLM----TNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 7e-22
Identities = 68/236 (28%), Positives = 118/236 (50%), Gaps = 19/236 (8%)
Query: 21 IGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+G G+FG V K K K DVAIKV+ E + +++ +E ++ Q +PYI G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAI----EYLHNEGKIH 134
L ++ME +GG + + DE++++ ++ +L+H + +YL + +H
Sbjct: 63 -VCEAEALMLVMEMASGGPLNKFLSGKK--DEITVSNVV-ELMHQVSMGMKYLEGKNFVH 118
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPF-WMAPEVIQNSEGYNE 191
RD+ A N+LL K++DFG+S L S + ++ P W APE I N ++
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI-NFRKFSS 177
Query: 192 KADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKE 242
++D+WS GIT+ E + G+ P + V+ I + + P + LMK+
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKD 233
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 88/335 (26%), Positives = 150/335 (44%), Gaps = 70/335 (20%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI-DLEESEDEIEDIQK---EISVLSQC 68
++ L+ +G+G++G V+KA D+ + VA+K I D + D Q+ EI L +
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA---TDAQRTFREIMFLQEL 63
Query: 69 RS-PYITEYYGSY--LHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLH 122
P I + + ++++ EYM DL I++ L+++ I+ LL
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYME----TDLHAVIRANI-LEDVHKRYIMYQLLK 118
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT---------FVG 173
A++Y+H+ IHRD+K +NILL + VK+ADFG L R++S + +V
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG----LARSLSELEENPENPVLTDYVA 174
Query: 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG---------------------EPPL 212
T ++ APE++ S Y + D+WS+G + EM G P
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234
Query: 213 ADLHPMR------VLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELL 262
D+ ++ +L +P LDE + + + L LKK+ P +R +A+E L
Sbjct: 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDL-LKKLLVFNPNKRLTAEEAL 293
Query: 263 RHRFI---RNARKSPRLLERIR----ERPKYPIQE 290
H ++ N P L I + K + E
Sbjct: 294 EHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSVAE 328
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 9e-22
Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 4/197 (2%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVL-SQCRSPYITE 75
++IG+GSFG V A K A+KV+ + + E I E +VL + P++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
+ S+ KL+ +++Y+ GG + +Q E ++ AI YLH+ I+R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K NILL G V + DFG+ + TF GTP ++APEV++ E Y+ D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDRTVDW 179
Query: 196 WSLGITVIEMAKGEPPL 212
W LG + EM G PP
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 70/265 (26%), Positives = 120/265 (45%), Gaps = 37/265 (13%)
Query: 17 SLELI---GRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
S++L+ G G FG+V++ N + V L+ + +D E ++ + R P +
Sbjct: 7 SIQLLRKLGAGQFGEVWEGL---WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKL 63
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMS--IACILRDLLHAI 124
+ Y + ++I+ E M GS+ + +Q G P L +M+ +A +
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS-------GM 116
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPE 181
YL + IHRD+ A N+L+ EN KVADFG++ + I + G F W APE
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE--GAKFPIKWTAPE 174
Query: 182 VIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHF 236
++ K+D+WS GI + E + G P + VL + + PP +
Sbjct: 175 AA-LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKEL 233
Query: 237 SRLMKEFVSLCLKKVPAERPSAKEL 261
+M + C K+ P +RP+ + L
Sbjct: 234 YDIMLD----CWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 81/261 (31%), Positives = 128/261 (49%), Gaps = 21/261 (8%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
S + ++ +G G FG V+ + K VAIK I+ E + E ED +E V+ + P
Sbjct: 4 SELTFMKELGSGQFGVVHLGKWRAQIK-VAIKAIN-EGAMSE-EDFIEEAKVMMKLSHPK 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ + YG Q L+I+ E+M G + + L Q L + + + +D+ +EYL
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRRKTFVGTPF---WMAPEVIQNS 186
IHRD+ A N L++ G VKV+DFG +TR + + G F W PEV S
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFG----MTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS 176
Query: 187 EGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKE 242
+ Y+ K+D+WS G+ + E+ +G+ P V+ +I R P+L S + E
Sbjct: 177 K-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLA---SMTVYE 232
Query: 243 FVSLCLKKVPAERPSAKELLR 263
+ C + P RP+ ELLR
Sbjct: 233 VMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 75/283 (26%), Positives = 125/283 (44%), Gaps = 45/283 (15%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCRS-PYITEYYG 78
IG G+F +V KA ++ K AIK + +S +++ ++ +EI L + P I
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65
Query: 79 SYLHQT--KLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHR 135
+ +L ++ E M ++ +LI+ PL E + + LL +++++H G HR
Sbjct: 66 VLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHR 124
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF---VGTPFWMAPEVIQNSEGYNEK 192
DIK NIL+ ++ +K+ADFG S R I + + + T ++ APE + Y K
Sbjct: 125 DIKPENILIKDD-ILKLADFG-SC---RGIYSKPPYTEYISTRWYRAPECLLTDGYYGPK 179
Query: 193 ADIWSLGITVIEMAK---------------------GEPP---LADLHPMRVL-FIIPRE 227
DIW++G E+ G P L R + + P +
Sbjct: 180 MDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSK 239
Query: 228 NPPQLDEHFSRLMKEFVSLCLKK----VPAERPSAKELLRHRF 266
L + E + L LKK P ER +AK+ LRH +
Sbjct: 240 KGTGLRKLLPNASAEGLDL-LKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 6/205 (2%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID--LEESEDEIEDIQKEISVL-SQCRSPYITE 75
++IG+GSFG V A K K A+KV+ + + E + I E +VL + P++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
+ S+ KL+ +++++ GG + +Q E ++ A+ YLH+ ++R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K NILL G V + DFG+ + TF GTP ++APEVI+ + Y+ D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QPYDNTVDW 179
Query: 196 WSLGITVIEMAKGEPPL--ADLHPM 218
W LG + EM G PP D+ M
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 81/289 (28%), Positives = 121/289 (41%), Gaps = 48/289 (16%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
L+ +G GS+ VYK K + VA+K I LE E +E S+L + I +
Sbjct: 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ L ++ EY+ DL Q G L ++ L LL + Y H +
Sbjct: 70 DIIHTKKTLTLVFEYL----DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRKTF---VGTPFWMAPEVIQNSEGY 189
HRD+K N+L++E G++K+ADFG L R S KT+ V T ++ P+V+ S Y
Sbjct: 126 HRDLKPQNLLISERGELKLADFG----LARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 190 NEKADIWSLGITVIEMAKGEP-------PLADLHPMRVLFIIPRE--------------- 227
+ D+W +G EMA G P LH + + P E
Sbjct: 182 STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241
Query: 228 -----NPPQLDEHFSRLMK-----EFVSLCLKKVPAERPSAKELLRHRF 266
P L H RL + E L+ P +R SA E ++H +
Sbjct: 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 72/288 (25%), Positives = 126/288 (43%), Gaps = 32/288 (11%)
Query: 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
A + + +LE +G GS+ VYK + + VA+KVI ++ E +E S+L +
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
I + + L + EYM +IQ L ++ + LL + Y+H +
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ 122
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
+HRD+K N+L++ G++K+ADFG++ + + V T ++ P+V+ + Y+
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182
Query: 191 EKADIWSLGITVIEMAKGEPPLA-------DLHPMRVLFIIPREN--------------- 228
DIW G IEM +G+P L + + +P E+
Sbjct: 183 SALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242
Query: 229 -----PPQLDEHFSRLMK-----EFVSLCLKKVPAERPSAKELLRHRF 266
P QL + RL + + S L P +R SA++ L H +
Sbjct: 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 68/237 (28%), Positives = 122/237 (51%), Gaps = 11/237 (4%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI-DLEESEDEIEDIQKEISVLSQCRSP 71
++F L ++G G++G V K KE + VAIK D EE+E+ E +E+ +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADL--IQSGPPLDEMSIACILRDLLHAIEYLHN 129
I E ++ + KL+++ EY+ + L + +G P ++ + + L+ AI + H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEK--VRSYIYQLIKAIHWCHK 118
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQNSEG 188
+HRDIK N+L++ N +K+ DFG + L+ + T +V T ++ +PE++ +
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP- 177
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245
Y + D+WS+G + E++ G+P + LF I + P E MK F S
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ----MKLFYS 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 73/255 (28%), Positives = 122/255 (47%), Gaps = 9/255 (3%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVL-SQCRSPYITE 75
++IG+GSFG V A K K A+KV+ + + E + I E +VL + P++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
+ S+ KL+ +++Y+ GG + +Q E ++ A+ YLH+ ++R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K NILL G + + DFG+ + TF GTP ++APEV+ + + Y+ D
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL-HKQPYDRTVDW 179
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255
W LG + EM G PP + + I + P QL + + + + L+K +R
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPNITNSARHLLEGLLQKDRTKR 238
Query: 256 PSAK----ELLRHRF 266
AK E+ H F
Sbjct: 239 LGAKDDFMEIKNHIF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 3e-21
Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 50/246 (20%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F ++++IG+G+FG+V K+ K A+K + E +D++ ++ E VL++ SP+
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ Y S+ L++IME++ GG + ++ E + + + AIE +H G
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF 122
Query: 133 IHRDIKAANILLTENGDVKVADFGVSA--------------------------------- 159
IHRDIK NIL+ G +K++DFG+S
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 160 QLTRTISRRKTF--------------VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM 205
+ T+S + VGTP ++APE I +GY ++ D WSLG + E
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLGAIMFEC 241
Query: 206 AKGEPP 211
G PP
Sbjct: 242 LIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 3e-21
Identities = 69/251 (27%), Positives = 129/251 (51%), Gaps = 23/251 (9%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
E+IG G FG V + + + VA+K I + + + E +V+++ + G
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRLLG 66
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILR---DLLHAIEYLHNEGKIH 134
LH L+I+ME M+ G++ + +++ G L +S+ +L+ D+ +EYL ++ +H
Sbjct: 67 VILHN-GLYIVMELMSKGNLVNFLRTRGRAL--VSVIQLLQFSLDVAEGMEYLESKKLVH 123
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+ A NIL++E+G KV+DFG++ + + K V W APE +++ + ++ K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK---WTAPEALKHKK-FSSKSD 179
Query: 195 IWSLGITVIEM-AKGEPPLADLHPMRVLFIIP---RENPPQLDEHFSRLMKEFVSLCLKK 250
+WS G+ + E+ + G P + V + R PP E + ++ C +
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP---EGCPADVYVLMTSCWET 236
Query: 251 VPAERPSAKEL 261
P +RPS +L
Sbjct: 237 EPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 16/210 (7%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
G R+ +L IG G++G V A K VAIK I E + + +EI +L + +
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 72 YITEYY-----GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHA 123
I S+ ++I+ E M DL I++ L I L +L
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELME----TDLYKLIKT-QHLSNDHIQYFLYQILRG 118
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGV--SAQLTRTISRRKT-FVGTPFWMAP 180
++Y+H+ +HRD+K +N+LL N D+K+ DFG+ A + T +V T ++ AP
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEP 210
E++ NS+GY + DIWS+G + EM P
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 67/249 (26%), Positives = 108/249 (43%), Gaps = 8/249 (3%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
IG G FGDVY+ + VA+K S E +E ++ Q P+I +
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIH 134
G + + +WI+ME G + +Q LD S+ L A+ YL ++ +H
Sbjct: 72 LIG-VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVH 130
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGYNEKA 193
RDI A N+L++ VK+ DFG+S L + + P WMAPE I N + +
Sbjct: 131 RDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI-NFRRFTSAS 189
Query: 194 DIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252
D+W G+ + E + G P + V+ I + + + ++ C P
Sbjct: 190 DVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 249
Query: 253 AERPSAKEL 261
++RP EL
Sbjct: 250 SKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 79/298 (26%), Positives = 133/298 (44%), Gaps = 44/298 (14%)
Query: 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK---EISVLSQ 67
GSR+ +E IG G++G V A D K VAIK I + D ++ E+ +L
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI--PHAFDVPTLAKRTLRELKILRH 60
Query: 68 CRSPYI----TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHA 123
+ I ++++M+ M + +I S PL E I L LL
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF----VGTPFWMA 179
++Y+H+ IHRD+K +N+L+ E+ ++++ DFG++ L+ + + K F V T ++ A
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEM---------------------AKGEPPLADLHPM 218
PE++ + Y D+WS+G EM G P L+ +
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239
Query: 219 ---RVLFII---PRENPPQLDEHF---SRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
RV I PR+ P + F S + +S L+ P ER + ++ L+H F+
Sbjct: 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-21
Identities = 71/247 (28%), Positives = 116/247 (46%), Gaps = 13/247 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
E IGRG+FG+V+ + N VA+K D +E +L Q P I G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ ++I+ME + GG +++ GP L + ++ + +EYL ++ IHRD+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTI-SRRKTFVGTPF-WMAPEVIQNSEGYNEKADI 195
A N L+TE +K++DFG+S + + + P W APE + N Y+ ++D+
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL-NYGRYSSESDV 179
Query: 196 WSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLKK 250
WS GI + E + G P A+L + I + P + RLM+ C +
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMER----CWEY 235
Query: 251 VPAERPS 257
P +RPS
Sbjct: 236 DPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-21
Identities = 73/255 (28%), Positives = 126/255 (49%), Gaps = 21/255 (8%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
L+ +G G FG V K DVAIK+I E S E E I+ E V+ + + + Y
Sbjct: 9 LKELGTGQFG-VVKYGKWRGQYDVAIKMIK-EGSMSEDEFIE-EAKVMMKLSHEKLVQLY 65
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMS-IACILRDLLHAIEYLHNEGKIHRD 136
G Q ++I+ EYM+ G + + ++ + S + + +D+ + YL ++ IHRD
Sbjct: 66 GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRD 125
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTI--SRRKTFVGTPF---WMAPEVIQNSEGYNE 191
+ A N L+ + G VKV+DFG L+R + + VG+ F W PEV+ S+ ++
Sbjct: 126 LAARNCLVDDQGCVKVSDFG----LSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK-FSS 180
Query: 192 KADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIP---RENPPQLDEHFSRLMKEFVSLC 247
K+D+W+ G+ + E+ + G+ P + + + R P L S + + C
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLA---SEKVYAIMYSC 237
Query: 248 LKKVPAERPSAKELL 262
+ ERP+ ++LL
Sbjct: 238 WHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ--KEISVLSQ--- 67
S++ L IG+G+FG+V+KA K+ + VA+K + L E+E E I +EI +L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALREIKILQLLKH 70
Query: 68 ---------CRSPYITE--YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACI 116
CR+ Y GS+ +++ E+ L I +
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSF------YLVFEFCEHDLAGLLSNKNVKFTLSEIKKV 124
Query: 117 LRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK------- 169
++ LL+ + Y+H +HRD+KAANIL+T++G +K+ADFG L R S K
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG----LARAFSLSKNSKPNRY 180
Query: 170 -TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM 205
V T ++ PE++ Y D+W G + EM
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 79/271 (29%), Positives = 127/271 (46%), Gaps = 36/271 (13%)
Query: 19 ELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYI 73
++IG G+FG V KA K+ L D AIK + S+D+ D E+ VL C+ P I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL--CKLGHHPNI 70
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----------------SGPPLDEMSIACIL 117
G+ H+ L++ +EY G++ D ++ + L +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 118 RDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF- 176
D+ ++YL + IHRD+ A NIL+ EN K+ADFG+S + + +KT P
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 188
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPR----ENPPQ 231
WMA E + N Y +D+WS G+ + E+ G P + + +P+ E P
Sbjct: 189 WMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 247
Query: 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
D+ LM++ C ++ P ERPS ++L
Sbjct: 248 CDDEVYDLMRQ----CWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 68/257 (26%), Positives = 125/257 (48%), Gaps = 14/257 (5%)
Query: 21 IGRGSFGDVYKAF--DKELNKDVAIKVIDLEESEDEIED-IQKEISVLSQCRSPYITEYY 77
+G G+FG V K K+ K VA+K++ + ++ ++D + +E +V+ Q +PYI
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 78 GSYLHQTKLWIIMEYMAG-GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
G + + + W+++ +A G + +Q + E +I ++ + ++YL +HRD
Sbjct: 63 G--ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 137 IKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPF-WMAPEVIQNSEGYNEKA 193
+ A N+LL K++DFG+S L + KT P W APE + N ++ K+
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM-NYYKFSSKS 179
Query: 194 DIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252
D+WS G+ + E + G+ P + V +I + + M + + LC
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239
Query: 253 AERP--SAKEL-LRHRF 266
ERP + EL LR+ +
Sbjct: 240 DERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-20
Identities = 78/263 (29%), Positives = 125/263 (47%), Gaps = 32/263 (12%)
Query: 19 ELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITE 75
++IG G+FG V KA K+ L D AIK + S+D+ D E+ VL + P I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDE-------------MSIACILR---D 119
G+ H+ L++ +EY G++ D ++ L+ +S +L D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 120 LLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WM 178
+ ++YL + IHRD+ A NIL+ EN K+ADFG+S + + +KT P WM
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWM 178
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPR----ENPPQLD 233
A E + N Y +D+WS G+ + E+ G P + + +P+ E P D
Sbjct: 179 AIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237
Query: 234 EHFSRLMKEFVSLCLKKVPAERP 256
+ LM++ C ++ P ERP
Sbjct: 238 DEVYDLMRQ----CWREKPYERP 256
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
R++SL+ +G G++G V A DK + VAIK + +SE + +E+++L +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 73 ITEYYGSYLHQTKL------WIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIE 125
+ + +++M YM DL + G PL E + ++ +L ++
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQ 184
Y+H+ G IHRD+K N+ + E+ ++K+ DFG L R T +V T ++ APEVI
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVVTRWYRAPEVIL 187
Query: 185 NSEGYNEKADIWSLGITVIEMAKGE 209
N YN+ DIWS+G + EM G+
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 73/284 (25%), Positives = 123/284 (43%), Gaps = 29/284 (10%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ LE +G G++ V+K K VA+K I LE E +E+S+L + I
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+ L ++ EY+ + G + ++ L +L + Y H +H
Sbjct: 68 TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K N+L+ E G++K+ADFG++ + V T ++ P+V+ S Y+ + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187
Query: 195 IWSLGITVIEMAKGEPPLA------DLHPM-RVL-------------------FIIPREN 228
+W +G EMA G P +LH + R+L + P+
Sbjct: 188 MWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYK 247
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAE---RPSAKELLRHRFIRN 269
P L H RL E + L K + E R SA+E ++H + R+
Sbjct: 248 PQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 67/249 (26%), Positives = 118/249 (47%), Gaps = 20/249 (8%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+G+G FG+V + K A K ++ + + E E +L++ S +I
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 79 SYLHQTKLWIIMEYMAGGS----VADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
++ +T L ++M M GG + ++ + P E ++ +E+LH I+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K N+LL +G+V+++D G++ +L S+ K + GTP +MAPE++Q E Y+ D
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE-YDFSVD 179
Query: 195 IWSLGITVIEM--------AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246
++LG+T+ EM A+GE R+L + + FS K F
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVENKELKQRIL-----NDSVTYPDKFSPASKSFCEA 234
Query: 247 CLKKVPAER 255
L K P +R
Sbjct: 235 LLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 80/281 (28%), Positives = 133/281 (47%), Gaps = 33/281 (11%)
Query: 19 ELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITE 75
++IG G+FG V +A K+ L + AIK++ SE++ D E+ VL + P I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLD-------EMSIACILR---------D 119
G+ ++ L+I +EY G++ D ++ L+ E A L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 120 LLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WM 178
+ ++YL + IHRD+ A N+L+ EN K+ADFG+S + +KT P WM
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLPVRWM 185
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPR----ENPPQLD 233
A E + N Y K+D+WS G+ + E+ G P + + +P+ E P D
Sbjct: 186 AIESL-NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCD 244
Query: 234 EHFSRLMKEFVSLCLKKVPAERPSAKEL-LRHRFIRNARKS 273
+ LM++ C + P ERP ++ ++ + ARK+
Sbjct: 245 DEVYELMRQ----CWRDRPYERPPFAQISVQLSRMLEARKA 281
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 72/275 (26%), Positives = 137/275 (49%), Gaps = 40/275 (14%)
Query: 21 IGRGSFGDVYKA----FDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQC-RSPY 72
+G G FG V A DK+ K+ VA+K++ + +E ++ D+ E+ ++ +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPL-------------DEMS----IAC 115
I G+ L++I+EY + G++ + +++ P ++M+ ++C
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 116 ILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT- 174
+ + +EYL ++ IHRD+ A N+L+TEN +K+ADFG++ + +KT G
Sbjct: 143 TYQ-VARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201
Query: 175 PF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRE----- 227
P WMAPE + + Y ++D+WS G+ + E+ G P + P+ LF + +E
Sbjct: 202 PVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMD 259
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
P +M++ C +P+ RP+ K+L+
Sbjct: 260 KPANCTNELYMMMRD----CWHAIPSHRPTFKQLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 44/278 (15%)
Query: 18 LELIGRGSFGDV----YKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
++ +G+G+FG V Y + VA+K + + + + D ++EI +L + I
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-HSTAEHLRDFEREIEILKSLQHDNI 67
Query: 74 TEYYG-SY-LHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
+Y G Y + L ++MEY+ GS+ D L + LD + + +EYL ++
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTP-----FWMAPEVI 183
+HRD+ NIL+ VK+ DFG LT+ + + K + V P FW APE +
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFG----LTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 184 QNSEGYNEKADIWSLGITVIEM-----AKGEPPLADLH--------PMRVLFIIP--REN 228
S+ ++ +D+WS G+ + E+ PP + M V +I + N
Sbjct: 184 TESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242
Query: 229 -----PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
PP +MKE C P++RPS EL
Sbjct: 243 GRLPAPPGCPAEIYAIMKE----CWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 65/260 (25%), Positives = 112/260 (43%), Gaps = 19/260 (7%)
Query: 21 IGRGSFGDVYKAFDKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
+G G+FG V K + +VA+K + E ++ +E SV++Q P I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
G + L ++ME G + ++ + + + + + YL ++ +HRD+
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121
Query: 138 KAANILLTENGDVKVADFGVSAQL--TRTISRRKTFVGTPF-WMAPEVIQNSEGYNEKAD 194
A N+LL K++DFG+S L R T P W APE I N ++ K+D
Sbjct: 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI-NYGKFSSKSD 180
Query: 195 IWSLGITVIEM-AKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLK 249
+WS G+T+ E + G P ++ V+ ++ P + + +M C K
Sbjct: 181 VWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIM----LSCWK 236
Query: 250 KVPAERPSAKELLRHRFIRN 269
P +RP+ EL R
Sbjct: 237 YRPEDRPTFSEL--ESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 35/299 (11%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ L+ +G G++ VYK K + VA+K I LE E +E+S+L + I
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+ + L ++ EY+ L G ++ ++ L LL + Y H +H
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLH 127
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K N+L+ E G++K+ADFG++ + V T ++ P+++ S Y+ + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187
Query: 195 IWSLGITVIEMAKGEPPLA------DLHPM-RVL-------------------FIIPREN 228
+W +G EM+ G P LH + R+L + P+
Sbjct: 188 MWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYR 247
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAE---RPSAKELLRHRFIRNARKSPRLLERIRERP 284
L H RL + L K + E R SA+E ++H + L ERI + P
Sbjct: 248 ADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC------LGERIHKLP 300
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 80/260 (30%), Positives = 133/260 (51%), Gaps = 37/260 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
L+ IG+G FGDV D NK VA+K I +++ + E SV++Q R + +
Sbjct: 11 LQTIGKGEFGDVMLG-DYRGNK-VAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 78 GSYLHQ-TKLWIIMEYMAGGSVADLIQS-------GPPLDEMSIACILRDLLHAIEYLHN 129
G + + L+I+ EYMA GS+ D ++S G L + S+ D+ A+EYL
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-----DVCEAMEYLEA 120
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+HRD+ A N+L++E+ KV+DFG++ + + T K V W APE ++ + +
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---WTAPEALREKK-F 176
Query: 190 NEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPR-ENPPQLD------EHFSRLMK 241
+ K+D+WS GI + E+ + G P + P++ ++PR E ++D +MK
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRI-PLKD--VVPRVEKGYKMDAPDGCPPVVYDVMK 233
Query: 242 EFVSLCLKKVPAERPSAKEL 261
+ C A RPS +L
Sbjct: 234 Q----CWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-19
Identities = 71/274 (25%), Positives = 126/274 (45%), Gaps = 55/274 (20%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS 70
S F ++ +G G+FG+V A + + A+K + ++ + +++ ++ E +L++ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
++ + Y S+ + L+ +M+Y+ GG + L+ E+ + +L AIE +H
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLT---------------------------- 162
G IHRDIK NIL+ +G +K+ DFG+
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 163 ---------RTISRRKT----------FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVI 203
+T+ +R T VGTP ++APEV+ +GY + D WS+G+ +
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILF 239
Query: 204 EMAKGEPPLADLHPMRV-LFIIPREN----PPQL 232
EM G+PP P L +I EN PPQ+
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQV 273
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 70/274 (25%), Positives = 135/274 (49%), Gaps = 38/274 (13%)
Query: 21 IGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVLSQC-RSPY 72
+G G FG V A L+K+ VA+K++ + +E ++ D+ E+ ++ +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-------------SGPPLDEMSIACILR- 118
I G+ L++I+EY + G++ + ++ + P +++S ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 119 --DLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT-P 175
+ +EYL ++ IHRD+ A N+L+TE+ +K+ADFG++ + +KT G P
Sbjct: 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 176 F-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRE-----N 228
WMAPE + + Y ++D+WS G+ + E+ G P + P+ LF + +E
Sbjct: 206 VKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDK 263
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
P +M++ C VP++RP+ K+L+
Sbjct: 264 PSNCTNELYMMMRD----CWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 70/228 (30%), Positives = 108/228 (47%), Gaps = 15/228 (6%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
E+IG G FG+V + K K VAIK + +E + D E S++ Q P I
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
G + II E+M G++ + Q+ + + +LR + ++YL +H
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT-----PF-WMAPEVIQNSEG 188
RD+ A NIL+ N KV+DFG+S L S T+ + P W APE I +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTS-DPTYTSSLGGKIPIRWTAPEAIAYRK- 187
Query: 189 YNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPREN--PPQLD 233
+ +D+WS GI + E M+ GE P D+ V+ I ++ PP +D
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMD 235
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 80/306 (26%), Positives = 133/306 (43%), Gaps = 63/306 (20%)
Query: 13 SRFSSLELIGRGSFGDVY------------KAFDKELNKD----VAIKVIDLEESEDEIE 56
+ +E +G G FG+V+ KAF + N D VA+KV+ + S++ E
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 57 DIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDE------ 110
D KE+ +LS+ P I G L +IMEYM G + +Q
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 111 --MSIACILRDLLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161
+S + LL+ + YL + +HRD+ N L+ +N +K+ADFG+S L
Sbjct: 125 KSLSFST----LLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 162 -TRTISRRKTFVGTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEM---AKGEPPLADLH 216
+ R + P WMA E + + + K+D+W+ G+T+ E+ + E P L
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCR-EQPYEHLT 238
Query: 217 PMRVL-------------FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
+V+ +PR PP + LM E C ++ +RP+ +E+
Sbjct: 239 DQQVIENAGHFFRDDGRQIYLPR--PPNCPKDIYELMLE----CWRRDEEDRPTFREI-- 290
Query: 264 HRFIRN 269
H F++
Sbjct: 291 HLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 75/259 (28%), Positives = 125/259 (48%), Gaps = 34/259 (13%)
Query: 17 SLELI---GRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+L+L+ G G FG+V+ + + VAIK L++ E E +++ Q + P +
Sbjct: 7 TLKLVKKLGAGQFGEVWMGYYNG-HTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRL 63
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG 131
Y + + Q ++II EYM GS+ D +++ G L + + + + ++ +
Sbjct: 64 VRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV--GTPF---WMAPEVIQNS 186
IHRD++AANIL++E K+ADFG L R I + G F W APE I N
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFG----LARLIEDNEYTAREGAKFPIKWTAPEAI-NY 177
Query: 187 EGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL------FIIPR-ENPPQLDEHFSR 238
+ K+D+WS GI + E+ G P + V+ + +PR +N P+ E +
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPE--ELYEL 235
Query: 239 LMKEFVSLCLKKVPAERPS 257
+ C K+ P ERP+
Sbjct: 236 MRL-----CWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-19
Identities = 48/146 (32%), Positives = 81/146 (55%), Gaps = 2/146 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F ++ I RG+FG VY K +K A+KV+ + +++ + +Q E L+ +SP+
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I Y S ++++MEY+ GG V L+ DE + ++ A++YLH G
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125
Query: 133 IHRDIKAANILLTENGDVKVADFGVS 158
IHRD+K N+L++ G +K+ DFG+S
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-19
Identities = 76/316 (24%), Positives = 135/316 (42%), Gaps = 65/316 (20%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRS 70
S F ++ +G G+FG+V A + A+K + ++ +++ ++ E +L++ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
++ Y S+ + L+ +M+Y+ GG + L+ E + +L A+E +H
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSA------------------------------- 159
G IHRDIK NIL+ +G +K+ DFG+
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 160 ----------QLTRTISRR------KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVI 203
L R +R+ + VGTP ++APEV+ + GY + D WS+G+ +
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILY 239
Query: 204 EMAKGEPPLADLHPMRVLFIIPREN-----PPQLDEHFSRLMKEFVSLCLK--KVPAER- 255
EM G+PP P+ + PPQ ++L E L +K + P +R
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ-----AKLSPEASDLIIKLCRGPEDRL 294
Query: 256 --PSAKELLRHRFIRN 269
A E+ H F +
Sbjct: 295 GKNGADEIKAHPFFKT 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 37/218 (16%)
Query: 21 IGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQ----KEISVLSQCRSPYIT 74
IGRG++G VYKA K K+ AIK + +++ I +EI++L + + +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF--KGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 75 EYYGSYLHQT--KLWIIMEYMAGGSVADLIQ--------SGPPLDEMSIACILRDLLHAI 124
+L ++++ +Y + DL Q + + +L +L+ +
Sbjct: 66 SLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 125 EYLHNEGKIHRDIKAANILLT----ENGDVKVADFGVSAQLTRTI-SRRKTF------VG 173
YLH+ +HRD+K ANIL+ E G VK+ D G L R + K V
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG----LARLFNAPLKPLADLDPVVV 177
Query: 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPP 211
T ++ APE++ + Y + DIW++G E+ EP
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVLSQCRSPY 72
++ +E IG G++G VYKA D+ N+ +A+K I LE+ ++ + +EIS+L + +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADL-----IQSGPPL--DEMSIACILRDLLHAIE 125
I + +L+++ EY+ DL + S P + I L +L I
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 126 YLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQL---TRTISRRKTFVGTPFWMAPE 181
Y H+ +HRD+K N+L+ +K+ADFG++ RT + V T ++ APE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE---VVTLWYRAPE 173
Query: 182 VIQNSEGYNEKADIWSLGITVIEMAKGEP 210
++ S Y+ DIWS+G EM +P
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 74/274 (27%), Positives = 132/274 (48%), Gaps = 40/274 (14%)
Query: 21 IGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVLSQC-RSPY 72
+G G FG V +A ++K VA+K++ ++ ++ D+ E+ ++ +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG-PPLDEMS----------------IAC 115
I G + L++I+EY A G++ + +++ PP + + ++C
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 116 ILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-T 174
+ + +EYL + IHRD+ A N+L+TE+ +K+ADFG++ + +KT G
Sbjct: 140 AYQ-VARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198
Query: 175 PF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPREN---- 228
P WMAPE + + Y ++D+WS GI + E+ G P + P+ LF + RE
Sbjct: 199 PVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELFKLLREGHRMD 256
Query: 229 -PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
P LM+E C VP +RP+ K+L
Sbjct: 257 KPSNCTHELYMLMRE----CWHAVPTQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 22/208 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSP 71
R+ +L+ IG G+ G V A+D ++VAIK + ++ + +E+ ++
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 72 YITEYYGSYLHQTKL------WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125
I + Q L +++ME M ++ +IQ LD ++ +L +L I+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQM--DLDHERMSYLLYQMLCGIK 132
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP-----FWMAP 180
+LH+ G IHRD+K +NI++ + +K+ DFG L RT +F+ TP ++ AP
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYVVTRYYRAP 186
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKG 208
EVI GY E DIWS+G + EM +G
Sbjct: 187 EVILGM-GYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 16/268 (5%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQCRSP 71
F ++G+G FG+V + K A K ++ +++ + E + E +L + S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQ 60
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHN 129
++ +Y + L +++ M GG + I P +E ++L +E LH
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
E ++RD+K NILL + G ++++D G++ ++ S R VGT +MAPEV+ N + Y
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR-VGTVGYMAPEVLNN-QRY 178
Query: 190 NEKADIWSLGITVIEMAKGEPPL-ADLHPMRVLFIIPR--ENPPQLDEHFSRLMKEFVSL 246
D W LG + EM +G+ P ++ + R E FS K +
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238
Query: 247 CLKKVPAER-----PSAKELLRHRFIRN 269
L K P +R A E+ RH F RN
Sbjct: 239 LLTKDPKQRLGCQEEGAGEVKRHPFFRN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 72/296 (24%), Positives = 127/296 (42%), Gaps = 34/296 (11%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ LE +G GS+ VYK K K VA+KVI L+E E +E S+L + I
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+ + L ++ EY+ + + L ++ L LL + Y+H +H
Sbjct: 67 LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILH 126
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K N+L+++ G++K+ADFG++ + V T ++ P+V+ S Y+ D
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLD 186
Query: 195 IWSLGITVIEMAKGE---PPLADLHPM--RVLFI--------------IPRENPPQLDEH 235
+W +G +EM +G P + D+ R+ + +P P + +
Sbjct: 187 MWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLY 246
Query: 236 FSRLMKE-------------FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278
+ +++ S L+ P R SA+ L H + + PRL E
Sbjct: 247 SPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL--PPRLWE 300
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-19
Identities = 75/286 (26%), Positives = 142/286 (49%), Gaps = 38/286 (13%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKE 61
E + +R + + +G G FG V A ++KD VA+K++ + ++ ++ D+ E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 62 ISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACIL- 117
+ ++ + I G+ L++++EY + G++ + +++ P +D C L
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 118 ------RDLL-------HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164
+DL+ +EYL ++ IHRD+ A N+L+TE+ +K+ADFG++ +
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI 187
Query: 165 ISRRKTFVGT-PF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVL 221
+KT G P WMAPE + + Y ++D+WS G+ + E+ G P + P+ L
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEEL 245
Query: 222 FIIPRE-----NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
F + +E P +M+E C VP++RP+ K+L+
Sbjct: 246 FKLLKEGHRMDKPANCTHELYMIMRE----CWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 8e-19
Identities = 67/231 (29%), Positives = 116/231 (50%), Gaps = 21/231 (9%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED------EI--------ED 57
GSR+ L +G GS G V+ A D + +K VA+K I L + + EI ++
Sbjct: 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 58 IQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACIL 117
I K VL S +TE GS ++I+ EYM +A++++ G PL E +
Sbjct: 64 IVKVYEVLGPSGSD-LTEDVGSLTELNSVYIVQEYME-TDLANVLEQG-PLSEEHARLFM 120
Query: 118 RDLLHAIEYLHNEGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRKTF---VG 173
LL ++Y+H+ +HRD+K AN+ + TE+ +K+ DFG++ + S + +
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII 224
T ++ +P ++ + Y + D+W+ G EM G+P A H + + +I
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 70/273 (25%), Positives = 122/273 (44%), Gaps = 33/273 (12%)
Query: 21 IGRGSFGDVYKAFDKELN-----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+G G FG V KA L VA+K++ S E+ D+ E ++L Q P++ +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQ-----------SGPPLDEMSI------ACILR 118
YG+ L +I+EY GS+ ++ S + + A +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 119 DLL-------HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171
DL+ ++YL +HRD+ A N+L+ E +K++DFG+S + S K
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 172 VG-TPF-WMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228
G P WMA E + + Y ++D+WS G+ + E+ G P + P R+ ++
Sbjct: 188 KGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY 246
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
+ E+ S M + C K+ P +RP+ ++
Sbjct: 247 RMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 78/284 (27%), Positives = 125/284 (44%), Gaps = 46/284 (16%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK---------EISVL 65
F ++G+G FG+V + K A K + E + I+K E +L
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKL-------EKKRIKKRKGEAMALNEKQIL 54
Query: 66 SQCRSPYITEYYGSYLHQTK--LWIIMEYMAGGSVA-DLIQSGPP-LDEMSIACILRDLL 121
+ S ++ +Y ++TK L +++ M GG + + G P DE ++
Sbjct: 55 EKVNSRFVVSL--AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEIT 112
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPFWMA 179
+E LH E ++RD+K NILL + G ++++D G++ ++ TI R VGT +MA
Sbjct: 113 CGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VGTVGYMA 169
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP--------MRVLFIIPRENPPQ 231
PEV++N E Y D W LG + EM +G+ P RV +E+ +
Sbjct: 170 PEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV-----KEDQEE 223
Query: 232 LDEHFSRLMKEFVSLCLKKVPAER-----PSAKELLRHRFIRNA 270
E FS + L K P R A+E+ H F R A
Sbjct: 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 73/281 (25%), Positives = 122/281 (43%), Gaps = 47/281 (16%)
Query: 21 IGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
IG+G+FG V++A L VA+K++ E S D D Q+E +++++ P I +
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSG----------------------PPLDEMSI 113
G + ++ EYMA G + + ++ PL
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 114 ACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
CI + + + YL +HRD+ N L+ EN VK+ADFG L+R I +
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG----LSRNIYSADYYKA 188
Query: 174 T-----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPR 226
+ P WM PE I + Y ++D+W+ G+ + E+ + G P + V++ +
Sbjct: 189 SENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD 247
Query: 227 EN----PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
N P LM+ LC K+P++RPS + R
Sbjct: 248 GNVLSCPDNCPLELYNLMR----LCWSKLPSDRPSFASINR 284
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 77/262 (29%), Positives = 118/262 (45%), Gaps = 17/262 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCR 69
S ++IG G FG+V K K VAIK + +E + D E S++ Q
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSV-ADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
P I G + I+ EYM GS+ A L + + + +LR + ++YL
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQN 185
+ G +HRD+ A NIL+ N KV+DFG+S L T G W APE I
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 186 SEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR--ENPPQLD--EHFSRLM 240
+ + +D+WS GI + E M+ GE P ++ V+ I P +D +LM
Sbjct: 184 RK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLM 242
Query: 241 KEFVSLCLKKVPAERPSAKELL 262
+ C +K ERP ++++
Sbjct: 243 LD----CWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 70/274 (25%), Positives = 124/274 (45%), Gaps = 23/274 (8%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEIS 63
E A + + +G+GSFG VY+ K + KD VAIK ++ S E + E S
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 64 VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLI------------QSGPPLDEM 111
V+ + ++ G +IME M G + + Q+ P L +M
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 112 SIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171
+ ++ + YL+ +HRD+ A N ++ E+ VK+ DFG++ + T RK
Sbjct: 122 --IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 172 VG-TPF-WMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228
G P WM+PE +++ + +D+WS G+ + E+A E P + +VL +
Sbjct: 180 KGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
++ ++ E + +C + P RPS E++
Sbjct: 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 67/254 (26%), Positives = 116/254 (45%), Gaps = 17/254 (6%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
EL+G+G+FG+V+K K+ VA+K + ++ E +L Q P I + G
Sbjct: 1 ELLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYLHNEGKIHR 135
+ ++I+ME + GG ++ DE+ +++ D + YL ++ IHR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGYNEKAD 194
D+ A N L+ EN +K++DFG+S Q I P W APE + N Y+ ++D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEAL-NYGRYSSESD 176
Query: 195 IWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLK 249
+WS GI + E + G P + + + + P + + ++M+ C
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQR----CWD 232
Query: 250 KVPAERPSAKELLR 263
P RP EL +
Sbjct: 233 YKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 51/281 (18%)
Query: 18 LELIGRGSFGDVYKAF--------DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR 69
+G G+FG V+ DKEL VA+K + S D +D ++E +L+ +
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKEL---VAVKTLKETASNDARKDFEREAELLTNFQ 66
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP----LDEMSIAC---ILRDLLH 122
I ++YG ++ EYM G + ++S P L L LL
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 123 -------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-- 173
+ YL ++ +HRD+ N L+ + VK+ DFG+S + T R VG
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR---VGGH 183
Query: 174 --TPF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFII----- 224
P WM PE I + + ++D+WS G+ + E+ G+ P L V+ I
Sbjct: 184 TMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242
Query: 225 ---PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
PR P ++ +M C K+ P +R + K++
Sbjct: 243 LQRPRTCPSEV----YDIMLG----CWKRDPQQRINIKDIH 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 9/211 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
++IG G FG+V++ K + VAIK + +E + +D E S++ Q I
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIH 134
G II EYM G++ ++ + +LR + ++YL + +H
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEGYNE 191
RD+ A NIL+ N + KV+DFG+S L T G W APE I + +
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK-FTS 189
Query: 192 KADIWSLGITVIE-MAKGEPPLADLHPMRVL 221
+D+WS GI + E M+ GE P D+ V+
Sbjct: 190 ASDVWSFGIVMWEVMSFGERPYWDMSNHEVM 220
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 78/291 (26%), Positives = 142/291 (48%), Gaps = 39/291 (13%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLE----ESEDEIEDIQKEISVLSQCRSPYITEY 76
+G+G FG+V K K A K +D + +S +++ ++KEI L + SP+I
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLI----QSGPPLDEM-----SIACILRDLLHAIEYL 127
++ +T L ++M M GG + I + G ++ + I C I +L
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITC-------GILHL 111
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPFWMAPEVIQN 185
H+ ++RD+K N+LL + G+ +++D G++ +L +TI++R GT +MAPE+++
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGTNGYMAPEILK- 167
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV----LFIIPRENPPQLD-EHFSRLM 240
E Y+ D +++G ++ EM G P D H +V L E+ + + ++F+
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGRTPFKD-HKEKVAKEELKRRTLEDEVKFEHQNFTEES 226
Query: 241 KEFVSLCLKKVPAERPSAKEL----LRHRFIRNARKSPRLLERIRERPKYP 287
K+ L L K P +R ++E +H F + PRL + P P
Sbjct: 227 KDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI-NFPRLEAGLIPPPFVP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 66/250 (26%), Positives = 114/250 (45%), Gaps = 26/250 (10%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G FG+V+ + N + V L+ ++ +E +++ + + Y
Sbjct: 14 LGAGQFGEVWMGY---YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ ++II EYMA GS+ D ++S P L + S + + Y+ + I
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEGMAYIERKNYI 125
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV--GTPF---WMAPEVIQNSEG 188
HRD++AAN+L++E+ K+ADFG L R I + G F W APE I N
Sbjct: 126 HRDLRAANVLVSESLMCKIADFG----LARVIEDNEYTAREGAKFPIKWTAPEAI-NFGS 180
Query: 189 YNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247
+ K+D+WS GI + E+ G+ P + V+ + R E+ + + + C
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTC 240
Query: 248 LKKVPAERPS 257
K+ ERP+
Sbjct: 241 WKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (218), Expect = 4e-18
Identities = 83/298 (27%), Positives = 142/298 (47%), Gaps = 43/298 (14%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQ 67
E+ + + ++ IG G FG+V+ K + K I E E + E++V+ +
Sbjct: 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68
Query: 68 CRSPYITEYYGSYLHQT--KLWIIMEYMAGGSVADLIQSG----PPLDEMSIACILRDLL 121
+ I Y +L++ KL+I+ME+ G ++ IQ ++E +I I R LL
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 122 HAIEYLHN-------EGKIHRDIKAANILLTE---------------NGD--VKVADFGV 157
HA+ Y HN E +HRD+K NI L+ NG K+ DFG+
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 158 SAQLTRTISRRKTFVGTPFWMAPEVI-QNSEGYNEKADIWSLGITVIEMAKGEPPLADLH 216
S + S + VGTP++ +PE++ ++ Y++K+D+W+LG + E+ G+ P +
Sbjct: 189 SKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247
Query: 217 PMRVLFIIPRENPPQL-----DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269
L I + P L + + L+K ++L K ERPSA + L ++ I+N
Sbjct: 248 NFSQL-ISELKRGPDLPIKGKSKELNILIKNLLNLSAK----ERPSALQCLGYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 39/269 (14%)
Query: 19 ELIGRGSFGDVYKA--FDKELNK-DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+IG+G FG VY D + K A+K ++ +E+E KE ++ P +
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 76 YYGSYLHQTKL-WIIMEYMAGGSVADLIQS---GPPLDEMSIACILRDLL-------HAI 124
G L +++ YM G + + I+S P ++DL+ +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP---------TVKDLIGFGLQVAKGM 111
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-------SRRKTFVGTPF- 176
EYL ++ +HRD+ A N +L E+ VKVADFG L R I T P
Sbjct: 112 EYLASKKFVHRDLAARNCMLDESFTVKVADFG----LARDIYDKEYYSVHNHTGAKLPVK 167
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRV-LFIIPRENPPQLDE 234
WMA E +Q ++ + K+D+WS G+ + E M +G PP D+ + ++++ Q E
Sbjct: 168 WMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ-PE 225
Query: 235 HFSRLMKEFVSLCLKKVPAERPSAKELLR 263
+ + E + C P RP+ EL+
Sbjct: 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 49/283 (17%)
Query: 14 RFSSLELIGRGSFGDVYKA-----FDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
RF LE +G G+FG VYK ++ VAIK + ++ ++E ++S
Sbjct: 8 RF--LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---------D 119
+ P I G + ++ EY+A G + + + P ++ D
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 120 LLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV-----SAQLTRTISR 167
LH +EYL + +HRD+ A N L+ E VK++DFG+ SA R S+
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFII-- 224
V WM PE I + + ++DIWS G+ + E+ + G P V+ +I
Sbjct: 186 SLLPVR---WMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241
Query: 225 ------PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
P + P ++ LM E C ++PA RP K++
Sbjct: 242 RQLLPCPEDCPARV----YALMIE----CWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 80/283 (28%), Positives = 116/283 (40%), Gaps = 31/283 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ L+L+G G FG V+K + VAIK I ++I + +
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL 66
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYL 127
YI G L ++ + GS+ D + Q LD + + + YL
Sbjct: 67 DHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL 125
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTPF-WMAPEVIQ 184
+HR++ A NILL + V++ADFGV A L ++ + TP WMA E I
Sbjct: 126 EEHRMVHRNLAARNILLKSDSIVQIADFGV-ADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 185 NSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243
Y ++D+WS G+TV E M+ G P A + P V P L E RL +
Sbjct: 185 FGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---------PDLLEKGERLAQPQ 234
Query: 244 VSL---------CLKKVPAERPSAKELLRHRFIRNARKSPRLL 277
+ C RP+ KE L + F R AR PR L
Sbjct: 235 ICTIDVYMVMVKCWMIDENVRPTFKE-LANEFTRMARDPPRYL 276
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 68/249 (27%), Positives = 115/249 (46%), Gaps = 17/249 (6%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G+G FG+V+ N + + L+ E +E V+ + R + + Y +
Sbjct: 14 LGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 69
Query: 81 LHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
+ + ++I+ EYM+ GS+ D + + G L + + + + Y+ +HRD++
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 129
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGYNEKADIWS 197
AANIL+ EN KVADFG++ + + P W APE + K+D+WS
Sbjct: 130 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWS 188
Query: 198 LGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLKKVP 252
GI + E+ KG P + VL + R PP+ E LM + C +K P
Sbjct: 189 FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ----CWRKEP 244
Query: 253 AERPSAKEL 261
ERP+ + L
Sbjct: 245 EERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 35/210 (16%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIK--------VIDLEESEDEIE-----DIQKEISVLSQ 67
IGRG++G V A + E N+ VAIK ID + + EI+ D + I++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 68 CRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAI 124
P+ + Y I+ E M DL I+S L + L LL +
Sbjct: 73 MPPPHREAFNDVY-------IVYELMD----TDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF----VGTPFWMAP 180
+Y+H+ +HRD+K +N+LL N D+K+ DFG L RT S + F V T ++ AP
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFG----LARTTSEKGDFMTEYVVTRWYRAP 177
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEP 210
E++ N Y D+WS+G E+ +P
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 6e-18
Identities = 74/266 (27%), Positives = 130/266 (48%), Gaps = 30/266 (11%)
Query: 20 LIGRGSFGDVYKAFDKELN---KDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSPYIT 74
++G+G FG V +A K + + VA+K++ D+ S D IE+ +E + + + P +
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVI 64
Query: 75 EYYGSYLH---QTKL---WIIMEYMAGGSV-ADLIQS--GPPLDEMSIACILR---DLLH 122
+ G L + +L +I+ +M G + L+ S G + + ++R D+
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-TRTISRRKTFVGTPF-WMAP 180
+EYL ++ IHRD+ A N +L EN V VADFG+S ++ + R+ P W+A
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184
Query: 181 EVIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVL-FIIPRE---NPPQLDEH 235
E + ++ Y +D+W+ G+T+ E M +G+ P A + + ++I PP E
Sbjct: 185 ESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLED 243
Query: 236 FSRLMKEFVSLCLKKVPAERPSAKEL 261
LM + C P RPS + L
Sbjct: 244 VYELMCQ----CWSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 40/278 (14%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDE--IEDIQKEISVLSQ 67
S + +GRG FG+V+ A K + + + V L++++DE + ++E+ + +
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 68 CRSPYITEYYGSYLHQTKLWIIMEYMAGG---------SVADLIQSGPPLDEMSIACILR 118
+ G ++I+EY G D PPL +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 119 DLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF----VGT 174
+ +++L N +HRD+ A N L++ +VKV+ L++ + + +
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS----LSKDVYNSEYYKLRNALI 180
Query: 175 PF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFII-------- 224
P W+APE +Q + ++ K+D+WS G+ + E+ +GE P L VL +
Sbjct: 181 PLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239
Query: 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
E P SRL K C P +RPS EL+
Sbjct: 240 VPEGCP------SRLYKLMTR-CWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-18
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 12/202 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
R+ +L+ IG G+ G V A+D L ++VAIK + +++ + +E+ ++
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 73 ITEYYGSYLHQTKL------WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEY 126
I + Q L +I+ME M ++ +IQ LD ++ +L +L I++
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKH 141
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
LH+ G IHRD+K +NI++ + +K+ DFG+ A+ T +V T ++ APEVI
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 187 EGYNEKADIWSLGITVIEMAKG 208
GY E DIWS+G + EM KG
Sbjct: 201 -GYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 70/263 (26%), Positives = 116/263 (44%), Gaps = 33/263 (12%)
Query: 21 IGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY-IT 74
+G G+FG V +A L+K VA+K++ E E + E+ ++S + I
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLH-------AIEYL 127
G+ + +I EY G + + ++ + L DLL + +L
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRR-----KRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV--GTPF----WMAPE 181
++ IHRD+ A N+LLT VK+ DFG L R I +V G WMAPE
Sbjct: 158 ASKNCIHRDLAARNVLLTHGKIVKICDFG----LARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 182 VIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSR 238
I N Y ++D+WS GI + E+ + G P + P+ F + ++ EH
Sbjct: 214 SIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGM-PVDSKFYKLIKEGYRMAQPEHAPA 271
Query: 239 LMKEFVSLCLKKVPAERPSAKEL 261
+ + + C P +RP+ K++
Sbjct: 272 EIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 1e-17
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
R+ +L+ IG G+ G V A+D L+++VAIK + +++ + +E+ ++
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 73 ITEYYGSYLHQTKL------WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEY 126
I + Q L +++ME M ++ +IQ LD ++ +L +L I++
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKH 134
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
LH+ G IHRD+K +NI++ + +K+ DFG+ A+ T +V T ++ APEVI
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 187 EGYNEKADIWSLGITVIEMAK 207
GY E DIWS+G + EM +
Sbjct: 194 -GYKENVDIWSVGCIMGEMVR 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSP 71
R+ L+ +G G++G V A D+ VAIK + +SE + +E+ +L +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 72 YITEYYGSYLHQTKL------WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125
+ + L +++M +M G+ + L E I ++ +L ++
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
Y+H G IHRD+K N+ + E+ ++K+ DFG++ Q T S +V T ++ APEVI N
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ---TDSEMTGYVVTRWYRAPEVILN 189
Query: 186 SEGYNEKADIWSLGITVIEMAKGEP 210
Y + DIWS+G + EM G+P
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 53/196 (27%), Positives = 92/196 (46%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ L+ +G G++ V+K K VA+K I LE E +E+S+L + I
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+ + L ++ EY+ L G + ++ + LL + Y H +H
Sbjct: 67 TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K N+L+ E G++K+ADFG++ + V T ++ P+V+ S Y+ D
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186
Query: 195 IWSLGITVIEMAKGEP 210
+W +G + EMA G P
Sbjct: 187 MWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 19/246 (7%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G+G FG+V+ K VAIK L+ E +E ++ + R + Y +
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKT--LKPGTMMPEAFLQEAQIMKKLRHDKLVPLY-AV 69
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ + ++I+ E+M GS+ D ++ G P L +M+ + + Y+ I
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA-----AQIADGMAYIERMNYI 124
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGYNEK 192
HRD++AANIL+ +N K+ADFG++ + + P W APE + K
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIK 183
Query: 193 ADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251
+D+WS GI + E+ KG P + VL + R + + E + LC KK
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKD 243
Query: 252 PAERPS 257
P ERP+
Sbjct: 244 PDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 71/256 (27%), Positives = 117/256 (45%), Gaps = 25/256 (9%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQCRSP 71
F ++G+G FG+V + K A K ++ +++ + E + E +L + S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKRILEKVNSR 60
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHN 129
++ +Y + L +++ M GG + I + P DE +L +E L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPFWMAPEVIQNSE 187
E ++RD+K NILL + G ++++D G++ Q+ T+ R VGT +MAPEVI N E
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR---VGTVGYMAPEVINN-E 176
Query: 188 GYNEKADIWSLGITVIEMAKGEPPLA--------DLHPMRVLFIIPRENPPQLDEHFSRL 239
Y D W LG + EM +G+ P + RV +E+ + E FS
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-----KEDQEEYSEKFSED 231
Query: 240 MKEFVSLCLKKVPAER 255
K + L K P ER
Sbjct: 232 AKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 53/220 (24%), Positives = 107/220 (48%), Gaps = 35/220 (15%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKD--VAIK--------VIDLEESEDEIEDIQ---- 59
R+ ++ +G+G++G V A + E +++ VAIK I + + E++ ++
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 60 -KEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR 118
K I+ L + + YL++ +ME + +I+SG PL + +
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEE----LMEA----DLHQIIRSGQPLTDAHFQSFIY 112
Query: 119 DLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR--------KT 170
+L ++Y+H+ +HRD+K N+L+ + ++K+ DFG L R S
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFG----LARGFSENPGENAGFMTE 168
Query: 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP 210
+V T ++ APE++ + + Y + D+WS+G + E+ +P
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 70/273 (25%), Positives = 127/273 (46%), Gaps = 26/273 (9%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQCRSP 71
F ++G+G FG+V + K A K ++ +++ + E + E +L + S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSR 60
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHAIEYL 127
++ +Y + L +++ M GG + I ++G +E ++ +E L
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDL 118
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPFWMAPEVIQN 185
H E ++RD+K NILL ++G ++++D G++ + +TI R VGT +MAPEV++N
Sbjct: 119 HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKN 175
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLAD----LHPMRVLFIIPRENPPQLDEHFSRLMK 241
E Y D W+LG + EM G+ P + V ++ +E + E FS +
Sbjct: 176 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDAR 233
Query: 242 EFVSLCLKKVPAER-----PSAKELLRHRFIRN 269
+ L K P ER A+E+ H +
Sbjct: 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI-DLEESEDEIEDIQKEISVLSQCRSPY 72
R+ E+IG+GS+G V A D + VAIK I D+ E + I +EI +L R P
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 73 ITEYYGSYLHQTK-----LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
I E L ++ ++++ E M + +I++ L L LL A++Y+
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFG---VSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
H HRD+K NIL + +K+ DFG V+ T T +V T ++ APE+
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 185 NSEG-YNEKADIWSLGITVIEMAKGEP 210
+ Y DIWS+G E+ G+P
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 75/283 (26%), Positives = 132/283 (46%), Gaps = 39/283 (13%)
Query: 21 IGRGSFGDVYKAFD-KELNKDVAIKVIDLEESEDEIE-DIQKEISVLSQCRS---PYITE 75
IG G++G V+KA D K + VA+K + ++ E+ + +E++VL + P +
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 76 YY-----GSYLHQTKLWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHN 129
+ +TKL ++ E++ L + P + +I ++ LL +++LH+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+HRD+K NIL+T +G +K+ADFG+ A++ + V T ++ APEV+ S Y
Sbjct: 129 HRVVHRDLKPQNILVTSSGQIKLADFGL-ARIYSFQMALTSVVVTLWYRAPEVLLQSS-Y 186
Query: 190 NEKADIWSLGITVIEMAKGEPPL---ADLHPMRVLFII---------PRE---------- 227
D+WS+G EM + +P +D+ + + + PR+
Sbjct: 187 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 246
Query: 228 NPPQLDEHF----SRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
Q E F L K+ + CL PA+R SA L H +
Sbjct: 247 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 74/280 (26%), Positives = 133/280 (47%), Gaps = 26/280 (9%)
Query: 21 IGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+G G+FG V+ A L + VA+K + + S++ +D +E +L+ + +I +
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVK 71
Query: 76 YYGSYLHQTKLWIIMEYM----------AGGSVADLIQSGPPLDEMSIACIL---RDLLH 122
+YG + L ++ EYM A G A L+ G E++ + +L + +
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGTPF-WMAP 180
+ YL ++ +HRD+ N L+ EN VK+ DFG+S + T R P WM P
Sbjct: 132 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 191
Query: 181 EVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL 239
E I + + ++D+WSLG+ + E+ G+ P L V+ I + Q +
Sbjct: 192 ESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKE 250
Query: 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRN-ARKSPRLLE 278
+ + + C ++ P R + KE+ H ++N A+ SP L+
Sbjct: 251 VYDLMLGCWQREPHMRLNIKEI--HSLLQNLAKASPVYLD 288
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 20/211 (9%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIE-DIQKEISVLSQCRS-- 70
++ + IG G++G VYKA D VA+K + ++ +ED + +E+++L + +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 71 -PYITEYYGSYL-----HQTKLWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLHA 123
P I +TK+ ++ E++ L + PP L +I ++R L
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGV----SAQLTRTISRRKTFVGTPFWMA 179
+++LH +HRD+K NIL+T G VK+ADFG+ S Q+ T V T ++ A
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT-----PVVVTLWYRA 175
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEMAKGEP 210
PEV+ S Y D+WS+G EM + +P
Sbjct: 176 PEVLLQST-YATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 72/265 (27%), Positives = 122/265 (46%), Gaps = 38/265 (14%)
Query: 17 SLELI---GRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
SL+LI G G FG+V+ N + + V L+ E +E ++ + R +
Sbjct: 7 SLQLIKKLGNGQFGEVWMG---TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEY 126
+ Y + + + ++I+ EYM+ GS+ D ++ G P L +M+ + + Y
Sbjct: 64 VQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA-----QVAAGMAY 117
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQN 185
+ IHRD+++ANIL+ + K+ADFG++ + + P W APE
Sbjct: 118 IERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 186 SEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFII--------PRENPPQLDEHF 236
+ K+D+WS GI + E+ KG P ++ VL + P++ P L E
Sbjct: 178 GR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE-- 234
Query: 237 SRLMKEFVSLCLKKVPAERPSAKEL 261
LM + C KK P ERP+ + L
Sbjct: 235 --LMLQ----CWKKDPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-17
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
R+ L+ IG G+ G V AFD L +VA+K + +++ + +E+ +L
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 73 ITEYYGSYLHQTKL------WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIE 125
I + Q L +++ME M A+L Q LD ++ +L +L I+
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLCGIK 137
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
+LH+ G IHRD+K +NI++ + +K+ DFG+ A+ T +V T ++ APEVI
Sbjct: 138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTACTNFMMTPYVVTRYYRAPEVILG 196
Query: 186 SEGYNEKADIWSLGITVIEMAKG 208
GY E DIWS+G + E+ KG
Sbjct: 197 M-GYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 52/203 (25%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
R+ +L +G G++G V A+D L + VA+K + +S +E+ +L +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 73 ITEYYGSYLHQTKL------WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEY 126
+ + T + +++ M G + ++++ DE + ++ LL ++Y
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDE-HVQFLIYQLLRGLKY 133
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
+H+ G IHRD+K +N+ + E+ ++++ DFG++ Q ++ +V T ++ APE++ N
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT---GYVATRWYRAPEIMLNW 190
Query: 187 EGYNEKADIWSLGITVIEMAKGE 209
YN+ DIWS+G + E+ KG+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 69/276 (25%), Positives = 126/276 (45%), Gaps = 41/276 (14%)
Query: 18 LELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+E +G +FG +YK + + VAIK + + + + Q+E S++++ P I
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLD-------EMSIACILR--DLLH- 122
G + + ++ EY+ G + + LI P D + ++ L D LH
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 123 ------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-TRTISRRKTFVGTP 175
+EYL + +H+D+ A NIL+ E VK++D G+S ++ + R + P
Sbjct: 130 AIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 176 F-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPP--------LADLHPMRVLFIIP 225
WM PE I + ++ +DIWS G+ + E+ + G P + ++ R L
Sbjct: 190 IRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCS 248
Query: 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
+ PP++ LM E C ++ P+ RP K++
Sbjct: 249 EDCPPRM----YSLMTE----CWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 57/197 (28%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 21 IGRGSFGDV----YKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEY 76
+G G FG V Y + + VA+K + E + +KEI++L I +Y
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 77 YGSYLHQTK--LWIIMEYMAGGSVADLIQSGPPLDEMSIACIL---RDLLHAIEYLHNEG 131
G Q L +IMEY+ GS+ D + P ++++A +L + + + YLH++
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTP-FWMAPEVIQNSEG 188
IHRD+ A N+LL + VK+ DFG++ + R + +P FW A E ++ ++
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK- 186
Query: 189 YNEKADIWSLGITVIEM 205
++ +D+WS G+T+ E+
Sbjct: 187 FSYASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 63/288 (21%), Positives = 112/288 (38%), Gaps = 61/288 (21%)
Query: 13 SRFSSLELIGRGSFGDVYKA------FDKELNKDVAIKVIDLEESEDEIEDIQKEISVLS 66
R + +L+ G+FG ++ KE ++V +K + SE ++ + +E +L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKE--EEVFVKTVKDHASEIQVTLLLQESCLLY 63
Query: 67 QCRSPYI-------TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMS-IACILR 118
I E +++ YM G++ +Q + + A +
Sbjct: 64 GLSHQNILPILHVCIEDGE------PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 119 DLLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL---------- 161
L+H + YLH G IH+DI A N ++ E VK+ D +S L
Sbjct: 118 QLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 162 --TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPM 218
R + WMA E + N E Y+ +D+WS G+ + E+ G+ P ++ P
Sbjct: 178 NENRPVK----------WMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPF 226
Query: 219 RVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
+ + P + +M + C P ERPS +L+
Sbjct: 227 EMAAYLKDGYRLAQPINCPDELFAVM----ACCWALDPEERPSFSQLV 270
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 59/263 (22%), Positives = 118/263 (44%), Gaps = 29/263 (11%)
Query: 21 IGRGSFGDVYKAF-----DKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+G+G+F ++YK D ++ ++V++ + L + + S++SQ +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACIL---RDLLHAIEYLHN 129
+ + YG + + ++ EY+ G + + + +S+ L + L A+ YL +
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLED 119
Query: 130 EGKIHRDIKAANILLTENG-------DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
+ +H ++ NIL+ G +K++D G+ T+ R+ V W+APE
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP----ITVLSREERVERIPWIAPEC 175
Query: 183 IQN-SEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
I+N AD WS G T++E+ + GE PL+ L ++ +L +
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH--RLPMPDCAEL 233
Query: 241 KEFVSLCLKKVPAERPSAKELLR 263
++ C P +RPS + +LR
Sbjct: 234 ANLINQCWTYDPTKRPSFRAILR 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 73/279 (26%), Positives = 127/279 (45%), Gaps = 33/279 (11%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEIS 63
E + + + L +G+GSFG VY+ +++ K VA+K ++ S E + E S
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 64 VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS------------GPPLDEM 111
V+ ++ G ++ME MA G + ++S P L EM
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 112 -SIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170
+A + D + YL+ + +HRD+ A N ++ + VK+ DFG++ + T RK
Sbjct: 122 IQMAAEIAD---GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 171 FVG-TPF-WMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL-FIIP- 225
G P WMAPE +++ + +D+WS G+ + E+ E P L +VL F++
Sbjct: 179 GKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237
Query: 226 --RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
+ P E + LM +C + P RP+ E++
Sbjct: 238 GYLDQPDNCPERVTDLM----RMCWQFNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 21 IGRGSFGDV----YKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEY 76
+G G FG V Y + VA+K + E + I D++KEI +L I +Y
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 77 YGSYLHQ--TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYLHNEG 131
G + +IME++ GS+ + + +++++ L+ + ++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF------VGTP-FWMAPEVIQ 184
+HRD+ A N+L+ VK+ DFG LT+ I K + + +P FW APE +
Sbjct: 130 YVHRDLAARNVLVESEHQVKIGDFG----LTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 185 NSEGYNEKADIWSLGITVIEM 205
S+ Y +D+WS G+T+ E+
Sbjct: 186 QSKFY-IASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-15
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 32/223 (14%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSP 71
R+ + LIG+G G+VY A+D ++ VA+K I DL E+ + +E + + P
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-------GPPLDE-MSIACILR---DL 120
I Y ++ M Y+ G ++ L++S L E S+ L +
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFG--------------VSAQLTRTIS 166
IEY+H++G +HRD+K NILL G+V + D+G +
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 167 RRKT----FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM 205
T VGTP +MAPE + +E DI++LG+ + +M
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQM 224
|
Length = 932 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 13/190 (6%)
Query: 24 GSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH 82
G FG V K K K+I + + E + L + +I YY
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPM-----VHQLMKDNPNFIKLYYSVTTL 81
Query: 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANI 142
+ + I M+Y+ G + DL++ L E + I+R L+ A+ LH IH DIK N+
Sbjct: 82 KGHVLI-MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENV 140
Query: 143 LLTENGD-VKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGIT 201
L D + + D+G L + I + GT + +PE I Y+ D W++G+
Sbjct: 141 LYDRAKDRIYLCDYG----LCKIIGTPSCYDGTLDYFSPEKI-KGHNYDVSFDWWAVGVL 195
Query: 202 VIEMAKGEPP 211
E+ G+ P
Sbjct: 196 TYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 47/183 (25%), Positives = 89/183 (48%), Gaps = 14/183 (7%)
Query: 41 VAIKV--IDLEESEDEIEDIQKEISVLSQCRSPYITEYYGS-YLHQTKLWIIMEYMAGGS 97
VAIK+ D E E + ++E ++ ++ P I S L+ + EY+ G +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 98 VADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD---VKVAD 154
+ +++ + L ++ +L A+ HN+G +HRD+K NI++++ G KV D
Sbjct: 66 LREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLD 125
Query: 155 FGVSAQLT-------RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK 207
FG+ L T++R +GTP + APE ++ E +D+++ G+ +E
Sbjct: 126 FGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG-EPVTPNSDLYAWGLIFLECLT 184
Query: 208 GEP 210
G+
Sbjct: 185 GQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 53/211 (25%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIK--------VIDLEESEDEI--------ED 57
R+ +L +G G++G V AFD + VA+K +I + + E+ E+
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 58 IQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACIL 117
+ + V + RS + E+ YL + ++ G + ++++ D+ + ++
Sbjct: 78 VIGLLDVFTPARS--LEEFNDVYL--------VTHLMGADLNNIVKCQKLTDD-HVQFLI 126
Query: 118 RDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFW 177
+L ++Y+H+ IHRD+K +N+ + E+ ++K+ DFG++ T +V T ++
Sbjct: 127 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVATRWY 183
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIEMAKG 208
APE++ N YN+ DIWS+G + E+ G
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-15
Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 31/236 (13%)
Query: 36 ELNKDVAIKVIDLEESEDEIE--DIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93
+++KD + + +++ + ++ DI+ S Y + Y YL
Sbjct: 180 DMSKDESADYVPMQDMKGTVKYADIES---------SNYESPY-DQYLPSAP-------- 221
Query: 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153
LI P L M + + + +E+L ++ +HRD+ A N+L+ E VK+
Sbjct: 222 ERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKIC 281
Query: 154 DFGVSAQLTRT---ISRRKTFVGTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKG 208
DFG++ + R IS+ TF+ P WMAPE I N+ Y +D+WS GI + E+ G
Sbjct: 282 DFGLARDIMRDSNYISKGSTFL--PLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLG 338
Query: 209 EPPLADLHPMRVLFIIPRENPPQLDE--HFSRLMKEFVSLCLKKVPAERPSAKELL 262
P +L PM F + ++ + H S + E + C ++ RP +L+
Sbjct: 339 GTPYPEL-PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 21 IGRGSFGDVYKAF--DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+GRG++G VYKA D + ++D A+K I E +EI++L + + P +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI---EGTGISMSACREIALLRELKHPNVISLQK 65
Query: 79 SYLHQT--KLWIIMEYMAGGSVADLIQ-------SGPP--LDEMSIACILRDLLHAIEYL 127
+L K+W++ +Y A + +I+ + P L + +L +L I YL
Sbjct: 66 VFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 128 HNEGKIHRDIKAANILLT----ENGDVKVADFGVSAQLT---RTISRRKTFVGTPFWMAP 180
H +HRD+K ANIL+ E G VK+AD G + + ++ V T ++ AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEP 210
E++ + Y + DIW++G E+ EP
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 69/275 (25%), Positives = 128/275 (46%), Gaps = 40/275 (14%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD------VAIKVIDLE-ESEDEIEDIQKEISVLSQCRSP 71
+++G G FG V + +L++D VA+K + L+ + EIE+ E + + P
Sbjct: 5 KILGEGEFGSVMEG---QLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 72 YITEYYGSYLHQTKL------WIIMEYMAGGSV-----ADLIQSGPPLDEMSIACILR-- 118
+ + G + L +I+ +M G + + P +++ + +L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP--EKLPLQTLLKFM 119
Query: 119 -DLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT-PF 176
D+ +EYL N IHRD+ A N +L E+ V VADFG+S ++ R+ + P
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 177 -WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRV---LFIIPRENPPQ 231
W+A E + + Y K+D+W+ G+T+ E+A +G+ P + + L R P+
Sbjct: 180 KWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238
Query: 232 --LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
LDE + + + C + P +RP+ +L
Sbjct: 239 DCLDELY-----DLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 71/268 (26%), Positives = 119/268 (44%), Gaps = 33/268 (12%)
Query: 21 IGRGSFGDVYKAFDKELNKD-----VAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYIT 74
+G G FG V + +LN+D VA+K + + + E+ED E + + P +
Sbjct: 7 LGEGEFGSV---MEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 75 EYYGSYLHQTKLW------IIMEYMAGGSV------ADLIQSGPPLDEMSIACILRDLLH 122
G L + +I+ +M G + + L L + + D+
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR-TISRRKTFVGTPF-WMAP 180
+EYL ++ IHRD+ A N +L EN +V VADFG+S ++ R+ P W+A
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPREN----PPQLDEH 235
E + + Y K+D+WS G+T+ E+A +G+ P + + + + N PP +
Sbjct: 184 ESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDG 242
Query: 236 FSRLMKEFVSLCLKKVPAERPSAKELLR 263
LM S C P +RPS + L
Sbjct: 243 LYSLM----SSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 76/303 (25%), Positives = 129/303 (42%), Gaps = 67/303 (22%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCR---------- 69
IG G+FG V+ D K VA+K + ++ ++ + + +E+ +L +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 70 --SPYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAI 124
P+I + +++++ E M +DL I S PL + L +L +
Sbjct: 68 LQPPHIDPF-------EEIYVVTELMQ----SDLHKIIVSPQPLSSDHVKVFLYQILRGL 116
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF-VGTPFWMAPEVI 183
+YLH+ G +HRDIK N+L+ N +K+ DFG++ S+ T V T ++ APE++
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 184 QNSEGYNEKADIWSLG------------------ITVIEMAK---GEPPLADL------- 215
S Y DIWS+G I +++ G P L +
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236
Query: 216 --HPMRVLFIIPRENP--PQLDEHFSRLMKEFVSLCLKKV---PAERPSAKELLRHRFIR 268
H +R P + P P L S+ E V L + + P +R SA + L H ++
Sbjct: 237 RAHILRG----PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292
Query: 269 NAR 271
R
Sbjct: 293 EGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 78/286 (27%), Positives = 121/286 (42%), Gaps = 37/286 (12%)
Query: 13 SRFSSLELIGRGSFGDVYKAF---DKE-LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ ++++G G+FG VYK D E + VAIKV+ S ++I E V++
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 66
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIE 125
SPY+ G L T + ++ + M G + D ++ D + +L + +
Sbjct: 67 GSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMS 123
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-TPF-WMAPEVI 183
YL +HRD+ A N+L+ VK+ DFG++ L + G P WMA E I
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 184 QNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
+ + ++D+WS G+TV E M G P IP P L E RL +
Sbjct: 184 LHRR-FTHQSDVWSYGVTVWELMTFGAKPYDG---------IPAREIPDLLEKGERLPQP 233
Query: 243 FVSLCLKKV-----------PAERPSAKELLRHRFIRNARKSPRLL 277
+C V RP +EL+ F R AR R +
Sbjct: 234 --PICTIDVYMIMVKCWMIDSECRPRFRELV-DEFSRMARDPSRFV 276
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 21 IGRGSFGDVYKAF--DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+GRG++G VYKA D + K+ A+K I E +EI++L + + P +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI---EGTGISMSACREIALLRELKHPNVIALQK 65
Query: 79 SYLHQT--KLWIIMEYMAGGSVADLIQ-------SGPP--LDEMSIACILRDLLHAIEYL 127
+L + K+W++ +Y A + +I+ + P L + +L +L I YL
Sbjct: 66 VFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 128 HNEGKIHRDIKAANILLT----ENGDVKVADFGVSAQLT---RTISRRKTFVGTPFWMAP 180
H +HRD+K ANIL+ E G VK+AD G + + ++ V T ++ AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEP 210
E++ + Y + DIW++G E+ EP
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 25/253 (9%)
Query: 20 LIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEY 76
++G G FG++ + K +K VAI + S+ + E L Q I
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHR 135
G + I+ EYM+ G++ ++ L + +L L ++YL G +H+
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHK 131
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP--FWMAPEVIQNSEGYNEKA 193
+ A +L+ + K++ F Q ++ + T G W APE IQ ++ +
Sbjct: 132 GLAAHKVLVNSDLVCKISGFR-RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH-FSSAS 189
Query: 194 DIWSLGITVIE-MAKGEPPLADLHPMRVLFII--------PRENPPQLDEHFSRLMKEFV 244
D+WS GI + E M+ GE P D+ V+ + PR P +LM +
Sbjct: 190 DVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPN----LLHQLMLD-- 243
Query: 245 SLCLKKVPAERPS 257
C +K ERP
Sbjct: 244 --CWQKERGERPR 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISV 64
AG+++A FS LE G+ G + D + + V IK + E +
Sbjct: 87 AGIEKAG---FSILETFTPGAEGFAFACIDNKTCEHVVIKA-------GQRGGTATEAHI 136
Query: 65 LSQCRSPYITEYYGSYLHQTKLWIIME--------YMAGGSVADLIQSGPPLDEMSIACI 116
L P I + G++ + +I+ Y+A ++ D ++I
Sbjct: 137 LRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAK------RNIAICDILAIE-- 188
Query: 117 LRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA-QLTRTISRRKTFVGTP 175
R +L AI+YLH IHRDIKA NI + GDV + DFG + + ++ + GT
Sbjct: 189 -RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPL 212
APE++ + Y DIWS GI + EMA L
Sbjct: 248 ATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 71/274 (25%), Positives = 119/274 (43%), Gaps = 45/274 (16%)
Query: 21 IGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+G G+FG V+ A L + VA+K + E SE +D Q+E +L+ + +I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTVLQHQHIVR 71
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP----LDEMSIACI----LRDLLH----- 122
+YG L ++ EYM G + ++S P L L +L
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 123 --AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR---KTFVGTPF- 176
+ YL + +HRD+ N L+ + VK+ DFG+S + T R +T + P
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--PIR 189
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFII--------PRE 227
WM PE I + + ++DIWS G+ + E+ G+ P L + I PR
Sbjct: 190 WMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRT 248
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
PP++ +M+ C ++ P +R K++
Sbjct: 249 CPPEVYA----IMQG----CWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 67/250 (26%), Positives = 114/250 (45%), Gaps = 27/250 (10%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G FG+V+ A NK + V ++ +E E +V+ + + + + +
Sbjct: 14 LGAGQFGEVWMA---TYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH-AV 69
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ + ++II E+MA GS+ D ++S P L + S + + ++ I
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-----QIAEGMAFIEQRNYI 124
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV--GTPF---WMAPEVIQNSEG 188
HRD++AANIL++ + K+ADFG L R I + G F W APE I N
Sbjct: 125 HRDLRAANILVSASLVCKIADFG----LARVIEDNEYTAREGAKFPIKWTAPEAI-NFGS 179
Query: 189 YNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247
+ K+D+WS GI ++E+ G P + V+ + R E+ + + C
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRC 239
Query: 248 LKKVPAERPS 257
K P ERP+
Sbjct: 240 WKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 62/262 (23%), Positives = 123/262 (46%), Gaps = 24/262 (9%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
E +G+G+F ++K +E+ V +KV+D + + E + S++SQ
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD-KSHRNYSESFFEAASMMSQLSHK 59
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
++ YG + + ++ EY+ GS+ L ++ ++ + + L A+ +L ++
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK 119
Query: 131 GKIHRDIKAANILLTENGD--------VKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
G H ++ A N+LL D +K++D G+S T+ ++ + W+ PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIPWVPPEC 175
Query: 183 IQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241
I+N + + AD WS G T+ E+ + G+ PL+ L + L E+ QL +
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--EDRHQLPAPKWTELA 233
Query: 242 EFVSLCLKKVPAERPSAKELLR 263
++ C+ P RPS + ++R
Sbjct: 234 NLINQCMDYEPDFRPSFRAIIR 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 56/209 (26%), Positives = 80/209 (38%), Gaps = 51/209 (24%)
Query: 107 PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166
PL I + +L + YLH + IHRD+K NI + + V + D G +AQ
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAP 211
Query: 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM------------AKGEPPLAD 214
GT APEV+ + YN KADIWS GI + EM + E +
Sbjct: 212 AFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKS 270
Query: 215 LHP-----MRVLFIIPRENPPQLDEHFSRLMKEFVSL------------CLKKV------ 251
H + L + P E P SRL++ F+ C ++V
Sbjct: 271 CHSHLLKIISTLKVHPEEFPRDPG---SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDG 327
Query: 252 -----------PAERPSAKELLRHRFIRN 269
A RPSA+E+L +
Sbjct: 328 EFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356
|
Length = 357 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 40/106 (37%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 104 SGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162
SGP PL++ I R LL A+ YLH G IHRD+K NI L E + + DFG + +L
Sbjct: 179 SGPLPLEQAIT--IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 163 RTISRRKTF--VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA 206
+ + GT +PE++ + Y K DIWS G+ + EM+
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLA-LDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 14/209 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ F ++++G G+FG VYK +++ VAIK + S ++I E V++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIE 125
+P++ G L T + +I + M G + D ++ D + +L + +
Sbjct: 67 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMN 123
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-TPF-WMAPEVI 183
YL +HRD+ A N+L+ VK+ DFG++ L G P WMA E I
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 184 QNSEGYNEKADIWSLGITVIE-MAKGEPP 211
+ Y ++D+WS G+TV E M G P
Sbjct: 184 LHRI-YTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 68/270 (25%), Positives = 125/270 (46%), Gaps = 32/270 (11%)
Query: 21 IGRGSFGDVYKA--FDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+G G+FG V+ A ++ KD VA+K + + + +D Q+E +L+ + +I +
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 76 YYGSYLHQTKLWIIMEYM----------AGGSVADLIQSGPPLD---EMSIACILR---D 119
+YG L ++ EYM A G A ++ G P E+ ++ +L
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 120 LLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG----TP 175
+ + YL ++ +HRD+ N L+ N VK+ DFG+S + T R VG P
Sbjct: 132 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR---VGGHTMLP 188
Query: 176 F-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLD 233
WM PE I + + ++D+WS G+ + E+ G+ P L V+ I + +
Sbjct: 189 IRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP 247
Query: 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
+ + + + C ++ P +R + KE+ +
Sbjct: 248 RVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 40/276 (14%)
Query: 21 IGRGSFGDVYKAFDKELNK-----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
IG G FG K E ++ V +K + + DE +E+ + P + +
Sbjct: 3 IGNGWFG---KVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQS--------GPPLDEMSIACILRDLLHAIEYL 127
G + +++E+ G + + ++S +AC ++ + +L
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMAC---EVASGLLWL 116
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT---ISRRKTFVGTPF-WMAPEVI 183
H IH D+ N LT + VK+ D+G++ + I++ V P W+APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV--PLRWLAPELV 174
Query: 184 QN------SEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN-----PPQ 231
+ + +K++IWSLG+T+ E+ + P DL +VL + RE PQ
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234
Query: 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
LD +S E + C P RP+A+E+ H +
Sbjct: 235 LDLKYSDRWYEVMQFCWLD-PETRPTAEEV--HELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 69/295 (23%), Positives = 122/295 (41%), Gaps = 57/295 (19%)
Query: 14 RFSSLELIGRGSFGDVY--------KAFDKELNKD--------VAIKVIDLEESEDEIED 57
R + E +G G FG+V+ K DK+ + D VA+K++ + +++ D
Sbjct: 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 58 IQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSI 113
KEI ++S+ + P I + L +I EYM G + + +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 114 ACILRDLLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR--- 163
L+ ++YL + +HRD+ N L+ +N +K+ADFG+S L
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 164 -TISRRKTFVGTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPPLADLHPMR 219
I R P WM+ E I + + +D+W+ G+T+ E+ E P + L +
Sbjct: 186 YRIQGRAVL---PIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241
Query: 220 VL-------------FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
V+ +P+ P + +LM C ++ ERPS +E+
Sbjct: 242 VIENTGEFFRDQGRQVYLPK--PALCPDSLYKLMLS----CWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 38/102 (37%), Positives = 54/102 (52%), Gaps = 3/102 (2%)
Query: 107 PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS--AQLTRT 164
PL + + R LL AI+Y+H EG IHRDIK N+L+ D+ + DFG + A+ + +
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315
Query: 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA 206
GT APEV+ + Y DIWS G+ + E A
Sbjct: 316 TPFHYGIAGTVDTNAPEVLA-GDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 75/304 (24%), Positives = 121/304 (39%), Gaps = 67/304 (22%)
Query: 19 ELIGRGSFGDVY----------KAFDKELNKD------VAIKVIDLEESEDEIEDIQKEI 62
E +G G FG+V+ N VA+K++ + +++ D KE+
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 63 SVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS------------GPPLDE 110
+LS+ + P I G + + L +I EYM G + + S P
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 111 MSIACILRDLLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-T 162
A LLH ++YL + +HRD+ N L+ EN +K+ADFG+S L
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 163 RTISRRKTFVGTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPPLADLHPMR 219
R + P WMA E I + + +D+W+ G+T+ E+ E P +L +
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249
Query: 220 VLFIIPREN----------------PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
V+ EN PP + LM + C + ERPS ++
Sbjct: 250 VI-----ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQ----CWSRDCRERPSFSDI-- 298
Query: 264 HRFI 267
H F+
Sbjct: 299 HAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 44/273 (16%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
IG G FG K E+N + ++E +Q+++ L + + PY + + +
Sbjct: 3 IGNGWFG---KVILGEVNSGYTPAQVVVKELRVS-ASVQEQMKFLEEAQ-PYRSLQHSNL 57
Query: 81 LH-------QTKLWIIMEYMAGGSVADLIQSGPPLDEMS--------IAC-ILRDLLHAI 124
L T ++ME+ G + ++S + M+ +AC I LLH
Sbjct: 58 LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH-- 115
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT---ISRRKTFVGTPF-WMAP 180
LH IH D+ N LLT + VK+ D+G+S + ++ + +V P W+AP
Sbjct: 116 --LHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAP 171
Query: 181 EVIQNSEG------YNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN----- 228
E++ G +++++WSLG+T+ E+ + G P L +VL RE
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLP 231
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
P+L S E + C + P +RPSA+E+
Sbjct: 232 KPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-12
Identities = 74/308 (24%), Positives = 132/308 (42%), Gaps = 52/308 (16%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
+IG GSFG VY+A + ++ VAIK + D + E+ ++ L+ ++ +YY
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKN----LNHINIIFLKDYY 128
Query: 78 GSYLHQTK-------LWIIMEYM---AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
Y K L ++ME++ + ++ L + L A+ Y+
Sbjct: 129 --YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 128 HNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
H++ HRD+K N+L+ N +K+ DFG SA+ R +++ + F+ APE++ +
Sbjct: 187 HSKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRSVSYICSRFYRAPELMLGA 245
Query: 187 EGYNEKADIWSLGITVIEMAKGEP------------------------PLADLHPMRVLF 222
Y D+WSLG + EM G P L +++P
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305
Query: 223 IIPRENPPQLDEHFSRLMKE----FVSLCLKKVPAERPSAKELLRHRFIRNAR----KSP 274
P P L + F + + F+S LK P +R + E L F + R K P
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365
Query: 275 RLLERIRE 282
+ ++++ +
Sbjct: 366 KYIDKLPD 373
|
Length = 440 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 19 ELIGRGSFGDVY---------------KAFDKELNKDVAIKVIDLEESEDEIEDIQKEIS 63
E +G G FG+V+ FD + VA+K++ + ++ D KEI
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVL-VAVKMLRADVTKTARNDFLKEIK 69
Query: 64 VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIA----CILR- 118
++S+ ++P I G + L +I EYM G + + + A +
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 119 DLLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-TRTISRRKT 170
+LL+ ++YL + +HRD+ N L+ + +K+ADFG+S L + R +
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 171 FVGTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEM 205
P WMA E I + + +D+W+ G+T+ EM
Sbjct: 190 RAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 43/164 (26%)
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-----RKTFVGTPF-W 177
+E+L + IHRD+ A NILL+EN VK+ DFG L R I + RK P W
Sbjct: 186 MEFLASRKCIHRDLAARNILLSENNVVKICDFG----LARDIYKDPDYVRKGDARLPLKW 241
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHF 236
MAPE I + + Y ++D+WS G+ + E+ + G P + Q+DE F
Sbjct: 242 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGV---------------QIDEEF 285
Query: 237 SRLMKEFVSL----------------CLKKVPAERPSAKELLRH 264
R +KE + C P +RP+ EL+
Sbjct: 286 CRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 53/181 (29%), Positives = 78/181 (43%), Gaps = 43/181 (23%)
Query: 107 PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166
L + C + +E+L + IHRD+ A NILL+EN VK+ DFG L R I
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG----LARDIY 230
Query: 167 R-----RKTFVGTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMR 219
+ RK P WMAPE I + Y ++D+WS G+ + E+ + G P +
Sbjct: 231 KDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--- 286
Query: 220 VLFIIPRENPPQLDEHFSRLMKEFVSL----------------CLKKVPAERPSAKELLR 263
+DE F R +KE + C P++RP+ EL+
Sbjct: 287 ------------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 334
Query: 264 H 264
H
Sbjct: 335 H 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 14/156 (8%)
Query: 116 ILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-------DVKVADFGVSAQLTRTISRR 168
+ + L A+ YL ++ +H ++ A NILL G +K++D GVS +SR
Sbjct: 122 VAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFT---ALSRE 178
Query: 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRE 227
+ P W+APE + + AD WS G T++E+ GE PL + P ++
Sbjct: 179 ERVERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKK 237
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
+ +L E + + +S CL P +RPS + +LR
Sbjct: 238 H--RLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 45/188 (23%)
Query: 98 VADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157
DL +S PL + C + +E+L + IHRD+ A NILL+EN VK+ DFG
Sbjct: 163 TDDLWKS--PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG- 219
Query: 158 SAQLTRTISR-----RKTFVGTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEP 210
L R I + RK P WMAPE I + + Y ++D+WS G+ + E+ + G
Sbjct: 220 ---LARDIYKDPDYVRKGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGAS 275
Query: 211 PLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL----------------CLKKVPAE 254
P + Q++E F + +K+ + C + P E
Sbjct: 276 PYPGV---------------QINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE 320
Query: 255 RPSAKELL 262
RP+ L+
Sbjct: 321 RPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 70/285 (24%), Positives = 114/285 (40%), Gaps = 35/285 (12%)
Query: 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ ++++G G+FG VYK + + VAIK+++ + E +++
Sbjct: 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIE 125
P++ G L T + ++ + M G + D + D + +L + +
Sbjct: 67 DHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMM 123
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEV 182
YL +HRD+ A N+L+ VK+ DFG+ A+L + G WMA E
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGL-ARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 183 IQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241
I + + ++D+WS G+T+ E M G P IP P L E RL +
Sbjct: 183 IHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDG---------IPTREIPDLLEKGERLPQ 232
Query: 242 EFVSL---------CLKKVPAERPSAKELLRHRFIRNARKSPRLL 277
+ C RP KEL F R AR R L
Sbjct: 233 PPICTIDVYMVMVKCWMIDADSRPKFKELAA-EFSRMARDPQRYL 276
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 34/95 (35%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 116 ILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGT 174
I++ LL A+EY+H++ IHRDIK NI L +G + + DFG + + + +VGT
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGT 331
Query: 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGE 209
+PE++ +GY E DIWS G+ +++M +
Sbjct: 332 VATNSPEILAG-DGYCEITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 43/190 (22%), Positives = 81/190 (42%), Gaps = 9/190 (4%)
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P + + + + +++++++ GG + I + E + +++ A++ LH E
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
G + RD+ NILL + G +++ F +++ + + APEV SE
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV---ENMYCAPEVGGISE-ET 160
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
E D WSLG + E+ G+ L + HP I + E S + + L+
Sbjct: 161 EACDWWSLGAILFELLTGK-TLVECHPSG----INTHTTLNIPEWVSEEARSLLQQLLQF 215
Query: 251 VPAERPSAKE 260
P ER A
Sbjct: 216 NPTERLGAGV 225
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 53/194 (27%), Positives = 84/194 (43%), Gaps = 39/194 (20%)
Query: 21 IGRGSFGDVYKA--FDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+G G+FG VYKA +K+ K+ V K + E I V C + +
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNERVRRACPN-SCAD 193
Query: 76 YYGSYLHQTK------LWIIMEYMAGGSVADLIQS--------------------GPPLD 109
+ +L W++ Y ++ADL+QS G +
Sbjct: 194 FVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERE 253
Query: 110 EMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRR 168
I I+R +L A++ LH+ G +HRD+K NI+ +E +G K+ D G +A L I+
Sbjct: 254 NKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI 313
Query: 169 -KTFVGTPFWMAPE 181
K F+ P + APE
Sbjct: 314 PKEFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 53/184 (28%), Positives = 82/184 (44%), Gaps = 20/184 (10%)
Query: 95 GGSVADLIQSGPPLDEMSIACILRDLL-------HAIEYLHNEGKIHRDIKAANILLTEN 147
GS D + L+E +A DLL + +L ++ IHRD+ A NILLT
Sbjct: 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG 250
Query: 148 GDVKVADFGVSAQLTRTISRRKTFV-----GTPF-WMAPEVIQNSEGYNEKADIWSLGIT 201
K+ DFG L R I +V P WMAPE I N Y ++D+WS GI
Sbjct: 251 RITKICDFG----LARDIRNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIL 305
Query: 202 VIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL-MKEFVSLCLKKVPAERPSAK 259
+ E+ + G P + + + +E L + M + + C P +RP+ K
Sbjct: 306 LWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFK 365
Query: 260 ELLR 263
++++
Sbjct: 366 QIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 35/107 (32%), Positives = 58/107 (54%), Gaps = 12/107 (11%)
Query: 109 DEMSIACILRDLL-------HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161
D+ S DLL +E+L ++ +HRD+ A N+LL + VK+ DFG++ +
Sbjct: 228 DDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI 287
Query: 162 ---TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM 205
+ +S+ TF+ WMAPE I ++ Y +D+WS GI + E+
Sbjct: 288 MHDSNYVSKGSTFLPVK-WMAPESIFDNL-YTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 17/158 (10%)
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT--ISRRKTFVGTPFWMAPE 181
+ ++H +H D+ N LT + VKV D+G+ + I W+APE
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 182 VIQNSEG------YNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPREN-----P 229
++ G + +++W+LG+T+ E+ P + L VL + ++
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK 231
Query: 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
PQL+ +S E + C P +R +A+E+ HR +
Sbjct: 232 PQLELPYSERWYEVLQFCWLS-PEKRATAEEV--HRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 39/112 (34%), Positives = 55/112 (49%), Gaps = 25/112 (22%)
Query: 107 PLDEMSIACILRDLLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159
PLD L DLL +++L ++ IHRD+ A N+LLT+ K+ DFG
Sbjct: 208 PLD-------LDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFG--- 257
Query: 160 QLTRTISRRKTFV-----GTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEM 205
L R I +V P WMAPE I + Y ++D+WS GI + E+
Sbjct: 258 -LARDIMNDSNYVVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 61/274 (22%), Positives = 113/274 (41%), Gaps = 37/274 (13%)
Query: 18 LELIGRGSFGDVYKAF-----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+E +G FG VYK E + VAIK + + E+ + E + S+ + P
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI-------QSGPPLDEMSIACILR--DLLHA 123
I G + L +I Y + + + + G D+ ++ L D +H
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 124 I-------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176
+ E+L + +H+D+ N+L+ + +VK++D G+ ++ + +G
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK--LMGNSL 187
Query: 177 ----WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPREN--- 228
WM+PE I + ++ +DIWS G+ + E+ + G P V+ +I
Sbjct: 188 LPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP 246
Query: 229 -PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
P LM E C + P+ RP K++
Sbjct: 247 CPDDCPAWVYTLMLE----CWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 36/234 (15%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEIS 63
+ + RF L L+G G+FG V +A+D++ + A+K++ +++ EI+ ++K
Sbjct: 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQ 184
Query: 64 VLSQCRSPY--ITEYYGSYLHQTKLWIIM-EYMAGGSVADLIQSGPPLDEMSIACILRDL 120
R P I Y+ + + I+M +Y G + D I P +A I+
Sbjct: 185 ADPADRFPLMKIQRYFQN--ETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQT 240
Query: 121 LHAIEYLHNEGKI-HRDIKAANILLTENGD-----------------VKVADFGVSAQLT 162
A++Y H E + H D+K NIL+ E D V++ D G
Sbjct: 241 GVALDYFHTELHLMHTDLKPENILM-ETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER 299
Query: 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH 216
+ R V T + +PEV+ G+ D+WS+G + E+ G+ L D H
Sbjct: 300 HS---RTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGK-LLYDTH 348
|
Length = 467 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 3/97 (3%)
Query: 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-FIIPRENP- 229
+GTP ++APE++ + + D W+LG+ + E G PP D P +V I+ R+ P
Sbjct: 541 LGTPDYLAPELLL-GKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPW 599
Query: 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
P+ +E S + + + L P +R KEL +H
Sbjct: 600 PEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 53/239 (22%), Positives = 107/239 (44%), Gaps = 22/239 (9%)
Query: 38 NKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----KLWIIME 91
NK+V I+ + + I+ + EI L + S I + YG + +L +I+E
Sbjct: 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDV 150
Y G + +++ L + + D + L+ K ++++ + + L+TEN +
Sbjct: 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKL 162
Query: 151 KVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKG 208
K+ G+ L+ + F+ + + +++ + SE Y K DI+SLG+ + E+ G
Sbjct: 163 KIICHGLEKILSSPPFKNVNFMV---YFSYKMLNDIFSE-YTIKDDIYSLGVVLWEIFTG 218
Query: 209 EPPL-----ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
+ P +++ + II + N +L +K V C +RP+ KE+L
Sbjct: 219 KIPFENLTTKEIYDL----IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 12/107 (11%)
Query: 116 ILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD-------VKVADFGVSAQLTRTISRR 168
+ + L A+ YL ++ +H ++ NILL G +K++D G+ + +SR+
Sbjct: 110 VAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV---LSRQ 166
Query: 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLAD 214
+ P W+APE +++S+ + AD WS G T+ E+ GE PL D
Sbjct: 167 ECVERIP-WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 24/173 (13%)
Query: 7 LQEAAGSRFSSLELIGRGSFGDVYK---AFDKELNKDVAIKVIDLEE----SEDEIEDIQ 59
L + G + +LIG G FG VY+ A D +N K+ +LE E + +
Sbjct: 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNI 65
Query: 60 KEISVLSQCRSPY------ITEYYG-SYLHQTKLW---IIME--YMAGGSVADLIQSGP- 106
+I ++ ++ + I +YYG + +++ I++E + I+
Sbjct: 66 YDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNK 125
Query: 107 PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159
L I I++D+L +EY+H G H DIK NI++ N + D+G+++
Sbjct: 126 KL----IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIAS 174
|
Length = 294 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 7/77 (9%)
Query: 93 MAGGSVADLIQSGPPLDEMSIACI---LRDLLHAIEYLHNEGKIHRDIKAANILLTENGD 149
MAG + D P D+ I I +R +L + LH G +HRDIK N+L+T +G
Sbjct: 292 MAGKKIPD----NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ 347
Query: 150 VKVADFGVSAQLTRTIS 166
VK+ DFG + + I+
Sbjct: 348 VKIIDFGAAVDMCTGIN 364
|
Length = 507 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 22/71 (30%), Positives = 40/71 (56%), Gaps = 5/71 (7%)
Query: 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147
I+MEY+ G + DLI S + + R++ + LH+ G IH D+ +N++L+
Sbjct: 76 IVMEYIEGEPLKDLINSNGMEELE----LSREIGRLVGKLHSAGIIHGDLTTSNMILS-G 130
Query: 148 GDVKVADFGVS 158
G + + DFG++
Sbjct: 131 GKIYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 22/68 (32%), Positives = 36/68 (52%), Gaps = 5/68 (7%)
Query: 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147
++MEY+ G + L LD + IL +L + + G +H D+ NIL+TE+
Sbjct: 184 VVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED 238
Query: 148 GDVKVADF 155
GD+ V D+
Sbjct: 239 GDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 28/143 (19%), Positives = 60/143 (41%), Gaps = 11/143 (7%)
Query: 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLS--QCRSPYI 73
SS++L+ G VY ++D +K+ E D ++E+++L + +
Sbjct: 1 SSIKLLKGGLTNRVYLL--GTKDEDYVLKINPSREKG---ADREREVAILQLLARKGLPV 55
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ S +++ME++ G + + ++ IA L +LL + L
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGET----LDEVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 134 HRDIKAANILLTENGDVKVADFG 156
H D+ NIL+ + + + D+
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 577 | |||
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.53 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.21 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.13 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.97 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.91 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.88 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.76 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.61 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.53 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.52 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.49 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.4 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.35 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.33 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.25 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.11 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.03 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.03 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.02 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.0 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.97 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.9 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.86 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.82 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.72 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.71 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.67 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.65 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.39 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.38 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.1 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.06 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.97 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.93 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.89 | |
| PLN02236 | 344 | choline kinase | 96.85 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.8 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.67 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.57 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.53 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.13 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.12 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.06 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.91 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.76 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.74 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.1 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.04 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.96 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 94.81 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.41 |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-62 Score=505.64 Aligned_cols=455 Identities=50% Similarity=0.753 Sum_probs=360.1
Q ss_pred chhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 6 ~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
.+.......|+.++.||+|+||.||+|++..+++.||||+++++...+.++.+++|+.+|.++++|||.++|+.|..+..
T Consensus 6 ~~~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 6 VLKIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred hhcCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence 34556678899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
+||+||||.||++.++++.+..+.+..+..++++++.||.|||.++.+|||||+.|||+...|.|||+|||++.++....
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999999998877
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~ 245 (577)
....+++|||.|||||++... +|+.++||||||++.|||++|.+||.+.+++.++..|++..||.+...+++.+++||.
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVE 244 (467)
T ss_pred hccccccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHH
Confidence 777899999999999999854 6999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCcHHHHhhcHhhhhccCChhHHHHhhcCCCCCCCCCCCCCCccccccccCCCccccccccCCccceeecc
Q 008116 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGTVKVVRDKRSEETVQVSS 325 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~hpff~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~~~ 325 (577)
.||.++|+.||+|.+||+|+|++...+...+.+.+.+...|.....+.+ ..+. .. + +.. .....
T Consensus 245 ~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L~~~i~r~~~~~~~~~~~~--~~~~---s~--p-----~~~----~~~~~ 308 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLKHKFIKRAKKTSELKELIDRYKRWRVKKLELP--EEIS---SE--P-----DSD----LSLES 308 (467)
T ss_pred HHhhcCcccCcCHHHHhhhHHHHhcCCchHHHHHHHHHHHHhhcccCCc--ccCC---Cc--c-----ccc----ccccc
Confidence 9999999999999999999999998888888888877666544320000 0000 00 0 000 00011
Q ss_pred CCceeecCCCcccccCccCCcccccccCCCCcccCCCccccC-CCCCCcccccccCCcCCCCCccccCCCCCccccccCC
Q 008116 326 QGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREKKPEFSYN-QYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDS 404 (577)
Q Consensus 326 ~g~~~~n~~~~~s~se~~~~~~~~~~~k~~q~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~ 404 (577)
.+.......|.|.. +.+. .++++.. .++-... .+..+++.. .+-...+++.. .+.+.++.+.+
T Consensus 309 ~~g~~~~~~W~f~~-------tvR~-~~~~~~~--~~~~~~~s~~~~~~~~~-~~~~~~ss~~~-----~s~~~~~~~~s 372 (467)
T KOG0201|consen 309 DNGVRGEPKWDFGS-------TVRA-SRPPVLR--ESSQSKSSDSPSQRTSS-PSGSQPSSGTT-----ASGSGFNKSTS 372 (467)
T ss_pred cCCCCCCccccccc-------cccC-CCChhhc--cccccCCcccccccccC-CCCcccccCCC-----CCcccccCCCc
Confidence 12134556798861 1111 1222222 1111001 111111110 00001111111 23344444444
Q ss_pred CCccccccCCCCCCCCCcccceEEEeCCCCcCccccccccCCCCCCccccccccCCcceEEEeccCCCCCCCCCcccccc
Q 008116 405 YFDDRQDDYYEDDDTSASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSARTPRSRLG 484 (577)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (577)
.....+. .+-++.-.+..++. ++.|+..++++++++.++.....|.+.+++..++++.+.|+.++..++... +|++
T Consensus 373 ~q~~s~~--~~~~s~~~~~~~~~-v~~~~~~~~~~~~~~~s~~~~~~~~~l~~~~~~~~~~~pg~~~~~~~~l~~-~~v~ 448 (467)
T KOG0201|consen 373 LQNESEY--AQPDSACPSPIPSP-VFGLLNCKLSSTIRDPSAGSSGALDSLRNAFSSAENSCPGICDDLISELML-SRVP 448 (467)
T ss_pred ccccccc--CCCccccccCCCCc-ccccccccccccccccCCccccchHhhhhhHhhhhhcCCCccchhhhHHHH-HHhh
Confidence 4433211 33344444677999 999999999999999999999999999999999999999999999999999 9999
Q ss_pred hhhhcccCccchhh
Q 008116 485 IQERSSSASLEDSA 498 (577)
Q Consensus 485 ~~~~~~~~~~~~~~ 498 (577)
.+++++... +++-
T Consensus 449 ~~s~s~~~~-~~~~ 461 (467)
T KOG0201|consen 449 QFSQSRSLE-EISR 461 (467)
T ss_pred hhccccccc-chhh
Confidence 999988766 4443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-56 Score=458.22 Aligned_cols=269 Identities=31% Similarity=0.555 Sum_probs=247.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
-..+|+++++||+|+||+||+++.+.+++.||+|++++... ...+..+..|..||..++||+||+++..|++.+++||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35799999999999999999999999999999999987763 2357889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
|+||+.||.|+.+|++.+.|+|..++.|+.+|+.||.|||++|||||||||+|||||.+|+++|+||||++.........
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999776666677
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
.++|||+.|||||++.+. +|+..+|+|||||+||+||+|.+||...+.......|.+...+..+..++.++++||+++|
T Consensus 183 ~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL 261 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLL 261 (357)
T ss_pred ccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHh
Confidence 789999999999999887 5999999999999999999999999999988888888887766677779999999999999
Q ss_pred ccCCCCCC----cHHHHhhcHhhhhccCChhHHHHh
Q 008116 249 KKVPAERP----SAKELLRHRFIRNARKSPRLLERI 280 (577)
Q Consensus 249 ~~dP~~Rp----Ta~elL~hpff~~~~~~~~~~~~i 280 (577)
.++|++|. ++.+|-.||||..+.+...+...+
T Consensus 262 ~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l 297 (357)
T KOG0598|consen 262 KRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKL 297 (357)
T ss_pred ccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCC
Confidence 99999995 689999999999987655444433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-56 Score=455.65 Aligned_cols=257 Identities=41% Similarity=0.705 Sum_probs=240.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC-EEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-KLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~-~~~LV~E 91 (577)
.+.+.+..||+|..|+||+++++.|++.+|+|++.........+++.+|+++++.++|||||.+|++|..+. .++|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 377889999999999999999999999999999977777777899999999999999999999999999999 5999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
||++|+|..+++..++++|..+..++.++++||.|||+ ++||||||||+||||+..|.|||||||.+..+... ...+
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~t 236 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANT 236 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hccc
Confidence 99999999999988999999999999999999999995 99999999999999999999999999999988765 5578
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCC-----CccceeeccCCCCCCCchhh-hhHHHHHHH
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL-----HPMRVLFIIPRENPPQLDEH-FSRLMKEFV 244 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~-----~~~~~~~~i~~~~~~~l~~~-~s~~l~~lI 244 (577)
++||..|||||.+.+.. |+.++||||||++++||++|+.||... ...+.+..|..+.+|.++.. +++++++||
T Consensus 237 fvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV 315 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFV 315 (364)
T ss_pred ccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 99999999999998874 999999999999999999999999874 55667788888899999986 999999999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 245 SLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
..||++||.+||++.|||+|||+++...
T Consensus 316 ~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 316 SCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 9999999999999999999999987644
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-56 Score=458.42 Aligned_cols=264 Identities=31% Similarity=0.492 Sum_probs=231.8
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH------HHHHHHHHHHHHHhCCCCceeEeEEEEE
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED------EIEDIQKEISVLSQCRSPYITEYYGSYL 81 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~------~~~~i~~Ev~iL~~L~HpnIV~l~~~~~ 81 (577)
.+.....|.+.+.||+|+||.|.+|..+.||+.||||++.+..... ....+++|+++|++|+|||||+++++|.
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 3446678999999999999999999999999999999997665322 2345789999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC---CCeeecccccc
Q 008116 82 HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVS 158 (577)
Q Consensus 82 ~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~---g~vKL~DFGls 158 (577)
..+..|+||||++||+|.+.+-.++.+.+.....+++||+.||.|||++||+||||||+||||..+ ..+||+|||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999999999998999999999999999999999999999999999999999765 67999999999
Q ss_pred ccccccccccccccCCCCCCChhhhhccc--CCccccchhhHHHHHHHHHhCCCCCCCCCccc-eeeccCCCC---CCCc
Q 008116 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSE--GYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VLFIIPREN---PPQL 232 (577)
Q Consensus 159 ~~~~~~~~~~~~~~GTp~Y~APEvl~~~~--~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~-~~~~i~~~~---~~~l 232 (577)
+... ....+.++||||.|+|||++.... .+..++|||||||+||-+|+|.+||.+..... ....|.++. .+..
T Consensus 327 K~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 327 KVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 9876 456778999999999999997542 34558899999999999999999998765443 445555544 3455
Q ss_pred hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 233 ~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
+..++.++++||..||..||++|||+.++|+||||+.+..
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 6789999999999999999999999999999999997653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-55 Score=469.53 Aligned_cols=258 Identities=32% Similarity=0.577 Sum_probs=239.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
-..+|+..++||+|||+.||.+.+..+|..||+|++++.. .....+.+.+||+|.++|+|||||+++++|++.+++||
T Consensus 16 ~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 16 RSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred CcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 3468999999999999999999999999999999997643 34456889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
|+|+|..++|.+++++.++++|.+++.|++||+.||.|||+++|||||||..||||+++.+|||+|||||+.+..+....
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998887888
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
.+.||||.|.|||++... +++..+||||+|||||-||.|+|||...+-.+.+..|..... .+|..++.++++||.++|
T Consensus 176 ~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-~~P~~ls~~A~dLI~~lL 253 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-SMPSHLSAEAKDLIRKLL 253 (592)
T ss_pred ceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-ccccccCHHHHHHHHHHh
Confidence 899999999999999854 699999999999999999999999999888888777765543 566789999999999999
Q ss_pred ccCCCCCCcHHHHhhcHhhhhc
Q 008116 249 KKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 249 ~~dP~~RpTa~elL~hpff~~~ 270 (577)
.++|.+|||+++||.|+||...
T Consensus 254 ~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 254 RPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred cCCcccCCCHHHHhcCHhhhCC
Confidence 9999999999999999999543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-56 Score=443.53 Aligned_cols=356 Identities=38% Similarity=0.692 Sum_probs=288.5
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
|.+....-|.++.+||+|+||.||+|+++++|..||||.++... .++.+.+||.||.+++.|+||++|++|.....+
T Consensus 27 L~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 27 LNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL 103 (502)
T ss_pred hcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence 55666678999999999999999999999999999999987654 678999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~-~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
|||||||..|+..++++ ++.++++.++..+++..++||+|||...-||||||..||||+.+|++||+|||.+.++....
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999999999999996 46899999999999999999999999999999999999999999999999999999999888
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--hhhhhHHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEF 243 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l--~~~~s~~l~~l 243 (577)
...++++|||.|||||++... +|+.++||||||++..||..|++||.+.+++..++.|+...||.+ ++.++.++.+|
T Consensus 184 AKRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DF 262 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDF 262 (502)
T ss_pred HhhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHH
Confidence 889999999999999999875 599999999999999999999999999999999999998888766 56899999999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhccCChhHHHHhhcC---------CCCCCCCCCC-------CCCccccccccCCC
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRER---------PKYPIQEEPD-------TPINGVRAVGEASG 307 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~~~~i~~~---------~~~~~~~~~~-------~~~~~~~~~~~~~~ 307 (577)
|++||.+.|++|.||.+|++|||+++++.-..+...+.+. +......... .....+...+...+
T Consensus 263 i~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~~A~e~~~~~q~~~~~~~~~~~~~~~~~m~s~~~~~~s~~~~~ 342 (502)
T KOG0574|consen 263 IRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLMIQDAQEKAILGQAPMAASSGNDATLLSEGMSTMIDGGESTLVQH 342 (502)
T ss_pred HHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHHHHHHHHHHHhccCchhcccCcccchhhhccccccccccccceec
Confidence 9999999999999999999999999876554333322211 1100000000 00112222222223
Q ss_pred ccccccccCCc---cceee--ccCCceeecCCCcccccCccCCcccccccCCCCcccCCCccccCCCCCCccc
Q 008116 308 TVKVVRDKRSE---ETVQV--SSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREKKPEFSYNQYTPKRTA 375 (577)
Q Consensus 308 ~~~~~~~~~~~---~t~~~--~~~g~~~~n~~~~~s~se~~~~~~~~~~~k~~q~~~~~p~~~~~~~~~~~~~ 375 (577)
+++.+...... +...+ +-.+..++|+. ++..+.++|+......|+. +|+| |+||.++..
T Consensus 343 ~~~~~~~~~~~s~~E~~~~~~~~~~s~~In~~-----~~~~~~~~~~~~~~t~~~~--~PS~--~~~F~q~~~ 406 (502)
T KOG0574|consen 343 KDNYVTAQSLRSQMESLRIGGEIPKSAYINSS-----SKNGNSPRVQPPGHTASAS--DPSK--NQPFAQDGT 406 (502)
T ss_pred cchhhHHHHHHHHHHhhhcccccccccccccc-----cccCCCCCcCCCCCCCCcC--Cccc--cCchhhcCC
Confidence 33221110000 00001 01244455543 5666678999999999999 9999 999988544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=432.55 Aligned_cols=262 Identities=31% Similarity=0.542 Sum_probs=236.7
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
.....-++|.+.+.||+|+||+||+|.++.++..||||.+.+.. ....++.+..|+.+|+.++|||||.+++++...+.
T Consensus 4 ~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 4 GSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred CcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 34456689999999999999999999999999999999998776 66677889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC------CCeeeccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN------GDVKVADFGVSA 159 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~------g~vKL~DFGls~ 159 (577)
+|||||||+||+|.++|++.+.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999764 458999999999
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCchhhhh
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFS 237 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~--~~~l~~~~s 237 (577)
.+.. .....+.||+|.|||||++... .|+.|+|+||+|+|||+|++|++||...++.+.+..+.++. .+.++..++
T Consensus 164 ~L~~-~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 164 FLQP-GSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS 241 (429)
T ss_pred hCCc-hhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence 8863 3445688999999999999765 49999999999999999999999999998888777665544 455667778
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
..+.+++...|.++|..|.+..+-+.|+|+...
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 888899999999999999999999999998754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=429.19 Aligned_cols=269 Identities=45% Similarity=0.814 Sum_probs=242.3
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
...|++.++||.|..++||+|+...++..||||++++++....+..+++|+..|+.++||||++++.+|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 47899999999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc-
Q 008116 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR- 168 (577)
Q Consensus 92 y~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~- 168 (577)
||.+|++.++|+.. ..|+|..|+.|++++++||.|||.+|.||||||+.||||+.+|.|||+|||++..+.......
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~ 184 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV 184 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence 99999999999763 359999999999999999999999999999999999999999999999999988775543322
Q ss_pred ---ccccCCCCCCChhh-hhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc---------hhh
Q 008116 169 ---KTFVGTPFWMAPEV-IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL---------DEH 235 (577)
Q Consensus 169 ---~~~~GTp~Y~APEv-l~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l---------~~~ 235 (577)
++++|||+|||||+ ++...+|+.|+||||||++..||.+|..||..+.+++++.....+.||.+ ...
T Consensus 185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~ 264 (516)
T KOG0582|consen 185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKK 264 (516)
T ss_pred EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhh
Confidence 46799999999999 66677899999999999999999999999999999998877766666522 235
Q ss_pred hhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCChhHHHHh
Q 008116 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280 (577)
Q Consensus 236 ~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~~~~i 280 (577)
++..++.+|..||++||.+||||.++|+|+||+..+....+...+
T Consensus 265 ~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~~ 309 (516)
T KOG0582|consen 265 FSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKKL 309 (516)
T ss_pred hcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchhh
Confidence 678899999999999999999999999999999887655444433
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=416.23 Aligned_cols=261 Identities=30% Similarity=0.552 Sum_probs=238.3
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
...+|+++++||.|+||.|.+++.+.+|..||+|++++... -.++++...|..+|+.+.||+++++++.|.+...+|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 34689999999999999999999999999999999987663 2356788899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
||||++||.|+.++++.++|++..++.++.||+.||+|||+++|++|||||+|||||.+|.+||.|||+|+.... ..
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---rT 198 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---RT 198 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---cE
Confidence 999999999999999999999999999999999999999999999999999999999999999999999987754 35
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
.+.||||.|+|||++... +|+.++|+|+|||++|||+.|.+||...++.....+|..... .+|..++.++++||.++|
T Consensus 199 ~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-~fP~~fs~~~kdLl~~LL 276 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-KFPSYFSSDAKDLLKKLL 276 (355)
T ss_pred EEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-cCCcccCHHHHHHHHHHH
Confidence 588999999999999876 599999999999999999999999999999888888876654 567788999999999999
Q ss_pred ccCCCCC-----CcHHHHhhcHhhhhccCChhH
Q 008116 249 KKVPAER-----PSAKELLRHRFIRNARKSPRL 276 (577)
Q Consensus 249 ~~dP~~R-----pTa~elL~hpff~~~~~~~~~ 276 (577)
+.|-.+| ....+|..||||+...+...+
T Consensus 277 ~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~ 309 (355)
T KOG0616|consen 277 QVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAIL 309 (355)
T ss_pred hhhhHhhhcCcCCCccccccCcccccccHHHHh
Confidence 9999999 467899999999987654433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-52 Score=452.19 Aligned_cols=296 Identities=29% Similarity=0.481 Sum_probs=256.5
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTK 85 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~ 85 (577)
...-.+|+++++||+|+||+|++|..+.+++.||||++++.. ..+.++.+..|..|+... +||+++.++.+|++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578999999999999999999999999999999998876 456789999999999998 59999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
+|+||||+.||++..+++ .+.|++..++.|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++......
T Consensus 444 l~fvmey~~Ggdm~~~~~-~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH-TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEEEecCCCcEEEEEe-cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 999999999999665554 4789999999999999999999999999999999999999999999999999999877666
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~ 245 (577)
....|+||||.|||||++.+.. |+.++|+|||||+|||||.|..||...+..++...|....+ .+|..++.++.++++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~-~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSKEAIAIMR 600 (694)
T ss_pred CccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCcccHHHHHHHH
Confidence 6778999999999999998875 99999999999999999999999999998888888877665 567789999999999
Q ss_pred HhcccCCCCCCc-----HHHHhhcHhhhhccCChhHHHHhhcCCCCCCCCCCCCCCccccccccCCCc
Q 008116 246 LCLKKVPAERPS-----AKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGT 308 (577)
Q Consensus 246 ~cL~~dP~~RpT-----a~elL~hpff~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (577)
++|.++|++|.. +.+|.+||||+.+.+. .+..+-..+|..|....+.+..+...........
T Consensus 601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~-~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~ 667 (694)
T KOG0694|consen 601 RLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD-DLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKPA 667 (694)
T ss_pred HHhccCcccccCCCCCCchhhhhCCccccCCHH-HHhhccCCCCCCcccCChhhhcccchhhhcCCCc
Confidence 999999999986 4789999999998754 3444444555555555555555555555444443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=437.26 Aligned_cols=259 Identities=32% Similarity=0.495 Sum_probs=233.5
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC----hHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCC
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES----EDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQT 84 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~----~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~ 84 (577)
...++|++.+.||+|+||+|++|.+..++..||||+++.... ....+.+.+|+.+++++. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456799999999999999999999999999999998876421 134567889999999998 999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC-CCeeeccccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTR 163 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~-g~vKL~DFGls~~~~~ 163 (577)
.+|||||||.||+|.+++...+++.|..++.+|+||+.||+|||++||+||||||+|||++.+ +++||+|||++.....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999999999999988999999999999999999999999999999999999999999 9999999999987743
Q ss_pred cccccccccCCCCCCChhhhhccc-CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhh-hHHHH
Q 008116 164 TISRRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF-SRLMK 241 (577)
Q Consensus 164 ~~~~~~~~~GTp~Y~APEvl~~~~-~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~-s~~l~ 241 (577)
......+.||||.|+|||++.+.. +-+.++|||||||+||.|++|..||.+.+.......|.... ..++..+ +.+++
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~-~~~p~~~~S~~~~ 252 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE-FKIPSYLLSPEAR 252 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC-ccCCCCcCCHHHH
Confidence 445667899999999999999876 55689999999999999999999999987777766665443 3455666 99999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 242 EFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
.||.+||..+|.+|+|+.+|+.||||+.
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999986
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-52 Score=415.27 Aligned_cols=257 Identities=29% Similarity=0.512 Sum_probs=225.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHH-HHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI-EDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~-~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++|+.+.++|+|+||.||+++++.||+.||||.+........+ +-..+||.+|++|+|||+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4799999999999999999999999999999998655443334 445799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
||+..-|.++-.....++...+..|++|++.|+.|||++++|||||||+||||+..|.+||||||+|+.+..+...++.+
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDY 161 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDY 161 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhh
Confidence 99876666665555679999999999999999999999999999999999999999999999999999998777778889
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC--------------C---------
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--------------N--------- 228 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~--------------~--------- 228 (577)
+.|.||.|||++.+...|+..+|||++||++.||++|.+.|....+.+.+..|.+- +
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP 241 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP 241 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence 99999999999999778999999999999999999999999988876666554211 0
Q ss_pred ----CCCchh---hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 229 ----PPQLDE---HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 229 ----~~~l~~---~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
+..+.. .++..+.+|++.||..||++|++.+++|.|+||..
T Consensus 242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 111111 35667999999999999999999999999999954
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-52 Score=442.08 Aligned_cols=269 Identities=42% Similarity=0.756 Sum_probs=246.3
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
......|.....||+|+.|.||.|....+++.||||.+++.... ..+-+..|+.+|+.++|+|||.+++.|...+.+|+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 34557899999999999999999999999999999999877643 34778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
|||||+||+|.+++.. ..++|.+|+.|++++++||+|||.+||||||||.+|||++.+|.+||+||||+.++.......
T Consensus 348 VMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred EEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 9999999999999976 569999999999999999999999999999999999999999999999999999998887788
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--hhhhhHHHHHHHHH
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEFVSL 246 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l--~~~~s~~l~~lI~~ 246 (577)
.+.+|||+|||||++.... |+.++||||||++++||+.|.+||-..++...+..|.....+.+ +..++..+++||.+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred ccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 8999999999999998764 99999999999999999999999999999999999987776665 56899999999999
Q ss_pred hcccCCCCCCcHHHHhhcHhhhhccCChhHHHHh
Q 008116 247 CLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~hpff~~~~~~~~~~~~i 280 (577)
||+.|+.+|++|.+||+||||+.+.....+...+
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~pLi 539 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLKMAKPESSLNPLI 539 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhhhcCCHHHhHHHH
Confidence 9999999999999999999997776555554443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=438.19 Aligned_cols=263 Identities=29% Similarity=0.528 Sum_probs=235.3
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~ 86 (577)
....+|.+.+.||.|+|++||+|.++.+++.||||++.+... +..++.+.+|-.+|.+| .||.||+||..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345789999999999999999999999999999999976542 22356678899999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|+|+||+++|+|.++|++.+.|++.-++.|+.||+.||+|||++|||||||||+|||||+++++||.|||.|+.+.....
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987754221
Q ss_pred c-------------cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCch
Q 008116 167 R-------------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD 233 (577)
Q Consensus 167 ~-------------~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~ 233 (577)
. ..+++||..|++||+|.... .++.+|||+||||||.|+.|.+||...+..-...+|..-.. .++
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y-~fp 307 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY-EFP 307 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc-cCC
Confidence 1 14589999999999998764 88999999999999999999999999988777777764433 566
Q ss_pred hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCCh
Q 008116 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274 (577)
Q Consensus 234 ~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~~ 274 (577)
..+++.+++||+++|..||.+|+|+.+|.+||||..+.+..
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 78889999999999999999999999999999999887654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=433.51 Aligned_cols=261 Identities=31% Similarity=0.531 Sum_probs=231.7
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
--.+|+++++||+|+||.||+|+.+.||..||||++++.. ...+++.++.|-.+|....+|+||+||..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3478999999999999999999999999999999998765 34568899999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc----
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT---- 164 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~---- 164 (577)
||||++||++..+|.+.+.|++..++.|+.+++.|++-||.+|+|||||||+|+|||..|++||+|||||+.+...
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998543220
Q ss_pred -------------------cc----c--------------------cccccCCCCCCChhhhhcccCCccccchhhHHHH
Q 008116 165 -------------------IS----R--------------------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGIT 201 (577)
Q Consensus 165 -------------------~~----~--------------------~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGvi 201 (577)
.. . ....+|||.|||||++.+.. |+..+|+||||||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHH
Confidence 00 0 01257999999999999864 9999999999999
Q ss_pred HHHHHhCCCCCCCCCccceeeccCCCCC---CCchhhhhHHHHHHHHHhcccCCCCCC---cHHHHhhcHhhhhccCC
Q 008116 202 VIEMAKGEPPLADLHPMRVLFIIPRENP---PQLDEHFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFIRNARKS 273 (577)
Q Consensus 202 LyeLltG~~Pf~~~~~~~~~~~i~~~~~---~~l~~~~s~~l~~lI~~cL~~dP~~Rp---Ta~elL~hpff~~~~~~ 273 (577)
|||||.|.+||...++.+...+|..... .+-...+++++++||.+||+ ||++|. ++.||.+||||+.+.+.
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 9999999999999999988888765431 12233577999999999999 999997 48999999999988653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=440.43 Aligned_cols=303 Identities=24% Similarity=0.394 Sum_probs=257.0
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
...-+-|++.+.||.|+.|.|.+|.+..||+.+|||++.+.. .......+.+||-||+.+.||||+++|++|+...++
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 344578999999999999999999999999999999997663 334467899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|+|+||++||.|++++-+.+++++.+++.+++||+.||.|||..+|+||||||+|+|||..+++||+|||+|..-.. ..
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-gk 166 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP-GK 166 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC-Cc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876543 34
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
...+.||+|.|.|||++.+.++.+.++||||+|||||.||+|++||++.+-...+.++..+.. .+|..++.++++||.+
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-EMPSNISSEAQDLLRR 245 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-cCCCcCCHHHHHHHHH
Confidence 556889999999999999999889999999999999999999999999888888888876664 6778999999999999
Q ss_pred hcccCCCCCCcHHHHhhcHhhhhccCChhHHHHhhcCCCCCCCCC----CCC--CCccccccccCCCccccccc
Q 008116 247 CLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEE----PDT--PINGVRAVGEASGTVKVVRD 314 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~hpff~~~~~~~~~~~~i~~~~~~~~~~~----~~~--~~~~~~~~~~~~~~~~~~~~ 314 (577)
||..||.+|.|.++|++|||+......+...+ ++.+..++.... +.+ -...+..++......++...
T Consensus 246 ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~-~~~~~~~~i~s~ps~~~IDp~Il~~l~iLwc~~d~~kl~~k 318 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPFLSGYTSLPSSKS-LRPPVSVPILSIPSIQEIDPLILQHLCILWCGRDPEKLVEK 318 (786)
T ss_pred HhccCccccccHHHHhhCchhhcCCCCChhhh-cCCCcccceeecCCcccCCHHHHhhhhheeecCChHHHHHH
Confidence 99999999999999999999988765443322 111111111111 111 23556666666666655543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-52 Score=412.46 Aligned_cols=249 Identities=35% Similarity=0.569 Sum_probs=225.6
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEE-EEEeCCE-
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYG-SYLHQTK- 85 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~-~~~~~~~- 85 (577)
.....+|+++++||+|+||+||++.+..+|..||.|.+.... .....+.+..|+.+|++|+|||||++++ .|..+..
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 344567999999999999999999999999999999987544 3345677899999999999999999998 5555444
Q ss_pred EEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHH--cC--CcccccccceEEEccCCCeeeccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHN--EG--KIHRDIKAANILLTENGDVKVADFGV 157 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs--~g--IiHrDIKPeNILld~~g~vKL~DFGl 157 (577)
++||||||.+|+|.+.|+. ...++|..+|.++.||+.||.+||+ .. |+||||||.||+|+.+|.|||+||||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 8999999999999999964 4679999999999999999999998 45 99999999999999999999999999
Q ss_pred cccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCch-hhh
Q 008116 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD-EHF 236 (577)
Q Consensus 158 s~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~-~~~ 236 (577)
++.+........+++|||.||+||.+...+ |+.++|||||||++|||+.-.+||...+-.....+|.....+++| ..+
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~Y 253 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHY 253 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHh
Confidence 999988777778899999999999998864 999999999999999999999999999888888889888888787 789
Q ss_pred hHHHHHHHHHhcccCCCCCCcH
Q 008116 237 SRLMKEFVSLCLKKVPAERPSA 258 (577)
Q Consensus 237 s~~l~~lI~~cL~~dP~~RpTa 258 (577)
|..+..+|..|+..||+.||+.
T Consensus 254 S~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 254 STDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hhHHHHHHHHHccCCcccCCCc
Confidence 9999999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=417.01 Aligned_cols=259 Identities=42% Similarity=0.719 Sum_probs=224.1
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC--EEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT--KLWII 89 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~--~~~LV 89 (577)
..++...+.||+|+||.||++.+..+|..+|||.+....... .+.+.+|+.+|++|+|||||+++|...... .++|+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 456888999999999999999999999999999998774433 678999999999999999999999755544 69999
Q ss_pred EeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc-CCCeeeccccccccccc---c
Q 008116 90 MEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTR---T 164 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~-~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~-~g~vKL~DFGls~~~~~---~ 164 (577)
|||+++|+|.+++.+.+ +|++..++.+.+||++||+|||++|||||||||+||||+. ++.+||+|||++..... .
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999999998866 8999999999999999999999999999999999999999 69999999999887653 1
Q ss_pred ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCC-CCccceeeccCCCC-CCCchhhhhHHHHH
Q 008116 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD-LHPMRVLFIIPREN-PPQLDEHFSRLMKE 242 (577)
Q Consensus 165 ~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~-~~~~~~~~~i~~~~-~~~l~~~~s~~l~~ 242 (577)
........|||.|||||++........++|||||||+++||+||.+||.. ......+..+.... .|.++..++.++++
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~ 254 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKD 254 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHH
Confidence 12234578999999999998532233599999999999999999999998 44444444444333 45788889999999
Q ss_pred HHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 243 FVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
||.+||.++|.+||||.+||.|||+....
T Consensus 255 Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 255 FLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 99999999999999999999999998653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=428.17 Aligned_cols=255 Identities=32% Similarity=0.577 Sum_probs=234.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+.. .+..+..+.+|++|++.|+|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57899999999999999999999999999999997665 55678999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
||.| +|+.+|...+.++|+.++.++.+++.||.|||+++|+|||+||.||||...|++||||||+|+.+.....-....
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi 160 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI 160 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence 9976 999999999999999999999999999999999999999999999999999999999999999887655555567
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccC
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~d 251 (577)
.|||.|||||++.+. .|+..+|+||||||+|||++|++||...........|.++.. ..+..++..+.+|+..+|.+|
T Consensus 161 kGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v-~~p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 161 KGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV-KPPSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred cCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC-CCcccccHHHHHHHHHHhhcC
Confidence 899999999999875 599999999999999999999999998877777777766554 445588999999999999999
Q ss_pred CCCCCcHHHHhhcHhhhhc
Q 008116 252 PAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 252 P~~RpTa~elL~hpff~~~ 270 (577)
|.+|.|..+++.|||.+..
T Consensus 239 P~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 239 PAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hhhcccHHHHhcChHHhhh
Confidence 9999999999999999753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=421.01 Aligned_cols=263 Identities=26% Similarity=0.420 Sum_probs=227.4
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCC-EE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQT-KL 86 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~-~~ 86 (577)
...-.+|.+++.||.|+||.||+|..+.++..||||.++.....-+.-.-.|||..|++|+ |||||++++++.+.+ .+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3455799999999999999999999999999999999876543322234468999999997 999999999999988 99
Q ss_pred EEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
||||||| ..+|.++++. +..|++..++.|++||++||+|+|.+|++|||||||||||.....|||+|||+|+.+...
T Consensus 86 ~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk- 163 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK- 163 (538)
T ss_pred eeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC-
Confidence 9999999 5699999975 468999999999999999999999999999999999999998889999999999877543
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-------------------
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------- 226 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------------- 226 (577)
..++.++.|.||+|||++.....|+.++|||++||||+|+++-++.|.+.+..+.+.+|..
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 5667899999999999999988999999999999999999999999998877666655421
Q ss_pred ---CCCC-------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCC
Q 008116 227 ---ENPP-------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 227 ---~~~~-------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
..|. .+...++.++.++|.+||.+||.+||||.++|+||||+.....
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 0010 1112467889999999999999999999999999999876544
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=403.77 Aligned_cols=252 Identities=30% Similarity=0.509 Sum_probs=219.9
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gG 96 (577)
++||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|++++||||+++++++..++.+||||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999997543 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCCC
Q 008116 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (577)
Q Consensus 97 sL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~ 176 (577)
+|..++.....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++.............+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 99999988889999999999999999999999999999999999999999999999999998754333333445789999
Q ss_pred CCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCC
Q 008116 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERP 256 (577)
Q Consensus 177 Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~Rp 256 (577)
|+|||++.+. .++.++|||||||+||+|++|..||...+.......+.... ..++..++..+.+||.+||.+||.+||
T Consensus 161 y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05571 161 YLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred ccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 9999999765 48999999999999999999999998766544444443332 345567889999999999999999999
Q ss_pred -----cHHHHhhcHhhhhccC
Q 008116 257 -----SAKELLRHRFIRNARK 272 (577)
Q Consensus 257 -----Ta~elL~hpff~~~~~ 272 (577)
++.+|++||||....+
T Consensus 239 ~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 239 GGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred CCCCCCHHHHHcCCCcCCCCH
Confidence 8999999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=401.36 Aligned_cols=256 Identities=28% Similarity=0.478 Sum_probs=225.3
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
.-.+|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+|++++||||+++++++..++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 3478999999999999999999999999999999986543 22345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
|||||.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---T 172 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---c
Confidence 9999999999999988889999999999999999999999999999999999999999999999999998765432 2
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
...+||+.|+|||++.+.. ++.++|||||||+||+|++|..||...++......+.... ..++..++..+++||.+||
T Consensus 173 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L 250 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKGLL 250 (329)
T ss_pred ceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHHHHh
Confidence 3568999999999997754 8899999999999999999999998877655555554333 3445567889999999999
Q ss_pred ccCCCCCCc-----HHHHhhcHhhhhcc
Q 008116 249 KKVPAERPS-----AKELLRHRFIRNAR 271 (577)
Q Consensus 249 ~~dP~~RpT-----a~elL~hpff~~~~ 271 (577)
..||.+||+ +.+|+.||||....
T Consensus 251 ~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 251 QTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 999999997 79999999998754
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=411.68 Aligned_cols=258 Identities=29% Similarity=0.498 Sum_probs=223.3
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC--CEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLW 87 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~--~~~~ 87 (577)
....|+.++.||+|+||.||+|++..+|+.||+|.+..... +.......+||.||++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34679999999999999999999999999999999987763 44566788999999999999999999998876 6899
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
||+|||+. +|.-++.. .-.|++.+|..||+||+.||+|||.+||+|||||.+|||||.+|.+||+|||||+.+.....
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99999964 89998876 45899999999999999999999999999999999999999999999999999997755433
Q ss_pred -ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC------------CCC---
Q 008116 167 -RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------NPP--- 230 (577)
Q Consensus 167 -~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~------------~~~--- 230 (577)
..+..+-|+||.|||++.+...|+.++|+||+||||.||++|++.|...+..+.+.+|-+- ..|
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 3556788999999999999989999999999999999999999999887766555444110 000
Q ss_pred ------Cc-------hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 231 ------QL-------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 231 ------~l-------~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
.+ ...++....+|+..+|..||.+|.||.++|+++||..
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 00 1246778899999999999999999999999999953
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=395.39 Aligned_cols=255 Identities=28% Similarity=0.502 Sum_probs=223.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
.+|++++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 479999999999999999999999999999999865432 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
||+.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~~ 157 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TWT 157 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---ccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998765432 235
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
.+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+.... ..++..++..+++||.+||..
T Consensus 158 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 235 (291)
T cd05612 158 LCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIKKLLVV 235 (291)
T ss_pred ccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHHHHcCC
Confidence 6799999999999765 48899999999999999999999998876655444443332 344556788999999999999
Q ss_pred CCCCCCc-----HHHHhhcHhhhhccC
Q 008116 251 VPAERPS-----AKELLRHRFIRNARK 272 (577)
Q Consensus 251 dP~~RpT-----a~elL~hpff~~~~~ 272 (577)
||.+||+ +.+++.||||.....
T Consensus 236 dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 236 DRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred CHHHccCCccCCHHHHhcCccccCCCH
Confidence 9999995 999999999986543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=395.95 Aligned_cols=248 Identities=31% Similarity=0.519 Sum_probs=217.9
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCH
Q 008116 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (577)
Q Consensus 21 IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL 98 (577)
||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|++++||||+++++++...+.+|+|||||++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999986532 233456788999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCCCCC
Q 008116 99 ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM 178 (577)
Q Consensus 99 ~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~ 178 (577)
.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 99998888899999999999999999999999999999999999999999999999999876543333344578999999
Q ss_pred ChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCC--
Q 008116 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERP-- 256 (577)
Q Consensus 179 APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~Rp-- 256 (577)
|||++.+. .++.++|||||||++|+|++|.+||...+.......+... +..++..++..+++||.+||..||.+||
T Consensus 161 aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 161 APELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFPDGFDRDAKDLLIGLLSRDPTRRLGY 238 (312)
T ss_pred CHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHcCCCHHHcCCC
Confidence 99999775 4899999999999999999999999877665544444332 3455667889999999999999999997
Q ss_pred -cHHHHhhcHhhhhc
Q 008116 257 -SAKELLRHRFIRNA 270 (577)
Q Consensus 257 -Ta~elL~hpff~~~ 270 (577)
++.++|.||||...
T Consensus 239 ~~~~e~l~hp~~~~~ 253 (312)
T cd05585 239 NGAQEIKNHPFFSQL 253 (312)
T ss_pred CCHHHHHcCCCcCCC
Confidence 58999999999876
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=416.91 Aligned_cols=353 Identities=27% Similarity=0.489 Sum_probs=268.6
Q ss_pred chhhhcCCCe-eEEeEEeecCceEEEEEEEcCCCcEEE---EEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEE
Q 008116 6 GLQEAAGSRF-SSLELIGRGSFGDVYKAFDKELNKDVA---IKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL 81 (577)
Q Consensus 6 ~l~~~~~~~f-~il~~IG~GsfG~Vy~a~~~~tg~~VA---IK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~ 81 (577)
.+.....++| +...+||+|+|-+||+|.|..+|..|| ||.-+....+..++++..|+.+|+.|+|||||++|.+|.
T Consensus 32 ~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 32 FVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV 111 (632)
T ss_pred ccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence 3555666777 456789999999999999999999998 666566667778899999999999999999999999999
Q ss_pred eCC--EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc--CCcccccccceEEEccC-CCeeecccc
Q 008116 82 HQT--KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE--GKIHRDIKAANILLTEN-GDVKVADFG 156 (577)
Q Consensus 82 ~~~--~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~--gIiHrDIKPeNILld~~-g~vKL~DFG 156 (577)
+.. .+.+|+|+|..|+|..|+++.+.++...+..|++||++||.|||++ .|||||||++||||+.+ |.|||+|+|
T Consensus 112 d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 112 DTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred cCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchh
Confidence 865 4899999999999999999999999999999999999999999998 49999999999999866 999999999
Q ss_pred ccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccCCCCCC-Cchh
Q 008116 157 VSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPP-QLDE 234 (577)
Q Consensus 157 ls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~-~~~~~~i~~~~~~-~l~~ 234 (577)
||+.+..... ...+|||.|||||++. +.|+..+||||||+||+||+|+..||..... .++..++..+..| .+..
T Consensus 192 LAtl~r~s~a--ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 192 LATLLRKSHA--KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK 267 (632)
T ss_pred HHHHhhcccc--ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc
Confidence 9998866533 3589999999999997 4599999999999999999999999987754 4444555544443 3444
Q ss_pred hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCC-----------hhHH-----HHhh--cCCCCC-----CCCC
Q 008116 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS-----------PRLL-----ERIR--ERPKYP-----IQEE 291 (577)
Q Consensus 235 ~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~-----------~~~~-----~~i~--~~~~~~-----~~~~ 291 (577)
.-.+++++||.+||.. ...|||+.+||+||||..-..- +.+. +... .++... ....
T Consensus 268 V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g~~~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~ 346 (632)
T KOG0584|consen 268 VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGGIVELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYNLN 346 (632)
T ss_pred cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccccccccccchhhcccccccccccccchhhcCCcccccccceeecC
Confidence 4468899999999999 8999999999999999763110 0000 0000 000000 0000
Q ss_pred CCCCCc--c-ccccccC--CC-------------cccccccc---CCccceeeccCCceeecCCCcccccCccCCccccc
Q 008116 292 PDTPIN--G-VRAVGEA--SG-------------TVKVVRDK---RSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRT 350 (577)
Q Consensus 292 ~~~~~~--~-~~~~~~~--~~-------------~~~~~~~~---~~~~t~~~~~~g~~~~n~~~~~s~se~~~~~~~~~ 350 (577)
.+.+.. . +...+.. .. .++-.+.. .....+++....+.++|..|+|.+..+++..++.+
T Consensus 347 ~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va~e 426 (632)
T KOG0584|consen 347 TDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVAHE 426 (632)
T ss_pred CCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHHHH
Confidence 000000 0 0000000 00 00000111 11233456667888999999999999999999999
Q ss_pred ccCCCCcccCCCc
Q 008116 351 AVKPPQVREKKPE 363 (577)
Q Consensus 351 ~~k~~q~~~~~p~ 363 (577)
|+++++++++.+-
T Consensus 427 Mv~el~~~dq~v~ 439 (632)
T KOG0584|consen 427 MVEELEITDQPVV 439 (632)
T ss_pred HHhhcCCcccchh
Confidence 9999999987776
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=389.29 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=213.3
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
.+|++++.||.|+||.||+|.+..++..||||+++..........+.+|+.++++++||||+++++++..+..+|+||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999999999999999997654443446678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 93 MAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 93 ~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~ 163 (288)
T cd07871 85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE 163 (288)
T ss_pred CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCc
Confidence 96 5899988653 458999999999999999999999999999999999999999999999999987654333333456
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-------------------------
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------------- 226 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------------------- 226 (577)
.|++.|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+..
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd07871 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP 243 (288)
T ss_pred eecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccC
Confidence 7899999999987655689999999999999999999999976554322211100
Q ss_pred -CCCC---CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 227 -ENPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 227 -~~~~---~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
.... .....++.++++||.+||..||.+|||+.++|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0000 0012457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=388.41 Aligned_cols=259 Identities=25% Similarity=0.464 Sum_probs=229.6
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
..+...|++.++||+|.|+.||++.+..+|+.+|+|+++..+ .....+.+.+|+.|-+.|+|||||++++.+......|
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 345678999999999999999999999999999999997655 2335788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC---CCeeecccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSAQLTRT 164 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~---g~vKL~DFGls~~~~~~ 164 (577)
||+|+|+|++|..-|-...-++|..+..+++||+.+|.|||.+||||||+||+|+||-.. .-+||+|||++..+. .
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~ 165 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D 165 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence 999999999997766444678999999999999999999999999999999999999533 469999999999887 3
Q ss_pred ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchhhhhHHHH
Q 008116 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMK 241 (577)
Q Consensus 165 ~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s~~l~ 241 (577)
......++|||.|||||++...+ |+..+|||++|||||.||.|.+||++.+.......|.... ++..+..+++.++
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred ccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 34445689999999999998765 9999999999999999999999999988877777776543 4445678899999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 242 EFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
+||++||..||.+|+|+.|.|+|||+.+
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCCchhcc
Confidence 9999999999999999999999999975
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=398.90 Aligned_cols=261 Identities=30% Similarity=0.468 Sum_probs=230.0
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
...|++++.||.|.-|+||+|....++..+|||++++... ...+.+++.|-+||+.++||.++.||..|+..+..|||
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3579999999999999999999999999999999987653 34567888999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccc----
Q 008116 90 MEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR---- 163 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~---- 163 (577)
||||.||+|..++++ +..|++..++.|+.+++.||+|||-.|||+|||||+||||.++|+|.|+||.|+.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 999999999999976 46799999999999999999999999999999999999999999999999998643210
Q ss_pred -----------------------------c-c----------------------cccccccCCCCCCChhhhhcccCCcc
Q 008116 164 -----------------------------T-I----------------------SRRKTFVGTPFWMAPEVIQNSEGYNE 191 (577)
Q Consensus 164 -----------------------------~-~----------------------~~~~~~~GTp~Y~APEvl~~~~~~~~ 191 (577)
. . .....++||-.|+|||++.+. +.+.
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-GHgs 314 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-GHGS 314 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC-CCCc
Confidence 0 0 011246899999999999886 5999
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCch-hhhhHHHHHHHHHhcccCCCCCCc----HHHHhhcHh
Q 008116 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD-EHFSRLMKEFVSLCLKKVPAERPS----AKELLRHRF 266 (577)
Q Consensus 192 ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~-~~~s~~l~~lI~~cL~~dP~~RpT----a~elL~hpf 266 (577)
++|||+|||+|||||.|..||...+..+.+..|....+.... ..++..+++||+++|.+||.+|.. |++|.+|||
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence 999999999999999999999999998888887765432221 267899999999999999999998 999999999
Q ss_pred hhhccCC
Q 008116 267 IRNARKS 273 (577)
Q Consensus 267 f~~~~~~ 273 (577)
|+.+.+.
T Consensus 395 F~gVnWa 401 (459)
T KOG0610|consen 395 FEGVNWA 401 (459)
T ss_pred ccCCChh
Confidence 9998775
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=387.36 Aligned_cols=259 Identities=26% Similarity=0.443 Sum_probs=214.1
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..+|++++.||+|+||.||+|.+..+++.||||++...........+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 47899999999999999999999999999999999765443334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|+. ++|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++............
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 995 678777754 467899999999999999999999999999999999999999999999999998755433333345
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-eeecc------------------CC-----
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VLFII------------------PR----- 226 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~-~~~~i------------------~~----- 226 (577)
.+||+.|+|||++.+...++.++|||||||+||+|++|..||....... .+..+ ..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence 6789999999998766568889999999999999999999998653311 00000 00
Q ss_pred ---CCCCCchh-----hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 227 ---ENPPQLDE-----HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 227 ---~~~~~l~~-----~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..+..+.. .++..+++||.+||+.||.+|||+.++|+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00000111 2346789999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=404.36 Aligned_cols=260 Identities=29% Similarity=0.475 Sum_probs=220.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-------------HHHHHHHHHHHHHHhCCCCceeEeE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-------------DEIEDIQKEISVLSQCRSPYITEYY 77 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-------------~~~~~i~~Ev~iL~~L~HpnIV~l~ 77 (577)
.-+.|++++.||+|.||.|.+|++..+++.||||++.+.... ..++.+++||.||++|.|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 457899999999999999999999999999999999654311 1256899999999999999999999
Q ss_pred EEEEeC--CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccc
Q 008116 78 GSYLHQ--TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADF 155 (577)
Q Consensus 78 ~~~~~~--~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DF 155 (577)
++..+. +.+|||+|||..|.+.+.-....-+.+.+++.|+++++.||+|||.+|||||||||+|+||+.+|+|||+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 998774 589999999999988776543233999999999999999999999999999999999999999999999999
Q ss_pred cccccccc-----cccccccccCCCCCCChhhhhc---ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC
Q 008116 156 GVSAQLTR-----TISRRKTFVGTPFWMAPEVIQN---SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE 227 (577)
Q Consensus 156 Gls~~~~~-----~~~~~~~~~GTp~Y~APEvl~~---~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~ 227 (577)
|.+..+.. ........+|||.|+|||.+.+ ....+.+.||||+||+||+|+.|+.||.+....+...+|...
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 99876622 1222234689999999999876 333567889999999999999999999998887777777654
Q ss_pred CCCCchh--hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 228 NPPQLDE--HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 228 ~~~~l~~--~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
. ..++. .+...+++||++||++||++|.+..+|..|||.....
T Consensus 335 p-L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 335 P-LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred c-ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 3 23332 4688999999999999999999999999999997643
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=392.57 Aligned_cols=251 Identities=30% Similarity=0.525 Sum_probs=218.1
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gG 96 (577)
++||+|+||.||+|.+..+|..||||++.... .......+.+|+.+++.++||||++++++|...+.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999987543 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCCC
Q 008116 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (577)
Q Consensus 97 sL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~ 176 (577)
+|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 99999988788999999999999999999999999999999999999999999999999998754333333345689999
Q ss_pred CCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCC
Q 008116 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERP 256 (577)
Q Consensus 177 Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~Rp 256 (577)
|+|||++.+. .++.++|||||||+||+|++|..||...+.......+.... ..++..++..+++||.+||.++|.+||
T Consensus 161 y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 161 YLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred cCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHHHhC
Confidence 9999999765 48999999999999999999999998776554444433222 234567889999999999999999998
Q ss_pred -----cHHHHhhcHhhhhcc
Q 008116 257 -----SAKELLRHRFIRNAR 271 (577)
Q Consensus 257 -----Ta~elL~hpff~~~~ 271 (577)
++.++++|+||....
T Consensus 239 ~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 239 GGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CCCCCCHHHHHcCCCcCCCC
Confidence 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=399.41 Aligned_cols=260 Identities=27% Similarity=0.506 Sum_probs=217.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
+.|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++++++|||||++++++.+...+||||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999997543 2344677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-----
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~----- 165 (577)
|||++|+|.+++.....+++..++.++.||+.||.|||.+||+||||||+||||+.++++||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999975331100
Q ss_pred ------------------------------------------cccccccCCCCCCChhhhhcccCCccccchhhHHHHHH
Q 008116 166 ------------------------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVI 203 (577)
Q Consensus 166 ------------------------------------------~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLy 203 (577)
....+.+||+.|+|||++.+. .++.++|||||||+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhhHHH
Confidence 001245799999999999765 4899999999999999
Q ss_pred HHHhCCCCCCCCCccceeeccCC-CCCCCc--hhhhhHHHHHHHHHhcc--cCCCCCCcHHHHhhcHhhhhccCC
Q 008116 204 EMAKGEPPLADLHPMRVLFIIPR-ENPPQL--DEHFSRLMKEFVSLCLK--KVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 204 eLltG~~Pf~~~~~~~~~~~i~~-~~~~~l--~~~~s~~l~~lI~~cL~--~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
||++|.+||...++......+.. .....+ ...++.++++||.+||. .+|..|+++.+|+.||||......
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 99999999987665443333321 111112 23578999999999554 555569999999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=396.03 Aligned_cols=251 Identities=30% Similarity=0.520 Sum_probs=218.9
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gG 96 (577)
++||+|+||.||+|.+..++..||||++.... .......+.+|+.+|+.++||||+++++++..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999997543 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCCC
Q 008116 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (577)
Q Consensus 97 sL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~ 176 (577)
+|..++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.............+||+.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 99999988788999999999999999999999999999999999999999999999999998754333333345689999
Q ss_pred CCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCC
Q 008116 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERP 256 (577)
Q Consensus 177 Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~Rp 256 (577)
|+|||++.+. .++.++|||||||+||+|++|..||...+.......+... ...++..++..+.+||.+||.+||.+|+
T Consensus 161 y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 161 YLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-DIKFPRTLSADAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred ccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-CccCCCCCCHHHHHHHHHHcCCCHHHcC
Confidence 9999999765 4899999999999999999999999876655544444332 2345567889999999999999999997
Q ss_pred -----cHHHHhhcHhhhhcc
Q 008116 257 -----SAKELLRHRFIRNAR 271 (577)
Q Consensus 257 -----Ta~elL~hpff~~~~ 271 (577)
++.+|++||||....
T Consensus 239 ~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 239 GGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred CCCCCCHHHHhcCCCcCCCC
Confidence 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=392.82 Aligned_cols=254 Identities=29% Similarity=0.504 Sum_probs=218.3
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHH---HhCCCCceeEeEEEEEeCCEEEEE
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVL---SQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL---~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
|++++.||+|+||.||+|.+..+++.||||+++... .....+.+.+|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999997543 223345677776665 566899999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
|||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...........
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 999999999998865 6799999999999999999999999999999999999999999999999999875443333445
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
..+|++.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+....+ .++..++..+.+||.+||.
T Consensus 160 ~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 160 TFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSREAISIMRRLLR 237 (324)
T ss_pred ccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHhh
Confidence 67899999999999765 488999999999999999999999987766555544443332 3455678999999999999
Q ss_pred cCCCCCC-----cHHHHhhcHhhhhcc
Q 008116 250 KVPAERP-----SAKELLRHRFIRNAR 271 (577)
Q Consensus 250 ~dP~~Rp-----Ta~elL~hpff~~~~ 271 (577)
+||.+|| ++.++++||||+...
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 9999999 799999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=390.57 Aligned_cols=257 Identities=28% Similarity=0.484 Sum_probs=222.2
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCC-CceeEeEEEEEeCCEEEEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~H-pnIV~l~~~~~~~~~~~LV~ 90 (577)
+|++++.||+|+||.||+|.+..+++.||||++.... .......+..|+.++..+.| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999987543 23345678889999999965 56889999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|||++|+|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++............
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 99999999999988788999999999999999999999999999999999999999999999999998654332233345
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
.+||+.|+|||++.+.. ++.++|||||||+||+|++|+.||...+.......+.... ..++..++..+.+||.+||.+
T Consensus 161 ~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 238 (324)
T cd05587 161 FCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLLTK 238 (324)
T ss_pred ecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhc
Confidence 68999999999998754 8899999999999999999999998776655555554333 344567889999999999999
Q ss_pred CCCCCCcH-----HHHhhcHhhhhccC
Q 008116 251 VPAERPSA-----KELLRHRFIRNARK 272 (577)
Q Consensus 251 dP~~RpTa-----~elL~hpff~~~~~ 272 (577)
+|.+|+++ .++++||||.....
T Consensus 239 ~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 239 HPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999976 89999999987643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=391.08 Aligned_cols=251 Identities=30% Similarity=0.553 Sum_probs=215.8
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
++||+|+||.||+|.+..+++.||||+++... .....+.+..|..++..+ +||||+++++++..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999997543 223445566777777755 899999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
|+|..++.....+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999876543333444678999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
.|+|||++.+.. ++.++|||||||+||+|++|..||...+.......+... .+.++..++..+.+||.+||..+|.+|
T Consensus 161 ~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ll~~~l~~~P~~R 238 (316)
T cd05592 161 DYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPRWISKEAKDCLSKLFERDPTKR 238 (316)
T ss_pred cccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999997754 899999999999999999999999887765555444332 334556788999999999999999999
Q ss_pred CcH-HHHhhcHhhhhcc
Q 008116 256 PSA-KELLRHRFIRNAR 271 (577)
Q Consensus 256 pTa-~elL~hpff~~~~ 271 (577)
|++ .+++.||||....
T Consensus 239 ~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 239 LGVDGDIRQHPFFRGID 255 (316)
T ss_pred CCChHHHHcCcccCCCC
Confidence 986 4788999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=392.73 Aligned_cols=252 Identities=28% Similarity=0.490 Sum_probs=214.3
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
++||+|+||.||+|.+..+++.||||+++... .......+.+|+.+++.+ +||||+++++++.....+|||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999997543 223456788999999998 799999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
|+|..++...+++++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 99999998878999999999999999999999999999999999999999999999999999875433333344678999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc--------eeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR--------VLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~--------~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
.|+|||++.+. .++.++|||||||++|+|++|..||....... ............++..++..+.+||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 239 (329)
T cd05588 161 NYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239 (329)
T ss_pred cccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 99999999775 48999999999999999999999996432111 1111112223345567888999999999
Q ss_pred cccCCCCCCc------HHHHhhcHhhhhcc
Q 008116 248 LKKVPAERPS------AKELLRHRFIRNAR 271 (577)
Q Consensus 248 L~~dP~~RpT------a~elL~hpff~~~~ 271 (577)
|.++|.+|++ +.++++||||....
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 240 LNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred hccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 9999999987 78999999997654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=375.31 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=225.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHH-HHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE-IEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~-~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.+|..++.||+|.||.||+|.+..+|+.||||.++..+..+. -....+||..|+.++||||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 478899999999999999999999999999999987764432 3567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|| ..+|..+|+. ...++..++..|+.++++||+|||.+.|+||||||.|+||+.+|.+||+|||+++.+..+......
T Consensus 82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 99 4699999975 457999999999999999999999999999999999999999999999999999999877666555
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-----------------------
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----------------------- 227 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~----------------------- 227 (577)
.+-|.+|.|||++.+...|+..+||||.|||+.||+-|.+-|.+.++.+.+..|-..
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~ 240 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ 240 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence 588999999999999999999999999999999999999999887776555443110
Q ss_pred CC-CC---chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 228 NP-PQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 228 ~~-~~---l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.| +. +-...+.++.+|+.+||..||.+|+++.|+|+|+||+..
T Consensus 241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 01 11 112346778999999999999999999999999999864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=397.53 Aligned_cols=256 Identities=25% Similarity=0.448 Sum_probs=222.8
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCC-cEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELN-KDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg-~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
..+|++++.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+++.++|||||++++++.++..+||
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 468999999999999999999876654 689999986543 22345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
|||||.+|+|.+++.....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ..
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~---~~ 185 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---RT 185 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC---Cc
Confidence 999999999999998888999999999999999999999999999999999999999999999999999876532 22
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
...+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...++......+.... ..++..++..+++||.+||
T Consensus 186 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l 263 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-IYFPKFLDNNCKHLMKKLL 263 (340)
T ss_pred ceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHc
Confidence 456899999999999775 48899999999999999999999998876654444444332 2345567889999999999
Q ss_pred ccCCCCCC-----cHHHHhhcHhhhhccC
Q 008116 249 KKVPAERP-----SAKELLRHRFIRNARK 272 (577)
Q Consensus 249 ~~dP~~Rp-----Ta~elL~hpff~~~~~ 272 (577)
..+|.+|+ +++++++||||.+..+
T Consensus 264 ~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 264 SHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred ccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 99999995 8999999999987654
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=393.70 Aligned_cols=255 Identities=26% Similarity=0.473 Sum_probs=221.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.....+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999975432 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~ 157 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANS 157 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCC
Confidence 9999999999998888899999999999999999999999999999999999999999999999999876543 2345
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC----CCCc---hhhhhHHHHHH
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQL---DEHFSRLMKEF 243 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~----~~~l---~~~~s~~l~~l 243 (577)
.+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...+..+....+.... .+.. ...++.++.+|
T Consensus 158 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~l 236 (333)
T cd05600 158 VVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL 236 (333)
T ss_pred cccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHH
Confidence 6899999999999876 58999999999999999999999998766544332222110 1111 12568899999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
|.+||..+|.+||++.+|++||||....
T Consensus 237 i~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 237 ITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred HHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 9999999999999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=415.77 Aligned_cols=268 Identities=45% Similarity=0.810 Sum_probs=243.2
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
...|.|+..||-|+||.||+|.++.++-..|.|+|... ....++.+.-||.||..|+||+||+|++.|..++.+||+.|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 34678899999999999999999999999999998644 45567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
||.||-...++-. +..|++.+|..+++|+|.||.|||+++|||||||..|||++-+|.++|+|||.+...........+
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 9999998888754 568999999999999999999999999999999999999999999999999999888777777789
Q ss_pred ccCCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--hhhhhHHHHHHH
Q 008116 171 FVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEFV 244 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l--~~~~s~~l~~lI 244 (577)
++|||+|||||++.+ ...|++++||||||++|+||..+.+|....+++.++.+|.+..||.+ |..|+..+.+|+
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfL 269 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFL 269 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHH
Confidence 999999999999753 23499999999999999999999999999999999999999998876 568999999999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhhhhccCChhHHHHh
Q 008116 245 SLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~~~~i 280 (577)
.+||.+||..||++++||+||||.++....-+.+.+
T Consensus 270 k~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ireLl 305 (1187)
T KOG0579|consen 270 KRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIRELL 305 (1187)
T ss_pred HHHHhcCCccCCCHHHHhhCcccccCCcchHHHHHH
Confidence 999999999999999999999999876664444443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=382.68 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=216.7
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.|++++.||+|+||.||+|.+..+++.||||.+..... ......+.+|+.+++++.|+||+++++++.+++.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38999999999999999999999999999999865432 2233567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||.+|+|..++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVR 159 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Ceec
Confidence 9999999988753 346899999999999999999999999999999999999999999999999998765322 2223
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee---ccCCCCCCCchhhhhHHHHHHHHH
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF---IIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~---~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
..+||+.|+|||++.+. .++.++|||||||+||+|++|+.||.......... .........++..++..+.+||.+
T Consensus 160 ~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 160 GRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred CCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence 46799999999999865 48999999999999999999999998654322111 111222334455688999999999
Q ss_pred hcccCCCCCCc-----HHHHhhcHhhhhcc
Q 008116 247 CLKKVPAERPS-----AKELLRHRFIRNAR 271 (577)
Q Consensus 247 cL~~dP~~RpT-----a~elL~hpff~~~~ 271 (577)
||..||.+||+ ++++++||||....
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 99999999997 89999999998865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=399.63 Aligned_cols=257 Identities=27% Similarity=0.489 Sum_probs=217.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|++++||||+++++.|.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999864321 223567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-----
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~----- 165 (577)
|||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred --------------------------------------cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh
Q 008116 166 --------------------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK 207 (577)
Q Consensus 166 --------------------------------------~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt 207 (577)
......+||+.|||||++.+. .++.++|||||||+||+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeeehhh
Confidence 001135799999999999765 48999999999999999999
Q ss_pred CCCCCCCCCccceeeccCCCC---CCCchhhhhHHHHHHHHHhcccCCCCCC---cHHHHhhcHhhhhcc
Q 008116 208 GEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFIRNAR 271 (577)
Q Consensus 208 G~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s~~l~~lI~~cL~~dP~~Rp---Ta~elL~hpff~~~~ 271 (577)
|++||....+......+.... .......++..+.+||.+|+ .+|.+|+ ++.++++||||+...
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 999998876654433332211 11122357889999999976 5999999 999999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=398.00 Aligned_cols=257 Identities=30% Similarity=0.542 Sum_probs=219.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||++++++|.++..+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997543 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc----
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---- 166 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~---- 166 (577)
|||.+|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999865432110
Q ss_pred ----------------------------------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCC
Q 008116 167 ----------------------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPL 212 (577)
Q Consensus 167 ----------------------------------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf 212 (577)
.....+||+.|+|||++... .++.++|||||||++|+|++|.+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCCCCC
Confidence 01134799999999998765 4899999999999999999999999
Q ss_pred CCCCccceeeccCCCC-CCCc--hhhhhHHHHHHHHHhcccCCCCCCc---HHHHhhcHhhhhcc
Q 008116 213 ADLHPMRVLFIIPREN-PPQL--DEHFSRLMKEFVSLCLKKVPAERPS---AKELLRHRFIRNAR 271 (577)
Q Consensus 213 ~~~~~~~~~~~i~~~~-~~~l--~~~~s~~l~~lI~~cL~~dP~~RpT---a~elL~hpff~~~~ 271 (577)
...+.......+.... ...+ ...++..+++||.+||. +|.+|++ +.++|.||||+...
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 8877655444332211 1111 22568899999999996 8999998 99999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=382.34 Aligned_cols=254 Identities=26% Similarity=0.455 Sum_probs=213.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++|++++.||+|+||.||+|.+..++..||||++..... ....+.+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 479999999999999999999999999999999875432 2335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-cccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~~~~ 170 (577)
|+.++.|..+......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 999887777666567899999999999999999999999999999999999999999999999999877643221 2234
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---------------------CCC
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------------ENP 229 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~---------------------~~~ 229 (577)
..||+.|+|||++.+.. ++.++|||||||+||+|++|++||...+.......+.. ...
T Consensus 161 ~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 161 YVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred cccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 67999999999997754 89999999999999999999999986543222111100 000
Q ss_pred C----------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 230 P----------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 230 ~----------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
+ .....++..+.+||.+||.+||.+|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 0112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=397.88 Aligned_cols=258 Identities=29% Similarity=0.504 Sum_probs=217.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++.+++||||+++++++.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999996543 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc----
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---- 166 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~---- 166 (577)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999875432100
Q ss_pred -------------------------------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCC
Q 008116 167 -------------------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL 215 (577)
Q Consensus 167 -------------------------------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~ 215 (577)
.....+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 01245899999999999775 4899999999999999999999999887
Q ss_pred CccceeeccCCCC-CCCch--hhhhHHHHHHHHHhccc--CCCCCCcHHHHhhcHhhhhcc
Q 008116 216 HPMRVLFIIPREN-PPQLD--EHFSRLMKEFVSLCLKK--VPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 216 ~~~~~~~~i~~~~-~~~l~--~~~s~~l~~lI~~cL~~--dP~~RpTa~elL~hpff~~~~ 271 (577)
+.......+.... ...++ ..++..+++||.+|+.. ++..||++.+|++||||....
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCC
Confidence 7655554443211 11122 24678999999987652 333568999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=390.85 Aligned_cols=251 Identities=29% Similarity=0.502 Sum_probs=218.1
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
++||+|+||.||+|.++.+++.||||++.... .......+..|+.++..+ .||||+++++++...+.+|||||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999986542 223456677899998877 799999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
|+|..++.....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 99999998888999999999999999999999999999999999999999999999999999875433333334568999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... ..++..++..+++||.+||.+||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R 238 (320)
T cd05590 161 DYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLSQDAVDILKAFMTKNPTMR 238 (320)
T ss_pred cccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 99999999765 48899999999999999999999998877665555554333 23455678999999999999999999
Q ss_pred CcH------HHHhhcHhhhhcc
Q 008116 256 PSA------KELLRHRFIRNAR 271 (577)
Q Consensus 256 pTa------~elL~hpff~~~~ 271 (577)
|++ .++++||||....
T Consensus 239 ~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 239 LGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred CCCCCCCCHHHHHcCCCcCCCC
Confidence 998 9999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=400.72 Aligned_cols=260 Identities=31% Similarity=0.551 Sum_probs=232.7
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH--HHHHHHHHHHHHHhCC-CCceeEeEEEEEeCC
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED--EIEDIQKEISVLSQCR-SPYITEYYGSYLHQT 84 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~--~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~ 84 (577)
.......|++.+.||+|.||.||+++.+.+|+.||+|++++..... ....+.+|+.+|+++. |||||.++++|++..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 3556678999999999999999999999999999999997766432 4578999999999997 999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC----CCeeecccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN----GDVKVADFGVSAQ 160 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~----g~vKL~DFGls~~ 160 (577)
.++||||+|.||.|.+.|... .+++..+..+++|++.++.|||+.||+||||||+|||+... +.+|++|||++..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999999765 49999999999999999999999999999999999999643 4799999999988
Q ss_pred ccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC---CCchhhhh
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP---PQLDEHFS 237 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~---~~l~~~~s 237 (577)
... .......||||.|+|||++... .|+..+||||+||++|.|++|.+||...+.......|..... ...+..++
T Consensus 189 ~~~-~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 189 IKP-GERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred ccC-CceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 876 5566788999999999999765 499999999999999999999999999887776666665543 34456789
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
..+++||..||..||.+|+|+.++|+|||+...
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999999999999999999999999998865
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=399.51 Aligned_cols=259 Identities=27% Similarity=0.500 Sum_probs=218.7
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|+++++||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++|||||+++++|.+++.+||||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999986543 2334677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-----
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~----- 165 (577)
|||++|+|.+++.+.+.+++..++.++.||+.||+|||+++|+||||||+||||+.+|.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999999999999887889999999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------------cccccccCCCCCCChhhhhcccCCccccchhhHHHHHH
Q 008116 166 ------------------------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVI 203 (577)
Q Consensus 166 ------------------------------------------~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLy 203 (577)
......+||+.|+|||++.+. .|+.++|||||||+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechHHHH
Confidence 001235799999999999775 4899999999999999
Q ss_pred HHHhCCCCCCCCCccceeeccCCCC-CC--CchhhhhHHHHHHHHHhcccCCCCCCc---HHHHhhcHhhhhccCC
Q 008116 204 EMAKGEPPLADLHPMRVLFIIPREN-PP--QLDEHFSRLMKEFVSLCLKKVPAERPS---AKELLRHRFIRNARKS 273 (577)
Q Consensus 204 eLltG~~Pf~~~~~~~~~~~i~~~~-~~--~l~~~~s~~l~~lI~~cL~~dP~~RpT---a~elL~hpff~~~~~~ 273 (577)
||++|.+||...++......+.... .. .....+++++.+||.+|+ .+|.+|++ +.+++.||||+.....
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 9999999998876654443333211 11 122457889999999976 59999997 9999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=393.32 Aligned_cols=258 Identities=31% Similarity=0.538 Sum_probs=222.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.++..++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 479999999999999999999999999999999975431 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-----
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~----- 165 (577)
||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999887889999999999999999999999999999999999999999999999999987664432
Q ss_pred ------------------------cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee
Q 008116 166 ------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL 221 (577)
Q Consensus 166 ------------------------~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~ 221 (577)
......+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 122346799999999999876 5899999999999999999999999887655444
Q ss_pred eccCC--C-CCCCchhhhhHHHHHHHHHhcccCCCCCCc-HHHHhhcHhhhhccC
Q 008116 222 FIIPR--E-NPPQLDEHFSRLMKEFVSLCLKKVPAERPS-AKELLRHRFIRNARK 272 (577)
Q Consensus 222 ~~i~~--~-~~~~l~~~~s~~l~~lI~~cL~~dP~~RpT-a~elL~hpff~~~~~ 272 (577)
..+.. . ........++..+.+||.+||. +|.+||+ +.++|+||||.....
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 33332 1 1111122368999999999997 9999999 999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=388.84 Aligned_cols=251 Identities=27% Similarity=0.501 Sum_probs=215.5
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
++||+|+||.||+|.++.++..||||+++.... ......+..|+.++..+ +||||+++++++...+.+|||||||.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999975431 23456677788888765 899999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
|+|..++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 99999998878899999999999999999999999999999999999999999999999999865433333344678999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+... .+.++..++..+++||.+||..||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R 238 (316)
T cd05620 161 DYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHYPRWITKESKDILEKLFERDPTRR 238 (316)
T ss_pred CccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 99999999775 4899999999999999999999999877665444444332 234455678999999999999999999
Q ss_pred CcH-HHHhhcHhhhhcc
Q 008116 256 PSA-KELLRHRFIRNAR 271 (577)
Q Consensus 256 pTa-~elL~hpff~~~~ 271 (577)
|++ +++++||||....
T Consensus 239 ~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 239 LGVVGNIRGHPFFKTIN 255 (316)
T ss_pred CCChHHHHcCCCcCCCC
Confidence 998 5888999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=388.14 Aligned_cols=257 Identities=28% Similarity=0.480 Sum_probs=222.2
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
+|++++.||+|+||.||+|.+..++..||||++.... .......+..|+.++..+ .||+|+++++++...+.+||||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999987543 223345677788888887 6899999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
||+++|+|..++.....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++............
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 99999999999988788999999999999999999999999999999999999999999999999998754333333345
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
.+||+.|+|||++.+.. ++.++|||||||+||+|++|..||...+.......+.... ..++..++..+.+||.+||.+
T Consensus 161 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~l~~ 238 (323)
T cd05616 161 FCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTK 238 (323)
T ss_pred CCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHHccc
Confidence 78999999999998754 8999999999999999999999998877665555554333 234567889999999999999
Q ss_pred CCCCCCcH-----HHHhhcHhhhhccC
Q 008116 251 VPAERPSA-----KELLRHRFIRNARK 272 (577)
Q Consensus 251 dP~~RpTa-----~elL~hpff~~~~~ 272 (577)
+|.+|+++ .++++||||+...+
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 239 HPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred CHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999984 89999999987643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=385.75 Aligned_cols=259 Identities=34% Similarity=0.608 Sum_probs=220.6
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
..++|++++.||+|+||.||+|.+..++..||+|++...........+.+|+.+|++++||||+++++++..++.+++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 35799999999999999999999999999999999987655555678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~-gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 160 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN 160 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--ccc
Confidence 9999999999998878899999999999999999999986 6999999999999999999999999998765432 233
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc-------------------------
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------------- 224 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i------------------------- 224 (577)
..+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+..+....+
T Consensus 161 ~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 161 SFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred cCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence 56799999999999875 4899999999999999999999999654332111000
Q ss_pred ---------------------CCCCCCCc-hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 225 ---------------------PRENPPQL-DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 225 ---------------------~~~~~~~l-~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
.....+.. ...++.++++||.+||.+||++|||+.+||+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 00011111 1246788999999999999999999999999999986543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=392.92 Aligned_cols=258 Identities=27% Similarity=0.516 Sum_probs=234.0
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
....+|++.+.||+|.||.|.+|.....|+.||||.|++.. ....+-.+++||+||+.|+||||+.+|++|+..+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 34568999999999999999999999999999999998776 4456778999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
|||||..+|.|.+++.+.+.+++.+++.||+||+.|+.|||.++++|||||.+|||||.++++||+||||+..+... ..
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kf 208 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KF 208 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-cH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999776543 45
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
..++||+|.|.+||++.+.++-++.+|.|||||+||.|+.|..||+..+....+..|..+..... .-+..+.-||+.|
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP--~~PSdA~gLIRwm 286 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP--ETPSDASGLIRWM 286 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC--CCCchHHHHHHHH
Confidence 57899999999999999988888999999999999999999999999988877777776653221 2356788899999
Q ss_pred cccCCCCCCcHHHHhhcHhhhhc
Q 008116 248 LKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 248 L~~dP~~RpTa~elL~hpff~~~ 270 (577)
|..+|++|.|+.+|-.|.|+.-.
T Consensus 287 LmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 287 LMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred HhcCcccchhHHHHhhhheeecc
Confidence 99999999999999999998643
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=387.53 Aligned_cols=251 Identities=28% Similarity=0.487 Sum_probs=218.0
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
++||+|+||.||+|.+..+++.||||++.... .......+..|+.++..+ +||||+++++++..++.+|||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999987543 233456677899999876 899999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
|+|..++.....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 99999998888899999999999999999999999999999999999999999999999999876443333344578999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
.|+|||++.+. .++.++|||||||++|+|++|.+||...+.......+..... ..+..++.++.+||.+||.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ll~~~L~~dp~~R 238 (321)
T cd05591 161 DYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-LYPVWLSKEAVSILKAFMTKNPNKR 238 (321)
T ss_pred cccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhccCHHHc
Confidence 99999999765 489999999999999999999999988776665555544332 3445578899999999999999999
Q ss_pred C-------cHHHHhhcHhhhhcc
Q 008116 256 P-------SAKELLRHRFIRNAR 271 (577)
Q Consensus 256 p-------Ta~elL~hpff~~~~ 271 (577)
| ++.++++||||....
T Consensus 239 ~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 239 LGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred CCCCCCCCCHHHHhcCCccCCCC
Confidence 9 999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=395.95 Aligned_cols=249 Identities=35% Similarity=0.594 Sum_probs=217.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcE-EEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC-EEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-VAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-KLWII 89 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~-VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~-~~~LV 89 (577)
..+.+.+.||.|+||+||+|.+. |.. ||||.+.... .......|.+|+.+|++|+|||||+|+|++.... .++||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 34455667999999999999988 556 9999997554 2223678999999999999999999999999887 79999
Q ss_pred EeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcC-CcccccccceEEEccCC-Ceeeccccccccccccc
Q 008116 90 MEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG-KIHRDIKAANILLTENG-DVKVADFGVSAQLTRTI 165 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~g-IiHrDIKPeNILld~~g-~vKL~DFGls~~~~~~~ 165 (577)
|||+++|+|.+++.. ...++...+..|+.||+.|+.|||+++ ||||||||+||||+.++ ++||||||+++......
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999999977 688999999999999999999999999 99999999999999997 99999999998776543
Q ss_pred cccccccCCCCCCChhhhhc-ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-CCCCCCchhhhhHHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQN-SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMKEF 243 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~-~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-~~~~~~l~~~~s~~l~~l 243 (577)
.......||+.|||||++.+ ...|+.++|||||||+||||+||..||....+..+...+. ....+.++..++..+..|
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l 278 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSL 278 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 33344789999999999984 2459999999999999999999999999998866665554 555667777799999999
Q ss_pred HHHhcccCCCCCCcHHHHhh
Q 008116 244 VSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~ 263 (577)
+..||..||..||++.+|+.
T Consensus 279 ~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 279 MERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999985
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=388.58 Aligned_cols=257 Identities=28% Similarity=0.480 Sum_probs=216.8
Q ss_pred CeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeccCC---ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~---~tg~~VAIK~i~~~~---~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~ 86 (577)
+|++++.||+|+||.||+|.+. .+++.||||++.... .....+.+..|+.+++.+ +||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999764 578999999986432 223356788999999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~- 165 (577)
|+|||||.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999987653322
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccce----eeccCCCCCCCchhhhhHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV----LFIIPRENPPQLDEHFSRLMK 241 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~----~~~i~~~~~~~l~~~~s~~l~ 241 (577)
......+||+.|+|||++.+...++.++|||||||+||+|++|..||........ ...+.. ..+.++..++..++
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPPFPSFIGPEAQ 239 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHH
Confidence 2223568999999999997655578899999999999999999999975432211 111221 22344556889999
Q ss_pred HHHHHhcccCCCCCC-----cHHHHhhcHhhhhcc
Q 008116 242 EFVSLCLKKVPAERP-----SAKELLRHRFIRNAR 271 (577)
Q Consensus 242 ~lI~~cL~~dP~~Rp-----Ta~elL~hpff~~~~ 271 (577)
+||.+||..||.+|| ++.++++||||+...
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999999 888999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=387.60 Aligned_cols=252 Identities=28% Similarity=0.507 Sum_probs=217.3
Q ss_pred EeEEeecCceEEEEEEEc---CCCcEEEEEEeccCC---ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 18 LELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~---~tg~~VAIK~i~~~~---~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+|+.++||||++++++|..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 468999999999999864 568899999986532 12234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
|+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999987544333334456
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccC
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~d 251 (577)
+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...+.......+.... ..++..++..+.+||.+||.++
T Consensus 161 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 161 CGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred CCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHcccC
Confidence 899999999999765 48899999999999999999999998876655554444332 2445567889999999999999
Q ss_pred CCCCC-----cHHHHhhcHhhhhcc
Q 008116 252 PAERP-----SAKELLRHRFIRNAR 271 (577)
Q Consensus 252 P~~Rp-----Ta~elL~hpff~~~~ 271 (577)
|.+|| ++.+++.||||....
T Consensus 239 p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 239 PSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred HhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999 899999999998753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=381.75 Aligned_cols=257 Identities=26% Similarity=0.455 Sum_probs=222.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-HHHHHHHHHHHHHhCCCCceeEeEEEEEe--CCEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-EIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWII 89 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~-~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~--~~~~~LV 89 (577)
++|+.+..|++|+||.||+|.++.|+..||+|.++...... ..-.-.+||.+|.+++|||||.+.++... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 57999999999999999999999999999999998776332 23345799999999999999999998764 3479999
Q ss_pred EeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
||||+. +|..+|..- .+|...++..++.|++.||+|||.++|+||||||+|+|++..|.+||+|||+|+.+..+....
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence 999964 899999764 589999999999999999999999999999999999999999999999999999999887778
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-----------CCC---------
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-----------REN--------- 228 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-----------~~~--------- 228 (577)
+..+-|.||.|||++.+...|+.++||||+||||.||+++++-|........+.+|- .+.
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 888999999999999999999999999999999999999999998776655554331 000
Q ss_pred -CC-----Cc----hh-hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 229 -PP-----QL----DE-HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 229 -~~-----~l----~~-~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.+ .+ .. .++....+|+..+|..||.+|.||.+.|+|.||...
T Consensus 315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 00 00 01 145788999999999999999999999999999874
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=391.83 Aligned_cols=251 Identities=29% Similarity=0.524 Sum_probs=217.6
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gG 96 (577)
++||+|+||.||+|.+..++..||||++.... .......+..|+.+++.++||||+++++++..+..+||||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999997543 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 97 sL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
+|..++.....+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 999999887889999999999999999999997 7999999999999999999999999999875433333334568999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+... ...++..++..+.+||.+||.+||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R 238 (325)
T cd05594 161 EYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLSGLLKKDPKQR 238 (325)
T ss_pred ccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHhhcCHHHh
Confidence 99999999765 4899999999999999999999999876654444444322 234456688999999999999999999
Q ss_pred C-----cHHHHhhcHhhhhcc
Q 008116 256 P-----SAKELLRHRFIRNAR 271 (577)
Q Consensus 256 p-----Ta~elL~hpff~~~~ 271 (577)
+ ++.++++||||....
T Consensus 239 ~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 239 LGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred CCCCCCCHHHHhcCCCcCCCC
Confidence 7 999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=378.56 Aligned_cols=260 Identities=31% Similarity=0.536 Sum_probs=232.4
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-------hHHHHHHHHHHHHHHhC-CCCceeEeEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------EDEIEDIQKEISVLSQC-RSPYITEYYGSYL 81 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-------~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~ 81 (577)
..-++|.-.+.||+|..++|.+++++.++..+|+|++..... ..-.+...+|+.||+++ .||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 344678888999999999999999999999999999965431 22356677899999999 7999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 82 HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 82 ~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
.+..+++|+|+|+.|.|++++.....++|...+.|++||+.|+.|||.++||||||||+|||++++.++||+|||+++.+
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999999999899999999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccCCCCCCChhhhh-----cccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC---Cch
Q 008116 162 TRTISRRKTFVGTPFWMAPEVIQ-----NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP---QLD 233 (577)
Q Consensus 162 ~~~~~~~~~~~GTp~Y~APEvl~-----~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~---~l~ 233 (577)
... ......||||+|+|||.+. +.++|+..+|+|++|||||-||.|.+||+....+-.+..|..+... +-+
T Consensus 174 ~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 174 EPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred CCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 654 5566789999999999875 3467999999999999999999999999998877777777766532 345
Q ss_pred hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 234 ~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.+++...++||.+||+.||.+|.|++|+|.||||...
T Consensus 253 adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 6789999999999999999999999999999999653
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=385.24 Aligned_cols=258 Identities=27% Similarity=0.455 Sum_probs=211.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-----CEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----TKLW 87 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~-----~~~~ 87 (577)
+|++.++||+|+||.||+|.+..++..||||.+.... .......+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6999999999999999999999999999999986432 222345788999999999999999999988643 3589
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~- 166 (577)
+||||| +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999 579999998878899999999999999999999999999999999999999999999999999875432211
Q ss_pred --ccccccCCCCCCChhhhhcc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeec--------------------
Q 008116 167 --RRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI-------------------- 223 (577)
Q Consensus 167 --~~~~~~GTp~Y~APEvl~~~-~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~-------------------- 223 (577)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||...+.......
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 12346799999999998652 3588999999999999999999999976543221110
Q ss_pred -------cCCCCCCCch---hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 224 -------IPRENPPQLD---EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 224 -------i~~~~~~~l~---~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
+....+..+. ..++..+.+||.+||..+|.+|||+.++|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0111111111 135678899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=396.29 Aligned_cols=257 Identities=29% Similarity=0.504 Sum_probs=215.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++|||||+++++|.+...+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999986543 2334677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc----
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---- 166 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~---- 166 (577)
|||++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999863321000
Q ss_pred -------------------------------------------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHH
Q 008116 167 -------------------------------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVI 203 (577)
Q Consensus 167 -------------------------------------------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLy 203 (577)
.....+||+.|+|||++.+. .++.++|||||||+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecchhhh
Confidence 00125799999999999765 4899999999999999
Q ss_pred HHHhCCCCCCCCCccceeeccCCC-CCCCch--hhhhHHHHHHHHHhcccCCCCC---CcHHHHhhcHhhhhcc
Q 008116 204 EMAKGEPPLADLHPMRVLFIIPRE-NPPQLD--EHFSRLMKEFVSLCLKKVPAER---PSAKELLRHRFIRNAR 271 (577)
Q Consensus 204 eLltG~~Pf~~~~~~~~~~~i~~~-~~~~l~--~~~s~~l~~lI~~cL~~dP~~R---pTa~elL~hpff~~~~ 271 (577)
||++|.+||...........+... ....++ ..++.++++||.+||. +|.+| +++.+++.||||....
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 999999999876654443333221 111222 2478899999999997 66665 5999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=402.39 Aligned_cols=266 Identities=44% Similarity=0.790 Sum_probs=236.9
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
.....|.-++.||.|+||.||.|.+..+...||||.+.... .....+.|.+||.+|++|.|||+|.+.+||..+.+.|
T Consensus 23 DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW 102 (948)
T KOG0577|consen 23 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW 102 (948)
T ss_pred CHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence 34457888999999999999999999999999999987654 3344678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|||||| -|+-.+++.- ..++-+.+|+.|..+.+.||+|||+++.||||||..||||++.|.|||+|||.+....
T Consensus 103 LVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---- 177 (948)
T KOG0577|consen 103 LVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---- 177 (948)
T ss_pred HHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC----
Confidence 999999 5687887742 4789999999999999999999999999999999999999999999999999987653
Q ss_pred ccccccCCCCCCChhhhhc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCch-hhhhHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD-EHFSRLMKEF 243 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~--~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~-~~~s~~l~~l 243 (577)
+.++++|||+|||||++.. ...|+.++|||||||+++||...+||+..++-+..++.|..+.+|.+. ..|+..+.+|
T Consensus 178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~F 257 (948)
T KOG0577|consen 178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 257 (948)
T ss_pred chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence 3468999999999999863 234999999999999999999999999999999999999888877775 5799999999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhccCChhHHHHh
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~~~~i 280 (577)
|..||++-|..|||.+++|+|+|+..-+....+.+.|
T Consensus 258 vd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLI 294 (948)
T KOG0577|consen 258 VDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLI 294 (948)
T ss_pred HHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHHH
Confidence 9999999999999999999999998877666555544
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=401.10 Aligned_cols=258 Identities=36% Similarity=0.562 Sum_probs=239.4
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE-EEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK-LWII 89 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~-~~LV 89 (577)
..+|.++++||+|+||.+++++++..+..|++|.+...... .......+|+.+++++.|||||.+++.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 46899999999999999999999999999999999877633 334578899999999999999999999999998 9999
Q ss_pred EeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
|+||+||+|.+.|++ +.-|+++.+..|+.||+.||.|||+++|+|||||+.|||+++++.|||+|||+|+.+......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 999999999999965 357999999999999999999999999999999999999999999999999999999887667
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
..+++|||.||+||++.+.+ |+.++|||||||++|||++-+++|...+......+|......+++..++.+++.+|..|
T Consensus 163 a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~ 241 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSM 241 (426)
T ss_pred hheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHH
Confidence 78899999999999998875 99999999999999999999999999999888888888888888999999999999999
Q ss_pred cccCCCCCCcHHHHhhcHhhhhc
Q 008116 248 LKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 248 L~~dP~~RpTa~elL~hpff~~~ 270 (577)
|.++|..||++.+||.+|.+...
T Consensus 242 l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 242 LRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred hhcCCccCCCHHHHhhChhhhhH
Confidence 99999999999999999877643
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=384.96 Aligned_cols=261 Identities=27% Similarity=0.425 Sum_probs=224.5
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEecc-CCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe-----
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL-EESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH----- 82 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~-~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~----- 82 (577)
-.+...|..++.||+|+||.|..|.++.+|..||||.+.. .......++..+|+.+|+.++|+||+.+++++..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 3456778889999999999999999999999999999862 3345567889999999999999999999999876
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
-+.+|+|+|+| +.+|..+|+.+..+++..+..+++||+.||.|+|+.+|+||||||.|||++.+..+||||||+|+...
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 34789999999 67999999998889999999999999999999999999999999999999999999999999998775
Q ss_pred c--cccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--------------
Q 008116 163 R--TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------------- 226 (577)
Q Consensus 163 ~--~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~-------------- 226 (577)
. .....+.++-|.+|.|||++.....|+.++||||+||||.|||+|++-|.+.+....+..|..
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 3 223446788999999999999888899999999999999999999999987665444433311
Q ss_pred -------------CCCCC---chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 227 -------------ENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 227 -------------~~~~~---l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
..+.. +-.+.++.+.+|+.+||..||.+|+|++|+|.|||+...
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 11111 112567889999999999999999999999999999764
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=384.85 Aligned_cols=252 Identities=28% Similarity=0.500 Sum_probs=218.1
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
++||+|+||+||+|.+..++..||||++.... .......+.+|+.++..+ +||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999997543 223456678899999888 799999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
|+|..++.....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 99999998878999999999999999999999999999999999999999999999999999865433333334568999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... ..++..++..+.+||.+||..||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R 238 (318)
T cd05570 161 DYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-VRYPRWLSKEAKSILKSFLTKNPEKR 238 (318)
T ss_pred cccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHccCCHHHc
Confidence 99999999775 48999999999999999999999998776555444443332 23455678999999999999999999
Q ss_pred CcH-----HHHhhcHhhhhccC
Q 008116 256 PSA-----KELLRHRFIRNARK 272 (577)
Q Consensus 256 pTa-----~elL~hpff~~~~~ 272 (577)
|++ .+++.||||+...+
T Consensus 239 ~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 239 LGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CCCCCCCHHHHhcCCCcCCCCH
Confidence 999 99999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=384.12 Aligned_cols=252 Identities=30% Similarity=0.533 Sum_probs=216.2
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
+.||+|+||.||+|.+..++..||||++.... .......+..|+.+++.+ +||||+++++++.+.+.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999987542 123445677788888865 999999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
|+|..++.....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 99999998878899999999999999999999999999999999999999999999999999875433323334568999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... +.++..++..+++||.+||.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R 238 (316)
T cd05619 161 DYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFVREPERR 238 (316)
T ss_pred cccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHhccCHhhc
Confidence 99999999765 48999999999999999999999998776655544443333 23455678899999999999999999
Q ss_pred CcHH-HHhhcHhhhhccC
Q 008116 256 PSAK-ELLRHRFIRNARK 272 (577)
Q Consensus 256 pTa~-elL~hpff~~~~~ 272 (577)
|++. +++.||||.....
T Consensus 239 ~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 239 LGVKGDIRQHPFFREIDW 256 (316)
T ss_pred CCChHHHHcCcccCCCCH
Confidence 9996 8999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=384.56 Aligned_cols=252 Identities=28% Similarity=0.495 Sum_probs=215.4
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
++||+|+||.||+|.+..+++.||||++..... ......+.+|+.++.++ +||||+++++++.....+|||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999976532 23456788999999998 699999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
|+|..++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 99999998878899999999999999999999999999999999999999999999999999875433333344678999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCc------cceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP------MRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~------~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
.|+|||++.+. .++.++|||||||+||+|++|..||..... ......+....+..++..++..+.++|.+||.
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 239 (327)
T cd05617 161 NYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239 (327)
T ss_pred ccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999765 489999999999999999999999964321 11122222233445666788999999999999
Q ss_pred cCCCCCCc------HHHHhhcHhhhhcc
Q 008116 250 KVPAERPS------AKELLRHRFIRNAR 271 (577)
Q Consensus 250 ~dP~~RpT------a~elL~hpff~~~~ 271 (577)
+||.+|++ +.+++.||||....
T Consensus 240 ~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 240 KDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred cCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 99999998 57999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=369.35 Aligned_cols=258 Identities=30% Similarity=0.475 Sum_probs=231.3
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
...-++|++.+.||+|.||.||+|+.+.++-.||+|++-+... .....++.+|++|-+.|+||||+++|++|.+...+
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 3455789999999999999999999999999999999865542 22346789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQ--SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~--~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
||++||...|+|...|+ ...++++...+.|++|++.||.|||.++||||||||+|+|++..|.+||+|||.+....
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999999998 66789999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHH
Q 008116 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 165 ~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI 244 (577)
.....+.|||..|.+||+..+. .++..+|+|++|++.||++.|.+||......+....|.+-.. .++..++..++++|
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~-~~p~~is~~a~dlI 253 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL-KFPSTISGGAADLI 253 (281)
T ss_pred CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc-cCCcccChhHHHHH
Confidence 4567799999999999999876 499999999999999999999999998886666666654332 45578899999999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.+||.++|.+|.+..+++.|||+...
T Consensus 254 ~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 254 SRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHhccCccccccHHHHhhhHHHHhc
Confidence 99999999999999999999999753
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=383.39 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=213.8
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHH-HHHhCCCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEIS-VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~-iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
++||+|+||+||+|.+..+++.||||++..... ......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 479999999999999999999999999865431 222344555555 56788999999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
|+|..++.....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 99999998888999999999999999999999999999999999999999999999999999875433333344568999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
.|+|||++.+. .++.++|||||||+||+|++|.+||...+.......+... +..++..++..+.+||.+||+++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (323)
T cd05575 161 EYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-PLRLKPNISVSARHLLEGLLQKDRTKR 238 (323)
T ss_pred hhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhhcCHHhC
Confidence 99999999775 4899999999999999999999999877655544444332 233445678999999999999999999
Q ss_pred CcH----HHHhhcHhhhhccC
Q 008116 256 PSA----KELLRHRFIRNARK 272 (577)
Q Consensus 256 pTa----~elL~hpff~~~~~ 272 (577)
|++ .+++.||||.....
T Consensus 239 ~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 239 LGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred CCCCCCHHHHHcCCCcCCCCH
Confidence 987 69999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=385.97 Aligned_cols=252 Identities=29% Similarity=0.501 Sum_probs=213.2
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
++||+|+||.||+|.+..+++.||||++.... .......+..|+.++.++ +||||+++++++...+.+|||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997643 233456788999998877 899999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
|+|..++.....+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 99999998878899999999999999999999999999999999999999999999999999875433333334578999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc--------eeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR--------VLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~--------~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
.|+|||++.+. .++.++|||||||++|+|++|..||....... ............++..++..+.+||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~ 239 (329)
T cd05618 161 NYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239 (329)
T ss_pred cccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 99999999775 48999999999999999999999996322111 1111111223345567788999999999
Q ss_pred cccCCCCCCc------HHHHhhcHhhhhcc
Q 008116 248 LKKVPAERPS------AKELLRHRFIRNAR 271 (577)
Q Consensus 248 L~~dP~~RpT------a~elL~hpff~~~~ 271 (577)
|..||.+||+ +.++++||||+...
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 240 LNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred hcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 9999999998 58999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=391.43 Aligned_cols=258 Identities=29% Similarity=0.512 Sum_probs=218.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
.+|++++.||+|+||.||+|.+..+++.||||+++... .......+.+|+.++.+++||||+++++++.+++.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999996532 2334577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-----
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~----- 165 (577)
|||+||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999986542210
Q ss_pred ------------------------------cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCC
Q 008116 166 ------------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL 215 (577)
Q Consensus 166 ------------------------------~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~ 215 (577)
....+.+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCCCCCC
Confidence 001245799999999999775 4899999999999999999999999887
Q ss_pred CccceeeccCCCC-CCCch--hhhhHHHHHHHHHhcccCCCCCC---cHHHHhhcHhhhhccC
Q 008116 216 HPMRVLFIIPREN-PPQLD--EHFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFIRNARK 272 (577)
Q Consensus 216 ~~~~~~~~i~~~~-~~~l~--~~~s~~l~~lI~~cL~~dP~~Rp---Ta~elL~hpff~~~~~ 272 (577)
++......+.... ...++ ..++..+++||.+|+ .+|.+|+ ++.++++||||....+
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 7655444443211 11111 236889999999977 4999998 4899999999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=390.14 Aligned_cols=255 Identities=33% Similarity=0.522 Sum_probs=215.2
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..+|++++.||+|+||.||+|.+..+++.||||++...........+.+|+.+|+.++||||+++++++..++.+|+|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 35788999999999999999999999999999999765555556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
||.+++|... ..+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..........
T Consensus 153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 228 (353)
T PLN00034 153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228 (353)
T ss_pred cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccccc
Confidence 9999998753 345788889999999999999999999999999999999999999999999988765443333456
Q ss_pred cCCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccce---eeccCCCCCCCchhhhhHHHHHHH
Q 008116 172 VGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV---LFIIPRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 172 ~GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~---~~~i~~~~~~~l~~~~s~~l~~lI 244 (577)
+||+.|+|||++.. ...++.++|||||||+||+|++|+.||........ ...+.....+..+..++..+++||
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 308 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFI 308 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHH
Confidence 89999999998743 22345689999999999999999999974332211 112222334445557789999999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.+||..+|.+||++.+||+||||...
T Consensus 309 ~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 309 SCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHccCChhhCcCHHHHhcCcccccC
Confidence 99999999999999999999999864
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=383.70 Aligned_cols=258 Identities=30% Similarity=0.463 Sum_probs=219.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
.+|++.+.||+|+||.||+|.+..+++.||||+++.... ......+.+|+.+++.++||||+++++++.+.+.+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999999999999999975432 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-c
Q 008116 91 EYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-R 168 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~-~ 168 (577)
||+++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++..+...... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999999775 68999999999999999999999999999999999999999999999999999766433221 2
Q ss_pred ccccCCCCCCChhhhhc-----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCc--hhhhhHHH
Q 008116 169 KTFVGTPFWMAPEVIQN-----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQL--DEHFSRLM 240 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~-----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~l--~~~~s~~l 240 (577)
...+||+.|+|||++.. ...++.++|||||||+||+|++|..||...........+.... ...+ ...++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence 23579999999999863 3347889999999999999999999998766544433332211 1111 22578899
Q ss_pred HHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 241 ~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.+||..||. +|.+||++.+++.||||....
T Consensus 241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 241 LDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred HHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 999999997 999999999999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=390.82 Aligned_cols=261 Identities=26% Similarity=0.463 Sum_probs=220.8
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
...+|++++.||+|+||.||+|.+..++..||||++.... .......+.+|+.+++.++||||+++++++.++..+||
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3468999999999999999999999999999999996532 12234567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-c
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~ 167 (577)
|||||++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .
T Consensus 121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence 9999999999999875 5689999999999999999999999999999999999999999999999999876543221 2
Q ss_pred cccccCCCCCCChhhhhccc---CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCchh--hhhHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSE---GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDE--HFSRLMK 241 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~---~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~l~~--~~s~~l~ 241 (577)
....+||+.|+|||++.+.. .++.++|||||||+||+|++|.+||...+.......+.... ...++. .++..++
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 279 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAK 279 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHH
Confidence 23568999999999986532 37889999999999999999999998876654444443221 122222 5789999
Q ss_pred HHHHHhcccCCCC--CCcHHHHhhcHhhhhccC
Q 008116 242 EFVSLCLKKVPAE--RPSAKELLRHRFIRNARK 272 (577)
Q Consensus 242 ~lI~~cL~~dP~~--RpTa~elL~hpff~~~~~ 272 (577)
+||.+||..+|.+ |+++.+|++||||+...+
T Consensus 280 ~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 280 DLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred HHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 9999999999988 999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=378.43 Aligned_cols=258 Identities=25% Similarity=0.428 Sum_probs=215.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
.+|++++.||+|+||.||+|.+..++..||||.++..........+.+|+.++++++||||+++++++..++.+|+||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67999999999999999999999999999999997655444445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 93 ~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
+.+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 164 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE 164 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccc
Confidence 964 88888754 3458999999999999999999999999999999999999999999999999987654433333456
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------------CCC
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------------------ENP 229 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~----------------------~~~ 229 (577)
.+|+.|+|||++.+...++.++|||||||++|+|++|.+||...+..+....+.. ..+
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07872 165 VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFP 244 (309)
T ss_pred cccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcC
Confidence 7899999999987655688999999999999999999999976554322111100 000
Q ss_pred C-------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 230 P-------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 230 ~-------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
. .....++.++++||.+||..||.+|||+.++|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred ccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0 01124678899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=388.03 Aligned_cols=251 Identities=30% Similarity=0.481 Sum_probs=213.0
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhC---CCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQC---RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 21 IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L---~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
||+|+||+||+|.+..+++.||||++..... ......+..|..++..+ .||||+++++++.....+||||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999864321 22334455677777665 699999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 99999998888999999999999999999999999999999999999999999999999999876443333445678999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
.|+|||++.+...++.++|||||||+||+|++|..||...+.......+...........++..+++||.+||.++|.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence 99999999766568899999999999999999999998776555444444333222223578899999999999999999
Q ss_pred C----cHHHHhhcHhhhhcc
Q 008116 256 P----SAKELLRHRFIRNAR 271 (577)
Q Consensus 256 p----Ta~elL~hpff~~~~ 271 (577)
| ++.++++||||....
T Consensus 241 ~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 241 LGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCCCHHHHhcCccccCCC
Confidence 8 799999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=380.81 Aligned_cols=271 Identities=30% Similarity=0.519 Sum_probs=243.9
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
++.-++|..+++||+|.||+|-+++-+.+++.||||+++++- ..+.+.....|-++|+.++||++..+..+|+..+++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 344578999999999999999999999999999999998765 455678888999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|+||||.+||.|+.+|.+...|++...+.+-.+|+.||.|||+++||+||||.+|+|||++|++||.||||++.--....
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999987666666
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
...++||||.|+|||++... .|+.++|+|.+||+||||++|.+||...+.......|.... ..+|..++++++.|+..
T Consensus 324 t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-~kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-LKFPRTLSPEAKTLLSG 401 (516)
T ss_pred eeccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-ccCCccCCHHHHHHHHH
Confidence 77899999999999999876 49999999999999999999999999887766666665443 35677899999999999
Q ss_pred hcccCCCCCC-----cHHHHhhcHhhhhccCChhHHHHhh
Q 008116 247 CLKKVPAERP-----SAKELLRHRFIRNARKSPRLLERIR 281 (577)
Q Consensus 247 cL~~dP~~Rp-----Ta~elL~hpff~~~~~~~~~~~~i~ 281 (577)
+|.+||.+|. .+.+|..|+||..+.+.......+.
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~ 441 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIE 441 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccC
Confidence 9999999997 5899999999999877666655543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=387.56 Aligned_cols=260 Identities=27% Similarity=0.486 Sum_probs=218.4
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
..++|++++.||+|+||.||+|.+..+++.||+|++.+.. .......+.+|+.+++.++||||+++++++..+..+|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3478999999999999999999999999999999986532 22234567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-c
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~ 167 (577)
|||||++|+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+..... .
T Consensus 121 v~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 121 VMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 9999999999999976 4689999999999999999999999999999999999999999999999999876643221 2
Q ss_pred cccccCCCCCCChhhhhccc---CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCch--hhhhHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSE---GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLD--EHFSRLMK 241 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~---~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~l~--~~~s~~l~ 241 (577)
..+.+||+.|+|||++.... .++.++|||||||+||+|++|.+||...+.......+.... ...++ ..++..++
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 279 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHH
Confidence 23568999999999987532 37789999999999999999999998776554444443221 11222 25688999
Q ss_pred HHHHHhcccCCCC--CCcHHHHhhcHhhhhcc
Q 008116 242 EFVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (577)
Q Consensus 242 ~lI~~cL~~dP~~--RpTa~elL~hpff~~~~ 271 (577)
++|..||..++.+ |+++.++++||||+...
T Consensus 280 ~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 280 NLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred HHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 9999999865544 89999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=381.79 Aligned_cols=256 Identities=28% Similarity=0.485 Sum_probs=220.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEEEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~LV~ 90 (577)
+|+++++||+|+||.||+|.+..+++.||||++.... .......+..|+.++..+. ||+|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4889999999999999999999999999999987543 2234566788999998885 678889999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
||+++|+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 99999999999988888999999999999999999999999999999999999999999999999998754333333345
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
.+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...........+.... ..++..++..+.+|+.+||.+
T Consensus 161 ~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~ 238 (323)
T cd05615 161 FCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLMTK 238 (323)
T ss_pred ccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHccc
Confidence 6799999999999765 48999999999999999999999998876655544444322 234556788999999999999
Q ss_pred CCCCCCc-----HHHHhhcHhhhhcc
Q 008116 251 VPAERPS-----AKELLRHRFIRNAR 271 (577)
Q Consensus 251 dP~~RpT-----a~elL~hpff~~~~ 271 (577)
+|.+|++ ..++++||||....
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 239 HPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred CHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 9999997 57899999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=371.30 Aligned_cols=249 Identities=27% Similarity=0.442 Sum_probs=211.0
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCH
Q 008116 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (577)
Q Consensus 21 IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL 98 (577)
||+|+||+||++.+..+++.||||++..... ....+.+..|+.+++.++||||+++++++..+..+|+|||||++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 7999999999999999999999999865432 22346678899999999999999999999999999999999999999
Q ss_pred HHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCC
Q 008116 99 ADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (577)
Q Consensus 99 ~~~l~----~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GT 174 (577)
..++. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+...........||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 98874 23579999999999999999999999999999999999999999999999999987665443333456899
Q ss_pred CCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc----eeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR----VLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 175 p~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~----~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ....+. ..+..++..++..+.+|+.+||..
T Consensus 161 ~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 161 PGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL-NDSVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred cCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc-ccCCCCcccCCHHHHHHHHHHhcC
Confidence 9999999998764 8899999999999999999999997643221 111111 123344556889999999999999
Q ss_pred CCCCCC-----cHHHHhhcHhhhhcc
Q 008116 251 VPAERP-----SAKELLRHRFIRNAR 271 (577)
Q Consensus 251 dP~~Rp-----Ta~elL~hpff~~~~ 271 (577)
+|.+|| ++.++++||||+...
T Consensus 239 ~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred CHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 999999 889999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=380.64 Aligned_cols=258 Identities=34% Similarity=0.622 Sum_probs=218.8
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
..++|++++.||.|+||.||+|.+..++..||+|.+...........+.+|+.++++++||||++++++|..++.+||||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 45799999999999999999999999999999999876655555678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~-gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||+.+++|.+++...+.+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++..+... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 160 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN 160 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--ccc
Confidence 9999999999998878899999999999999999999975 7999999999999999999999999998765332 223
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee---------------------------
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--------------------------- 222 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~--------------------------- 222 (577)
..+|++.|+|||++.+. .++.++|||||||++|+|++|..||..........
T Consensus 161 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 161 SFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred cCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence 46799999999999765 48899999999999999999999997543211110
Q ss_pred -----------------ccCCCCCCCch-hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 223 -----------------IIPRENPPQLD-EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 223 -----------------~i~~~~~~~l~-~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.+....++.++ ..++.++++||.+||.+||.+|||+.+|+.||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00011111111 13567899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=383.33 Aligned_cols=252 Identities=27% Similarity=0.492 Sum_probs=216.8
Q ss_pred EeEEeecCceEEEEEEE---cCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEecc
Q 008116 18 LELIGRGSFGDVYKAFD---KELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~---~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
++.||+|+||.||++.+ ..+|..||||++..... ......+.+|+.+|++++||||+++++++..+..+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 46899999999999976 35789999999975432 223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccC
Q 008116 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173 (577)
Q Consensus 94 ~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~G 173 (577)
++|+|.+++.....+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.............+|
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 99999999988788999999999999999999999999999999999999999999999999998765443333445789
Q ss_pred CCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCC
Q 008116 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPA 253 (577)
Q Consensus 174 Tp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~ 253 (577)
|+.|+|||++.+. .++.++|||||||+||+|++|+.||...+.......+.... ..++..++..+++||.+||.+||.
T Consensus 161 ~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 161 TVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred ChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHh
Confidence 9999999999765 47899999999999999999999998776655554443332 234556789999999999999999
Q ss_pred CCCc-----HHHHhhcHhhhhcc
Q 008116 254 ERPS-----AKELLRHRFIRNAR 271 (577)
Q Consensus 254 ~RpT-----a~elL~hpff~~~~ 271 (577)
+||+ +.+++.||||....
T Consensus 239 ~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 239 NRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred HcCCCCCCCHHHHhCCCCcCCCC
Confidence 9999 77899999998754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=376.46 Aligned_cols=260 Identities=31% Similarity=0.463 Sum_probs=222.1
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCc-eeEeEEEEEeCC-----
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQT----- 84 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~Hpn-IV~l~~~~~~~~----- 84 (577)
-..|..++.||+|+||+||+|+++.+|+.||+|++..... +.......+|+.+|+.|+|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3468888999999999999999999999999999987764 334466789999999999999 999999999877
Q ss_pred -EEEEEEeccCCCCHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccc
Q 008116 85 -KLWIIMEYMAGGSVADLIQSGP----PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 85 -~~~LV~Ey~~gGsL~~~l~~~~----~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
.+++||||+ .-+|..++.... .++...+..+++||+.||+|||+++|+||||||+||||+..|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 899999999 569999997644 57888999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC--------------
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-------------- 225 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-------------- 225 (577)
...-+.......++|.+|.|||++.+...|+..+||||+|||++||+++.+.|........+..|-
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 777666666778999999999999999889999999999999999999999998766644443331
Q ss_pred ----CCC--------CCCchh---hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 226 ----REN--------PPQLDE---HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 226 ----~~~--------~~~l~~---~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
... +..+.. .......+++.+||+.+|.+|.|+..+|.||||.....
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 000 001111 12247889999999999999999999999999987643
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=381.38 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=213.0
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHH-HHHHhCCCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEI-SVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev-~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
+.||+|+||.||+|.+..+++.||||++..... ......+..|. .+++.+.||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999999999999999865431 12233444444 456788999999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999876544333445678999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
.|+|||++.+. .++.++|||||||+||+|++|.+||...+.......+... +..+...++..+.+||.+||+++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (325)
T cd05602 161 EYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPNITNSARHLLEGLLQKDRTKR 238 (325)
T ss_pred cccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CcCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 99999999775 4889999999999999999999999877665544444322 233445678999999999999999999
Q ss_pred CcHH----HHhhcHhhhhccC
Q 008116 256 PSAK----ELLRHRFIRNARK 272 (577)
Q Consensus 256 pTa~----elL~hpff~~~~~ 272 (577)
|++. ++++|+||....+
T Consensus 239 ~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 239 LGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred CCCCCCHHHHhcCcccCCCCH
Confidence 9875 8999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=395.98 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=207.9
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC------
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------ 83 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~------ 83 (577)
....+|++.++||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++|||||+++++|...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 34568999999999999999999999999999999885432 2345799999999999999999887542
Q ss_pred --CEEEEEEeccCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC-Ceeecccc
Q 008116 84 --TKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFG 156 (577)
Q Consensus 84 --~~~~LV~Ey~~gGsL~~~l~----~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g-~vKL~DFG 156 (577)
..+++|||||. ++|.+++. ....+++..++.++.||+.||.|||+++|+||||||+||||+.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 24779999996 57777664 356799999999999999999999999999999999999998664 79999999
Q ss_pred ccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------
Q 008116 157 VSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------- 226 (577)
Q Consensus 157 ls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~---------- 226 (577)
+++.+... ......+||+.|+|||++.+...|+.++|||||||+||+|++|.+||........+..+..
T Consensus 217 la~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 217 SAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred cchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 99866433 2233568999999999987765689999999999999999999999987654332221110
Q ss_pred --------------CCC----CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 227 --------------ENP----PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 227 --------------~~~----~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..+ ..++...+.++++||.+||.++|.+|||+.++|+||||....
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 000 012234578899999999999999999999999999998653
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=380.14 Aligned_cols=251 Identities=29% Similarity=0.427 Sum_probs=213.1
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHH-HHHhCCCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEIS-VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~-iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
++||+|+||.||+|.+..++..||||++..... ......+..|+. +++.++||||+++++++.+.+.+|||||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999865432 223344555554 67889999999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
++|..++.....+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 99999998878899999999999999999999999999999999999999999999999999875433333344578999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
.|+|||++.+. .++.++|||||||++|+|++|.+||...+.......+... +..++...+..+.++|.+||.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (321)
T cd05603 161 EYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PLQLPGGKTVAACDLLVGLLHKDQRRR 238 (321)
T ss_pred ccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHccCCHhhc
Confidence 99999998765 4889999999999999999999999887655444444332 344555678899999999999999999
Q ss_pred CcH----HHHhhcHhhhhcc
Q 008116 256 PSA----KELLRHRFIRNAR 271 (577)
Q Consensus 256 pTa----~elL~hpff~~~~ 271 (577)
|++ .++++|+||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 239 LGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred CCCCCCHHHHhCCCCcCCCC
Confidence 875 5999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=363.42 Aligned_cols=259 Identities=72% Similarity=1.184 Sum_probs=230.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
++|++++.||.|+||.||+|.+..++..||||.+...........+.+|+.+++.++||||+++++++..+..+|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47899999999999999999999999999999997665455567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccccc
Q 008116 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (577)
Q Consensus 93 ~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 172 (577)
+.+++|.+++... ++++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++..+...........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV 159 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccccc
Confidence 9999999999764 899999999999999999999999999999999999999999999999999987765433444568
Q ss_pred CCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhh-hhHHHHHHHHHhcccC
Q 008116 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH-FSRLMKEFVSLCLKKV 251 (577)
Q Consensus 173 GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~-~s~~l~~lI~~cL~~d 251 (577)
|++.|+|||++.+.. ++.++|||||||++|+|++|.+||...++......+....++.+... ++..+.+||.+||..+
T Consensus 160 ~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~ 238 (274)
T cd06609 160 GTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKD 238 (274)
T ss_pred CCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCC
Confidence 899999999998765 89999999999999999999999987776655555555555555555 8899999999999999
Q ss_pred CCCCCcHHHHhhcHhhhhccCC
Q 008116 252 PAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 252 P~~RpTa~elL~hpff~~~~~~ 273 (577)
|.+|||+.++++||||......
T Consensus 239 p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 239 PKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred hhhCcCHHHHhhChhhcCCCcc
Confidence 9999999999999999887655
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=378.66 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=212.4
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHH-HHHhCCCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEIS-VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~-iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
++||+|+||+||+|.+..+|+.||||++.... .......+..|.. +++.++||||+++++++...+.+||||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999999999999999986542 1223345556655 56778999999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCC
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp 175 (577)
|+|..++....++++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 99999998888999999999999999999999999999999999999999999999999999875433333334578999
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
.|+|||++.+. .++.++|||||||+||+|++|.+||...+.......+.... ..+...++..+.++|.+||.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~ll~~~p~~R 238 (325)
T cd05604 161 EYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-LVLRPGASLTAWSILEELLEKDRQRR 238 (325)
T ss_pred hhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-ccCCCCCCHHHHHHHHHHhccCHHhc
Confidence 99999999775 48899999999999999999999998776555444443332 23334578889999999999999999
Q ss_pred CcH----HHHhhcHhhhhcc
Q 008116 256 PSA----KELLRHRFIRNAR 271 (577)
Q Consensus 256 pTa----~elL~hpff~~~~ 271 (577)
|++ .++++||||....
T Consensus 239 ~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 239 LGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred CCCCCCHHHHhcCCCcCCCC
Confidence 976 5999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=368.27 Aligned_cols=252 Identities=27% Similarity=0.451 Sum_probs=203.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcC-CCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhC---CCCceeEeEEEEEe-----
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEESE-DEIEDIQKEISVLSQC---RSPYITEYYGSYLH----- 82 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~-tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L---~HpnIV~l~~~~~~----- 82 (577)
.+|++++.||+|+||.||+|.+.. ++..||||.+...... .....+.+|+.+++.+ .||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 4688999998654422 2234566788777766 69999999998853
Q ss_pred CCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
...+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999995 6899998652 4589999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-------------
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------- 227 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~------------- 227 (577)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||........+..+...
T Consensus 160 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 160 YSFQ-MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred ccCC-cccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 5432 233456799999999999765 4889999999999999999999999876543322222100
Q ss_pred ---------CCC----CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 228 ---------NPP----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 228 ---------~~~----~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
.+. .+...++..+++||.+||+.+|++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 000 0112467788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=386.00 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=207.8
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..+|++++.||+|+||.||+|.+..+++.||||... ...+.+|+.+|++|+|||||+++++|..+...++|||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 468999999999999999999999999999999753 2456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc-cccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~-~~~~~~ 170 (577)
++ +++|..++.....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++...... ......
T Consensus 164 ~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 164 RY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred cC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 99 5789999887788999999999999999999999999999999999999999999999999998654322 122335
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-------eeeccC------------------
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-------VLFIIP------------------ 225 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~-------~~~~i~------------------ 225 (577)
.+||+.|+|||++.+. .++.++|||||||+||+|++|..||....... .+..+.
T Consensus 243 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 243 WAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred ccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 6899999999999775 48999999999999999999998875432110 000000
Q ss_pred -----------CCCC---CCc--hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 226 -----------RENP---PQL--DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 226 -----------~~~~---~~l--~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
...+ +.. ...++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 0000 000 01346789999999999999999999999999999764
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=362.64 Aligned_cols=266 Identities=63% Similarity=1.086 Sum_probs=234.0
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
...|+.++.||.|+||.||+|.+..++..||||++...........+.+|+.+++.+.||||+++++++.++..+|+|||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 45688999999999999999999999999999999876655667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
|+.+++|.+++.. .++++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++.............
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence 9999999999875 679999999999999999999999999999999999999999999999999987665433333445
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccC
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~d 251 (577)
.++..|+|||++.+. .++.++|+|||||++|+|++|.+||....+......+....++.+...++..+.+||.+||..+
T Consensus 162 ~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (277)
T cd06640 162 VGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKD 240 (277)
T ss_pred cCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccC
Confidence 789999999998765 4889999999999999999999999887766655555555566677788899999999999999
Q ss_pred CCCCCcHHHHhhcHhhhhccCChhHHHH
Q 008116 252 PAERPSAKELLRHRFIRNARKSPRLLER 279 (577)
Q Consensus 252 P~~RpTa~elL~hpff~~~~~~~~~~~~ 279 (577)
|.+||++.+++.|+||.........+..
T Consensus 241 p~~Rp~~~~il~~~~~~~~~~~~~~~~~ 268 (277)
T cd06640 241 PSFRPTAKELLKHKFIVKNAKKTSYLTE 268 (277)
T ss_pred cccCcCHHHHHhChHhhhcchhhhHHHH
Confidence 9999999999999999887665444443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=394.69 Aligned_cols=257 Identities=27% Similarity=0.487 Sum_probs=222.4
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCC-CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKEL-NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~t-g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+|+.++|||||++++++..++.+||||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 34599999999999999999998877 7889999875443 334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 91 Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
||+++|+|.+++.. ..++++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++..+.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999987743 45799999999999999999999999999999999999999999999999999987643321
Q ss_pred --ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHH
Q 008116 167 --RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 167 --~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI 244 (577)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.......++..++..+++||
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 303 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL 303 (478)
T ss_pred cccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHH
Confidence 23356799999999999765 489999999999999999999999987766555555544444455567889999999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.+||.++|.+||++.++|.|+|++..
T Consensus 304 ~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 304 DPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHhccChhhCcCHHHHHhCHHHHHH
Confidence 99999999999999999999999754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=377.46 Aligned_cols=259 Identities=28% Similarity=0.453 Sum_probs=215.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++++.||+|+||.||++.+..+++.||||++.+.. .......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999986432 2234566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-c
Q 008116 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-R 168 (577)
Q Consensus 91 Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~-~ 168 (577)
||+.+|+|.+++.+ ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+...... .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999975 467999999999999999999999999999999999999999999999999998765432221 2
Q ss_pred ccccCCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC----CCCCchhhhhHHH
Q 008116 169 KTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----NPPQLDEHFSRLM 240 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~----~~~~l~~~~s~~l 240 (577)
...+||+.|+|||++.. ...++.++|||||||+||+|++|..||......+....+... ..+.....++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence 23579999999999863 234788999999999999999999999876554433333211 1112223478899
Q ss_pred HHHHHHhcccCCCC--CCcHHHHhhcHhhhhcc
Q 008116 241 KEFVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (577)
Q Consensus 241 ~~lI~~cL~~dP~~--RpTa~elL~hpff~~~~ 271 (577)
++||.+||..++.+ |+++.++++||||....
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 99999988764443 78999999999997754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=356.08 Aligned_cols=253 Identities=34% Similarity=0.597 Sum_probs=223.7
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+|.+.+.||+|+||.||+|.+..++..|++|.+.... .......+.+|+.+++.++||||+++++++.....+|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5899999999999999999999999999999987543 334567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 93 MAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 93 ~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999999663 67899999999999999999999999999999999999999999999999998776554333445
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
..|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+.....+.++..++..+.++|.+||..
T Consensus 161 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08529 161 IVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239 (256)
T ss_pred cccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccC
Confidence 67999999999997764 88999999999999999999999987776555555555555556667889999999999999
Q ss_pred CCCCCCcHHHHhhcHhh
Q 008116 251 VPAERPSAKELLRHRFI 267 (577)
Q Consensus 251 dP~~RpTa~elL~hpff 267 (577)
+|++||++.++++|||+
T Consensus 240 ~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 240 DYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CcccCcCHHHHhhCCCC
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=384.77 Aligned_cols=258 Identities=27% Similarity=0.426 Sum_probs=234.2
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-HHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-EIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~-~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
..+=|.+.+.||+|-|+.|.+|.+..||..||||++++.+... ...++.+||..|+.++|||||+||++......+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 4567889999999999999999999999999999998877433 357899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc-CCCeeeccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~-~g~vKL~DFGls~~~~~~~~~ 167 (577)
+|+-.+|+|+++|.+ ...+.|..+.+||.||+.|+.|||...+|||||||+||.+-+ -|-|||.||||+..+.. ...
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-G~k 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-GKK 174 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC-cch
Confidence 999999999999854 467999999999999999999999999999999999987754 59999999999977654 356
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
..+.||+..|-|||++.+..+..+++||||||||||-|++|.+||...++.+.+.+|..-. ..+|..++.+.++||..|
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK-YtvPshvS~eCrdLI~sM 253 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK-YTVPSHVSKECRDLIQSM 253 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-ccCchhhhHHHHHHHHHH
Confidence 6789999999999999998877788999999999999999999999999988888886443 357789999999999999
Q ss_pred cccCCCCCCcHHHHhhcHhhhhc
Q 008116 248 LKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 248 L~~dP~~RpTa~elL~hpff~~~ 270 (577)
|..||.+|.+.++|..|+|++..
T Consensus 254 LvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 254 LVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred HhcCchhhccHHHHhccccccCC
Confidence 99999999999999999999864
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=383.36 Aligned_cols=261 Identities=27% Similarity=0.480 Sum_probs=218.6
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
...++|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++..+..+|
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34589999999999999999999999999999999986432 2223456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~- 166 (577)
+|||||++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 99999999999999976 5689999999999999999999999999999999999999999999999999876643221
Q ss_pred ccccccCCCCCCChhhhhccc---CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CC--CchhhhhHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSE---GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PP--QLDEHFSRLM 240 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~---~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~--~l~~~~s~~l 240 (577)
.....+||+.|+|||++.... .++.++|||||||+||+|++|.+||...+.......+.... .. .....++..+
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 278 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence 223568999999999987532 37889999999999999999999998876654444443221 11 1223678999
Q ss_pred HHHHHHhcccCCCC--CCcHHHHhhcHhhhhcc
Q 008116 241 KEFVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (577)
Q Consensus 241 ~~lI~~cL~~dP~~--RpTa~elL~hpff~~~~ 271 (577)
++||..||..++.+ |+++.+|++|+||++..
T Consensus 279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred HHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 99999999854443 78999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=396.69 Aligned_cols=262 Identities=29% Similarity=0.448 Sum_probs=226.0
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC--
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-- 84 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~-- 84 (577)
......+|++.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+|..++|+||+++++.+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3456689999999999999999999999999999999997654 3445677889999999999999999998775432
Q ss_pred ------EEEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecc
Q 008116 85 ------KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVAD 154 (577)
Q Consensus 85 ------~~~LV~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~D 154 (577)
.+++||||+++|+|.++++. ...+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 37899999999999999864 35799999999999999999999999999999999999999999999999
Q ss_pred ccccccccccc--cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc
Q 008116 155 FGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL 232 (577)
Q Consensus 155 FGls~~~~~~~--~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l 232 (577)
||+++.+.... ......+||+.|+|||++.+.. ++.++|||||||+||+|++|..||...+.......+.......+
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 265 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 99987654321 2234578999999999998754 89999999999999999999999988776555555555555556
Q ss_pred hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 233 ~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
+..++..+.+||.+||..+|.+||++.++|.|||++..
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 67788999999999999999999999999999999764
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=361.07 Aligned_cols=253 Identities=41% Similarity=0.680 Sum_probs=213.6
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHH-HHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEecc
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE-IEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~-~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
|++.+.||+|+||+||+|.+..+++.||+|++........ .....+|+.++++++||||+++++++.....+++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999987754332 234466999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccC
Q 008116 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173 (577)
Q Consensus 94 ~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~G 173 (577)
.+++|.+++.....+++..++.++.||+.||.+||+++|+|+||||+|||++.++.++|+|||++..............+
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 160 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG 160 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999986788999999999999999999999999999999999999999999999999998764333344456789
Q ss_pred CCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCch------hhhhHHHHHHHHHh
Q 008116 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD------EHFSRLMKEFVSLC 247 (577)
Q Consensus 174 Tp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~------~~~s~~l~~lI~~c 247 (577)
++.|+|||++.....++.++||||||+++|+|++|..||...........+......... ...+..+.++|..|
T Consensus 161 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 240 (260)
T PF00069_consen 161 TPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKM 240 (260)
T ss_dssp SGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHH
Confidence 999999999873345899999999999999999999999876322222111111111111 11237899999999
Q ss_pred cccCCCCCCcHHHHhhcHhh
Q 008116 248 LKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 248 L~~dP~~RpTa~elL~hpff 267 (577)
|..+|.+||++.++++||||
T Consensus 241 l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 241 LSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp SSSSGGGSTTHHHHHTSGGG
T ss_pred ccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=359.47 Aligned_cols=258 Identities=51% Similarity=0.960 Sum_probs=226.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCceeEeEEEEEeCCEEEEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~---HpnIV~l~~~~~~~~~~~LV~ 90 (577)
.|++++.||.|+||.||+|.+..++..||||.++..........+.+|+.+++++. ||||+++++++..+..+|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 58899999999999999999999999999999876655556678899999999996 999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
||+.+++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++............
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST 160 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccccc
Confidence 99999999999876 58999999999999999999999999999999999999999999999999998876554444445
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchh-hhhHHHHHHHHHhcc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE-HFSRLMKEFVSLCLK 249 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~-~~s~~l~~lI~~cL~ 249 (577)
..|++.|+|||++.+...++.++|||||||++|+|++|.+||...........+....++.+.. .++..+.+|+..||.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 240 (277)
T cd06917 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLD 240 (277)
T ss_pred ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcC
Confidence 6799999999998765557889999999999999999999998776655544444444444444 378899999999999
Q ss_pred cCCCCCCcHHHHhhcHhhhhccC
Q 008116 250 KVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 250 ~dP~~RpTa~elL~hpff~~~~~ 272 (577)
.+|.+||++.+++.|+||+....
T Consensus 241 ~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 241 EEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred CCcccCcCHHHHhhChHhhcccc
Confidence 99999999999999999987654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=366.56 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=215.8
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~--~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.|+++++||+|+||+||++.+..+++.||||++...... .....+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 589999999999999999999999999999998654322 223556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
|+++|+|..++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIR 159 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-Cccc
Confidence 99999999888542 46999999999999999999999999999999999999999999999999998765322 2223
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc---CCCCCCCchhhhhHHHHHHHHH
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII---PRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i---~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
..+|++.|+|||++.+. .++.++|||||||++|+|++|..||...........+ ....+..++..++..+.+||.+
T Consensus 160 ~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 160 GRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred cccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHH
Confidence 45799999999999765 4889999999999999999999999875442211111 1122334455688999999999
Q ss_pred hcccCCCCCC-----cHHHHhhcHhhhhcc
Q 008116 247 CLKKVPAERP-----SAKELLRHRFIRNAR 271 (577)
Q Consensus 247 cL~~dP~~Rp-----Ta~elL~hpff~~~~ 271 (577)
||..||.+|| ++.+|++||||....
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 9999999999 899999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=358.05 Aligned_cols=254 Identities=39% Similarity=0.694 Sum_probs=219.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC----hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~----~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
++|++.+.||+|+||.||+|.+..++..||||.+..... ......+.+|+.++++++||||+++++++..+..+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 579999999999999999999999999999999865432 2235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~- 167 (577)
|+||+++++|.+++.....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999999988788999999999999999999999999999999999999999999999999998765332111
Q ss_pred --cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-CCCCCCchhhhhHHHHHHH
Q 008116 168 --RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 168 --~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-~~~~~~l~~~~s~~l~~lI 244 (577)
.....|++.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+. ....+.++..++..+.+||
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 12456889999999998764 8899999999999999999999998765543332222 2233455667889999999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhh
Q 008116 245 SLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff 267 (577)
.+||.++|.+|||+.++|+|+||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=375.50 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=217.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++++.||+|+||.||++.+..+++.||||++.+.. .......+..|+.++..++||+|+++++++.+...+||||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986432 2223455788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-cc
Q 008116 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (577)
Q Consensus 91 Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~~ 168 (577)
||+.+|+|.+++.+ ...+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++..+..... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999976 46799999999999999999999999999999999999999999999999999876533222 12
Q ss_pred ccccCCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC----CCCchhhhhHHH
Q 008116 169 KTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRLM 240 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~----~~~l~~~~s~~l 240 (577)
...+||+.|+|||++.. ...++.++|||||||+||+|++|+.||...+.......+.... .+.....++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 240 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence 24579999999999863 2347889999999999999999999998876655544443221 122234578999
Q ss_pred HHHHHHhcccCCCC--CCcHHHHhhcHhhhhcc
Q 008116 241 KEFVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (577)
Q Consensus 241 ~~lI~~cL~~dP~~--RpTa~elL~hpff~~~~ 271 (577)
++||.+||..++.+ |+++.++++||||....
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred HHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 99999999765544 68999999999998764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=355.68 Aligned_cols=255 Identities=48% Similarity=0.901 Sum_probs=221.5
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
++|++.+.||.|+||+||+|.+..++..||||++...........+.+|+.+++.++||||+++++.+.....+|+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999998899999999997665444678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc--
Q 008116 93 MAGGSVADLIQSG---PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-- 167 (577)
Q Consensus 93 ~~gGsL~~~l~~~---~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~-- 167 (577)
+++++|.+++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..+......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999999999763 45899999999999999999999999999999999999999999999999998776543322
Q ss_pred --cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCch-----hhhhHHH
Q 008116 168 --RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD-----EHFSRLM 240 (577)
Q Consensus 168 --~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~-----~~~s~~l 240 (577)
....+|++.|+|||++.....++.++|+|||||++|+|++|+.||...+.......+....++.+. ..++..+
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHH
Confidence 134578999999999876646889999999999999999999999877665444443333332222 2567899
Q ss_pred HHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 241 KEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 241 ~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
.+||.+||.++|.+||++.+|++||||
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=365.35 Aligned_cols=262 Identities=43% Similarity=0.767 Sum_probs=225.0
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
....+|++++.||.|+||.||+|.+..++..||||.+...... ..+.+.+|+.+++.++||||+++++++..+..+|+|
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3448999999999999999999999999999999998755433 346688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
|||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++...........
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 999999999999965 5689999999999999999999999999999999999999999999999999876544333334
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC--CCchhhhhHHHHHHHHHh
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP--PQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~--~~l~~~~s~~l~~lI~~c 247 (577)
...|++.|+|||.+.+. .++.++|||||||++|+|++|..||...++......+..... ...+..++..+++||.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (297)
T cd06656 174 TMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252 (297)
T ss_pred cccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence 56789999999998765 488999999999999999999999987665444443333222 223456788899999999
Q ss_pred cccCCCCCCcHHHHhhcHhhhhccCCh
Q 008116 248 LKKVPAERPSAKELLRHRFIRNARKSP 274 (577)
Q Consensus 248 L~~dP~~RpTa~elL~hpff~~~~~~~ 274 (577)
|..+|.+||++.+|++||||...+...
T Consensus 253 l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 253 LEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred ccCChhhCcCHHHHhcCchhccccccc
Confidence 999999999999999999998765544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=363.06 Aligned_cols=265 Identities=45% Similarity=0.811 Sum_probs=226.4
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
...+|++++.||.|+||.||+|.+..++..||+|++... .......+.+|+.++++++||||+++++++..+..+|+||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 356899999999999999999999889999999998654 3445577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 91 Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||+++++|..++.. ...+++..++.++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++...........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 99999999999865 35799999999999999999999999999999999999999999999999999876544433344
Q ss_pred cccCCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--chhhhhHHHHHH
Q 008116 170 TFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEF 243 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--l~~~~s~~l~~l 243 (577)
...|++.|+|||++.. ...++.++|||||||++|+|++|.+||...........+....++. .+..++..+.+|
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF 241 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence 5679999999999852 2236778999999999999999999998876655444444433332 244678899999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhccCChhH
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRL 276 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~ 276 (577)
|..||..+|.+||++.++|+||||........+
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~ 274 (280)
T cd06611 242 LKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAI 274 (280)
T ss_pred HHHHhccChhhCcCHHHHhcChhhcccchhHHH
Confidence 999999999999999999999999877544333
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=355.25 Aligned_cols=253 Identities=30% Similarity=0.548 Sum_probs=218.8
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe-CCEEEEEEe
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTKLWIIME 91 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~-~~~~~LV~E 91 (577)
.|++++.||+|+||.||++.+..+++.||||.+.... .......+.+|+.++++++||||+++++.+.. ...+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999999999999999987544 23445678899999999999999999998864 446899999
Q ss_pred ccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
|+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 9999999999865 35689999999999999999999999999999999999999999999999999876654333344
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
...|++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.....+.++..++..+.+||.+||.
T Consensus 161 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 239 (257)
T cd08223 161 TLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS 239 (257)
T ss_pred cccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhc
Confidence 56789999999998775 48889999999999999999999998766544444444444445566788999999999999
Q ss_pred cCCCCCCcHHHHhhcHhh
Q 008116 250 KVPAERPSAKELLRHRFI 267 (577)
Q Consensus 250 ~dP~~RpTa~elL~hpff 267 (577)
.+|.+||++.++++||||
T Consensus 240 ~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 240 KRPEKRPSVKSILRQPYI 257 (257)
T ss_pred cCcccCCCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=372.67 Aligned_cols=259 Identities=26% Similarity=0.432 Sum_probs=216.5
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++++.||+|+||.||++.+..+++.||||++.... .......+.+|+.++..+.||||+++++++..++.+||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986532 2233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-c
Q 008116 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-R 168 (577)
Q Consensus 91 Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~-~ 168 (577)
||+.||+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||++......... .
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999976 468999999999999999999999999999999999999999999999999998765433221 2
Q ss_pred ccccCCCCCCChhhhhcc----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC----CCCchhhhhHHH
Q 008116 169 KTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRLM 240 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~----~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~----~~~l~~~~s~~l 240 (577)
...+||+.|+|||++.+. ..++.++|||||||+||+|++|+.||...+.......+.... .+.....++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~ 240 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence 245799999999998652 247889999999999999999999998776554444333221 122223468899
Q ss_pred HHHHHHhcccCCCC--CCcHHHHhhcHhhhhcc
Q 008116 241 KEFVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (577)
Q Consensus 241 ~~lI~~cL~~dP~~--RpTa~elL~hpff~~~~ 271 (577)
++||.+||...+.+ |+++.++++|+||....
T Consensus 241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred HHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 99999999876554 56999999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=367.10 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=215.4
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
-.+|++++.||.|+||.||+|.+..++..||||.+...........+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 36799999999999999999999999999999999765544444567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|+. ++|..++.. ...+++..++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++............
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence 996 589888864 457899999999999999999999999999999999999999999999999998765443333334
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---------------------CCCC
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---------------------RENP 229 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~---------------------~~~~ 229 (577)
..+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+....+. ....
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence 5789999999998776568889999999999999999999997654322111000 0000
Q ss_pred C--------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 230 P--------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 230 ~--------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
+ .....++..+++||.+||..||.+|||+.++|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0 1113467889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=381.45 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=215.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC-----EEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-----KLW 87 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~-----~~~ 87 (577)
+|++++.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.+|+.++||||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999999999999999999999999986442 2234567889999999999999999999998876 789
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~- 166 (577)
+||||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999995 68999888778899999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--------------------
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------------------- 226 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~-------------------- 226 (577)
.....++|+.|+|||++.+...++.++|||||||++|+|++|++||...++...+..+..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 223457899999999998766688999999999999999999999987655433222110
Q ss_pred -----CCCC------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 227 -----ENPP------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 227 -----~~~~------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..++ .+....+..+.+||.+||..||.+|||+.++|.||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0111 11223578899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=364.70 Aligned_cols=267 Identities=64% Similarity=1.081 Sum_probs=231.8
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
...|++++.||.|+||.||+|.+..++..||||.++..........+.+|+.+++++.||||+++++++..+..+|+|||
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 34678889999999999999999999999999998766555566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
|+.+++|.+++.. ..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++..+..........
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 9999999999865 678999999999999999999999999999999999999999999999999987665433333345
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccC
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~d 251 (577)
.|+..|+|||++.+. .++.++|||||||++|+|++|..||....+......+....++.+...++..+.+||.+||..+
T Consensus 162 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (277)
T cd06642 162 VGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKD 240 (277)
T ss_pred cCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence 789999999999765 4888999999999999999999999877665555555555555566677889999999999999
Q ss_pred CCCCCcHHHHhhcHhhhhccCChhHHHHh
Q 008116 252 PAERPSAKELLRHRFIRNARKSPRLLERI 280 (577)
Q Consensus 252 P~~RpTa~elL~hpff~~~~~~~~~~~~i 280 (577)
|.+||++.+++.||||.........+..+
T Consensus 241 p~~Rp~~~~il~~~~~~~~~~~~~~~~~~ 269 (277)
T cd06642 241 PRFRPTAKELLKHKFITRYTKKTSFLTEL 269 (277)
T ss_pred cccCcCHHHHHHhHHHHHHhhhHHHHHHH
Confidence 99999999999999998876665544433
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=373.55 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=217.6
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC-----
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----- 84 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~----- 84 (577)
...-.|...++||.|+||.||+|+...++..||||.+-... +.-.+|+.+|+.++|||||+|..+|....
T Consensus 21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 34557899999999999999999999999999999875443 22357999999999999999999887532
Q ss_pred EEEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC-CCeeeccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSA 159 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~-g~vKL~DFGls~ 159 (577)
.+.||||||+ .+|.++++. +..++...++-+++||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+
T Consensus 96 ~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 4578999995 599999974 5789999999999999999999999999999999999999976 999999999999
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------C
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------E 227 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------~ 227 (577)
.+... ....+++.|..|+|||++.+...|+.+.||||.||||.||+.|++-|.+.+....+..|.+ .
T Consensus 175 ~L~~~-epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 175 VLVKG-EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeccC-CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 88765 4446889999999999999999999999999999999999999999987665444432210 0
Q ss_pred C-------CC---------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCC
Q 008116 228 N-------PP---------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 228 ~-------~~---------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
+ .+ .+....+.++.+|+.++|..+|.+|.++.++|.||||...+..
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0 00 1234568899999999999999999999999999999876543
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=356.47 Aligned_cols=257 Identities=48% Similarity=0.903 Sum_probs=217.8
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
.....+|++.+.||+|+||.||+|.+..++..||||++..... .....+.+|+.++++++||||+++++++..+..+|+
T Consensus 5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred cCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3456789999999999999999999999999999999865432 234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
||||+.+++|.+++....++++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++..+.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 99999999999999877889999999999999999999999999999999999999999999999999988664433333
Q ss_pred ccccCCCCCCChhhhhc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCc--hhhhhHHHHH
Q 008116 169 KTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQL--DEHFSRLMKE 242 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~--~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~--~~~l--~~~~s~~l~~ 242 (577)
....|++.|+|||++.. ...++.++|||||||++|+|++|..||....+......+.... ++.. ...++..+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence 45679999999998742 2336789999999999999999999997665544333322221 1111 2356789999
Q ss_pred HHHHhcccCCCCCCcHHHHhhcHh
Q 008116 243 FVSLCLKKVPAERPSAKELLRHRF 266 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~hpf 266 (577)
||.+||..+|++||++++||+|+|
T Consensus 244 li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 244 FVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=375.30 Aligned_cols=256 Identities=28% Similarity=0.445 Sum_probs=208.7
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC----
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT---- 84 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~---- 84 (577)
.+..+|++++.||+|+||.||+|.+..++..||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 56789999999999999999999999999999999986543 2334567889999999999999999999987543
Q ss_pred --EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 85 --KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 85 --~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999965 6766664 358899999999999999999999999999999999999999999999999987543
Q ss_pred ccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------
Q 008116 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------- 226 (577)
Q Consensus 163 ~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~---------------- 226 (577)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+..
T Consensus 175 ~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 175 TN-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred cC-ccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 32 223356899999999999775 489999999999999999999999986543221110000
Q ss_pred ------CCC-------------------CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 227 ------ENP-------------------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 227 ------~~~-------------------~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
..+ .......+..+++||.+||..||.+|||+.|+|.||||...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 000 00111235678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=373.76 Aligned_cols=252 Identities=24% Similarity=0.432 Sum_probs=207.0
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeC-
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ- 83 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~- 83 (577)
...+|++.+.||+|+||.||+|.+. .++..||||++...........+.+|+.+|+.+ +|||||++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4578999999999999999999752 345789999997655555567889999999999 899999999988764
Q ss_pred CEEEEEEeccCCCCHHHHHHcC----------------------------------------------------------
Q 008116 84 TKLWIIMEYMAGGSVADLIQSG---------------------------------------------------------- 105 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~---------------------------------------------------------- 105 (577)
..+|+|||||++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999998642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc--ccccccCCCCCCC
Q 008116 106 ----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMA 179 (577)
Q Consensus 106 ----~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~A 179 (577)
.++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ......+++.|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 2477888999999999999999999999999999999999999999999999876533211 1123456788999
Q ss_pred hhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccce-eeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCc
Q 008116 180 PEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRV-LFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPS 257 (577)
Q Consensus 180 PEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~-~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpT 257 (577)
||++.+. .++.++|||||||+||||++ |.+||........ ...+........+..++..+.+||.+||..+|.+|||
T Consensus 245 PE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs 323 (338)
T cd05102 245 PESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT 323 (338)
T ss_pred cHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence 9999765 48999999999999999997 9999987543222 2222223333445567889999999999999999999
Q ss_pred HHHHhh
Q 008116 258 AKELLR 263 (577)
Q Consensus 258 a~elL~ 263 (577)
+.+|++
T Consensus 324 ~~el~~ 329 (338)
T cd05102 324 FSALVE 329 (338)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=362.13 Aligned_cols=265 Identities=45% Similarity=0.797 Sum_probs=224.2
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
..+.|++++.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++..+..+|+||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 3478999999999999999999999999999999986543 445677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 91 Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||+.+++|..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 99999999988754 46789999999999999999999999999999999999999999999999999876544333334
Q ss_pred cccCCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CchhhhhHHHHHH
Q 008116 170 TFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEF 243 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~l~~~~s~~l~~l 243 (577)
...|++.|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+....++ ..+..++..+.+|
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence 5678999999999852 223678899999999999999999999876654443333322222 2244677889999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhccCChhH
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRL 276 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~ 276 (577)
|.+||..+|++||++.++++||||......+..
T Consensus 249 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~ 281 (292)
T cd06644 249 LKTALDKHPETRPSAAQLLEHPFVSSVTSNRPL 281 (292)
T ss_pred HHHHhcCCcccCcCHHHHhcCccccccccchhH
Confidence 999999999999999999999999877665533
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=362.54 Aligned_cols=259 Identities=43% Similarity=0.783 Sum_probs=221.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
...+|++++.||+|+||.||+|.+..++..||||.+...... ....+.+|+.+++.+.||||+++++.+..+...|+||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 447999999999999999999999999999999998765433 3467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
||+.+++|.+++.. ..+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++............
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 99999999999865 56899999999999999999999999999999999999999999999999998765443333344
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCchhhhhHHHHHHHHHhc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~--~~~l~~~~s~~l~~lI~~cL 248 (577)
..|++.|+|||.+.+. .++.++|||||||++|+|++|++||....+......+.... +...+..++..+.+||.+||
T Consensus 176 ~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (296)
T cd06654 176 MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (296)
T ss_pred ccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence 6799999999998765 47899999999999999999999998766543332222222 22234567889999999999
Q ss_pred ccCCCCCCcHHHHhhcHhhhhccC
Q 008116 249 KKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 249 ~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
.++|.+||++.+|+.||||.....
T Consensus 255 ~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 255 DMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred cCCcccCcCHHHHhhChhhhccCC
Confidence 999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=357.88 Aligned_cols=256 Identities=47% Similarity=0.874 Sum_probs=216.3
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeC-----
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ----- 83 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~----- 83 (577)
.+.+.|++.+.||+|+||.||+|.+..+++.||||.+..... ....+..|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 467899999999999999999999999999999999865432 336788999999998 799999999998753
Q ss_pred -CEEEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccc
Q 008116 84 -TKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 84 -~~~~LV~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
..+|+||||+.+++|.+++.. ...+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 468999999999999999875 34689999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccCCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCchhh
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDEH 235 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~l~~~ 235 (577)
...........+|++.|+|||++.. ...++.++|||||||++|+|++|..||....+......+.... .......
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 6443334456789999999999863 2247889999999999999999999997765544333332222 2222345
Q ss_pred hhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 236 ~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
++..+.+||.+||..+|.+|||+.++++||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 77899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=359.08 Aligned_cols=255 Identities=29% Similarity=0.486 Sum_probs=215.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++++.||||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 479999999999999999999999999999999865432 2223567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
|++++.|..++.....+++..++.++.||+.||.|||+++++|+||||+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence 99999999888777789999999999999999999999999999999999999999999999999998765543333456
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------------CCC
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------------------ENP 229 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~----------------------~~~ 229 (577)
.++..|+|||++.+...++.++|||||||++|+|++|.+||......+....+.. ..+
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence 7899999999987655588899999999999999999999986654322211100 000
Q ss_pred C-----C---chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 230 P-----Q---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 230 ~-----~---l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
. . ....++..+.+||.+||.++|++||++.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 0 112457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=355.55 Aligned_cols=253 Identities=36% Similarity=0.685 Sum_probs=219.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--------HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--------DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~--------~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
+|.+...||.|+||.||+|.+..++..||||.+...... ...+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 578889999999999999999989999999988654321 124678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
.++||||+++++|..++...+.+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999987664211
Q ss_pred ------cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHH
Q 008116 166 ------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL 239 (577)
Q Consensus 166 ------~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~ 239 (577)
.......|++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.....+.++..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 111235689999999998765 4788999999999999999999999876654444444444445566678899
Q ss_pred HHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 240 MKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 240 l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
+.++|.+||+++|.+||++.+|++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=359.73 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=203.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhC---CCCceeEeEEEEEe-----CC
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQC---RSPYITEYYGSYLH-----QT 84 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L---~HpnIV~l~~~~~~-----~~ 84 (577)
+|++++.||+|+||+||+|.+..+++.||||.++..... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 599999999999999999999999999999998754322 1223456777777665 79999999998865 34
Q ss_pred EEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
.+++||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 6899999996 5898888653 458999999999999999999999999999999999999999999999999987664
Q ss_pred ccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-----------------
Q 008116 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP----------------- 225 (577)
Q Consensus 163 ~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~----------------- 225 (577)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||........+..+.
T Consensus 160 ~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 160 CQ-MALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred Cc-ccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 32 222346789999999999765 48999999999999999999999997654322111110
Q ss_pred -CCC-----C---CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 226 -REN-----P---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 226 -~~~-----~---~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
... + ..+...++..+.+||.+||++||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000 0 01122467789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=361.45 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=214.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.|++.++||+|+||.||+|.+..+++.||||.+..... ......+.+|+.++++++|++|+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999865432 2234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
|+.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIK 159 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-cccc
Confidence 99999999988542 36899999999999999999999999999999999999999999999999998654322 2223
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc---eeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR---VLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~---~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
..+|++.|+|||++.+.. ++.++|||||||++|+|++|.+||....... ....+........+..++..+++||.+
T Consensus 160 ~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 160 GRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238 (285)
T ss_pred CCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHH
Confidence 457999999999997754 8999999999999999999999998643211 111111222223445678899999999
Q ss_pred hcccCCCCCCc-----HHHHhhcHhhhhc
Q 008116 247 CLKKVPAERPS-----AKELLRHRFIRNA 270 (577)
Q Consensus 247 cL~~dP~~RpT-----a~elL~hpff~~~ 270 (577)
||+.+|.+||| +.++++||||...
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 99999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=375.62 Aligned_cols=261 Identities=23% Similarity=0.432 Sum_probs=213.8
Q ss_pred cchhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC
Q 008116 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (577)
Q Consensus 5 ~~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~ 83 (577)
....-.+..+|++++.||.|+||.||+|.+..++..||||.+..... ......+.+|+.+|++++||||+++++++...
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07878 7 NKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA 86 (343)
T ss_pred hHHHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence 33445667899999999999999999999999999999999865432 22345677999999999999999999988643
Q ss_pred ------CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccc
Q 008116 84 ------TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (577)
Q Consensus 84 ------~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGl 157 (577)
..+|+++|++ +++|.++++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 87 TSIENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred ccccccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 3579999998 7899988864 6799999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---C-------
Q 008116 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---E------- 227 (577)
Q Consensus 158 s~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~---~------- 227 (577)
+...... ....+||+.|+|||++.+...++.++|||||||+||+|++|..||...+....+..+.. .
T Consensus 165 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 165 ARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred ceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 8765432 33568999999999997755688999999999999999999999976543222111100 0
Q ss_pred ----------------CCC----CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 228 ----------------NPP----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 228 ----------------~~~----~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.+. ......++.+.+||.+||..||.+|||+.++|.||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 000 0011245668899999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=357.63 Aligned_cols=254 Identities=50% Similarity=0.910 Sum_probs=215.9
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.++|++.+.||+|+||.||+|.+..+++.||||+++.... .....+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 3589999999999999999999999999999999875543 234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
|+++++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+|||++.++.++|+|||++.............
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccc
Confidence 99999999999888899999999999999999999999999999999999999999999999999987665433333456
Q ss_pred cCCCCCCChhhhhc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCc--hhhhhHHHHHHHH
Q 008116 172 VGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQL--DEHFSRLMKEFVS 245 (577)
Q Consensus 172 ~GTp~Y~APEvl~~--~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~--~~~l--~~~~s~~l~~lI~ 245 (577)
.|++.|+|||++.. ...++.++|||||||++|+|++|..||....+......+.... ++.. ...++..+.+||.
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHH
Confidence 89999999999742 2347889999999999999999999997665433322221111 1111 1246788999999
Q ss_pred HhcccCCCCCCcHHHHhhcHh
Q 008116 246 LCLKKVPAERPSAKELLRHRF 266 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~hpf 266 (577)
+||..+|++||++.+|+.|||
T Consensus 247 ~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 247 MALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=363.50 Aligned_cols=255 Identities=36% Similarity=0.633 Sum_probs=216.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
++|++++.||+|+||.||+|.+..++..||+|.+...........+.+|+.++++++||||+++++++..++.+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999999999999999987655555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 93 ~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
+++++|.+++....++++..+..++.||+.||.|||+ ++++|+||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 158 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSF 158 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccccC
Confidence 9999999999887889999999999999999999997 69999999999999999999999999998655332 22356
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC--------------------------
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-------------------------- 225 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-------------------------- 225 (577)
+|++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.
T Consensus 159 ~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 159 VGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 899999999998765 48889999999999999999999996543322111110
Q ss_pred ----------CCCCCCch-hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 226 ----------RENPPQLD-EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 226 ----------~~~~~~l~-~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
...++.++ ..++..+++||.+||..+|++||++.+|++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00011111 1367789999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=357.09 Aligned_cols=260 Identities=65% Similarity=1.112 Sum_probs=227.5
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+-|++++.||.|+||.||+|.+..++..||||.+...........+.+|+.++++++||||+++++++..+..+|+||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45889999999999999999999899999999987665555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccccc
Q 008116 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (577)
Q Consensus 93 ~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 172 (577)
+.+++|.+++.. ..+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++..+...........
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence 999999999875 5789999999999999999999999999999999999999999999999999876544333334567
Q ss_pred CCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCC
Q 008116 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (577)
Q Consensus 173 GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP 252 (577)
|+..|+|||.+.+. .++.++|||||||++|+|++|..||...........+....++.+...++..+.+||.+||..+|
T Consensus 163 ~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 241 (277)
T cd06641 163 GTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 241 (277)
T ss_pred CCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 89999999998765 47889999999999999999999998776655555554455555666788999999999999999
Q ss_pred CCCCcHHHHhhcHhhhhccCCh
Q 008116 253 AERPSAKELLRHRFIRNARKSP 274 (577)
Q Consensus 253 ~~RpTa~elL~hpff~~~~~~~ 274 (577)
.+||++.++++||||.......
T Consensus 242 ~~Rp~~~~~l~~~~~~~~~~~~ 263 (277)
T cd06641 242 SFRPTAKELLKHKFIVRFAKKT 263 (277)
T ss_pred hhCcCHHHHHhCHHHhhhhhcc
Confidence 9999999999999998765443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=358.31 Aligned_cols=253 Identities=29% Similarity=0.478 Sum_probs=209.9
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+|++++.||.|+||.||+|.+..++..||||.+..... ......+.+|+.+++++.||||+++++++..+..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58999999999999999999999999999999865432 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 93 MAGGSVADLIQS---GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 93 ~~gGsL~~~l~~---~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
+. ++|.+++.. ...+++..++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++...........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 96 689888854 25689999999999999999999999999999999999999999999999999876544333333
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc-------------------------
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------------- 224 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i------------------------- 224 (577)
...+++.|+|||++.+...++.++|||||||++|+|++|.+||...........+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 4567899999999876656788999999999999999999999764332111000
Q ss_pred CCCC---CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 225 PREN---PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 225 ~~~~---~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
.... .......++.++++||.+||..||.+|||+.+|+.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000 001122467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=351.69 Aligned_cols=254 Identities=55% Similarity=0.974 Sum_probs=220.2
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..+|++.+.||.|+||.||+|.+..++..||+|++...... ....+.+|+.++++++||||+++++++..+..+|++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 46899999999999999999999999999999999765433 56789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|+.+++|.+++... .++++..++.++.|++.||.|||+++|+|+||||+||+++.++.+||+|||++............
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99999999999765 78999999999999999999999999999999999999999999999999998776544333445
Q ss_pred ccCCCCCCChhhhhcc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC--CCC--CchhhhhHHHHHHH
Q 008116 171 FVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--NPP--QLDEHFSRLMKEFV 244 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~--~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~--~~~--~l~~~~s~~l~~lI 244 (577)
.+|++.|+|||++... ..++.++|||||||++|+|++|.+||...++......+... .++ .....++..+.+||
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI 240 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHH
Confidence 6889999999998654 24788999999999999999999999887655444333322 111 12345678899999
Q ss_pred HHhcccCCCCCCcHHHHhhcHh
Q 008116 245 SLCLKKVPAERPSAKELLRHRF 266 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpf 266 (577)
.+||..+|..|||+.+|+.|+|
T Consensus 241 ~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 241 KKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHcCCChhhCCCHHHHhcCCC
Confidence 9999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=360.71 Aligned_cols=255 Identities=28% Similarity=0.523 Sum_probs=223.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+++.||||+++++++..+..+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 479999999999999999999999999999999865432 234577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
||+++++|.+++.....+++..+..++.||+.||.|||++||+|+||+|.||||+.++.+||+|||++...... ...
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~ 157 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYT 157 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCC
Confidence 99999999999988889999999999999999999999999999999999999999999999999998766433 335
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
.+|++.|+|||.+.+. .++.++||||||+++|+|++|..||...........+.. ....++..++..++++|.+||..
T Consensus 158 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~ 235 (290)
T cd05580 158 LCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE-GKVRFPSFFSPDAKDLIRNLLQV 235 (290)
T ss_pred CCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCccCCccCCHHHHHHHHHHccC
Confidence 6799999999998765 478899999999999999999999987665443333332 23345566789999999999999
Q ss_pred CCCCCC-----cHHHHhhcHhhhhccC
Q 008116 251 VPAERP-----SAKELLRHRFIRNARK 272 (577)
Q Consensus 251 dP~~Rp-----Ta~elL~hpff~~~~~ 272 (577)
+|.+|+ ++.++++||||....+
T Consensus 236 ~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 236 DLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred CHHHccCcccCCHHHHHcCcccccCCH
Confidence 999999 9999999999987653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=350.79 Aligned_cols=250 Identities=31% Similarity=0.550 Sum_probs=220.8
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEecc
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
+|++.+.||.|+||.||++.+..++..||+|.++........+.+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 58999999999999999999999999999999976655556788899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 94 AGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 94 ~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.............
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence 99999998864 3568999999999999999999999999999999999999999999999999987665443333456
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccC
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~d 251 (577)
.|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+.......++..++..+.+||.+||.++
T Consensus 161 ~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (255)
T cd08219 161 VGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRN 239 (255)
T ss_pred cCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCC
Confidence 7999999999987654 889999999999999999999999877665555555555555566678889999999999999
Q ss_pred CCCCCcHHHHhhc
Q 008116 252 PAERPSAKELLRH 264 (577)
Q Consensus 252 P~~RpTa~elL~h 264 (577)
|.+||++.+|+.-
T Consensus 240 P~~Rp~~~~il~~ 252 (255)
T cd08219 240 PRSRPSATTILSR 252 (255)
T ss_pred cccCCCHHHHhhc
Confidence 9999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=349.43 Aligned_cols=253 Identities=32% Similarity=0.558 Sum_probs=222.6
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+|+++++||.|+||.||.+.+..++..|++|.+.... .......+.+|+.++++++||||+++++++.....+++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 6999999999999999999999999999999987654 344567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 93 MAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 93 ~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.+||+|||++............
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999999764 56899999999999999999999999999999999999999999999999998776544333345
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
..|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+...........++..+.+||.+||.+
T Consensus 161 ~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08221 161 VVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239 (256)
T ss_pred cCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccc
Confidence 67999999999987654 78899999999999999999999987666555555544444445566789999999999999
Q ss_pred CCCCCCcHHHHhhcHhh
Q 008116 251 VPAERPSAKELLRHRFI 267 (577)
Q Consensus 251 dP~~RpTa~elL~hpff 267 (577)
+|.+||++.++|+|+|+
T Consensus 240 ~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 240 DPEKRPTADEVLDQPLL 256 (256)
T ss_pred CcccCCCHHHHhhCcCC
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=372.87 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=208.9
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-----
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ----- 83 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~----- 83 (577)
.+..+|++++.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 46789999999999999999999999999999999987543 233456788999999999999999999998654
Q ss_pred -CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 84 -TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 84 -~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
..+|+||||+.+ +|.+.+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999964 67777653 58899999999999999999999999999999999999999999999999987654
Q ss_pred ccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------
Q 008116 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------- 226 (577)
Q Consensus 163 ~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~---------------- 226 (577)
.. ......+||+.|+|||++.+. .++.++|||||||+||+|++|+.||...+.......+..
T Consensus 171 ~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 171 TS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred Cc-cccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 32 223456899999999999765 489999999999999999999999976543211110000
Q ss_pred ------CC--------C-----------CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 227 ------EN--------P-----------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 227 ------~~--------~-----------~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.. + .......+..+++||.+||..||.+|||+.++|+||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00 0 00111235678999999999999999999999999999744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=373.39 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=209.4
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-----
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ----- 83 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~----- 83 (577)
.+.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 45689999999999999999999999999999999987543 233456788999999999999999999988643
Q ss_pred -CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 84 -TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 84 -~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
..+|+||||+. ++|...+.. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 35799999995 578777753 58899999999999999999999999999999999999999999999999987654
Q ss_pred ccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC-------------
Q 008116 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP------------- 229 (577)
Q Consensus 163 ~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~------------- 229 (577)
.. ......+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+.....
T Consensus 178 ~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 178 TS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CC-CcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 32 222356899999999999775 489999999999999999999999976554332221110000
Q ss_pred ----------------------------CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 230 ----------------------------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 230 ----------------------------~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.......+..+++||.+||..||.+|||+.++|+||||...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 00011234678999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=387.21 Aligned_cols=253 Identities=23% Similarity=0.406 Sum_probs=202.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC------CceeEeEEEEEeC-
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS------PYITEYYGSYLHQ- 83 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~H------pnIV~l~~~~~~~- 83 (577)
..++|+++++||+|+||+||+|.+..+++.||||+++... .....+..|+.+++.+.| ++|++++++|..+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 4578999999999999999999999999999999986432 223455677777777654 4689999988765
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCC--------------
Q 008116 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENG-------------- 148 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g-------------- 148 (577)
.++|||||++ +++|.+++.+.+.+++..++.|+.||+.||.|||. .|||||||||+||||+.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 5789999998 78999998877899999999999999999999998 5999999999999998765
Q ss_pred --CeeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC
Q 008116 149 --DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR 226 (577)
Q Consensus 149 --~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~ 226 (577)
.+||+|||++..... .....+||+.|+|||++.+. .|+.++|||||||+||||++|++||...+..+.+..+..
T Consensus 284 ~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 284 PCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CceEEECCCCccccCcc---ccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 499999998754322 23457899999999999876 489999999999999999999999976554322211100
Q ss_pred C---CC-----------------------CCc-h-------------h-hhhHHHHHHHHHhcccCCCCCCcHHHHhhcH
Q 008116 227 E---NP-----------------------PQL-D-------------E-HFSRLMKEFVSLCLKKVPAERPSAKELLRHR 265 (577)
Q Consensus 227 ~---~~-----------------------~~l-~-------------~-~~s~~l~~lI~~cL~~dP~~RpTa~elL~hp 265 (577)
. .+ +.. + . .....+.+||.+||++||.+|||+.|||+||
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 0 00 000 0 0 1135578999999999999999999999999
Q ss_pred hhhhc
Q 008116 266 FIRNA 270 (577)
Q Consensus 266 ff~~~ 270 (577)
||...
T Consensus 440 ~~~~~ 444 (467)
T PTZ00284 440 YVLKY 444 (467)
T ss_pred ccccc
Confidence 99764
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=366.60 Aligned_cols=256 Identities=32% Similarity=0.580 Sum_probs=207.8
Q ss_pred eEEeEEeec--CceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 16 SSLELIGRG--SFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 16 ~il~~IG~G--sfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+++++||+| +|++||++.++.+|+.||||.++.... ......+.+|+.+++.++|||||+++++|..++..|+||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 357899999 789999999999999999999976543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc---
Q 008116 93 MAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR--- 167 (577)
Q Consensus 93 ~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~--- 167 (577)
+++|+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999964 346899999999999999999999999999999999999999999999999865443221111
Q ss_pred ----cccccCCCCCCChhhhhcc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--------------
Q 008116 168 ----RKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-------------- 228 (577)
Q Consensus 168 ----~~~~~GTp~Y~APEvl~~~-~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~-------------- 228 (577)
.....++..|+|||++.+. ..++.++|||||||++|+|++|..||................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 1123577889999998753 358899999999999999999999997543221110000000
Q ss_pred -------------------------------CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 229 -------------------------------PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 229 -------------------------------~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.......++..+.+||.+||+.||.+|||+++||+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0011224567899999999999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=387.68 Aligned_cols=256 Identities=31% Similarity=0.517 Sum_probs=214.6
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-C-----CceeEeEEEEE
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-S-----PYITEYYGSYL 81 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-H-----pnIV~l~~~~~ 81 (577)
.+....+|.++++||+|+||.|.+|.+..|++.||||+++... ....+...||.+|..|+ | -|||+++++|.
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 3445569999999999999999999999999999999996543 35677889999999996 4 48999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC--CCeeeccccc
Q 008116 82 HQTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN--GDVKVADFGV 157 (577)
Q Consensus 82 ~~~~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~--g~vKL~DFGl 157 (577)
..+++|||+|++ ..+|.++|+.+ ..|+...++.|+.||+.||.+||+.+|||+|||||||||..- ..|||+|||.
T Consensus 259 fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 259 FRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred cccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999999999 67999999864 468999999999999999999999999999999999999754 4799999999
Q ss_pred cccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC------------
Q 008116 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP------------ 225 (577)
Q Consensus 158 s~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~------------ 225 (577)
|+..... ..+++-+..|+|||++.+.+ |+.+.||||||||++||++|.+.|.+.+..+.+..|.
T Consensus 338 Sc~~~q~---vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 338 SCFESQR---VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred ccccCCc---ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9876543 23889999999999999986 9999999999999999999999887655533322210
Q ss_pred ------------C---------C----------------------CCCC---c----hhhhhHHHHHHHHHhcccCCCCC
Q 008116 226 ------------R---------E----------------------NPPQ---L----DEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 226 ------------~---------~----------------------~~~~---l----~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
. . .|+. + ...-...+.+||++||..||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 0 0 0000 0 00113568999999999999999
Q ss_pred CcHHHHhhcHhhhhc
Q 008116 256 PSAKELLRHRFIRNA 270 (577)
Q Consensus 256 pTa~elL~hpff~~~ 270 (577)
+|+.++|+||||...
T Consensus 494 ~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 494 ITPAQALNHPFLTGT 508 (586)
T ss_pred CCHHHHhcCcccccc
Confidence 999999999999853
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=348.17 Aligned_cols=257 Identities=40% Similarity=0.712 Sum_probs=226.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
++|++.+.||.|++|.||+|.+..+++.||||.+...........+.+|+.++.+++||||+++++++.....+++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47999999999999999999999999999999997765545567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 93 ~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
+++++|.+++....++++..++.++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 160 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF 160 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccce
Confidence 9999999999877889999999999999999999999 999999999999999999999999999988765544433456
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCC---ccceeeccCCCCCCCchhh-hhHHHHHHHHHh
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH---PMRVLFIIPRENPPQLDEH-FSRLMKEFVSLC 247 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~---~~~~~~~i~~~~~~~l~~~-~s~~l~~lI~~c 247 (577)
.++..|+|||.+... .++.++||||||+++|+|++|..||.... ..+....+.....+.++.. ++..+.+||..|
T Consensus 161 ~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 239 (264)
T cd06623 161 VGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239 (264)
T ss_pred eecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHH
Confidence 789999999998765 58889999999999999999999997764 2223333333344445555 889999999999
Q ss_pred cccCCCCCCcHHHHhhcHhhhhc
Q 008116 248 LKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 248 L~~dP~~RpTa~elL~hpff~~~ 270 (577)
|..+|.+||++.++++|||++.+
T Consensus 240 l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 240 LQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=349.85 Aligned_cols=253 Identities=33% Similarity=0.588 Sum_probs=221.3
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+|++++.||+|+||.||++.+..+++.||||.+.... .......+.+|+.++++++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 6999999999999999999999999999999987543 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 93 MAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 93 ~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
+.+++|.+++... ..+++..+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++............
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 9999999998653 36899999999999999999999999999999999999999999999999998766443333334
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
..|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+.....+..+..++..+.++|.+||..
T Consensus 161 ~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08218 161 CIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR 239 (256)
T ss_pred ccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhC
Confidence 57899999999987654 78899999999999999999999987666555545545555556667889999999999999
Q ss_pred CCCCCCcHHHHhhcHhh
Q 008116 251 VPAERPSAKELLRHRFI 267 (577)
Q Consensus 251 dP~~RpTa~elL~hpff 267 (577)
+|.+||++.+||+||||
T Consensus 240 ~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 240 NPRDRPSVNSILEKNFI 256 (256)
T ss_pred ChhhCcCHHHHhhCcCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=356.99 Aligned_cols=257 Identities=45% Similarity=0.787 Sum_probs=219.6
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEecc
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
-|++++.||.|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.++||||+++++++..+...|+||||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 4788999999999999999999999999999986543 345677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccccc
Q 008116 94 AGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (577)
Q Consensus 94 ~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 172 (577)
.+++|..++.. ..++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..............
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 99999998754 46799999999999999999999999999999999999999999999999999876544333344567
Q ss_pred CCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CchhhhhHHHHHHHHH
Q 008116 173 GTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEFVSL 246 (577)
Q Consensus 173 GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~l~~~~s~~l~~lI~~ 246 (577)
|++.|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+....++ ..+..++..+++||.+
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKK 244 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHH
Confidence 9999999999842 234678999999999999999999999877665544444332222 2344678899999999
Q ss_pred hcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 247 CLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
||..+|.+||++.++++||||....
T Consensus 245 ~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 245 CLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HccCChhhCcCHHHHhcCCCEeccC
Confidence 9999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=359.35 Aligned_cols=257 Identities=42% Similarity=0.764 Sum_probs=221.6
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..+|++++.||.|+||.||+|.+..+++.||||.+...... ....+.+|+.+++.++||||+++++++.....+|+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 35799999999999999999999999999999998754432 34678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
|+.+++|..++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.............
T Consensus 97 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (296)
T cd06655 97 YLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (296)
T ss_pred ecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence 9999999999875 569999999999999999999999999999999999999999999999999987665443333445
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCchhhhhHHHHHHHHHhcc
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~--~~~l~~~~s~~l~~lI~~cL~ 249 (577)
.|++.|+|||.+.+. .++.++|||||||++|+|++|..||...++......+.... ....+..++..+.+||.+||.
T Consensus 176 ~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 254 (296)
T cd06655 176 VGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE 254 (296)
T ss_pred CCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence 789999999998765 48889999999999999999999998776544333332222 222345678899999999999
Q ss_pred cCCCCCCcHHHHhhcHhhhhcc
Q 008116 250 KVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 250 ~dP~~RpTa~elL~hpff~~~~ 271 (577)
.+|.+||++.+|+.||||+...
T Consensus 255 ~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 255 MDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred cChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=356.89 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=218.5
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCC-----cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELN-----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg-----~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
.++|++++.||+|+||.||+|.+...+ ..||+|.+...........+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 357999999999999999999876554 689999987665555667789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCe
Q 008116 87 WIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDV 150 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~v 150 (577)
|++|||+++++|.+++... ..+++..+..++.||+.||.|||+++++|+||||+|||++.++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 9999999999999999753 457889999999999999999999999999999999999999999
Q ss_pred eecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCC
Q 008116 151 KVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRE 227 (577)
Q Consensus 151 KL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~ 227 (577)
+|+|||++........ ......+++.|+|||++.+.. ++.++|||||||+||||++ |..||......+....+...
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999876533211 122346788999999987654 8999999999999999998 99999887776666666666
Q ss_pred CCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 228 ~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
..+..+..++..+.+|+.+||..+|.+||++.+|+++
T Consensus 243 ~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 243 QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6666677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=355.61 Aligned_cols=252 Identities=35% Similarity=0.650 Sum_probs=213.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
.+|+++++||+|+||.||+|.+..++..||||.+...........+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36899999999999999999999999999999997665455567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccccc
Q 008116 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (577)
Q Consensus 93 ~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 172 (577)
+++++|..+ ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+... .....+
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~~ 154 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYV 154 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCCC
Confidence 999999765 35789999999999999999999999999999999999999999999999998765432 223568
Q ss_pred CCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-------eeeccCCCCCCCc-hhhhhHHHHHHH
Q 008116 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-------VLFIIPRENPPQL-DEHFSRLMKEFV 244 (577)
Q Consensus 173 GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~-------~~~~i~~~~~~~l-~~~~s~~l~~lI 244 (577)
|++.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+....++.+ ...++..+++||
T Consensus 155 ~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (279)
T cd06619 155 GTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233 (279)
T ss_pred CChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence 99999999999765 48899999999999999999999997543211 1111111122222 234678899999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 245 SLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.+||..+|.+||++.+++.||||....
T Consensus 234 ~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 234 TQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHhhCChhhCCCHHHHhcCccccccc
Confidence 999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=357.91 Aligned_cols=248 Identities=24% Similarity=0.389 Sum_probs=205.6
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCH
Q 008116 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (577)
Q Consensus 21 IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL 98 (577)
||+|+||.||++.+..+|+.||+|.+..... ......+..|+.++++++||||+++++++..+..+|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999999999999999864321 12234556799999999999999999999999999999999999999
Q ss_pred HHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCCC
Q 008116 99 ADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (577)
Q Consensus 99 ~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~ 176 (577)
..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... ......|++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNG 159 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCC
Confidence 9888543 358899999999999999999999999999999999999999999999999987654321 2234579999
Q ss_pred CCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----ceeeccCCCCCCCchhhhhHHHHHHHHHhcccCC
Q 008116 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM----RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (577)
Q Consensus 177 Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~----~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP 252 (577)
|+|||++.+.. ++.++|||||||+||+|++|..||...... .....+...........++.++++||.+||.++|
T Consensus 160 y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P 238 (277)
T cd05607 160 YMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKP 238 (277)
T ss_pred ccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCH
Confidence 99999998765 899999999999999999999999754321 1111122222222224678899999999999999
Q ss_pred CCCCcH----HHHhhcHhhhhc
Q 008116 253 AERPSA----KELLRHRFIRNA 270 (577)
Q Consensus 253 ~~RpTa----~elL~hpff~~~ 270 (577)
.+||++ .+++.|+||+..
T Consensus 239 ~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 239 EDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hhCCCCccchhhhhcChhhcCC
Confidence 999999 678899999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=357.58 Aligned_cols=258 Identities=33% Similarity=0.643 Sum_probs=221.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
.+|++++.||+|+||.||+|.+..++..||+|.+...........+.+|+.++++++||||+++++++..++.+|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46899999999999999999999999999999987655555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 93 MAGGSVADLIQSG---PPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 93 ~~gGsL~~~l~~~---~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
+++++|..++... ..+++..+..++.||+.||.|||+ ++|+|+||||+|||++.++.+||+|||++..+... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 158 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LA 158 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--cc
Confidence 9999999998763 379999999999999999999996 59999999999999999999999999998765432 22
Q ss_pred ccccCCCCCCChhhhhccc-----CCccccchhhHHHHHHHHHhCCCCCCCCCcccee---eccCCCCCCCchhhhhHHH
Q 008116 169 KTFVGTPFWMAPEVIQNSE-----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---FIIPRENPPQLDEHFSRLM 240 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~-----~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~---~~i~~~~~~~l~~~~s~~l 240 (577)
...+|++.|+|||++.+.. .++.++|||||||++|+|++|..||......... ..+....++.++..++..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence 3457899999999985432 2578999999999999999999999765443322 2233344555666789999
Q ss_pred HHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 241 ~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
.+||.+||..+|.+||++.+++.||||.....
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred HHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 99999999999999999999999999977643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=351.15 Aligned_cols=255 Identities=50% Similarity=0.914 Sum_probs=217.2
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCC-----
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT----- 84 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~----- 84 (577)
..++|++.+.||.|+||.||+|.+..+++.|++|++..... ....+.+|+.+++++ .||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 46899999999999999999999998899999999875543 346789999999999 7999999999997644
Q ss_pred -EEEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccc
Q 008116 85 -KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 85 -~~~LV~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
.+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 58999999999999999864 3579999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccccCCCCCCChhhhhcc----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--h
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--D 233 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~----~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l--~ 233 (577)
.............|++.|+|||++... ..++.++|||||||+||+|++|.+||...........+....++.+ +
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCch
Confidence 665443444456799999999987532 3467889999999999999999999987665544444444333222 2
Q ss_pred hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 234 ~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
..++..+++||.+||..||.+|||+.+|++|||+
T Consensus 242 ~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 3477899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=348.23 Aligned_cols=252 Identities=58% Similarity=0.999 Sum_probs=219.5
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.++|++.+.||.|+||.||+|.+..++..||+|.+.... ..+.+.+|+.++++++||||+++++++.....+|+++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 478999999999999999999999889999999986543 26789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|+.+++|.+++.. ...+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++............
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 9999999999964 467899999999999999999999999999999999999999999999999998876554333345
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CchhhhhHHHHHHHHHhc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~l~~~~s~~l~~lI~~cL 248 (577)
..|++.|+|||++.+. .++.++|||||||++|+|++|.+||....+......+...... ..+..++..+.+||.+||
T Consensus 159 ~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd06612 159 VIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL 237 (256)
T ss_pred ccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence 6689999999998775 4889999999999999999999999876654444333322222 223467789999999999
Q ss_pred ccCCCCCCcHHHHhhcHhh
Q 008116 249 KKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 249 ~~dP~~RpTa~elL~hpff 267 (577)
..+|.+|||+.+||.||||
T Consensus 238 ~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 238 VKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hcChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=347.60 Aligned_cols=253 Identities=36% Similarity=0.592 Sum_probs=221.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe--CCEEEEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWIIM 90 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~--~~~~~LV~ 90 (577)
+|++++.||.|+||.||+|.+..++..||+|.+.... .....+.+..|+.+++.++||||+++++++.. +..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999987543 34446778899999999999999999998764 45789999
Q ss_pred eccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH-----HcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLH-----NEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 91 Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLH-----s~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
||+++++|.+++.. ..++++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999999865 467999999999999999999999 899999999999999999999999999998877
Q ss_pred cccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHH
Q 008116 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (577)
Q Consensus 162 ~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~ 241 (577)
...........|++.|+|||++.... ++.++|+||||+++|+|++|..||...+.......+.....+.++..++..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN 239 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHH
Confidence 55433234567999999999987654 88899999999999999999999987765555555555555666778889999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 242 EFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
+|+.+||..+|.+||++.+||+|||+
T Consensus 240 ~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 240 EVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=357.83 Aligned_cols=253 Identities=26% Similarity=0.468 Sum_probs=208.6
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+|++++.||+|+||.||+|.+..+|..||+|.++..... .....+.+|+.++++++||||+++++++.+...+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 699999999999999999999999999999998754322 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 93 ~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
+. ++|..++.. .+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 96 578877754 5679999999999999999999999999999999999999999999999999987654433333456
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-ceeecc------------------CC-CCCC-
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFII------------------PR-ENPP- 230 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~-~~~~~i------------------~~-~~~~- 230 (577)
.+++.|+|||++.+...++.++|||||||++|+|++|..||...... ..+..+ .. ...+
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence 78999999999877666789999999999999999999886432221 110000 00 0000
Q ss_pred --------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 231 --------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 231 --------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
.....++..+++||.+||..||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 1112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=403.82 Aligned_cols=270 Identities=29% Similarity=0.484 Sum_probs=222.7
Q ss_pred CccccchhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEE
Q 008116 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGS 79 (577)
Q Consensus 1 ~~~l~~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~ 79 (577)
|+..-.......++|++++.||+|+||+||+|.+..++..||+|++.... .......+..|+.+|++|.|||||+++++
T Consensus 1 Mp~~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred CCccccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 55555667777889999999999999999999999999999999987654 33446778999999999999999999998
Q ss_pred EEe--CCEEEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHc-------CCcccccccceEEEcc
Q 008116 80 YLH--QTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNE-------GKIHRDIKAANILLTE 146 (577)
Q Consensus 80 ~~~--~~~~~LV~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~-------gIiHrDIKPeNILld~ 146 (577)
|.. ...+|||||||.+|+|.++|.. ...+++..++.|+.||+.||.|||.. +||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 865 4579999999999999999864 35799999999999999999999984 4999999999999964
Q ss_pred -----------------CCCeeeccccccccccccccccccccCCCCCCChhhhhcc-cCCccccchhhHHHHHHHHHhC
Q 008116 147 -----------------NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKG 208 (577)
Q Consensus 147 -----------------~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~-~~~~~ksDVwSLGviLyeLltG 208 (577)
.+.+||+|||++..+... ......+||+.|+|||++... ..++.++||||||||||+|++|
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 235899999998765432 222356799999999998643 3478899999999999999999
Q ss_pred CCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 209 EPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 209 ~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..||...+....+..+....+......++..+.+||..||..+|.+||++.++|.|+||....
T Consensus 240 k~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 240 KTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 999976654433322222222222235688999999999999999999999999999998653
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=356.02 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=215.9
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.|+..+.||.|+||+||+|.+..+++.||||.+..... ......+.+|+.+|+.++|+||+++++.+..++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999865432 2234557889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
|+.+++|..++.. ..++++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIR 159 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cccc
Confidence 9999999988854 346999999999999999999999999999999999999999999999999998654322 2223
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---CCCCCCchhhhhHHHHHHHHH
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---RENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~---~~~~~~l~~~~s~~l~~lI~~ 246 (577)
...|++.|+|||++.+. .++.++|+|||||++|+|++|..||...........+. ......+...++..+.+|+..
T Consensus 160 ~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred CCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 45799999999999765 48899999999999999999999998654432211111 111223345678889999999
Q ss_pred hcccCCCCCCc-----HHHHhhcHhhhhccC
Q 008116 247 CLKKVPAERPS-----AKELLRHRFIRNARK 272 (577)
Q Consensus 247 cL~~dP~~RpT-----a~elL~hpff~~~~~ 272 (577)
||.++|.+||+ +.+++.|+||+....
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred HccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 99999999999 899999999988743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=351.91 Aligned_cols=251 Identities=21% Similarity=0.356 Sum_probs=213.4
Q ss_pred CCCeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~---~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
..+|++.+.||+|+||.||+|.+. ..+..||||.++..........+.+|+.++++++||||+++++++..++..||
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457999999999999999999765 44678999999876555556778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-
Q 008116 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~- 166 (577)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++++||||||+||||+.++.++|+|||++........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 9999999999999976 35789999999999999999999999999999999999999999999999998755322111
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~ 245 (577)
......+++.|+|||++.+. .++.++|||||||++|+|++ |..||...........+........+..++..+.+++.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLML 242 (266)
T ss_pred cccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 11123456789999998775 48999999999999999775 99999887766555555544444556678899999999
Q ss_pred HhcccCCCCCCcHHHHhh
Q 008116 246 LCLKKVPAERPSAKELLR 263 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~ 263 (577)
+||.++|.+||++.+|++
T Consensus 243 ~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 243 DCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHcCCCchhCCCHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=352.33 Aligned_cols=254 Identities=41% Similarity=0.707 Sum_probs=219.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
++|++.+.||.|+||.||+|.+..+++.||||.+...........+.+|+.+++++.||||+++++++.....+|+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46889999999999999999999999999999997765555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 93 MAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 93 ~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
+.+++|.+++... .++++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++......... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~ 158 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--T 158 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--c
Confidence 9999999999765 789999999999999999999999 99999999999999999999999999998766433222 2
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCC-----ccceeeccCCCCCCCchhh-hhHHHHHHH
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH-----PMRVLFIIPRENPPQLDEH-FSRLMKEFV 244 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~-----~~~~~~~i~~~~~~~l~~~-~s~~l~~lI 244 (577)
..|++.|+|||++.+. .++.++||||||+++|+|++|..||.... .......+.....+.++.. ++..+.+||
T Consensus 159 ~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (265)
T cd06605 159 FVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237 (265)
T ss_pred ccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence 6789999999998765 58899999999999999999999997652 1122222223333344443 889999999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 245 SLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
.+||..+|.+|||+.+++.||||+.
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 238 NLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHcCCCchhCcCHHHHhhCchhhc
Confidence 9999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=407.21 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=227.3
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
..+|+++++||+|+||.|.+++.+.+++.||+|++++-.. ......|+.|-.+|...+.+-||.++..|+++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 4689999999999999999999999999999999876321 22346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-ccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRR 168 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~-~~~ 168 (577)
|||++||+|..++.+..++++..+++|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+-.+...+ -..
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s 233 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRS 233 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEe
Confidence 9999999999999888899999999999999999999999999999999999999999999999999887776432 334
Q ss_pred ccccCCCCCCChhhhhcc----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCch--hhhhHHHH
Q 008116 169 KTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLD--EHFSRLMK 241 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~----~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~l~--~~~s~~l~ 241 (577)
.+.+|||.|++||+++.. ..|+..+|+||+||+|||||.|..||....-.+...+|.... ...+| ..+|.+++
T Consensus 234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeak 313 (1317)
T KOG0612|consen 234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAK 313 (1317)
T ss_pred ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHH
Confidence 567999999999998632 348999999999999999999999999887777776665431 22222 35899999
Q ss_pred HHHHHhcccCCCCCCc---HHHHhhcHhhhhccC
Q 008116 242 EFVSLCLKKVPAERPS---AKELLRHRFIRNARK 272 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpT---a~elL~hpff~~~~~ 272 (577)
+||.++|. +|+.|.. +.++..||||.+..+
T Consensus 314 dLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 314 DLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 99999885 5788888 999999999999876
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=349.89 Aligned_cols=252 Identities=39% Similarity=0.729 Sum_probs=214.5
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-----hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-----~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
+|++.+.||.|+||.||+|.+. ++..||||.+..... ......+.+|+.++++++|+||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4888999999999999999874 688999999865431 2335678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc----
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT---- 164 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~---- 164 (577)
||||+.+++|.+++.+..++++..++.++.||+.||+|||+.+|+|+||||+|||++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999988788999999999999999999999999999999999999999999999999998754321
Q ss_pred --ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--CCCCCchhhhhHHH
Q 008116 165 --ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR--ENPPQLDEHFSRLM 240 (577)
Q Consensus 165 --~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~--~~~~~l~~~~s~~l 240 (577)
........|++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.. ...+.++..++..+
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 1112245689999999998765 488999999999999999999999987654433222221 12334556788999
Q ss_pred HHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 241 KEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 241 ~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
.+||.+||.++|.+||++.++|.||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=346.42 Aligned_cols=253 Identities=41% Similarity=0.750 Sum_probs=219.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC----hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~----~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
+|+..+.||+|+||.||+|.+..++..|+||.+..... ......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58889999999999999999998999999999865432 33567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
+||+++++|.+++.+...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~ 159 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAK 159 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-ccc
Confidence 9999999999999887789999999999999999999999999999999999999999999999999987654332 234
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-CCCCCchhhhhHHHHHHHHHhc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-ENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~-~~~~~l~~~~s~~l~~lI~~cL 248 (577)
...|++.|++||.+.....++.++|+|||||++|+|++|..||...........+.. ...+.++..++..+++|+.+||
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence 567899999999986543478899999999999999999999987665443333333 2334455677899999999999
Q ss_pred ccCCCCCCcHHHHhhcHhh
Q 008116 249 KKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 249 ~~dP~~RpTa~elL~hpff 267 (577)
..+|.+||++.++|.|||+
T Consensus 240 ~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 240 QRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hcCcccCcCHHHHhcCCCC
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=354.17 Aligned_cols=256 Identities=48% Similarity=0.881 Sum_probs=216.1
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEe------
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH------ 82 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~------ 82 (577)
...+.|++.+.||.|+||.||+|.+..++..||+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 46689999999999999999999999999999999986543 2346788999999998 79999999999853
Q ss_pred CCEEEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
...+|++|||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++|+|+||||+||+|+.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 4578999999999999999964 34688999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccCCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC-chhh
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ-LDEH 235 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~-l~~~ 235 (577)
............|++.|+|||++.. ...++.++|||||||++|+|++|.+||....+......+....++. ....
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKK 250 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccc
Confidence 5443333445679999999999853 2347889999999999999999999998766544443333332222 2345
Q ss_pred hhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 236 ~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
++..+.+||.+||..+|.+||++.+||+||||
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 251 WSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 78899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=353.31 Aligned_cols=256 Identities=45% Similarity=0.816 Sum_probs=215.7
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeC-----C
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ-----T 84 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~-----~ 84 (577)
+.++|++.+.||.|+||.||+|.+..+++.||||++..... ....+.+|+.+++++ +||||+++++++... .
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 56899999999999999999999999999999999865432 235678899999999 899999999998754 3
Q ss_pred EEEEEEeccCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~----~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
.+|+||||+++++|.++++ ....+++..++.++.|++.||.|||+++++|+||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 6899999999999999885 346789999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccCCCCCCChhhhhccc----CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--hh
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQNSE----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DE 234 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~~~----~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l--~~ 234 (577)
............|++.|+|||++.... .++.++|||||||++|+|++|.+||........+..+....++.+ +.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence 544332333467899999999985432 257899999999999999999999987765544444443333222 34
Q ss_pred hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 235 ~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
.++..+.+||.+||.++|++||++.+|++||||+
T Consensus 258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 5677899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=351.57 Aligned_cols=256 Identities=45% Similarity=0.827 Sum_probs=213.6
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEE-----eC
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYL-----HQ 83 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~-----~~ 83 (577)
...++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++.+ +||||+++++++. .+
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 356899999999999999999999999999999998764322 235678899999999 7999999999874 34
Q ss_pred CEEEEEEeccCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccc
Q 008116 84 TKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~----~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
..+|+||||+++++|.+++. ....+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 57899999999999999874 23578999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccccCCCCCCChhhhhcc----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--ch
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LD 233 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~----~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--l~ 233 (577)
.............|++.|+|||++... ..++.++|||||||++|+|++|..||....+......+....++. .+
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP 252 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCC
Confidence 664433333456799999999997532 237889999999999999999999998776544433332222221 23
Q ss_pred hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 234 ~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
..++..+.+||.+||..+|.+|||+.+|++|+||
T Consensus 253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 4567889999999999999999999999999996
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=361.31 Aligned_cols=246 Identities=26% Similarity=0.425 Sum_probs=194.2
Q ss_pred EeEEeecCceEEEEEEEc--CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe--CCEEEEEEecc
Q 008116 18 LELIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWIIMEYM 93 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~--~~~~~LV~Ey~ 93 (577)
.++||+|+||.||+|.++ .+++.||||.+..... ...+.+|+.+|++++||||+++++++.. +..+|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 368999999999999975 4678999999865432 2457789999999999999999999865 45789999999
Q ss_pred CCCCHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE----ccCCCeeecccccccc
Q 008116 94 AGGSVADLIQS---------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL----TENGDVKVADFGVSAQ 160 (577)
Q Consensus 94 ~gGsL~~~l~~---------~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl----d~~g~vKL~DFGls~~ 160 (577)
. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++..
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 5 688888752 1358999999999999999999999999999999999999 4557899999999976
Q ss_pred cccccc---ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccce---------eeccC--C
Q 008116 161 LTRTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV---------LFIIP--R 226 (577)
Q Consensus 161 ~~~~~~---~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~---------~~~i~--~ 226 (577)
...... .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||........ +..+. .
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 543221 223568999999999998766689999999999999999999999964332100 00000 0
Q ss_pred CCC-----------C-----------------C-------chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 227 ENP-----------P-----------------Q-------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 227 ~~~-----------~-----------------~-------l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
+.+ + . .....+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000 0 0 000124568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=358.58 Aligned_cols=258 Identities=31% Similarity=0.497 Sum_probs=219.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~--~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
.+|++.+.||.|+||.||+|.+..+++.||||.+...... .....+..|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4799999999999999999999999999999999765433 35677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc--
Q 008116 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-- 166 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-- 166 (577)
||+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||||+.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999999753 5799999999999999999999999999999999999999999999999999765432110
Q ss_pred ---------------------------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc
Q 008116 167 ---------------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR 219 (577)
Q Consensus 167 ---------------------------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~ 219 (577)
.....+||..|+|||++.+. .++.++||||||+++|+|++|..||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 11234789999999999765 48889999999999999999999998766544
Q ss_pred eeeccCCCCC-CCchhhhhHHHHHHHHHhcccCCCCCCc----HHHHhhcHhhhhcc
Q 008116 220 VLFIIPRENP-PQLDEHFSRLMKEFVSLCLKKVPAERPS----AKELLRHRFIRNAR 271 (577)
Q Consensus 220 ~~~~i~~~~~-~~l~~~~s~~l~~lI~~cL~~dP~~RpT----a~elL~hpff~~~~ 271 (577)
....+..... ......++..+++||.+||.++|.+||+ +.+||.||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 4433332221 1112236899999999999999999999 99999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=348.45 Aligned_cols=254 Identities=39% Similarity=0.703 Sum_probs=214.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC----ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe--CCEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKL 86 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~----~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~--~~~~ 86 (577)
.+|++.++||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++++.. +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999986543 22345678899999999999999999998876 3678
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~- 165 (577)
+++|||+.+++|.+++.....+++..++.++.||+.||+|||+++|+|+||||+||+++.++.+||+|||++..+....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999999999999887789999999999999999999999999999999999999999999999999987553211
Q ss_pred --cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-CCCCCCchhhhhHHHHH
Q 008116 166 --SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMKE 242 (577)
Q Consensus 166 --~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-~~~~~~l~~~~s~~l~~ 242 (577)
.......|+..|+|||++.+. .++.++|||||||++|+|++|+.||...........+. ....+.++..++..+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 111235689999999999765 48889999999999999999999998765444333222 22234556677888999
Q ss_pred HHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 243 FVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
|| .||..+|.+||++.+|++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 67778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=353.19 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=208.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
...+|++++.||+|+||.||+|.+..++..||||.+...........+.+|+.+++.++|+||+++++++..+...|+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 35789999999999999999999999999999999875543333456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 91 Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||+. ++|...+.. ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++...........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 9995 677666643 45688999999999999999999999999999999999999999999999999876544333334
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-ceeec------------------cCC----
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFI------------------IPR---- 226 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~-~~~~~------------------i~~---- 226 (577)
...+++.|+|||++.+...++.++|||||||++|+|++|..||...... +.+.. +..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 5578999999999876555788999999999999999999999754421 00000 000
Q ss_pred ---C-CCCCch---h--hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 227 ---E-NPPQLD---E--HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 227 ---~-~~~~l~---~--~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
. .+..+. . ..+..+.+||.+||..||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 000000 0 125678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=347.63 Aligned_cols=254 Identities=31% Similarity=0.588 Sum_probs=216.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-----hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-----~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
+|+..+.||+|+||.||+|.+..++..||||++..... ......+.+|+.++++++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 58889999999999999999999999999999875432 1235778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC-Ceeeccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g-~vKL~DFGls~~~~~~~~~ 167 (577)
||||+.+++|.+++....++++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998878899999999999999999999999999999999999998776 5999999998766433111
Q ss_pred ----cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc----CCCCCCCchhhhhHH
Q 008116 168 ----RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII----PRENPPQLDEHFSRL 239 (577)
Q Consensus 168 ----~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i----~~~~~~~l~~~~s~~ 239 (577)
.....|+..|+|||++.+. .++.++||||||+++|+|++|..||...........+ .....+..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1235689999999998765 4889999999999999999999999755432221111 112234556678899
Q ss_pred HHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 240 MKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 240 l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
+.+||.+||..+|.+||++.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=354.49 Aligned_cols=260 Identities=43% Similarity=0.787 Sum_probs=223.2
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
...+|++++.||.|+||.||++.+..++..||||.+...... ..+.+.+|+.+++.++||||+++++++...+..|+|+
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 357999999999999999999999989999999998654332 3467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
||+++++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred ecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 99999999999975 46889999999999999999999999999999999999999999999999998766544333345
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--chhhhhHHHHHHHHHhc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--l~~~~s~~l~~lI~~cL 248 (577)
..|++.|+|||++... .++.++|||||||++|+|++|..||...+.......+.....+. .+..++..+++||.+||
T Consensus 175 ~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (293)
T cd06647 175 MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 253 (293)
T ss_pred ccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHc
Confidence 6799999999998765 47889999999999999999999998776554444333222222 23456788999999999
Q ss_pred ccCCCCCCcHHHHhhcHhhhhccCC
Q 008116 249 KKVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 249 ~~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
..+|.+||++.+++.|+||+..+..
T Consensus 254 ~~~p~~Rp~~~~il~h~~~~~~~~~ 278 (293)
T cd06647 254 EMDVEKRGSAKELLQHPFLKIAKPL 278 (293)
T ss_pred cCChhhCcCHHHHhcCHHHhcCccc
Confidence 9999999999999999999887643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=355.88 Aligned_cols=257 Identities=27% Similarity=0.412 Sum_probs=215.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh----HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~----~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
+|++.+.||.|+||.||+|.+..+++.||||.+...... .....+..|+.++++++||||+++++++.....+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999755432 2235567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~-~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
|||+ +++|.+++.... .+++..+..++.||++||.|||++||+|+||||+|||++.++.++|+|||++..........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 999999998765 79999999999999999999999999999999999999999999999999998765543333
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------------
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------------- 226 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~---------------------- 226 (577)
....+++.|+|||++.+...++.++|||||||++|+|++|.+||........+..+..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 4456788999999986655678899999999999999999888876554221111100
Q ss_pred CCCC-----CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 227 ENPP-----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 227 ~~~~-----~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
...+ .+....+..+.+||.+||.++|.+|||+.++|.|+||.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0000 01134578899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=344.21 Aligned_cols=252 Identities=32% Similarity=0.532 Sum_probs=219.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+|++++.||+|+||.||+|.+..++..||||.+.... .......+.+|+.+|++++||||+++++.+..+..+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 6999999999999999999999999999999987654 334467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC-CCeeeccccccccccccccccc
Q 008116 93 MAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 93 ~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~-g~vKL~DFGls~~~~~~~~~~~ 169 (577)
+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.+ +.+||+|||++....... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-ccc
Confidence 9999999999653 458999999999999999999999999999999999999865 468999999987664332 223
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
...|++.|+|||++... .++.++||||||+++|+|++|..||...+.......+.......++..++..+++||..||.
T Consensus 160 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 238 (256)
T cd08220 160 TVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLN 238 (256)
T ss_pred ccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHcc
Confidence 45789999999998765 47889999999999999999999998776655555554444555666788999999999999
Q ss_pred cCCCCCCcHHHHhhcHhh
Q 008116 250 KVPAERPSAKELLRHRFI 267 (577)
Q Consensus 250 ~dP~~RpTa~elL~hpff 267 (577)
.+|.+|||+.+|+.||||
T Consensus 239 ~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 239 LDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CChhhCCCHHHHhhCCCC
Confidence 999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=360.58 Aligned_cols=264 Identities=38% Similarity=0.716 Sum_probs=222.3
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
.......|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+..++..|
T Consensus 17 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 17 PGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred cCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 3444566777889999999999999999999999999986543 334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
+||||+++++|.+++.. +.+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||++.........
T Consensus 96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 99999999999998865 57999999999999999999999999999999999999999999999999998765444333
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--hhhhhHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEFVS 245 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l--~~~~s~~l~~lI~ 245 (577)
.....|++.|+|||++.+. .++.++|||||||++|+|++|+.||...........+....++.+ ...++..+.+||.
T Consensus 175 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253 (292)
T ss_pred CceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence 3456799999999998765 488899999999999999999999987665443333322222222 2356788999999
Q ss_pred HhcccCCCCCCcHHHHhhcHhhhhccCCh
Q 008116 246 LCLKKVPAERPSAKELLRHRFIRNARKSP 274 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~hpff~~~~~~~ 274 (577)
+||..+|.+|||+.++++||||.......
T Consensus 254 ~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 254 LMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred HHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 99999999999999999999998765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=352.43 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=207.7
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.++|++.+.||.|+||.||+|.++.+++.||||.+...........+.+|+.++++++||||+++++++......|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 46899999999999999999999989999999998755433333456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|+. ++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++............
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 997 599998865 356899999999999999999999999999999999999999999999999998654332222233
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-ceeecc-------------------------
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFII------------------------- 224 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~-~~~~~i------------------------- 224 (577)
..+++.|+|||++.+...++.++|||||||++|+|++|.+||...... .....+
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 457899999999876555888999999999999999999999755411 000000
Q ss_pred -CCCCCCCch---hhhh--HHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 225 -PRENPPQLD---EHFS--RLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 225 -~~~~~~~l~---~~~s--~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
....+..+. ..++ ..+.+||.+||..+|.+|||+.++|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000000000 1233 778899999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=370.82 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=208.6
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEc--CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
.....+|++++.||+|+||.||+|... .++..||||.+... ....+|+.+|++++|||||++++++.....+
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 345568999999999999999999764 45678999987543 2356899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|+|||++. ++|.+++.....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99999995 68999987778899999999999999999999999999999999999999999999999999876543322
Q ss_pred c--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee---ecc-----------C-----
Q 008116 167 R--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---FII-----------P----- 225 (577)
Q Consensus 167 ~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~---~~i-----------~----- 225 (577)
. ....+||+.|+|||++.... |+.++|||||||+||+|++|..||......... ..+ +
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 1 22467999999999997654 889999999999999999999999765432100 000 0
Q ss_pred ------------CCCCCCc-----hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 226 ------------RENPPQL-----DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 226 ------------~~~~~~l-----~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
...+..+ ...++..+++||.+||..+|.+|||+.++|.||||...
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0000001 12346778999999999999999999999999999764
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=384.89 Aligned_cols=251 Identities=36% Similarity=0.654 Sum_probs=222.6
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCH
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL 98 (577)
-+||+|.||+||.|++..+....|||.++... ....+-+..||.+.++|+|.|||+++|++..++.+-|+||-++||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 37999999999999999999999999997544 34567789999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCC--CHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc-CCCeeeccccccccccccccccccccCC
Q 008116 99 ADLIQS-GPPL--DEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRRKTFVGT 174 (577)
Q Consensus 99 ~~~l~~-~~~l--~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~-~g~vKL~DFGls~~~~~~~~~~~~~~GT 174 (577)
..+++. .+|+ +|..+..|.+||++||.|||++.|||||||-+||||+. .|.+||+|||-++.+..-+...-++.||
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence 999975 4777 89999999999999999999999999999999999974 5999999999999887766666689999
Q ss_pred CCCCChhhhh-cccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-ceeeccC-CCCCCCchhhhhHHHHHHHHHhcccC
Q 008116 175 PFWMAPEVIQ-NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFIIP-RENPPQLDEHFSRLMKEFVSLCLKKV 251 (577)
Q Consensus 175 p~Y~APEvl~-~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~-~~~~~i~-~~~~~~l~~~~s~~l~~lI~~cL~~d 251 (577)
..|||||++. +..+|+.++|||||||++.||.||++||...... ....++- ...-|.+|..++.+++.||.+|+.++
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd 819 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPD 819 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCC
Confidence 9999999996 4457999999999999999999999999876533 2333321 23456788999999999999999999
Q ss_pred CCCCCcHHHHhhcHhhhhc
Q 008116 252 PAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 252 P~~RpTa~elL~hpff~~~ 270 (577)
|..||+|.+||.+||++..
T Consensus 820 ~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 820 PCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred cccCccHHHhccCcccccC
Confidence 9999999999999999865
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=352.41 Aligned_cols=252 Identities=27% Similarity=0.436 Sum_probs=206.9
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHHHHHHHHHH---HhCCCCceeEeEEEEEeCCEEEEEEeccC
Q 008116 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKEISVL---SQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (577)
Q Consensus 20 ~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~--~~~~~i~~Ev~iL---~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~ 94 (577)
+||+|+||.||++.+..++..||||.+...... .......+|..++ ....||||+.+++++..++.+|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998654321 1122334444443 34479999999999999999999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCC
Q 008116 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (577)
Q Consensus 95 gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GT 174 (577)
+++|.+++...+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++...... ......|+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGT 158 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCCC
Confidence 9999999988788999999999999999999999999999999999999999999999999998755432 22245799
Q ss_pred CCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc--eeeccCCCCCCCchhhhhHHHHHHHHHhcccCC
Q 008116 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR--VLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (577)
Q Consensus 175 p~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~--~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP 252 (577)
+.|+|||++.....++.++|||||||++|+|++|..||....... ............++..++..+++||.+||..+|
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 238 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV 238 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence 999999998654458899999999999999999999997543321 111122223344566788999999999999999
Q ss_pred CCCC-----cHHHHhhcHhhhhccCC
Q 008116 253 AERP-----SAKELLRHRFIRNARKS 273 (577)
Q Consensus 253 ~~Rp-----Ta~elL~hpff~~~~~~ 273 (577)
.+|| +++++++||||+.....
T Consensus 239 ~~R~~~~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 239 SKRLGCLGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred HHhcCCCCCCHHHHHhCccccCCCHh
Confidence 9999 69999999999886543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=353.58 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=208.7
Q ss_pred CCeeEE--eEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEe----CC
Q 008116 13 SRFSSL--ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QT 84 (577)
Q Consensus 13 ~~f~il--~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~----~~ 84 (577)
.+++.. ..||+|+++.||+|.. +|+.||||.+..... ....+.+.+|+.+|++++|||||++++++.+ ..
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence 344444 6899999999999987 589999999876532 2235778899999999999999999999877 34
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeeccccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~ 163 (577)
.+++|||||.+|+|.+++.....+++.....++.|++.||.|||. .+++||||||+|||++.++.+||+|||++..+..
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 789999999999999999887889999999999999999999998 4999999999999999999999999999876543
Q ss_pred cccccccccCCCCCCChhhhhcc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-CCCCCCchhhhhHHHH
Q 008116 164 TISRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMK 241 (577)
Q Consensus 164 ~~~~~~~~~GTp~Y~APEvl~~~-~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-~~~~~~l~~~~s~~l~ 241 (577)
. ....+|++.|+|||++.+. ..++.++|||||||++|||++|..||...+.......+. ....+.++..++..++
T Consensus 176 ~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 252 (283)
T PHA02988 176 P---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIK 252 (283)
T ss_pred c---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHH
Confidence 2 1245789999999998752 358999999999999999999999999877655544442 2233445556789999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhc
Q 008116 242 EFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+||.+||+.||.+|||+.+|+..
T Consensus 253 ~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 253 CIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HHHHHHhcCCcccCcCHHHHHHH
Confidence 99999999999999999999863
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=353.43 Aligned_cols=255 Identities=31% Similarity=0.501 Sum_probs=213.7
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++|++++.||+|+||.||+|.+..+++.||||.+...... ...+.+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4799999999999999999999989999999988654322 234667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
|+.++.|..++.....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++..+..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY 160 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence 99999999888776679999999999999999999999999999999999999999999999999987765444444456
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC--------------------------
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-------------------------- 225 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-------------------------- 225 (577)
.+++.|+|||++.+...++.++|||||||++|+|++|.+||...........+.
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07846 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240 (286)
T ss_pred cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence 789999999998765557889999999999999999999996543211100000
Q ss_pred CC-CCC---CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 226 RE-NPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 226 ~~-~~~---~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
.. ... .....++..+.+|+.+||..+|.+||++.+|++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 000 0112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=345.33 Aligned_cols=254 Identities=38% Similarity=0.670 Sum_probs=214.7
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC----ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC--CEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKL 86 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~----~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~--~~~ 86 (577)
.+|++.++||+|+||.||+|.+..++..||||.+.... .......+.+|+.+++++.||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 58999999999999999999999999999999986432 223457888999999999999999999998763 578
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc--
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-- 164 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~-- 164 (577)
++||||+++++|.+++.....+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999999999987778999999999999999999999999999999999999999999999999998755321
Q ss_pred -ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-CCCCchhhhhHHHHH
Q 008116 165 -ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRLMKE 242 (577)
Q Consensus 165 -~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~-~~~~l~~~~s~~l~~ 242 (577)
........|+..|+|||++.+. .++.++|||||||++|+|++|+.||...........+... ..+..+..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 1122345689999999998765 4889999999999999999999999876544333322222 233455677889999
Q ss_pred HHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 243 FVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
+|.+||. +|.+||++++|++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 899999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=354.20 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=204.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcC----------------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCcee
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKE----------------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~----------------tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV 74 (577)
..++|++.+.||+|+||.||+|.+.. ++..||||++...........+.+|+.+|++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 45789999999999999999998632 34579999997665555667899999999999999999
Q ss_pred EeEEEEEeCCEEEEEEeccCCCCHHHHHHcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccc
Q 008116 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSG-------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHR 135 (577)
Q Consensus 75 ~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~-------------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHr 135 (577)
++++++...+..||||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 9999999999999999999999999998542 236778899999999999999999999999
Q ss_pred ccccceEEEccCCCeeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh--CCCC
Q 008116 136 DIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPP 211 (577)
Q Consensus 136 DIKPeNILld~~g~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt--G~~P 211 (577)
||||+||||+.++.+||+|||++..+..... ......+++.|+|||++.... ++.++|||||||++|+|++ +..|
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999876533211 112335678899999987654 8999999999999999986 6678
Q ss_pred CCCCCccceeeccC-------CCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 212 LADLHPMRVLFIIP-------RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 212 f~~~~~~~~~~~i~-------~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
|...........+. .......+..++..+.+||.+||..+|.+|||+.+|..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 87665443322110 01111223356788999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=350.90 Aligned_cols=265 Identities=47% Similarity=0.844 Sum_probs=227.7
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
+.....|++.+.||.|+||.||+|.+..++..||+|++..... ....+.+|+.++++++||||+++++++......|+
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 4567889999999999999999999998899999999976543 45778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~-~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
|+||+++++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 999999999999998765 8999999999999999999999999999999999999999999999999998765544333
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--hhhhhHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEFVS 245 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l--~~~~s~~l~~lI~ 245 (577)
.....+++.|++||++.+. .++.++|||||||+||+|++|..||...++......+.....+.. ...++..+++||.
T Consensus 173 ~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 3455789999999998765 488999999999999999999999987765443333333222222 2347889999999
Q ss_pred HhcccCCCCCCcHHHHhhcHhhhhccCChhH
Q 008116 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRL 276 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~hpff~~~~~~~~~ 276 (577)
+||..+|.+||++.++|.|+||...-+.+..
T Consensus 252 ~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~ 282 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQHPFLKKACPKEEF 282 (286)
T ss_pred HHhccChhhCcCHHHHhhChHhhccCchHhh
Confidence 9999999999999999999999986554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=348.23 Aligned_cols=252 Identities=26% Similarity=0.497 Sum_probs=219.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
+|++.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.++++++||||+++++++..+..+|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999999999999997543 22456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
|+.+++|..++....++++..+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 159 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTST 159 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-ccccc
Confidence 99999999999877789999999999999999999999999999999999999999999999999987654332 23356
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~--~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
.|+..|+|||++.... ++.++|+||||+++|+|++|..||..... ...............+..++..+.+||.+||.
T Consensus 160 ~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (258)
T cd05578 160 SGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLE 238 (258)
T ss_pred CCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHcc
Confidence 7899999999987654 88999999999999999999999987653 11111222213344556678999999999999
Q ss_pred cCCCCCCcH--HHHhhcHhh
Q 008116 250 KVPAERPSA--KELLRHRFI 267 (577)
Q Consensus 250 ~dP~~RpTa--~elL~hpff 267 (577)
.+|.+||++ .++++||||
T Consensus 239 ~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 239 RDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CChhHcCCccHHHHhcCCCC
Confidence 999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=385.12 Aligned_cols=260 Identities=48% Similarity=0.895 Sum_probs=239.8
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEe-----C
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH-----Q 83 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~-----~ 83 (577)
.....|++.++||.|.+|.||++.++.+++.+|||+....... .+.+..|.+||+.+ .|||++.+|++|.. +
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 4567899999999999999999999999999999998765543 37788999999998 79999999999874 5
Q ss_pred CEEEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 84 TKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
+.+|||||||.||+.-++++. +.++.|+.++.|++.++.||.+||.+.+||||||-.|||++.++.|||+|||++.++
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 689999999999999999975 568999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCChhhhhccc----CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--hhh
Q 008116 162 TRTISRRKTFVGTPFWMAPEVIQNSE----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEH 235 (577)
Q Consensus 162 ~~~~~~~~~~~GTp~Y~APEvl~~~~----~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l--~~~ 235 (577)
.......++.+|||+|||||++...+ .|+..+|+||||++..||..|.+|+.+++++..+..|+...||.+ +..
T Consensus 174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence 99989999999999999999987543 377789999999999999999999999999999999999988877 578
Q ss_pred hhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 236 ~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
++..+.+||..||.+|-++||+..++|+|||+....
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 999999999999999999999999999999998654
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=350.31 Aligned_cols=253 Identities=28% Similarity=0.464 Sum_probs=211.7
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEecc
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
+|++++.||.|++|.||+|.+..++..||||+++..........+.+|+.++++++||||+++++++...+..||||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58999999999999999999999999999999976654444567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 94 AGGSVADLIQSG---PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 94 ~gGsL~~~l~~~---~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
. ++|.+++... .++++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 7 4888888643 46899999999999999999999999999999999999999999999999998765433223334
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---------------------CCCC
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---------------------RENP 229 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~---------------------~~~~ 229 (577)
..+++.|++||++.+...++.++|||||||++|+|++|++||...+..+....+. ...+
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence 5688999999998766567889999999999999999999997655332211110 0000
Q ss_pred C-------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 230 P-------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 230 ~-------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
. .+...++..+.+||.+||+.+|.+||++.+|++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 0112457789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=350.57 Aligned_cols=254 Identities=30% Similarity=0.544 Sum_probs=212.6
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+|++.+.||.|+||.||+|.+..++..||||++..... ......+.+|+.++++++||||+++++++..+..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58999999999999999999999999999999876543 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-cccc
Q 008116 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRKT 170 (577)
Q Consensus 93 ~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~~~~ 170 (577)
+ +++|.+++.. ..++++..++.++.||+.||.|||+++++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 9999999864 46799999999999999999999999999999999999999999999999999876654321 1234
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------------------
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------------ 226 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------------------ 226 (577)
..|++.|+|||++.+...++.++|||||||++|+|++|.+||...........+..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 57899999999987665578999999999999999999888865543221111100
Q ss_pred -CCCC----CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 227 -ENPP----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 227 -~~~~----~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
.... ......+..+.+||.+||..+|.+||++.++|.||||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 01124568899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=376.53 Aligned_cols=259 Identities=25% Similarity=0.447 Sum_probs=231.2
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
.-+.|.+++.||+|.|+.|.+|.+..++..||||.+++... ....+.+.+|+.+|+.|.|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 45789999999999999999999999999999999987653 33456699999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
|||+.+|.|++++.+.+.+.+..++.++.|++.|++|||+++|||||||++||||+.+.++||+|||++..+. ......
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~~~~lq 212 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-YGLMLQ 212 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec-cccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998886 445567
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
++||+|.|.|||++.+..+.++.+|+||||++||.|+.|.+||.+.+-......+.... ..++..++.+..++|+++|.
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk-~rIp~~ms~dce~lLrk~lv 291 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK-YRIPFYMSCDCEDLLRKFLV 291 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee-ecccceeechhHHHHHHhhc
Confidence 89999999999999998888899999999999999999999999766544333332222 23455678899999999999
Q ss_pred cCCCCCCcHHHHhhcHhhhhcc
Q 008116 250 KVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 250 ~dP~~RpTa~elL~hpff~~~~ 271 (577)
++|.+|++++++++|.|.....
T Consensus 292 l~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 292 LNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred cCccccCCHHHhhhhcccchhh
Confidence 9999999999999999987543
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=352.50 Aligned_cols=256 Identities=34% Similarity=0.614 Sum_probs=219.1
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..+|++++.||+|+||+||+|.+..++..||+|++...........+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 46899999999999999999999999999999998765544456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|+++++|..++...+++++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++...... ....
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~~~ 161 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IADT 161 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--ccCc
Confidence 99999999999887889999999999999999999997 69999999999999999999999999998654332 1234
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----------ceeeccCCCCCCCchh-hhhH
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-----------RVLFIIPRENPPQLDE-HFSR 238 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~-----------~~~~~i~~~~~~~l~~-~~s~ 238 (577)
.+|++.|+|||++.+. .++.++|||||||++|+|++|..||...... .....+....++.++. .++.
T Consensus 162 ~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd06620 162 FVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240 (284)
T ss_pred cccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence 6799999999998765 4889999999999999999999999865432 1112222223333333 3778
Q ss_pred HHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 239 LMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 239 ~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.+.+||.+||.++|.+|||+.++++|+||...
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 89999999999999999999999999988653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=344.74 Aligned_cols=248 Identities=31% Similarity=0.589 Sum_probs=214.3
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCH
Q 008116 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (577)
Q Consensus 21 IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL 98 (577)
||.|+||.||+|.+..++..||||++..... ....+.+.+|+.+++.++||||+++++++.++..+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999999999999999975542 23457789999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCCCCC
Q 008116 99 ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM 178 (577)
Q Consensus 99 ~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~ 178 (577)
.+++.+...+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++....... ......|++.|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~ 159 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYV 159 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCcc
Confidence 9999887789999999999999999999999999999999999999999999999999987765432 223457899999
Q ss_pred ChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCC--ccceeeccCC-CCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH--PMRVLFIIPR-ENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 179 APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~--~~~~~~~i~~-~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
+||++... .++.++|+||||+++|+|++|..||.... .......+.. ......+..++..+.+||.+||.++|.+|
T Consensus 160 ~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 238 (262)
T cd05572 160 APEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238 (262)
T ss_pred ChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhC
Confidence 99998765 48899999999999999999999998765 3333333331 22334445558899999999999999999
Q ss_pred Cc-----HHHHhhcHhhhhc
Q 008116 256 PS-----AKELLRHRFIRNA 270 (577)
Q Consensus 256 pT-----a~elL~hpff~~~ 270 (577)
|+ +.++++||||+..
T Consensus 239 ~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 239 LGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred cCCcccCHHHHhcChhhhCC
Confidence 99 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=366.62 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=200.3
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..+|++++.||+|+||.||+|.+..++..||+|+.... ....|+.++++++||||+++++++......|+|||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 45799999999999999999999999999999985432 23569999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|+. ++|..++.. ..++++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~ 215 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLG 215 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-ccccc
Confidence 995 688887754 567999999999999999999999999999999999999999999999999998654322 22234
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc----------eeec-c------CCCCC----
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR----------VLFI-I------PRENP---- 229 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~----------~~~~-i------~~~~~---- 229 (577)
..||+.|+|||++.+. .++.++|||||||+||||+++..|+....+.. .+.. + +...+
T Consensus 216 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 216 LAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred ccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 6799999999999775 48999999999999999998655542221110 0000 0 00000
Q ss_pred ----------------C-C----c-hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 230 ----------------P-Q----L-DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 230 ----------------~-~----l-~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
+ . + ...++..+.+||.+||..||.+|||+.|||+||||+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0 0 0 0134567788999999999999999999999999975
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=339.85 Aligned_cols=253 Identities=38% Similarity=0.639 Sum_probs=224.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+|++.+.||.|+||.||++.+..++..||+|++..... ......+.+|+++++.++||||+++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 68999999999999999999999999999999976543 34567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 93 MAGGSVADLIQSG----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 93 ~~gGsL~~~l~~~----~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 9999999999763 779999999999999999999999999999999999999999999999999987765543333
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
....|++.|+|||.+.... ++.++||||||+++|+|++|..||...........+.......++..++..+.++|..||
T Consensus 161 ~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 239 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239 (258)
T ss_pred cceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 4568999999999987654 888999999999999999999999877655555555455555666678899999999999
Q ss_pred ccCCCCCCcHHHHhhcHhh
Q 008116 249 KKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 249 ~~dP~~RpTa~elL~hpff 267 (577)
..+|.+||++.++|+||||
T Consensus 240 ~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 240 QKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=345.98 Aligned_cols=259 Identities=34% Similarity=0.600 Sum_probs=211.3
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHH-HHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISV-LSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~i-L~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.+|++++.||+|+||.||+|.+..+|..||||.++..........+..|+.+ ++.++||||+++++++..+..+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4799999999999999999999999999999999765433334556666665 566799999999999999999999999
Q ss_pred ccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 92 YMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 92 y~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~-gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|++ |+|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 996 688877743 35789999999999999999999998 99999999999999999999999999987654321
Q ss_pred ccccccCCCCCCChhhhhcc---cCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccCCCCCCCc-hhhhhHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNS---EGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQL-DEHFSRLMK 241 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~---~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~-~~~~~~i~~~~~~~l-~~~~s~~l~ 241 (577)
......|++.|+|||++.+. ..++.++|+|||||++|+|++|..||..... .+.+..+.....+.+ ...++..+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQ 238 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHH
Confidence 12235789999999988642 2367899999999999999999999975322 122222222222222 235788999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhcHhhhhccCC
Q 008116 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
+||.+||..+|.+||++.+|+.||||......
T Consensus 239 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 239 DFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred HHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 99999999999999999999999999886544
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=341.99 Aligned_cols=254 Identities=38% Similarity=0.733 Sum_probs=216.8
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+|++.+.||+|+||.||+|.+..+++.||||.++..... .....+..|+.+++.++||||+++++++.....+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 689999999999999999999989999999998766532 4678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc----
Q 008116 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR---- 168 (577)
Q Consensus 93 ~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~---- 168 (577)
+.+++|.+++.....+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 9999999999887789999999999999999999999999999999999999999999999999987764432221
Q ss_pred ccccCCCCCCChhhhhccc--CCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccCCCCCCCchh--hhhHHHHHH
Q 008116 169 KTFVGTPFWMAPEVIQNSE--GYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLDE--HFSRLMKEF 243 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~--~~~~ksDVwSLGviLyeLltG~~Pf~~~~~-~~~~~~i~~~~~~~l~~--~~s~~l~~l 243 (577)
....+++.|+|||++.... .++.++||||||+++|+|++|..||..... ......+.....+.++. .++..+.+|
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDF 240 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHH
Confidence 1356889999999987542 277899999999999999999999976532 22222222233333433 348889999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhh
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff 267 (577)
|.+||..+|.+||++.+++.|||+
T Consensus 241 i~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 241 LDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=343.26 Aligned_cols=253 Identities=32% Similarity=0.587 Sum_probs=217.5
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+|++.+.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++.+.....+|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 68999999999999999999999999999999865432 22446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC-Ceeeccccccccccccccccc
Q 008116 93 MAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 93 ~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g-~vKL~DFGls~~~~~~~~~~~ 169 (577)
+.+++|.+++... ..+++..+..++.||+.||.|||+++++|+||||+|||++.++ .+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 9999999998653 3579999999999999999999999999999999999998875 469999999877654433333
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
...|++.|+|||++.... ++.++||||||+++|+|++|..||...+.......+...........++..+.++|.+||.
T Consensus 161 ~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (257)
T cd08225 161 TCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239 (257)
T ss_pred ccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhc
Confidence 457899999999987654 8889999999999999999999998766554444444444444455678899999999999
Q ss_pred cCCCCCCcHHHHhhcHhh
Q 008116 250 KVPAERPSAKELLRHRFI 267 (577)
Q Consensus 250 ~dP~~RpTa~elL~hpff 267 (577)
.+|++|||+.+|++||||
T Consensus 240 ~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 240 VSPRDRPSITSILKRPFL 257 (257)
T ss_pred cChhhCcCHHHHhhCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=352.43 Aligned_cols=253 Identities=28% Similarity=0.441 Sum_probs=209.9
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+|++++.||.|+||.||+|.+..++..||||.+..... ......+.+|+.++++++||||+++++++..++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 58999999999999999999999999999999865432 22335788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 93 MAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 93 ~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
+. ++|..++.. ...+++..++.++.||+.||+|||+++++|+||+|+||+++.++.+||+|||++............
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 95 689988854 357899999999999999999999999999999999999999999999999998765443333344
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------------------
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------------ 226 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------------------ 226 (577)
..+++.|+|||++.+...++.++|||||||++|+|++|+.||...+.......+..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 56889999999887655568899999999999999999999976543221111100
Q ss_pred -CCCC---CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 227 -ENPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 227 -~~~~---~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
.... .....++..+++||.+||..||.+|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0000 0112356788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=348.14 Aligned_cols=254 Identities=24% Similarity=0.414 Sum_probs=212.7
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~ 84 (577)
...++|++.+.||+|+||.||+|.+. .++..||||++...........+.+|+.+++.++||||+++++++..+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45688999999999999999999864 2356799999865544444567889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecc
Q 008116 85 KLWIIMEYMAGGSVADLIQSG----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVAD 154 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~----------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~D 154 (577)
..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+|||++.++.++|+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 999999999999999998642 2357788999999999999999999999999999999999999999999
Q ss_pred ccccccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCC
Q 008116 155 FGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQ 231 (577)
Q Consensus 155 FGls~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~ 231 (577)
||++......... .....+++.|+|||++.+. .++.++|||||||+||+|++ |..||...+.......+.....+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD 241 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9998755332111 1123567889999999765 48999999999999999999 789998776655555444444445
Q ss_pred chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 232 l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 566778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=349.40 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=215.4
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
..+|.+++.||+|+||.||+|.+.. ++..||||.+.........+.+.+|+.+|+.+.||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4679999999999999999998753 46789999997665554567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeee
Q 008116 87 WIIMEYMAGGSVADLIQSG--------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKV 152 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~--------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL 152 (577)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 9999999999999999653 34788999999999999999999999999999999999999999999
Q ss_pred ccccccccccccc--cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCC
Q 008116 153 ADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENP 229 (577)
Q Consensus 153 ~DFGls~~~~~~~--~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~ 229 (577)
+|||++....... .......+++.|+|||++.+.. ++.++|||||||+||+|++ |..||...+.......+.....
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999987543221 1112345678899999997754 8999999999999999998 9999987776666655555555
Q ss_pred CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 230 ~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
...+..++..+.+||.+||.++|.+||++.++++
T Consensus 243 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 243 LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5555678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=350.42 Aligned_cols=257 Identities=41% Similarity=0.730 Sum_probs=220.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
..|...+.||.|++|.||++.+..++..||||.+..... .....+.+|+.+++.+.||||+++++++...+..|+|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 467778999999999999999998999999999865432 2346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccccc
Q 008116 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (577)
Q Consensus 93 ~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 172 (577)
+.+++|.+++.. .++++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..............
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 999999999977 6799999999999999999999999999999999999999999999999998876544333334467
Q ss_pred CCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--hhhhhHHHHHHHHHhccc
Q 008116 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 173 GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l--~~~~s~~l~~lI~~cL~~ 250 (577)
|++.|+|||++.+.. ++.++|||||||++|+|++|..||...++......+....++.. +..++..+.+||.+||..
T Consensus 177 ~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 255 (285)
T cd06648 177 GTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR 255 (285)
T ss_pred CCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence 999999999987654 88999999999999999999999987665544444433333222 223678999999999999
Q ss_pred CCCCCCcHHHHhhcHhhhhccC
Q 008116 251 VPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 251 dP~~RpTa~elL~hpff~~~~~ 272 (577)
+|.+||++.++++||||.+...
T Consensus 256 ~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 256 DPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ChhhCcCHHHHccCcccccCCC
Confidence 9999999999999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=338.38 Aligned_cols=253 Identities=45% Similarity=0.764 Sum_probs=223.7
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+|++.+.||+|++|.||+|.+..+++.||||.+..... ......+.+|+.+++++.||||+++++++.....+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999999999999999876542 24567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccccc
Q 008116 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (577)
Q Consensus 93 ~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 172 (577)
+++++|.+++.....+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++..............
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 160 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV 160 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccc
Confidence 99999999998878899999999999999999999999999999999999999999999999999987655443334567
Q ss_pred CCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCC
Q 008116 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (577)
Q Consensus 173 GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP 252 (577)
|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...........+.....+.++..++..+.+||.+||..+|
T Consensus 161 ~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 239 (254)
T cd06627 161 GTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDP 239 (254)
T ss_pred cchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCCh
Confidence 899999999987654 8889999999999999999999998766544444444444455666788999999999999999
Q ss_pred CCCCcHHHHhhcHhh
Q 008116 253 AERPSAKELLRHRFI 267 (577)
Q Consensus 253 ~~RpTa~elL~hpff 267 (577)
++||++.+++.||||
T Consensus 240 ~~R~~~~~~l~~~~~ 254 (254)
T cd06627 240 NLRPTAKQLLKHPWI 254 (254)
T ss_pred hhCcCHHHHhcCCCC
Confidence 999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=354.84 Aligned_cols=259 Identities=27% Similarity=0.477 Sum_probs=212.4
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-HHHHHHHHHHHHHhCCCCceeEeEEEEEeC--CEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-EIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLW 87 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~-~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~--~~~~ 87 (577)
...+|++.+.||.|+||.||+|.+..+|..||||++....... ....+.+|+.++++++||||+++++++... +.+|
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3568999999999999999999999999999999987544221 223466899999999999999999998765 5789
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 9999996 588888865 46799999999999999999999999999999999999999999999999999877654333
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--------------------
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------------------- 226 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~-------------------- 226 (577)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+..
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 333445688999999987655688999999999999999999999986655433221110
Q ss_pred ------CCCCCc---hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 227 ------ENPPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 227 ------~~~~~l---~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.....+ ...++..+.+||.+||..||.+|||+.++|.||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 000000 01257889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=367.01 Aligned_cols=260 Identities=28% Similarity=0.481 Sum_probs=233.4
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~L 88 (577)
..+|..+.+||+|+||.|.+|..+.+...||||++++.- ..+.++-...|-++|... +-|.++.++.+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 468999999999999999999999999999999997664 233455566788888887 67899999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
||||+.||+|--+|+.-++|.|..+..++.+|+-||-|||++|||+||||.+||||+.+|++||+|||+++...-.....
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TT 507 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTT 507 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998766666666
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
.++||||.|+|||++.-.+ |+..+|+||+||+|||||.|++||...+..+....|...+ ..++..+|.++.++++.+|
T Consensus 508 kTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-vsyPKslSkEAv~ickg~l 585 (683)
T KOG0696|consen 508 KTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-VSYPKSLSKEAVAICKGLL 585 (683)
T ss_pred eeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-CcCcccccHHHHHHHHHHh
Confidence 7899999999999998764 9999999999999999999999999998888877776544 3567889999999999999
Q ss_pred ccCCCCCCcH-----HHHhhcHhhhhccCC
Q 008116 249 KKVPAERPSA-----KELLRHRFIRNARKS 273 (577)
Q Consensus 249 ~~dP~~RpTa-----~elL~hpff~~~~~~ 273 (577)
.+.|.+|..+ .+|-.||||+.+.+.
T Consensus 586 tK~P~kRLGcg~~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 586 TKHPGKRLGCGPEGERDIREHPFFRRIDWE 615 (683)
T ss_pred hcCCccccCCCCccccchhhCcchhhccHH
Confidence 9999999754 678899999988653
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=348.03 Aligned_cols=251 Identities=24% Similarity=0.416 Sum_probs=213.4
Q ss_pred CCeeEEeEEeecCceEEEEEEE----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFD----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~----~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
..|++.+.||+|+||.||+|.+ ..++..||||.+...........+.+|+.+++.++||||+++++++..+...|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5789999999999999999985 345678999999765555566788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCee
Q 008116 89 IMEYMAGGSVADLIQSG-----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~-----------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vK 151 (577)
||||+.+++|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEE
Confidence 99999999999998532 2478889999999999999999999999999999999999999999
Q ss_pred eccccccccccccc--cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC
Q 008116 152 VADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228 (577)
Q Consensus 152 L~DFGls~~~~~~~--~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~ 228 (577)
|+|||++....... .......++..|+|||++.+.. ++.++|||||||+||+|++ |.+||....+......+....
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 243 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ 243 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999987653321 1122345677899999987654 8899999999999999998 999998766555555554444
Q ss_pred CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 229 ~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
....+..++..+.+|+.+||.++|.+||++.+|+++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 244 LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 445566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=352.26 Aligned_cols=259 Identities=30% Similarity=0.517 Sum_probs=218.3
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++++.||+|+||.||++.+..+++.||||.+..... ......+.+|+.+++.++||||+++++.+..+..+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 479999999999999999999999999999999875532 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-----
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~----- 165 (577)
||++|++|.+++...+++++..+..++.|++.||.|||+++++||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999999999999887889999999999999999999999999999999999999999999999999875311000
Q ss_pred ----------cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCch
Q 008116 166 ----------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLD 233 (577)
Q Consensus 166 ----------~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~--~~~l~ 233 (577)
.......|++.|+|||.+... .++.++|+|||||++|+|++|..||......+....+.... .+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 001124678899999998765 48999999999999999999999998766554444433222 12222
Q ss_pred hhhhHHHHHHHHHhcccCCCCCCc---HHHHhhcHhhhhccC
Q 008116 234 EHFSRLMKEFVSLCLKKVPAERPS---AKELLRHRFIRNARK 272 (577)
Q Consensus 234 ~~~s~~l~~lI~~cL~~dP~~RpT---a~elL~hpff~~~~~ 272 (577)
..++..+.+||.+||.++|.+||+ +.++|+||||.....
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 357889999999999999999998 799999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=351.29 Aligned_cols=255 Identities=31% Similarity=0.487 Sum_probs=208.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCE-----
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTK----- 85 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~----- 85 (577)
++|++.+.||.|+||.||+|.+..+++.||||.+...... .....+.+|+.+++.+ +||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998654322 2345688899999999 56999999999987665
Q ss_pred EEEEEeccCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc-CCCeeeccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS-----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSA 159 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~-----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~-~g~vKL~DFGls~ 159 (577)
+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999975 88888753 245899999999999999999999999999999999999998 8899999999987
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-------------
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------- 226 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------- 226 (577)
.+...........+++.|+|||++.+...++.++||||||+++|+|++|.+||...........+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 6544333333456789999999987655578999999999999999999999976544322211100
Q ss_pred -----------CCCCC---chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 227 -----------ENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 227 -----------~~~~~---l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
..+.. ....++..+.+||.+||..+|.+||++.++|.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00000 1124678899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=343.08 Aligned_cols=254 Identities=35% Similarity=0.604 Sum_probs=211.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
.++.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++++++..++.+++|+||
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 45555678999999999999999999999999986543 33457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC-CCC--CHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc-CCCeeecccccccccccccccc
Q 008116 93 MAGGSVADLIQSG-PPL--DEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 93 ~~gGsL~~~l~~~-~~l--~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~-~g~vKL~DFGls~~~~~~~~~~ 168 (577)
+.+++|.+++... .++ ++..+..++.||+.||.|||+++|+||||||+||+++. .+.++|+|||++..........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence 9999999999753 456 88899999999999999999999999999999999976 6799999999987654333333
Q ss_pred ccccCCCCCCChhhhhcc-cCCccccchhhHHHHHHHHHhCCCCCCCCCcccee-ecc-CCCCCCCchhhhhHHHHHHHH
Q 008116 169 KTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-FII-PRENPPQLDEHFSRLMKEFVS 245 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~-~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~-~~i-~~~~~~~l~~~~s~~l~~lI~ 245 (577)
....|++.|+|||++... ..++.++||||||+++|+|++|.+||......... ..+ .....+.++..++..+++|+.
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHH
Confidence 345689999999998653 23788999999999999999999999765432111 111 112233456678889999999
Q ss_pred HhcccCCCCCCcHHHHhhcHhh
Q 008116 246 LCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~hpff 267 (577)
+||..+|.+|||+.+++.||||
T Consensus 247 ~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 247 RCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=348.71 Aligned_cols=255 Identities=29% Similarity=0.518 Sum_probs=214.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++|++.+.||.|+||.||+|.+..+++.||||.++.... ......+.+|+.+++++.||||+++++++..++.+|+|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 479999999999999999999999999999999865432 2335778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-cccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~~~~ 170 (577)
|+.++.|..++.....+++..++.++.||+.||.|||+++++|+||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 999887877777667799999999999999999999999999999999999999999999999999877654432 3345
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---------------------C-CC
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---------------------R-EN 228 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~---------------------~-~~ 228 (577)
.++++.|+|||++.....++.++||||||++||+|++|.+||........+..+. . ..
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 6789999999999876468899999999999999999999997543321110000 0 00
Q ss_pred CC---------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 229 PP---------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 229 ~~---------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
+. ..+..++..+.+||.+||..+|.+||++.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 0122347889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=353.37 Aligned_cols=245 Identities=25% Similarity=0.428 Sum_probs=192.8
Q ss_pred eEEeecCceEEEEEEEcC--CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe--CCEEEEEEeccC
Q 008116 19 ELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWIIMEYMA 94 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~--tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~--~~~~~LV~Ey~~ 94 (577)
..||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+|++++||||+++++++.. +..+|+||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 589999999999998754 568899999865432 2457889999999999999999998854 567899999995
Q ss_pred CCCHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE----ccCCCeeeccccccccc
Q 008116 95 GGSVADLIQS---------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL----TENGDVKVADFGVSAQL 161 (577)
Q Consensus 95 gGsL~~~l~~---------~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl----d~~g~vKL~DFGls~~~ 161 (577)
++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||+ +..+.+||+|||++...
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 588887742 1358899999999999999999999999999999999999 45678999999999766
Q ss_pred ccccc---ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee-----------------
Q 008116 162 TRTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL----------------- 221 (577)
Q Consensus 162 ~~~~~---~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~----------------- 221 (577)
..... ......||+.|+|||++.+...++.++|||||||+||+|++|.+||.........
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 43322 2234678999999999977556889999999999999999999999643211000
Q ss_pred -------ec---cCC----------C--CCC-------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 222 -------FI---IPR----------E--NPP-------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 222 -------~~---i~~----------~--~~~-------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
.. ... . ... ......+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 000 0 000 0011234568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=346.81 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=205.0
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeC--CEEEEEEe
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQ--TKLWIIME 91 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~--~~~~LV~E 91 (577)
|++++.||+|+||.||+|.+..++..||||.+.............+|+.+++++. ||||+++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7899999999999999999999999999999875433223334567999999984 99999999999987 89999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|+. ++|.+.+.. ...+++..++.++.||+.||.|||+++++||||||+||+++. +.+||+|||++..+.... ....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-~~~~ 157 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-PYTE 157 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-CcCC
Confidence 996 578777764 457899999999999999999999999999999999999999 999999999987664332 2234
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---------------------CCCC
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---------------------RENP 229 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~---------------------~~~~ 229 (577)
..+++.|+|||++.....++.++|||||||++|+|++|.+||...+..+....+. ...+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 5689999999987655557889999999999999999999997654322111110 0000
Q ss_pred C-------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 230 P-------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 230 ~-------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
. .+...++..+.+||.+||.++|.+||++.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0 1122467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=348.61 Aligned_cols=258 Identities=27% Similarity=0.462 Sum_probs=210.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++|++.+.||.|++|.||+|.+..+++.||||.+..... ......+.+|+.++++++||||+++++++.....+|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 579999999999999999999999999999999865432 2234668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc-CCCeeecccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 92 y~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~-~g~vKL~DFGls~~~~~~~~~~ 168 (577)
|+. ++|..++.... .+++..++.++.||+.||+|||+++++|+||||+|||++. ++.+||+|||++..........
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 995 58888875533 3588899999999999999999999999999999999985 4579999999987654332233
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-----------------------
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP----------------------- 225 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~----------------------- 225 (577)
....|++.|+|||++.+...++.++|||||||++|+|++|.+||...........+.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence 345788999999998765557889999999999999999999997654322221110
Q ss_pred --CCCCCC---chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 226 --RENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 226 --~~~~~~---l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
...... ....++..+.+||.+||..+|.+||++.++|+||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 000000 1124578899999999999999999999999999998764
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.59 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=207.8
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHHHHHH---HHHHHhCCCCceeEeEEEEEeCCEEEEEEeccC
Q 008116 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKE---ISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (577)
Q Consensus 20 ~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~--~~~~~i~~E---v~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~ 94 (577)
+||+|+||.||+|.+..+++.||||.+...... .....+..| +.+++...||+|+++++++.....+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999998654321 111223333 344555689999999999999999999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCC
Q 008116 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (577)
Q Consensus 95 gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GT 174 (577)
|++|..++...+.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++..+... .....+|+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGT 158 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCCC
Confidence 9999999988788999999999999999999999999999999999999999999999999998765432 22345799
Q ss_pred CCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccce--eeccCCCCCCCchhhhhHHHHHHHHHhcccCC
Q 008116 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV--LFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (577)
Q Consensus 175 p~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~--~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP 252 (577)
+.|+|||++.+...++.++|||||||++|+|++|..||........ ...........++..++..+.++|.+||..+|
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p 238 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 238 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence 9999999987654588999999999999999999999986632211 11111222334555678999999999999999
Q ss_pred CCCC-----cHHHHhhcHhhhhccCCh
Q 008116 253 AERP-----SAKELLRHRFIRNARKSP 274 (577)
Q Consensus 253 ~~Rp-----Ta~elL~hpff~~~~~~~ 274 (577)
.+|| ++.++++||||+......
T Consensus 239 ~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 239 NRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred HhccCCCCCCHHHHHhCccccCCCchH
Confidence 9999 999999999998865433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=344.73 Aligned_cols=259 Identities=36% Similarity=0.653 Sum_probs=214.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC--CEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~--~~~~LV~ 90 (577)
++|+.++.||.|++|.||+|.+..+++.||+|.+...........+.+|++++++++||||++++++|... ..+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47999999999999999999999999999999997665555567889999999999999999999988654 4789999
Q ss_pred eccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 91 Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999999988743 45689999999999999999999999999999999999999999999999999865543221
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cceeeccCCCCCCCc------hhh
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-----MRVLFIIPRENPPQL------DEH 235 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~-----~~~~~~i~~~~~~~l------~~~ 235 (577)
....++..|+|||.+.+. .++.++|||||||++|+|++|..||..... .+....+.....+.+ ...
T Consensus 161 --~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd06621 161 --GTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237 (287)
T ss_pred --ccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence 245688999999998765 488999999999999999999999976522 111111111111111 124
Q ss_pred hhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCCh
Q 008116 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274 (577)
Q Consensus 236 ~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~~ 274 (577)
++..+.+||.+||.++|.+|||+.+|++||||++.....
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~ 276 (287)
T cd06621 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK 276 (287)
T ss_pred hHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccch
Confidence 567899999999999999999999999999997765543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=344.10 Aligned_cols=254 Identities=33% Similarity=0.657 Sum_probs=212.9
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC---------hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES---------EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~---------~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~ 84 (577)
+|.+.+.||.|+||.||+|.+..++..||||.+..... ....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 68899999999999999999999999999998864321 112456889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
.+++||||+.+++|.+++...+++++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988788999999999999999999999999999999999999999999999999998755332
Q ss_pred cc--ccccccCCCCCCChhhhhccc-CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-----CCCCchhhh
Q 008116 165 IS--RRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-----NPPQLDEHF 236 (577)
Q Consensus 165 ~~--~~~~~~GTp~Y~APEvl~~~~-~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~-----~~~~l~~~~ 236 (577)
.. ......|+..|+|||++.... .++.++||||||+++|+|++|..||...........+... .+......+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 11 122456899999999987543 4788999999999999999999999765443222221111 112222356
Q ss_pred hHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 237 s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
+..+++||.+||.++|..||++.++|+|||+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=346.18 Aligned_cols=254 Identities=25% Similarity=0.433 Sum_probs=214.0
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~ 84 (577)
...++|++.+.||+|+||.||+|.+.. ++..||+|.+...........+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 345789999999999999999999977 778999999876655555567899999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC---Ceeecc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGP-------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKVAD 154 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~-------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g---~vKL~D 154 (577)
..|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+++++|+||||+|||++..+ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999996543 589999999999999999999999999999999999998654 599999
Q ss_pred ccccccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCC
Q 008116 155 FGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQ 231 (577)
Q Consensus 155 FGls~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~ 231 (577)
||++..+...... .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+.......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9998765322111 11223456799999997654 8999999999999999997 999998776655554444444444
Q ss_pred chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 232 l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.+..++..+.+|+.+||..+|++||++.+|++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 556778899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=340.19 Aligned_cols=251 Identities=32% Similarity=0.541 Sum_probs=212.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++.++||+|+||.||+|.+..++..||||.+.... .......+.+|+.+++.++||||+++++++...+.+++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999886532 3344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 91 Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
||+++++|..++.. ...+++..+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999988852 35589999999999999999999999999999999999999999999999999877654333
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cceeeccCCCC-CCCchhhhhHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPREN-PPQLDEHFSRLMKEF 243 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~--~~~~~~i~~~~-~~~l~~~~s~~l~~l 243 (577)
......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||..... ......+.... ++.....++..+.+|
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLREL 240 (267)
T ss_pred HHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 333567899999999987654 78899999999999999999999965432 22222332222 333345678899999
Q ss_pred HHHhcccCCCCCCcHHHHhhc
Q 008116 244 VSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~h 264 (577)
|.+||..+|.+||++.++++.
T Consensus 241 i~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 241 VSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999973
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=353.04 Aligned_cols=252 Identities=27% Similarity=0.487 Sum_probs=214.0
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEEeccCCCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAGGS 97 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~Ey~~gGs 97 (577)
++||+|+|+.|--+++..++..||||++.+.. .....++.+|++++.++ .|+||+.|+++|++++.+|||||.|.||+
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 67999999999999999999999999998773 34568899999999999 69999999999999999999999999999
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC---Ceeeccccccccccccc-------cc
Q 008116 98 VADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKVADFGVSAQLTRTI-------SR 167 (577)
Q Consensus 98 L~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g---~vKL~DFGls~~~~~~~-------~~ 167 (577)
|..+|++...|+|.++..+.++|+.||.|||.+||.||||||+|||..... .||||||.|...+.... ..
T Consensus 163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~ 242 (463)
T KOG0607|consen 163 LLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPE 242 (463)
T ss_pred HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCcc
Confidence 999999989999999999999999999999999999999999999997654 58999999876542211 12
Q ss_pred cccccCCCCCCChhhhh----cccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---------------ceeeccCCCC
Q 008116 168 RKTFVGTPFWMAPEVIQ----NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---------------RVLFIIPREN 228 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~----~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~---------------~~~~~i~~~~ 228 (577)
..+.+|+..|||||+.. ....|+.++|+||||||||.||+|++||...-.. .....|..+.
T Consensus 243 L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk 322 (463)
T KOG0607|consen 243 LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 322 (463)
T ss_pred ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC
Confidence 23578999999999864 2345899999999999999999999999754321 1112233222
Q ss_pred ---CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 229 ---PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 229 ---~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
|..-+..++.+.+++|..+|.+++..|.++.++++|||++.+.
T Consensus 323 YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 323 YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 3333457899999999999999999999999999999998764
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=354.70 Aligned_cols=259 Identities=39% Similarity=0.712 Sum_probs=219.9
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
...|.....||+|+||.||+|.+..++..||||++..... ...+.+.+|+.+++.+.||||+++++++..++.+|+|||
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 4566777789999999999999998999999999865433 234668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
|+++++|..++.. ..+++..++.++.||+.||.|||+++++||||||+|||++.++.+||+|||++..+..........
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 9999999998865 678999999999999999999999999999999999999999999999999987654443334456
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CchhhhhHHHHHHHHHhcc
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~l~~~~s~~l~~lI~~cL~ 249 (577)
+|++.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.....+ .....++..+.+||.+||.
T Consensus 178 ~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 256 (297)
T cd06659 178 VGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256 (297)
T ss_pred ecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence 8999999999997654 889999999999999999999999866554433333222221 1233567889999999999
Q ss_pred cCCCCCCcHHHHhhcHhhhhccCC
Q 008116 250 KVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 250 ~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
.+|.+||++.+|++||||.+....
T Consensus 257 ~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 257 REPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred CCcccCcCHHHHhhChhhccCCCc
Confidence 999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=347.81 Aligned_cols=259 Identities=23% Similarity=0.407 Sum_probs=213.0
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
...+|++.+.||+|+||.||+|.++. .+..||||.+...........+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999997652 3558999998755544445668899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccc
Q 008116 86 LWIIMEYMAGGSVADLIQSG----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADF 155 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~----------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DF 155 (577)
.|+||||+.+|+|.+++... ..++...+..++.||+.||.|||+++|+||||||+|||++.++.++|+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcC
Confidence 99999999999999999642 23567788999999999999999999999999999999999999999999
Q ss_pred cccccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCc
Q 008116 156 GVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQL 232 (577)
Q Consensus 156 Gls~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l 232 (577)
|++......... .....++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||......+....+........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 242 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 998754322111 11234577899999987654 8899999999999999998 7899987766555444444444444
Q ss_pred hhhhhHHHHHHHHHhcccCCCCCCcHHHHhh------cHhhhhc
Q 008116 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLR------HRFIRNA 270 (577)
Q Consensus 233 ~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~------hpff~~~ 270 (577)
+..++..+++|+.+||..+|.+|||+.++++ ||||..+
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 243 PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 5567789999999999999999999999986 5666543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=369.42 Aligned_cols=243 Identities=26% Similarity=0.471 Sum_probs=215.8
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEecc
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
.+++++.||+|-||.||.|.+.. ...||||.++.... ..+.+.+|+++|++|+|++||+++++|..++.+|||||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 45667899999999999999874 34899999875432 2366789999999999999999999999989999999999
Q ss_pred CCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 94 AGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 94 ~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
..|+|.++|+. +..+...+...++.|||+|++||+++++|||||-..||||+++..+||+|||||+...+. .....
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~--~Y~~~ 361 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD--EYTAS 361 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC--ceeec
Confidence 99999999986 567999999999999999999999999999999999999999999999999999954332 22222
Q ss_pred cC---CCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 172 VG---TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 172 ~G---Tp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
.| ...|.|||.+.... ++.++|||||||+|+||+| |..||......+++..+..+...+.|..+|..+.+++..|
T Consensus 362 ~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC 440 (468)
T ss_pred CCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence 22 34699999998764 9999999999999999998 9999999999999999999998888999999999999999
Q ss_pred cccCCCCCCcHHHHh
Q 008116 248 LKKVPAERPSAKELL 262 (577)
Q Consensus 248 L~~dP~~RpTa~elL 262 (577)
|..+|++|||+..+.
T Consensus 441 W~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 441 WHEDPEDRPTFETLR 455 (468)
T ss_pred hhCCcccCCCHHHHH
Confidence 999999999999765
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=366.72 Aligned_cols=251 Identities=24% Similarity=0.428 Sum_probs=207.4
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCC-----cEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELN-----KDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTK 85 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg-----~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~ 85 (577)
..+|++.+.||+|+||.||+|++..++ ..||||.+...........+.+|+.+++.+ .|||||+++++|.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457999999999999999999865433 579999997665555667889999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC------------------------------------------------------------
Q 008116 86 LWIIMEYMAGGSVADLIQSG------------------------------------------------------------ 105 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~------------------------------------------------------------ 105 (577)
+|+|||||.+|+|.+++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999998532
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc--cccccC
Q 008116 106 ----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR--RKTFVG 173 (577)
Q Consensus 106 ----------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~--~~~~~G 173 (577)
.++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .....+
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 24788899999999999999999999999999999999999999999999998765432111 112335
Q ss_pred CCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeec-cCCCCCCCchhhhhHHHHHHHHHhcccC
Q 008116 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFI-IPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (577)
Q Consensus 174 Tp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~-i~~~~~~~l~~~~s~~l~~lI~~cL~~d 251 (577)
++.|||||++... .++.++|||||||+||+|++ |..||........... +.....+..+..++.++.++|.+||..+
T Consensus 277 ~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 355 (374)
T cd05106 277 PVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLE 355 (374)
T ss_pred ccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCC
Confidence 6789999998765 48999999999999999997 9999987654332222 2222233344456889999999999999
Q ss_pred CCCCCcHHHHhh
Q 008116 252 PAERPSAKELLR 263 (577)
Q Consensus 252 P~~RpTa~elL~ 263 (577)
|.+||++.+|++
T Consensus 356 p~~RPs~~~l~~ 367 (374)
T cd05106 356 PTERPTFSQISQ 367 (374)
T ss_pred hhhCcCHHHHHH
Confidence 999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=340.28 Aligned_cols=244 Identities=27% Similarity=0.433 Sum_probs=206.5
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCH
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL 98 (577)
+.||+|+||.||+|.+..+++.||+|.+...........+.+|+.+++++.||||+++++++.....+||||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999999999999999987555555567899999999999999999999999999999999999999999
Q ss_pred HHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc--ccccCCC
Q 008116 99 ADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR--KTFVGTP 175 (577)
Q Consensus 99 ~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~--~~~~GTp 175 (577)
.+++... ..+++..++.++.|++.||.|||+++|+|+||||+|||++.++.+||+|||++.......... ....++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 9999653 468999999999999999999999999999999999999999999999999986543211110 0112345
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCC
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~ 254 (577)
.|+|||.+.+.. ++.++|||||||++|+|++ |.+||...........+....+...+..++..+.+|+.+||.++|.+
T Consensus 161 ~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (252)
T cd05084 161 KWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQ 239 (252)
T ss_pred eecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhh
Confidence 699999987654 8889999999999999997 99999876655444444444444556677899999999999999999
Q ss_pred CCcHHHHhh
Q 008116 255 RPSAKELLR 263 (577)
Q Consensus 255 RpTa~elL~ 263 (577)
|||+.+|++
T Consensus 240 Rps~~~~~~ 248 (252)
T cd05084 240 RPSFSTVHQ 248 (252)
T ss_pred CcCHHHHHH
Confidence 999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=347.74 Aligned_cols=257 Identities=32% Similarity=0.583 Sum_probs=226.3
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++.+++..||.|+.|+|+++..+.+|...|||.+.........+++.+.+.++...+ +|+||+++|+|..+..++|.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 345678899999999999999999999999999999888888899999999988874 9999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
.| +..+..++++ .++++|..+-.+...+++||.||.+ ++||||||||+|||+|+.|++||||||++..+...... .
T Consensus 172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-t 249 (391)
T KOG0983|consen 172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-T 249 (391)
T ss_pred HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc-c
Confidence 99 4456666654 5789999999999999999999995 58999999999999999999999999999888765433 2
Q ss_pred cccCCCCCCChhhhhc--ccCCccccchhhHHHHHHHHHhCCCCCCCCC-ccceeeccCCCCCCCchh--hhhHHHHHHH
Q 008116 170 TFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQLDE--HFSRLMKEFV 244 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~--~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~-~~~~~~~i~~~~~~~l~~--~~s~~l~~lI 244 (577)
--.|.+.|||||-+.- ...|+.++||||||++|+||.||..||...+ ..+++.+|....||.++. .++..+.+|+
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv 329 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFV 329 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHH
Confidence 3479999999998853 3459999999999999999999999998754 567777888888877764 5899999999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 245 SLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..||.+|+.+||...+||+|||+....
T Consensus 330 ~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 330 KDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHhhcCcccCcchHHHhcCcceeecc
Confidence 999999999999999999999997653
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=357.59 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=211.3
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-----CE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----TK 85 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~-----~~ 85 (577)
++++|++.+.||+|+||.||+|.+..+|..||||++...........+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 5689999999999999999999999999999999986544334456778899999999999999999987654 35
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
+|+|+||+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 899999995 589888865 679999999999999999999999999999999999999999999999999987654322
Q ss_pred cc---cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc------------------
Q 008116 166 SR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------ 224 (577)
Q Consensus 166 ~~---~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i------------------ 224 (577)
.. ....+|++.|+|||++.+...++.++|||||||++|+|++|++||...+.......+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 11 123578999999999866556889999999999999999999999764321111000
Q ss_pred ---------CCCCCCC---chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 225 ---------PRENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 225 ---------~~~~~~~---l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
....... +...++..+.+||.+||..+|.+|||+.++++||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000000 1123567899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=365.91 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=206.7
Q ss_pred CCCeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTK 85 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~ 85 (577)
.++|++.+.||+|+||.||+|.+ ..++..||||+++........+.+.+|+.+|+.+ +|||||++++++.....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34799999999999999999974 3457789999997555445567789999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC------------------------------------------------------------
Q 008116 86 LWIIMEYMAGGSVADLIQSG------------------------------------------------------------ 105 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~------------------------------------------------------------ 105 (577)
.|+|||||++|+|.+++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999998542
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc--c
Q 008116 106 ---------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR--R 168 (577)
Q Consensus 106 ---------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~--~ 168 (577)
..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......... .
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 14788899999999999999999999999999999999999999999999998765432211 1
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccce-eeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRV-LFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~-~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
....+++.|+|||++.+. .++.++|||||||+||+|++ |..||........ ...+........+...+.++++||..
T Consensus 274 ~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 352 (375)
T cd05104 274 GNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKS 352 (375)
T ss_pred CCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHH
Confidence 123356679999999775 48999999999999999998 8999976543322 22222222233344567899999999
Q ss_pred hcccCCCCCCcHHHHhhc
Q 008116 247 CLKKVPAERPSAKELLRH 264 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~h 264 (577)
||..+|.+||++.+|++.
T Consensus 353 cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 353 CWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HccCChhHCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=337.12 Aligned_cols=245 Identities=28% Similarity=0.489 Sum_probs=215.5
Q ss_pred eEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
+.||+|+||.||+|.+... +..||||.+...........+.+|+.+++.+.||||+++++++.....+++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4799999999999999866 8899999998766554578899999999999999999999999999999999999999
Q ss_pred CCHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-
Q 008116 96 GSVADLIQSG---------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (577)
Q Consensus 96 GsL~~~l~~~---------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~- 165 (577)
++|.+++... ..+++..++.++.||+.||.|||+++++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999999875 789999999999999999999999999999999999999999999999999987765432
Q ss_pred -cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHH
Q 008116 166 -SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (577)
Q Consensus 166 -~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~l 243 (577)
.......+++.|+|||++... .++.++|||||||++|+|++ |..||...........+........+..++..+.++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYEL 239 (262)
T ss_pred cccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHH
Confidence 122345678999999998765 48999999999999999999 699998887666666665555555666778999999
Q ss_pred HHHhcccCCCCCCcHHHHhhc
Q 008116 244 VSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~h 264 (577)
+.+||..+|.+||++.+++.+
T Consensus 240 i~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 240 MLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=340.70 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=214.8
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
.++|++.+.||+|+||.||+|.+..+ ...||||.++..........+.+|+.++++++||||+++++++...+.+|+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 36799999999999999999988644 457999998766555556778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
||||+++++|.+++.. .+.+++..+..++.|++.||.|||+++|+|+||||+||||+.++.++|+|||++.........
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 9999999999999965 357899999999999999999999999999999999999999999999999999876422222
Q ss_pred ccc--ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHH
Q 008116 168 RKT--FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 168 ~~~--~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI 244 (577)
..+ ..+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...........+........+..++..+.+|+
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLM 241 (266)
T ss_pred eeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 222 2346789999998765 48899999999999999998 9999987766555555544444344556788999999
Q ss_pred HHhcccCCCCCCcHHHHhhc
Q 008116 245 SLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~h 264 (577)
.+||..+|.+||++.+|+++
T Consensus 242 ~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 242 LDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=332.76 Aligned_cols=250 Identities=54% Similarity=0.967 Sum_probs=217.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEecc
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
.|++.+.||.|++|.||++.+..++..|++|++..... .....+.+|+.+++++.||||+++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 48899999999999999999998999999999876543 35678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccccc
Q 008116 94 AGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (577)
Q Consensus 94 ~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 172 (577)
.+++|.+++... ..+++..++.++.|++.||.|||.++++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 158 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMV 158 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-cccee
Confidence 999999999775 6899999999999999999999999999999999999999999999999999877654322 34567
Q ss_pred CCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchh--hhhHHHHHHHHHhccc
Q 008116 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE--HFSRLMKEFVSLCLKK 250 (577)
Q Consensus 173 GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~--~~s~~l~~lI~~cL~~ 250 (577)
|+..|++||++.... ++.++||||||++||+|++|..||...+.......+.....+.+.. .++..+.+||.+||..
T Consensus 159 ~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (253)
T cd05122 159 GTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237 (253)
T ss_pred cCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence 899999999987654 7889999999999999999999998775544433333333333332 2478899999999999
Q ss_pred CCCCCCcHHHHhhcHh
Q 008116 251 VPAERPSAKELLRHRF 266 (577)
Q Consensus 251 dP~~RpTa~elL~hpf 266 (577)
+|.+|||+.++|+|||
T Consensus 238 ~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 238 NPEKRPTAEQLLKHPF 253 (253)
T ss_pred ChhhCCCHHHHhcCCC
Confidence 9999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=349.10 Aligned_cols=265 Identities=44% Similarity=0.809 Sum_probs=221.1
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
.....+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 345578999999999999999999999899999999986443 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~-~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
|+||||+. |+|.+++. ...++++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++.....
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 99999996 57777664 346799999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccCCCCCCChhhhhc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc-hhhhhHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-DEHFSRLMKE 242 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~--~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l-~~~~s~~l~~ 242 (577)
.....|++.|+|||++.. ...++.++||||||+++|+|++|.+||...+.......+....++.+ ...++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred --CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 234678999999998742 23478899999999999999999999987765544443433333332 3457889999
Q ss_pred HHHHhcccCCCCCCcHHHHhhcHhhhhccCChhHHH
Q 008116 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~~~ 278 (577)
||.+||..+|.+||++.+|+.||||..........+
T Consensus 246 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~ 281 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIID 281 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhcChhhcccCCcHHHHH
Confidence 999999999999999999999999987654443333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=353.17 Aligned_cols=251 Identities=23% Similarity=0.371 Sum_probs=209.5
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
..+|++++.||+|+||.||+|.+..++. .||||++.........+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 5689999999999999999999866555 48999987655555667889999999999999999999998764 578
Q ss_pred EEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
+|+||+.+|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+.....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999999999999763 4688999999999999999999999999999999999999999999999999987643322
Q ss_pred cc--ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHH
Q 008116 167 RR--KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (577)
Q Consensus 167 ~~--~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~l 243 (577)
.. ....+++.|+|||++... .++.++|||||||+||||++ |..||...........+........+..++..+.++
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 243 (316)
T ss_pred ceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 11 122346789999998765 48999999999999999997 999998766544333333333333445567889999
Q ss_pred HHHhcccCCCCCCcHHHHhhc
Q 008116 244 VSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~h 264 (577)
+.+||..+|.+||++.+++.+
T Consensus 244 i~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 244 MVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=344.15 Aligned_cols=249 Identities=27% Similarity=0.396 Sum_probs=209.7
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCH
Q 008116 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (577)
Q Consensus 21 IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL 98 (577)
||+|+||+||+|.+..+++.||||.+..... ......+..|+.+|++++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999999999999999999865431 22345567899999999999999999999999999999999999999
Q ss_pred HHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCCC
Q 008116 99 ADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (577)
Q Consensus 99 ~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~ 176 (577)
.+++.... .+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++...... .......|+..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCCC
Confidence 99997654 7999999999999999999999999999999999999999999999999998765432 22234578899
Q ss_pred CCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee---ccCCCCCCCchhhhhHHHHHHHHHhcccCCC
Q 008116 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF---IIPRENPPQLDEHFSRLMKEFVSLCLKKVPA 253 (577)
Q Consensus 177 Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~---~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~ 253 (577)
|+|||++.+.. ++.++|||||||++|+|++|+.||.......... ......+...+..++..+.+||.+||..+|.
T Consensus 160 y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (277)
T cd05577 160 YMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE 238 (277)
T ss_pred cCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChh
Confidence 99999987765 8889999999999999999999997654311111 1111223344556789999999999999999
Q ss_pred CCC-----cHHHHhhcHhhhhcc
Q 008116 254 ERP-----SAKELLRHRFIRNAR 271 (577)
Q Consensus 254 ~Rp-----Ta~elL~hpff~~~~ 271 (577)
+|| ++.+|+.||||....
T Consensus 239 ~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 239 KRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred HccCCCcccHHHHHhChhhhcCC
Confidence 999 899999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=332.10 Aligned_cols=253 Identities=45% Similarity=0.799 Sum_probs=219.8
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC--CEEEEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLWIIM 90 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~--~~~~LV~ 90 (577)
+|++.+.||+|++|.||+|.+..++..|+||++..... ....+.+.+|+.++++++||||+++++.+... ..+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58899999999999999999999999999999876543 34568899999999999999999999999988 8999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc--cc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RR 168 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~--~~ 168 (577)
||+++++|.+++.....+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 9999999999998877999999999999999999999999999999999999999999999999999877655432 13
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccC-CCCCCCchhhhhHHHHHHHHH
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIP-RENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~-~~~~~~i~-~~~~~~l~~~~s~~l~~lI~~ 246 (577)
....++..|+|||.+.... ++.++||||||+++|+|++|..||..... ......+. ....+.++..++..+++||.+
T Consensus 161 ~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 239 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239 (260)
T ss_pred cCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence 3467899999999987654 88999999999999999999999987652 11222222 123445566778999999999
Q ss_pred hcccCCCCCCcHHHHhhcHhh
Q 008116 247 CLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~hpff 267 (577)
||..+|.+||++.+++.||||
T Consensus 240 ~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 240 CLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred hCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=349.80 Aligned_cols=254 Identities=25% Similarity=0.452 Sum_probs=211.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeC--CEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLWII 89 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~--~~~~LV 89 (577)
.+|++.+.||.|+||.||+|.+..+++.||||.++..... .....+.+|+.+++++.||||+++++++... ..+|||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5799999999999999999999999999999999755432 2234567899999999999999999999887 899999
Q ss_pred EeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
|||+. ++|.+++... ..+++..++.++.||+.||+|||+++++|+||||+|||++.++.+||+|||++..........
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 99996 5999988653 459999999999999999999999999999999999999999999999999988765543334
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------------
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------------- 226 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~---------------------- 226 (577)
....+++.|+|||++.+...++.++||||||+++|+|++|.+||...........+..
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK 243 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence 4567899999999987655578899999999999999999999976544322211100
Q ss_pred ----CC----CCCchhh-hhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 227 ----EN----PPQLDEH-FSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 227 ----~~----~~~l~~~-~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
.. ...++.. ++..+.+||.+||..+|++|||+.|+|.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00 0011112 57889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=341.45 Aligned_cols=251 Identities=26% Similarity=0.442 Sum_probs=214.0
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~t-----g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
.++|++.+.||+|+||.||+|.+... +..||||.+...........+.+|+.+|+.+.||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 46899999999999999999988644 4789999987655545567788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccc
Q 008116 87 WIIMEYMAGGSVADLIQSG----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFG 156 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~----------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFG 156 (577)
|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcc
Confidence 9999999999999999642 246788999999999999999999999999999999999999999999999
Q ss_pred cccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCch
Q 008116 157 VSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLD 233 (577)
Q Consensus 157 ls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~ 233 (577)
++..+..... ......+++.|+|||++... .++.++|||||||++|+|++ |.+||...+.......+........+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLP 243 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCC
Confidence 9876543221 12234578899999998765 48899999999999999998 99999877666555555544445556
Q ss_pred hhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 234 ~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
..++..+.+||.+||..+|.+|||+.+|+.
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 244 ENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 667899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=365.10 Aligned_cols=266 Identities=26% Similarity=0.409 Sum_probs=229.2
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~--~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~ 84 (577)
++-...+.|+.-++||+|+||.||-+..+.||+-||+|.+.+.... ....-...|..||.+++.++||.+-..|++.+
T Consensus 179 ~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 179 LQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred hhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 3445567899999999999999999999999999999988654322 22344578999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
.++|||..|+||+|.-+|-..+ .|++..+..|+.+|+.||++||..+||+|||||+|||||+.|++.|+|+|||..+.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999999886544 79999999999999999999999999999999999999999999999999998876
Q ss_pred ccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---ceeeccCCCCCCCchhhhhHH
Q 008116 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---RVLFIIPRENPPQLDEHFSRL 239 (577)
Q Consensus 163 ~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~---~~~~~i~~~~~~~l~~~~s~~ 239 (577)
.. ......+||.+|||||++.+.. |+..+|+|||||+||||+.|+.||...... +.+.......+..+++.++++
T Consensus 339 ~g-~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~e 416 (591)
T KOG0986|consen 339 EG-KPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEE 416 (591)
T ss_pred CC-CccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHH
Confidence 54 3334569999999999998876 999999999999999999999999765432 122333344566777899999
Q ss_pred HHHHHHHhcccCCCCCC-----cHHHHhhcHhhhhccCCh
Q 008116 240 MKEFVSLCLKKVPAERP-----SAKELLRHRFIRNARKSP 274 (577)
Q Consensus 240 l~~lI~~cL~~dP~~Rp-----Ta~elL~hpff~~~~~~~ 274 (577)
+++|...+|.+||.+|. +++++.+||||+.+.+..
T Consensus 417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred HHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 99999999999999997 568999999999876543
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=339.20 Aligned_cols=250 Identities=32% Similarity=0.533 Sum_probs=208.6
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHH-HhCCCCceeEeEEEEEeCCEEEEEEeccC
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVL-SQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL-~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~ 94 (577)
++.||.|+||.||+|.+..+++.||||++..... ......+..|..++ ..+.||||+++++++..++.+|+||||++
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 3679999999999999999999999999865432 22233445555544 45589999999999999999999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCC
Q 008116 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (577)
Q Consensus 95 gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GT 174 (577)
+++|..++....++++..+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++..... .....|+
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~ 156 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGT 156 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCC
Confidence 999999998878899999999999999999999999999999999999999999999999999865432 2345789
Q ss_pred CCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC---CCCCchhhhhHHHHHHHHHhcccC
Q 008116 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---NPPQLDEHFSRLMKEFVSLCLKKV 251 (577)
Q Consensus 175 p~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~---~~~~l~~~~s~~l~~lI~~cL~~d 251 (577)
+.|+|||++.+.. ++.++||||||+++|+|++|.+||...+.......+... .+......++..+.+||.+||..+
T Consensus 157 ~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 157 PDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred cCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 9999999987764 889999999999999999999999876655433333211 223334467899999999999999
Q ss_pred CCCCCc---HHHHhhcHhhhhccC
Q 008116 252 PAERPS---AKELLRHRFIRNARK 272 (577)
Q Consensus 252 P~~RpT---a~elL~hpff~~~~~ 272 (577)
|++||+ +.++|.||||.+..+
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HHHccCCCcHHHHHcChHhhcCCC
Confidence 999995 479999999987543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=367.29 Aligned_cols=236 Identities=31% Similarity=0.546 Sum_probs=210.8
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCC
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGS 97 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGs 97 (577)
++-||.|+.|.||+|... ++.||||+++. .-..+|..|++|+||||+.|.|+|...-.+|||||||..|.
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e--------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE--------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh--------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 667999999999999776 78999998752 23457899999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCCCC
Q 008116 98 VADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFW 177 (577)
Q Consensus 98 L~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y 177 (577)
|.++|+.+.+++...+..|..+|+.|+.|||.++|||||||.-||||..+..|||+|||-++.+... ...-.++||..|
T Consensus 199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaW 277 (904)
T KOG4721|consen 199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAW 277 (904)
T ss_pred HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhh
Confidence 9999999999999999999999999999999999999999999999999999999999999877655 333468999999
Q ss_pred CChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCchhhhhHHHHHHHHHhcccCCCCCC
Q 008116 178 MAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDEHFSRLMKEFVSLCLKKVPAERP 256 (577)
Q Consensus 178 ~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~l~~~~s~~l~~lI~~cL~~dP~~Rp 256 (577)
||||++.+.+ ++.|+|||||||||||||||..||.+.+...++.-+-.+. ...++..+++-++-||++||.-.|..||
T Consensus 278 MAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRP 356 (904)
T KOG4721|consen 278 MAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRP 356 (904)
T ss_pred hCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCc
Confidence 9999998865 9999999999999999999999999988776655443222 2345678889999999999999999999
Q ss_pred cHHHHhhcH
Q 008116 257 SAKELLRHR 265 (577)
Q Consensus 257 Ta~elL~hp 265 (577)
++.+||.|.
T Consensus 357 SFrqil~Hl 365 (904)
T KOG4721|consen 357 SFRQILLHL 365 (904)
T ss_pred cHHHHHHHH
Confidence 999999984
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=338.05 Aligned_cols=253 Identities=36% Similarity=0.677 Sum_probs=216.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC----ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC--CEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKL 86 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~----~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~--~~~ 86 (577)
.+|++.+.||+|+||.||+|.+..++..||||.+.... .......+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 58999999999999999999999999999999875432 234457889999999999999999999998764 568
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~- 165 (577)
++||||+.+++|.+++...+.+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 9999999999999999877789999999999999999999999999999999999999999999999999987653211
Q ss_pred --cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-CCCCCchhhhhHHHHH
Q 008116 166 --SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-ENPPQLDEHFSRLMKE 242 (577)
Q Consensus 166 --~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~-~~~~~l~~~~s~~l~~ 242 (577)
.......|++.|+|||++.+. .++.++|||||||++|+|++|.+||...........+.. ...+.++..++..+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 112245789999999998765 488899999999999999999999987655444433332 2344567788999999
Q ss_pred HHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 243 FVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
||.+||. +|.+||++.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.77 Aligned_cols=250 Identities=27% Similarity=0.367 Sum_probs=203.4
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
.+..|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++|+|||||++++++..++..||||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 35689999999999999999999999999999996422 34578999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc--
Q 008116 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-- 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~-- 167 (577)
|++. ++|..++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 9994 688888865 357999999999999999999999999999999999999999999999999998765432111
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--------ceeeccCC------CCCC---
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM--------RVLFIIPR------ENPP--- 230 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~--------~~~~~i~~------~~~~--- 230 (577)
....+||+.|+|||++.+.. ++.++|||||||+||||++|..|+...... .....+.. ..+.
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred ccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 12457999999999997764 899999999999999999988765332110 00011100 0000
Q ss_pred ----------------------Cch--hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 231 ----------------------QLD--EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 231 ----------------------~l~--~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
... ..++..+.+||.+||..||.+|||+.|||+||||+.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000 124557899999999999999999999999999964
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=355.92 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=210.4
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC--
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-- 84 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~-- 84 (577)
.-....+|++++.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.++++++||||++++++|....
T Consensus 11 ~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 11 TFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 3356789999999999999999999999999999999986543 2334566788999999999999999999986543
Q ss_pred ----EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccc
Q 008116 85 ----KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 85 ----~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
..|+||||+. ++|.+.+... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 5799999995 5898888653 89999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--------------
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------------- 226 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~-------------- 226 (577)
.... .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+..
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 168 AGTS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCC-CCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 5432 222345789999999999775 489999999999999999999999976543211111000
Q ss_pred ------------CCCC----------------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 227 ------------ENPP----------------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 227 ------------~~~~----------------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.... ......+..+++||.+||..||.+|||+.++|.||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 0000 0011345678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=348.55 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=208.8
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcE--EEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKD--VAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~--VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~L 88 (577)
-++|++.+.||+|+||.||+|.+..++.. +|+|.+...........+.+|+.++.++ +||||+++++++..++.+|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 35899999999999999999998877754 5777766544455567889999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeee
Q 008116 89 IMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKV 152 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL 152 (577)
||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 99999999999999643 25789999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCC
Q 008116 153 ADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQ 231 (577)
Q Consensus 153 ~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~ 231 (577)
+|||++....... ......+++.|+|||++... .++.++|||||||+||+|++ |.+||...+..+....+.......
T Consensus 166 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd05088 166 ADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 243 (303)
T ss_pred CccccCcccchhh-hcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCC
Confidence 9999985432111 11122346679999998765 48899999999999999998 999998766555444444433333
Q ss_pred chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 232 l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.+..++..+.+||.+||..+|.+||++.++|.+
T Consensus 244 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 244 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 445578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.00 Aligned_cols=259 Identities=25% Similarity=0.424 Sum_probs=213.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-----C
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----T 84 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~-----~ 84 (577)
+..+|++++.||+|+||.||+|.+..++..||||.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 4678999999999999999999999999999999986532 222345677899999999999999999988654 3
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
.+|||+||+. ++|.+++...+.+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999995 799999988888999999999999999999999999999999999999999999999999998766443
Q ss_pred ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee---------------c------
Q 008116 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF---------------I------ 223 (577)
Q Consensus 165 ~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~---------------~------ 223 (577)
........|+..|+|||++.....++.++|||||||++|+|++|.+||...+...... .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 3333456789999999998764458899999999999999999999997543211000 0
Q ss_pred ------cCCCCCC---CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 224 ------IPRENPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 224 ------i~~~~~~---~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
+...... .....++..+.+||.+||..+|.+|||+.++|+||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000000 1123567889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=345.95 Aligned_cols=252 Identities=27% Similarity=0.434 Sum_probs=214.2
Q ss_pred cCCCeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEe----CC
Q 008116 11 AGSRFSSL-ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH----QT 84 (577)
Q Consensus 11 ~~~~f~il-~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~----~~ 84 (577)
+..+|.+- ++||-|-.|.|..+.++.|++.+|+|++... ...++||++.... .|||||.++++|.. ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 45667664 6899999999999999999999999998532 5678999988777 69999999998863 45
Q ss_pred EEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC---CCeeeccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSA 159 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~---g~vKL~DFGls~ 159 (577)
++.+|||.|+||.|+..|+..+ .|+|.++..|++||+.||.|||+.+|+||||||+|+|.... ..+||+|||||+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 7899999999999999997654 59999999999999999999999999999999999999754 469999999998
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccce----eeccCC---CCCCCc
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV----LFIIPR---ENPPQL 232 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~----~~~i~~---~~~~~l 232 (577)
..... ....+.|-||+|+|||++... .|+..+|+||+||+||.||+|++||...+.... ...|.. .+|..-
T Consensus 213 ~t~~~-~~L~TPc~TPyYvaPevlg~e-KydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 213 ETQEP-GDLMTPCFTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred ccCCC-ccccCCcccccccCHHHhCch-hcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 76543 445578999999999999665 599999999999999999999999987654221 122322 234445
Q ss_pred hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 233 ~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
+..+|..++++|+.+|..+|.+|.|+.+++.|||+...
T Consensus 291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 66889999999999999999999999999999999764
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=343.86 Aligned_cols=255 Identities=24% Similarity=0.467 Sum_probs=214.2
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEe
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH 82 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~t-----g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~ 82 (577)
....++|++.+.||+|+||.||++.+... ...||+|.+...........+.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 44557899999999999999999988643 3789999987665555567789999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQS----------------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE 146 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~----------------~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~ 146 (577)
++.+|+||||+.+|+|..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 9999999999999999999953 246889999999999999999999999999999999999999
Q ss_pred CCCeeeccccccccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeec
Q 008116 147 NGDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFI 223 (577)
Q Consensus 147 ~g~vKL~DFGls~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~ 223 (577)
++.+||+|||++..+...... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||......+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999998765432211 1122346789999998665 48899999999999999997 9999987766555544
Q ss_pred cCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 224 i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+........+..++..+.+|+.+||..+|.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 44444334455677899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.14 Aligned_cols=251 Identities=21% Similarity=0.367 Sum_probs=214.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~t-----g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
.+|++++.||+|+||.||+|.+..+ +..||||+++..........+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4588899999999999999987543 57899999976554445577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCee
Q 008116 88 IIMEYMAGGSVADLIQS----------------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~----------------~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vK 151 (577)
+++||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 99999999999999852 13578889999999999999999999999999999999999999999
Q ss_pred ecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC
Q 008116 152 VADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228 (577)
Q Consensus 152 L~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~ 228 (577)
|+|||++........ ......+++.|+|||++.... ++.++|||||||++|||++ |..||......+....+....
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999876533221 112345678999999987654 8899999999999999998 889998877766666666655
Q ss_pred CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 229 ~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
...++..++..+.+|+..||+.+|.+||++.+|+..
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 244 VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 555667889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=344.45 Aligned_cols=252 Identities=31% Similarity=0.493 Sum_probs=209.6
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEecc
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
|++++.||.|++|.||+|.+..+|..||||++...... .....+.+|+.+++.++||||+++++++.++...|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 78899999999999999999999999999998755422 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 94 AGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 94 ~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
. ++|.+++.... .+++..+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++.............
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 4 68999987655 79999999999999999999999999999999999999999999999999987654333333344
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc-------------------------CC
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------------------------PR 226 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i-------------------------~~ 226 (577)
.+++.|+|||++.+...++.++||||||+++|+|++|.+||...+.......+ ..
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence 67899999998876555788999999999999999999999765432211110 00
Q ss_pred CCC---CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 227 ENP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 227 ~~~---~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
... ......++..+.+||.+||+.+|.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 000 11123566889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=335.37 Aligned_cols=251 Identities=35% Similarity=0.558 Sum_probs=221.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+|++.+.||.|+||.||++.+..++..||||.+.... .......+.+|+.+++.++||||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999999999999987543 334456778999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 93 MAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 93 ~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
+++++|..++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~ 158 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MA 158 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--Cc
Confidence 999999999865 457899999999999999999999999999999999999999999999999998766543 22
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
....|++.|++||.+.+. .++.++|+||||+++|+|++|+.||...+.......+.....+.++..++.+++++|.+||
T Consensus 159 ~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237 (256)
T ss_pred ccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHc
Confidence 345789999999998765 4888999999999999999999999887765555555555555666688899999999999
Q ss_pred ccCCCCCCcHHHHhhcHhh
Q 008116 249 KKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 249 ~~dP~~RpTa~elL~hpff 267 (577)
..+|.+||++.++++||++
T Consensus 238 ~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 238 QVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCcccCCCHHHHhcCCCC
Confidence 9999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=336.69 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=209.3
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
.+|++++.||+|+||.||+|.++. +..||+|.+..... ....+.+|+.+|+.++||||+++++++.....+|+||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 569999999999999999998764 56799998764432 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-ccc
Q 008116 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKT 170 (577)
Q Consensus 93 ~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~-~~~ 170 (577)
+++|+|.+++.. .+.+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++......... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 999999999964 356899999999999999999999999999999999999999999999999998765332111 112
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
..++..|+|||++.+. .++.++||||||++||+|++ |+.||...+..+....+.....+..+...+..+.+|+.+||.
T Consensus 161 ~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~ 239 (256)
T cd05114 161 AKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWH 239 (256)
T ss_pred CCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcc
Confidence 2456689999998765 48899999999999999999 999998877666655565544444455667889999999999
Q ss_pred cCCCCCCcHHHHhh
Q 008116 250 KVPAERPSAKELLR 263 (577)
Q Consensus 250 ~dP~~RpTa~elL~ 263 (577)
.+|.+||++.+|++
T Consensus 240 ~~p~~Rps~~~l~~ 253 (256)
T cd05114 240 EKPEGRPTFAELLR 253 (256)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=334.20 Aligned_cols=250 Identities=32% Similarity=0.540 Sum_probs=211.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++.+.||.|+||.||+|.+..+++.||+|.++... .......+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999986433 2334577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 91 Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
||+++++|..++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999999853 35689999999999999999999999999999999999999999999999999876544333
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cceeeccCCCCCCCchh-hhhHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPRENPPQLDE-HFSRLMKEF 243 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~--~~~~~~i~~~~~~~l~~-~~s~~l~~l 243 (577)
......|++.|+|||++.+. .++.++|||||||++|+|++|..||..... ......+.....+..+. .++..+.+|
T Consensus 162 ~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDL 240 (267)
T ss_pred ccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHH
Confidence 33456789999999998765 488899999999999999999999965432 11222222222233333 678899999
Q ss_pred HHHhcccCCCCCCcHHHHhh
Q 008116 244 VSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~ 263 (577)
|.+||..+|.+||++.+|++
T Consensus 241 i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=346.45 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=205.5
Q ss_pred CeeEEeEEeecCceEEEEEEEcC--CCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC--CEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLW 87 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~--tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~--~~~~ 87 (577)
+|++++.||+|+||.||+|.+.. ++..||||.+.... .......+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 89999999987632 122346678899999999999999999999988 8899
Q ss_pred EEEeccCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc----CCCeeecccccc
Q 008116 88 IIMEYMAGGSVADLIQS-----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE----NGDVKVADFGVS 158 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~-----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~----~g~vKL~DFGls 158 (577)
+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 477776642 237899999999999999999999999999999999999999 899999999998
Q ss_pred cccccccc---ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee--------------
Q 008116 159 AQLTRTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-------------- 221 (577)
Q Consensus 159 ~~~~~~~~---~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~-------------- 221 (577)
........ .....++++.|+|||++.+...++.++|||||||+||+|++|.+||.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76543322 1234578999999999877656889999999999999999999999755432200
Q ss_pred -------------------ec---c-CCC-CC-CCchh------hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 222 -------------------FI---I-PRE-NP-PQLDE------HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 222 -------------------~~---i-~~~-~~-~~l~~------~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
.. . ... .+ ..+.. ..+..+.+||.+||..+|.+|||+.+++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00 0 000 00 00101 345679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=338.33 Aligned_cols=250 Identities=26% Similarity=0.457 Sum_probs=213.3
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..+|.+.+.||+|+||.||+|.+..++..||+|.+.... .....+.+|+.+++.++||||+++++++..+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 457999999999999999999999999999999986432 235678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc-
Q 008116 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR- 168 (577)
Q Consensus 92 y~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~- 168 (577)
|+++++|.+++... ..+++..++.++.|++.||.|||+++++||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 99999999999653 468999999999999999999999999999999999999999999999999987654322111
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+.....+..+..++..+.+||.+|
T Consensus 163 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 241 (263)
T cd05052 163 AGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRAC 241 (263)
T ss_pred CCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 122346789999998765 48889999999999999998 9999987666555455544444555667889999999999
Q ss_pred cccCCCCCCcHHHHhhc
Q 008116 248 LKKVPAERPSAKELLRH 264 (577)
Q Consensus 248 L~~dP~~RpTa~elL~h 264 (577)
|..+|.+||++.++++.
T Consensus 242 l~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 242 WQWNPSDRPSFAEIHQA 258 (263)
T ss_pred ccCCcccCCCHHHHHHH
Confidence 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=345.92 Aligned_cols=250 Identities=26% Similarity=0.437 Sum_probs=210.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCc--EEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~--~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV 89 (577)
++|++.++||+|+||.||+|.+..++. .+++|.++........+.+.+|+.+++++ +||||+++++++.....+|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999999877765 47888887544444567789999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeec
Q 008116 90 MEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~ 153 (577)
|||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 9999999999999653 248899999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCc
Q 008116 154 DFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQL 232 (577)
Q Consensus 154 DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l 232 (577)
|||++........ ......+..|+|||++.... ++.++|||||||++|+|++ |.+||...........+........
T Consensus 162 dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (297)
T cd05089 162 DFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239 (297)
T ss_pred CcCCCccccceec-cCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 9999754321111 11123355799999987654 8899999999999999997 9999988776655555555444445
Q ss_pred hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 233 ~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+..++..+.+||.+||..+|.+||++.++++.
T Consensus 240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=338.13 Aligned_cols=248 Identities=33% Similarity=0.565 Sum_probs=212.6
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCH
Q 008116 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (577)
Q Consensus 21 IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL 98 (577)
||.|+||.||+|.+..+++.||||++..... ......+.+|+.+++++.||||+++++++..+..+|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999999999999999865432 24567889999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc--------cccc
Q 008116 99 ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--------RRKT 170 (577)
Q Consensus 99 ~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~--------~~~~ 170 (577)
.+++.+.+.+++..+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998877899999999999999999999999999999999999999999999999999875433211 2234
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchh--hhhHHHHHHHHHhc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE--HFSRLMKEFVSLCL 248 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~--~~s~~l~~lI~~cL 248 (577)
..+++.|++||++.... ++.++||||||+++|+|++|..||...........+..... ..+. .++..+.+||.+||
T Consensus 161 ~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l 238 (265)
T cd05579 161 IVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISKLL 238 (265)
T ss_pred cccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-CCCccccCCHHHHHHHHHHh
Confidence 57889999999987654 88899999999999999999999987766554444333221 1222 24889999999999
Q ss_pred ccCCCCCCcH---HHHhhcHhhhhc
Q 008116 249 KKVPAERPSA---KELLRHRFIRNA 270 (577)
Q Consensus 249 ~~dP~~RpTa---~elL~hpff~~~ 270 (577)
..+|.+|||+ .++|+||||..+
T Consensus 239 ~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 239 VPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred cCCHhhcCCCccHHHHhcCccccCC
Confidence 9999999999 999999999865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=343.08 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=211.9
Q ss_pred CCCeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
..+|.+.+.||+|+||.||++.+ ..++..||+|.+.... ......+.+|+.+++++.||||+++++++.....+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 35799999999999999999985 3345679999886543 34457789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeec
Q 008116 87 WIIMEYMAGGSVADLIQSGP-------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~-------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~ 153 (577)
|+||||+++++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 99999999999999996433 48999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCC
Q 008116 154 DFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPP 230 (577)
Q Consensus 154 DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~ 230 (577)
|||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++ |.+||...........+......
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~ 241 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999876532211 11233457889999998765 48899999999999999998 99999887766555555555555
Q ss_pred CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 231 ~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
..+..++..+.+|+.+||.++|.+|||+.+++.
T Consensus 242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 555677889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=347.27 Aligned_cols=261 Identities=39% Similarity=0.685 Sum_probs=218.1
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccC
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~ 94 (577)
|....+||+|+||.||++.+..++..||||.+.... ......+.+|+.+++.++||||+++++++..++..|+||||++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 344568999999999999999999999999986443 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCC
Q 008116 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (577)
Q Consensus 95 gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GT 174 (577)
+++|.+++.. ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..............|+
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence 9999998865 578999999999999999999999999999999999999999999999999987654433333456789
Q ss_pred CCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--chhhhhHHHHHHHHHhcccCC
Q 008116 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEFVSLCLKKVP 252 (577)
Q Consensus 175 p~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--l~~~~s~~l~~lI~~cL~~dP 252 (577)
+.|+|||++.+. .++.++|+||||+++|+|++|.+||...........+....+.. ....++..+.+||.+||..+|
T Consensus 180 ~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 180 PYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred ccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence 999999998765 47889999999999999999999998765544333332222222 123567889999999999999
Q ss_pred CCCCcHHHHhhcHhhhhccCChhHHH
Q 008116 253 AERPSAKELLRHRFIRNARKSPRLLE 278 (577)
Q Consensus 253 ~~RpTa~elL~hpff~~~~~~~~~~~ 278 (577)
.+||++.++|.||||.........++
T Consensus 259 ~~R~~~~~ll~~~~~~~~~~~~~~~~ 284 (292)
T cd06657 259 AQRATAAELLKHPFLAKAGPPSCIVP 284 (292)
T ss_pred ccCcCHHHHhcChHHhccCCCccccc
Confidence 99999999999999988765444333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=342.46 Aligned_cols=257 Identities=36% Similarity=0.628 Sum_probs=211.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.+|+.++.||+|+||.||++.+..++..||||.+...........+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 467788899999999999999999999999999976655555677899999999995 9999999999999999999999
Q ss_pred ccCCCCHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 92 YMAGGSVADLIQ-----SGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 92 y~~gGsL~~~l~-----~~~~l~e~~i~~il~QLl~aL~yLHs~-gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
|+. ++|..+.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 995 46555432 246799999999999999999999974 99999999999999999999999999987654332
Q ss_pred cccccccCCCCCCChhhhhcc--cCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccCCCCCCCc----hhhhhH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQL----DEHFSR 238 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~--~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~-~~~~~~i~~~~~~~l----~~~~s~ 238 (577)
. .....|++.|+|||++.+. ..++.++|||||||++|+|++|++||..... ......+....++.+ ...++.
T Consensus 163 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd06616 163 A-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSP 241 (288)
T ss_pred c-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCH
Confidence 2 2334789999999998765 3588999999999999999999999976542 111122222222222 234788
Q ss_pred HHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 239 LMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 239 ~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.+.+||.+||.++|.+|||+.+|+.||||+...
T Consensus 242 ~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 242 SFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=340.27 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=210.4
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
...+|++++.||.|+||+||+|.+..++. .||||++...........+.+|+.+++.+.||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 35789999999999999999999877666 4899998766666666788999999999999999999998875 457
Q ss_pred EEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
++++||+++|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 899999999999999976 3579999999999999999999999999999999999999999999999999987664322
Q ss_pred ccc--ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHH
Q 008116 166 SRR--KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (577)
Q Consensus 166 ~~~--~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~ 242 (577)
... ....+++.|+|||++.+. .++.++|||||||++|||++ |.+||...........+.....+..+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred ceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHH
Confidence 211 122346789999998765 48899999999999999998 99999876554444444443444445567889999
Q ss_pred HHHHhcccCCCCCCcHHHHhh
Q 008116 243 FVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~ 263 (577)
+|.+||..+|..||++.+++.
T Consensus 243 li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 243 IMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=342.28 Aligned_cols=247 Identities=32% Similarity=0.584 Sum_probs=208.0
Q ss_pred eEEeEEeecCceEEEEEEEc----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 16 SSLELIGRGSFGDVYKAFDK----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 16 ~il~~IG~GsfG~Vy~a~~~----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++.+.||.|.||.||+|.+. ..+..|+||.+.........+.+.+|+.++++++||||+++++++...+.+++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 57889999999999999987 45678999999765566667899999999999999999999999998888999999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc--cc
Q 008116 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SR 167 (577)
Q Consensus 92 y~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~--~~ 167 (577)
||++|+|.++|... ..+++..++.|+.||+.||.|||+++++|++|+|.|||++.++.+||+|||++....... ..
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999875 689999999999999999999999999999999999999999999999999987762211 11
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....+...|+|||.+.... ++.++||||||++||||++ |..||...+.......+........+..++..+.++|..
T Consensus 162 ~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (259)
T PF07714_consen 162 DSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQ 240 (259)
T ss_dssp STTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHH
T ss_pred cccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHH
Confidence 22345678899999998765 8999999999999999999 789999887776666665555555667789999999999
Q ss_pred hcccCCCCCCcHHHHhh
Q 008116 247 CLKKVPAERPSAKELLR 263 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~ 263 (577)
||..+|.+||++.+|++
T Consensus 241 C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 241 CWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HT-SSGGGS--HHHHHH
T ss_pred HcCCChhhCcCHHHHHh
Confidence 99999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=341.39 Aligned_cols=253 Identities=30% Similarity=0.525 Sum_probs=218.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~LV 89 (577)
++|.+.+.||.|+||.||+|.+..++..||||++.... .......+.+|+.+++++. ||||+++++++...+.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999986533 2234567889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc----
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI---- 165 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~---- 165 (577)
|||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 9999999999999887899999999999999999999999999999999999999999999999999987654322
Q ss_pred ----------------cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC
Q 008116 166 ----------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP 229 (577)
Q Consensus 166 ----------------~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~ 229 (577)
.......|++.|+|||++... .++.++||||||+++++|++|..||...........+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~ 238 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK-LE 238 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-cC
Confidence 122345688999999998765 488899999999999999999999987764333333321 22
Q ss_pred CCchhhhhHHHHHHHHHhcccCCCCCCcH----HHHhhcHhh
Q 008116 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSA----KELLRHRFI 267 (577)
Q Consensus 230 ~~l~~~~s~~l~~lI~~cL~~dP~~RpTa----~elL~hpff 267 (577)
..++..++..+.+||..||..+|.+||++ .+||+||||
T Consensus 239 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 23445668899999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=342.24 Aligned_cols=249 Identities=26% Similarity=0.454 Sum_probs=210.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
+|++.+.||+|+||.||+|.+.. ....||+|.+...........+.+|+.+++.+.||||+++++.+...+..|+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 2357999998766555566789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE
Q 008116 89 IMEYMAGGSVADLIQSG------------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL 144 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~------------------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl 144 (577)
||||+.+++|.+++... .++++..++.++.|++.||.|||+++|+||||||+||||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999998542 247889999999999999999999999999999999999
Q ss_pred ccCCCeeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCcccee
Q 008116 145 TENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL 221 (577)
Q Consensus 145 d~~g~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~ 221 (577)
+.++.+||+|||++........ ......++..|+|||++.+. .++.++||||||+++|+|++ |..||....+....
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999876533221 11223467789999998765 48899999999999999998 99999877765554
Q ss_pred eccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 222 ~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
..+........+..++..+.+|+..||..+|.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 444443334445667889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=337.82 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=211.6
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCC---cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
..+|++.+.||+|+||.||+|.+..++ ..||||.++..........+.+|+.++++++||||+++++++..++.+|+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 368999999999999999999886444 37999998765555556788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
||||+++++|.+++... ..+++..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||++..+......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999999999754 56899999999999999999999999999999999999999999999999998766433221
Q ss_pred cc---cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHH
Q 008116 168 RK---TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (577)
Q Consensus 168 ~~---~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~l 243 (577)
.. ...+++.|+|||++.+. .++.++|+|||||++|+|++ |..||......+....+........+..++..+.+|
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQL 241 (267)
T ss_pred eeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHH
Confidence 11 12235689999999765 48999999999999999886 999998776655444444443334445678899999
Q ss_pred HHHhcccCCCCCCcHHHHhh
Q 008116 244 VSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~ 263 (577)
+.+||.++|.+||++.++++
T Consensus 242 i~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 242 MLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHcccCchhCCCHHHHHH
Confidence 99999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=339.67 Aligned_cols=250 Identities=27% Similarity=0.426 Sum_probs=215.1
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
...+|+++++||.|+||.||+|.+.. +..||+|++..... .....+.+|+.+++.++||||+++++++.....+|+||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 45679999999999999999999987 88999999875543 23467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 91 EYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 91 Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 99999999999975 3568999999999999999999999999999999999999999999999999987664332222
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
....+++.|+|||++... .++.++||||||+++|+|++ |..||...+..+....+........+..++..+.++|.+|
T Consensus 162 ~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 240 (261)
T cd05148 162 SDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC 240 (261)
T ss_pred cCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHH
Confidence 233456789999998765 48889999999999999998 8999987776655555554444455567789999999999
Q ss_pred cccCCCCCCcHHHHhh
Q 008116 248 LKKVPAERPSAKELLR 263 (577)
Q Consensus 248 L~~dP~~RpTa~elL~ 263 (577)
|..+|.+|||+.+|++
T Consensus 241 l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 241 WAAEPEDRPSFKALRE 256 (261)
T ss_pred cCCCchhCcCHHHHHH
Confidence 9999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=345.61 Aligned_cols=253 Identities=23% Similarity=0.433 Sum_probs=211.1
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcC-------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEe
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKE-------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH 82 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~-------tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~ 82 (577)
...+|.+.+.||+|+||.||+|.+.. +...||+|.+...........+.+|+.+++.+ +||||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 34789999999999999999998643 23579999997655445567788999999999 79999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE 146 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~ 146 (577)
...+|+||||+.+|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 99999999999999999999653 24788999999999999999999999999999999999999
Q ss_pred CCCeeecccccccccccccccc--ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeec
Q 008116 147 NGDVKVADFGVSAQLTRTISRR--KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFI 223 (577)
Q Consensus 147 ~g~vKL~DFGls~~~~~~~~~~--~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~ 223 (577)
++.+||+|||++.......... ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...........
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 9999999999987654321111 122345789999998765 48899999999999999998 8899977665444444
Q ss_pred cCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 224 i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+........+..++..+++||.+||..+|.+||++.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 255 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 44444445556778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=352.45 Aligned_cols=260 Identities=27% Similarity=0.474 Sum_probs=214.1
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEe----CCE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QTK 85 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~----~~~ 85 (577)
++.+|++.+.||.|+||.||+|.+..++..||||++..... ......+.+|+.+|++++||||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 45899999999999999999999999999999999875432 2345677889999999999999999998763 357
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 899999995 6999999877889999999999999999999999999999999999999999999999999987654322
Q ss_pred cc----cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeec------------------
Q 008116 166 SR----RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI------------------ 223 (577)
Q Consensus 166 ~~----~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~------------------ 223 (577)
.. .....|+..|+|||++.....++.++|||||||++|+|++|.+||...+....+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 11 12457899999999987655588999999999999999999999976543211100
Q ss_pred ---------cCCCCCCC---chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 224 ---------IPRENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 224 ---------i~~~~~~~---l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
........ +...++..+.+||.+||+.+|.+||++.+++.||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 00000111 1134578899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=335.99 Aligned_cols=250 Identities=31% Similarity=0.550 Sum_probs=210.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
.+|++.+.||.|+||.||+|.+..++..||||.+.... .......+.+|+.+++.+.||||+++++++..++.++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999999999999999886543 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 91 Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+|||++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998863 35689999999999999999999999999999999999999999999999999876644333
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--ceeeccCCCC-CCCchhhhhHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM--RVLFIIPREN-PPQLDEHFSRLMKEF 243 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~--~~~~~i~~~~-~~~l~~~~s~~l~~l 243 (577)
......|++.|+|||++.+. .++.++||||||+++|+|++|..||...... .....+.... ++.....++..+++|
T Consensus 162 ~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 240 (267)
T ss_pred ccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHH
Confidence 33356799999999998765 4888999999999999999999999654321 2222222222 222334678899999
Q ss_pred HHHhcccCCCCCCcHHHHhh
Q 008116 244 VSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~ 263 (577)
|.+||..+|.+|||+.+|++
T Consensus 241 i~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 241 VNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHhcCCCcccCCCHHHHHH
Confidence 99999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=344.00 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=204.2
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC------
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQT------ 84 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~------ 84 (577)
-++|++++.||+|+||.||+|.+..++..||||.+...... .....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45799999999999999999999999999999998654322 22345678999999999999999999987653
Q ss_pred --EEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 85 --KLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 85 --~~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
..|+||||+. ++|..++... ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 4599999995 5888877653 47899999999999999999999999999999999999999999999999998765
Q ss_pred cccccc----cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc---C---------
Q 008116 162 TRTISR----RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII---P--------- 225 (577)
Q Consensus 162 ~~~~~~----~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i---~--------- 225 (577)
...... .....+++.|+|||++.+...++.++||||||+++|+|++|.+||...+.......+ .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 432211 123567899999999876555788999999999999999999999765432211100 0
Q ss_pred --------------CCCCCCch-----hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 226 --------------RENPPQLD-----EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 226 --------------~~~~~~l~-----~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
........ ...+..+.+||.+||..+|.+|||++++|+||||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00000000 0124667899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=334.12 Aligned_cols=243 Identities=24% Similarity=0.406 Sum_probs=206.5
Q ss_pred eEEeecCceEEEEEEEcCCC---cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
+.||+|+||.||+|.+..++ ..||+|.+...........+.+|+.+++.+.|||||++++++. ...+++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876554 7899999976665455678899999999999999999999875 5568999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc---cc
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT---FV 172 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~---~~ 172 (577)
++|.+++.....+++..+..++.|++.||+|||.++++|+||||+|||++.++.+||+|||++............ ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence 999999988778999999999999999999999999999999999999999999999999998766433222111 12
Q ss_pred CCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccC
Q 008116 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (577)
Q Consensus 173 GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~d 251 (577)
++..|+|||.+... .++.++|||||||+||+|++ |.+||...+.......+....+...+..++..+++||.+||..+
T Consensus 160 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 238 (257)
T cd05060 160 WPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYR 238 (257)
T ss_pred ccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCC
Confidence 34679999998765 48999999999999999998 99999887765555555444444556678899999999999999
Q ss_pred CCCCCcHHHHhh
Q 008116 252 PAERPSAKELLR 263 (577)
Q Consensus 252 P~~RpTa~elL~ 263 (577)
|.+||++.+|++
T Consensus 239 p~~Rp~~~~l~~ 250 (257)
T cd05060 239 PEDRPTFSELES 250 (257)
T ss_pred hhhCcCHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=340.48 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=209.5
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCC----------------cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELN----------------KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg----------------~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~ 75 (577)
.++|++++.||+|+||.||+|.+..++ ..||+|.+.........+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 468999999999999999999876544 5689999887666666788999999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCCHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE
Q 008116 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-----------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL 144 (577)
Q Consensus 76 l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~-----------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl 144 (577)
+++++..+..+++||||+.+++|..++.... .+++..++.++.||+.||.|||+++|+|+||||+|||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 9999999999999999999999999997654 68999999999999999999999999999999999999
Q ss_pred ccCCCeeeccccccccccccc--cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh--CCCCCCCCCccce
Q 008116 145 TENGDVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPPLADLHPMRV 220 (577)
Q Consensus 145 d~~g~vKL~DFGls~~~~~~~--~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt--G~~Pf~~~~~~~~ 220 (577)
+.++.++|+|||++....... .......+++.|+|||++... .++.++|||||||++|+|++ +..||........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 999999999999987653321 112234567889999998765 48999999999999999998 7788876654433
Q ss_pred eeccCCC-------CCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 221 LFIIPRE-------NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 221 ~~~i~~~-------~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
+..+... .....+..++.++.+||.+||..+|.+|||+.+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 2222111 111223456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=334.81 Aligned_cols=249 Identities=24% Similarity=0.428 Sum_probs=210.2
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
...+|++++.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 3468999999999999999999875 467799998764332 3577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-
Q 008116 91 EYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~- 167 (577)
||+.+++|.+++.. ...+++..+..++.||+.||+|||+++++||||||+|||++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999999999964 356889999999999999999999999999999999999999999999999999766432211
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....++..|+|||++.... ++.++|||||||++|+|++ |..||...........+...........++..+.+|+.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKT 239 (261)
T ss_pred cCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 12234567899999987654 8889999999999999998 999998776655555544444434445678899999999
Q ss_pred hcccCCCCCCcHHHHhh
Q 008116 247 CLKKVPAERPSAKELLR 263 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~ 263 (577)
||..+|++||+++++++
T Consensus 240 ~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 240 CWKEKAEERPTFDYLQS 256 (261)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=335.23 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=208.9
Q ss_pred eeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE-----
Q 008116 15 FSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK----- 85 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~t---g~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~----- 85 (577)
|++.+.||+|+||.||+|.+..+ +..||||.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999987643 4789999987654 33456789999999999999999999998876554
Q ss_pred -EEEEEeccCCCCHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccc
Q 008116 86 -LWIIMEYMAGGSVADLIQSG------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (577)
Q Consensus 86 -~~LV~Ey~~gGsL~~~l~~~------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls 158 (577)
.++||||+.+++|..++... ..+++..+..++.||+.||.|||+++++||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999999999998432 36899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhh
Q 008116 159 AQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEH 235 (577)
Q Consensus 159 ~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~ 235 (577)
......... .....+++.|+|||++... .++.++|||||||++|||++ |.+||......+....+........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED 239 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcC
Confidence 765432211 1122356789999998654 48899999999999999999 9999988776665555555555556677
Q ss_pred hhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 236 ~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
++..+.++|.+||..+|.+||++.+++++
T Consensus 240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 240 CLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=335.16 Aligned_cols=243 Identities=24% Similarity=0.415 Sum_probs=206.6
Q ss_pred EEeecCceEEEEEEE--cCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCC
Q 008116 20 LIGRGSFGDVYKAFD--KELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (577)
Q Consensus 20 ~IG~GsfG~Vy~a~~--~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gG 96 (577)
.||+|+||.||+|.+ ..++..||||+++.... ....+.+.+|+.+++.+.||||+++++++. ....++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 45678999999865442 334677899999999999999999999875 45679999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc---cccccC
Q 008116 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR---RKTFVG 173 (577)
Q Consensus 97 sL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~---~~~~~G 173 (577)
+|.+++.....+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++..+...... .....+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 99999987788999999999999999999999999999999999999999999999999998766433221 112234
Q ss_pred CCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCC
Q 008116 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (577)
Q Consensus 174 Tp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP 252 (577)
++.|+|||++... .++.++|||||||++|||++ |.+||...........+.....+..+..++..+++||.+||..+|
T Consensus 161 ~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p 239 (257)
T cd05116 161 PVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239 (257)
T ss_pred CccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCc
Confidence 6789999998654 48889999999999999998 999998877666666666555556667789999999999999999
Q ss_pred CCCCcHHHHhhc
Q 008116 253 AERPSAKELLRH 264 (577)
Q Consensus 253 ~~RpTa~elL~h 264 (577)
.+||++.+|.+.
T Consensus 240 ~~Rp~~~~i~~~ 251 (257)
T cd05116 240 DERPGFAVVELR 251 (257)
T ss_pred hhCcCHHHHHHH
Confidence 999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=339.69 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=208.8
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
..+|++++.||+|+||+||+|.+..++. .|++|.+...........+..|+.+++.+.||||+++++++. ....+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 3689999999999999999999977776 477888754444445577888999999999999999999875 45678
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
+++||+.+|+|.+++.. ...+++..+..|+.||+.||.|||+++++||||||+|||++.++.+||+|||++........
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 99999999999999965 46789999999999999999999999999999999999999999999999999876543221
Q ss_pred --ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHH
Q 008116 167 --RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (577)
Q Consensus 167 --~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~l 243 (577)
......|++.|+|||++.+.. ++.++|||||||++|||++ |..||...........+.....+..+..++..+..+
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMV 243 (279)
T ss_pred ccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHH
Confidence 112345778899999987654 8999999999999999998 999998876654444444444444455567889999
Q ss_pred HHHhcccCCCCCCcHHHHhh
Q 008116 244 VSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~ 263 (577)
+..||..+|.+|||+.++++
T Consensus 244 i~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 244 MVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=353.45 Aligned_cols=253 Identities=25% Similarity=0.416 Sum_probs=207.7
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEe-C
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH-Q 83 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~-~ 83 (577)
...+|++.++||.|+||.||+|.+.. +++.||+|+++........+.+.+|+.+++++ +||||+++++++.. +
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 45689999999999999999997543 45789999997655555567788999999999 89999999998865 4
Q ss_pred CEEEEEEeccCCCCHHHHHHcC----------------------------------------------------------
Q 008116 84 TKLWIIMEYMAGGSVADLIQSG---------------------------------------------------------- 105 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~---------------------------------------------------------- 105 (577)
..++++|||+.+++|.+++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5789999999999999998531
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc--ccccccCCCCCCCh
Q 008116 106 ---PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAP 180 (577)
Q Consensus 106 ---~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~AP 180 (577)
.++++..+..++.||+.||+|||+++|+||||||+||||+.++.++|+|||++..+..... ......+++.|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 2678999999999999999999999999999999999999999999999999987543221 11234567789999
Q ss_pred hhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCcccee-eccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcH
Q 008116 181 EVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL-FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258 (577)
Q Consensus 181 Evl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~-~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa 258 (577)
|++.+.. ++.++|||||||+||+|++ |..||......+.. ..+........+..++..+.+++.+||+.+|++||++
T Consensus 245 E~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 245 ESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred HHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 9997754 8999999999999999998 99999764432221 2222223333445677889999999999999999999
Q ss_pred HHHhhc
Q 008116 259 KELLRH 264 (577)
Q Consensus 259 ~elL~h 264 (577)
.+|++|
T Consensus 324 ~ell~~ 329 (337)
T cd05054 324 SELVEI 329 (337)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=338.78 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=204.0
Q ss_pred CCCeeEEeEE--eecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELI--GRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~I--G~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~L 88 (577)
.++|++.+.+ |.|+||.||++.++.++..+|+|.+....... .|+.....+ +||||++++++|..++.+|+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 4677887777 99999999999999999999999986543211 123233323 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC-Ceeeccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g-~vKL~DFGls~~~~~~~~~ 167 (577)
||||+++++|.+++....++++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 999999999999998877999999999999999999999999999999999999999988 9999999998765432
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccce----eeccCCCCCCCchhhhhHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV----LFIIPRENPPQLDEHFSRLMKEF 243 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~----~~~i~~~~~~~l~~~~s~~l~~l 243 (577)
....|++.|+|||++.+.. ++.++|||||||++|+|++|..||........ ..... .........++..+++|
T Consensus 164 -~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 240 (267)
T PHA03390 164 -SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDF 240 (267)
T ss_pred -ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHH
Confidence 2457899999999997654 88999999999999999999999975433221 11111 22223445688999999
Q ss_pred HHHhcccCCCCCCc-HHHHhhcHhhhh
Q 008116 244 VSLCLKKVPAERPS-AKELLRHRFIRN 269 (577)
Q Consensus 244 I~~cL~~dP~~RpT-a~elL~hpff~~ 269 (577)
|.+||+.+|.+||+ ++++|+||||.+
T Consensus 241 i~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 241 VQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHhccChhhCCchHHHHhcCCcccC
Confidence 99999999999996 699999999963
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=335.82 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=205.1
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCc--EEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC------CE
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNK--DVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------TK 85 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~--~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~------~~ 85 (577)
|.+.++||+|+||.||+|.+..++. .||||.++... .....+.+.+|+.+++.++||||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4577899999999999999887765 69999987643 344567889999999999999999999977532 24
Q ss_pred EEEEEeccCCCCHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~------~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
.++||||+.+|+|..++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 6899999999999998732 2358899999999999999999999999999999999999999999999999987
Q ss_pred cccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhh
Q 008116 160 QLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHF 236 (577)
Q Consensus 160 ~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~ 236 (577)
.+...... .....+++.|+|||++... .++.++|||||||++|+|++ |.+||...........+........+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC 239 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 65432211 1233567889999998765 48899999999999999999 89999876655544444444443445567
Q ss_pred hHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 237 SRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 237 s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+..++++|.+||..+|++|||+.+|+++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 240 LDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=350.37 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=215.8
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC-----EEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-----KLW 87 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~-----~~~ 87 (577)
+|++.+.||.|+||.||+|.+..++..||||.+..... ....+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999875432 334577899999999999999999999998775 789
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc--
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-- 165 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~-- 165 (577)
+||||+. ++|..++....++++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999996 5899999887799999999999999999999999999999999999999999999999999998765442
Q ss_pred -cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-----------------
Q 008116 166 -SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----------------- 227 (577)
Q Consensus 166 -~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~----------------- 227 (577)
.......+++.|+|||++.+...++.++||||||+++|+|++|.+||...+..+....+...
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 12334578999999999987646889999999999999999999999765542211111000
Q ss_pred ----------CC---CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 228 ----------NP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 228 ----------~~---~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.. ..+...++..+.+||.+||.++|.+||++.+++.||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00 001123578899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=348.24 Aligned_cols=254 Identities=32% Similarity=0.551 Sum_probs=204.7
Q ss_pred eEEeec--CceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRG--SFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~G--sfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
..||+| +||+||+|.+..+++.||||++.... .....+.+.+|+.+++.++||||++++++|..+..+|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 99999999999999999999987654 344567889999999999999999999999999999999999999
Q ss_pred CCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc----
Q 008116 96 GSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK---- 169 (577)
Q Consensus 96 GsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~---- 169 (577)
++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.++++||+.+...........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 9999998753 3589999999999999999999999999999999999999999999999986543322111111
Q ss_pred ---cccCCCCCCChhhhhcc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC------------------
Q 008116 170 ---TFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------------ 227 (577)
Q Consensus 170 ---~~~GTp~Y~APEvl~~~-~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~------------------ 227 (577)
...++..|+|||++.+. ..++.++|||||||++|+|++|.+||...........+...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 12356679999998753 34788999999999999999999999765322111100000
Q ss_pred ----------------------------CCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 228 ----------------------------NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 228 ----------------------------~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
........++..+.+||.+||..||.+|||+.++|+||||.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 001112346788999999999999999999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.24 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=208.9
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..+|++++.||+|+||.||+|.+.. +..||||.+..... ....+.+|+.++++++||||+++++++.....+|+|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 3579999999999999999998764 45699998864432 23668899999999999999999999999899999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-cc
Q 008116 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~-~~ 169 (577)
|+.+++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++......... ..
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99999999999753 47899999999999999999999999999999999999999999999999998765432111 11
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
...++..|+|||++.+.. ++.++|||||||+||+|++ |..||...+.......+........+...+..+++++.+||
T Consensus 160 ~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 238 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCW 238 (256)
T ss_pred CCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 123556799999997654 8899999999999999998 99999877665544455444444445567889999999999
Q ss_pred ccCCCCCCcHHHHhhc
Q 008116 249 KKVPAERPSAKELLRH 264 (577)
Q Consensus 249 ~~dP~~RpTa~elL~h 264 (577)
..+|.+||++.+|+.+
T Consensus 239 ~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 239 HEKAEERPTFQQLLSS 254 (256)
T ss_pred CCCcccCCCHHHHHHh
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=333.52 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=212.5
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~---~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
.++|+..+.||+|+||.||+|.+..++. .||||.+.........+.+..|+.+++++.||||+++++++...+..|+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4689999999999999999999876654 7999998766555556788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
||||+++++|..++.. ...+++..+..++.|++.||.|||+++++|+||||+|||++.++.+||+|||++.........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 9999999999999965 467899999999999999999999999999999999999999999999999998765432221
Q ss_pred ccc---ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHH
Q 008116 168 RKT---FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (577)
Q Consensus 168 ~~~---~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~l 243 (577)
... ...++.|+|||++... .++.++|||||||++|+|++ |..||...........+...........++..+.+|
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 242 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQL 242 (268)
T ss_pred ceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 111 1234579999998765 48899999999999999997 999998776655555554443434445678899999
Q ss_pred HHHhcccCCCCCCcHHHHhh
Q 008116 244 VSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~ 263 (577)
+.+||..+|..||++.+|++
T Consensus 243 i~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 243 MLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.23 Aligned_cols=249 Identities=24% Similarity=0.428 Sum_probs=210.3
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
...+|++.+.||+|+||.||+|.+.. +..||||.+..... ....+.+|+.++++++||||+++++++.....+|+||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 35689999999999999999998754 57899999865432 2466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
||+.+++|.+++.... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999999997643 68999999999999999999999999999999999999999999999999987664321111
Q ss_pred -ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 169 -KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 169 -~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
....++..|+|||++.+. .++.++||||||+++|+|++ |+.||...........+........+..++..+.+|+.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 161 REGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred cCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 111234579999998765 48899999999999999999 999998877665555554444444455678999999999
Q ss_pred hcccCCCCCCcHHHHhh
Q 008116 247 CLKKVPAERPSAKELLR 263 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~ 263 (577)
||..+|.+||++.+|++
T Consensus 240 ~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 240 CWKEDPDDRPTFETLQW 256 (261)
T ss_pred HhhcCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=350.42 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=212.9
Q ss_pred hcCCCeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-------------HHHHHHHHHHHHHhCCCCceeE
Q 008116 10 AAGSRFSSL-ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-------------EIEDIQKEISVLSQCRSPYITE 75 (577)
Q Consensus 10 ~~~~~f~il-~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~-------------~~~~i~~Ev~iL~~L~HpnIV~ 75 (577)
...++|..+ +.||.|+||+||+|.+..+++.||||++....... ....+.+|+.++++++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 456788755 77999999999999999999999999986543211 0124778999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccc
Q 008116 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADF 155 (577)
Q Consensus 76 l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DF 155 (577)
+++++..+...|+||||+. |+|.+++.....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999999996 699999988788999999999999999999999999999999999999999999999999
Q ss_pred cccccccc--------------cccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee
Q 008116 156 GVSAQLTR--------------TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL 221 (577)
Q Consensus 156 Gls~~~~~--------------~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~ 221 (577)
|++..... .........+++.|+|||++.+...++.++|||||||++|+|++|.+||...+....+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99876541 1111223457889999999876555788999999999999999999999866543222
Q ss_pred eccCC------------------------CCCCC---chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 222 FIIPR------------------------ENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 222 ~~i~~------------------------~~~~~---l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
..+.. ..+.. .....+..+.+||.+||.++|.+||++.++|.||||+..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 11100 00000 112346789999999999999999999999999999754
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.95 Aligned_cols=243 Identities=26% Similarity=0.420 Sum_probs=205.0
Q ss_pred EEeecCceEEEEEEEc--CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCC
Q 008116 20 LIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGS 97 (577)
Q Consensus 20 ~IG~GsfG~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGs 97 (577)
.||+|+||.||+|.+. ..+..||||++.........+.+.+|+.++++++||||+++++++. ...+++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999875 4456799999976655555677999999999999999999999875 457899999999999
Q ss_pred HHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc---cccC
Q 008116 98 VADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK---TFVG 173 (577)
Q Consensus 98 L~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~---~~~G 173 (577)
|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++........... ...+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 9999864 46799999999999999999999999999999999999999999999999999875543222111 1223
Q ss_pred CCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCC
Q 008116 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (577)
Q Consensus 174 Tp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP 252 (577)
++.|+|||++... .++.++|||||||++|+|++ |.+||...........+.....+.++..++..+.++|.+||..+|
T Consensus 161 ~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~ 239 (257)
T cd05115 161 PLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKW 239 (257)
T ss_pred CcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence 5789999998765 48889999999999999996 999998877766665555555556667788999999999999999
Q ss_pred CCCCcHHHHhhc
Q 008116 253 AERPSAKELLRH 264 (577)
Q Consensus 253 ~~RpTa~elL~h 264 (577)
++||++.+|++.
T Consensus 240 ~~Rp~~~~i~~~ 251 (257)
T cd05115 240 EDRPNFAKVEER 251 (257)
T ss_pred hhCcCHHHHHHH
Confidence 999999999763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=342.09 Aligned_cols=254 Identities=36% Similarity=0.609 Sum_probs=204.5
Q ss_pred EEeec--CceEEEEEEEcCCCcEEEEEEeccC-CChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCC
Q 008116 20 LIGRG--SFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (577)
Q Consensus 20 ~IG~G--sfG~Vy~a~~~~tg~~VAIK~i~~~-~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gG 96 (577)
+||+| +++.||.+.+..+++.||||++... ........+.+|+.+++.++||||+++++++...+..|++|||+.++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 44444 5566777777778999999999765 24456788999999999999999999999999999999999999999
Q ss_pred CHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-------c
Q 008116 97 SVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-------R 167 (577)
Q Consensus 97 sL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-------~ 167 (577)
+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||.+........ .
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 99999975 34689999999999999999999999999999999999999999999999998865532211 1
Q ss_pred cccccCCCCCCChhhhhcc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccceee-cc---------------------
Q 008116 168 RKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-II--------------------- 224 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~-~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~-~i--------------------- 224 (577)
.....++..|+|||++... ..++.++|||||||++|+|++|..||.......... .+
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 1234578899999998653 347889999999999999999999998654321110 00
Q ss_pred -----------CCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCC
Q 008116 225 -----------PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 225 -----------~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
...........++..+.+||..||..+|.+|||+.++|+||||+..+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~ 304 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR 304 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence 0000111223456789999999999999999999999999999877543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=339.68 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=211.2
Q ss_pred CCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
..+|.+.+.||+|+||.||+|.+. .++..|++|.+.... ......+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 457999999999999999999854 345678999875433 33346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCe
Q 008116 87 WIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDV 150 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~v 150 (577)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999996532 38899999999999999999999999999999999999999999
Q ss_pred eecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCC
Q 008116 151 KVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRE 227 (577)
Q Consensus 151 KL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~ 227 (577)
+|+|||++........ ......|++.|+|||++.+. .++.++|||||||++|+|++ |..||...........+...
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence 9999999875533211 12234578899999998765 48889999999999999998 99999877765555555555
Q ss_pred CCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 228 ~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
..+..+..++..+.+|+.+||.++|.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 555555667889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=329.80 Aligned_cols=248 Identities=29% Similarity=0.512 Sum_probs=213.2
Q ss_pred eeEEeEEeecCceEEEEEEEcCCC----cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELN----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg----~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
|++.+.||.|+||.||+|.+...+ ..||+|++...........+..|+.+++.++||||+++++++.+.+..|++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 467899999999999999998766 8999999976655546788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~--l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
||+.+++|.+++..... +++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 99999999999976444 9999999999999999999999999999999999999999999999999987664431111
Q ss_pred c-cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 169 K-TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 169 ~-~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
. ...+++.|+|||.+... .++.++||||||+++|+|++ |.+||...+.......+........+..++..+.+++.+
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQ 239 (258)
T ss_pred cccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 1 12367899999998654 58999999999999999998 899998766655555555555555556688999999999
Q ss_pred hcccCCCCCCcHHHHhh
Q 008116 247 CLKKVPAERPSAKELLR 263 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~ 263 (577)
||..+|.+|||+.++++
T Consensus 240 ~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 240 CWAEDPEDRPTFSELVE 256 (258)
T ss_pred HCcCChhhCcCHHHHHh
Confidence 99999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=343.16 Aligned_cols=254 Identities=24% Similarity=0.436 Sum_probs=212.5
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcC-------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKE-------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSY 80 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~-------tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~ 80 (577)
.....+|.+.+.||+|+||.||+|.+.. ....||+|.+...........+..|+.+++++ .||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 3445799999999999999999997632 34579999987655555677889999999999 699999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE
Q 008116 81 LHQTKLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL 144 (577)
Q Consensus 81 ~~~~~~~LV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl 144 (577)
.....+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 9999999999999999999999652 348889999999999999999999999999999999999
Q ss_pred ccCCCeeecccccccccccccccc--ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCcccee
Q 008116 145 TENGDVKVADFGVSAQLTRTISRR--KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL 221 (577)
Q Consensus 145 d~~g~vKL~DFGls~~~~~~~~~~--~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~ 221 (577)
+.++.+||+|||++.......... ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999987654321111 122345689999998765 48899999999999999999 89999877665555
Q ss_pred eccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 222 ~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
..+........+..++..+++||.+||..+|.+||++.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 555444444455667889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.07 Aligned_cols=252 Identities=27% Similarity=0.467 Sum_probs=212.6
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
...+|++++.||+|+||.||+|.+. .++..||||++...........+.+|+.+++++.||||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3468999999999999999999874 36789999998766555556779999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEE
Q 008116 86 LWIIMEYMAGGSVADLIQSG----------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANIL 143 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~----------------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNIL 143 (577)
+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+++++||||||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 99999999999999999642 24788889999999999999999999999999999999
Q ss_pred EccCCCeeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccce
Q 008116 144 LTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRV 220 (577)
Q Consensus 144 ld~~g~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~ 220 (577)
++.++.++|+|||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++ |..||......+.
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999875432211 11123456779999998765 48999999999999999997 8889987766655
Q ss_pred eeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 221 LFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 221 ~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
...+........+..++..+.+||.+||..+|.+|||+.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 242 IYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 5555544444445567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.90 Aligned_cols=264 Identities=25% Similarity=0.426 Sum_probs=217.1
Q ss_pred cccchhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEE
Q 008116 3 DLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYL 81 (577)
Q Consensus 3 ~l~~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~ 81 (577)
++.+..-...++|++++.||+|+||.||+|.+..++..||||.+.... .......+.+|+.+|++++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07880 5 EVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred hhhhhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeec
Confidence 345556667899999999999999999999999999999999986543 2233456889999999999999999999987
Q ss_pred eCC------EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccc
Q 008116 82 HQT------KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADF 155 (577)
Q Consensus 82 ~~~------~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DF 155 (577)
... .+++||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 85 PDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred CCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeec
Confidence 654 469999999 7899998865 67999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---------
Q 008116 156 GVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR--------- 226 (577)
Q Consensus 156 Gls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~--------- 226 (577)
|++...... .....+++.|+|||++.+...++.++|||||||++|+|++|.+||...+.......+..
T Consensus 163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 163 GLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 998765332 23457899999999987644578899999999999999999999976543221111100
Q ss_pred ------------------CCC---CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 227 ------------------ENP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 227 ------------------~~~---~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..+ ..+...++..+.++|.+||..+|.+|||+.+++.||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 000 011134567899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.02 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=207.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
.+|++.+.||+|+||.||+|.+. ++..+|||.+..... ....+.+|+.++++++||||+++++++......|+||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 46899999999999999999886 467899999864332 235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc-cc
Q 008116 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR-KT 170 (577)
Q Consensus 93 ~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~-~~ 170 (577)
+++++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 999999999965 3578999999999999999999999999999999999999999999999999987654321111 11
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
..++..|+|||++.+. .++.++||||||++||+|++ |.+||......+....+........+..++..+.+|+.+||.
T Consensus 161 ~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 239 (256)
T cd05059 161 TKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWH 239 (256)
T ss_pred CCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 1234579999998765 48899999999999999998 899998766655555554444444555678999999999999
Q ss_pred cCCCCCCcHHHHhhc
Q 008116 250 KVPAERPSAKELLRH 264 (577)
Q Consensus 250 ~dP~~RpTa~elL~h 264 (577)
.+|.+|||+.++++.
T Consensus 240 ~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 240 EKPEDRPAFKKLLSQ 254 (256)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=370.20 Aligned_cols=253 Identities=26% Similarity=0.443 Sum_probs=209.1
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEE-EEEe---C-
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYG-SYLH---Q- 83 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~-~~~~---~- 83 (577)
.-..+++|.++|.+|||+.||+|.+...+..||+|.+-.. .+..+..+.+||++|++|+ |+|||.|++ .... +
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 3345789999999999999999999988899999988655 6777899999999999995 999999999 3322 1
Q ss_pred --CEEEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEccCCCeeeccccc
Q 008116 84 --TKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKVADFGV 157 (577)
Q Consensus 84 --~~~~LV~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~g--IiHrDIKPeNILld~~g~vKL~DFGl 157 (577)
-.++|+||||.||.|-++|.. ...|+|.++++||+|+++||++||... |||||||-|||||..+|++||||||.
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 257899999999999999963 356999999999999999999999987 99999999999999999999999999
Q ss_pred cccccccccccc---------cccCCCCCCChhhhhc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC
Q 008116 158 SAQLTRTISRRK---------TFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR 226 (577)
Q Consensus 158 s~~~~~~~~~~~---------~~~GTp~Y~APEvl~~--~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~ 226 (577)
++-......... ...-||.|+|||++.- ....+.|+|||+|||+||-||....||.......++ .
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl----n 268 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL----N 268 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE----e
Confidence 865433321111 1346999999999752 223788999999999999999999999886543332 2
Q ss_pred CCC-CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 227 ENP-PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 227 ~~~-~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
... .+....++..+++||+.||+.+|.+||++-|++.+-+.
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 221 11124789999999999999999999999999987554
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=330.68 Aligned_cols=245 Identities=27% Similarity=0.439 Sum_probs=211.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
...+|++.+.||.|+||.||+|... ++.||||.+..... ..+.+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 3568999999999999999999875 78999999975543 4678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
||+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+|||++.++.+||+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999999997654 799999999999999999999999999999999999999999999999999876633211
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
...++..|+|||++... .++.++||||||+++|+|++ |..||...........+........+..++..+.+||.+|
T Consensus 158 -~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05039 158 -SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235 (256)
T ss_pred -cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence 23456679999998765 48889999999999999997 9999987766555444444444445566789999999999
Q ss_pred cccCCCCCCcHHHHhh
Q 008116 248 LKKVPAERPSAKELLR 263 (577)
Q Consensus 248 L~~dP~~RpTa~elL~ 263 (577)
|..+|.+||++.+|++
T Consensus 236 l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 236 WELDPAKRPTFKQLRE 251 (256)
T ss_pred hccChhhCcCHHHHHH
Confidence 9999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=337.37 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=210.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
.+|.+.++||+|+||.||+|... .++..||+|.+... .......+.+|+.+++.+.||||+++++++......|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 57889999999999999999743 35678999987644 3445678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeee
Q 008116 88 IIMEYMAGGSVADLIQSGP---------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKV 152 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~---------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL 152 (577)
+||||+.+++|.+++.... .+++..++.++.||+.||+|||++|++||||||+|||++.++.+||
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence 9999999999999997542 4789999999999999999999999999999999999999999999
Q ss_pred cccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCC
Q 008116 153 ADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENP 229 (577)
Q Consensus 153 ~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~ 229 (577)
+|||++........ ......+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||...........+....+
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE 242 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc
Confidence 99999875432211 112234578899999987654 8999999999999999998 9999987766555555544444
Q ss_pred CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 230 ~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
...+..++..+.+||.+||+++|.+||++.+|+.
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 243 LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4555678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=333.80 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=211.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~---~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
++|++.+.||+|+||.||+|.+..++. .||||.+...........+..|+.+++++.||||+++++++..+..+++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 568999999999999999999877664 69999987665565678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-
Q 008116 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~- 167 (577)
|||+.+++|.+++.. .+.+++..++.++.|++.||.|||++|++|+||||+||||+.++.+||+|||++.........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 999999999999975 456899999999999999999999999999999999999999999999999998755432211
Q ss_pred -ccccc---CCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHH
Q 008116 168 -RKTFV---GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (577)
Q Consensus 168 -~~~~~---GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~ 242 (577)
..... .+..|+|||++... .++.++|||||||++|||++ |..||...........+........+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 242 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQ 242 (269)
T ss_pred ccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHH
Confidence 11111 24579999998765 48899999999999999886 99999887665555555444333444567888999
Q ss_pred HHHHhcccCCCCCCcHHHHhh
Q 008116 243 FVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~ 263 (577)
++.+||.++|.+||++.+|+.
T Consensus 243 li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 243 LMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=333.19 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=207.2
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
..++|++.+.||+|+||.||+|.+..+ ..||||.+..... ....+.+|+.+++.++||||+++++++. ....|+||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 79 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence 357899999999999999999988765 4599999875433 2356889999999999999999999874 45689999
Q ss_pred eccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-
Q 008116 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~- 167 (577)
||+.+|+|.+++... ..+++..+..++.||+.||+|||+++|+|+||||+|||++.++.++|+|||++..+......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999999753 45889999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....++..|+|||++.... ++.++|||||||++|+|++ |.+||...........+....+......++..+.+||.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred ccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 11234667899999987654 8999999999999999999 899998776655554444444444456678899999999
Q ss_pred hcccCCCCCCcHHHHhh
Q 008116 247 CLKKVPAERPSAKELLR 263 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~ 263 (577)
||.++|.+||++.++++
T Consensus 239 ~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 239 CWRKEPEERPTFEYLQA 255 (262)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.70 Aligned_cols=257 Identities=26% Similarity=0.469 Sum_probs=208.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-------
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------- 83 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~------- 83 (577)
.+++|++.+.||.|+||.||+|.+..++..||||.+..... .....+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 46899999999999999999999999999999999866543 3457788999999999999999999876653
Q ss_pred -------CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc-CCCeeeccc
Q 008116 84 -------TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADF 155 (577)
Q Consensus 84 -------~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~-~g~vKL~DF 155 (577)
..+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35799999996 699988865 57999999999999999999999999999999999999975 467899999
Q ss_pred ccccccccccc---ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------
Q 008116 156 GVSAQLTRTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------ 226 (577)
Q Consensus 156 Gls~~~~~~~~---~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------ 226 (577)
|++..+..... ......|++.|+|||++.....++.++|||||||++|+|++|..||...++......+..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99876532211 112346889999999876655688899999999999999999999976543222111100
Q ss_pred ------------------CCCC-----CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 227 ------------------ENPP-----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 227 ------------------~~~~-----~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.... .+...++.++.+||.+||..+|.+|||+.+||.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0000 0112467889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=337.50 Aligned_cols=257 Identities=28% Similarity=0.491 Sum_probs=214.1
Q ss_pred CeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeccCCC---hHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEES---EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~---~tg~~VAIK~i~~~~~---~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~ 86 (577)
+|++.+.||.|+||.||+|.+. .+|..||+|++..... ....+.+.+|+.+++++ +||||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999874 4789999999865321 22346778999999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~- 165 (577)
|+||||+++++|.+++....++++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999987653321
Q ss_pred cccccccCCCCCCChhhhhcc-cCCccccchhhHHHHHHHHHhCCCCCCCCCcccee----eccCCCCCCCchhhhhHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL----FIIPRENPPQLDEHFSRLM 240 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~-~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~----~~i~~~~~~~l~~~~s~~l 240 (577)
.......|++.|+|||++... ..++.++||||||+++|+|++|..||......... ..+... .+.++..++..+
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 239 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQEMSALA 239 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-CCCCCccCCHHH
Confidence 122346789999999998653 24678999999999999999999999743322111 111111 223455678899
Q ss_pred HHHHHHhcccCCCCCC-----cHHHHhhcHhhhhcc
Q 008116 241 KEFVSLCLKKVPAERP-----SAKELLRHRFIRNAR 271 (577)
Q Consensus 241 ~~lI~~cL~~dP~~Rp-----Ta~elL~hpff~~~~ 271 (577)
.+|+.+||..+|.+|| ++.+++.||||....
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999999999997 899999999998875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=335.07 Aligned_cols=252 Identities=34% Similarity=0.573 Sum_probs=214.3
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC----ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~----~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
+|.+.+.||+|+||.||++.+..++..+++|+++... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6899999999999999999998877777777765322 222345677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 90 MEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
|||+.+++|..++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988853 457999999999999999999999999999999999999975 679999999987665443
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~ 245 (577)
.......|++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.....+.++..++..+.+||.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence 333456789999999998654 4788999999999999999999999766555444444445555666778899999999
Q ss_pred HhcccCCCCCCcHHHHhhcHhh
Q 008116 246 LCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~hpff 267 (577)
+||..+|.+||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=340.60 Aligned_cols=255 Identities=22% Similarity=0.429 Sum_probs=214.0
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEc-------CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDK-------ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSY 80 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~-------~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~ 80 (577)
.....+|.+.+.||+|+||.||+|.+. ..+..||||.+...........+.+|+.+++.+ .||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 455689999999999999999999753 234579999987554455567899999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE
Q 008116 81 LHQTKLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL 144 (577)
Q Consensus 81 ~~~~~~~LV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl 144 (577)
.....+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 9999999999999999999999653 246788899999999999999999999999999999999
Q ss_pred ccCCCeeeccccccccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCcccee
Q 008116 145 TENGDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL 221 (577)
Q Consensus 145 d~~g~vKL~DFGls~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~ 221 (577)
+.++.+||+|||++......... .....+++.|+|||++.+. .++.++||||||++||+|++ |..||......+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 99999999999998766432211 1233567889999998765 48899999999999999998 88999877666555
Q ss_pred eccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 222 ~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
..+........+..++..+++||.+||..+|.+||++.+|++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 5554444444456778999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=358.17 Aligned_cols=251 Identities=22% Similarity=0.396 Sum_probs=207.5
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTK 85 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~t-----g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~ 85 (577)
.++|++.++||+|+||.||+|.+... +..||||++.........+.+.+|+.+|+++. |||||++++++.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 56788999999999999999987433 34799999976655555678999999999995 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC------------------------------------------------------------
Q 008116 86 LWIIMEYMAGGSVADLIQSG------------------------------------------------------------ 105 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~------------------------------------------------------------ 105 (577)
+|||||||++|+|.++|...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999988531
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC
Q 008116 106 ------------------------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD 149 (577)
Q Consensus 106 ------------------------------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~ 149 (577)
..+++..+..++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE
Confidence 24778888999999999999999999999999999999999999
Q ss_pred eeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCcccee-eccC
Q 008116 150 VKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL-FIIP 225 (577)
Q Consensus 150 vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~-~~i~ 225 (577)
+||+|||++........ ......+++.|+|||++.+. .++.++|||||||+||+|++ |..||......... ..+.
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~ 354 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK 354 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHh
Confidence 99999999876543221 11234577889999998765 48999999999999999997 99999765432222 2233
Q ss_pred CCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 226 ~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
.......+..++..+.+||.+||..+|++||++.+|.+
T Consensus 355 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 355 SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 33333445577899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=341.29 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=209.3
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC---
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT--- 84 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~--- 84 (577)
....++|++.+.||.|+||.||+|.+..+++.||||.++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 3456789999999999999999999999999999999975432 223356788999999999999999999987654
Q ss_pred -------EEEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccc
Q 008116 85 -------KLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFG 156 (577)
Q Consensus 85 -------~~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFG 156 (577)
.+|+|+||+.+ +|..++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999975 77777754 3579999999999999999999999999999999999999999999999999
Q ss_pred cccccccccc-ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---CC----
Q 008116 157 VSAQLTRTIS-RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---EN---- 228 (577)
Q Consensus 157 ls~~~~~~~~-~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~---~~---- 228 (577)
++........ ......+++.|+|||++.+...++.++|||||||++|+|++|++||...+....+..+.. ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 9876644322 112345688899999987655578899999999999999999999976543221111100 00
Q ss_pred ----------------------CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 229 ----------------------PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 229 ----------------------~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
.......++..+.+||..||..+|.+||++.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 000112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=335.10 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=208.6
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC--CEEEEEEe
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLWIIME 91 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~--~~~~LV~E 91 (577)
|++++.||.|+||.||+|.+..++..||||.+.... .......+.+|+.+++++.||||+++++++... +.+|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 789999999999999999999999999999997653 223346688999999999999999999999988 89999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-ccc
Q 008116 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~~~ 169 (577)
|+. ++|..++... ..+++..++.++.||+.||+|||+++++|+||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 996 5899988664 5899999999999999999999999999999999999999999999999999876654321 122
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC----------------------
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---------------------- 227 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~---------------------- 227 (577)
...+++.|+|||.+.+...++.++||||||+++|+|++|..||...+....+..+...
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 3467889999998776555789999999999999999999999765542221111000
Q ss_pred CCCC--------chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 228 NPPQ--------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 228 ~~~~--------l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
.... +...++..+.++|.+||..+|.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0000 011137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=342.07 Aligned_cols=261 Identities=28% Similarity=0.480 Sum_probs=228.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~ 87 (577)
-.++|.++++||+|+|++|.++..+.|.+.||||+++++- ....+.-++.|-.+..+- +||++|-++.+|+.+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3479999999999999999999999999999999997654 334466678888888887 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
+|.||++||+|--++++..+++++.++.+..+|+.||.|||++|||+||||.+|+||+..|++||.|+|+++.--.+...
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence 99999999999999999899999999999999999999999999999999999999999999999999999887777777
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCC-------CCccceeeccCCCCCCCchhhhhHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD-------LHPMRVLFIIPRENPPQLDEHFSRLM 240 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~-------~~~~~~~~~i~~~~~~~l~~~~s~~l 240 (577)
..++||||.|.|||++.+.. |+..+|+|+|||+|+||+.|..||.- .+....+..+.......++..++-.+
T Consensus 408 tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvka 486 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKA 486 (593)
T ss_pred cccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhh
Confidence 78999999999999998865 99999999999999999999999962 22233334444344445566677778
Q ss_pred HHHHHHhcccCCCCCC------cHHHHhhcHhhhhccC
Q 008116 241 KEFVSLCLKKVPAERP------SAKELLRHRFIRNARK 272 (577)
Q Consensus 241 ~~lI~~cL~~dP~~Rp------Ta~elL~hpff~~~~~ 272 (577)
..+++..|.+||.+|. .+.++..|+||+.+.+
T Consensus 487 s~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 487 SHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred HHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 8888889999999996 4688999999997654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.38 Aligned_cols=255 Identities=28% Similarity=0.480 Sum_probs=205.1
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-HHHHHHHHHHHHHhCCCCceeEeEEEEEeC-------
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-EIEDIQKEISVLSQCRSPYITEYYGSYLHQ------- 83 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~-~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~------- 83 (577)
.++|++.+.||.|+||.||+|.+..++..||||.+....... ....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 589999999999999999999999999999999986543222 234577899999999999999999987543
Q ss_pred -CEEEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 84 -TKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 84 -~~~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
..+|+||||+.+ +|...+.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 357999999964 67776654 457999999999999999999999999999999999999999999999999998765
Q ss_pred ccccc-----------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc------
Q 008116 162 TRTIS-----------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------ 224 (577)
Q Consensus 162 ~~~~~-----------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i------ 224 (577)
..... ......|++.|+|||++.+...++.++|||||||++|+|++|++||...+.......+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 33211 1123467899999999876555889999999999999999999999765443211111
Q ss_pred --------------------CCCCCCCch---hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 225 --------------------PRENPPQLD---EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 225 --------------------~~~~~~~l~---~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
....++.+. ..+...+.+||.+||..+|.+|||+.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000111111 1344678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=329.73 Aligned_cols=242 Identities=28% Similarity=0.456 Sum_probs=206.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEE-eCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL-HQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~-~~~~~~LV~E 91 (577)
.+|++.+.||+|+||.||++... +..||+|.+.... ..+.+.+|+.+++++.||||+++++++. .+..+|+|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 47999999999999999999765 7889999986443 3467889999999999999999999764 4567999999
Q ss_pred ccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
|+++++|.++++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~ 157 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---D 157 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC---C
Confidence 999999999997543 48899999999999999999999999999999999999999999999999987543321 2
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
...++..|+|||++... .++.++|||||||++|+|++ |..||...........+.....+..+..++..+.+||.+||
T Consensus 158 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05082 158 TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCW 236 (256)
T ss_pred CCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHh
Confidence 34456789999998765 48889999999999999997 99999877665555555555555566678899999999999
Q ss_pred ccCCCCCCcHHHHhh
Q 008116 249 KKVPAERPSAKELLR 263 (577)
Q Consensus 249 ~~dP~~RpTa~elL~ 263 (577)
..+|.+|||+.++++
T Consensus 237 ~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 237 HLDAATRPSFLQLRE 251 (256)
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=330.33 Aligned_cols=248 Identities=27% Similarity=0.468 Sum_probs=208.1
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
....|+++++||+|+||.||+|.+. +++.||||.+..... ....+.+|+.++++++||||+++++++. ...+|+||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 4578999999999999999999865 477899999875443 2467889999999999999999999874 56789999
Q ss_pred eccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-cc
Q 008116 91 EYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SR 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~-~~ 167 (577)
||+.+++|.+++.. ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 99999999999864 3468999999999999999999999999999999999999999999999999987654221 11
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....++..|+|||++... .++.++||||||+++|+|++ |++||...+.......+........+..++..+.+||.+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05067 160 REGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRL 238 (260)
T ss_pred ccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 1233466789999998765 48889999999999999998 999998776655444444444444556678899999999
Q ss_pred hcccCCCCCCcHHHHhh
Q 008116 247 CLKKVPAERPSAKELLR 263 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~ 263 (577)
||..+|.+||++++|+.
T Consensus 239 ~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 239 CWKEKPEERPTFEYLRS 255 (260)
T ss_pred HccCChhhCCCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=330.80 Aligned_cols=248 Identities=25% Similarity=0.430 Sum_probs=208.3
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
...+|++++.||+|+||.||+|.+. .+..||+|.+..... ..+.+.+|+.++++++||||+++++++. ....|+||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 3468999999999999999999876 466799999865433 2356889999999999999999999875 45689999
Q ss_pred eccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-c
Q 008116 91 EYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~ 167 (577)
||+.+++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++..+..... .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99999999999965 34689999999999999999999999999999999999999999999999999876543211 1
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....++..|+|||++.+. .++.++||||||+++|+|++ |.+||...+..+....+........+..++..+.+|+.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQ 238 (260)
T ss_pred ccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 1123456689999998765 48899999999999999999 999998877666555555554555566788999999999
Q ss_pred hcccCCCCCCcHHHHhh
Q 008116 247 CLKKVPAERPSAKELLR 263 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~ 263 (577)
||.++|.+|||+.+++.
T Consensus 239 ~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 239 CWKKDPEERPTFEYLQS 255 (260)
T ss_pred HcccCcccCcCHHHHHH
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=340.36 Aligned_cols=263 Identities=43% Similarity=0.793 Sum_probs=218.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
....|..+..||+|+||.||+|.+..++..||||.+.... .......+.+|+.+++.++||||+++++++.+....|+
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3455788899999999999999999999999999986543 23345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
||||+. ++|.+++.. ..++++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.... .
T Consensus 99 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----~ 173 (313)
T cd06633 99 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----P 173 (313)
T ss_pred EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC----C
Confidence 999995 577777654 5679999999999999999999999999999999999999999999999999875432 2
Q ss_pred cccccCCCCCCChhhhhc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC-CchhhhhHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP-QLDEHFSRLMKEFV 244 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~--~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~-~l~~~~s~~l~~lI 244 (577)
.....|++.|+|||++.. ...++.++|||||||+||+|++|.+||...+.......+.....+ .....++..+++||
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 235678999999999852 234788999999999999999999999877654444443333222 23345678899999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhhhhccCChhHHH
Q 008116 245 SLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~~~ 278 (577)
.+||.++|.+||++.+++.||||........+.+
T Consensus 254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~~~~ 287 (313)
T cd06633 254 DYCLQKIPQERPASAELLRHDFVRRDRPARVLID 287 (313)
T ss_pred HHHccCChhhCcCHHHHhcCcccCCCchhHHHHH
Confidence 9999999999999999999999987655444433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.00 Aligned_cols=264 Identities=26% Similarity=0.470 Sum_probs=225.9
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
++-..-|..++.||-|+||.|.++...+|...||+|.+.+.. ....+..++.|-.||..-+++-||+||..|++.+++
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 344567899999999999999999999999999999997665 345678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~- 165 (577)
|+||+|++||++-.+|-+.+-|+|..+++|+.+|..|+++.|..|+|||||||+|||||.+|++||.||||++-+.-..
T Consensus 705 YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999986442110
Q ss_pred --------c---------------------------------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHH
Q 008116 166 --------S---------------------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIE 204 (577)
Q Consensus 166 --------~---------------------------------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLye 204 (577)
. .....+||+.|+|||++... +|+..+|+||.||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVILYE 863 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhhHHHHH
Confidence 0 00235799999999999875 59999999999999999
Q ss_pred HHhCCCCCCCCCccceeeccCCCC-CCC--chhhhhHHHHHHHHHhcccCCCCCC---cHHHHhhcHhhhhccCCh
Q 008116 205 MAKGEPPLADLHPMRVLFIIPREN-PPQ--LDEHFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFIRNARKSP 274 (577)
Q Consensus 205 LltG~~Pf~~~~~~~~~~~i~~~~-~~~--l~~~~s~~l~~lI~~cL~~dP~~Rp---Ta~elL~hpff~~~~~~~ 274 (577)
|+.|.+||-...+.+...+|..+. ... ...+++.++.++|.+++ .+++.|. .+++|..||||+.+....
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHh
Confidence 999999999988877766664432 222 23578999999998854 4567886 577899999999886544
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=336.35 Aligned_cols=252 Identities=30% Similarity=0.504 Sum_probs=211.2
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEecc
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
|++++.||.|++|.||+|.+..++..|+||.+...... .....+.+|+.++++++||||+++++++..+..+|+||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999999999999999998755422 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccccc
Q 008116 94 AGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (577)
Q Consensus 94 ~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 172 (577)
.+ +|.+++.. ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 65 88888765 46899999999999999999999999999999999999999999999999999877655432333457
Q ss_pred CCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC--------------------------C
Q 008116 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP--------------------------R 226 (577)
Q Consensus 173 GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~--------------------------~ 226 (577)
++..|+|||.+.+...++.++||||||++||+|++|+.||...+..+....+. .
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 88999999998776468899999999999999999999997655322111110 0
Q ss_pred CCC---CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 227 ENP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 227 ~~~---~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
... ..+...++..+.+||.+||.++|.+||++.+|+.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 000 01223467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=333.42 Aligned_cols=249 Identities=24% Similarity=0.408 Sum_probs=201.4
Q ss_pred CCe-eEEeEEeecCceEEEEEE----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC--CE
Q 008116 13 SRF-SSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TK 85 (577)
Q Consensus 13 ~~f-~il~~IG~GsfG~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~--~~ 85 (577)
++| ++++.||+|+||+||++. ...++..||+|.++..........+.+|+.+|+.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 999999999999998764 34568899999997655444557788999999999999999999988653 46
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
+|+||||+++++|.+++.. ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 8999999999999999976 569999999999999999999999999999999999999999999999999987654322
Q ss_pred cc---cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc--ee-------------eccCCC
Q 008116 166 SR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR--VL-------------FIIPRE 227 (577)
Q Consensus 166 ~~---~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~--~~-------------~~i~~~ 227 (577)
.. .....++..|+|||++... .++.++||||||+++|+|++|..||......- .. ..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 11 1123456779999998765 48899999999999999999999986533210 00 000011
Q ss_pred CCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 228 ~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
.....+..++..+.+|+.+||..+|..|||+.+|+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111234457789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=326.26 Aligned_cols=244 Identities=25% Similarity=0.410 Sum_probs=205.3
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCH
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL 98 (577)
++||.|+||.||+|... ++..||+|.+...........+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 47999999999999865 58899999987665555556788999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc-ccccCCCC
Q 008116 99 ADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR-KTFVGTPF 176 (577)
Q Consensus 99 ~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~-~~~~GTp~ 176 (577)
.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......... ....+++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 999865 3568999999999999999999999999999999999999999999999999986543221111 12244677
Q ss_pred CCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 177 Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
|+|||++... .++.++||||||+++|+|++ |..||...........+........+..++..+.+|+.+||..+|.+|
T Consensus 160 y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (250)
T cd05085 160 WTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238 (250)
T ss_pred ccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 9999998765 48889999999999999998 999998776555444444444444455678999999999999999999
Q ss_pred CcHHHHhhc
Q 008116 256 PSAKELLRH 264 (577)
Q Consensus 256 pTa~elL~h 264 (577)
|++.++++.
T Consensus 239 p~~~~l~~~ 247 (250)
T cd05085 239 PKFSELQKE 247 (250)
T ss_pred CCHHHHHHH
Confidence 999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=339.69 Aligned_cols=259 Identities=44% Similarity=0.785 Sum_probs=217.0
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
.....|+.++.||+|+||.||+|.+..++..||||.+.... .......+.+|+.++++++||||+++++++..+...|
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 34456899999999999999999999999999999986543 2344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~-~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|||||+. |+|.+++. ...++++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++.....
T Consensus 102 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 102 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred EEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 9999996 57777764 356799999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccCCCCCCChhhhhc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCchhhhhHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDEHFSRLMKEF 243 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~--~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~l~~~~s~~l~~l 243 (577)
.....|++.|+|||++.. ...++.++|||||||++|+|++|.+||...........+.... +......++..+++|
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 234578999999999742 2347889999999999999999999998766544444443332 222334678889999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhccCC
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
|.+||..+|.+||++.++++|+|+......
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 999999999999999999999999765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=396.38 Aligned_cols=261 Identities=37% Similarity=0.669 Sum_probs=231.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
+.-++.-.-.||.|.||.||-|.+..+|...|||.++..... .....+.+|..+|..|+|||||++||+-...+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 445667778899999999999999999999999998765533 3467889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc----
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI---- 165 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~---- 165 (577)
||||++|+|.+++..+...+|-....+..|++.||.|||++|||||||||+||||+.+|.+|++|||.|..+....
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999999999999988888888889999999999999999999999999999999999999999999998775442
Q ss_pred cccccccCCCCCCChhhhhccc--CCccccchhhHHHHHHHHHhCCCCCCCCC-ccceeeccCCCCCCCchhhhhHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSE--GYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQLDEHFSRLMKE 242 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~--~~~~ksDVwSLGviLyeLltG~~Pf~~~~-~~~~~~~i~~~~~~~l~~~~s~~l~~ 242 (577)
+.....+|||.|||||++.+.. +...++||||||||++||+||+.||...+ .....+.+..+-.|++|..++.+.++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence 2234678999999999997643 46778999999999999999999998775 45566777777888999999999999
Q ss_pred HHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 243 FVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
||..||..||.+|-++.|||+|.|-+...
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 99999999999999999999998876543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=357.31 Aligned_cols=258 Identities=27% Similarity=0.463 Sum_probs=222.6
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCC
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gG 96 (577)
.++||.|-||+||-|+++.+|+.||||+|++.. ......+++.|+.||.++.||.||.+-..|+..+.+++|||.+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 378999999999999999999999999998765 33445789999999999999999999999999999999999995 5
Q ss_pred CHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC---CCeeeccccccccccccccccccc
Q 008116 97 SVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 97 sL~~~l--~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~---g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
++.+.| .+.+++++.....++.||+.||.|||.++|+|+||||+||||... .++||||||+|+.+... ....+.
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsV 726 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSV 726 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhhh
Confidence 666665 346899999999999999999999999999999999999999654 57999999999988653 456688
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~-~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
+|||.|+|||++++. +|...-||||.|||+|--|+|..||....+ .+.+.....-.|+..+..++..+.+||..+|+.
T Consensus 727 VGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqV 805 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQV 805 (888)
T ss_pred cCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHH
Confidence 999999999999876 599999999999999999999999976533 223333333456777789999999999999999
Q ss_pred CCCCCCcHHHHhhcHhhhhccCChhHHH
Q 008116 251 VPAERPSAKELLRHRFIRNARKSPRLLE 278 (577)
Q Consensus 251 dP~~RpTa~elL~hpff~~~~~~~~~~~ 278 (577)
.-.+|.+.++.|.|||+++...+..+.+
T Consensus 806 km~kRysvdk~lsh~Wlq~yq~w~DLRe 833 (888)
T KOG4236|consen 806 KMRKRYSVDKSLSHPWLQDYQTWLDLRE 833 (888)
T ss_pred HHHHhcchHhhccchhhhcchHHHHHHH
Confidence 9999999999999999998765544433
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=338.64 Aligned_cols=252 Identities=24% Similarity=0.405 Sum_probs=208.8
Q ss_pred cCCCeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCC
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~ 84 (577)
..++|.+.+.||+|+||.||+|.+ ..++..||||.++........+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 345899999999999999999975 3345689999987665555567889999999999 7999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
.+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 999999999999999999753 238999999999999999999999999999999999999999999999999987654
Q ss_pred cccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceee-ccCCCCCCCchhhhhH
Q 008116 163 RTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLF-IIPRENPPQLDEHFSR 238 (577)
Q Consensus 163 ~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~-~i~~~~~~~l~~~~s~ 238 (577)
.... ......+++.|+|||++.... ++.++|||||||++|+|++ |.+||.......... .+........+...+.
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPA 271 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCH
Confidence 3221 111234678899999987654 8899999999999999998 999997765433221 2222223333445678
Q ss_pred HHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 239 LMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 239 ~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
.+.+|+.+||.++|++|||+.+|++
T Consensus 272 ~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 272 EIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=326.74 Aligned_cols=244 Identities=28% Similarity=0.436 Sum_probs=206.6
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCH
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL 98 (577)
++||.|+||.||+|.+.. ++.||+|.+...........+.+|+.+++++.||||+++++++......|+||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 479999999999999987 9999999987665555567899999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc--ccccCCC
Q 008116 99 ADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR--KTFVGTP 175 (577)
Q Consensus 99 ~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~--~~~~GTp 175 (577)
.+++.. ...+++..+..++.|++.||.|||+++++||||||+||||+.++.++|+|||++.......... ....++.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 999965 4568999999999999999999999999999999999999999999999999987554211111 1223456
Q ss_pred CCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCC
Q 008116 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254 (577)
Q Consensus 176 ~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~ 254 (577)
.|+|||++.+. .++.++|||||||++|+|++ |..||...........+........+..++..+.+||.+||..+|.+
T Consensus 160 ~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 238 (251)
T cd05041 160 KWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238 (251)
T ss_pred ccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhh
Confidence 79999998765 48899999999999999998 89999877655444444433334445667889999999999999999
Q ss_pred CCcHHHHhhc
Q 008116 255 RPSAKELLRH 264 (577)
Q Consensus 255 RpTa~elL~h 264 (577)
||++.+|++.
T Consensus 239 Rp~~~ell~~ 248 (251)
T cd05041 239 RPSFSEIYNE 248 (251)
T ss_pred CcCHHHHHHH
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=332.50 Aligned_cols=244 Identities=28% Similarity=0.461 Sum_probs=202.8
Q ss_pred eEEeecCceEEEEEEEcCCCc--EEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~--~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
++||+|+||.||+|.+..++. .+|+|.+.........+.+.+|+.++.++ +||||+++++++.....+|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999988775 46888887544455567889999999999 899999999999999999999999999
Q ss_pred CCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccc
Q 008116 96 GSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 96 GsL~~~l~~~~----------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999996532 47899999999999999999999999999999999999999999999999975
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhH
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSR 238 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~ 238 (577)
...... .......++.|+|||++... .++.++|||||||++|+|++ |..||...+.......+........+..++.
T Consensus 161 ~~~~~~-~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05047 161 GQEVYV-KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD 238 (270)
T ss_pred ccchhh-hccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCH
Confidence 322111 11122346679999998665 48899999999999999997 9999987665554444544444444556788
Q ss_pred HHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 239 LMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 239 ~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.+.+|+.+||..+|.+|||+.+++..
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 239 EVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHH
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.81 Aligned_cols=260 Identities=23% Similarity=0.432 Sum_probs=215.7
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
......++|++...||.|+||.||+|.+..++..||||++.... .......+.+|+.+++++.||||+++++++...+.
T Consensus 9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 34456789999999999999999999999999999999986543 22344667889999999999999999998876554
Q ss_pred ------EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccc
Q 008116 86 ------LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 86 ------~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
+|+|+||+ +++|.+++.. .++++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 7799999876 679999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-------------
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------- 226 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------- 226 (577)
..... .....+++.|+|||++.+...++.++|||||||++|+|++|..||........+..+..
T Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 167 HTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred ccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 65432 33567899999999987644578899999999999999999999976554332221110
Q ss_pred --------------CCCCCc---hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 227 --------------ENPPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 227 --------------~~~~~l---~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.....+ ...++..+.+||.+||.++|.+|||+.+|+.||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 000011 123578899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=332.36 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=213.3
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
...+|++++.||+|+||.||+|.++.++. .||+|.+...........+.+|+.+++++.||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 35789999999999999999999876654 6899998766665566788999999999999999999999887 789
Q ss_pred EEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
++||||+.+|+|.+++.. ...+++..+..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++.......
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 999999999999999976 3579999999999999999999999999999999999999999999999999987664322
Q ss_pred cccc--cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHH
Q 008116 166 SRRK--TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (577)
Q Consensus 166 ~~~~--~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~ 242 (577)
.... ...+++.|+|||.+... .++.++|||||||++|+|++ |..||......+....+........+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred cceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 2111 12235679999998654 48899999999999999998 99999887766555555554444555567788999
Q ss_pred HHHHhcccCCCCCCcHHHHhh
Q 008116 243 FVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~ 263 (577)
++.+||..+|..||++.++++
T Consensus 243 ~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 243 VLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=327.09 Aligned_cols=249 Identities=25% Similarity=0.418 Sum_probs=210.7
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
..++|++.+.||+|+||.||+|.+.. +..||||.+..... ....+.+|+.++++++||||+++++++.....+++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 45789999999999999999999764 57899999875433 2467889999999999999999999999889999999
Q ss_pred eccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-c
Q 008116 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~ 167 (577)
||+++++|.+++... ..+++..+..++.||+.||.|||+++++|+||||+||+|+.++.+||+|||++..+..... .
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999999999753 4689999999999999999999999999999999999999999999999999876542111 1
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||...........+........+..++..+.+++.+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05034 161 REGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQ 239 (261)
T ss_pred hhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 1122345789999998765 48899999999999999998 999998776665555555444444455668899999999
Q ss_pred hcccCCCCCCcHHHHhh
Q 008116 247 CLKKVPAERPSAKELLR 263 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~ 263 (577)
||..+|.+||++++++.
T Consensus 240 ~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 240 CWDKDPEERPTFEYLQS 256 (261)
T ss_pred HcccCcccCCCHHHHHH
Confidence 99999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=332.66 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=212.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcC----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe-CCE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKE----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTK 85 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~----tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~-~~~ 85 (577)
-..+|++.++||+|+||.||+|.+.. ++..|++|.+...........+.+|+.+++.+.||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999999876 3578999998765556667889999999999999999999998766 567
Q ss_pred EEEEEeccCCCCHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSG--------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~--------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGl 157 (577)
.++++||+.+++|..++... ..+++..++.++.||+.||+|||+++++|+||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 89999999999999998642 4589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchh
Q 008116 158 SAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDE 234 (577)
Q Consensus 158 s~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~ 234 (577)
++.+...... .....++..|+|||++.+. .++.++|||||||++|+|++ |.+||...++......+........+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPI 242 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCC
Confidence 8765332111 1123457789999998765 48899999999999999999 999998877655554444444444455
Q ss_pred hhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 235 HFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 235 ~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
.++..+.+++.+||..+|.+|||+.+++.
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 243 NCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 67889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=345.19 Aligned_cols=260 Identities=22% Similarity=0.407 Sum_probs=212.6
Q ss_pred chhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-
Q 008116 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ- 83 (577)
Q Consensus 6 ~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~- 83 (577)
.....+..+|.+++.||+|+||.||+|.+..++..||||++.... .......+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 344567799999999999999999999999999999999987543 222346688999999999999999999988653
Q ss_pred -----CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccc
Q 008116 84 -----TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (577)
Q Consensus 84 -----~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls 158 (577)
..+|++++++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence 3478888887 7899988865 56999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------
Q 008116 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------ 226 (577)
Q Consensus 159 ~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------ 226 (577)
..... ......|++.|+|||++.+...++.++|||||||++|+|++|.+||...+.......+..
T Consensus 168 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 168 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred ccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 76432 223467899999999987655588899999999999999999999976543222111100
Q ss_pred ------------------CCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 227 ------------------ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 227 ------------------~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
..........+..+.+||..||.++|.+||++.++|.||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 00000111346789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.46 Aligned_cols=260 Identities=27% Similarity=0.459 Sum_probs=212.9
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeC--C
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ--T 84 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~--~ 84 (577)
..+.++|++.+.||+|+||.||+|.+..++..||||.+.... .......+.+|+.+++++ +||||+++++++... .
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 345689999999999999999999999899999999885432 223345677899999999 999999999988653 3
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
.+|+||||+. ++|..++... .+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 6899999996 5999999775 8899999999999999999999999999999999999999999999999998765432
Q ss_pred cc-----ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc---------------
Q 008116 165 IS-----RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII--------------- 224 (577)
Q Consensus 165 ~~-----~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i--------------- 224 (577)
.. ....+.|++.|+|||++.+...++.++|||||||++|+|++|++||...........+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 21 2224578999999998876556888999999999999999999999754432211110
Q ss_pred ------------CCCC---CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 225 ------------PREN---PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 225 ------------~~~~---~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.... .......++..+.+||.+||..+|.+|||+.++++||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0000 111122367889999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=362.84 Aligned_cols=262 Identities=26% Similarity=0.514 Sum_probs=237.2
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
....+++++..||-|+||.|-++........+|+|++++.. ...+.+++..|-.||..++.|+||++|-.|.+.+.+|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34567888999999999999999877666679999987765 2345688999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
++||-|-||.|+.+|+..+.|.+..++.++..+++|++|||++|||+|||||+|++|+.+|-+||.|||+|+.+... ..
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-~K 575 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-RK 575 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC-Cc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999988654 55
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~l~~~~s~~l~~lI~~ 246 (577)
..++||||.|+|||++.+. +.+.++|.||||+++||||+|.+||...+++.....|.++. ...+|..++..+.+||++
T Consensus 576 TwTFcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~ 654 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK 654 (732)
T ss_pred eeeecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence 6789999999999999886 58999999999999999999999999999999888887664 345667889999999999
Q ss_pred hcccCCCCCCc-----HHHHhhcHhhhhccCC
Q 008116 247 CLKKVPAERPS-----AKELLRHRFIRNARKS 273 (577)
Q Consensus 247 cL~~dP~~RpT-----a~elL~hpff~~~~~~ 273 (577)
++..+|.+|.. +.+|-+|.||....+.
T Consensus 655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 655 LCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred HHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 99999999985 8999999999887553
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=376.14 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=206.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|+++++||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999987543 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccc
Q 008116 91 EYMAGGSVADLIQSG-----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~-----------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
||++|++|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998531 235567788999999999999999999999999999999999999999999987
Q ss_pred cccccc------------------cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee
Q 008116 160 QLTRTI------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL 221 (577)
Q Consensus 160 ~~~~~~------------------~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~ 221 (577)
...... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 652110 0111357999999999997764 899999999999999999999999775443322
Q ss_pred eccCCCCCCCc--hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 222 FIIPRENPPQL--DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 222 ~~i~~~~~~~l--~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.......+... ...++..+.+++.+||..+|.+||+..+.|.+
T Consensus 241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22111111111 23578889999999999999999877766654
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=335.45 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=204.6
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcC----------------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCcee
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKE----------------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~----------------tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV 74 (577)
+.++|++.+.||+|+||.||+|.+.. ++..||||++...........+.+|+.+|+.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 45689999999999999999986432 34579999987655555567899999999999999999
Q ss_pred EeEEEEEeCCEEEEEEeccCCCCHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEE
Q 008116 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-----------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANIL 143 (577)
Q Consensus 75 ~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~-----------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNIL 143 (577)
++++++......|+||||+.+++|.+++.... .+++..+..++.||+.||+|||++|++|+||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999986532 3667889999999999999999999999999999999
Q ss_pred EccCCCeeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh--CCCCCCCCCccc
Q 008116 144 LTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPPLADLHPMR 219 (577)
Q Consensus 144 ld~~g~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt--G~~Pf~~~~~~~ 219 (577)
++.++.++|+|||++..+..... ......+++.|++||++... .++.++|||||||++|||++ |..||......+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999876533211 11123456789999988765 48999999999999999998 788997665443
Q ss_pred eeeccC-------CCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 220 VLFIIP-------RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 220 ~~~~i~-------~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
...... .......+..++..+.+|+..||..+|.+||++.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 322110 01111223456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=343.10 Aligned_cols=252 Identities=22% Similarity=0.437 Sum_probs=210.8
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCC-------CcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeC
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKEL-------NKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ 83 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~t-------g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~ 83 (577)
..+|++.+.||+|+||.||+|.+... +..||||.+...........+.+|+.+++++ .||||+++++++..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35799999999999999999986432 2368999987655555667899999999999 899999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC
Q 008116 84 TKLWIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~ 147 (577)
+.+|+||||+.+|+|.+++.... .++...+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 99999999999999999996532 36778889999999999999999999999999999999999
Q ss_pred CCeeeccccccccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeecc
Q 008116 148 GDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFII 224 (577)
Q Consensus 148 g~vKL~DFGls~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i 224 (577)
+.+||+|||++......... .....+++.|+|||++.+. .++.++|||||||+||+|++ |..||...+.......+
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 249 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 249 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999998765432111 1122345679999999765 48899999999999999998 89999887666555555
Q ss_pred CCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 225 ~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
........+..++..+.+||.+||..+|.+||++.+|+.+
T Consensus 250 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 250 KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4444444555678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=328.10 Aligned_cols=245 Identities=32% Similarity=0.572 Sum_probs=213.5
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCH
Q 008116 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (577)
Q Consensus 21 IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL 98 (577)
||.|+||.||++.+..++..||+|++..... ......+..|+.+++++.||||+++++.+..+..+|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999998899999999876542 23467889999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCCCCC
Q 008116 99 ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM 178 (577)
Q Consensus 99 ~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~ 178 (577)
.+++.....+++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++..............|+..|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 99998877899999999999999999999999999999999999999999999999999877654323334567899999
Q ss_pred ChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcH
Q 008116 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258 (577)
Q Consensus 179 APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa 258 (577)
+||.+.+.. ++.++|+||||+++|+|++|..||...........+.. ....++..++..+.+||.+||..+|..||++
T Consensus 161 ~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~ 238 (250)
T cd05123 161 APEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKRLGS 238 (250)
T ss_pred ChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCc
Confidence 999987654 78899999999999999999999977664433333333 3334556678999999999999999999999
Q ss_pred ---HHHhhcHhh
Q 008116 259 ---KELLRHRFI 267 (577)
Q Consensus 259 ---~elL~hpff 267 (577)
.++++||||
T Consensus 239 ~~~~~l~~~~~f 250 (250)
T cd05123 239 GGAEEIKAHPFF 250 (250)
T ss_pred ccHHHHHhCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=328.30 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=206.6
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
..++|++.+.||+|+||.||+|.+..+ ..||||.+..... ..+.+.+|+.+++.+.||||+++++++. .+..|+||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 346799999999999999999988764 4699998764432 2356889999999999999999999875 45689999
Q ss_pred eccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-
Q 008116 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~- 167 (577)
||+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999999653 35889999999999999999999999999999999999999999999999998765332111
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....++..|+|||++.... ++.++|||||||++|+|++ |.+||...........+........+..++..+++|+.+
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKL 238 (260)
T ss_pred cCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence 11234667899999987654 8899999999999999999 999998876655555554444444556788999999999
Q ss_pred hcccCCCCCCcHHHHhh
Q 008116 247 CLKKVPAERPSAKELLR 263 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~ 263 (577)
||.++|.+||++++|++
T Consensus 239 ~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 239 CWKKDPDERPTFEYIQS 255 (260)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=327.97 Aligned_cols=245 Identities=25% Similarity=0.419 Sum_probs=200.4
Q ss_pred eEEeecCceEEEEEEEcC---CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEE-eCCEEEEEEeccC
Q 008116 19 ELIGRGSFGDVYKAFDKE---LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL-HQTKLWIIMEYMA 94 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~---tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~-~~~~~~LV~Ey~~ 94 (577)
+.||+|+||.||+|.+.. .+..||||.+...........+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998753 345799999865544555678889999999999999999999775 4556899999999
Q ss_pred CCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc----cccc
Q 008116 95 GGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----SRRK 169 (577)
Q Consensus 95 gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~----~~~~ 169 (577)
+++|.+++... ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 99999999653 456788889999999999999999999999999999999999999999999987543211 1111
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
...+++.|+|||++... .++.++|||||||++|+|++ |.+||...+.......+....++..+..++..+.+++.+||
T Consensus 161 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 239 (262)
T cd05058 161 GAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCW 239 (262)
T ss_pred cCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHc
Confidence 33467789999998765 48899999999999999999 56777766655444444444444445567889999999999
Q ss_pred ccCCCCCCcHHHHhhc
Q 008116 249 KKVPAERPSAKELLRH 264 (577)
Q Consensus 249 ~~dP~~RpTa~elL~h 264 (577)
..+|++||++.+|++.
T Consensus 240 ~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 240 HPKPEMRPTFSELVSR 255 (262)
T ss_pred CCChhhCCCHHHHHHH
Confidence 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=332.82 Aligned_cols=252 Identities=32% Similarity=0.518 Sum_probs=210.6
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEecc
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+..|+.++++++||||+++++++.....+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 678899999999999999999999999999997654 2223467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccccc
Q 008116 94 AGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (577)
Q Consensus 94 ~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 172 (577)
. ++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..............
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 7 5999999775 5899999999999999999999999999999999999999999999999999877654433334456
Q ss_pred CCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC------------------------CCC
Q 008116 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP------------------------REN 228 (577)
Q Consensus 173 GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~------------------------~~~ 228 (577)
+++.|+|||++.+...++.++|||||||++|+|++|.+||........+..+. ...
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF 239 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence 78899999998766468899999999999999999999997654322111100 000
Q ss_pred CC----CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 229 PP----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 229 ~~----~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
.. .....++..+.+||.+||..+|.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00 0011346789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=349.02 Aligned_cols=252 Identities=29% Similarity=0.496 Sum_probs=201.7
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC-EEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-KLW 87 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~-~~~ 87 (577)
..++++|....+||+|+||.||+|.... +..||||.+....... ..+|..|+.+|.+++|||||+|+|+|.+.+ ..+
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 3456889999999999999999998875 4899999876655432 456999999999999999999999999988 599
Q ss_pred EEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEccCCCeeecccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEG---KIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~g---IiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
||+|||+.|+|.++|.... +++|.....|+.++++||+|||... ||||||||+|||||++.++||+|||+|....
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 9999999999999997644 8999999999999999999999753 9999999999999999999999999996543
Q ss_pred ccccccccc-cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccce---eec----cCCCC-----C
Q 008116 163 RTISRRKTF-VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV---LFI----IPREN-----P 229 (577)
Q Consensus 163 ~~~~~~~~~-~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~---~~~----i~~~~-----~ 229 (577)
.......+. .||.+|+|||++... ..+.++|||||||+|+||++|+.|.....+... ..+ +.... -
T Consensus 229 ~~~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 229 EGDTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred ccccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 311222223 899999999999764 489999999999999999999988875431111 110 00100 1
Q ss_pred CCch-hhhh-----HHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 230 PQLD-EHFS-----RLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 230 ~~l~-~~~s-----~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
+.+. ..++ ..+..+...|+..+|..||++.++++
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 1122 23567778899999999999999865
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=333.82 Aligned_cols=251 Identities=21% Similarity=0.402 Sum_probs=203.4
Q ss_pred CCeeEEeEEeecCceEEEEEEE----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC--CEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFD----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKL 86 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~----~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~--~~~ 86 (577)
.-|++++.||+|+||.||+|.. ..++..||||.++..........+.+|+.+++.+.||||+++++++... ..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3479999999999999999974 4568899999987665555567899999999999999999999998875 578
Q ss_pred EEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
++||||+++++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999999654 468999999999999999999999999999999999999999999999999987664322
Q ss_pred cc---cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--c-------------eeeccCCC
Q 008116 166 SR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM--R-------------VLFIIPRE 227 (577)
Q Consensus 166 ~~---~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~--~-------------~~~~i~~~ 227 (577)
.. .....|+..|+|||++.+. .++.++|||||||++|+|+++..|+...... . ....+...
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 21 1234577789999998765 4889999999999999999987765321100 0 00001111
Q ss_pred CCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 228 ~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.....+..++..+.+||.+||..+|.+||++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1222344578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=330.52 Aligned_cols=251 Identities=23% Similarity=0.423 Sum_probs=210.3
Q ss_pred CCeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
.+|++++.||.|+||.||+|..+. ....|++|.+...........+.+|+.++++++||||+++++++......|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 689999999999999999999754 346799999876555445678999999999999999999999999989999
Q ss_pred EEEeccCCCCHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccc
Q 008116 88 IIMEYMAGGSVADLIQSGP---------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~---------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls 158 (577)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999999997655 6899999999999999999999999999999999999999999999999998
Q ss_pred cccccc-ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC-CCCchhh
Q 008116 159 AQLTRT-ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN-PPQLDEH 235 (577)
Q Consensus 159 ~~~~~~-~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~l~~~ 235 (577)
...... ........+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+.... ....+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG 243 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCC
Confidence 654321 11222345678899999987654 7889999999999999998 889997765554444443222 1223446
Q ss_pred hhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 236 ~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
++..+.+||.+||..+|.+||++.+++..
T Consensus 244 ~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 244 CPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 78899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=329.01 Aligned_cols=252 Identities=26% Similarity=0.381 Sum_probs=211.1
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
...+|.+.++||+|+||.||+|.+... ...||||...........+.+.+|+.+++.+.||||+++++++.+ ...|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 356799999999999999999987644 457999998765545566789999999999999999999998875 5578
Q ss_pred EEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++++|+||||+|||++..+.+||+|||++........
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999999999999764 3689999999999999999999999999999999999999999999999999876543311
Q ss_pred c-cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHH
Q 008116 167 R-RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 167 ~-~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI 244 (577)
. .....+++.|+|||++... .++.++|||||||++|+|++ |.+||...........+........+..++..+.+||
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 241 (270)
T ss_pred eecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence 1 1122345689999998654 48899999999999999986 9999987766555555555554455667889999999
Q ss_pred HHhcccCCCCCCcHHHHhhc
Q 008116 245 SLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~h 264 (577)
.+||..+|.+|||+.+++..
T Consensus 242 ~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 242 TKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.60 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=207.7
Q ss_pred CeeEEeEEeecCceEEEEEEEcCC--CcEEEEEEeccCCC-hHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeC----CE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKEL--NKDVAIKVIDLEES-EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ----TK 85 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~t--g~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~----~~ 85 (577)
+|++.+.||+|+||.||+|.+..+ +..||||.+..... ....+.+.+|+.+++++ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999888 89999999864332 22346678899999999 699999999875432 45
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
+|+++||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 789999995 6999999887889999999999999999999999999999999999999999999999999987654321
Q ss_pred c----ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeec---------------c--
Q 008116 166 S----RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI---------------I-- 224 (577)
Q Consensus 166 ~----~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~---------------i-- 224 (577)
. ......||+.|+|||++.+...++.++|||||||++|+|++|.+||...+....+.. +
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 122357999999999987655688999999999999999999999976542211110 0
Q ss_pred ----------CCCCCC---CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 225 ----------PRENPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 225 ----------~~~~~~---~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
...... .....++..+.+||.+||..+|.+|||+.+++.||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 000001 1112346789999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=337.49 Aligned_cols=259 Identities=42% Similarity=0.765 Sum_probs=216.9
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
.....|..++.||.|+||.||+|.+..++..||||.+.... .......+.+|+.+++.++||||+++++++......|
T Consensus 12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 34566888999999999999999999999999999986432 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~-~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
+||||+. |+|.+++. ...++++..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence 9999996 67877764 456789999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccCCCCCCChhhhhc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC-CCchhhhhHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP-PQLDEHFSRLMKEF 243 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~--~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~-~~l~~~~s~~l~~l 243 (577)
.....|++.|+|||++.. ...++.++|||||||++|+|++|..||...+.......+..... ......++..+++|
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 234578999999999753 23478899999999999999999999987655444333333332 22344678899999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhccCC
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
|.+||..+|.+||++.++++|||+......
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence 999999999999999999999999875443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=346.10 Aligned_cols=259 Identities=26% Similarity=0.433 Sum_probs=210.1
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC---
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--- 83 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~--- 83 (577)
.-.+..+|.+.+.||+|+||.||+|.+..++..||||.+..... ......+.+|+.+++.+.||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 10 VWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 33456899999999999999999999999999999999865432 22345688999999999999999999998754
Q ss_pred ---CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccc
Q 008116 84 ---TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 84 ---~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
..+|+|+||+. .+|..++. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 90 DEFQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred CCCceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 35699999995 57877652 4689999999999999999999999999999999999999999999999999865
Q ss_pred ccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--------------
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------------- 226 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~-------------- 226 (577)
... ......|++.|+|||++.+...++.++|||||||+||+|++|+.||...+.......+..
T Consensus 167 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 167 ADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 432 223457899999999987644588899999999999999999999986543222111100
Q ss_pred -------------CCCCC---chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 227 -------------ENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 227 -------------~~~~~---l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
..... ....++..+.+||.+||..||.+||++.++|.||||...+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000 11235677899999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=336.16 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=204.6
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCC--------------CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKEL--------------NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~t--------------g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~ 77 (577)
..+|++.+.||+|+||.||+|.+..+ ...||||.+...........+.+|+.++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 46899999999999999999987543 2358999987655555567899999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc
Q 008116 78 GSYLHQTKLWIIMEYMAGGSVADLIQSG------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT 145 (577)
Q Consensus 78 ~~~~~~~~~~LV~Ey~~gGsL~~~l~~~------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld 145 (577)
+++......|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+++++|+||||+|||++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 9999999999999999999999998542 1468889999999999999999999999999999999999
Q ss_pred cCCCeeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh--CCCCCCCCCcccee
Q 008116 146 ENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPPLADLHPMRVL 221 (577)
Q Consensus 146 ~~g~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt--G~~Pf~~~~~~~~~ 221 (577)
.++.+||+|||++........ ......+++.|+|||++.... ++.++|||||||++|+|++ |..||.........
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~ 242 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence 999999999999876532211 111234577899999987654 8999999999999999988 67788776544332
Q ss_pred eccC-------CCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 222 FIIP-------RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 222 ~~i~-------~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
..+. .......+..++..+.+||.+||..+|.+||++.+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 243 ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2211 11111223346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.19 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=207.9
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..+|++.+.||.|+||.||+|.+.. +..+|||.+..... ....+.+|+.+++++.||||+++++++.....+|+|||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 3589999999999999999998863 67899998864432 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-cc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~-~~ 169 (577)
|+.+++|.+++.. ...+++..++.++.|++.||+|||+++++|+||||+||+++.++.++|+|||++......... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 9999999999975 356899999999999999999999999999999999999999999999999998755332111 11
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
...++..|+|||++.+. .++.++||||||+++|+|++ |..||...........+........+...+..+.+|+.+||
T Consensus 160 ~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 238 (256)
T cd05112 160 GTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCW 238 (256)
T ss_pred CCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHc
Confidence 23356789999998765 48889999999999999998 99999876655544444433333334456789999999999
Q ss_pred ccCCCCCCcHHHHhhc
Q 008116 249 KKVPAERPSAKELLRH 264 (577)
Q Consensus 249 ~~dP~~RpTa~elL~h 264 (577)
..+|.+||++.+++++
T Consensus 239 ~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 239 KERPEDRPSFSLLLHQ 254 (256)
T ss_pred ccChhhCCCHHHHHHh
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.87 Aligned_cols=260 Identities=35% Similarity=0.611 Sum_probs=211.7
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV 89 (577)
..++|++.+.||.|+||.||+|.+..+++.||||.++..........+.+|+.++.++ .||||+++++++.+...+|+|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3478999999999999999999999999999999997655444556677788777776 599999999999999999999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
|||+. ++|..++.. ..++++..+..++.||+.||.|||+ ++|+||||+|+|||++.++.+||+|||++..+.....
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 99994 577777754 4579999999999999999999997 6999999999999999999999999999876543322
Q ss_pred cccccCCCCCCChhhhhcc---cCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccCCCCCCCch--hhhhHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNS---EGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLD--EHFSRLMK 241 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~---~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~-~~~~~~i~~~~~~~l~--~~~s~~l~ 241 (577)
.....+++.|+|||++.+. ..++.++||||||+++|+|++|+.||..... .+.+..+.....+..+ ..++..+.
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFC 250 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHH
Confidence 2234578899999998654 2377899999999999999999999976332 1222222222222222 24678899
Q ss_pred HHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
+||.+||..+|.+||++.+++.|+||.....
T Consensus 251 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 251 SFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred HHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 9999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.86 Aligned_cols=250 Identities=28% Similarity=0.494 Sum_probs=214.8
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
...+.+.+...||+|.||+||+|.+-. .||||+++... .+..++.|+.||.++++-+|.||+-|.|+|..... .|
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 345667889999999999999998864 59999998776 45678999999999999999999999999987777 99
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc--
Q 008116 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-- 165 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~-- 165 (577)
|+.||+|.+|..+|+- ...|.....+.|++||++|+.|||.++|||||||..||||.+++.|||+||||+..-....
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 9999999999999953 3578999999999999999999999999999999999999999999999999987544322
Q ss_pred cccccccCCCCCCChhhhhcc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC----CCchhhhhHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP----PQLDEHFSRL 239 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~--~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~----~~l~~~~s~~ 239 (577)
.......|...|||||++... ..|+..+||||||||+|||++|..||...+....+..+-.+.. ......++.+
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~ 624 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKA 624 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHH
Confidence 223345688999999998643 2388899999999999999999999997777777777766632 2233467789
Q ss_pred HHHHHHHhcccCCCCCCcHHHHhh
Q 008116 240 MKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 240 l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
+++|+..||..++++||.+.+||.
T Consensus 625 mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 625 MKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHhcCcccCccHHHHHH
Confidence 999999999999999999999985
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=345.60 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=204.7
Q ss_pred cCCCeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEe-C
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH-Q 83 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~-~ 83 (577)
..++|++.+.||+|+||.||+|.+ ..+++.||||.++..........+.+|+.+|.++ +||||+++++++.. +
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 456899999999999999999985 3467899999997655555567788999999999 78999999998865 4
Q ss_pred CEEEEEEeccCCCCHHHHHHcC----------------------------------------------------------
Q 008116 84 TKLWIIMEYMAGGSVADLIQSG---------------------------------------------------------- 105 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~---------------------------------------------------------- 105 (577)
..+++|||||++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 5689999999999999998542
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc--cccccCC
Q 008116 106 ---------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR--RKTFVGT 174 (577)
Q Consensus 106 ---------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~--~~~~~GT 174 (577)
..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++......... .....++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 23677888999999999999999999999999999999999999999999998765332111 1123456
Q ss_pred CCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccce-eeccCCCCCCCchhhhhHHHHHHHHHhcccCC
Q 008116 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRV-LFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (577)
Q Consensus 175 p~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~-~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP 252 (577)
+.|+|||++.+. .++.++|||||||++|+|++ |..||........ ...+........+..++..+.+++..||..+|
T Consensus 245 ~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p 323 (343)
T cd05103 245 LKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 323 (343)
T ss_pred cceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 789999998765 48899999999999999997 9999976543221 11222222233344567889999999999999
Q ss_pred CCCCcHHHHhhc
Q 008116 253 AERPSAKELLRH 264 (577)
Q Consensus 253 ~~RpTa~elL~h 264 (577)
.+||++.+|++|
T Consensus 324 ~~Rps~~eil~~ 335 (343)
T cd05103 324 SQRPTFSELVEH 335 (343)
T ss_pred hhCcCHHHHHHH
Confidence 999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=334.69 Aligned_cols=251 Identities=27% Similarity=0.479 Sum_probs=206.9
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEEEEEecc
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
|++.+.||.|+||+||+|.+..+++.||||.+.............+|+..++++. ||||+++++++..+...|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999998999999999865443223334567999999998 999999999999999999999999
Q ss_pred CCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 94 AGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 94 ~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
+|+|.+++.... .+++..+..++.||+.+|.|||+++++|+||||+||+++.++.++|+|||++...... ......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-~~~~~~ 158 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-PPYTDY 158 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-CCcCCC
Confidence 889999887644 7899999999999999999999999999999999999999999999999998765432 222346
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC--------------------------
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-------------------------- 225 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-------------------------- 225 (577)
.|+..|+|||++.....++.++|+||||+++++|++|.+||...........+.
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 789999999998665557899999999999999999999997654322111100
Q ss_pred CCCCCCc---hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 226 RENPPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 226 ~~~~~~l---~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
...+..+ ....+..+.+||.+||..+|.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0000001 11225789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=354.63 Aligned_cols=259 Identities=25% Similarity=0.466 Sum_probs=207.6
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEE
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~ 86 (577)
...-+..|++++.||+||.+.||+++..+.+..++.|+.........+.-+..|+.+|.+| .|.+||+||++-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3455678999999999999999999887654444444544555666788999999999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~-l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
|+||||= ..+|..+|+.... ++.-.++.|.+|+|.|+.++|.+||||.||||.|+|+- .|.+||+|||+|..+....
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 9999986 5799999977543 34358889999999999999999999999999999995 5799999999998775432
Q ss_pred cc--cccccCCCCCCChhhhhccc----------CCccccchhhHHHHHHHHHhCCCCCCCCC-ccceeeccCCC----C
Q 008116 166 SR--RKTFVGTPFWMAPEVIQNSE----------GYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRE----N 228 (577)
Q Consensus 166 ~~--~~~~~GTp~Y~APEvl~~~~----------~~~~ksDVwSLGviLyeLltG~~Pf~~~~-~~~~~~~i~~~----~ 228 (577)
.. ..+.+||+.||+||.+.... ..+.++||||||||||+|+.|++||.... ....+..|... .
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE 593 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence 22 22568999999999986432 15678999999999999999999998764 22233333222 1
Q ss_pred CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 229 ~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.+.++.. .++.++++.||.+||.+||++.+||+|||++..
T Consensus 594 fp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 594 FPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred ccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 2233332 239999999999999999999999999999863
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=325.35 Aligned_cols=243 Identities=26% Similarity=0.418 Sum_probs=203.5
Q ss_pred eEEeecCceEEEEEEEcC-CC--cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDKE-LN--KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~-tg--~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
++||+|+||.||+|.+.. .+ ..||||.+.........+.+.+|+.++++++||||+++++.+.. ..+++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998865 33 36999999776654567789999999999999999999999988 899999999999
Q ss_pred CCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc---cc
Q 008116 96 GSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR---KT 170 (577)
Q Consensus 96 GsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~---~~ 170 (577)
++|.+++.... .+++..++.++.|++.||.|||+++++|+||||+|||++.++.+||+|||++..+....... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 99999997643 68999999999999999999999999999999999999999999999999987764422211 12
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCC-CCCCCchhhhhHHHHHHHHHhc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPR-ENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~-~~~~~l~~~~s~~l~~lI~~cL 248 (577)
..++..|+|||++.... ++.++|||||||++|+|++ |..||...+..+....+.. ......+..++..+.+++..||
T Consensus 160 ~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd05040 160 LKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW 238 (257)
T ss_pred CCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence 45778999999987654 8899999999999999998 9999977665544333331 1222234457789999999999
Q ss_pred ccCCCCCCcHHHHhh
Q 008116 249 KKVPAERPSAKELLR 263 (577)
Q Consensus 249 ~~dP~~RpTa~elL~ 263 (577)
..+|.+||++.+++.
T Consensus 239 ~~~p~~Rps~~~~~~ 253 (257)
T cd05040 239 AHNPADRPTFAALRE 253 (257)
T ss_pred CCCcccCCCHHHHHH
Confidence 999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=328.55 Aligned_cols=244 Identities=27% Similarity=0.498 Sum_probs=204.0
Q ss_pred eEEeecCceEEEEEEEcCCC------cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 19 ELIGRGSFGDVYKAFDKELN------KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg------~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
+.||+|+||.||+|.+.... ..||||.+...........+.+|+.+++.++||||+++++++......|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999886544 689999886554444567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC-----Ceeecccccccc
Q 008116 93 MAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-----DVKVADFGVSAQ 160 (577)
Q Consensus 93 ~~gGsL~~~l~~~-------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g-----~vKL~DFGls~~ 160 (577)
+++++|.+++... ..+++..+..++.||+.||.|||+++++|+||||+|||++.++ .++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999999632 3478899999999999999999999999999999999999877 899999999875
Q ss_pred cccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhh
Q 008116 161 LTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFS 237 (577)
Q Consensus 161 ~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s 237 (577)
...... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+........+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCP 239 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccch
Confidence 532211 112335678899999997754 8999999999999999998 999998766555444444334444556678
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
..+.+||.+||.++|.+||++.+|++
T Consensus 240 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 240 DKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 89999999999999999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=327.33 Aligned_cols=250 Identities=29% Similarity=0.433 Sum_probs=203.8
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhC---CCCceeEeEEEEEeCCE-----
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQC---RSPYITEYYGSYLHQTK----- 85 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L---~HpnIV~l~~~~~~~~~----- 85 (577)
|++.+.||.|+||.||+|.+..++..||||.+...... .....+.+|+.+++++ .||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78999999999999999999988999999999754332 2234566788877766 59999999999988776
Q ss_pred EEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~ 163 (577)
++++|||+. ++|.+++... ..+++..++.++.||+.||.|||+++++|+||+|+|||++.++.+||+|||++.....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 999999996 5899888653 3589999999999999999999999999999999999999999999999999876643
Q ss_pred cccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-----------------
Q 008116 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------------- 226 (577)
Q Consensus 164 ~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~----------------- 226 (577)
. .......+++.|+|||++.+.. ++.++|||||||++|+|++|.+||......+....+..
T Consensus 160 ~-~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 160 E-MALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred C-cccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 3 2223446889999999997754 88999999999999999999999976554322211100
Q ss_pred ------CCC---CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 227 ------ENP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 227 ------~~~---~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
... ......++..+.+||.+||..+|.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000 01112456788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=362.03 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=195.7
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCC-CcEEEEEEec--------------c--CCChHHHHHHHHHHHHHHhCCCCc
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKEL-NKDVAIKVID--------------L--EESEDEIEDIQKEISVLSQCRSPY 72 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~t-g~~VAIK~i~--------------~--~~~~~~~~~i~~Ev~iL~~L~Hpn 72 (577)
...++|++++.||+|+||+||+|..+.. +..+++|.+. + .........+.+|+.+|++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 3457899999999999999999876432 2222222110 0 111223466889999999999999
Q ss_pred eeEeEEEEEeCCEEEEEEeccCCCCHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC
Q 008116 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG-----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (577)
Q Consensus 73 IV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~-----~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~ 147 (577)
||++++++...+..|+|+|++ +++|..++... .......++.|+.||+.||.|||++|||||||||+||||+.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 999999999999999999999 46787776432 234466788899999999999999999999999999999999
Q ss_pred CCeeeccccccccccccccc-cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCC-CCCCCcc--ceeec
Q 008116 148 GDVKVADFGVSAQLTRTISR-RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPP-LADLHPM--RVLFI 223 (577)
Q Consensus 148 g~vKL~DFGls~~~~~~~~~-~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~P-f~~~~~~--~~~~~ 223 (577)
+.+||+|||++..+...... ....+||+.|+|||++.+. .|+.++|||||||+||||++|..| |...... ..+..
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999876543222 2346899999999999875 489999999999999999998764 4322110 00000
Q ss_pred cC------CC-CC-------------------CCc-----hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 224 IP------RE-NP-------------------PQL-----DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 224 i~------~~-~~-------------------~~l-----~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
+. .. .+ ..+ ...++..+.++|.+||..||.+|||+.|+|.||||....
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 00 00 00 000 012456678889999999999999999999999997653
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.27 Aligned_cols=252 Identities=20% Similarity=0.354 Sum_probs=208.0
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
...+|++++.||+|+||.||+|.+..++. .||+|.+...........+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 35789999999999999999999877775 57899887655444556788999999999999999999988654 57
Q ss_pred EEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
++++||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 8999999999999998764 468999999999999999999999999999999999999999999999999997654322
Q ss_pred cc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHH
Q 008116 166 SR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (577)
Q Consensus 166 ~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~ 242 (577)
.. .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...........+........+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM 242 (303)
T ss_pred cccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 21 1123457789999998765 48899999999999999997 99999776544433333333333344456788999
Q ss_pred HHHHhcccCCCCCCcHHHHhhc
Q 008116 243 FVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~h 264 (577)
++..||..+|++||++.+|++.
T Consensus 243 li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 243 VMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=369.25 Aligned_cols=148 Identities=32% Similarity=0.589 Sum_probs=137.6
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
-.+|++++.||+|+||.||+|.+..+++.||||++.... .......+..|+.+++.++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997543 234457789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
|||+.+++|..++...+.+++..++.|+.||+.||+|||.++||||||||+||||+.++.+||+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999887889999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.87 Aligned_cols=256 Identities=27% Similarity=0.468 Sum_probs=210.8
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe-CCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~-~~~~~ 87 (577)
...++|++++.||.|+||.||+|.+..++..||||.+.... .......+.+|+.++++++||||++++++|.. ...+|
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35789999999999999999999999999999999886533 22335678899999999999999999999876 56789
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
+||||+ +++|..+++. .++++..+..++.||+.||.|||+++|+||||||.|||++.++.++|+|||++..... .
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~ 161 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---Q 161 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---C
Confidence 999999 6789988865 5789999999999999999999999999999999999999999999999999875432 2
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee--------------------------
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-------------------------- 221 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~-------------------------- 221 (577)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.........
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 234578899999998866455889999999999999999999999765431100
Q ss_pred -eccCCCCCCCc---hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 222 -FIIPRENPPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 222 -~~i~~~~~~~l---~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.......+... ...++..+.+||.+||..+|.+||++.+++.||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00000111111 12457889999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=326.54 Aligned_cols=244 Identities=24% Similarity=0.417 Sum_probs=195.1
Q ss_pred eEEeecCceEEEEEEEcC--CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCC
Q 008116 19 ELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~--tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gG 96 (577)
+.||+|+||.||+|.... ....+|+|.+...........+.+|+.+++.++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999996532 345789998765555555667889999999999999999999999999999999999999
Q ss_pred CHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc--ccc
Q 008116 97 SVADLIQSGP-----PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRK 169 (577)
Q Consensus 97 sL~~~l~~~~-----~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~--~~~ 169 (577)
+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 9999996532 346778899999999999999999999999999999999999999999999865322111 112
Q ss_pred cccCCCCCCChhhhhc------ccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC-----CCCchhhhh
Q 008116 170 TFVGTPFWMAPEVIQN------SEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN-----PPQLDEHFS 237 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~------~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~-----~~~l~~~~s 237 (577)
...+++.|+|||++.. ...++.++|||||||++|+|++ |.+||....+...+..+.... .+.+...++
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 3346778999999753 2246789999999999999999 888998765544333222111 233445678
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
..+..++..|| .+|++|||+++|++
T Consensus 241 ~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 241 DRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHHHHh-cCcccccCHHHHHH
Confidence 88999999999 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=321.89 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=208.3
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
...++|++.+.||+|+||.||+|.+.. +..||||.+.... .....+.+|+.+++.++|+||+++++++.. ...|++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 456899999999999999999998653 5679999876432 235678899999999999999999999887 788999
Q ss_pred EeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-
Q 008116 90 MEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~- 166 (577)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999999999965 34678889999999999999999999999999999999999999999999999876543211
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~ 245 (577)
......++..|+|||++... .++.++|||||||++|+|++ |.+||...+.......+........+..++..+.+|+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 237 (260)
T ss_pred cccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHH
Confidence 11123456779999998765 48889999999999999998 99999877665555444444444455677889999999
Q ss_pred HhcccCCCCCCcHHHHhh
Q 008116 246 LCLKKVPAERPSAKELLR 263 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~ 263 (577)
+||.++|.+||++.+++.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 238 RCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=323.10 Aligned_cols=236 Identities=24% Similarity=0.419 Sum_probs=194.1
Q ss_pred eEEeecCceEEEEEEEcCCC----------cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 19 ELIGRGSFGDVYKAFDKELN----------KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg----------~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
+.||+|+||.||+|.+..++ ..|++|.+...... ...+.+|+.+|++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 47999999999999998776 35788877544322 5778899999999999999999999888 77899
Q ss_pred EEeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC-------Ceeecccccccc
Q 008116 89 IMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-------DVKVADFGVSAQ 160 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~-~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g-------~vKL~DFGls~~ 160 (577)
||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++..
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 999999999999997655 799999999999999999999999999999999999999887 799999999876
Q ss_pred ccccccccccccCCCCCCChhhhhcc-cCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhH
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSR 238 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~~-~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~ 238 (577)
... .....+++.|+|||++... ..++.++|||||||++|+|++ |..||................. .+.....
T Consensus 158 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (259)
T cd05037 158 VLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR--LPMPDCA 231 (259)
T ss_pred ccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC--CCCCCch
Confidence 543 2244677889999998765 358889999999999999999 6888877653332222211111 1111237
Q ss_pred HHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 239 LMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 239 ~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
.+.+||.+||..+|.+|||+.+|++
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 8999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=330.48 Aligned_cols=258 Identities=28% Similarity=0.478 Sum_probs=211.8
Q ss_pred CeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeccCCC---hHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEES---EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~---~tg~~VAIK~i~~~~~---~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~ 86 (577)
+|++.+.||+|+||.||+|.+. .++..||||++..... ......+.+|+.++.++ +||||+++++++..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 4678999999865432 22346678999999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|+||||+.+++|..++.....+++..+..++.|++.||.|||+.+++|+||||.|||++.++.++|+|||++..+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998777899999999999999999999999999999999999999999999999999876543322
Q ss_pred c-cccccCCCCCCChhhhhccc-CCccccchhhHHHHHHHHHhCCCCCCCCCccce----eeccCCCCCCCchhhhhHHH
Q 008116 167 R-RKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHPMRV----LFIIPRENPPQLDEHFSRLM 240 (577)
Q Consensus 167 ~-~~~~~GTp~Y~APEvl~~~~-~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~----~~~i~~~~~~~l~~~~s~~l 240 (577)
. .....|++.|+|||.+.+.. .++.++||||||+++|+|++|..||........ ...+... .+..+..++..+
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 239 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-KPPFPKTMSAEA 239 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-CCCCCcccCHHH
Confidence 1 22356899999999986532 367899999999999999999999964332111 1111111 123445578899
Q ss_pred HHHHHHhcccCCCCCCc---HHHHhhcHhhhhccC
Q 008116 241 KEFVSLCLKKVPAERPS---AKELLRHRFIRNARK 272 (577)
Q Consensus 241 ~~lI~~cL~~dP~~RpT---a~elL~hpff~~~~~ 272 (577)
++||.+||..+|++||| +.++|+||||+...+
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 99999999999999998 567899999987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.13 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=207.6
Q ss_pred CCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTK 85 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~ 85 (577)
..+|.+.+.||+|+||.||+|.+. .++..||||+++........+.+.+|+.+|.++. |||||++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 356888899999999999999864 3456899999976655555567889999999997 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCC-----------------------------------------------------------
Q 008116 86 LWIIMEYMAGGSVADLIQSGP----------------------------------------------------------- 106 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~----------------------------------------------------------- 106 (577)
+|||||||.+|+|.+++.+..
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999986421
Q ss_pred ---------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC
Q 008116 107 ---------------------------------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (577)
Q Consensus 107 ---------------------------------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~ 147 (577)
.+++..+..|+.||+.||.|||+++|+||||||+|||++..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCC
Confidence 35677888999999999999999999999999999999999
Q ss_pred CCeeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCcccee-ec
Q 008116 148 GDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL-FI 223 (577)
Q Consensus 148 g~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~-~~ 223 (577)
+.+||+|||++........ ......+++.|+|||++... .++.++|||||||++|||++ |..||......+.. ..
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~ 354 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA 354 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHH
Confidence 9999999999876432211 11234678899999999765 48899999999999999998 89999765443322 22
Q ss_pred cCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 224 i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+.....+..+..++..+.+||.+||.++|..||++.+|+..
T Consensus 355 ~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 355 IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22233334455678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=324.03 Aligned_cols=244 Identities=24% Similarity=0.368 Sum_probs=195.5
Q ss_pred eEEeecCceEEEEEEEc--CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCC
Q 008116 19 ELIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gG 96 (577)
+.||+|+||.||+|.+. .++..+|+|.+...........+.+|+.++++++||||+++++++.+...+++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999764 3456899999876655445567889999999999999999999999989999999999999
Q ss_pred CHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc--cc
Q 008116 97 SVADLIQSG-----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR--RK 169 (577)
Q Consensus 97 sL~~~l~~~-----~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~--~~ 169 (577)
+|.+++... ..+++..+..++.|++.||.|||+++++|+||||+|||++.++.+||+|||++......... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 999998642 24567788899999999999999999999999999999999999999999998654322111 12
Q ss_pred cccCCCCCCChhhhhccc------CCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCC-----CCCCCchhhhh
Q 008116 170 TFVGTPFWMAPEVIQNSE------GYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPR-----ENPPQLDEHFS 237 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~------~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~-----~~~~~l~~~~s 237 (577)
...|++.|+|||++.... .++.++|||||||++|+|++ |..||......+....... ...+.+...++
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence 346788999999986421 25779999999999999996 9999987655433222111 11223333567
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
..+.+++..|| .+|++|||+++|+.
T Consensus 241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 241 DRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred hHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 88999999999 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=321.72 Aligned_cols=241 Identities=25% Similarity=0.444 Sum_probs=203.7
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
.+|++.+.||+|+||.||++.. +++.||||.+.... ....+.+|+.+++.++||||+++++++..+ ..|+||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 5799999999999999999864 58899999986543 235788999999999999999999998654 47999999
Q ss_pred cCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 93 MAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 93 ~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
+.+++|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++...... ...
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~~~ 156 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDN 156 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---CCC
Confidence 9999999999753 35899999999999999999999999999999999999999999999999998654321 112
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
...+..|+|||++.+. .++.++|||||||++|+|++ |.+||...........+........+..++..+.+|+.+||.
T Consensus 157 ~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (254)
T cd05083 157 SKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWE 235 (254)
T ss_pred CCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcC
Confidence 3446789999998765 48899999999999999997 999998776655555554444444455678899999999999
Q ss_pred cCCCCCCcHHHHhh
Q 008116 250 KVPAERPSAKELLR 263 (577)
Q Consensus 250 ~dP~~RpTa~elL~ 263 (577)
++|..||++++|+.
T Consensus 236 ~~p~~Rp~~~~l~~ 249 (254)
T cd05083 236 TEPKKRPSFHKLRE 249 (254)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=324.24 Aligned_cols=250 Identities=23% Similarity=0.427 Sum_probs=200.0
Q ss_pred CCCeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe--CCE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTK 85 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~--~~~ 85 (577)
..+|++++.||+|+||.||+|. +..++..||||.+.... ......+.+|+.++++++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 3589999999999999999997 44578899999986443 3446788999999999999999999998754 346
Q ss_pred EEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 89999999999999999653 56899999999999999999999999999999999999999999999999998765432
Q ss_pred cccc---ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee-----------------cc
Q 008116 165 ISRR---KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-----------------II 224 (577)
Q Consensus 165 ~~~~---~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~-----------------~i 224 (577)
.... ....++..|+|||++.+. .++.++|||||||++|||++|..|+...... ... .+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHHHHHHH
Confidence 2111 112234569999998765 4889999999999999999987775432210 000 01
Q ss_pred CCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 225 ~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
........+..++..+.+||.+||..+|++|||+.+|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1111222334567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=327.90 Aligned_cols=239 Identities=25% Similarity=0.451 Sum_probs=195.7
Q ss_pred eEEeecCceEEEEEEEcCCCc-------EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 19 ELIGRGSFGDVYKAFDKELNK-------DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~-------~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
+.||.|+||.||+|.+...+. .||+|.+.... ....+.+..|+.+++.+.||||+++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 469999999999999865543 48888875432 2345678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC--------eeecccccccccc
Q 008116 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD--------VKVADFGVSAQLT 162 (577)
Q Consensus 92 y~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~--------vKL~DFGls~~~~ 162 (577)
|+.+|+|..++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++. ++|+|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99999999999764 46899999999999999999999999999999999999987654 6999999876543
Q ss_pred ccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhC-CCCCCCCCccceeeccCCCCCCCchhhhhHHHH
Q 008116 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (577)
Q Consensus 163 ~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG-~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~ 241 (577)
. .....+++.|+|||++.+...++.++|||||||++|+|++| .+||............. ....++...+..+.
T Consensus 160 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (258)
T cd05078 160 P----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE--DRHQLPAPKWTELA 233 (258)
T ss_pred C----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH--ccccCCCCCcHHHH
Confidence 2 22457899999999998755688899999999999999998 46766555433222111 12233444567899
Q ss_pred HHHHHhcccCCCCCCcHHHHhhc
Q 008116 242 EFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+||.+||+.+|.+|||+.+|++.
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=310.44 Aligned_cols=257 Identities=25% Similarity=0.447 Sum_probs=217.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-HHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-EIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~-~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.+|..+++||+|.||+||+|.+..+++.||+|.+++....+ ......+||.+|+.|+|.|||+++++...++.+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 36788899999999999999999999999999998776433 34567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|| ..+|..+... ++.++.+.++.++.|+++||.|||++++.||||||.|+||+.+|.+||+|||+++-++-+......
T Consensus 82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 99 5688888754 578999999999999999999999999999999999999999999999999999988777666666
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccC------------------CCCC-C
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIP------------------RENP-P 230 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~------------------~~~~-~ 230 (577)
.+-|.+|.+|.++.+..-|+...|+||.|||+.||.. |.+.|...+....+..|- ...+ |
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 6789999999999998889999999999999999986 666677655443332221 0000 1
Q ss_pred Cc---------hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 231 QL---------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 231 ~l---------~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.+ ...+...-+++++++|.-+|.+|+++++.|+||||...
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 11 12334557899999999999999999999999999753
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=323.22 Aligned_cols=239 Identities=23% Similarity=0.378 Sum_probs=192.8
Q ss_pred eEEeecCceEEEEEEEcC------------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 19 ELIGRGSFGDVYKAFDKE------------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~------------tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
+.||+|+||.||+|.... ....|++|++.... ......+.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999998532 23368899875433 33445788899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC-------eeecccccc
Q 008116 87 WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD-------VKVADFGVS 158 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~-------vKL~DFGls 158 (577)
++||||+++++|..++.. ..++++..++.++.||+.||+|||+++|+||||||+||||+.++. ++|+|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 999999999999998865 467999999999999999999999999999999999999987654 899999998
Q ss_pred ccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHH-hCCCCCCCCCccceeeccCCCCCCCchhhhh
Q 008116 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDEHFS 237 (577)
Q Consensus 159 ~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLl-tG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s 237 (577)
...... ....|++.|+|||++.....++.++|||||||+||+|+ +|..||......+..... .... ......+
T Consensus 160 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~~-~~~~~~~ 233 (262)
T cd05077 160 ITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EGQC-MLVTPSC 233 (262)
T ss_pred ccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hcCc-cCCCCCh
Confidence 655322 24568899999999875556889999999999999998 588888765433221111 1111 1122245
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
..+.+||.+||..+|.+||++.+|+++
T Consensus 234 ~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 234 KELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=321.85 Aligned_cols=249 Identities=28% Similarity=0.548 Sum_probs=207.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcC-CCcEEEEEEeccCC---------ChHHHHHHHHHHHHHHh-CCCCceeEeEEEEEe
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEE---------SEDEIEDIQKEISVLSQ-CRSPYITEYYGSYLH 82 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~-tg~~VAIK~i~~~~---------~~~~~~~i~~Ev~iL~~-L~HpnIV~l~~~~~~ 82 (577)
.|++.+.||+|+||.||+|.+.. ++..||||.+.... .......+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 67899999885432 22345667789998875 699999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeeccccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGV 157 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~----~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGl 157 (577)
++..|+||||+++++|.+++. ....+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999998873 34579999999999999999999996 7899999999999999999999999999
Q ss_pred cccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc-hhhh
Q 008116 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-DEHF 236 (577)
Q Consensus 158 s~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l-~~~~ 236 (577)
+....... ......|+..|+|||++.+.. ++.++||||||+++|+|++|.+||...........+........ ...+
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd08528 161 AKQKQPES-KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238 (269)
T ss_pred eeeccccc-ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence 87654432 334567899999999997654 88999999999999999999999977655443333332222222 2357
Q ss_pred hHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 237 SRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 237 s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+..+.+||.+||..||.+||++.++..+
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 8899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=327.03 Aligned_cols=238 Identities=24% Similarity=0.384 Sum_probs=192.2
Q ss_pred EEeecCceEEEEEEEcCC------------------------CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeE
Q 008116 20 LIGRGSFGDVYKAFDKEL------------------------NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75 (577)
Q Consensus 20 ~IG~GsfG~Vy~a~~~~t------------------------g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~ 75 (577)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.++++++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 699999999999975321 2458899886443 223456888999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC------
Q 008116 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG------ 148 (577)
Q Consensus 76 l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g------ 148 (577)
+++++..+...||||||+++|+|..++.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 99999999999999999999999999865 46789999999999999999999999999999999999997644
Q ss_pred -CeeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHH-hCCCCCCCCCccceeeccCC
Q 008116 149 -DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR 226 (577)
Q Consensus 149 -~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLl-tG~~Pf~~~~~~~~~~~i~~ 226 (577)
.+||+|||++...... ....+++.|+|||++.+...++.++|||||||++|||+ +|..||....+......+..
T Consensus 161 ~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 236 (274)
T cd05076 161 PFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK 236 (274)
T ss_pred ceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh
Confidence 3899999987544222 23467889999999876556889999999999999985 79999987654332222111
Q ss_pred CCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 227 ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 227 ~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
...++...+..+.+||.+||..+|.+||++.+||++
T Consensus 237 --~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 237 --KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred --ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 112223345679999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=320.01 Aligned_cols=229 Identities=20% Similarity=0.305 Sum_probs=193.0
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCHHHHHH
Q 008116 24 GSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ 103 (577)
Q Consensus 24 GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~ 103 (577)
|.||.||+|.+..+++.||+|.+.... ...+|...+....||||+++++++.....+|+||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999999999999999986543 23345555566679999999999999999999999999999999998
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCCCCCChhhh
Q 008116 104 SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI 183 (577)
Q Consensus 104 ~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl 183 (577)
....+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+|||++...... .....++..|+|||++
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~~ 154 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEVG 154 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCccc
Confidence 7778999999999999999999999999999999999999999999999999987655432 2234567889999988
Q ss_pred hcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcH-----
Q 008116 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA----- 258 (577)
Q Consensus 184 ~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa----- 258 (577)
... .++.++|||||||++|+|++|..||...... . .......++..++..+++||.+||+.||.+||++
T Consensus 155 ~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~ 228 (237)
T cd05576 155 GIS-EETEACDWWSLGAILFELLTGKTLVECHPSG-I----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGV 228 (237)
T ss_pred CCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh-c----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccch
Confidence 654 4788999999999999999999987643221 1 1111123445678899999999999999999986
Q ss_pred HHHhhcHhh
Q 008116 259 KELLRHRFI 267 (577)
Q Consensus 259 ~elL~hpff 267 (577)
.++++||||
T Consensus 229 ~~~~~h~~~ 237 (237)
T cd05576 229 EDIKSHPFF 237 (237)
T ss_pred HHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=322.36 Aligned_cols=251 Identities=25% Similarity=0.431 Sum_probs=204.3
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcC----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe--CCE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKE----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTK 85 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~----tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~--~~~ 85 (577)
...|++++.||+|+||.||+|.... ++..||||++...........+.+|+.+++.+.||||+++++++.. +..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 3578899999999999999998653 4789999999766544456789999999999999999999999887 557
Q ss_pred EEEEEeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~-~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
.++||||+++++|.+++.... .+++..+..++.||+.||+|||++|++|+||||+|||++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 999999999999999997643 6999999999999999999999999999999999999999999999999998776532
Q ss_pred cccc---ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccce---------------eeccCC
Q 008116 165 ISRR---KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV---------------LFIIPR 226 (577)
Q Consensus 165 ~~~~---~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~---------------~~~i~~ 226 (577)
.... ....++..|++||.+... .++.++||||||+++|+|++|..||........ ...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 2111 123455679999998765 488999999999999999999999865322110 011111
Q ss_pred CCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 227 ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 227 ~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
......+..++..+.+|+.+||..+|.+|||+.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1122223456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.23 Aligned_cols=255 Identities=20% Similarity=0.303 Sum_probs=197.3
Q ss_pred cchhhhcCCCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHH----------HHHHHHHHHHHhCCCC
Q 008116 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEI----------EDIQKEISVLSQCRSP 71 (577)
Q Consensus 5 ~~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~----------~~i~~Ev~iL~~L~Hp 71 (577)
.++.+..+.+|++.++||+|+||.||+|.+..+ +..+|+|+.......... .....+...+..+.|+
T Consensus 4 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~ 83 (294)
T PHA02882 4 IPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL 83 (294)
T ss_pred eeeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence 456677889999999999999999999998877 677888875443321111 1122333455667899
Q ss_pred ceeEeEEEEEeCC----EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC
Q 008116 72 YITEYYGSYLHQT----KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (577)
Q Consensus 72 nIV~l~~~~~~~~----~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~ 147 (577)
+|+++++++.... ..++++|++ ..++.+++.....+++..++.++.||+.||.|||+++|+||||||+|||++.+
T Consensus 84 ~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 84 GIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN 162 (294)
T ss_pred CCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 9999999776543 347888988 45788887765667899999999999999999999999999999999999999
Q ss_pred CCeeeccccccccccccc-------cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccce
Q 008116 148 GDVKVADFGVSAQLTRTI-------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV 220 (577)
Q Consensus 148 g~vKL~DFGls~~~~~~~-------~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~ 220 (577)
+.++|+|||+|+.+.... .......||+.|+|||++.+.. ++.++|||||||+||+|++|.+||........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999997653221 1122357999999999987754 89999999999999999999999987632211
Q ss_pred -e--------eccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 221 -L--------FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 221 -~--------~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
. ..+.... .....++..+.+|+..||..+|++||++++|++
T Consensus 242 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhHHHHHHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1 1111111 112345788999999999999999999999975
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=315.82 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=207.1
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC-----EE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-----KL 86 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~-----~~ 86 (577)
.++|++.+.||+|||+-||++.+..++..||+|.+.... ....+...+|++..++++||||++++++...+. ..
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 579999999999999999999999999999999997766 456788999999999999999999998776544 48
Q ss_pred EEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEccCCCeeecccccccc
Q 008116 87 WIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~g--IiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
||++.|...|+|.+.+.. +.-++|.++..|+.+|++||++||+.. ++||||||.|||+.+.+.++|.|||.++.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999999853 347999999999999999999999998 99999999999999999999999999875
Q ss_pred cccccccc---------ccccCCCCCCChhhhhccc--CCccccchhhHHHHHHHHHhCCCCCCCCCc--cceeeccCCC
Q 008116 161 LTRTISRR---------KTFVGTPFWMAPEVIQNSE--GYNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPRE 227 (577)
Q Consensus 161 ~~~~~~~~---------~~~~GTp~Y~APEvl~~~~--~~~~ksDVwSLGviLyeLltG~~Pf~~~~~--~~~~~~i~~~ 227 (577)
..-..... ..-..|..|.|||++.... ..+.++|||||||+||+|+.|..||...-. ..+...+...
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~ 258 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA 258 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc
Confidence 43211111 1234688999999985432 367899999999999999999999974322 1122222221
Q ss_pred CC-CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 228 NP-PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 228 ~~-~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.. .+-...++..+.+||+.||+.||.+||++.+|+.+
T Consensus 259 q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 259 QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11 11122488999999999999999999999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=349.00 Aligned_cols=249 Identities=27% Similarity=0.469 Sum_probs=215.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCc---E-EEEEEecc--CCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNK---D-VAIKVIDL--EESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~---~-VAIK~i~~--~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
+-.+.++||+|+||.||+|..+..+. . ||||..+. ......+..+.+|+++|++++|||||++||++.....+|
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34456899999999999998765422 3 89999875 245667889999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~-~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
||||+|.||+|.++|++.+ .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+||||+........
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~ 317 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM 317 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence 9999999999999998876 499999999999999999999999999999999999999999999999999865431111
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeecc-CCCCCCCchhhhhHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFII-PRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i-~~~~~~~l~~~~s~~l~~lI 244 (577)
......-...|+|||.+... .|+.++|||||||++||+++ |..||......++...| ..+.+...+...+..+..++
T Consensus 318 ~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~ 396 (474)
T KOG0194|consen 318 KKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVM 396 (474)
T ss_pred ccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHH
Confidence 11011234679999999877 59999999999999999998 88999999988888888 55666677778899999999
Q ss_pred HHhcccCCCCCCcHHHHhh
Q 008116 245 SLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~ 263 (577)
.+||..+|+.||++.++.+
T Consensus 397 ~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 397 KQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHhccCChhhccCHHHHHH
Confidence 9999999999999999975
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=367.14 Aligned_cols=256 Identities=27% Similarity=0.481 Sum_probs=223.7
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCC-----cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELN-----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL 81 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg-----~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~ 81 (577)
|......+.++.+.||+|.||.||.|...... ..||||.++..........|.+|..+|+.++|||||+++|++.
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 44455678889999999999999999875433 3499999988888888999999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecc
Q 008116 82 HQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVAD 154 (577)
Q Consensus 82 ~~~~~~LV~Ey~~gGsL~~~l~~~-------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~D 154 (577)
+....+|++|||+||+|..+|++. ..++..++..++.||++|+.||+++++|||||-..|+||+....|||+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999999764 3588999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccc--cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCC
Q 008116 155 FGVSAQLTRTISRRKTF--VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQ 231 (577)
Q Consensus 155 FGls~~~~~~~~~~~~~--~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~ 231 (577)
||+|+.+....-..... .-...|||||.+... .++.++|||||||+|||+++ |..||.+.+..+++..+..+....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC
Confidence 99999654432211111 123569999999875 59999999999999999998 999999999988887666666666
Q ss_pred chhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 232 l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
.+..++..+.+++..||..+|++||++..|++
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 77889999999999999999999999999997
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=320.09 Aligned_cols=249 Identities=25% Similarity=0.413 Sum_probs=202.6
Q ss_pred eeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC------
Q 008116 15 FSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT------ 84 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~---~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~------ 84 (577)
|++.++||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 357899999986543 3345677899999999999999999999886532
Q ss_pred EEEEEEeccCCCCHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSG------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls 158 (577)
..++++||+.+|+|..++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 347899999999999887421 25789999999999999999999999999999999999999999999999998
Q ss_pred cccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhh
Q 008116 159 AQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEH 235 (577)
Q Consensus 159 ~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~ 235 (577)
........ ......+++.|++||.+... .++.++|||||||++|+|++ |.+||...+.......+........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPD 239 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence 76533211 11233456789999998765 48889999999999999999 8999987665444444433333333445
Q ss_pred hhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 236 ~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
++..+.+|+.+||..+|..||++.+++.+
T Consensus 240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 67899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=320.42 Aligned_cols=243 Identities=21% Similarity=0.360 Sum_probs=194.0
Q ss_pred EEeecCceEEEEEEEcCC--CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCC
Q 008116 20 LIGRGSFGDVYKAFDKEL--NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGS 97 (577)
Q Consensus 20 ~IG~GsfG~Vy~a~~~~t--g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGs 97 (577)
.||+|+||.||+|..... ...+++|.+...........+.+|+.+++.++||||+++++++.....+|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975433 345678877665555556789999999999999999999999999999999999999999
Q ss_pred HHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc--cccccc
Q 008116 98 VADLIQSG----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRRKTF 171 (577)
Q Consensus 98 L~~~l~~~----~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~--~~~~~~ 171 (577)
|.+++... ..+++..+..++.||+.||+|||+++++||||||+|||++.++.++|+|||++....... ......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 161 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK 161 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCC
Confidence 99999653 346777888999999999999999999999999999999999999999999875432211 112345
Q ss_pred cCCCCCCChhhhhcc------cCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC-----CCCchhhhhHH
Q 008116 172 VGTPFWMAPEVIQNS------EGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN-----PPQLDEHFSRL 239 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~------~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~-----~~~l~~~~s~~ 239 (577)
+|++.|+|||++... ..++.++|||||||++|+|++ |..||......+....+.... .+.+...++..
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (268)
T cd05086 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSER 241 (268)
T ss_pred cCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHH
Confidence 788999999987531 125678999999999999996 577887666544433332221 22334457888
Q ss_pred HHHHHHHhcccCCCCCCcHHHHhh
Q 008116 240 MKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 240 l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
+.+++..|| .+|.+||++.+|++
T Consensus 242 ~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 242 WYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHh-hCcccCCCHHHHHH
Confidence 999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=360.23 Aligned_cols=251 Identities=26% Similarity=0.444 Sum_probs=222.7
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
...+-+..+.||+|.||+||+|... .....||||.++.....+..+.|++|+++|..|+|||||+|+|+|..++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3456677899999999999999764 33568999999888777788999999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCee
Q 008116 86 LWIIMEYMAGGSVADLIQSG--------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~--------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vK 151 (577)
+|+|+|||..|+|.++|... .+++..+...|+.||+.|++||-++.+|||||-..|+||.++-.||
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 99999999999999999531 2388999999999999999999999999999999999999999999
Q ss_pred ecccccccccccccccc-c-cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC
Q 008116 152 VADFGVSAQLTRTISRR-K-TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228 (577)
Q Consensus 152 L~DFGls~~~~~~~~~~-~-~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~ 228 (577)
|+||||++.+....... . ...-...||+||.+...+ |+.++|||||||+|||+++ |+.||......+++..|..+.
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 99999998765432111 0 112246799999998765 9999999999999999997 999999999999999999998
Q ss_pred CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHh
Q 008116 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262 (577)
Q Consensus 229 ~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL 262 (577)
....++.+|..+.+|+..||+.+|.+||++++|-
T Consensus 723 lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 723 LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 8889999999999999999999999999999984
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=352.43 Aligned_cols=244 Identities=29% Similarity=0.449 Sum_probs=211.6
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV 89 (577)
....|++...||.|+|+.|-.+.+..+++.+++|++.... ....+|+.++... +||||+++++++.++...|+|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 4678899999999999999999999999999999997663 3356678776666 899999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE-ccCCCeeecccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl-d~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
||++.|+.|.+.+.....+. ..+..|+.+|+.||.|||++|||||||||+|||+ +..|+++|+|||+++..... .
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---C 470 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---h
Confidence 99999999999887755555 8888999999999999999999999999999999 58899999999999877554 2
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-ceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~-~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
-+.|-|..|+|||++... .|+.++||||||++||+||+|..||...... +....| ..+.+...+|..+++||.+|
T Consensus 471 ~tp~~t~~y~APEvl~~~-~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i---~~~~~s~~vS~~AKdLl~~L 546 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQ-EYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI---QMPKFSECVSDEAKDLLQQL 546 (612)
T ss_pred cccchhhcccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh---cCCccccccCHHHHHHHHHh
Confidence 344668899999999854 5999999999999999999999999876544 222223 33444578999999999999
Q ss_pred cccCCCCCCcHHHHhhcHhh
Q 008116 248 LKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 248 L~~dP~~RpTa~elL~hpff 267 (577)
|+.||.+||++.+++.||||
T Consensus 547 L~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 547 LQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCChhhCcChhhhccCcch
Confidence 99999999999999999999
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=330.57 Aligned_cols=259 Identities=26% Similarity=0.467 Sum_probs=208.9
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEe-CCE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTK 85 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~----~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~-~~~ 85 (577)
...|+++..||+|+||.||+|..+.++. .+|||.++..+.. ..-....+|+.+++.|+||||+.+..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3579999999999999999997665543 7999999766432 233567899999999999999999999988 789
Q ss_pred EEEEEeccCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC----CCeeecccc
Q 008116 86 LWIIMEYMAGGSVADLIQS-----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN----GDVKVADFG 156 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~-----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~----g~vKL~DFG 156 (577)
+|+++||.+. +|.++|+- ...++...+..|++||+.|+.|||++.|+||||||.||||..+ |.|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999965 89999953 2468999999999999999999999999999999999999877 899999999
Q ss_pred cccccccccccc---ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------c--eeecc
Q 008116 157 VSAQLTRTISRR---KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-------R--VLFII 224 (577)
Q Consensus 157 ls~~~~~~~~~~---~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~-------~--~~~~i 224 (577)
|++.+..+.... ..++-|.+|.|||++.+...|+.+.|||++|||+.|||+-.+.|...... . .+..|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 999887765443 24577999999999999999999999999999999999988887543210 0 00000
Q ss_pred ---C-----CCCC-----CC-----------------chh------hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 225 ---P-----RENP-----PQ-----------------LDE------HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 225 ---~-----~~~~-----~~-----------------l~~------~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
. ...| |. +.. .-++...+|+.++|..||.+|.|+.++|+|+||.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 0 0000 00 000 0123477899999999999999999999999998
Q ss_pred hcc
Q 008116 269 NAR 271 (577)
Q Consensus 269 ~~~ 271 (577)
...
T Consensus 342 ~d~ 344 (438)
T KOG0666|consen 342 EDP 344 (438)
T ss_pred cCC
Confidence 653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=369.68 Aligned_cols=255 Identities=30% Similarity=0.526 Sum_probs=205.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe--------
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-------- 82 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~-------- 82 (577)
...+|+.+++||+||||.||+++++-+|+.||||.|+..........+.+|+..|.+|+|||||++|..|.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 346889999999999999999999999999999999888766667889999999999999999999954420
Q ss_pred --------------------------------------------------------------------------------
Q 008116 83 -------------------------------------------------------------------------------- 82 (577)
Q Consensus 83 -------------------------------------------------------------------------------- 82 (577)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C--------CEEEEEEeccCCCCHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHHc
Q 008116 83 -----------------------Q--------TKLWIIMEYMAGGSVADLIQSGPPL-DEMSIACILRDLLHAIEYLHNE 130 (577)
Q Consensus 83 -----------------------~--------~~~~LV~Ey~~gGsL~~~l~~~~~l-~e~~i~~il~QLl~aL~yLHs~ 130 (577)
+ -.+||-||||+..+|.+++.++... ....+|.+++||+.||.|+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 1368899999999999999876554 5778999999999999999999
Q ss_pred CCcccccccceEEEccCCCeeecccccccccc------------------ccccccccccCCCCCCChhhhhccc--CCc
Q 008116 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLT------------------RTISRRKTFVGTPFWMAPEVIQNSE--GYN 190 (577)
Q Consensus 131 gIiHrDIKPeNILld~~g~vKL~DFGls~~~~------------------~~~~~~~~~~GTp~Y~APEvl~~~~--~~~ 190 (577)
|||||||||.||||+.++.|||+|||+++... ...+..+..+||.-|+|||++.+.. .|+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999999999999999998721 0111234578999999999997765 599
Q ss_pred cccchhhHHHHHHHHHhCCCCCCCC-CccceeeccCCCCCCCc---hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHh
Q 008116 191 EKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPRENPPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266 (577)
Q Consensus 191 ~ksDVwSLGviLyeLltG~~Pf~~~-~~~~~~~~i~~~~~~~l---~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpf 266 (577)
.|+|||||||||+||+. ||... ....++..+.....|.. ...--+.-..+|..||.+||.+||||.|||++.|
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~l 873 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSEL 873 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccC
Confidence 99999999999999984 45432 22222333332222221 2222345677999999999999999999999988
Q ss_pred hh
Q 008116 267 IR 268 (577)
Q Consensus 267 f~ 268 (577)
|-
T Consensus 874 lp 875 (1351)
T KOG1035|consen 874 LP 875 (1351)
T ss_pred CC
Confidence 86
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=328.38 Aligned_cols=260 Identities=33% Similarity=0.553 Sum_probs=221.6
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~ 87 (577)
.....+.+-+..||.|+||+|++-.++.+|+..|||.|.........+++..|.+...+- +.||||++||....++..|
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 334455666788999999999999999999999999998888777778899999876665 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeeccccccccc
Q 008116 88 IIMEYMAGGSVADLIQ-----SGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~-----~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
|.||+| ..+|..+.+ ....++|..+..|...++.||.||-. .+||||||||+||||+..|.|||||||++.++
T Consensus 140 iCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 140 ICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 999999 567766553 24679999999999999999999995 58999999999999999999999999999888
Q ss_pred cccccccccccCCCCCCChhhhhccc-CCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccCCCCCCCch-----h
Q 008116 162 TRTISRRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLD-----E 234 (577)
Q Consensus 162 ~~~~~~~~~~~GTp~Y~APEvl~~~~-~~~~ksDVwSLGviLyeLltG~~Pf~~~~~-~~~~~~i~~~~~~~l~-----~ 234 (577)
...... +.-.|...|||||-+.... +|+.++||||||++|||+.||..||...+. .+.+..+..+.||.+. .
T Consensus 219 v~SiAk-T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 219 VDSIAK-TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred HHHHHh-hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence 665333 3457899999999987544 499999999999999999999999986543 4455556666666553 2
Q ss_pred hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 235 ~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
+++..+..||..||.+|-..||.+.+|+++||++..
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 578999999999999999999999999999999754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.16 Aligned_cols=211 Identities=32% Similarity=0.527 Sum_probs=186.7
Q ss_pred ccchhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC
Q 008116 4 LAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (577)
Q Consensus 4 l~~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~ 83 (577)
.+.++......+...+.||+|+||.||+++++.+|+.||||.++........+..-+|+++|++|+|||||+++++-.+.
T Consensus 4 ~~~l~~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~ 83 (732)
T KOG4250|consen 4 PPVLTSGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETK 83 (732)
T ss_pred CcccccCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcc
Confidence 34466677788889999999999999999999999999999998877666678889999999999999999999986654
Q ss_pred C------EEEEEEeccCCCCHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc--cCC--Ce
Q 008116 84 T------KLWIIMEYMAGGSVADLIQS---GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT--ENG--DV 150 (577)
Q Consensus 84 ~------~~~LV~Ey~~gGsL~~~l~~---~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld--~~g--~v 150 (577)
. ...+|||||.||+|..+|.+ ...+++.++..++..++.||.|||++|||||||||.||++- .+| ..
T Consensus 84 ~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~Iy 163 (732)
T KOG4250|consen 84 FLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIY 163 (732)
T ss_pred ccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEE
Confidence 3 45899999999999999964 35799999999999999999999999999999999999984 334 37
Q ss_pred eeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCC
Q 008116 151 KVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL 215 (577)
Q Consensus 151 KL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~ 215 (577)
||+|||.|+.+... ....+++||+.|.+||++.....|+..+|.|||||++|+++||..||...
T Consensus 164 KLtDfG~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 164 KLTDFGAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred eeecccccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99999999988665 46678999999999999986567999999999999999999999999644
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=348.36 Aligned_cols=261 Identities=50% Similarity=0.918 Sum_probs=239.7
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
.....+|+++..||.|+||.||+|+++.+++..|||++++.... .+.-+++|+-+++.++|||||.+++.|.....+||
T Consensus 11 rnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 11 RNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred cCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 35678999999999999999999999999999999999887644 45788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
+||||.||+|.++-.-.+++++.++..+.++.++||+|||+.|-+|||||-.|||++..|.+||+|||.+.+++....+.
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR 169 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence 99999999999999888999999999999999999999999999999999999999999999999999999998888888
Q ss_pred ccccCCCCCCChhhhh--cccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC--CCc--hhhhhHHHHH
Q 008116 169 KTFVGTPFWMAPEVIQ--NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP--PQL--DEHFSRLMKE 242 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~--~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~--~~l--~~~~s~~l~~ 242 (577)
..++|||+|||||+.. ...+|...+|||++|++..||-.-++|..+..++..+..+.+..+ +.+ +..++..+.+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHN 249 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence 8999999999999864 334599999999999999999999999999999998888766543 333 3478899999
Q ss_pred HHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 243 FVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
|++.||.++|.+||+++.+|.|||+...
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccc
Confidence 9999999999999999999999999765
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=297.35 Aligned_cols=241 Identities=41% Similarity=0.666 Sum_probs=205.0
Q ss_pred CceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCHHHHHHc
Q 008116 25 SFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS 104 (577)
Q Consensus 25 sfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~ 104 (577)
+||.||+|.+..++..||+|++...........+.+|+..+++++|+||+++++++......++++||+.+++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999987655433267899999999999999999999999999999999999999999999987
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCCCCCChhhhh
Q 008116 105 GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184 (577)
Q Consensus 105 ~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~ 184 (577)
...+++..++.++.+++.+|.|||..+++|+||+|.||+++.++.++|+|||++....... ......|++.|++||++.
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~ 159 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLL 159 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHc
Confidence 6669999999999999999999999999999999999999999999999999987765432 334567899999999987
Q ss_pred cccCCccccchhhHHHHHHHHHhCCCCCCC-CCccceeeccCCCCCCCchhh--hhHHHHHHHHHhcccCCCCCCcHHHH
Q 008116 185 NSEGYNEKADIWSLGITVIEMAKGEPPLAD-LHPMRVLFIIPRENPPQLDEH--FSRLMKEFVSLCLKKVPAERPSAKEL 261 (577)
Q Consensus 185 ~~~~~~~ksDVwSLGviLyeLltG~~Pf~~-~~~~~~~~~i~~~~~~~l~~~--~s~~l~~lI~~cL~~dP~~RpTa~el 261 (577)
.. .++.++||||||+++++|++|..||.. .+.......+........... ++..+.+|+.+||..+|.+||++.++
T Consensus 160 ~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 238 (244)
T smart00220 160 GK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA 238 (244)
T ss_pred cC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence 54 478899999999999999999999977 333333333322222221111 77899999999999999999999999
Q ss_pred hhcHhh
Q 008116 262 LRHRFI 267 (577)
Q Consensus 262 L~hpff 267 (577)
++||||
T Consensus 239 ~~~~~~ 244 (244)
T smart00220 239 LQHPFF 244 (244)
T ss_pred hhCCCC
Confidence 999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=322.16 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=209.8
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-C-C----ceeEeEEEE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-S-P----YITEYYGSY 80 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-H-p----nIV~l~~~~ 80 (577)
+.+...++|++++++|+|.||.|..+.+..++..||||+++... ...+...-|+.+|.++. + | -+|.+.++|
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 56677899999999999999999999999999999999986332 23355677999999993 2 3 378888889
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc------------
Q 008116 81 LHQTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE------------ 146 (577)
Q Consensus 81 ~~~~~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~------------ 146 (577)
...+++|||+|.+ |-++.++|+.+ .+++...++.+.+||+++++|||+.+++|-||||+|||+..
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999999 77999999874 47999999999999999999999999999999999999832
Q ss_pred --------CCCeeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc
Q 008116 147 --------NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM 218 (577)
Q Consensus 147 --------~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~ 218 (577)
...|+|+|||.|+.... ...+.+.|..|.|||++.+-. ++.++||||+||||+||++|...|...+..
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcH
Confidence 12489999999876543 335778999999999999874 999999999999999999999999876654
Q ss_pred cee---eccCCCCC------------------------------------CCch------hhhhHHHHHHHHHhcccCCC
Q 008116 219 RVL---FIIPRENP------------------------------------PQLD------EHFSRLMKEFVSLCLKKVPA 253 (577)
Q Consensus 219 ~~~---~~i~~~~~------------------------------------~~l~------~~~s~~l~~lI~~cL~~dP~ 253 (577)
+-+ ..|....| .++. ..--..+.+||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 422 11211111 0000 01123588999999999999
Q ss_pred CCCcHHHHhhcHhhhhc
Q 008116 254 ERPSAKELLRHRFIRNA 270 (577)
Q Consensus 254 ~RpTa~elL~hpff~~~ 270 (577)
+|+|+.|+|.||||...
T Consensus 396 ~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 396 RRITLREALSHPFFARL 412 (415)
T ss_pred ccccHHHHhcCHHhhcC
Confidence 99999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=341.65 Aligned_cols=299 Identities=26% Similarity=0.405 Sum_probs=245.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCC---cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
+..+|.++||.|.||.||+|..+..+ ..||||.++....+.+...|..|+.||-+++||||++|.|+......++||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 45678899999999999999987665 479999999888888889999999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-
Q 008116 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~- 167 (577)
+|||++|+|..+|+. .+.|+..++..+++.|+.|+.||-+.++|||||-..||||+.+-..|++||||++.+.+....
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 999999999999965 478999999999999999999999999999999999999999999999999999988655433
Q ss_pred cccccC--CCCCCChhhhhcccCCccccchhhHHHHHHHHH-hCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHH
Q 008116 168 RKTFVG--TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 168 ~~~~~G--Tp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLl-tG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI 244 (577)
..+.-| ...|.|||.+.-. .++.++||||+||+|||.+ .|..||+++...+++..|..+...+.|..+|..|..|+
T Consensus 789 ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLM 867 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLM 867 (996)
T ss_pred ccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHH
Confidence 333334 3579999999876 4999999999999999966 59999999999999999999988778889999999999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhhhhccCChhHHHHhhcCCCCC---CCCCCCCCCccccccccCCCccccccc
Q 008116 245 SLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYP---IQEEPDTPINGVRAVGEASGTVKVVRD 314 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (577)
..||++|-.+||.+.||+.+ |.+....+..++.+......+ ..............++++...+++.+.
T Consensus 868 ldCWqkdR~~RP~F~qiV~~--lDklIrnP~SLk~~~~~~~r~s~~lld~~~~~~~~f~sv~~WL~aIkm~rY 938 (996)
T KOG0196|consen 868 LDCWQKDRNRRPKFAQIVST--LDKLIRNPNSLKTIAPESPRPSQPLLDRSGSDFTPFRSVGDWLEAIKMGRY 938 (996)
T ss_pred HHHHHHHhhcCCCHHHHHHH--HHHHhcCchhhcccCCCCCCCcccccCCCCCCCcccCCHHHHHHHhhhhHH
Confidence 99999999999999999975 333222333333332211111 111112223345556666666655544
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=326.65 Aligned_cols=244 Identities=27% Similarity=0.445 Sum_probs=215.3
Q ss_pred EeEEeecCceEEEEEEEcCC----CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEecc
Q 008116 18 LELIGRGSFGDVYKAFDKEL----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~t----g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
.++||.|-||.||+|+.... .-.||||+.+.....+..+.|..|..+|++++|||||+++|+|.+ ...|||||++
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~ 472 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELA 472 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecc
Confidence 46899999999999986433 336999999887777778999999999999999999999999864 5789999999
Q ss_pred CCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc-c
Q 008116 94 AGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-F 171 (577)
Q Consensus 94 ~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~-~ 171 (577)
+-|.|..+++.+ ..++...+..+++||+.||+|||+.++|||||-..|||+.....|||+|||+++.+....-...+ .
T Consensus 473 ~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~ 552 (974)
T KOG4257|consen 473 PLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRG 552 (974)
T ss_pred cchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhcccc
Confidence 999999999754 57899999999999999999999999999999999999999999999999999988654322222 1
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
.-..-|||||-+.-. .++.++|||-|||+|||++. |..||......+++..|.++...++|.++|+.+..|+.+||..
T Consensus 553 kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWay 631 (974)
T KOG4257|consen 553 KLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAY 631 (974)
T ss_pred ccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhcc
Confidence 224569999998544 59999999999999999875 9999999999999999999999999999999999999999999
Q ss_pred CCCCCCcHHHHhh
Q 008116 251 VPAERPSAKELLR 263 (577)
Q Consensus 251 dP~~RpTa~elL~ 263 (577)
+|.+||.+.+|..
T Consensus 632 eP~kRPrftei~~ 644 (974)
T KOG4257|consen 632 EPSKRPRFTEIKA 644 (974)
T ss_pred CcccCCcHHHHHH
Confidence 9999999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=313.81 Aligned_cols=262 Identities=25% Similarity=0.424 Sum_probs=212.0
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe-----
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH----- 82 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~----- 82 (577)
....++|+.+.+||+|.||.||+|..+.+|+.||+|++-.+. ....-....+|+.+|..|+|+|++.++++|..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 345678999999999999999999999999999998764433 22234556889999999999999999988753
Q ss_pred ---CCEEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccc
Q 008116 83 ---QTKLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (577)
Q Consensus 83 ---~~~~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls 158 (577)
...+|+||.+|+ .+|.-++... .+|+..+|..++++++.||.|+|.+.|+|||+||+|+||+.+|.+||+|||++
T Consensus 93 ~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 336899999996 4899998654 68999999999999999999999999999999999999999999999999999
Q ss_pred ccccccc----cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-------CC
Q 008116 159 AQLTRTI----SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-------RE 227 (577)
Q Consensus 159 ~~~~~~~----~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-------~~ 227 (577)
+.+.... ..+...+-|.+|.+||.+.+...|+.+.|||..||||.||+++.+-|........+..|. ++
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 7664321 112345669999999999999899999999999999999999999887655543332221 00
Q ss_pred C--------------CCCchh-------------hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 228 N--------------PPQLDE-------------HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 228 ~--------------~~~l~~-------------~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
. .++++. .-.+++.+|+.++|..||.+|++++++|.|.||+.-.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 0 011111 0124678999999999999999999999999997643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=338.94 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=178.6
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCC----CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEE------E
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKEL----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGS------Y 80 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~t----g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~------~ 80 (577)
..++|++.+.||+|+||.||+|.+..+ +..||||.+...... +....| .++...+.+++.++.. .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 457899999999999999999999988 899999987543211 111111 1122222223222221 2
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHcCC-C-------------------CCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Q 008116 81 LHQTKLWIIMEYMAGGSVADLIQSGP-P-------------------LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAA 140 (577)
Q Consensus 81 ~~~~~~~LV~Ey~~gGsL~~~l~~~~-~-------------------l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPe 140 (577)
..+..++|||||+.+++|.+++.... + ..+..+..++.||+.||.|||+++|+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 34668999999999999999986432 1 123456789999999999999999999999999
Q ss_pred eEEEcc-CCCeeeccccccccccccc-cccccccCCCCCCChhhhhccc---------------------CCccccchhh
Q 008116 141 NILLTE-NGDVKVADFGVSAQLTRTI-SRRKTFVGTPFWMAPEVIQNSE---------------------GYNEKADIWS 197 (577)
Q Consensus 141 NILld~-~g~vKL~DFGls~~~~~~~-~~~~~~~GTp~Y~APEvl~~~~---------------------~~~~ksDVwS 197 (577)
||||+. ++.+||+|||+++.+.... .....++|++.|||||++.... .+..++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999986 5899999999997654322 2234578999999999764221 1345679999
Q ss_pred HHHHHHHHHhCCCCCCCCCcc-------------ceeeccCCCCCCCch------hhhhHHHHHHHHHhcccCCCCCCcH
Q 008116 198 LGITVIEMAKGEPPLADLHPM-------------RVLFIIPRENPPQLD------EHFSRLMKEFVSLCLKKVPAERPSA 258 (577)
Q Consensus 198 LGviLyeLltG~~Pf~~~~~~-------------~~~~~i~~~~~~~l~------~~~s~~l~~lI~~cL~~dP~~RpTa 258 (577)
|||+||||+++..|+...... .....+.....+.+. .......++||.+||.+||.+|||+
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 999999999987765432100 000000000000100 1112345689999999999999999
Q ss_pred HHHhhcHhhhhcc
Q 008116 259 KELLRHRFIRNAR 271 (577)
Q Consensus 259 ~elL~hpff~~~~ 271 (577)
.++|+||||....
T Consensus 445 ~e~L~Hpff~~~~ 457 (566)
T PLN03225 445 KAALAHPYFDREG 457 (566)
T ss_pred HHHhCCcCcCCCC
Confidence 9999999998653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=319.63 Aligned_cols=259 Identities=25% Similarity=0.453 Sum_probs=213.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC------ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe-C
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE------SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-Q 83 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~------~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~-~ 83 (577)
+..+|-++.+||+|+|+.||+|.+....+.||||+-.+.+ .....+..-+|..|.+.|+||-||++|++|.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 4568888999999999999999999999999999865443 23345677899999999999999999999975 5
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc--CCcccccccceEEEcc---CCCeeecccccc
Q 008116 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE--GKIHRDIKAANILLTE---NGDVKVADFGVS 158 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~--gIiHrDIKPeNILld~---~g~vKL~DFGls 158 (577)
+.+|-|+|||+|.+|.-+|+.+..+++.+++.|+-||+.||.||.+. .|||-||||.||||-. .|.+||.||||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 57899999999999999999989999999999999999999999976 5999999999999943 478999999999
Q ss_pred ccccccccc-------cccccCCCCCCChhhhhc---ccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-ee--eccC
Q 008116 159 AQLTRTISR-------RKTFVGTPFWMAPEVIQN---SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VL--FIIP 225 (577)
Q Consensus 159 ~~~~~~~~~-------~~~~~GTp~Y~APEvl~~---~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~-~~--~~i~ 225 (577)
+.+...... .....||.||++||.+.- .+..+.++||||+|||+|.+|.|+.||....... ++ .-|.
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 988653222 234689999999998753 2346789999999999999999999998653321 11 1122
Q ss_pred CCCCCCc--hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 226 RENPPQL--DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 226 ~~~~~~l--~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
+.....+ ...++.++++||++||..--+.|....+|-.||+|..
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 2221122 2357899999999999999999999999999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=294.29 Aligned_cols=252 Identities=23% Similarity=0.427 Sum_probs=211.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCC--EEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQT--KLW 87 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~--~~~ 87 (577)
...+|++++.+|+|.|+.||.|++..++..++||+++..+ .+.+++|+.||..|. ||||++++++..+.. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 3468999999999999999999999999999999986543 477999999999995 999999999998754 578
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC-CCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~-g~vKL~DFGls~~~~~~~~ 166 (577)
||+||+++.+...+. +.++...++.++.+|++||.|||+.||+|||+||.|++||.. -.++|+|||+|..... ..
T Consensus 112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp-~~ 187 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GK 187 (338)
T ss_pred hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC-Cc
Confidence 999999998888775 568999999999999999999999999999999999999976 5699999999976643 45
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCC-CccceeeccCC----------------CCC
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPR----------------ENP 229 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~-~~~~~~~~i~~----------------~~~ 229 (577)
..+..+.+..|-.||++...+.|++.-|+|||||+|..|+..+-||... +....+.+|.+ .-.
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 6677889999999999998888999999999999999999999998533 22222222210 000
Q ss_pred CCc--------------------hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 230 PQL--------------------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 230 ~~l--------------------~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
+.+ ..-.++++.+|+.++|..|..+|+||.|++.||||...
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 110 01235889999999999999999999999999999764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.19 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=215.6
Q ss_pred cchhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC
Q 008116 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (577)
Q Consensus 5 ~~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~ 84 (577)
.++.+.+.....+.+.||+|-||.|.+++-.. +..||||.++.....+....|.+||++|.+|+|||||+++++|..++
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 45677788889999999999999999997654 68999999988877777789999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
.+++|+|||+.|+|.+++.++. .+.-.....|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++-+.
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999999998753 33455667799999999999999999999999999999999999999999998654
Q ss_pred cccccc--ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHH--hCCCCCCCCCccceeeccC---CC----CCCC
Q 008116 163 RTISRR--KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA--KGEPPLADLHPMRVLFIIP---RE----NPPQ 231 (577)
Q Consensus 163 ~~~~~~--~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLl--tG~~Pf~~~~~~~~~~~i~---~~----~~~~ 231 (577)
...... .-.+-...|||||.+...+ ++.++|||+||++|||++ +...||....+.++..... .. ..+.
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence 332111 1234467899999988765 999999999999999976 5889998877655443221 11 1223
Q ss_pred chhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 232 l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
.|..++..+.+++..||..+-.+||++++|..
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 45677888999999999999999999999854
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.69 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=222.3
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCC-C--cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKEL-N--KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~t-g--~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
+..++.++||+|.||.|++|.|+.. | ..||||++...........|.+|+.+|.+|.|||+|+|||+..+ ..+.+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 4566778999999999999998643 2 46999999877655578899999999999999999999999887 778999
Q ss_pred EeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
||++++|+|.+.|.+ ...|....+..|+.||+.|+.||..+++|||||-..||||-....||||||||.+-+......
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999999975 457888999999999999999999999999999999999998889999999999887655433
Q ss_pred ccccc----CCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHH
Q 008116 168 RKTFV----GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (577)
Q Consensus 168 ~~~~~----GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~ 242 (577)
+ ++. -...|+|||.+.... ++.++|||+|||+||||++ |.-||.......++..|..+....-+..+++.+.+
T Consensus 269 Y-vm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~ 346 (1039)
T KOG0199|consen 269 Y-VMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQ 346 (1039)
T ss_pred e-EecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHH
Confidence 2 222 234699999998764 9999999999999999997 88999999999999988877777777889999999
Q ss_pred HHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 243 FVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
+++.||..+|.+|||+..|.+.-++..+
T Consensus 347 imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 347 IMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred HHHHhccCCccccccHHHHHHhHHHHhc
Confidence 9999999999999999999876555543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=317.40 Aligned_cols=259 Identities=21% Similarity=0.367 Sum_probs=187.8
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEc----------------CCCcEEEEEEeccCCChH-------------HHHHHHHH
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDK----------------ELNKDVAIKVIDLEESED-------------EIEDIQKE 61 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~----------------~tg~~VAIK~i~~~~~~~-------------~~~~i~~E 61 (577)
..++|++.++||+|+||+||+|.+. ..++.||||.+....... ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3569999999999999999999752 235679999986543211 11223357
Q ss_pred HHHHHhCCCCce-----eEeEEEEEe--------CCEEEEEEeccCCCCHHHHHHcC-----------------------
Q 008116 62 ISVLSQCRSPYI-----TEYYGSYLH--------QTKLWIIMEYMAGGSVADLIQSG----------------------- 105 (577)
Q Consensus 62 v~iL~~L~HpnI-----V~l~~~~~~--------~~~~~LV~Ey~~gGsL~~~l~~~----------------------- 105 (577)
+.++.+++|.++ ++++++|.. .+..||||||+++++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778766544 667776653 35689999999999999988531
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-cccccCCCCCCChhhh
Q 008116 106 -PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKTFVGTPFWMAPEVI 183 (577)
Q Consensus 106 -~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~-~~~~~GTp~Y~APEvl 183 (577)
..+++..++.++.||+.+|.|||.++|+||||||+|||++.++.+||+|||++..+...... .....+||.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 12356778899999999999999999999999999999999999999999998655332111 1123458999999987
Q ss_pred hcccC-------------------Cc--cccchhhHHHHHHHHHhCCC-CCCCCCcccee-----------eccC-CCCC
Q 008116 184 QNSEG-------------------YN--EKADIWSLGITVIEMAKGEP-PLADLHPMRVL-----------FIIP-RENP 229 (577)
Q Consensus 184 ~~~~~-------------------~~--~ksDVwSLGviLyeLltG~~-Pf~~~~~~~~~-----------~~i~-~~~~ 229 (577)
..... |+ .+.||||+||+||+|++|.+ ||......... ..+. ....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 53211 12 24799999999999999986 77532211100 0000 0111
Q ss_pred CCchhhhhHHHHHHHHHhcccCC---CCCCcHHHHhhcHhhhh
Q 008116 230 PQLDEHFSRLMKEFVSLCLKKVP---AERPSAKELLRHRFIRN 269 (577)
Q Consensus 230 ~~l~~~~s~~l~~lI~~cL~~dP---~~RpTa~elL~hpff~~ 269 (577)
.......+...++||.+||.++| .+|+|+.|+|.||||..
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 12234568899999999999876 68999999999999953
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=316.08 Aligned_cols=257 Identities=24% Similarity=0.408 Sum_probs=211.2
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC------CceeEeEEEE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS------PYITEYYGSY 80 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~H------pnIV~l~~~~ 80 (577)
+++.+..+|.+....|+|-|++|..|.+..-|..||||+|..... -.+.=++|++||++|.. -|+++|+-.|
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 778889999999999999999999999999999999999965432 23445789999999953 4799999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC-CCeeecccc
Q 008116 81 LHQTKLWIIMEYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFG 156 (577)
Q Consensus 81 ~~~~~~~LV~Ey~~gGsL~~~l~~~~---~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~-g~vKL~DFG 156 (577)
...+++|||||-+ ..+|.++|++.+ .|....++.|+.||+.||..|-..||+|.||||+|||+++. ..+||||||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 9999999999998 579999998744 58889999999999999999999999999999999999976 568999999
Q ss_pred ccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc------------
Q 008116 157 VSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------ 224 (577)
Q Consensus 157 ls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i------------ 224 (577)
.|...... ....+.-+..|.|||++.+.. |++..|+||+||+||||+||+..|++.....++...
T Consensus 583 SA~~~~en--eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 583 SASFASEN--EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccccccc--cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 98766443 334566788899999999986 999999999999999999999988764432222100
Q ss_pred ---------------------------------CCCCCC-----------Cchh---hhhHHHHHHHHHhcccCCCCCCc
Q 008116 225 ---------------------------------PRENPP-----------QLDE---HFSRLMKEFVSLCLKKVPAERPS 257 (577)
Q Consensus 225 ---------------------------------~~~~~~-----------~l~~---~~s~~l~~lI~~cL~~dP~~RpT 257 (577)
..-.|. .++. .+-..+++||.+||..||++|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 000110 0111 12246889999999999999999
Q ss_pred HHHHhhcHhhhh
Q 008116 258 AKELLRHRFIRN 269 (577)
Q Consensus 258 a~elL~hpff~~ 269 (577)
..++|+||||..
T Consensus 740 ~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQALKHPFITE 751 (752)
T ss_pred HHHHhcCCcccC
Confidence 999999999963
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=312.15 Aligned_cols=245 Identities=27% Similarity=0.491 Sum_probs=216.6
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEecc
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
+.....+||.|-||.||.|.|+.-...||||.++... ..+++|..|+.+|+.++|||+|+|+++|..+-.+|||+|||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 3445678999999999999999989999999986443 35789999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 94 AGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 94 ~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
..|+|.++|++. ..++...+..++.||..|++||..+++|||||-..|+|+.++..||++||||++.+.... +...
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT--YTAH 423 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT--YTAH 423 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc--eecc
Confidence 999999999763 357777888899999999999999999999999999999999999999999999886542 2222
Q ss_pred cC---CCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 172 VG---TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 172 ~G---Tp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
.| ..-|.|||-+.-. .++.++|||+|||+|||+.| |-.||...+..++...+.+++...-+..+++.+..|++.|
T Consensus 424 AGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraC 502 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRAC 502 (1157)
T ss_pred cCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHH
Confidence 33 4569999998765 48999999999999999997 8889999998888888888888788889999999999999
Q ss_pred cccCCCCCCcHHHHhh
Q 008116 248 LKKVPAERPSAKELLR 263 (577)
Q Consensus 248 L~~dP~~RpTa~elL~ 263 (577)
|+++|..||++.+|-+
T Consensus 503 W~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 503 WNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred hcCCcccCccHHHHHH
Confidence 9999999999999854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=340.09 Aligned_cols=238 Identities=19% Similarity=0.336 Sum_probs=189.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
..|....+||+|+||.||+|.+..++..||||.+..... ....|+.++++++|||||++++++......|+||||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 456777899999999999999998999999999864432 123568999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH---NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 93 ~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLH---s~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
|++|+|.++++. +++..+..++.||+.||+||| +.+|+||||||+|||++.++..+++ ||....... ..
T Consensus 765 ~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~ 836 (968)
T PLN00113 765 IEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----DT 836 (968)
T ss_pred CCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----CC
Confidence 999999999964 899999999999999999999 6699999999999999988887775 665433221 12
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc--eee-------------ccCCC--CCCCc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR--VLF-------------IIPRE--NPPQL 232 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~--~~~-------------~i~~~--~~~~l 232 (577)
...||+.|+|||++.+. .++.++|||||||+||||++|+.||....... ... .+... .....
T Consensus 837 ~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 837 KCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 34789999999998765 48999999999999999999999985422110 000 00000 00111
Q ss_pred hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 233 ~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.......+.+++.+||..+|.+|||+.++++.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 22334567889999999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.60 Aligned_cols=253 Identities=28% Similarity=0.427 Sum_probs=199.1
Q ss_pred EeEEeecCceE-EEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 18 LELIGRGSFGD-VYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 18 l~~IG~GsfG~-Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
.+++|.|+-|+ ||+|... |+.||||.+-.. .....++||..|+.. .|||||++|+.-.+...+||+.|+| .
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 46789999985 7999876 889999987432 446788999999999 6999999999999999999999999 5
Q ss_pred CCHHHHHHcCCC----CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc---C--CCeeecccccccccccccc
Q 008116 96 GSVADLIQSGPP----LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---N--GDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 96 GsL~~~l~~~~~----l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~---~--g~vKL~DFGls~~~~~~~~ 166 (577)
.+|.+++..... ......+.++.|++.||++||+.+||||||||.||||.. + ..++|+|||+++.+.....
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 699999976311 111456788999999999999999999999999999975 3 4699999999998865433
Q ss_pred c---cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhC-CCCCCCCCccceeeccCCCCCC--CchhhhhHHH
Q 008116 167 R---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPP--QLDEHFSRLM 240 (577)
Q Consensus 167 ~---~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG-~~Pf~~~~~~~~~~~i~~~~~~--~l~~~~s~~l 240 (577)
. ..+..||-+|+|||++.... -..++|||||||++|+.++| .+||.+.-..+. .|..++.. .+...-..++
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchHHH
Confidence 3 34567999999999998764 56789999999999998886 999987543321 12222211 1111111289
Q ss_pred HHHHHHhcccCCCCCCcHHHHhhcHhhhhccCChhHHHHh
Q 008116 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280 (577)
Q Consensus 241 ~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~~~~i 280 (577)
.+||.+||.++|..||+|.++|.||||+...+.-..+..+
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dv 783 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDV 783 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhh
Confidence 9999999999999999999999999999765554444443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=276.13 Aligned_cols=220 Identities=33% Similarity=0.587 Sum_probs=187.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
....-+..||+|+||.|-+.++..+|...|+|.+...-......++.+|+.+..+. .+|++|.+||.+..+..+||.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 34445678999999999999999999999999998777777788899999998877 79999999999999999999999
Q ss_pred ccCCCCHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 92 YMAGGSVADLI----QSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 92 y~~gGsL~~~l----~~~~~l~e~~i~~il~QLl~aL~yLHs~-gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
.| ..+|..+- +.++.++|..+-+|+..+++||.|||++ .|||||+||+||||+.+|+||+||||.+..+.+.-.
T Consensus 126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 99 56887654 5678999999999999999999999976 899999999999999999999999999988766533
Q ss_pred ccccccCCCCCCChhhhhc---ccCCccccchhhHHHHHHHHHhCCCCCCCC-CccceeeccCCCCCCCchh
Q 008116 167 RRKTFVGTPFWMAPEVIQN---SEGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPRENPPQLDE 234 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~---~~~~~~ksDVwSLGviLyeLltG~~Pf~~~-~~~~~~~~i~~~~~~~l~~ 234 (577)
. +...|.-.|||||.+.. ...|+.++||||||++++||.+++.||... .+.+.+..+....+|.++.
T Consensus 205 k-t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 205 K-TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred H-HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 2 23578889999998753 336999999999999999999999999754 4566666666666666653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=314.84 Aligned_cols=250 Identities=28% Similarity=0.497 Sum_probs=212.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEc----C---CCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCC
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDK----E---LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~----~---tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~ 84 (577)
.+..+.+.||+|.||.|++|... . ....||||.++........+.+..|+.+|+.+ .||||+.+++++...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34456679999999999999643 1 14579999998777667788999999999999 6999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC
Q 008116 85 KLWIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG 148 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g 148 (577)
.+++|+|||..|+|..+++... .++..++..+++||+.|++||++.++|||||-..||||..+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence 9999999999999999997644 388999999999999999999999999999999999999999
Q ss_pred Ceeecccccccccccccccc-ccccCC--CCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCC-ccceeec
Q 008116 149 DVKVADFGVSAQLTRTISRR-KTFVGT--PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLH-PMRVLFI 223 (577)
Q Consensus 149 ~vKL~DFGls~~~~~~~~~~-~~~~GT--p~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~-~~~~~~~ 223 (577)
.+||+|||+++......... ..-.|+ ..|||||.+... .|+.++|||||||+||||++ |..||.+.. ..+....
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~-~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR-VFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC-cccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 99999999998654432111 111222 349999999874 59999999999999999998 899998865 4444555
Q ss_pred cCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 224 i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
+..+.....|..++.++.+|++.||..+|++||++.++.+
T Consensus 535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 7777777888889999999999999999999999999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=289.55 Aligned_cols=136 Identities=27% Similarity=0.473 Sum_probs=117.5
Q ss_pred hhhhcC-CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----C---CceeEeE
Q 008116 7 LQEAAG-SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----S---PYITEYY 77 (577)
Q Consensus 7 l~~~~~-~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-----H---pnIV~l~ 77 (577)
+++.+. ++|.+.++||.|-|++||+|.+....+.||+|+++-.. ...+....||.+|+++. | .+||+|+
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 556666 89999999999999999999999999999999986433 23466788999999883 2 3799999
Q ss_pred EEEEe----CCEEEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEc
Q 008116 78 GSYLH----QTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLT 145 (577)
Q Consensus 78 ~~~~~----~~~~~LV~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld 145 (577)
+.|.. +.++|+|+|++ |-+|..+|+. ...++...+..|++|||.||.|||. .||||-||||+||||.
T Consensus 149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 99975 45899999999 7788888865 4579999999999999999999995 5999999999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=255.23 Aligned_cols=213 Identities=46% Similarity=0.771 Sum_probs=189.5
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCHHH
Q 008116 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVAD 100 (577)
Q Consensus 21 IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL~~ 100 (577)
||.|.+|.||++.+..+++.++||++...........+.+|+.+++.+.|++|+++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999999766543345789999999999999999999999999999999999999999999
Q ss_pred HHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc-CCCeeeccccccccccccccccccccCCCCCC
Q 008116 101 LIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRRKTFVGTPFWM 178 (577)
Q Consensus 101 ~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~-~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~ 178 (577)
++... ..+++..++.++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|||.+..............+...|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYM 160 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCcc
Confidence 99765 57899999999999999999999999999999999999999 89999999999876654322233456889999
Q ss_pred ChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcH
Q 008116 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258 (577)
Q Consensus 179 APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa 258 (577)
+||.+.....++.+.|+|+||++|++| ..+.+++..||..+|.+||++
T Consensus 161 ~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~~R~~~ 208 (215)
T cd00180 161 APEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPEKRPSA 208 (215)
T ss_pred ChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcccCcCH
Confidence 999987653578899999999999999 678999999999999999999
Q ss_pred HHHhhcH
Q 008116 259 KELLRHR 265 (577)
Q Consensus 259 ~elL~hp 265 (577)
.++++|+
T Consensus 209 ~~l~~~~ 215 (215)
T cd00180 209 KEILEHL 215 (215)
T ss_pred HHHhhCC
Confidence 9999863
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=287.48 Aligned_cols=256 Identities=28% Similarity=0.425 Sum_probs=209.0
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC-
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT- 84 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~- 84 (577)
.......+|..+..+|.|.- .|.-|.+.-+++.||||.+-... .....++..+|..++..+.|+||++++.+|.-..
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 44556789999999999999 88889999999999999875443 2334577899999999999999999999997654
Q ss_pred -----EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccc
Q 008116 85 -----KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 85 -----~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
.+|+||||| ..+|.+.+. -.++-..+..+++|++.|+.|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 90 l~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 90 LEEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence 579999999 579999886 457888999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC--------------
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-------------- 225 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-------------- 225 (577)
..... -..+.++.|..|.|||++.+.. |...+||||+||++.||++|+..|.+.+......++.
T Consensus 167 ~e~~~-~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 167 TEDTD-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred ccCcc-cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 54332 2345688999999999999876 9999999999999999999999887544322221110
Q ss_pred --------------------CCCCCCc-------hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 226 --------------------RENPPQL-------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 226 --------------------~~~~~~l-------~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
...|..+ ...-...+++++.+||..+|++|.+++++|.||||+
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0000000 001135688999999999999999999999999997
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=307.47 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=217.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCC----cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELN----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg----~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
...+..++||.|+||+||+|++...| .+||||++...........+..|+-+|.+|+|||+++|++++.... +.|
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 45566789999999999999986544 4799999877766666788999999999999999999999997655 899
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
|++|+++|+|.++++. ..++-......|..||++|+.|||+++++||||-..||||..-.++||.|||+++.+......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999975 467889999999999999999999999999999999999999999999999999988766555
Q ss_pred cccccC--CCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHH
Q 008116 168 RKTFVG--TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 168 ~~~~~G--Tp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI 244 (577)
.....| .+-|||-|.+... .|+..+|||||||++|||+| |..||......++-..+.++.....+..++-++.-++
T Consensus 855 y~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 554444 4569999988765 49999999999999999997 9999999887777777777776677778899999999
Q ss_pred HHhcccCCCCCCcHHHHhh
Q 008116 245 SLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~ 263 (577)
.+||..|+..||+++++..
T Consensus 934 vkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHhccCcccCccHHHHHH
Confidence 9999999999999999865
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=285.12 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=209.8
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC-----EEEE
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-----KLWI 88 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~-----~~~L 88 (577)
.+-.+.||.|+||.||-+.+..+|+.||+|.+.... .-..-+.+.+|+.+|..++|.|++..++...... .+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344578999999999999999999999999875332 2223477889999999999999999998876544 4688
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~- 167 (577)
|+|+| ..+|..+|-....++.+.+.-+++||++||.|||+.+|.||||||.|+|++.+..+||||||+++........
T Consensus 135 ~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 99999 5699999988889999999999999999999999999999999999999999999999999999866443222
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC----------------------
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---------------------- 225 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~---------------------- 225 (577)
+...+-|-+|.|||++.+...|+.++||||.|||+.|||..+..|...++.+.+..|.
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 2234668899999999999899999999999999999999988888777765554431
Q ss_pred -CC--CCCCch--------hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 226 -RE--NPPQLD--------EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 226 -~~--~~~~l~--------~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.. .+|.++ .....+...++..+|..||++|.+..+.+.|+++...+
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 00 111111 12234677888999999999999999999999987643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=299.32 Aligned_cols=200 Identities=31% Similarity=0.502 Sum_probs=181.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-------hHHHHHHHHHHHHHHhCC---CCceeEeEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------EDEIEDIQKEISVLSQCR---SPYITEYYGSYLH 82 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-------~~~~~~i~~Ev~iL~~L~---HpnIV~l~~~~~~ 82 (577)
..|..++.+|.|+||.|++|+++.....|+||.|.++.. ...+..+-.||+||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 349999999999999999999999999999999976652 112445668999999996 9999999999999
Q ss_pred CCEEEEEEecc-CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 83 QTKLWIIMEYM-AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 83 ~~~~~LV~Ey~-~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
++.+||+||-- +|.+|+++|...+.++|.++..|++|++.|+++||+.||||||||-+|+.++.+|.+||+|||.+...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 99999999975 56799999999999999999999999999999999999999999999999999999999999998765
Q ss_pred cccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCC
Q 008116 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD 214 (577)
Q Consensus 162 ~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~ 214 (577)
.. ++..+++||..|.|||++.+..+.+..-|||+||++||-++....||.+
T Consensus 721 ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 721 KS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 43 5667899999999999999998888999999999999999999999865
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=290.81 Aligned_cols=259 Identities=29% Similarity=0.445 Sum_probs=209.3
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcC---CCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCC
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKE---LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~---tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~ 84 (577)
-...+.|+++.+||.|+|++||+|++.. ....||+|.+.....+ ..+..|+++|..+ .+.||+++.+++..++
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3556899999999999999999999877 7889999999776643 5689999999999 6999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc-CCCeeeccccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTR 163 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~-~g~vKL~DFGls~~~~~ 163 (577)
...+||||++.....++... ++...+..+++.++.||.++|.+|||||||||+|+|.+. .+.-.|+|||++.....
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999999999999999865 778999999999999999999999999999999999985 47899999999862110
Q ss_pred c---------------------------------cc-----------ccccccCCCCCCChhhhhcccCCccccchhhHH
Q 008116 164 T---------------------------------IS-----------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLG 199 (577)
Q Consensus 164 ~---------------------------------~~-----------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLG 199 (577)
. .+ ......|||+|.|||++...+..+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 00 001246999999999998877788899999999
Q ss_pred HHHHHHHhCCCCCCCCCc-ccee-------------------ec--cCC-CCC---------------------------
Q 008116 200 ITVIEMAKGEPPLADLHP-MRVL-------------------FI--IPR-ENP--------------------------- 229 (577)
Q Consensus 200 viLyeLltG~~Pf~~~~~-~~~~-------------------~~--i~~-~~~--------------------------- 229 (577)
||++-++++..||..... ...+ .. ++. .+.
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 999999999999843211 0000 00 000 000
Q ss_pred -CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCC
Q 008116 230 -PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 230 -~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
....+.++..+.+|+.+||..||.+|.||+++|+||||......
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~ 390 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT 390 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence 00112345678999999999999999999999999999865433
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=286.76 Aligned_cols=243 Identities=26% Similarity=0.469 Sum_probs=191.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC--CCCceeEeEEEEEeCC----EE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC--RSPYITEYYGSYLHQT----KL 86 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L--~HpnIV~l~~~~~~~~----~~ 86 (577)
...+++++||+|.||.||+|... ++.||||+++.. ..+.++.|-+|.+.. .|+||++|++.-.... .+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 35677899999999999999776 699999998644 457888888888875 8999999999876555 79
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCcccccccceEEEccCCCeeeccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE---------GKIHRDIKAANILLTENGDVKVADFGV 157 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~---------gIiHrDIKPeNILld~~g~vKL~DFGl 157 (577)
+||+||.+.|+|.++|+. ..+++.....++..+++||+|||+. .|+|||||..||||..+++..|+||||
T Consensus 284 wLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999999987 6799999999999999999999963 599999999999999999999999999
Q ss_pred cccccccc--cccccccCCCCCCChhhhhcccCCc-----cccchhhHHHHHHHHHhCCC------------CCCC---C
Q 008116 158 SAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYN-----EKADIWSLGITVIEMAKGEP------------PLAD---L 215 (577)
Q Consensus 158 s~~~~~~~--~~~~~~~GTp~Y~APEvl~~~~~~~-----~ksDVwSLGviLyeLltG~~------------Pf~~---~ 215 (577)
|..+.... +.....+||..|||||++.+...+. ..+||||+|.|||||++.-. ||.. .
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 98775432 2233468999999999998754444 35899999999999997432 2220 0
Q ss_pred Cc--ccee-eccCCCCCCCchhhh-----hHHHHHHHHHhcccCCCCCCcHHHHh
Q 008116 216 HP--MRVL-FIIPRENPPQLDEHF-----SRLMKEFVSLCLKKVPAERPSAKELL 262 (577)
Q Consensus 216 ~~--~~~~-~~i~~~~~~~l~~~~-----s~~l~~lI~~cL~~dP~~RpTa~elL 262 (577)
+| .++. ..+.+...|.++..+ ...+.+.+..||..||+.|.||.=+.
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 11 0000 111222334444332 35688999999999999999986554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=254.59 Aligned_cols=214 Identities=37% Similarity=0.630 Sum_probs=183.1
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccC
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~ 94 (577)
|++.+.||.|++|.||++.+..++..||||.+...........+.+|+..++.++|+||+++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 67889999999999999999988999999999765443356788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-ccccccc
Q 008116 95 GGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRRKTFV 172 (577)
Q Consensus 95 gGsL~~~l~~~~~-l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~-~~~~~~~ 172 (577)
+++|.+++..... +++..++.++.+++.+|.|||.++++|+||+|.||+++..+.++|+|||++....... .......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 9999999987666 8999999999999999999999999999999999999999999999999987765432 1223567
Q ss_pred CCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCC-CCcc-ceeeccCCCC
Q 008116 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD-LHPM-RVLFIIPREN 228 (577)
Q Consensus 173 GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~-~~~~-~~~~~i~~~~ 228 (577)
++..|++||++.....++.++|||+||+++++|++|+.||.. .++. .....+..+.
T Consensus 161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 889999999984334477899999999999999999999977 3433 3444444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=275.94 Aligned_cols=249 Identities=24% Similarity=0.451 Sum_probs=196.2
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHh--CCCCceeEeEEEEEeCC
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ--CRSPYITEYYGSYLHQT 84 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~--L~HpnIV~l~~~~~~~~ 84 (577)
++-.++....+.+.||+|-||.||+|.+. |..||||++... +.....+|.+|... |+|+||+.|++.-...+
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 45667788899999999999999999988 899999998544 23667888888875 49999999998765433
Q ss_pred ----EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCcccccccceEEEccCCCeee
Q 008116 85 ----KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE--------GKIHRDIKAANILLTENGDVKV 152 (577)
Q Consensus 85 ----~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~--------gIiHrDIKPeNILld~~g~vKL 152 (577)
.+|||++|.+.|+|+++|.+ ..++.....+++..++.||+|||-. .|+|||||..||||.++|...|
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 68999999999999999988 7899999999999999999999953 4999999999999999999999
Q ss_pred ccccccccccccc----cccccccCCCCCCChhhhhcccCC----c-cccchhhHHHHHHHHHh----------CCCCCC
Q 008116 153 ADFGVSAQLTRTI----SRRKTFVGTPFWMAPEVIQNSEGY----N-EKADIWSLGITVIEMAK----------GEPPLA 213 (577)
Q Consensus 153 ~DFGls~~~~~~~----~~~~~~~GTp~Y~APEvl~~~~~~----~-~ksDVwSLGviLyeLlt----------G~~Pf~ 213 (577)
+|+|||....... -..+..+||-.|||||++...-.. + ..+||||||+||||++- -.+||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 9999997664431 224568999999999998643211 1 35899999999999874 357887
Q ss_pred CCCccc-------eeeccCCCCCCCchh-----hhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 214 DLHPMR-------VLFIIPRENPPQLDE-----HFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 214 ~~~~~~-------~~~~i~~~~~~~l~~-----~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
+..+.+ ....+.+- .|.++. ..-..+..+++.||..+|.-|.||--|-+
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~-RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKL-RPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cCCCCCCCHHHHhcceeeccc-CCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 654421 11112211 122222 23356778999999999999999877654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=303.70 Aligned_cols=198 Identities=18% Similarity=0.296 Sum_probs=147.4
Q ss_pred hCCC-CceeEeEEEE-------EeCCEEEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccc
Q 008116 67 QCRS-PYITEYYGSY-------LHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137 (577)
Q Consensus 67 ~L~H-pnIV~l~~~~-------~~~~~~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDI 137 (577)
.+.| +||+.++++| .....++++|||+ +++|.++|.. ...+++..++.|++||+.||.|||++|||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3344 5777777777 2334678889988 6799999965 356999999999999999999999999999999
Q ss_pred ccceEEEcc-------------------CCCeeeccccccccccccc----------------cccccccCCCCCCChhh
Q 008116 138 KAANILLTE-------------------NGDVKVADFGVSAQLTRTI----------------SRRKTFVGTPFWMAPEV 182 (577)
Q Consensus 138 KPeNILld~-------------------~g~vKL~DFGls~~~~~~~----------------~~~~~~~GTp~Y~APEv 182 (577)
||+||||+. ++.+||+|||+++...... ......+||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999954 4456777777765321100 00112468999999999
Q ss_pred hhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-CCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHH
Q 008116 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261 (577)
Q Consensus 183 l~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~-~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~el 261 (577)
+.+.. |+.++|||||||+||||++|.+|+..... ....+... .++..... ......++..||.++|.+||++.+|
T Consensus 187 ~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 187 DNGSS-SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLN-WPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred hccCC-CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhc-CHHHHHHHHHhCCCChhhCcChHHH
Confidence 88764 89999999999999999999998764321 11111111 11111111 3446788999999999999999999
Q ss_pred hhcHhhhh
Q 008116 262 LRHRFIRN 269 (577)
Q Consensus 262 L~hpff~~ 269 (577)
|+||||..
T Consensus 263 l~h~~~~~ 270 (793)
T PLN00181 263 LQSEFINE 270 (793)
T ss_pred hhchhhhh
Confidence 99999965
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=258.56 Aligned_cols=252 Identities=23% Similarity=0.388 Sum_probs=216.8
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCC-----cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe-CC
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELN-----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QT 84 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg-----~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~-~~ 84 (577)
...++++..++-+|.||.||.|++.+.. +.|-+|.++...++-++..+..|..+|..+.|||+..+.+++.. ..
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 3457899999999999999999886543 35678888777777778889999999999999999999998765 45
Q ss_pred EEEEEEeccCCCCHHHHHH-----c---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccc
Q 008116 85 KLWIIMEYMAGGSVADLIQ-----S---GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFG 156 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~-----~---~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFG 156 (577)
..++++.++.-|+|..++. . ...++-.++..++.|++.|++|||.+||||.||-..|.+|++.-+|||+|=.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 7899999999999999996 1 1346777888899999999999999999999999999999999999999999
Q ss_pred ccccccccccccc--cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCch
Q 008116 157 VSAQLTRTISRRK--TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLD 233 (577)
Q Consensus 157 ls~~~~~~~~~~~--~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~ 233 (577)
+++.+....-... ..-....||+||.+.+.. |+.++|||||||+||||+| |+.||.+.+|.++...+..+.....|
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP 520 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP 520 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC
Confidence 9987754322110 112245699999998875 9999999999999999998 99999999999999888888888888
Q ss_pred hhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 234 ~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
-++|+++..++..||...|++||+++|+..
T Consensus 521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 521 FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 899999999999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=231.78 Aligned_cols=160 Identities=36% Similarity=0.516 Sum_probs=129.5
Q ss_pred CCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCC
Q 008116 96 GSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (577)
Q Consensus 96 GsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GT 174 (577)
|+|.+++.. +.++++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence 689999976 457999999999999999999999998 999999999999999 9998765432 23689
Q ss_pred CCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccce-eecc----CCCCCC--CchhhhhH--HHHHHHH
Q 008116 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV-LFII----PRENPP--QLDEHFSR--LMKEFVS 245 (577)
Q Consensus 175 p~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~-~~~i----~~~~~~--~l~~~~s~--~l~~lI~ 245 (577)
+.|||||++.+.. |+.++|||||||+||||++|.+||........ ...+ ....+. .....++. .+++||.
T Consensus 68 ~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 68 PYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred ccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 9999999998764 89999999999999999999999976543221 1111 111111 12334454 6999999
Q ss_pred HhcccCCCCCCcHHHHhhcHhhhh
Q 008116 246 LCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
+||..+|.+||++.++++|+|+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=232.85 Aligned_cols=252 Identities=38% Similarity=0.609 Sum_probs=207.3
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH--HHHHHHHHHHHHHhCCCC-ceeEeEEEEEeCCEEEEEEe
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED--EIEDIQKEISVLSQCRSP-YITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~--~~~~i~~Ev~iL~~L~Hp-nIV~l~~~~~~~~~~~LV~E 91 (577)
|.+.+.||.|+|+.||++.+. ..+++|.+....... ....+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999887 789999987665443 468899999999999888 79999999988888999999
Q ss_pred ccCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC-Ceeecccccccccccccc-
Q 008116 92 YMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTIS- 166 (577)
Q Consensus 92 y~~gGsL~~~l~~~~---~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g-~vKL~DFGls~~~~~~~~- 166 (577)
|+.+++|.+++.... .+++..+..++.|++.+|.|+|..+++||||||+|||++..+ .++++|||++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887654 799999999999999999999999999999999999999988 799999999875544332
Q ss_pred -----ccccccCCCCCCChhhhhcc--cCCccccchhhHHHHHHHHHhCCCCCCCCCc----cceeeccCCCCCC----C
Q 008116 167 -----RRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHP----MRVLFIIPRENPP----Q 231 (577)
Q Consensus 167 -----~~~~~~GTp~Y~APEvl~~~--~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~----~~~~~~i~~~~~~----~ 231 (577)
.....+||+.|++||++... ..+....|+||+|++++++++|..||..... ......+.....+ .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 23567899999999999773 4588899999999999999999999776653 2222222222211 1
Q ss_pred chhh----hhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 232 LDEH----FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 232 l~~~----~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
.... ....+.+++..|+..+|..|.++.+...++|...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 1111 1257899999999999999999999988855543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-29 Score=247.40 Aligned_cols=253 Identities=21% Similarity=0.333 Sum_probs=194.1
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEE-EEEeCCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYG-SYLHQTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~-~~~~~~~~~ 87 (577)
.+...|.+.+.||+|-||.+.+|.++.++..+++|.++.... .+..|.+|...--.| .|.||+.-|+ .|+.-+.++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 345789999999999999999999999999999999976654 457899999887677 6899998886 566778899
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc--CCCeeeccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE--NGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~--~g~vKL~DFGls~~~~~~~ 165 (577)
+++||++-|+|..-+.. ..+-|.....++.|++.||.|||++++||||||.+||||-. ...|||||||+....+...
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 99999999999998865 45889999999999999999999999999999999999943 3579999999976543221
Q ss_pred cccccccCCCCCCChhhhhccc----CCccccchhhHHHHHHHHHhCCCCCCCCCccc-----eeeccCCCC--CCCchh
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSE----GYNEKADIWSLGITVIEMAKGEPPLADLHPMR-----VLFIIPREN--PPQLDE 234 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~----~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~-----~~~~i~~~~--~~~l~~ 234 (577)
.. .--+..|.+||++.... ...+.+|+|.||+++|.+|||.+||.....+. ...+..... .|..-.
T Consensus 178 ~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~ 254 (378)
T KOG1345|consen 178 KY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN 254 (378)
T ss_pred hh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhc
Confidence 11 12355699999875322 14567899999999999999999997322111 111111111 122233
Q ss_pred hhhHHHHHHHHHhcccCCCCCC---cHHHHhhcHhhh
Q 008116 235 HFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFIR 268 (577)
Q Consensus 235 ~~s~~l~~lI~~cL~~dP~~Rp---Ta~elL~hpff~ 268 (577)
.+++.+..+.++-|.++|.+|. +++...+..|..
T Consensus 255 ~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 255 PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 5678889999999999999994 444444455553
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-28 Score=274.09 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=206.9
Q ss_pred CCe-eEEeEEeecCceEEEEEEEcCCCcEEEEEEecc----CCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 13 SRF-SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL----EES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 13 ~~f-~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~----~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
..| ....++|.|++|.|+.+........++.|.+.. ... ......+..|+.+-..|.||||+..+..+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 334 467789999999999888776666666665431 111 22233377888888999999999888877777666
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
+-+||||++ +|+.++...+.+...++..+++||+.||.|||+.||.||||||+||+++..|.+||+|||.+..+..+..
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 666999999 9999999877999999999999999999999999999999999999999999999999999876654433
Q ss_pred c----cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee-----ecc---CCCCCCCchh
Q 008116 167 R----RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-----FII---PRENPPQLDE 234 (577)
Q Consensus 167 ~----~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~-----~~i---~~~~~~~l~~ 234 (577)
. ....+|+..|+|||++.+..+-...+||||.|++++.|++|+.||......+.. ... ....+..+..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 2 335789999999999988774455689999999999999999999755433221 011 1112334455
Q ss_pred hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 235 ~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.++...+.+|.+||+.+|.+|.|+.+|++.+||+.+.
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 7788999999999999999999999999999998753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-26 Score=236.28 Aligned_cols=252 Identities=22% Similarity=0.281 Sum_probs=197.2
Q ss_pred hcCC-CeeEEeEEeecCceEEEEEEEcCCC-cEEEEEEeccCCChHHHHHHHHHHHHHHhCCC----CceeEeEEEE-Ee
Q 008116 10 AAGS-RFSSLELIGRGSFGDVYKAFDKELN-KDVAIKVIDLEESEDEIEDIQKEISVLSQCRS----PYITEYYGSY-LH 82 (577)
Q Consensus 10 ~~~~-~f~il~~IG~GsfG~Vy~a~~~~tg-~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~H----pnIV~l~~~~-~~ 82 (577)
.... +|++.+.||+|+||.||+|.+..++ ..+|+|+.......... .+..|+.++..+.. +++..+++.. ..
T Consensus 14 ~~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~ 92 (322)
T KOG1164|consen 14 DKVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRST 92 (322)
T ss_pred cccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence 3344 8999999999999999999998774 68999987655432222 68889999998862 6899999998 47
Q ss_pred CCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC-----CCeeeccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-----GDVKVADF 155 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~-----g~vKL~DF 155 (577)
+...||||+++ |.+|.++.+.. +.|+...+..++.|++.+|++||+.|++||||||+|+++... ..++|.||
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 77899999999 88999998543 589999999999999999999999999999999999999754 36999999
Q ss_pred cccc--ccccccc-------c-cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC
Q 008116 156 GVSA--QLTRTIS-------R-RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP 225 (577)
Q Consensus 156 Gls~--~~~~~~~-------~-~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~ 225 (577)
|+++ ....... . ...+.||..|+++.++.+.+ .+.+.|+||++.++.+|+.|..||...........+.
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 9998 3322211 1 12356999999999998865 8999999999999999999999997665432222111
Q ss_pred C---CCCCC-chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 226 R---ENPPQ-LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 226 ~---~~~~~-l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
. ..... +....+..+..+...+-..+...+|....+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1 11111 223345677888888777899999999888753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-27 Score=258.60 Aligned_cols=243 Identities=25% Similarity=0.449 Sum_probs=207.2
Q ss_pred EEeecCceEEEEEEE---cCCCcEEEEEEeccCCChH-HHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEEEEEeccC
Q 008116 20 LIGRGSFGDVYKAFD---KELNKDVAIKVIDLEESED-EIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEYMA 94 (577)
Q Consensus 20 ~IG~GsfG~Vy~a~~---~~tg~~VAIK~i~~~~~~~-~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~LV~Ey~~ 94 (577)
++|.|+||.|+++.. .+.+..||+|+.++..... .......|..++..++ ||.+|+++..++.+..++++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998743 4557889999986654221 1225667888999886 9999999999999999999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccCC
Q 008116 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (577)
Q Consensus 95 gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GT 174 (577)
||.|...+.....+.+.....+...++-+++++|..+|+|||+|++||+++.+|++++.|||+++....... .|||
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~cgt 156 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----ACGT 156 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----cccc
Confidence 999999998888999999999999999999999999999999999999999999999999999987765422 2999
Q ss_pred CCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCC
Q 008116 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254 (577)
Q Consensus 175 p~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~ 254 (577)
..|||||++. +....+|+||||+++++|++|..||.. +....|.+.. ...+..++..+++++..++.++|..
T Consensus 157 ~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-~~~p~~l~~~a~~~~~~l~~r~p~n 228 (612)
T KOG0603|consen 157 YEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-LEMPRELSAEARSLFRQLFKRNPEN 228 (612)
T ss_pred hhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-cCCchhhhHHHHHHHHHHHhhCHHH
Confidence 9999999997 367899999999999999999999988 3344444433 3566788899999999999999999
Q ss_pred CCc-----HHHHhhcHhhhhccCCh
Q 008116 255 RPS-----AKELLRHRFIRNARKSP 274 (577)
Q Consensus 255 RpT-----a~elL~hpff~~~~~~~ 274 (577)
|.. +.++++|+||+.+.+..
T Consensus 229 rLg~~~~~~~eik~h~f~~~i~~~~ 253 (612)
T KOG0603|consen 229 RLGAGPDGVDEIKQHEFFQSIDWNE 253 (612)
T ss_pred HhccCcchhHHHhccchheeeeHhh
Confidence 975 47899999999876543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=235.62 Aligned_cols=167 Identities=19% Similarity=0.210 Sum_probs=132.7
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcC-CCcEEEEEEeccCC----ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~-tg~~VAIK~i~~~~----~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~ 83 (577)
-.+..+|.+.+.||+|+||+||+|.+.. ++..||||++.... .......+.+|+.+|++|.|+||++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 3466889999999999999999999876 67888999875331 22345678999999999999999853322 2
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccc-ccceEEEccCCCeeecccccccccc
Q 008116 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI-KAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDI-KPeNILld~~g~vKL~DFGls~~~~ 162 (577)
+..|||||||+|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 468999999999999732 11 11 1467899999999999999999999 9999999989999999999998665
Q ss_pred ccccc--------cccccCCCCCCChhhhhc
Q 008116 163 RTISR--------RKTFVGTPFWMAPEVIQN 185 (577)
Q Consensus 163 ~~~~~--------~~~~~GTp~Y~APEvl~~ 185 (577)
..... ....++++.|+|||++..
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 43211 124578899999998853
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=217.12 Aligned_cols=248 Identities=22% Similarity=0.312 Sum_probs=200.4
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~ 87 (577)
..++-+|++.++||+|+||.+|.|.+.-++.+||||.-+... ...++..|....+.| ..++|...|.+..++.+-.
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 367889999999999999999999999999999999854433 347788999999999 5799999999888888889
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC-----CCeeeccccccccc
Q 008116 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-----GDVKVADFGVSAQL 161 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~-----g~vKL~DFGls~~~ 161 (577)
||+|++ |-+|.++..- +..|+...++.++.|++.-++|+|++.+|+|||||+|+||... ..|.|+|||+|+..
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999999 8899998854 4679999999999999999999999999999999999999654 35899999999988
Q ss_pred ccccccc-------ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---ceeeccCCCC---
Q 008116 162 TRTISRR-------KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---RVLFIIPREN--- 228 (577)
Q Consensus 162 ~~~~~~~-------~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~---~~~~~i~~~~--- 228 (577)
.++.... ....||..||+-.-..+.+ .+.+.|+-|||-|++++|-|.+||....-. +...+|-...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 7665442 3467999999988887765 788999999999999999999999876432 2223332111
Q ss_pred -CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHH
Q 008116 229 -PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261 (577)
Q Consensus 229 -~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~el 261 (577)
...+...+|.++...+.-.-..+-.+-|..+-+
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 122345677777777776655666666766543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=211.52 Aligned_cols=246 Identities=22% Similarity=0.316 Sum_probs=196.8
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~ 87 (577)
..++++|++++.||.|+||.+|+|+....|..||||+-... ....++..|..+.+.|+ .+.|+.+..++.+...-.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 35689999999999999999999999999999999985322 23466888999999995 578888888888888899
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc---CCCeeeccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVSAQLTR 163 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~---~g~vKL~DFGls~~~~~ 163 (577)
+||+++ |-+|.+++.- ...|+...+.-++-|++.-|+|+|.+++|||||||+|+|+.- ...+.|+|||+|+.+.+
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 999999 8899998853 357899999999999999999999999999999999999953 35799999999987755
Q ss_pred ccccc-------ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee---eccCCC----CC
Q 008116 164 TISRR-------KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---FIIPRE----NP 229 (577)
Q Consensus 164 ~~~~~-------~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~---~~i~~~----~~ 229 (577)
..... ....||..|.+-..+.+.+ .+.+.|+-|+|.+|.++.-|..||.+....... .+|... .+
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 43322 2457999999988776654 677899999999999999999999876543222 222211 12
Q ss_pred CCchhhhhHHHHHHHHHhcccCCCCCCcHH
Q 008116 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAK 259 (577)
Q Consensus 230 ~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~ 259 (577)
..+-..+|.++.-.+.-|-..--++-|...
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 234456788888888888776666777654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=203.11 Aligned_cols=141 Identities=19% Similarity=0.209 Sum_probs=112.2
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-H------------------------HHHHHHHHHHHHhCCCCc
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-E------------------------IEDIQKEISVLSQCRSPY 72 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~-~------------------------~~~i~~Ev~iL~~L~Hpn 72 (577)
...||+|+||.||+|.+. +|+.||||+++...... . .....+|+.+|.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 89999999996542110 0 122345999999998777
Q ss_pred eeEeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHcCCcccccccceEEEccCCCee
Q 008116 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL-HNEGKIHRDIKAANILLTENGDVK 151 (577)
Q Consensus 73 IV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yL-Hs~gIiHrDIKPeNILld~~g~vK 151 (577)
|...+..... ..+|||||++|++|...+....++++..+..++.||+.+|.|| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6443333222 2389999999888776644457899999999999999999999 799999999999999998 57899
Q ss_pred ecccccccccc
Q 008116 152 VADFGVSAQLT 162 (577)
Q Consensus 152 L~DFGls~~~~ 162 (577)
|+|||+|....
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-24 Score=241.03 Aligned_cols=228 Identities=30% Similarity=0.524 Sum_probs=179.2
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
.....|..+++|..|+||.||++.++.+.+.+|+|+ ++.+. +.+- ||....+|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l------ilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL------ILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch------hhhc--cccccCCccee---------------
Confidence 345789999999999999999999999999999954 32221 1111 44444566666
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc--
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-- 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~-- 167 (577)
|+-..+++.-++++... +.+++|||+.||+|||+||+|+||+.-|++||.|||+++...-....
T Consensus 136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 67777777767777654 78999999999999999999999999999999999998643211000
Q ss_pred -------------cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--Cc
Q 008116 168 -------------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QL 232 (577)
Q Consensus 168 -------------~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~l 232 (577)
....||||.|.|||++... +|+..+|||++|+|+|+++-|..||....+.+.+..+...... .-
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 0135899999999999875 5999999999999999999999999999887766555443322 22
Q ss_pred hhhhhHHHHHHHHHhcccCCCCCC---cHHHHhhcHhhhhccCChhH
Q 008116 233 DEHFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFIRNARKSPRL 276 (577)
Q Consensus 233 ~~~~s~~l~~lI~~cL~~dP~~Rp---Ta~elL~hpff~~~~~~~~~ 276 (577)
...++.+++++|.++|+.+|..|. .+-++.+|+||+...+...+
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~ll 327 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLL 327 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhh
Confidence 456789999999999999999995 57788899999988766444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=203.73 Aligned_cols=176 Identities=16% Similarity=0.238 Sum_probs=137.1
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHH------HHHHHHHHHhCCCCceeEeEE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIED------IQKEISVLSQCRSPYITEYYG 78 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~------i~~Ev~iL~~L~HpnIV~l~~ 78 (577)
+-+.+.++|+++++||.|+||.||++.. ++..||||++..... +..... +.+|+..+.+|.||+|+.+.+
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d 102 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLND 102 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceE
Confidence 3456789999999999999999999654 467899999964432 222233 579999999999999999998
Q ss_pred EEEeC--------CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCe
Q 008116 79 SYLHQ--------TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDV 150 (577)
Q Consensus 79 ~~~~~--------~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~v 150 (577)
++... +..+|||||++|.+|.++.. +++ ..+.+++.+|..||.+|++||||||+||+++.+| +
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-E
Confidence 87654 35799999999999988742 333 2456999999999999999999999999999888 9
Q ss_pred eeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHH
Q 008116 151 KVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA 206 (577)
Q Consensus 151 KL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLl 206 (577)
+|+|||........... ..++... .|+.++|+|+||++|..+.
T Consensus 174 ~liDfg~~~~~~e~~a~------------d~~vler-~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK------------DRIDLER-HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH------------HHHHHHh-HhcccccccceeEeehHHH
Confidence 99999987654322111 0122232 3778999999999988765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=205.14 Aligned_cols=233 Identities=21% Similarity=0.301 Sum_probs=153.7
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCC----------CceeEeEEEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS----------PYITEYYGSYL 81 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~H----------pnIV~l~~~~~ 81 (577)
.+...+.||.|+++.||.+.+..||+.+|||++.... .....+.+++|......+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4566789999999999999999999999999986544 23357788888766655432 12332233222
Q ss_pred e---------C---C-----EEEEEEeccCCCCHHHHHH---cCCCC----CHHHHHHHHHHHHHHHHHHHHcCCccccc
Q 008116 82 H---------Q---T-----KLWIIMEYMAGGSVADLIQ---SGPPL----DEMSIACILRDLLHAIEYLHNEGKIHRDI 137 (577)
Q Consensus 82 ~---------~---~-----~~~LV~Ey~~gGsL~~~l~---~~~~l----~e~~i~~il~QLl~aL~yLHs~gIiHrDI 137 (577)
. . . +.+++|+-+ .++|..++. ..... .......+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 1 1 236778877 568888763 21111 12222345579999999999999999999
Q ss_pred ccceEEEccCCCeeeccccccccccccccccccccCCCCCCChhhhhcc-------cCCccccchhhHHHHHHHHHhCCC
Q 008116 138 KAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS-------EGYNEKADIWSLGITVIEMAKGEP 210 (577)
Q Consensus 138 KPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~-------~~~~~ksDVwSLGviLyeLltG~~ 210 (577)
||+|+|++.+|.++|+||+.....+.. ......+..|.+||+.... ..++.+.|.|+||+++|.|++|..
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999999999999876554332 1223456789999987542 237788999999999999999999
Q ss_pred CCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 211 PLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 211 Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
||....+...... ....+. .+|+.++.||..+|+++|.+|
T Consensus 249 Pf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9986644322211 122334 788999999999999999887
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=194.01 Aligned_cols=142 Identities=18% Similarity=0.233 Sum_probs=114.4
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-------------------------HHHHHHHHHHHHHHhCCCCc
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-------------------------DEIEDIQKEISVLSQCRSPY 72 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-------------------------~~~~~i~~Ev~iL~~L~Hpn 72 (577)
...||+|+||.||+|.+. +|+.||||+++..... .....+.+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 8999999998754210 00123468999999999998
Q ss_pred eeEeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCee
Q 008116 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVK 151 (577)
Q Consensus 73 IV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vK 151 (577)
|.....+.... .||||||++|+++...+....++++..+..++.|++.+|.+||. +||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 75554443332 48999999988654443334678899999999999999999999 9999999999999998 88999
Q ss_pred eccccccccccc
Q 008116 152 VADFGVSAQLTR 163 (577)
Q Consensus 152 L~DFGls~~~~~ 163 (577)
|+|||++..+..
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=192.96 Aligned_cols=189 Identities=15% Similarity=0.103 Sum_probs=144.3
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC---hHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEE
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES---EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~---~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
+.+...|++|+||+||.+.. .+..++.+.+....- ......+.+|+++|++| +|++|++++++ ...|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 45678999999999997765 477888777654432 11223578999999999 45889999886 3469999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccc-ccceEEEccCCCeeeccccccccccccccc--
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI-KAANILLTENGDVKVADFGVSAQLTRTISR-- 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDI-KPeNILld~~g~vKL~DFGls~~~~~~~~~-- 167 (577)
||+.|.+|...+.. . ...++.|++.+|.+||.+||+|||| ||+|||++.+|.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999999765422 1 1357889999999999999999999 799999999999999999999855433210
Q ss_pred --c---------ccccCCCCCCChhhhhcccCCc-cccchhhHHHHHHHHHhCCCCCCCCC
Q 008116 168 --R---------KTFVGTPFWMAPEVIQNSEGYN-EKADIWSLGITVIEMAKGEPPLADLH 216 (577)
Q Consensus 168 --~---------~~~~GTp~Y~APEvl~~~~~~~-~ksDVwSLGviLyeLltG~~Pf~~~~ 216 (577)
. .-...++.|++|+...-....+ ...++++.|+.+|.++|+..|+...+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0123689999999754332233 45688899999999999999876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=188.19 Aligned_cols=136 Identities=20% Similarity=0.262 Sum_probs=109.8
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-----CCCceeEeEEEEEeCC---E-E
Q 008116 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-----RSPYITEYYGSYLHQT---K-L 86 (577)
Q Consensus 16 ~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-----~HpnIV~l~~~~~~~~---~-~ 86 (577)
.-.++||+|+||.||. +..++.. +||++...... ....+.+|+.+++.| .||||+++++++.++. . +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 3457899999999995 7766666 69998764322 346799999999999 5799999999999863 4 3
Q ss_pred EEEEec--cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHHcCCcccccccceEEEccC----CCeeecccccc
Q 008116 87 WIIMEY--MAGGSVADLIQSGPPLDEMSIACILRDLLHAI-EYLHNEGKIHRDIKAANILLTEN----GDVKVADFGVS 158 (577)
Q Consensus 87 ~LV~Ey--~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL-~yLHs~gIiHrDIKPeNILld~~----g~vKL~DFGls 158 (577)
.+|+|| +.+++|.++++. +.+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 478999 557999999976 457666 35678888887 99999999999999999999743 37999995443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-21 Score=198.45 Aligned_cols=189 Identities=26% Similarity=0.377 Sum_probs=144.5
Q ss_pred CCCceeEeEEEEEe---------------------------CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHH
Q 008116 69 RSPYITEYYGSYLH---------------------------QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLL 121 (577)
Q Consensus 69 ~HpnIV~l~~~~~~---------------------------~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl 121 (577)
+|||||+++..|.+ +..+|+||... ..+|.+++.. ...+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-RHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-CCCchHHHHHHHHHHH
Confidence 69999999988753 23679999988 4699999976 4466677788999999
Q ss_pred HHHHHHHHcCCcccccccceEEEc--cC--CCeeeccccccccccc------cccccccccCCCCCCChhhhhcccCC--
Q 008116 122 HAIEYLHNEGKIHRDIKAANILLT--EN--GDVKVADFGVSAQLTR------TISRRKTFVGTPFWMAPEVIQNSEGY-- 189 (577)
Q Consensus 122 ~aL~yLHs~gIiHrDIKPeNILld--~~--g~vKL~DFGls~~~~~------~~~~~~~~~GTp~Y~APEvl~~~~~~-- 189 (577)
+|+.|||.+||.|||+|.+||||. .+ ..++|+|||++---.. .....-..-|.-.-||||+....++.
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999993 33 4689999997532111 00111134578889999998654331
Q ss_pred ---ccccchhhHHHHHHHHHhCCCCCCCCCccceee-ccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHH
Q 008116 190 ---NEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAK 259 (577)
Q Consensus 190 ---~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~-~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~ 259 (577)
-.++|.|+.|.+.||+++...||.....+-... .......|.++..++..+++++..+|++||.+|+++.
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 147999999999999999999998744322111 1233456778889999999999999999999999854
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-21 Score=222.46 Aligned_cols=244 Identities=22% Similarity=0.301 Sum_probs=180.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH---HHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED---EIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~---~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
.+|...+.||.+-|=+|.+|.+.+ | .|+||++-+....- ...+...|++ ...+++||++++.-+...+...|||
T Consensus 23 ~e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 23 VECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred cceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 378999999999999999998874 4 49999985554322 2333444555 5666999999998887788888999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc---cc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT---IS 166 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~---~~ 166 (577)
-+|+ .-+|.+.|.-++-+...+-..|+.||+.||.-||..||+|+|||.+||||+.=+.+.|+||..-+...-+ ..
T Consensus 100 Rqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 9999 4599999987677888888999999999999999999999999999999999989999999764432111 11
Q ss_pred ccccc----cCCCCCCChhhhhcc----------cCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCC---C
Q 008116 167 RRKTF----VGTPFWMAPEVIQNS----------EGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRE---N 228 (577)
Q Consensus 167 ~~~~~----~GTp~Y~APEvl~~~----------~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~---~ 228 (577)
...-+ .--.+|.|||-+... ....+++||||+||+++||++ |.+||.--. +.....+ .
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~~~~ 254 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGNADD 254 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccCccC
Confidence 11111 223469999987531 115678999999999999987 788885211 0000001 1
Q ss_pred CCCchhhh-hHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 229 PPQLDEHF-SRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 229 ~~~l~~~~-s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+..+-+.+ +..++.+|..|++.||.+|.+|++.|+.
T Consensus 255 ~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 255 PEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11111111 2358999999999999999999999975
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.7e-20 Score=186.28 Aligned_cols=145 Identities=21% Similarity=0.228 Sum_probs=116.6
Q ss_pred CeeEEeEEeecCceEEEEEE-EcCCCcEEEEEEeccCCCh-----------------------HHHHHHHHHHHHHHhCC
Q 008116 14 RFSSLELIGRGSFGDVYKAF-DKELNKDVAIKVIDLEESE-----------------------DEIEDIQKEISVLSQCR 69 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~-~~~tg~~VAIK~i~~~~~~-----------------------~~~~~i~~Ev~iL~~L~ 69 (577)
-|++.+.||+|+||.||+|. +..+|+.||||+++..... .....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 6778999999998754210 01134578999999996
Q ss_pred C--CceeEeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC-CcccccccceEEEcc
Q 008116 70 S--PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG-KIHRDIKAANILLTE 146 (577)
Q Consensus 70 H--pnIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~g-IiHrDIKPeNILld~ 146 (577)
+ ..++++++. ...||||||+.|.+|...+.....+....+..++.||+.+|.+||.+| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 5 334455542 235899999999888776544456777778899999999999999999 99999999999999
Q ss_pred CCCeeeccccccccccc
Q 008116 147 NGDVKVADFGVSAQLTR 163 (577)
Q Consensus 147 ~g~vKL~DFGls~~~~~ 163 (577)
++.++|+|||++.....
T Consensus 184 ~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCCEEEEEChhhhccCC
Confidence 88999999999865433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=208.34 Aligned_cols=242 Identities=25% Similarity=0.313 Sum_probs=178.9
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCceeEeEEEEEeCC
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGSYLHQT 84 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~---HpnIV~l~~~~~~~~ 84 (577)
...-+..|.|-+.||+|+||+||+|.... |+.||||+-+.... -.|.--.+++.+|+ -+.|..+..++.-.+
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP----WEFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc----eeeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 44556799999999999999999999887 99999998654432 11222234444554 245666666667778
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC-------CCeeeccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-------GDVKVADFGV 157 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~-------g~vKL~DFGl 157 (577)
.-+||+||.+.|+|.+++...+.+++..+..+..|++.-|++||..+|||+||||+|+||... --++|+|||.
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 889999999999999999988899999999999999999999999999999999999999532 2489999999
Q ss_pred cccccc--cccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhh
Q 008116 158 SAQLTR--TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH 235 (577)
Q Consensus 158 s~~~~~--~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~ 235 (577)
+..+.- ........++|-.+-++|+..+.. +++.+|.|.|..+++.||.|+.-= ...-..+.. ...++..
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y~q----~~~g~~~~~---~~~~~Ry 919 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKYME----VKNGSSWMV---KTNFPRY 919 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHHHH----hcCCcceec---cccchhh
Confidence 876642 223455678899999999998865 999999999999999999997531 000000111 1112222
Q ss_pred hh-HHHHHHHHHhcccCCCCCCcHHHHh
Q 008116 236 FS-RLMKEFVSLCLKKVPAERPSAKELL 262 (577)
Q Consensus 236 ~s-~~l~~lI~~cL~~dP~~RpTa~elL 262 (577)
+- ....+|+..+|..|-..=|...+|.
T Consensus 920 ~~~~~W~~~F~~lLN~~~~~~p~l~~lr 947 (974)
T KOG1166|consen 920 WKRDMWNKFFDLLLNPDCDTLPNLQELR 947 (974)
T ss_pred hhHHHHHHHHHHHhCcCcccchhHHHHH
Confidence 22 2345677788885544445555543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-21 Score=218.15 Aligned_cols=258 Identities=26% Similarity=0.360 Sum_probs=214.9
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcC-CCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~-tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~L 88 (577)
...|.+.+.||+|+|+.|-.+.+.. ....+|+|.+.... ......++..|+.+-+.+. |+|++.+++........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 5679999999999999999987743 35567777775553 4455677888999999996 9999999999999999999
Q ss_pred EEeccCCCCHHHHH-HcCC-CCCHHHHHHHHHHHHHHHHHHH-HcCCcccccccceEEEccCC-Ceeeccccccccccc-
Q 008116 89 IMEYMAGGSVADLI-QSGP-PLDEMSIACILRDLLHAIEYLH-NEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTR- 163 (577)
Q Consensus 89 V~Ey~~gGsL~~~l-~~~~-~l~e~~i~~il~QLl~aL~yLH-s~gIiHrDIKPeNILld~~g-~vKL~DFGls~~~~~- 163 (577)
+++|..|+++...+ .... ..+...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .++++|||+|..+..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999999999 5544 6788889999999999999999 99999999999999999999 999999999988766
Q ss_pred cccc--cccccC-CCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee--ccCCCC--CCCchhhh
Q 008116 164 TISR--RKTFVG-TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--IIPREN--PPQLDEHF 236 (577)
Q Consensus 164 ~~~~--~~~~~G-Tp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~--~i~~~~--~~~l~~~~ 236 (577)
.... ....+| ++.|+|||.+.+..+.+...|+||+|+++.-+++|..||.......... .+.... .......+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 2222 234688 9999999999876667888999999999999999999997654433322 222111 23445678
Q ss_pred hHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 237 s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
+....+++.++|..+|..|.+..++..++|+..
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ChhhhhcccccccCCchhccccccccccccccc
Confidence 888999999999999999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.7e-19 Score=173.00 Aligned_cols=136 Identities=25% Similarity=0.384 Sum_probs=114.8
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--h-----HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--E-----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~-----~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++.||+|++|.||+|.+ .+..|+||+...... . .....+.+|+.++..+.|++|+....++......++||
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 46899999999999987 577899998653321 1 11345788999999999999887777777788899999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
||++|++|.+++..... ....++.+|+.+|.+||..+++|+|++|.|||++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999865322 7888999999999999999999999999999999 78999999998754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.9e-20 Score=181.93 Aligned_cols=238 Identities=22% Similarity=0.386 Sum_probs=189.8
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccC
Q 008116 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (577)
Q Consensus 16 ~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~ 94 (577)
.++.+|.+.-.|..|+|++. |..+++|+++..... ..-..|..|.-.|+-+.||||+.+++.|....++.++..||+
T Consensus 193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 44566788889999999987 556777887655432 223567888888999999999999999999999999999999
Q ss_pred CCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEccCCCeeec--ccccccccccccccc
Q 008116 95 GGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKVA--DFGVSAQLTRTISRR 168 (577)
Q Consensus 95 gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~g--IiHrDIKPeNILld~~g~vKL~--DFGls~~~~~~~~~~ 168 (577)
-|+|+.++.... -.+..++..++.+++.|++|||+.. |----|....++||++-+++|. |--++-+.
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe------- 343 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE------- 343 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec-------
Confidence 999999997643 3677889999999999999999874 4444678888999998766553 43332111
Q ss_pred ccccCCCCCCChhhhhcccCC--ccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-CCCCchhhhhHHHHHHHH
Q 008116 169 KTFVGTPFWMAPEVIQNSEGY--NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRLMKEFVS 245 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~--~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~-~~~~l~~~~s~~l~~lI~ 245 (577)
...+-.|.||+||.++..+.. -.++|+|||.++|+||.|...||.+..+++.-.+|..+ -.+.++..++..+..|+.
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~ 423 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMN 423 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHH
Confidence 122447899999999765421 24689999999999999999999999998877776543 355677889999999999
Q ss_pred HhcccCCCCCCcHHHHh
Q 008116 246 LCLKKVPAERPSAKELL 262 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL 262 (577)
-|+..||.+||.++.|+
T Consensus 424 icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 424 ICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHhcCCCCcCCCcceeh
Confidence 99999999999998876
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.1e-20 Score=195.83 Aligned_cols=175 Identities=27% Similarity=0.472 Sum_probs=134.7
Q ss_pred EEEEEEeccCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~---~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
.+||.|++|...+|.++|.+.. ..+...+..++.|+..|++| +|.+|||+||.||+...+..+||.||||....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5799999999999999997533 45677889999999999999 99999999999999999999999999998766
Q ss_pred cccc------cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCC-Cch
Q 008116 162 TRTI------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPP-QLD 233 (577)
Q Consensus 162 ~~~~------~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~-~l~ 233 (577)
.... .......||++||+||.+.+.. |+.++||||||++|+||+. -..+|.... .+..+..+..| ...
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~~---t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERIA---TLTDIRDGIIPPEFL 482 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHHH---hhhhhhcCCCChHHh
Confidence 5432 2334568999999999998865 9999999999999999997 333332221 11222222222 222
Q ss_pred hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 234 ~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
..+ +.-..|+.++|.+.|.+||++.+.-.|.|.
T Consensus 483 ~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 483 QDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 222 334579999999999999977777666664
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.6e-19 Score=169.46 Aligned_cols=132 Identities=24% Similarity=0.350 Sum_probs=107.8
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeccCCC-------hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 20 ~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-------~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
.||+|+||.||+|.. ++..|+||+...... ......+.+|+.+++.+.|++|.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 478899998643221 11236678999999999888765555555566778999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 93 ~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
++|++|.+++..... .++.+++.+|.+||+.|++|+||+|.|||++ ++.++|+|||++...
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999998865321 7889999999999999999999999999999 789999999987653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=169.48 Aligned_cols=138 Identities=23% Similarity=0.248 Sum_probs=110.6
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh---------------------HHHHHHHHHHHHHHhCCCC-
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE---------------------DEIEDIQKEISVLSQCRSP- 71 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~---------------------~~~~~i~~Ev~iL~~L~Hp- 71 (577)
.|.+.+.||.|+||.||+|.+. +|+.||||+++..... .......+|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3889999999999999999875 7999999987653310 0112367899999999777
Q ss_pred -ceeEeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCe
Q 008116 72 -YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDV 150 (577)
Q Consensus 72 -nIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~v 150 (577)
.++.+++ ....++||||++|++|..+... .....++.+|+.++.++|..||+||||||+||||+.++.+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 4455544 2445899999999999876431 3456788999999999999999999999999999999999
Q ss_pred eecccccccccc
Q 008116 151 KVADFGVSAQLT 162 (577)
Q Consensus 151 KL~DFGls~~~~ 162 (577)
+|+|||++....
T Consensus 165 ~liDfg~~~~~~ 176 (198)
T cd05144 165 YIIDWPQMVSTD 176 (198)
T ss_pred EEEECCccccCC
Confidence 999999985544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.5e-18 Score=187.97 Aligned_cols=137 Identities=23% Similarity=0.311 Sum_probs=111.7
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEe--ccCCCh-----HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESE-----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i--~~~~~~-----~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
..|...+.||+|+||+||+|.+... .+++|+. +..... .....+.+|+.+++.+.|++|+..+.++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3445678999999999999987643 4444432 111111 123568899999999999999988877777778
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
.++||||++|++|.+++. ....++.+++.+|.|||+++++||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999885 356789999999999999999999999999999 678999999999865
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.3e-18 Score=184.37 Aligned_cols=199 Identities=23% Similarity=0.460 Sum_probs=156.7
Q ss_pred HHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCC-cccccccceE
Q 008116 65 LSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGK-IHRDIKAANI 142 (577)
Q Consensus 65 L~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gI-iHrDIKPeNI 142 (577)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.. ...+++.....++++|++||.|||.-.| .|+.|+..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999976 5678888899999999999999998765 9999999999
Q ss_pred EEccCCCeeeccccccccccc--cccccccccCCCCCCChhhhhcccC------CccccchhhHHHHHHHHHhCCCCCCC
Q 008116 143 LLTENGDVKVADFGVSAQLTR--TISRRKTFVGTPFWMAPEVIQNSEG------YNEKADIWSLGITVIEMAKGEPPLAD 214 (577)
Q Consensus 143 Lld~~g~vKL~DFGls~~~~~--~~~~~~~~~GTp~Y~APEvl~~~~~------~~~ksDVwSLGviLyeLltG~~Pf~~ 214 (577)
+++....+||.|||+...... .........-..-|.|||++..... .+.+.||||||++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999766532 1111111223456999999876321 35678999999999999999999986
Q ss_pred CCc----cceeeccCC-CCCC---Cch--hhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 215 LHP----MRVLFIIPR-ENPP---QLD--EHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 215 ~~~----~~~~~~i~~-~~~~---~l~--~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
... .+....+.+ ...+ .+. ..+.+.+..+++.||..+|..||++.++-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 432 223333333 2221 111 145567999999999999999999988754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.5e-17 Score=156.82 Aligned_cols=138 Identities=21% Similarity=0.315 Sum_probs=100.7
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHH---------------------HHHHHHHHHhCCCC--c
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIED---------------------IQKEISVLSQCRSP--Y 72 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~--~~~~~---------------------i~~Ev~iL~~L~Hp--n 72 (577)
.+.||+|+||.||+|.+. ++..||||++...... ..... ...|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999887 7899999998653311 11111 14566777776443 3
Q ss_pred eeEeEEEEEeCCEEEEEEeccCCCCHHH-HHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCe
Q 008116 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDV 150 (577)
Q Consensus 73 IV~l~~~~~~~~~~~LV~Ey~~gGsL~~-~l~~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~v 150 (577)
+.+++++ ...++||||++++.+.. .+.. ... ...+..++.+++.++.++|. ++|+|+||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKD-VRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhh-hhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4555543 23599999999854322 1111 111 16788999999999999999 9999999999999999 8899
Q ss_pred eeccccccccccc
Q 008116 151 KVADFGVSAQLTR 163 (577)
Q Consensus 151 KL~DFGls~~~~~ 163 (577)
+|+|||.+.....
T Consensus 154 ~liDfg~a~~~~~ 166 (187)
T cd05119 154 YIIDVPQAVEIDH 166 (187)
T ss_pred EEEECcccccccC
Confidence 9999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-16 Score=157.84 Aligned_cols=135 Identities=20% Similarity=0.272 Sum_probs=106.0
Q ss_pred eEEe-ecCceEEEEEEEcCCCcEEEEEEeccCCC------------hHHHHHHHHHHHHHHhCCCCce--eEeEEEEEeC
Q 008116 19 ELIG-RGSFGDVYKAFDKELNKDVAIKVIDLEES------------EDEIEDIQKEISVLSQCRSPYI--TEYYGSYLHQ 83 (577)
Q Consensus 19 ~~IG-~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~------------~~~~~~i~~Ev~iL~~L~HpnI--V~l~~~~~~~ 83 (577)
.+|| .|+.|+||++... +..++||.+..... ......+.+|+.++.+|.|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4687 8899999988765 77899998753211 1223567899999999988775 6777764433
Q ss_pred C----EEEEEEeccCC-CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccc
Q 008116 84 T----KLWIIMEYMAG-GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (577)
Q Consensus 84 ~----~~~LV~Ey~~g-GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls 158 (577)
. ..+|||||++| .+|.+++.. .++++.. +.+|+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 23599999997 699999865 4566543 568999999999999999999999999998889999999987
Q ss_pred cc
Q 008116 159 AQ 160 (577)
Q Consensus 159 ~~ 160 (577)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 54
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.3e-16 Score=142.65 Aligned_cols=132 Identities=20% Similarity=0.288 Sum_probs=112.9
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC--CceeEeEEEEEeCCEEEEEEeccC
Q 008116 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PYITEYYGSYLHQTKLWIIMEYMA 94 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~H--pnIV~l~~~~~~~~~~~LV~Ey~~ 94 (577)
+++.||.|.++.||++.... ..++||.+..... ...+.+|+.+++.+.+ +++++++.++...+..|++|||+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 56889999999999998864 7899999865433 4678899999999966 589999998888888999999998
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEccCCCeeecccccccc
Q 008116 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE---GKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 95 gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~---gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
++.+..+ +......++.+++.+|++||.. +++|+||+|.|||++..+.++|+|||++..
T Consensus 77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8877654 5566677889999999999984 799999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-16 Score=173.46 Aligned_cols=255 Identities=23% Similarity=0.214 Sum_probs=200.1
Q ss_pred hhcCCCeeEEeEEee--cCceEEEEEEE--cCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhC-CCCceeEeEEEEEe
Q 008116 9 EAAGSRFSSLELIGR--GSFGDVYKAFD--KELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQC-RSPYITEYYGSYLH 82 (577)
Q Consensus 9 ~~~~~~f~il~~IG~--GsfG~Vy~a~~--~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~ 82 (577)
......|-+...+|. |.+|.||.+.. ..++..+|+|.-+.... ...-..-.+|+...+.+ .|+|.|+.+..|..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 445567888899999 99999999988 88899999998433321 11223345677777777 59999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCC-CCHHHHHHHHHHHHH----HHHHHHHcCCcccccccceEEEccC-CCeeecccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLH----AIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFG 156 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~~~-l~e~~i~~il~QLl~----aL~yLHs~gIiHrDIKPeNILld~~-g~vKL~DFG 156 (577)
.+..|+-+|+| +.+|..+...... +++..++.++.++.. ||.++|..+++|-|+||.||++..+ ...+++|||
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 99999999999 5788888876555 889999999999999 9999999999999999999999998 889999999
Q ss_pred ccccccccccccc-----cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCC--CccceeeccCCCCC
Q 008116 157 VSAQLTRTISRRK-----TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL--HPMRVLFIIPRENP 229 (577)
Q Consensus 157 ls~~~~~~~~~~~-----~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~--~~~~~~~~i~~~~~ 229 (577)
+...+....-... ..-|..-|++||++.+. ++...|+|+||.++.+-.++..++... ..+..+... ..+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~--~ip 344 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG--YIP 344 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc--cCc
Confidence 9887755431111 12577889999998764 788999999999999988877665433 211111111 123
Q ss_pred CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 230 ~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
..+....+..+...+..++..+|..|++++.++.|+++.
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 333445567777899999999999999999999998886
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1e-16 Score=182.55 Aligned_cols=265 Identities=23% Similarity=0.374 Sum_probs=213.6
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
....|.+.+-+-+|+++.++.+.-..+|...++|+..+... ..+.+.+..+-.++-...+|.++.....+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 44567888899999999999998877787777776543321 1123445555555555567888888877777889999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccc-----
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR----- 163 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~----- 163 (577)
+++|..+++|...++..++.+++.++.++..+..+++|||...++|+|++|.|+|+..+|+.++.|||.......
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 999999999999999888899999999999999999999999999999999999999999999999984221100
Q ss_pred -c--------------------c-----cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCc
Q 008116 164 -T--------------------I-----SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP 217 (577)
Q Consensus 164 -~--------------------~-----~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~ 217 (577)
. . .......||+.|.+||.+.+.. .+..+|+|++|+++++.++|.+||....+
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 0 0012346899999999998865 78899999999999999999999999999
Q ss_pred cceeeccCCCCCCCc--hhhhhHHHHHHHHHhcccCCCCCCcHH---HHhhcHhhhhccCChhH
Q 008116 218 MRVLFIIPRENPPQL--DEHFSRLMKEFVSLCLKKVPAERPSAK---ELLRHRFIRNARKSPRL 276 (577)
Q Consensus 218 ~~~~~~i~~~~~~~l--~~~~s~~l~~lI~~cL~~dP~~RpTa~---elL~hpff~~~~~~~~~ 276 (577)
.+....|.....+.. +...+..+++++..+|..+|.+|..+. ++-.|+||+...+....
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccc
Confidence 888887776665433 456788999999999999999999887 88899999987655433
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.9e-14 Score=153.37 Aligned_cols=180 Identities=19% Similarity=0.300 Sum_probs=141.0
Q ss_pred eEEeecCceEEE-EEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCC
Q 008116 19 ELIGRGSFGDVY-KAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGS 97 (577)
Q Consensus 19 ~~IG~GsfG~Vy-~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGs 97 (577)
....-++.+ +| .|..+.++.+|.|.+.+.... .....+.+-+..|+.|+||||+++++.++..+.+|||+|.+ ..
T Consensus 18 e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~P 93 (690)
T KOG1243|consen 18 EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RP 93 (690)
T ss_pred ccccCCCcc-cccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--cc
Confidence 333344444 34 567778899999998876655 45677889999999999999999999999999999999999 47
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCcccccccceEEEccCCCeeeccccccccccccccccccccCCCC
Q 008116 98 VADLIQSGPPLDEMSIACILRDLLHAIEYLH-NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (577)
Q Consensus 98 L~~~l~~~~~l~e~~i~~il~QLl~aL~yLH-s~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~ 176 (577)
|..++++ +....+...+.||+.||.||| +.+++|++|.-.-|+|+..|.+||++|-++..............---.
T Consensus 94 l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s 170 (690)
T KOG1243|consen 94 LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIES 170 (690)
T ss_pred HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhc
Confidence 8888876 447788888999999999998 668999999999999999999999999987654333221112222234
Q ss_pred CCChhhhhcccCCccccchhhHHHHHHHHHhC
Q 008116 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKG 208 (577)
Q Consensus 177 Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG 208 (577)
|..|+.+.... ...|.|-|||++++++.|
T Consensus 171 ~~~P~~~~~s~---~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 171 FDDPEEIDPSE---WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccChhhcCccc---cchhhhhHHHHHHHHhCc
Confidence 67777654322 357999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.9e-15 Score=152.80 Aligned_cols=206 Identities=21% Similarity=0.318 Sum_probs=144.7
Q ss_pred HHHHHhCCCCceeEeEEEEEeCC-----EEEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHc--
Q 008116 62 ISVLSQCRSPYITEYYGSYLHQT-----KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNE-- 130 (577)
Q Consensus 62 v~iL~~L~HpnIV~l~~~~~~~~-----~~~LV~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~-- 130 (577)
..-|-++-|.|||+++.+|.+.+ ...+++|||+.|+|..+|++ ...+....+.+|+-||+.||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 44556667999999999987643 57899999999999999975 35688899999999999999999987
Q ss_pred CCcccccccceEEEccCCCeeecccccccccccc----ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHH
Q 008116 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRT----ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA 206 (577)
Q Consensus 131 gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~----~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLl 206 (577)
-|+|+++.+.-|++..+|-+|++---.......- ........|-++|.+||.=... ....++|||+||.+.++|.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhHHHHHHH
Confidence 4999999999999999888887632211111000 0011123567899999975443 3567899999999999998
Q ss_pred hCCCCCCC-CCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 207 KGEPPLAD-LHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 207 tG~~Pf~~-~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
.+..--.. .........|.. ....+. ...-+.+|.+||+..|..||+|..+|-||.+-++..
T Consensus 277 ilEiq~tnseS~~~~ee~ia~-~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs 339 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIAN-VIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS 339 (458)
T ss_pred HheeccCCCcceeehhhhhhh-heeecc---CccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence 77543111 111100001100 000011 122357899999999999999999999998766543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.3e-14 Score=161.07 Aligned_cols=144 Identities=20% Similarity=0.291 Sum_probs=98.9
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh---------------------------------HHHHHH
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE---------------------------------DEIEDI 58 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~---------------------------------~~~~~i 58 (577)
-..|+. +.||+|++|+||+|..+.+|+.||||+++..-.. .....+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 7899999999999999988999999998643100 111223
Q ss_pred H------HHHHHHHhC----CCCceeEeEEEEEe-CCEEEEEEeccCCCCHHHH--HHcCC----CCCHHHHHHHHHHHH
Q 008116 59 Q------KEISVLSQC----RSPYITEYYGSYLH-QTKLWIIMEYMAGGSVADL--IQSGP----PLDEMSIACILRDLL 121 (577)
Q Consensus 59 ~------~Ev~iL~~L----~HpnIV~l~~~~~~-~~~~~LV~Ey~~gGsL~~~--l~~~~----~l~e~~i~~il~QLl 121 (577)
. +|+..+.++ .+...+.+-.+|.+ -+..+||||||+|+.|.++ +...+ .+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 3 344333333 23333333333322 3456899999999999875 33322 244555555666655
Q ss_pred HHHHHHHHcCCcccccccceEEEccCC----Ceeeccccccccccc
Q 008116 122 HAIEYLHNEGKIHRDIKAANILLTENG----DVKVADFGVSAQLTR 163 (577)
Q Consensus 122 ~aL~yLHs~gIiHrDIKPeNILld~~g----~vKL~DFGls~~~~~ 163 (577)
..|++|+|+||.||+++.+| .++++|||++..+..
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 58999999999999999887 999999999877654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.5e-13 Score=150.04 Aligned_cols=141 Identities=21% Similarity=0.343 Sum_probs=96.9
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH---H--------------------------H----H------HHH
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED---E--------------------------I----E------DIQ 59 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~---~--------------------------~----~------~i~ 59 (577)
+.||.|++|.||+|... +|+.||||+.+...... + + . .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999875 68999999985432110 0 0 0 133
Q ss_pred HHHHHHHhC----C-CCceeEeEEEEEeCCEEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHH-HHHHHHHcCC
Q 008116 60 KEISVLSQC----R-SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLH-AIEYLHNEGK 132 (577)
Q Consensus 60 ~Ev~iL~~L----~-HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~-aL~yLHs~gI 132 (577)
+|+..+.++ . +++|.-..-++...+..+|||||++|++|.++.... ..+. ...++..++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 455555554 2 344332222222234569999999999999876431 1222 2345555555 4778999999
Q ss_pred cccccccceEEEccCCCeeeccccccccccc
Q 008116 133 IHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (577)
Q Consensus 133 iHrDIKPeNILld~~g~vKL~DFGls~~~~~ 163 (577)
+|+|+||.||+++.+|.++|+|||++..+..
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999877643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.6e-14 Score=153.42 Aligned_cols=251 Identities=22% Similarity=0.217 Sum_probs=190.2
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEc-CCCcEEEEEEeccCCChH-HHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDK-ELNKDVAIKVIDLEESED-EIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~-~tg~~VAIK~i~~~~~~~-~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~ 86 (577)
....+|-.+..||.|.|+.||.+... .++..|++|.+....... ....-..|+.+...+ .|.+++.++..|......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 45678999999999999999998655 778899999775433211 112224567666666 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC-CCeeeccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~-g~vKL~DFGls~~~~~~~ 165 (577)
||-.|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +.-++.|||+.+.+....
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec
Confidence 9999999999988877555678899999999999999999999999999999999999876 788999999876533221
Q ss_pred cccccccCCCCCC-ChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHH
Q 008116 166 SRRKTFVGTPFWM-APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 166 ~~~~~~~GTp~Y~-APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI 244 (577)
......-+++ .+|++.....+..++|++|||..+++.+++.+--..... ...|..+..+..+.. ..+++.+.
T Consensus 422 ---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~~~~~-~~~~q~~~ 494 (524)
T KOG0601|consen 422 ---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPNLPGL-KLQLQVLL 494 (524)
T ss_pred ---ccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccCCCch-HHhhhhhh
Confidence 1223344455 356665555688899999999999999998754332221 222333333333333 38889999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhh
Q 008116 245 SLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff 267 (577)
+.++.+++..||.+.++..|.-|
T Consensus 495 kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 495 KVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhhcCCccccchhhhhhcccchh
Confidence 99999999999999999888644
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.9e-13 Score=127.19 Aligned_cols=128 Identities=16% Similarity=0.208 Sum_probs=97.2
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCce-eEeEEEEEeCCEEEEEEeccCCC
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIMEYMAGG 96 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnI-V~l~~~~~~~~~~~LV~Ey~~gG 96 (577)
++.|+.|.++.||++... +..|+||+...... ....+.+|+.+++.+.+.++ ++++.+. ....++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 567899999999999865 77899998754321 12346789999999865444 4455443 33458999999998
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCC-----cccccccceEEEccCCCeeecccccccc
Q 008116 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK-----IHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 97 sL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gI-----iHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
++... ......++.+++.+|+.||..++ +|+|++|.||+++ ++.++|+|||.+..
T Consensus 77 ~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 87653 01123467899999999999985 9999999999999 67899999998653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.7e-12 Score=127.05 Aligned_cols=141 Identities=20% Similarity=0.211 Sum_probs=103.5
Q ss_pred EeEEeecCceEEEEEEEcC------CCcEEEEEEeccCCC---------------------hHHHHHHH----HHHHHHH
Q 008116 18 LELIGRGSFGDVYKAFDKE------LNKDVAIKVIDLEES---------------------EDEIEDIQ----KEISVLS 66 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~------tg~~VAIK~i~~~~~---------------------~~~~~~i~----~Ev~iL~ 66 (577)
...||.|.-+.||.|.... .+..+|||+.+.... ......+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998654 357999998742210 01122333 8999999
Q ss_pred hCC--CCceeEeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHcCCcccccccceEE
Q 008116 67 QCR--SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL-HNEGKIHRDIKAANIL 143 (577)
Q Consensus 67 ~L~--HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yL-Hs~gIiHrDIKPeNIL 143 (577)
+|. .-++++++++ ..-+|||||+.+..+....-+...+++..+..++.+++.+|..| |..||||+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 984 3566666654 45689999997654432222224566677788899999999998 8999999999999999
Q ss_pred EccCCCeeeccccccccccc
Q 008116 144 LTENGDVKVADFGVSAQLTR 163 (577)
Q Consensus 144 ld~~g~vKL~DFGls~~~~~ 163 (577)
+. ++.+.|+|||.+.....
T Consensus 158 ~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EE-CCcEEEEECCCceeCCC
Confidence 96 46899999998765543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.9e-11 Score=119.20 Aligned_cols=141 Identities=17% Similarity=0.235 Sum_probs=107.5
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC--CceeEeEEEEEeC---CEEEEEEec
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PYITEYYGSYLHQ---TKLWIIMEY 92 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~H--pnIV~l~~~~~~~---~~~~LV~Ey 92 (577)
++.|+.|.++.||++.... |..|+||.............+..|+.+++.+.+ ..+++++.+.... +..++||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3678999999999998753 688999997544322234578899999999965 4467777766553 367899999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 008116 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN------------------------------------------- 129 (577)
Q Consensus 93 ~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs------------------------------------------- 129 (577)
++|.+|...+.. ..+++.....++.+++.+|..||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999988876532 456777777778888888888873
Q ss_pred -------------cCCcccccccceEEEcc--CCCeeecccccccc
Q 008116 130 -------------EGKIHRDIKAANILLTE--NGDVKVADFGVSAQ 160 (577)
Q Consensus 130 -------------~gIiHrDIKPeNILld~--~g~vKL~DFGls~~ 160 (577)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23599999999999988 56789999997643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=9e-11 Score=112.60 Aligned_cols=131 Identities=21% Similarity=0.298 Sum_probs=100.3
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccC-C-Ch-----HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-E-SE-----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~-~-~~-----~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..|++|+-+.+|.+.+. |.++++|.-... . .+ -...+..+|+.+|.++.--.|...+=++.+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 46889999999999664 556777753211 1 11 123567789999999865555444445566777899999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
|++|..|.+.+... ...+++.+-.-+.-||..||||+||.++||++..++ +.++||||+.
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 99999999998764 256777888888899999999999999999997654 9999999975
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.6e-10 Score=107.51 Aligned_cols=142 Identities=27% Similarity=0.350 Sum_probs=107.3
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--C-----hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--S-----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~-----~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
.+.+|-+|+-+.|+++.+. |+.++||.-.... . .-...+.++|+.+|.++.--.|.-..-+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 7889999999999999765 8888888642211 1 11246678999999998654554444455666677899
Q ss_pred EeccCC-CCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC---Ceeecccccccc
Q 008116 90 MEYMAG-GSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKVADFGVSAQ 160 (577)
Q Consensus 90 ~Ey~~g-GsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g---~vKL~DFGls~~ 160 (577)
|||++| .++.+++... ..........+++.|-..|.-||.++|||+||..+||+|..++ .+.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999976 4788888652 2333334478899999999999999999999999999997664 358999999743
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.3e-09 Score=117.74 Aligned_cols=216 Identities=15% Similarity=0.234 Sum_probs=157.8
Q ss_pred ceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe----CCEEEEEEeccCC-CCHHH
Q 008116 26 FGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QTKLWIIMEYMAG-GSVAD 100 (577)
Q Consensus 26 fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~----~~~~~LV~Ey~~g-GsL~~ 100 (577)
-.+.|++....+|..|++|.+...... .....-.-+++++++.|+|||++.++|.. +..++||++|.++ ++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 357899999999999999998332211 11223345899999999999999999974 3468999999875 57777
Q ss_pred HHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 101 LIQS---------------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 101 ~l~~---------------~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
+--. +...+|..+|.|+.||..||.++|+.|+..+-|.|.+||++.+..++|...|+...+....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 6521 2357899999999999999999999999999999999999988889998777665443321
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCC-CccceeeccCCCCCCCchhhhhHHHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~-~~~~~~~~i~~~~~~~l~~~~s~~l~~lI 244 (577)
. |-+... .+-|.=.||.+++.|.+|..--... .... .....+...++.+++++|
T Consensus 448 ------------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~-------s~~~~I~~~yS~D~rn~v 502 (655)
T KOG3741|consen 448 ------------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQS-------SHLTRITTTYSTDLRNVV 502 (655)
T ss_pred ------------C--cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHH-------HHHHHhhhhhhHHHHHHH
Confidence 0 112222 2568889999999999985421111 0000 011233456789999999
Q ss_pred HHhcccCCCCCCcHHHHhhc---Hhhh
Q 008116 245 SLCLKKVPAERPSAKELLRH---RFIR 268 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~h---pff~ 268 (577)
..+...+++. -++.+++.+ .||.
T Consensus 503 ~yl~s~~~~~-ksI~~llp~~~~~ff~ 528 (655)
T KOG3741|consen 503 EYLESLNFRE-KSIQDLLPMIGSRFFT 528 (655)
T ss_pred HHHHhcCccc-ccHHHHHHHHHHHHHH
Confidence 9999998886 678888865 4664
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.8e-09 Score=108.43 Aligned_cols=130 Identities=15% Similarity=0.098 Sum_probs=93.3
Q ss_pred EEEEEEEcCCCcEEEEEEeccCCChHHHH----------HHHHHHHHHHhCCCCc--eeEeEEEEEe-----CCEEEEEE
Q 008116 28 DVYKAFDKELNKDVAIKVIDLEESEDEIE----------DIQKEISVLSQCRSPY--ITEYYGSYLH-----QTKLWIIM 90 (577)
Q Consensus 28 ~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~----------~i~~Ev~iL~~L~Hpn--IV~l~~~~~~-----~~~~~LV~ 90 (577)
.|+++.. .|+.|.||...........+ .+.+|...+.+|..-+ +++++++.+. ...-+|||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3556543 37789999763322111111 3778888888873222 2333444432 23578999
Q ss_pred eccCCC-CHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc-------CCCeeeccccccc
Q 008116 91 EYMAGG-SVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-------NGDVKVADFGVSA 159 (577)
Q Consensus 91 Ey~~gG-sL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~-------~g~vKL~DFGls~ 159 (577)
|++++. +|.+++.. ..+.+......++.+++..+.-||.+||+|+|+++.||||+. ++.+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999876 89999853 345667788899999999999999999999999999999975 4679999999764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.2e-10 Score=127.96 Aligned_cols=241 Identities=29% Similarity=0.401 Sum_probs=179.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCc-eeEeEEEEEeCCEEEEEEec
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~Hpn-IV~l~~~~~~~~~~~LV~Ey 92 (577)
-+....-+++|++++++|.+...+...+ .+++... ..+.-++++|.+++||| .+..++.+..+...++++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3444556789999999999877655554 6766433 45677899999999999 88888888888899999999
Q ss_pred cCCC-CHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 93 MAGG-SVA-DLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 93 ~~gG-sL~-~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
+.++ +-. ..-...-.+.+.+...+++.-+++|++||+---+|+| |||..+ +..++.||+....+.... ..++
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t 389 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRT 389 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-cccc
Confidence 9877 221 1111122345556667777888999999998789999 888765 679999999988876654 4567
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCchh--hhhHHHH-HHHHH
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDE--HFSRLMK-EFVSL 246 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~l~~--~~s~~l~-~lI~~ 246 (577)
..+++.|+|||+..... +..+.|+|++|+-..+|.-|.+|-.. +......+..+. .+.+.. .++.... ++...
T Consensus 390 ~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~ 466 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAP 466 (829)
T ss_pred CCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCccc
Confidence 89999999999987765 88899999999988888888887544 444444443322 222211 2222233 48889
Q ss_pred hcccCCCCCCcHHHHhhcHhhhhc
Q 008116 247 CLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
|+...|..++....++.|.+|..+
T Consensus 467 ~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 467 CLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred ccCCCCCCCcchhhHHHHHHhccC
Confidence 999999999999999999999765
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.3e-10 Score=127.21 Aligned_cols=151 Identities=20% Similarity=0.311 Sum_probs=109.6
Q ss_pred HHHHHHHHHHHHc-CCcccccccceEEEccCCCeeecccccccccccccc----cc-----ccccCCCCCCChhhhhccc
Q 008116 118 RDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS----RR-----KTFVGTPFWMAPEVIQNSE 187 (577)
Q Consensus 118 ~QLl~aL~yLHs~-gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~----~~-----~~~~GTp~Y~APEvl~~~~ 187 (577)
.+++.||.|+|.. ++||+.|.|++|.++..|.+||+.|+++.....+.. .. ....-...|.|||++...
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~- 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT- 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-
Confidence 3455899999965 899999999999999999999999998765433111 00 012235679999999874
Q ss_pred CCccccchhhHHHHHHHHHh-CCCCCCCCCcccee-eccCCCC--CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 188 GYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL-FIIPREN--PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 188 ~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~-~~i~~~~--~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
..+.++|+|||||++|.+.. |+.-+......... ......+ .......++.++++-|.++|..++.-||++..++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 47889999999999999994 55444332211100 0011111 11233578899999999999999999999999999
Q ss_pred cHhhhh
Q 008116 264 HRFIRN 269 (577)
Q Consensus 264 hpff~~ 269 (577)
-+||..
T Consensus 265 ~~ff~D 270 (700)
T KOG2137|consen 265 IPFFSD 270 (700)
T ss_pred ccccCC
Confidence 999965
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.2e-09 Score=101.88 Aligned_cols=127 Identities=28% Similarity=0.383 Sum_probs=84.2
Q ss_pred EEEEEEEcCCCcEEEEEEeccCCC-------------------------hHHHHHHHHHHHHHHhCCCC--ceeEeEEEE
Q 008116 28 DVYKAFDKELNKDVAIKVIDLEES-------------------------EDEIEDIQKEISVLSQCRSP--YITEYYGSY 80 (577)
Q Consensus 28 ~Vy~a~~~~tg~~VAIK~i~~~~~-------------------------~~~~~~i~~Ev~iL~~L~Hp--nIV~l~~~~ 80 (577)
.||.|... .|..+|||+.+.... .......++|+..|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999885 478999998743210 01134567899999999654 566666542
Q ss_pred EeCCEEEEEEeccC--CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHHcCCcccccccceEEEccCCCeeeccccc
Q 008116 81 LHQTKLWIIMEYMA--GGSVADLIQSGPPLDEMSIACILRDLLHAIEY-LHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (577)
Q Consensus 81 ~~~~~~~LV~Ey~~--gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~y-LHs~gIiHrDIKPeNILld~~g~vKL~DFGl 157 (577)
+ -+|||||++ |..|..+... .++......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||.
T Consensus 80 --~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp --T--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred --C--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2 379999998 6666555432 22245566777888885555 679999999999999999877 899999998
Q ss_pred ccccc
Q 008116 158 SAQLT 162 (577)
Q Consensus 158 s~~~~ 162 (577)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 76543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5.5e-08 Score=103.09 Aligned_cols=243 Identities=16% Similarity=0.242 Sum_probs=155.8
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEE-------E
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSY-------L 81 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~-------~ 81 (577)
..+.--...+.||+|+.+.+|-.-.. +. .+.|+......... .+-+..|... .||-+-.-+.+= .
T Consensus 8 ~~ge~i~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~ 80 (637)
T COG4248 8 VYGEPIPPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQ----AQKVAELAATPDAPLLNYRVAWPQATLHGGR 80 (637)
T ss_pred ccCcccCCCccccCCccceeeecchh--hc-hhheeecCCCchHH----HHHHHHhccCCCCcchhhhhcccHHHhhCCC
Confidence 33344445678999999999976322 22 34566544433221 2223444444 566544311111 1
Q ss_pred eCCEEEEEEeccCCCC-HHHHH------HcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecc
Q 008116 82 HQTKLWIIMEYMAGGS-VADLI------QSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVAD 154 (577)
Q Consensus 82 ~~~~~~LV~Ey~~gGs-L~~~l------~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~D 154 (577)
....+.++|..+.|.. ...+. +......+..+..+.+.|+.+.+.||.+|.+-+|+.++|||+.+++.|.|.|
T Consensus 81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEc
Confidence 1234788999987752 22222 1234578899999999999999999999999999999999999999999998
Q ss_pred ccccccccccccccccccCCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhC-CCCCCCCCc-------ccee-
Q 008116 155 FGVSAQLTRTISRRKTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKG-EPPLADLHP-------MRVL- 221 (577)
Q Consensus 155 FGls~~~~~~~~~~~~~~GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG-~~Pf~~~~~-------~~~~- 221 (577)
-..-. +........+.+|.+.|.+||.-.- ...-+...|.|.|||++++||.| .+||..... .+..
T Consensus 161 sDsfq-i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 161 SDSFQ-INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred cccee-eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 65322 2233344557789999999997431 11245678999999999999886 999975421 1100
Q ss_pred ----ec-cCCC----CCC--Cc-hhhhhHHHHHHHHHhcccC--CCCCCcHHH
Q 008116 222 ----FI-IPRE----NPP--QL-DEHFSRLMKEFVSLCLKKV--PAERPSAKE 260 (577)
Q Consensus 222 ----~~-i~~~----~~~--~l-~~~~s~~l~~lI~~cL~~d--P~~RpTa~e 260 (577)
+. ..+. .++ .. ..-+++.++.++.+|+... +.-|||++.
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 00 0000 011 11 2346788999999999743 568999865
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.8e-08 Score=97.88 Aligned_cols=106 Identities=24% Similarity=0.284 Sum_probs=84.1
Q ss_pred HHHHHHHHHHHHhCCC--CceeEeEEEEEeC----CEEEEEEeccCCC-CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 008116 55 IEDIQKEISVLSQCRS--PYITEYYGSYLHQ----TKLWIIMEYMAGG-SVADLIQSGPPLDEMSIACILRDLLHAIEYL 127 (577)
Q Consensus 55 ~~~i~~Ev~iL~~L~H--pnIV~l~~~~~~~----~~~~LV~Ey~~gG-sL~~~l~~~~~l~e~~i~~il~QLl~aL~yL 127 (577)
.....+|...+..|.. =.+++.+++.... ...+||+|++++. +|.+++.....++......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 3467788888777742 2344555555442 2458999999884 8999997655577888899999999999999
Q ss_pred HHcCCcccccccceEEEccCC---Ceeecccccccc
Q 008116 128 HNEGKIHRDIKAANILLTENG---DVKVADFGVSAQ 160 (577)
Q Consensus 128 Hs~gIiHrDIKPeNILld~~g---~vKL~DFGls~~ 160 (577)
|.+||+|+|++|.|||++.++ .+.|+||+-+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.6e-08 Score=100.91 Aligned_cols=135 Identities=27% Similarity=0.337 Sum_probs=102.7
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC---------------------hHHHHHHHHHHHHHHhCCCC--
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES---------------------EDEIEDIQKEISVLSQCRSP-- 71 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~---------------------~~~~~~i~~Ev~iL~~L~Hp-- 71 (577)
..+...||-|.-+.||.|.+. .|.++|||.=+.... .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 345688999999999999987 589999997532211 01234567899999999644
Q ss_pred ceeEeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCee
Q 008116 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (577)
Q Consensus 72 nIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vK 151 (577)
.|++.+++ +...+||||++|-.|...- ++...+..++..|+.-+.-+-..||||+|+.+-|||++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 67777663 5668999999997776542 24455566666777777666689999999999999999999999
Q ss_pred eccccccc
Q 008116 152 VADFGVSA 159 (577)
Q Consensus 152 L~DFGls~ 159 (577)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99996543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.61 E-value=7e-07 Score=87.21 Aligned_cols=137 Identities=20% Similarity=0.352 Sum_probs=84.0
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC--CceeEeEEEEEe---CCEEEEEEec
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PYITEYYGSYLH---QTKLWIIMEY 92 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~H--pnIV~l~~~~~~---~~~~~LV~Ey 92 (577)
++.|+.|..+.||++.... ..++||..... .....+.+|+.+++.|.. ..+++++..... ....+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 5789999999999998775 48999997543 345778899999888842 235566664433 3467999999
Q ss_pred cCCCCHHH----------------HHH---cC----CCCCHHH------HHHH---------------HHHHHH-HHHHH
Q 008116 93 MAGGSVAD----------------LIQ---SG----PPLDEMS------IACI---------------LRDLLH-AIEYL 127 (577)
Q Consensus 93 ~~gGsL~~----------------~l~---~~----~~l~e~~------i~~i---------------l~QLl~-aL~yL 127 (577)
++|..+.. .+. .. .++.... ...+ +..+.. .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99988877 111 11 1111100 0000 111222 33344
Q ss_pred HH-------cCCcccccccceEEEc-cCCCeeeccccccc
Q 008116 128 HN-------EGKIHRDIKAANILLT-ENGDVKVADFGVSA 159 (577)
Q Consensus 128 Hs-------~gIiHrDIKPeNILld-~~g~vKL~DFGls~ 159 (577)
+. ..++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 42 3599999999999999 55667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.7e-06 Score=85.60 Aligned_cols=137 Identities=18% Similarity=0.194 Sum_probs=99.1
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccC--CC---hHHHHHHHHHHHHHHhCCC--CceeEeEEEEE--eC--CEEEEE
Q 008116 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLE--ES---EDEIEDIQKEISVLSQCRS--PYITEYYGSYL--HQ--TKLWII 89 (577)
Q Consensus 21 IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~--~~---~~~~~~i~~Ev~iL~~L~H--pnIV~l~~~~~--~~--~~~~LV 89 (577)
-|+||.+.|+..... |..|-+|.-... .+ +.-...+.+|+..|.+|.. -.++++..... .+ -.-+||
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 367999999997654 446778865311 00 2234678999999998842 22444442211 11 146899
Q ss_pred EeccCC-CCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC--eeeccccccc
Q 008116 90 MEYMAG-GSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD--VKVADFGVSA 159 (577)
Q Consensus 90 ~Ey~~g-GsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~--vKL~DFGls~ 159 (577)
+|-+.| .+|.+++... .+.+......++.+++.+|.-||..|+.|+|+.+.|||++.+|. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998754 5898888652 35577777899999999999999999999999999999987677 9999997543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.52 E-value=7.2e-07 Score=89.33 Aligned_cols=134 Identities=17% Similarity=0.200 Sum_probs=85.3
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCC--ceeEeEEEEEeCCEEEEEEeccCC
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP--YITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~Hp--nIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
...||.|..+.||+. .+..+++|...... ....+.+|.++++.+..- -+++.+++....+..++|||+++|
T Consensus 6 ~~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 6 WTQTGEGGNGESYTH----KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred heeecCCCCcceeEe----cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 468999999999984 25567899876433 234578999999988532 356777777778888999999998
Q ss_pred CC-HHHH--------------H-------HcC--CCCCHHH-HHHHHHH----------HHH-HHHHHHH----cCCccc
Q 008116 96 GS-VADL--------------I-------QSG--PPLDEMS-IACILRD----------LLH-AIEYLHN----EGKIHR 135 (577)
Q Consensus 96 Gs-L~~~--------------l-------~~~--~~l~e~~-i~~il~Q----------Ll~-aL~yLHs----~gIiHr 135 (577)
.+ +... + +.- ....... ...+..+ +.. ...+|.. ..++|+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 63 1111 1 110 0111111 1111101 111 1222221 246899
Q ss_pred ccccceEEEccCCCeeeccccccc
Q 008116 136 DIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 136 DIKPeNILld~~g~vKL~DFGls~ 159 (577)
|+.|.||+++.++ +.|+||+.+.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.1e-06 Score=85.34 Aligned_cols=140 Identities=17% Similarity=0.223 Sum_probs=91.6
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHH------HHHHHHHHHhC---CCCceeEe
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIED------IQKEISVLSQC---RSPYITEY 76 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~--~~~~~------i~~Ev~iL~~L---~HpnIV~l 76 (577)
-+...++|++++++-......|.+..- .|..+++|........ ..... ..+.+..+..+ .--.++.+
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 345678999999998888777766643 4789999987543211 11111 12233333333 22333333
Q ss_pred EEEEEe-----CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCee
Q 008116 77 YGSYLH-----QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (577)
Q Consensus 77 ~~~~~~-----~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vK 151 (577)
+.+... -...+|||||++|..|.++.. +++ .+...|.+++.-||..|++|+|+.|.|++++.+ .++
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEE
Confidence 333222 235578999999988887642 333 244567778899999999999999999999865 499
Q ss_pred ecccccc
Q 008116 152 VADFGVS 158 (577)
Q Consensus 152 L~DFGls 158 (577)
++||+..
T Consensus 175 iID~~~k 181 (229)
T PF06176_consen 175 IIDTQGK 181 (229)
T ss_pred EEECccc
Confidence 9999864
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.5e-07 Score=99.06 Aligned_cols=141 Identities=23% Similarity=0.325 Sum_probs=94.2
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-----------------------------hH----HHHH------HH
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-----------------------------ED----EIED------IQ 59 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-----------------------------~~----~~~~------i~ 59 (577)
..|+.++-|+||+|+... |+.||||+.+..-. .. ..+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 578999999999999876 99999999743210 00 1111 23
Q ss_pred HHHHHHHhC-----CCCceeEeEEEEEeCCEEEEEEeccCCCCHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 008116 60 KEISVLSQC-----RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEGK 132 (577)
Q Consensus 60 ~Ev~iL~~L-----~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l--~~~~~l~e~~i~~il~QLl~aL~yLHs~gI 132 (577)
+|...+.++ +.|+|.-..=++.--+.-.|+|||++|..+.++. +. ..++...+...+.++. +..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 444444444 2355433333344445668999999999998884 44 4455444433322221 223334899
Q ss_pred cccccccceEEEccCCCeeeccccccccccc
Q 008116 133 IHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (577)
Q Consensus 133 iHrDIKPeNILld~~g~vKL~DFGls~~~~~ 163 (577)
+|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 9999999999999999999999999876644
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.40 E-value=9.9e-07 Score=103.34 Aligned_cols=206 Identities=22% Similarity=0.297 Sum_probs=149.4
Q ss_pred HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE----EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 008116 53 DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL----WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128 (577)
Q Consensus 53 ~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~----~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLH 128 (577)
..+.....|...+.++.|+|++.++.+-...... .+..|+|..-++...+..-+.++...++.+..++++||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 3455566788888899999999999887664433 355689999999999998899999999999999999999999
Q ss_pred HcCCcccccccc---eEEEccCCCeeec--cccccccccccccccccccCCCCCCChhhhhcccCCcc--ccchhhHHHH
Q 008116 129 NEGKIHRDIKAA---NILLTENGDVKVA--DFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE--KADIWSLGIT 201 (577)
Q Consensus 129 s~gIiHrDIKPe---NILld~~g~vKL~--DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~--ksDVwSLGvi 201 (577)
+....|.-|-.. +-.++..+.+.+. ||+.+..+..... .....-+..|.+||...... +.. ..|+|.+|..
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLL 381 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCcccccccccccccc-chhhhhhHHHHHHHH
Confidence 996666655554 3344455666666 8888776654322 22344566788888776442 333 3699999999
Q ss_pred HHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 202 VIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 202 LyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
+..+..|..+-.... . ....++......+.+++.+|+..++++|+++.+++.|+|.+..
T Consensus 382 ~~~~~~~~~i~~~~~-------~---~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA-------V---PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred HhhhhhcCccccccc-------c---hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 999998765422110 0 0111122222267888999999999999999999999998753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.6e-06 Score=85.39 Aligned_cols=134 Identities=17% Similarity=0.159 Sum_probs=84.3
Q ss_pred EEeecCc-eEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEEEEEeccCCCC
Q 008116 20 LIGRGSF-GDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEYMAGGS 97 (577)
Q Consensus 20 ~IG~Gsf-G~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~LV~Ey~~gGs 97 (577)
.|-.|.. ..||++... +..+.||...... ...+.+|+.+++.+. +--+++++++....+..++|||+++|.+
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 3445555 789999654 4678889875432 245778999998883 4446678887777777899999999987
Q ss_pred HHHHH----------------H---cC----CCCCHH--HHHHHHH--------------------HHHHHHHHHHH---
Q 008116 98 VADLI----------------Q---SG----PPLDEM--SIACILR--------------------DLLHAIEYLHN--- 129 (577)
Q Consensus 98 L~~~l----------------~---~~----~~l~e~--~i~~il~--------------------QLl~aL~yLHs--- 129 (577)
|.... . .- .++... ....... .+...+..|-.
T Consensus 79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 158 (244)
T cd05150 79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP 158 (244)
T ss_pred HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence 76432 0 00 011100 0000000 01111222211
Q ss_pred ----cCCcccccccceEEEccCCCeeeccccccc
Q 008116 130 ----EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 130 ----~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
..++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 248999999999999988778899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.6e-06 Score=84.02 Aligned_cols=139 Identities=21% Similarity=0.302 Sum_probs=95.3
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh---------------------HHHH--HHHHHHHHHHhCC--CCc
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE---------------------DEIE--DIQKEISVLSQCR--SPY 72 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~---------------------~~~~--~i~~Ev~iL~~L~--Hpn 72 (577)
...|..|.-+.||+|.. ..+..||||+++..... ..+. =..+|+.-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34666788889999976 34889999998543211 0111 1246888888873 445
Q ss_pred eeEeEEEEEeCCEEEEEEeccCCCCH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCe
Q 008116 73 ITEYYGSYLHQTKLWIIMEYMAGGSV-ADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDV 150 (577)
Q Consensus 73 IV~l~~~~~~~~~~~LV~Ey~~gGsL-~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~v 150 (577)
+++.+.+. .-.|||||+...-+ .-.|+ ..++...++..+..++++.+.-|-. .++||+||..-|||+. ++.+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 56666554 23799999954311 11111 1234444678888899999888776 8999999999999999 8899
Q ss_pred eeccccccccccc
Q 008116 151 KVADFGVSAQLTR 163 (577)
Q Consensus 151 KL~DFGls~~~~~ 163 (577)
.|+|||-|.....
T Consensus 206 ~iID~~QaV~~~h 218 (268)
T COG1718 206 YIIDVSQAVTIDH 218 (268)
T ss_pred EEEECccccccCC
Confidence 9999998765543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.8e-06 Score=97.04 Aligned_cols=144 Identities=16% Similarity=0.269 Sum_probs=92.2
Q ss_pred EEeEEeecCceEEEEEEEcCCC--cEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCce--eEeEEEEEeC---CEEEE
Q 008116 17 SLELIGRGSFGDVYKAFDKELN--KDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYI--TEYYGSYLHQ---TKLWI 88 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~tg--~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnI--V~l~~~~~~~---~~~~L 88 (577)
.++.|+.|.+..+|+......+ ..+++|..+..........+.+|+.+|+.|. |++| ++++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4688899999999998765432 4678887654332222356889999999995 6665 7778777654 46799
Q ss_pred EEeccCCCCHHH--------------------HHH---cC----------C-C--CCHHHHHHHHHH-------------
Q 008116 89 IMEYMAGGSVAD--------------------LIQ---SG----------P-P--LDEMSIACILRD------------- 119 (577)
Q Consensus 89 V~Ey~~gGsL~~--------------------~l~---~~----------~-~--l~e~~i~~il~Q------------- 119 (577)
||||++|..+.+ .+. .- + + ....++..|..+
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 999998864321 111 10 0 0 011233332222
Q ss_pred --HHHHHHHHHH-----------cCCcccccccceEEEccC-C-Ceeecccccccc
Q 008116 120 --LLHAIEYLHN-----------EGKIHRDIKAANILLTEN-G-DVKVADFGVSAQ 160 (577)
Q Consensus 120 --Ll~aL~yLHs-----------~gIiHrDIKPeNILld~~-g-~vKL~DFGls~~ 160 (577)
+...+.+|.. ..+||+|++|.|||++.+ + .+-|.||.++..
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2234566643 249999999999999853 3 357899998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.11 E-value=4e-05 Score=75.44 Aligned_cols=129 Identities=21% Similarity=0.355 Sum_probs=95.0
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCC---------------ChHHHHHHHHHHHHHHhCC------CCceeEe
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE---------------SEDEIEDIQKEISVLSQCR------SPYITEY 76 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~---------------~~~~~~~i~~Ev~iL~~L~------HpnIV~l 76 (577)
...||+|+.=.||.- . .....+||+..... ......+..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457999999999964 2 34457899886554 1122456677777766665 7899999
Q ss_pred EEEEEeCCEEEEEEeccCC------CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC--C
Q 008116 77 YGSYLHQTKLWIIMEYMAG------GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN--G 148 (577)
Q Consensus 77 ~~~~~~~~~~~LV~Ey~~g------GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~--g 148 (577)
+|+.+++--+.+|+|.+.+ -+|.++++. +.+++ .+. ..|-.-..||-+++|+.+||+|.||++... +
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999998743 368888865 45666 333 344455678899999999999999999643 2
Q ss_pred --Ceeecc
Q 008116 149 --DVKVAD 154 (577)
Q Consensus 149 --~vKL~D 154 (577)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.4e-05 Score=75.18 Aligned_cols=130 Identities=24% Similarity=0.273 Sum_probs=92.4
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCcee-EeEEEEEeCCEEEEEEeccC
Q 008116 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT-EYYGSYLHQTKLWIIMEYMA 94 (577)
Q Consensus 16 ~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV-~l~~~~~~~~~~~LV~Ey~~ 94 (577)
++.+.|++|.+|.||++.+. |..+|+|+-..+. ....+..|+++|..+...++- ++|.+- ..++.|||+.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~ 95 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYID 95 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhc
Confidence 45678999999999999877 6799999865443 457899999999999876664 444432 2255699999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccc-cceEEEccCCCeeeccccccccc
Q 008116 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK-AANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 95 gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIK-PeNILld~~g~vKL~DFGls~~~ 161 (577)
|-.|.+..... + +.-+..+++..--|-..||-|..|. |..++|-.++.+.|+||.-|+..
T Consensus 96 G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 96 GRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred Ccchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 98888765321 2 2233445555555667899999886 44444444558999999988643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.1e-05 Score=74.68 Aligned_cols=127 Identities=24% Similarity=0.363 Sum_probs=90.3
Q ss_pred CCCeeEEeEEeecCc-eEEEEEEEcCCCcEEEEEEecc---CCC-------h----------HHHHHHHHHHHHHHhC--
Q 008116 12 GSRFSSLELIGRGSF-GDVYKAFDKELNKDVAIKVIDL---EES-------E----------DEIEDIQKEISVLSQC-- 68 (577)
Q Consensus 12 ~~~f~il~~IG~Gsf-G~Vy~a~~~~tg~~VAIK~i~~---~~~-------~----------~~~~~i~~Ev~iL~~L-- 68 (577)
+.+++.++.||.|.- |.||++... |+.||||++.. ... . ....-|..|.+...+|
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 379999999999999 999999776 78999999321 110 0 1123466677766666
Q ss_pred -CCCce--eEeEEEEEeC------------------CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 008116 69 -RSPYI--TEYYGSYLHQ------------------TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127 (577)
Q Consensus 69 -~HpnI--V~l~~~~~~~------------------~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yL 127 (577)
.+.++ |+++|+..-. ....||.||+.... .+.... +.+|+.-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHH
Confidence 45566 9999988432 12367888876533 233333 45667777889
Q ss_pred HHcCCcccccccceEEEccCCCeeecccccc
Q 008116 128 HNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (577)
Q Consensus 128 Hs~gIiHrDIKPeNILld~~g~vKL~DFGls 158 (577)
|..||+-+|+|+.|.. .-||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999984 3589999854
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.5e-05 Score=88.72 Aligned_cols=139 Identities=24% Similarity=0.340 Sum_probs=88.5
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCCC------------------------------hHHHHHHHHHHHHH---
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES------------------------------EDEIEDIQKEISVL--- 65 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~------------------------------~~~~~~i~~Ev~iL--- 65 (577)
+.||.-+.|.||+|+.+. |..||||+-+..-. +...+.+..|+..+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999999887 99999998532210 01112222232222
Q ss_pred -------HhCCCCc------eeEeEEEEEeCCEEEEEEeccCCCCHHHH--HHcCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 008116 66 -------SQCRSPY------ITEYYGSYLHQTKLWIIMEYMAGGSVADL--IQSGPPLDEMSIACILRDLLHAIEYLHNE 130 (577)
Q Consensus 66 -------~~L~Hpn------IV~l~~~~~~~~~~~LV~Ey~~gGsL~~~--l~~~~~l~e~~i~~il~QLl~aL~yLHs~ 130 (577)
+.+.|-+ |+++|-.+ -....|+||||+|..+.++ |.+ ..++...+...+.++.. .-|=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHH--HHHHhc
Confidence 2233444 44444333 3456899999999877654 333 34555544443333221 223357
Q ss_pred CCcccccccceEEEcc----CCCeeeccccccccccc
Q 008116 131 GKIHRDIKAANILLTE----NGDVKVADFGVSAQLTR 163 (577)
Q Consensus 131 gIiHrDIKPeNILld~----~g~vKL~DFGls~~~~~ 163 (577)
|++|.|-+|.|||++. ++.+.|.|||+...+..
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999984 56899999999876654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.00 E-value=1.7e-05 Score=79.35 Aligned_cols=74 Identities=14% Similarity=0.271 Sum_probs=47.2
Q ss_pred EeEEeecCce-EEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCC---ceeEeEEEEEeC---CEEEEEE
Q 008116 18 LELIGRGSFG-DVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP---YITEYYGSYLHQ---TKLWIIM 90 (577)
Q Consensus 18 l~~IG~GsfG-~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~Hp---nIV~l~~~~~~~---~~~~LV~ 90 (577)
++.|+.|+.. .||+. +..+++|...... ....+.+|+.+|..|... -+.++++..... ...|++|
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 3567777776 59976 3357888754322 235788999999887421 344545443332 2358899
Q ss_pred eccCCCCHH
Q 008116 91 EYMAGGSVA 99 (577)
Q Consensus 91 Ey~~gGsL~ 99 (577)
++++|.++.
T Consensus 74 ~~i~G~~l~ 82 (235)
T cd05155 74 RWLEGETAT 82 (235)
T ss_pred EeecCCCCC
Confidence 999987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=6.4e-07 Score=106.62 Aligned_cols=210 Identities=13% Similarity=0.068 Sum_probs=143.0
Q ss_pred HHHHHHHHHHhCCCCceeEeEEEEEe--CCEEEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHc
Q 008116 57 DIQKEISVLSQCRSPYITEYYGSYLH--QTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNE 130 (577)
Q Consensus 57 ~i~~Ev~iL~~L~HpnIV~l~~~~~~--~~~~~LV~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~ 130 (577)
-...|+..++...|+++...+.-... ....|.+++||.+|.++.+|-+ ..++.+..+.....+.+.+..-+|+.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 34456666777889999887765543 3356999999999999999854 34566666666666767777777754
Q ss_pred -----CCcccccccceEEEccCCCeeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHH
Q 008116 131 -----GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM 205 (577)
Q Consensus 131 -----gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeL 205 (577)
-.+|++||+-|.+|..+.++|++++|+.+.............++|.|+.|++...-. ++.++|+|..|+.+|++
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHHHH
Confidence 279999999999999999999999999985555555556778899999999887654 78889999999999999
Q ss_pred HhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 206 AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 206 ltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
..|..+|-..........+.....-.++.-.|.++-.....+|-..-..||.-...+.-+.|
T Consensus 1434 s~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1434 SDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred hcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence 99988874322221112222222111211112222222223333333677777777665544
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.90 E-value=6.4e-05 Score=77.49 Aligned_cols=150 Identities=16% Similarity=0.139 Sum_probs=90.2
Q ss_pred ccchhhhcC-CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCC--ceeEeEE--
Q 008116 4 LAGLQEAAG-SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP--YITEYYG-- 78 (577)
Q Consensus 4 l~~l~~~~~-~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~Hp--nIV~l~~-- 78 (577)
+..+.+..+ ++..-++.|..|....+|+.... +..+++|+... . ....+..|+.++..|.+- .+++++.
T Consensus 4 l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~-~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~ 77 (296)
T cd05153 4 LASFLADYDLGELLSFEGISAGIENTNYFVTTD--SGRYVLTLFEK-V---SAEELPFFLALLDHLAERGLPVPRPIADR 77 (296)
T ss_pred HHHHHHHcCCCchhheecccCccccceEEEEeC--CCcEEEEEcCC-C---ChHhccHHHHHHHHHHHCCCCCCccccCC
Confidence 334444444 35555788888988999998653 45789998754 2 235577788888877322 2445443
Q ss_pred ----EEEeCCEEEEEEeccCCCCHHH-----------HHHc------C--CC------CCHHHH--H--------HHHHH
Q 008116 79 ----SYLHQTKLWIIMEYMAGGSVAD-----------LIQS------G--PP------LDEMSI--A--------CILRD 119 (577)
Q Consensus 79 ----~~~~~~~~~LV~Ey~~gGsL~~-----------~l~~------~--~~------l~e~~i--~--------~il~Q 119 (577)
+...++..++|++|++|..+.. .+.+ . .. ..+... . .....
T Consensus 78 ~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 157 (296)
T cd05153 78 DGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRAL 157 (296)
T ss_pred CCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHH
Confidence 2233556789999999876421 1100 0 00 000000 0 01111
Q ss_pred HHHHHHHHHH-------cCCcccccccceEEEccCCCeeeccccccc
Q 008116 120 LLHAIEYLHN-------EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 120 Ll~aL~yLHs-------~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
+..++.++.. .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 158 ~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 158 LADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2334444443 369999999999999987777899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00019 Score=74.89 Aligned_cols=82 Identities=20% Similarity=0.244 Sum_probs=59.4
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC---CceeEeEEEEEeC---CE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS---PYITEYYGSYLHQ---TK 85 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~H---pnIV~l~~~~~~~---~~ 85 (577)
+..-.-++.||.|..+.||...... ..+++|..+... ....+..|+..|+.|.- -.|+++++++..+ +.
T Consensus 13 ~~~~~~~~~i~~G~~~~vy~~~~~~--~~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 13 GEKLSRVECISEQPYAALWALYDSQ--GNPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred chhhheeeecCCccceeEEEEEcCC--CCEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 3355667889999999999986442 357778754311 12568899999998842 4678888877543 66
Q ss_pred EEEEEeccCCCCH
Q 008116 86 LWIIMEYMAGGSV 98 (577)
Q Consensus 86 ~~LV~Ey~~gGsL 98 (577)
.+||||+++|+++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 8999999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00013 Score=72.45 Aligned_cols=75 Identities=17% Similarity=0.294 Sum_probs=49.5
Q ss_pred EeEEeecCceEEEEEEEcC-CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC-CceeEeEEEEEeCCEEEEEEeccCC
Q 008116 18 LELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~-tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~H-pnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
++.|..|-...+|++.... .+..|++|+...... ..-...+|+.+++.+.. .-+++++..+. + .+||||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence 5678888899999996543 356889997653221 11234578999998843 33455554432 2 489999998
Q ss_pred CCH
Q 008116 96 GSV 98 (577)
Q Consensus 96 GsL 98 (577)
.+|
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00024 Score=74.16 Aligned_cols=137 Identities=17% Similarity=0.210 Sum_probs=76.1
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-----CCCceeEeE---EEEEeCCEEEE
Q 008116 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-----RSPYITEYY---GSYLHQTKLWI 88 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-----~HpnIV~l~---~~~~~~~~~~L 88 (577)
.++.|+.|....+|+.... +..+++|++. .... ..+..|+.++..| ..|.+++-. .+....+..++
T Consensus 26 ~~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~ 99 (319)
T PRK05231 26 SLKGIAEGIENSNFFLTTT--QGEYVLTLFE-RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA 99 (319)
T ss_pred ccchhccccccceEEEEeC--CCcEEEEEec-cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence 3566778888899998654 3368999875 2222 3344455555554 233333211 01233567899
Q ss_pred EEeccCCCCHH-----------HHHHc----CCCC--------C---HHHHHH------------HHHH-HHHHHHHHH-
Q 008116 89 IMEYMAGGSVA-----------DLIQS----GPPL--------D---EMSIAC------------ILRD-LLHAIEYLH- 128 (577)
Q Consensus 89 V~Ey~~gGsL~-----------~~l~~----~~~l--------~---e~~i~~------------il~Q-Ll~aL~yLH- 128 (577)
++||++|..+. ..+.+ ...+ . +..... .+.+ +...++.+.
T Consensus 100 l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (319)
T PRK05231 100 IVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLAS 179 (319)
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhc
Confidence 99999887431 11110 0000 0 111110 1111 111222332
Q ss_pred ------HcCCcccccccceEEEccCCCeeeccccccc
Q 008116 129 ------NEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 129 ------s~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
..++||+|+.|.|||++.+...-|+||+.+.
T Consensus 180 ~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 180 AAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2379999999999999866556899999764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.71 E-value=8.2e-05 Score=72.54 Aligned_cols=99 Identities=19% Similarity=0.181 Sum_probs=79.9
Q ss_pred HHHHHHHHhCCC-CceeEeEEEEEeCCEEEEEEeccCCCCHHHH---HHcCCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 008116 59 QKEISVLSQCRS-PYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAIEYLHN---EG 131 (577)
Q Consensus 59 ~~Ev~iL~~L~H-pnIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~---l~~~~~l~e~~i~~il~QLl~aL~yLHs---~g 131 (577)
..|.-+|+.+.+ +++++++|+|-. ++|+||...+++... +......++.....|+.+++..+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888999965 799999999832 678999987766421 1122346899999999999999999997 45
Q ss_pred CcccccccceEEEccCCCeeeccccccccc
Q 008116 132 KIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 132 IiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
+.-.|++|+|+-|+.+|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00064 Score=73.79 Aligned_cols=79 Identities=19% Similarity=0.188 Sum_probs=56.8
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeccC-----C-ChHHHHHHHHHHHHHHhCC---CCceeEeEEEEEeCCEEE
Q 008116 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-----E-SEDEIEDIQKEISVLSQCR---SPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~-----~-~~~~~~~i~~Ev~iL~~L~---HpnIV~l~~~~~~~~~~~ 87 (577)
..+.||.|.+..||++.+...++.|+||.-... . -.-..++...|...|+.+. ..++++++.+ +.+..+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 357899999999999998754468999985311 1 0224567788888888862 2457777776 456678
Q ss_pred EEEeccCCCC
Q 008116 88 IIMEYMAGGS 97 (577)
Q Consensus 88 LV~Ey~~gGs 97 (577)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00036 Score=72.74 Aligned_cols=140 Identities=18% Similarity=0.217 Sum_probs=83.0
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC--CceeEeEEE------EEeCCEE
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PYITEYYGS------YLHQTKL 86 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~H--pnIV~l~~~------~~~~~~~ 86 (577)
...++.|+.|....+|++... +..+++|+....... ..+..|+.++..|.. -.|++++.. ....+..
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred ceeccccCCccccceEEEEeC--CCcEEEEEecCCCCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 445777888888899998643 336788987543322 345566777776632 123444431 1234677
Q ss_pred EEEEeccCCCCHH-----------HHHH---c-CCCC--------CHHHHH---------------HHHHHHHHHHHHHH
Q 008116 87 WIIMEYMAGGSVA-----------DLIQ---S-GPPL--------DEMSIA---------------CILRDLLHAIEYLH 128 (577)
Q Consensus 87 ~LV~Ey~~gGsL~-----------~~l~---~-~~~l--------~e~~i~---------------~il~QLl~aL~yLH 128 (577)
++++||++|..+. ..+. . ...+ ...... .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 9999999885431 1111 0 0000 001000 00112334555554
Q ss_pred H-------cCCcccccccceEEEccCCCeeeccccccc
Q 008116 129 N-------EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 129 s-------~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
. .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 579999999999999988777899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00012 Score=74.18 Aligned_cols=133 Identities=17% Similarity=0.272 Sum_probs=77.8
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCce-eEeEEEEEeCCEEEEEEeccCCCCH
Q 008116 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIMEYMAGGSV 98 (577)
Q Consensus 20 ~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnI-V~l~~~~~~~~~~~LV~Ey~~gGsL 98 (577)
.+..|-...+|+.. .++..+++|........-. -...+|..+++.+..-.+ ++++... . -++||||++|..+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~ 75 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVI 75 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccc
Confidence 35667788999886 3467888997543221110 135789999998853323 3444433 2 2789999998765
Q ss_pred HH--------------HHHc-------CCCCCH-HHHHHHHHHH---------HHHHHHHHHc--------CCccccccc
Q 008116 99 AD--------------LIQS-------GPPLDE-MSIACILRDL---------LHAIEYLHNE--------GKIHRDIKA 139 (577)
Q Consensus 99 ~~--------------~l~~-------~~~l~e-~~i~~il~QL---------l~aL~yLHs~--------gIiHrDIKP 139 (577)
.. .+.+ ..+++. ..+..+..++ ...+..+-.. .++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 32 1111 111221 1222322222 1112222221 489999999
Q ss_pred ceEEEccCCCeeecccccccc
Q 008116 140 ANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 140 eNILld~~g~vKL~DFGls~~ 160 (577)
.||+++.++ +.|+||..+..
T Consensus 156 ~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 156 YNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcEEEeCCC-CEEEeccccCc
Confidence 999999877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00071 Score=70.08 Aligned_cols=76 Identities=18% Similarity=0.273 Sum_probs=50.3
Q ss_pred EeEEeecCceEEEEEEEcC------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCc-eeEeEEEEEeCCEEEEEE
Q 008116 18 LELIGRGSFGDVYKAFDKE------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~------tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~Hpn-IV~l~~~~~~~~~~~LV~ 90 (577)
++.|..|-...||++.... .++.|++|+..... .......+|+.+++.+.... .+++++++. + .+|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchh
Confidence 4567777778999987543 25789999965432 12345678888888884322 345555553 2 3689
Q ss_pred eccCCCCHH
Q 008116 91 EYMAGGSVA 99 (577)
Q Consensus 91 Ey~~gGsL~ 99 (577)
||++|..|.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.38 E-value=9.9e-05 Score=76.99 Aligned_cols=134 Identities=22% Similarity=0.307 Sum_probs=96.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-------------------HH--HHHHHHHHHHHhCC-CC
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-------------------EI--EDIQKEISVLSQCR-SP 71 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~-------------------~~--~~i~~Ev~iL~~L~-Hp 71 (577)
-+.+...||-|.-+.||.+-+.. |.+.++|.-++..... .+ -...+|+..|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 45667899999999999998764 8889999643322100 01 12357899999884 33
Q ss_pred c-eeEeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCe
Q 008116 72 Y-ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDV 150 (577)
Q Consensus 72 n-IV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~v 150 (577)
. |++.++ ....++|||++.|-+|...-+- ..+..+...|..-+.-|-.+|+||+|..--||+|++++.+
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 2 344444 3567899999999888766422 2233455556666677889999999999999999999999
Q ss_pred eecccccc
Q 008116 151 KVADFGVS 158 (577)
Q Consensus 151 KL~DFGls 158 (577)
+++||--.
T Consensus 242 ~vIDFPQm 249 (465)
T KOG2268|consen 242 VVIDFPQM 249 (465)
T ss_pred EEeechHh
Confidence 99999643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.002 Score=67.91 Aligned_cols=145 Identities=16% Similarity=0.245 Sum_probs=87.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEec-cCCChHHHHHHHHHHHHHHhCCC--CceeEeEEEEEeCC--EEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID-LEESEDEIEDIQKEISVLSQCRS--PYITEYYGSYLHQT--KLW 87 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~-~~~~~~~~~~i~~Ev~iL~~L~H--pnIV~l~~~~~~~~--~~~ 87 (577)
....+++.+-.|.--.+|..... ++.++++ .+ ............+|..+|+.+.- .-+...+++|.++. ..|
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 34556666655555556666554 7888998 43 23334456778889999998843 23445566666555 679
Q ss_pred EEEeccCCCCHH------------------HHHHc-------C----C---CCCHHHHHHHHHH--------------HH
Q 008116 88 IIMEYMAGGSVA------------------DLIQS-------G----P---PLDEMSIACILRD--------------LL 121 (577)
Q Consensus 88 LV~Ey~~gGsL~------------------~~l~~-------~----~---~l~e~~i~~il~Q--------------Ll 121 (577)
.||+|++|..+. ++|.. + + .....++..+..+ +.
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 999999884222 22210 0 0 0011111111111 22
Q ss_pred HHHHHHHHc--------CCcccccccceEEEccCCCeeecccccccc
Q 008116 122 HAIEYLHNE--------GKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 122 ~aL~yLHs~--------gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
.-..||+.+ .++|+|+.+.||+|+..+-+-+.||+++..
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 234455543 379999999999999888899999998754
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.00094 Score=73.40 Aligned_cols=168 Identities=22% Similarity=0.319 Sum_probs=108.3
Q ss_pred HHHHHHHHHHHhCCCCceeEeEEEEEe-CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcc
Q 008116 56 EDIQKEISVLSQCRSPYITEYYGSYLH-QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134 (577)
Q Consensus 56 ~~i~~Ev~iL~~L~HpnIV~l~~~~~~-~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiH 134 (577)
.++.--..+++.+.|+|...++++-.. .....+|||++ +.+|.+++..+. +-..... .+++.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccccce
Confidence 345556788999999999999987654 34688999999 679999987643 2211111 223322
Q ss_pred cccccceEEEccCCCeeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCC
Q 008116 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD 214 (577)
Q Consensus 135 rDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~ 214 (577)
-|| ++.+| -++ ... .+.+| +++||||+|.++.++.-|..-+..
T Consensus 91 -----~~~-------~~~td-~~~---t~~----~~~~~-----------------pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 91 -----LNI-------IYITD-HFL---TKY----PSPIG-----------------PKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred -----ehh-------hhccc-ccc---ccC----CCCCC-----------------cchhhhhHHHHHHHHHHhhHHHHH
Confidence 122 22333 110 000 11111 389999999999999999887766
Q ss_pred CCccceeeccCCCCCCCc-----------hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCChhH
Q 008116 215 LHPMRVLFIIPRENPPQL-----------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRL 276 (577)
Q Consensus 215 ~~~~~~~~~i~~~~~~~l-----------~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~ 276 (577)
....+.+..+.+-..... ...++..+..+..+|+...|..||...++++++-|..+-.....
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~~~t~ 206 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYKDLTV 206 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHhhhhH
Confidence 655554444433222111 12345567788889999999999999999999999877444333
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0051 Score=63.54 Aligned_cols=30 Identities=20% Similarity=0.379 Sum_probs=24.8
Q ss_pred CCcccccccceEEEccCCC-eeecccccccc
Q 008116 131 GKIHRDIKAANILLTENGD-VKVADFGVSAQ 160 (577)
Q Consensus 131 gIiHrDIKPeNILld~~g~-vKL~DFGls~~ 160 (577)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3799999999999987555 56999998654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0059 Score=65.03 Aligned_cols=143 Identities=17% Similarity=0.211 Sum_probs=94.8
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-----------------------ChHHHHH--HHHHHHHHHhCCC
Q 008116 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-----------------------SEDEIED--IQKEISVLSQCRS 70 (577)
Q Consensus 16 ~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-----------------------~~~~~~~--i~~Ev~iL~~L~H 70 (577)
.+-..|..|.-+.||.|... +|..+|||+.+..- .+...-. ..+|+.-|++|+.
T Consensus 147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 34457888999999999765 47889999864210 1111111 2467888888865
Q ss_pred CceeEeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCcccccccceEEEccCCC
Q 008116 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH-NEGKIHRDIKAANILLTENGD 149 (577)
Q Consensus 71 pnIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLH-s~gIiHrDIKPeNILld~~g~ 149 (577)
-.|...--... ....|||+|+.......-.-+...++...+..+-.|++.-+.-|- ..++||.||.--|+|+. +|.
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~ 302 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK 302 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE
Confidence 55433222222 223799999953222211122356788888888888888777665 66999999999999994 678
Q ss_pred eeecccccccccc
Q 008116 150 VKVADFGVSAQLT 162 (577)
Q Consensus 150 vKL~DFGls~~~~ 162 (577)
+.|+|.+-+....
T Consensus 303 lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 303 LYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEccccccCC
Confidence 9999988765443
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0074 Score=64.60 Aligned_cols=81 Identities=16% Similarity=0.219 Sum_probs=53.8
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEec----c--CCChHHHHHHHHHHHHHHhCC--CC-ceeEeEEEEEeCCEEEEEE
Q 008116 20 LIGRGSFGDVYKAFDKELNKDVAIKVID----L--EESEDEIEDIQKEISVLSQCR--SP-YITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 20 ~IG~GsfG~Vy~a~~~~tg~~VAIK~i~----~--~~~~~~~~~i~~Ev~iL~~L~--Hp-nIV~l~~~~~~~~~~~LV~ 90 (577)
.||.|....||++.+...++.|+||.-. . ..-+-.+.+..-|...|+... .| .++++|.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 5799999999999986444689999742 1 111334566778888887763 34 45555543 566677999
Q ss_pred eccCCC-CHHHHH
Q 008116 91 EYMAGG-SVADLI 102 (577)
Q Consensus 91 Ey~~gG-sL~~~l 102 (577)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999543 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0058 Score=65.09 Aligned_cols=137 Identities=16% Similarity=0.222 Sum_probs=81.2
Q ss_pred EEeEEeecCceEEEEEEEcC----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCce-eEeEEEEEeCCEEEEEEe
Q 008116 17 SLELIGRGSFGDVYKAFDKE----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~----tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnI-V~l~~~~~~~~~~~LV~E 91 (577)
-+..|-.|-...+|++.... .++.|++|+..... ... -...+|+.+++.+..-++ +++++.+.. + .|+|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~e 113 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEE 113 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Cee-echHHHHHHHHHHHHcCCCCceEEEECC-c---eEEE
Confidence 34556668888999986532 24689999875432 222 223778999988853333 455665532 2 5799
Q ss_pred ccCCCCHHHH--------------HH---c-C---C--CCCHHHHHHHHHHHH-----------------HHHHHH----
Q 008116 92 YMAGGSVADL--------------IQ---S-G---P--PLDEMSIACILRDLL-----------------HAIEYL---- 127 (577)
Q Consensus 92 y~~gGsL~~~--------------l~---~-~---~--~l~e~~i~~il~QLl-----------------~aL~yL---- 127 (577)
|+++.+|... ++ . . . ......+..++.++. ..+..|
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9987766421 11 1 0 0 111333444432221 112222
Q ss_pred H----HcCCcccccccceEEEcc-CCCeeeccccccc
Q 008116 128 H----NEGKIHRDIKAANILLTE-NGDVKVADFGVSA 159 (577)
Q Consensus 128 H----s~gIiHrDIKPeNILld~-~g~vKL~DFGls~ 159 (577)
. ...++|+|+++.|||++. ++.+.|+||.++.
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 125799999999999986 4789999998763
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.016 Score=59.86 Aligned_cols=29 Identities=38% Similarity=0.549 Sum_probs=25.2
Q ss_pred cCCcccccccceEEEccCCCeeeccccccc
Q 008116 130 EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 130 ~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.011 Score=61.48 Aligned_cols=84 Identities=15% Similarity=0.225 Sum_probs=52.4
Q ss_pred hhhhcCCCe--eEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCceeEeEEEEE
Q 008116 7 LQEAAGSRF--SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGSYL 81 (577)
Q Consensus 7 l~~~~~~~f--~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~---HpnIV~l~~~~~ 81 (577)
+.+..+..+ +-.+.|+.|....+|+.. .+++.+.||+-... ....+..|+.-|+.|. --.+++.+++..
T Consensus 9 ~~~~~~~~~~i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~ 82 (288)
T PF03881_consen 9 ISEQLGADFKITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGE 82 (288)
T ss_dssp HHHHHTS-----EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE
T ss_pred HHHHhCCCCceeeeEecCCCChhheEEEE--CCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 455556664 446679999999999986 56889999987622 2355778888888873 345778888887
Q ss_pred eCCEEEEEEeccCCC
Q 008116 82 HQTKLWIIMEYMAGG 96 (577)
Q Consensus 82 ~~~~~~LV~Ey~~gG 96 (577)
..+.-||||||++.+
T Consensus 83 ~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 83 YDDDAFLLLEFLEMG 97 (288)
T ss_dssp -SSCCEEEEE-----
T ss_pred ecCCceEEEEeecCC
Confidence 777779999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.027 Score=61.36 Aligned_cols=82 Identities=18% Similarity=0.114 Sum_probs=56.1
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC---C---hHHHHHHHHHHHHHHhCC---CCceeEeEEEEEeCCEEE
Q 008116 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE---S---EDEIEDIQKEISVLSQCR---SPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~---~---~~~~~~i~~Ev~iL~~L~---HpnIV~l~~~~~~~~~~~ 87 (577)
..+.||.|....||+..+. +..|+||.-.... . +....+...|+..|+.+. ...+++++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4778899999999998874 4579999864111 0 123456666778777663 247888888775 4568
Q ss_pred EEEeccCC--CCHHHHH
Q 008116 88 IIMEYMAG--GSVADLI 102 (577)
Q Consensus 88 LV~Ey~~g--GsL~~~l 102 (577)
++|||+++ ..|.+-+
T Consensus 112 lvME~L~~~~~ilr~~L 128 (418)
T PLN02756 112 IGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEeecCCcceehhhhh
Confidence 88999977 3454444
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.013 Score=62.12 Aligned_cols=140 Identities=17% Similarity=0.215 Sum_probs=80.9
Q ss_pred CeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCce-eEeEEEEEeCCEEEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWII 89 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnI-V~l~~~~~~~~~~~LV 89 (577)
..+ ++.|..|-...+|++..... +..|++|+..... . ..-.-.+|+.+++.+..-++ +++++++. ++ +|
T Consensus 16 ~i~-i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i 88 (330)
T PLN02421 16 DFS-VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-D-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MI 88 (330)
T ss_pred ceE-EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-C-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Ee
Confidence 344 44555588888999865432 3479999874332 1 22234678889888854444 45565552 22 58
Q ss_pred EeccCCCCHHH--------------HHHc--CCC------C-CHHHHHHHHHHHH----------------------HHH
Q 008116 90 MEYMAGGSVAD--------------LIQS--GPP------L-DEMSIACILRDLL----------------------HAI 124 (577)
Q Consensus 90 ~Ey~~gGsL~~--------------~l~~--~~~------l-~e~~i~~il~QLl----------------------~aL 124 (577)
.+|++|.+|.. .+++ ..+ + ....+..++.++. .-+
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 99998776521 1111 111 1 1233333333321 112
Q ss_pred HHHH----Hc----CCcccccccceEEEcc-CCCeeecccccccc
Q 008116 125 EYLH----NE----GKIHRDIKAANILLTE-NGDVKVADFGVSAQ 160 (577)
Q Consensus 125 ~yLH----s~----gIiHrDIKPeNILld~-~g~vKL~DFGls~~ 160 (577)
..+. .. -++|.||.|.|||++. ++.++|+||..|..
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 2221 11 2699999999999975 47899999998643
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.1 Score=54.44 Aligned_cols=30 Identities=13% Similarity=0.175 Sum_probs=27.1
Q ss_pred CCcccccccceEEEccCCCeeecccccccc
Q 008116 131 GKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 131 gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
+++|+|+.+.|||++.++.+.|+||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999987643
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.023 Score=61.69 Aligned_cols=83 Identities=20% Similarity=0.292 Sum_probs=56.7
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEec----cC-CChHHHHHHHHHHHHHHhCC--CC-ceeEeEEEEEeCCEEEEE
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVID----LE-ESEDEIEDIQKEISVLSQCR--SP-YITEYYGSYLHQTKLWII 89 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~----~~-~~~~~~~~i~~Ev~iL~~L~--Hp-nIV~l~~~~~~~~~~~LV 89 (577)
++.||-|.-.-||++.+...++.|+||.-. .. .-+-...+..-|..+|+.+. .| .++++|.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678999999999999985445689999742 11 11334677788888888773 34 45556653 56677899
Q ss_pred EeccCCC-CHHHHH
Q 008116 90 MEYMAGG-SVADLI 102 (577)
Q Consensus 90 ~Ey~~gG-sL~~~l 102 (577)
||+++.. .|.+.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 9998543 344444
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.02 Score=57.35 Aligned_cols=101 Identities=15% Similarity=0.108 Sum_probs=66.8
Q ss_pred EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHH
Q 008116 40 DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRD 119 (577)
Q Consensus 40 ~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~Q 119 (577)
+..+|++......-....++.+..++.+++ .|+++..- .+-.+.+++|+|... ... ...++.-
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~----------~i~---~~N~i~a 149 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI----------KIN---FSNFITA 149 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc----------ccc---hhHHHHH
Confidence 344555543332212355678899999875 48888732 344678999999431 111 1112222
Q ss_pred HHHHHHHHHH--cCCcccccccceEEEccCCCeeeccccc
Q 008116 120 LLHAIEYLHN--EGKIHRDIKAANILLTENGDVKVADFGV 157 (577)
Q Consensus 120 Ll~aL~yLHs--~gIiHrDIKPeNILld~~g~vKL~DFGl 157 (577)
=+++|.-.|+ .+.+|+|..|+||+-|+.|.+||.|=+.
T Consensus 150 gi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 150 GIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred hHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 2467888894 3699999999999999999999999663
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.074 Score=64.58 Aligned_cols=138 Identities=18% Similarity=0.267 Sum_probs=76.7
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-------CCCceeEeEE-----EEEe-CC
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-------RSPYITEYYG-----SYLH-QT 84 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-------~HpnIV~l~~-----~~~~-~~ 84 (577)
++.|+ |..-.+|+.... +|..|++|+.+..... ..+..|..+|..| .-|.+++-.+ .... ++
T Consensus 30 ~~~L~-s~~d~nf~v~~~-~g~~yVLKi~~~~~~~---~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G 104 (1013)
T PRK06148 30 ATPLD-GERDLNFRLTTD-DGADYILKIVNPSEPR---VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDG 104 (1013)
T ss_pred EeecC-CcCCceEEEEeC-CCCeEEEEEcCCccch---hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCC
Confidence 35564 445778888643 4778999998754322 2334444555433 3345444321 1111 22
Q ss_pred --EEEEEEeccCCCCHHHH-------H--------------HcC------CCCCHH-----------------HHHHHHH
Q 008116 85 --KLWIIMEYMAGGSVADL-------I--------------QSG------PPLDEM-----------------SIACILR 118 (577)
Q Consensus 85 --~~~LV~Ey~~gGsL~~~-------l--------------~~~------~~l~e~-----------------~i~~il~ 118 (577)
.++.+++|++|..|.+. + +.. ..+.|. ..+.++.
T Consensus 105 ~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~ 184 (1013)
T PRK06148 105 EPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVE 184 (1013)
T ss_pred ceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHH
Confidence 56788999999877651 1 000 001111 1112222
Q ss_pred HHHHHHH-----HHH--HcCCcccccccceEEEccCC--Cee-ecccccccc
Q 008116 119 DLLHAIE-----YLH--NEGKIHRDIKAANILLTENG--DVK-VADFGVSAQ 160 (577)
Q Consensus 119 QLl~aL~-----yLH--s~gIiHrDIKPeNILld~~g--~vK-L~DFGls~~ 160 (577)
+++..+. .|. ..++||.|+.+.|||++.++ .+. |+|||.+..
T Consensus 185 ~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 185 RFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3333222 122 24799999999999999775 555 999998754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.019 Score=61.15 Aligned_cols=71 Identities=18% Similarity=0.304 Sum_probs=56.4
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEccCCCeeecccccccc
Q 008116 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~-gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
...|++|++- |++|.-+ .....+++..|+++.+..++-+..+ ..-|||+...||||+ .|+|.|+||-+++.
T Consensus 299 ~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 3568888886 6666533 2245778888999888877777755 689999999999999 99999999999873
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.015 Score=57.02 Aligned_cols=30 Identities=33% Similarity=0.587 Sum_probs=21.1
Q ss_pred CCcccccccceEEE-ccCCCeeecccccccc
Q 008116 131 GKIHRDIKAANILL-TENGDVKVADFGVSAQ 160 (577)
Q Consensus 131 gIiHrDIKPeNILl-d~~g~vKL~DFGls~~ 160 (577)
-+.|.||.|.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47999999999999 7889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.16 Score=55.10 Aligned_cols=78 Identities=15% Similarity=0.201 Sum_probs=47.6
Q ss_pred eEEeEEeecCceEEEEEEEcCC-CcE-----EEEEEeccCCChHHHHHHHHHHHHHHhCCCCc-eeEeEEEEEeCCEEEE
Q 008116 16 SSLELIGRGSFGDVYKAFDKEL-NKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQTKLWI 88 (577)
Q Consensus 16 ~il~~IG~GsfG~Vy~a~~~~t-g~~-----VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~Hpn-IV~l~~~~~~~~~~~L 88 (577)
..++.|..|-...+|++..... +.. |.++... ......-.-.+|+.+++.|..-+ -.++++.+.. ++
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g--~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS--TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEecc--CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 3455666688899999975432 122 4444321 11111223467899999996544 4566666532 69
Q ss_pred EEeccCCCCHH
Q 008116 89 IMEYMAGGSVA 99 (577)
Q Consensus 89 V~Ey~~gGsL~ 99 (577)
|.||++|-+|.
T Consensus 127 l~efIeGr~l~ 137 (383)
T PTZ00384 127 IQEWVEGNTMG 137 (383)
T ss_pred EEEEeccccCC
Confidence 99999987664
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.35 Score=51.03 Aligned_cols=70 Identities=19% Similarity=0.124 Sum_probs=42.4
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCceeEeE---E--EEEeCCEEEEEEeccCC
Q 008116 24 GSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYY---G--SYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 24 GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~---HpnIV~l~---~--~~~~~~~~~LV~Ey~~g 95 (577)
+.-..||+.... ++..|++|+...... ....+..|+.++..|. -| |+... + ....++..+.|+++++|
T Consensus 36 s~eN~vy~v~~~-~~~~~vlKv~r~~~~--~~~~i~~E~~~l~~L~~~gip-v~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGDE-DGRRVVAKFYRPERW--SDAQILEEHAFALELAEAEIP-VVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEecC-CCCEEEEEEcCcccC--CHHHHHHHHHHHHHHHHCCCC-CCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 344568888653 366799998753321 2356777888877663 22 22211 1 22335678889999987
Q ss_pred CC
Q 008116 96 GS 97 (577)
Q Consensus 96 Gs 97 (577)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 64
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.11 Score=53.39 Aligned_cols=72 Identities=14% Similarity=0.160 Sum_probs=45.3
Q ss_pred eecCceEEEEEEEcC----C----CcEEEEEEeccCCC----hHHHHHHHHHHHHHHhCC-------------CCceeEe
Q 008116 22 GRGSFGDVYKAFDKE----L----NKDVAIKVIDLEES----EDEIEDIQKEISVLSQCR-------------SPYITEY 76 (577)
Q Consensus 22 G~GsfG~Vy~a~~~~----t----g~~VAIK~i~~~~~----~~~~~~i~~Ev~iL~~L~-------------HpnIV~l 76 (577)
|.|-.|.+|++.-.. + ...++||....... ......+.+|+.+.+.+- ...+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 677788888876532 2 23688998762221 112456778888776541 1245677
Q ss_pred EEEEEeCCEEEEEEecc
Q 008116 77 YGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 77 ~~~~~~~~~~~LV~Ey~ 93 (577)
+.........+||||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 77665556788999866
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.096 Score=57.36 Aligned_cols=27 Identities=26% Similarity=0.474 Sum_probs=21.9
Q ss_pred CcccccccceEEEccCCC-----eeecccccc
Q 008116 132 KIHRDIKAANILLTENGD-----VKVADFGVS 158 (577)
Q Consensus 132 IiHrDIKPeNILld~~g~-----vKL~DFGls 158 (577)
++|+||...|||++.++. ..|+||-++
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~v 301 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCV 301 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHh
Confidence 699999999999987543 578888764
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.3 Score=51.93 Aligned_cols=135 Identities=19% Similarity=0.307 Sum_probs=79.4
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCc---eeEeEEEE--EeCC--EEEE
Q 008116 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPY---ITEYYGSY--LHQT--KLWI 88 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~---Hpn---IV~l~~~~--~~~~--~~~L 88 (577)
..|.+ .-..||+..... | .+++|+..... ....+..|...|..|. .|- |..+-|-. .-.. ..+-
T Consensus 32 ~~l~s-~eN~~f~~~~~~-g-~~iLki~~~~~---~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 32 RGLNS-EENSNFRVQTED-G-RYILKIYRPGW---TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred ccccc-ccCceEEEEecC-C-CeEEEEecCCC---CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 33444 456788887653 3 34999987652 2356777788887772 222 22222211 1133 7788
Q ss_pred EEeccCCCCHHH------------HH---H---cCCC---------CCHH----HH---------HHHHHHHHHHHHHHH
Q 008116 89 IMEYMAGGSVAD------------LI---Q---SGPP---------LDEM----SI---------ACILRDLLHAIEYLH 128 (577)
Q Consensus 89 V~Ey~~gGsL~~------------~l---~---~~~~---------l~e~----~i---------~~il~QLl~aL~yLH 128 (577)
|++|++|..+.. .+ . +..+ ..+. .. .....++...++.+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999999887772 11 0 0011 1111 00 012234445555555
Q ss_pred Hc--------C--CcccccccceEEEccCCC-eeeccccccc
Q 008116 129 NE--------G--KIHRDIKAANILLTENGD-VKVADFGVSA 159 (577)
Q Consensus 129 s~--------g--IiHrDIKPeNILld~~g~-vKL~DFGls~ 159 (577)
+. + +||+|+.|.|||++.+.. +.++|||.+.
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 42 3 999999999999998875 8999999763
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 577 | ||||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-91 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-91 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-91 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-91 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-89 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-87 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-69 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-62 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-59 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-58 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-55 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-55 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-54 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-54 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-54 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-54 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-54 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-54 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-53 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-53 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-52 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-49 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-48 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-45 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-43 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-43 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-43 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-43 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-42 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-42 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-42 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-35 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-34 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-34 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-31 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-31 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-31 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-30 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-30 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-30 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-30 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-30 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-30 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-29 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-29 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-29 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-29 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-29 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-29 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-29 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-29 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-29 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-29 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-29 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-29 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-29 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-29 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-29 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-28 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-28 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-28 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-28 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-28 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-28 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-28 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-28 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-28 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-28 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-28 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-28 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-28 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-28 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-28 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-28 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-28 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-28 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-27 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-27 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-26 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-26 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-26 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-26 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-26 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-25 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-25 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-25 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-25 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-25 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-25 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-25 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-25 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-25 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-25 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-25 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-25 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-25 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-25 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-25 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-25 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-25 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-24 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-24 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-24 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-24 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-24 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-24 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-24 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-24 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-24 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-23 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-23 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-23 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-23 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-23 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-23 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-23 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-23 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-23 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-23 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-23 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-23 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-23 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-23 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-23 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-23 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-23 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-23 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-23 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-23 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-23 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-23 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-23 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-23 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-22 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-22 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-22 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-22 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-22 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-22 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-22 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-22 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-22 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-22 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-22 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-22 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-22 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-22 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-22 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-22 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-22 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-22 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-22 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-22 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-22 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-22 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-22 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-22 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-22 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-22 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-22 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-22 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-22 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-22 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-22 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-22 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-22 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-22 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-22 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-22 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-22 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-22 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-22 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-22 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-22 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-22 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-22 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-22 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-22 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-22 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-22 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-22 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-22 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-21 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-21 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-21 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-21 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-21 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-21 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-21 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-21 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-21 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-21 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-21 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-21 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-21 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-21 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-21 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-21 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-21 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-21 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-20 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-20 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-20 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-20 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-20 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-20 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-20 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-20 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-20 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-20 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-20 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-20 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-20 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-20 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-20 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-19 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-19 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-19 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-19 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-19 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-19 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-19 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-19 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-19 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-19 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-19 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-19 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-19 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-19 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-19 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-19 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-19 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-19 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-19 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-18 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-18 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-18 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-18 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-18 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-18 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-18 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-18 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-18 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-18 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-18 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-18 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-18 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-18 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-18 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-18 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-18 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-18 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-18 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-18 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-18 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-18 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-18 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-18 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-18 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-18 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-18 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-17 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-17 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-17 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-17 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-17 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-17 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-17 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-17 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-17 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-17 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-17 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-17 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-17 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-17 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-17 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-17 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-17 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-16 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-16 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-16 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-16 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-16 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-16 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-16 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-16 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-16 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-16 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-16 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-16 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-15 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-15 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-15 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-15 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-14 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-14 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-14 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-14 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-14 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-14 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-14 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-13 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-13 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-13 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-11 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-11 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-10 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 |
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 493 bits (1271), Expect = e-174
Identities = 175/282 (62%), Positives = 224/282 (79%), Gaps = 3/282 (1%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
F+ LE IG+GSFG+V+K D K VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPY
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+T+YYGSYL TKLWIIMEY+ GGS DL++ G PLDE IA ILR++L ++YLH+E K
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKK 140
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ K
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSK 199
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252
ADIWSLGIT IE+A+GEPP ++LHPM+VLF+IP+ NPP L+ ++S+ +KEFV CL K P
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 259
Query: 253 AERPSAKELLRHRFI-RNARKSPRLLERIRERPKYPIQEEPD 293
+ RP+AKELL+H+FI RNA+K+ L E I ++ ++ D
Sbjct: 260 SFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHD 301
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 479 bits (1235), Expect = e-168
Identities = 123/289 (42%), Positives = 177/289 (61%), Gaps = 22/289 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ E+IG G+ V A+ + VAIK I+LE+ + ++++ KEI +SQC P
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP--------LDEMSIACILRDLLHAI 124
I YY S++ + +LW++M+ ++GGSV D+I+ LDE +IA ILR++L +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-----SRRKTFVGTPFWMA 179
EYLH G+IHRD+KA NILL E+G V++ADFGVSA L RKTFVGTP WMA
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----- 234
PEV++ GY+ KADIWS GIT IE+A G P PM+VL + + +PP L+
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDK 254
Query: 235 ----HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLER 279
+ + ++ +SLCL+K P +RP+A ELLRH+F + A+ L E+
Sbjct: 255 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK 303
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 477 bits (1231), Expect = e-168
Identities = 121/285 (42%), Positives = 178/285 (62%), Gaps = 9/285 (3%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ + +G G+FG VYKA +KE A KVI+ + SE+E+ED EI +L+ C PYI
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYI 78
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGK 132
+ G+Y H KLWI++E+ GG+V ++ L E I + R +L A+ +LH++
Sbjct: 79 VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 138
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI----QNSEG 188
IHRD+KA N+L+T GD+++ADFGVSA+ +T+ +R +F+GTP+WMAPEV+
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSL 246
Y+ KADIWSLGIT+IEMA+ EPP +L+PMRVL I + +PP L +S ++F+ +
Sbjct: 199 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKI 258
Query: 247 CLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEE 291
L K P RPSA +LL H F+ + + L E + K + EE
Sbjct: 259 ALDKNPETRPSAAQLLEHPFVSSITSNKALRELV-AEAKAEVMEE 302
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 466 bits (1201), Expect = e-163
Identities = 141/283 (49%), Positives = 185/283 (65%), Gaps = 7/283 (2%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
F LE +G GS+G VYKA KE + VAIK + +E ++++I KEIS++ QC SP++
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHV 86
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGK 132
+YYGSY T LWI+MEY GSV+D+I+ L E IA IL+ L +EYLH K
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRDIKA NILL G K+ADFGV+ QLT T+++R T +GTPFWMAPEVIQ GYN
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNCV 205
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKK 250
ADIWSLGIT IEMA+G+PP AD+HPMR +F+IP PP E +S +FV CL K
Sbjct: 206 ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVK 265
Query: 251 VPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPD 293
P +R +A +LL+H F+R+A+ L + I E ++ +
Sbjct: 266 SPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQES 308
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 466 bits (1201), Expect = e-163
Identities = 133/315 (42%), Positives = 201/315 (63%), Gaps = 22/315 (6%)
Query: 3 DLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEI 62
DL+ L++ AG F +EL+G G++G VYK + + AIKV+D+ DE E+I++EI
Sbjct: 15 DLSALRDPAG-IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEI 71
Query: 63 SVLSQ-CRSPYITEYYGSYLHQ------TKLWIIMEYMAGGSVADLIQS--GPPLDEMSI 113
++L + I YYG+++ + +LW++ME+ GSV DLI++ G L E I
Sbjct: 72 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI 131
Query: 114 ACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
A I R++L + +LH IHRDIK N+LLTEN +VK+ DFGVSAQL RT+ RR TF+G
Sbjct: 132 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG 191
Query: 174 TPFWMAPEVIQNSE----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP 229
TP+WMAPEVI E Y+ K+D+WSLGIT IEMA+G PPL D+HPMR LF+IPR
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251
Query: 230 PQL-DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRE-----R 283
P+L + +S+ + F+ CL K ++RP+ ++L++H FIR+ ++ ++++ +
Sbjct: 252 PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTK 311
Query: 284 PKYPIQEEPDTPING 298
K ++E + +G
Sbjct: 312 KKRGEKDETEYEYSG 326
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 461 bits (1189), Expect = e-161
Identities = 115/288 (39%), Positives = 172/288 (59%), Gaps = 12/288 (4%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL--EESEDEIEDIQKEISVLSQCRS 70
FS L IG GSFG VY A D ++ VAIK + ++S ++ +DI KE+ L + R
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHN 129
P +Y G YL + W++MEY GS +DL++ PL E+ IA + L + YLH+
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSE-- 187
IHRD+KA NILL+E G VK+ DFG ++ + +FVGTP+WMAPEVI +
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANSFVGTPYWMAPEVILAMDEG 228
Query: 188 GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-DEHFSRLMKEFVSL 246
Y+ K D+WSLGIT IE+A+ +PPL +++ M L+ I + P L H+S + FV
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 288
Query: 247 CLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDT 294
CL+K+P +RP+++ LL+HRF+ R +++ I +R K ++E +
Sbjct: 289 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI-QRTKDAVRELDNL 335
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 457 bits (1178), Expect = e-160
Identities = 115/272 (42%), Positives = 171/272 (62%), Gaps = 5/272 (1%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+++ E IG+G+ G VY A D ++VAI+ ++L++ + E I EI V+ + ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-ELIINEILVMRENKNPN 78
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I Y SYL +LW++MEY+AGGS+ D++ +DE IA + R+ L A+E+LH+
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQV 137
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRDIK+ NILL +G VK+ DFG AQ+T S+R T VGTP+WMAPEV+ Y K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPK 196
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKK 250
DIWSLGI IEM +GEPP + +P+R L++I P+L E S + ++F++ CL+
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 256
Query: 251 VPAERPSAKELLRHRFIRNARKSPRLLERIRE 282
+R SAKELL+H+F++ A+ L I
Sbjct: 257 DVEKRGSAKELLQHQFLKIAKPLSSLTPLIAA 288
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 454 bits (1170), Expect = e-158
Identities = 105/276 (38%), Positives = 161/276 (58%), Gaps = 5/276 (1%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
S IG GS G V A +K + VA+K++DL + + E + E+ ++ +
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR-ELLFNEVVIMRDYQHFN 103
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ E Y SYL +LW++ME++ GG++ D++ L+E IA + +L A+ YLH +G
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQGV 162
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRDIK+ +ILLT +G VK++DFG AQ+++ + +RK+ VGTP+WMAPEVI S Y +
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRS-LYATE 221
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKK 250
DIWSLGI VIEM GEPP P++ + + PP+L S ++++F+ L +
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR 281
Query: 251 VPAERPSAKELLRHRFIRNARKSPRLLERIRERPKY 286
P ER +A+ELL H F+ L+ I+ K
Sbjct: 282 DPQERATAQELLDHPFLLQTGLPECLVPLIQLYRKQ 317
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 438 bits (1127), Expect = e-151
Identities = 88/346 (25%), Positives = 150/346 (43%), Gaps = 63/346 (18%)
Query: 13 SRFSSLELIGRG--SFGDVYKAFDKELNKDVAIKVIDLEESEDE-IEDIQKEISVLSQCR 69
+ L +IG+G V A K + V ++ I+LE +E + +Q E+ V
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYL 127
P I Y +++ +LW++ +MA GS DLI + ++E++IA IL+ +L A++Y+
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-------FVGTPFWMAP 180
H+ G +HR +KA++IL++ +G V ++ + + R++ V W++P
Sbjct: 145 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 181 EVI-QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD------ 233
EV+ QN +GY+ K+DI+S+GIT E+A G P D+ ++L P L
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 234 ---------------------------------------EHFSRLMKEFVSLCLKKVPAE 254
FS FV CL++ P
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324
Query: 255 RPSAKELLRHRFIRNARKSPR-----LLERIRERPKYPIQEEPDTP 295
RPSA LL H F + ++ LL + + + D
Sbjct: 325 RPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHS 370
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 399 bits (1028), Expect = e-137
Identities = 94/302 (31%), Positives = 149/302 (49%), Gaps = 23/302 (7%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISV-LSQCRSPYI 73
L IGRG++G V K K + +A+K I E E + + ++ V + PYI
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHN 129
++YG+ + WI ME M+ + E + I + A+ +L
Sbjct: 84 VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 130 EGKI-HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS-- 186
KI HRDIK +NILL +G++K+ DFG+S QL +I++ G +MAPE I S
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT-RDAGCRPYMAPERIDPSAS 202
Query: 187 -EGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFIIPRENPPQL----DEHFSRLM 240
+GY+ ++D+WSLGIT+ E+A G P + + L + + +PPQL + FS
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSF 262
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP--------RLLERIRERPKYPIQEEP 292
FV+LCL K ++RP KELL+H FI + ++L+++ P P+ +
Sbjct: 263 INFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMYVDH 322
Query: 293 DT 294
Sbjct: 323 HH 324
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 390 bits (1003), Expect = e-133
Identities = 85/310 (27%), Positives = 146/310 (47%), Gaps = 25/310 (8%)
Query: 2 ADLAGLQEAAGSRFSS-------LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE 54
G G R+ + L +G G+ G V+K ++ +A+K + +++E
Sbjct: 7 GKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE 66
Query: 55 IEDIQKEISVL-SQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSI 113
+ I ++ V+ PYI + +G+++ T ++I ME M + + P+ E +
Sbjct: 67 NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL 126
Query: 114 ACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172
+ ++ A+ YL + G IHRD+K +NILL E G +K+ DFG+S +L ++
Sbjct: 127 GKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD-RSA 185
Query: 173 GTPFWMAPEVIQNSE----GYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRE 227
G +MAPE I + Y+ +AD+WSLGI+++E+A G+ P + VL + +E
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245
Query: 228 NPPQL--DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP--------RLL 277
PP L FS + FV CL K +RP +LL H FI+ ++
Sbjct: 246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVM 305
Query: 278 ERIRERPKYP 287
+ P
Sbjct: 306 AKTESPRSGP 315
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 389 bits (1001), Expect = e-132
Identities = 77/271 (28%), Positives = 113/271 (41%), Gaps = 15/271 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +GRGSFG+V++ DK+ A+K + LE E E+ + SP I
Sbjct: 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ELVACAGLSSPRI 112
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
YG+ + I ME + GGS+ LI+ L E L L +EYLH +
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172
Query: 134 HRDIKAANILLTENG-DVKVADFGVSAQLT-----RTISRRKTFVGTPFWMAPEVIQNSE 187
H D+KA N+LL+ +G + DFG + L +++ GT MAPEV+
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK- 231
Query: 188 GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVS 245
+ K DIWS ++ M G P + I E PP + + L + +
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQ 291
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRL 276
L+K P R SA EL R
Sbjct: 292 EGLRKEPVHRASAMELRRKVGKALQEVGGLK 322
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 385 bits (992), Expect = e-132
Identities = 90/269 (33%), Positives = 148/269 (55%), Gaps = 8/269 (2%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
++G+G++G VY D +AIK I +S + + +EI++ + I +Y G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR-YSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQS--GP-PLDEMSIACILRDLLHAIEYLHNEGKIHR 135
S+ + I ME + GGS++ L++S GP +E +I + +L ++YLH+ +HR
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 136 DIKAANILL-TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI-QNSEGYNEKA 193
DIK N+L+ T +G +K++DFG S +L +TF GT +MAPE+I + GY + A
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 194 DIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPREN-PPQLDEHFSRLMKEFVSLCLKKV 251
DIWSLG T+IEMA G+PP +L P +F + P++ E S K F+ C +
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPD 266
Query: 252 PAERPSAKELLRHRFIRNARKSPRLLERI 280
P +R A +LL F++ + K + ++
Sbjct: 267 PDKRACANDLLVDEFLKVSSKKKKTQPKL 295
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-131
Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 11/270 (4%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISV-LSQCRSPYI 73
+ +GRG++G V K + +A+K I + E + + ++ + + P+
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAIEYLHNE 130
+YG+ + +WI ME M I G + E + I ++ A+E+LH++
Sbjct: 69 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 131 GK-IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ---NS 186
IHRD+K +N+L+ G VK+ DFG+S L +++ G +MAPE I N
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD-IDAGCKPYMAPERINPELNQ 187
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPRENPPQL-DEHFSRLMKEFV 244
+GY+ K+DIWSLGIT+IE+A P P + L + E PQL + FS +F
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247
Query: 245 SLCLKKVPAERPSAKELLRHRFIRNARKSP 274
S CLKK ERP+ EL++H F
Sbjct: 248 SQCLKKNSKERPTYPELMQHPFFTLHESKG 277
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 363 bits (934), Expect = e-122
Identities = 94/304 (30%), Positives = 150/304 (49%), Gaps = 47/304 (15%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F + +G G+ G V+K K +A K+I LE I +E+ VL +C SPYI
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI- 133
+YG++ ++ I ME+M GGS+ +++ + E + + ++ + YL + KI
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 154
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRD+K +NIL+ G++K+ DFGVS QL ++ +FVGT +M+PE +Q Y+ ++
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQG-THYSVQS 211
Query: 194 DIWSLGITVIEMAKGEPPLA--------------------------------------DL 215
DIWS+G++++EMA G P+ D
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271
Query: 216 HPMRVLF----IIPRENPPQLD-EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270
P +F I E PP+L FS ++FV+ CL K PAER K+L+ H FI+ +
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331
Query: 271 RKSP 274
Sbjct: 332 DAEE 335
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 356 bits (915), Expect = e-120
Identities = 65/285 (22%), Positives = 119/285 (41%), Gaps = 32/285 (11%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQ-CRS 70
+ F LE IG G FG V+K + AIK + ++ +E+ + +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEY 126
++ Y+ ++ + I EY GGS+AD I E + +L + + Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 127 LHNEGKIHRDIKAANILLTENGD-------------------VKVADFGVSAQLTRTISR 167
+H+ +H DIK +NI ++ K+ D G ++ S
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----SS 186
Query: 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE 227
+ G ++A EV+Q + + KADI++L +TV+ A EP + I +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIRQG 243
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272
P++ + S+ E + + + P RPSA L++H + +A +
Sbjct: 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 346 bits (890), Expect = e-116
Identities = 73/261 (27%), Positives = 126/261 (48%), Gaps = 14/261 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
IGRGSF VYK D E +VA + + ++ E + ++E +L + P I +Y
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 78 GSYLHQTK----LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK- 132
S+ K + ++ E M G++ ++ + + R +L +++LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 133 -IHRDIKAANILLT-ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
IHRD+K NI +T G VK+ D G++ S K +GTP +MAPE+ + E Y+
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYE--EKYD 207
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFII--PRENPPQLDEHFSRLMKEFVSLCL 248
E D+++ G+ ++EMA E P ++ ++ P D+ +KE + C+
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267
Query: 249 KKVPAERPSAKELLRHRFIRN 269
++ ER S K+LL H F +
Sbjct: 268 RQNKDERYSIKDLLNHAFFQE 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-112
Identities = 81/302 (26%), Positives = 151/302 (50%), Gaps = 35/302 (11%)
Query: 13 SRFSS----LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
R++S + ++G+G+FG V KA + ++ AIK I +E+++ I E+ +L+
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASL 59
Query: 69 RSPYITEYYGSYLHQ-------------TKLWIIMEYMAGGSVADLIQS-GPPLDEMSIA 114
Y+ YY ++L + + L+I MEY G++ DLI S
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 115 CILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--------- 165
+ R +L A+ Y+H++G IHRD+K NI + E+ +VK+ DFG++ + R++
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 166 -----SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMR 219
+ +GT ++A EV+ + YNEK D++SLGI EM + ++ ++
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILK 239
Query: 220 VLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLER 279
L + E PP D++ ++ K+ + L + P +RP A+ LL ++ + + E
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEA 299
Query: 280 IR 281
++
Sbjct: 300 LK 301
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 329 bits (846), Expect = e-109
Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 10/273 (3%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS 70
+ F + IGRG F +VY+A VA+K + + + D KEI +L Q
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEY 126
P + +YY S++ +L I++E G ++ +I+ + E ++ L A+E+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
+H+ +HRDIK AN+ +T G VK+ D G+ + + + VGTP++M+PE I
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE- 210
Query: 187 EGYNEKADIWSLGITVIEMAKGEPP-LADLHPMRVLF--IIPRENPPQLDEHFSRLMKEF 243
GYN K+DIWSLG + EMA + P D + L I + PP +H+S +++
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 270
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRL 276
V++C+ P +RP + +A + L
Sbjct: 271 VNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-105
Identities = 82/306 (26%), Positives = 150/306 (49%), Gaps = 4/306 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPY 72
++ L+ IG GSFG E + IK I++ S E E+ ++E++VL+ + P
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNE 130
I +Y S+ L+I+M+Y GG + I Q G E I + A++++H+
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
+HRDIK+ NI LT++G V++ DFG++ L T+ + +GTP++++PE+ +N + YN
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYN 203
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
K+DIW+LG + E+ + ++ I + P + H+S ++ VS K+
Sbjct: 204 NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKR 263
Query: 251 VPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGTVK 310
P +RPS +L FI + + I E + + + ++
Sbjct: 264 NPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSIS 323
Query: 311 VVRDKR 316
V+ ++
Sbjct: 324 VMPAQK 329
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-105
Identities = 69/262 (26%), Positives = 117/262 (44%), Gaps = 15/262 (5%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQ-CRS 70
F L +G GS+G+V+K KE + A+K + E+ + +
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHN 129
P ++ L++ E G S+ + G L E + LRD L A+ +LH+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+G +H D+K ANI L G K+ DFG+ +L + G P +MAPE++Q Y
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELLQG--SY 232
Query: 190 NEKADIWSLGITVIEMAKGEPP---LADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246
AD++SLG+T++E+A +R ++ PP+ S ++ + +
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL-----PPEFTAGLSSELRSVLVM 287
Query: 247 CLKKVPAERPSAKELLRHRFIR 268
L+ P R +A+ LL +R
Sbjct: 288 MLEPDPKLRATAEALLALPVLR 309
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = 7e-99
Identities = 72/286 (25%), Positives = 124/286 (43%), Gaps = 32/286 (11%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
G F +ELIG G FG V+KA + K IK + E ++E+ L++
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHV 64
Query: 72 YITEYYGSYL----------------HQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSI 113
I Y G + L+I ME+ G++ I + G LD++
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 114 ACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
+ + ++Y+H++ I+RD+K +NI L + VK+ DFG+ L +R G
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTRSKG 183
Query: 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD 233
T +M+PE I + + Y ++ D+++LG+ + E+ +
Sbjct: 184 TLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFTDLRDGIIS 237
Query: 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLER 279
+ F + K + L K P +RP+ E+LR + +KSP ER
Sbjct: 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW--KKSPEKNER 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 2e-92
Identities = 75/298 (25%), Positives = 129/298 (43%), Gaps = 30/298 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ F ++ +GRG FG V++A +K + + AIK I L E E + +E+ L++ P
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 73 ITEYYGSYLHQTK------------LWIIMEYMAGGSVADLIQ---SGPPLDEMSIACIL 117
I Y+ ++L + L+I M+ ++ D + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 118 RDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF------ 171
+ A+E+LH++G +HRD+K +NI T + VKV DFG+ + + +
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 172 ------VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP 225
VGT +M+PE I Y+ K DI+SLG+ + E+ P + +R L +
Sbjct: 185 ARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDVR 241
Query: 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRER 283
P L V L P ERP A ++ + + + + R R R
Sbjct: 242 NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSR 299
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 2e-89
Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 13/268 (4%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPY 72
+ L IG GS+G K K K + K +D +E E + + E+++L + + P
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 73 ITEYYGSYLHQT--KLWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHAIEY 126
I YY + +T L+I+MEY GG +A +I + LDE + ++ L A++
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 127 LHNEGK-----IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPE 181
H +HRD+K AN+ L +VK+ DFG++ L S KTFVGTP++M+PE
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE 186
Query: 182 VIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241
+ YNEK+DIWSLG + E+ PP + I ++ +S +
Sbjct: 187 QMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 245
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRN 269
E ++ L RPS +E+L + I
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 275 bits (704), Expect = 7e-88
Identities = 76/338 (22%), Positives = 153/338 (45%), Gaps = 23/338 (6%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR- 69
G +S L+ IG G V++ +++ + AIK ++LEE ++ + EI+ L++ +
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 70 -SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
S I Y + ++++ME + ++ +D +++L A+ +H
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPFWMAPEVIQNS 186
G +H D+K AN L+ +G +K+ DFG++ Q+ T + + VGT +M PE I++
Sbjct: 126 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 187 ----------EGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPREN-PPQLDE 234
+ K+D+WSLG + M G+ P + + + L I N + +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR-NARKSPRLLERIRERPKYPIQEEPD 293
+ +++ + CLK+ P +R S ELL H +++ ++ + E KY + +
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVG 304
Query: 294 TPINGVRAVGEASGTVKVVRDKRSEETVQVSSQGQTVR 331
+N ++ +A+ T+ S + R
Sbjct: 305 --LNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKR 340
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 4e-85
Identities = 68/275 (24%), Positives = 134/275 (48%), Gaps = 20/275 (7%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR- 69
G +S L+ IG G V++ +++ + AIK ++LEE ++ + EI+ L++ +
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 70 -SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
S I Y + ++++ME + ++ +D +++L A+ +H
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPFWMAPEVIQNS 186
G +H D+K AN L+ +G +K+ DFG++ Q+ T + + VGT +M PE I++
Sbjct: 145 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 187 ----------EGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLF-IIPRENPPQLDE 234
+ K+D+WSLG + M G+ P + + + L II + + +
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263
Query: 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269
+ +++ + CLK+ P +R S ELL H +++
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 1e-83
Identities = 75/338 (22%), Positives = 152/338 (44%), Gaps = 23/338 (6%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR- 69
G +S L+ IG G V++ +++ + AIK ++LEE ++ + EI+ L++ +
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 70 -SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
S I Y + ++++ME + ++ +D +++L A+ +H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPFWMAPEVIQNS 186
G +H D+K AN L+ +G +K+ DFG++ Q+ T + + VG +M PE I++
Sbjct: 173 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 187 ----------EGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPREN-PPQLDE 234
+ K+D+WSLG + M G+ P + + + L I N + +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR-NARKSPRLLERIRERPKYPIQEEPD 293
+ +++ + CLK+ P +R S ELL H +++ ++ + E KY + +
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQ--L 349
Query: 294 TPINGVRAVGEASGTVKVVRDKRSEETVQVSSQGQTVR 331
+N ++ +A+ T+ S + R
Sbjct: 350 VGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKR 387
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 6e-74
Identities = 64/298 (21%), Positives = 128/298 (42%), Gaps = 24/298 (8%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPY 72
F +++G G+ G + N+DVA+K I E +E+ +L + P
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPN 79
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEG 131
+ Y+ + + +I +E ++ + ++ + +L+ + +LH+
Sbjct: 80 VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 132 KIHRDIKAANILLTENGD-----VKVADFGVSAQLT---RTISRRKTFVGTPFWMAPEVI 183
+HRD+K NIL++ ++DFG+ +L + SRR GT W+APE++
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 184 QNS--EGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSR 238
E DI+S G + ++G P + ++ + ++H
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDV 258
Query: 239 LMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPI 296
+ +E + + P +RPSAK +L+H F + K + + + +R + +E D PI
Sbjct: 259 IARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIE---KESLDGPI 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 4e-73
Identities = 76/257 (29%), Positives = 136/257 (52%), Gaps = 18/257 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
E IG GSFG V++A DVA+K++ ++ + + + +E++++ + R P I +
Sbjct: 43 EKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQ---SGPPLDEMSIACILRDLLHAIEYLHNEGK-- 132
G+ L I+ EY++ GS+ L+ + LDE + D+ + YLHN
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
+HR++K+ N+L+ + VKV DFG+S T K+ GTP WMAPEV+++ E NEK
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEK 219
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-----PPQLDEHFSRLMKEFVSLC 247
+D++S G+ + E+A + P +L+P +V+ + + P L+ + +++ C
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG----C 275
Query: 248 LKKVPAERPSAKELLRH 264
P +RPS ++
Sbjct: 276 WTNEPWKRPSFATIMDL 292
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 2e-70
Identities = 59/274 (21%), Positives = 102/274 (37%), Gaps = 22/274 (8%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
+ ++ +G G F V A+K I E +D E+ Q+E + P
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR-EEAQREADMHRLFNHP 86
Query: 72 YITEYYGSYLHQT----KLWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHA 123
I L + + W+++ + G++ + I G L E I +L +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK---------TFVGT 174
+E +H +G HRD+K NILL + G + D G Q + + T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 175 PFWMAPEVIQNSEG--YNEKADIWSLGITVIEMAKGEPP--LADLHPMRVLFIIPRENPP 230
+ APE+ +E+ D+WSLG + M GE P + V + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
S + + ++ + P +RP LL
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 7e-68
Identities = 77/272 (28%), Positives = 131/272 (48%), Gaps = 32/272 (11%)
Query: 15 FSSLEL---IGRGSFGDVYKAFDKELNKDVAIKVI---DLEESEDEIEDIQKEISVLSQC 68
F+ L L IG G FG VY+AF +VA+K E+ IE++++E + +
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
+ P I G L + L ++ME+ GG + ++ G + + + + YLH
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLH 122
Query: 129 NEGK---IHRDIKAANILLTE--------NGDVKVADFGVSAQLTRTISRRKTFVGTPFW 177
+E IHRD+K++NIL+ + N +K+ DFG++ + RT + + G W
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAYAW 180
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-----PPQL 232
MAPEVI+ S +++ +D+WS G+ + E+ GE P + + V + + P
Sbjct: 181 MAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
E F++LM++ C P RPS +L
Sbjct: 240 PEPFAKLMED----CWNPDPHSRPSFTNILDQ 267
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-67
Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 39/272 (14%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE------IEDIQKEISVLSQCRSPY 72
+ IG+G FG V+K + VAIK + L +SE E ++ Q+E+ ++S P
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEG 131
I + YG + ++ME++ G + + P+ ++ D+ IEY+ N+
Sbjct: 85 IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 132 K--IHRDIKAANILLTENGD-----VKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
+HRD+++ NI L + KVADFG+S Q ++ +G WMAPE I
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SGLLGNFQWMAPETIG 199
Query: 185 -NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI-----------IPRENPPQL 232
E Y EKAD +S + + + GE P + ++ FI IP + PP+L
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL 259
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+++ C P +RP +++
Sbjct: 260 ----RNVIEL----CWSGDPKKRPHFSYIVKE 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 2e-67
Identities = 55/286 (19%), Positives = 112/286 (39%), Gaps = 40/286 (13%)
Query: 15 FSSLEL---IGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRS 70
F L + G+++K + D+ +KV+ + + S + D +E L
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 71 PYITEYYGSYLH--QTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEY 126
P + G+ +I +M GS+ +++ +D+ D+ + +
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 127 LHNEGK--IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
LH + + ++++ E+ +++ V + P W+APE +Q
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPAWVAPEALQ 181
Query: 185 N--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-----PPQLDEHFS 237
+ AD+WS + + E+ E P ADL M + + E PP + H S
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS 241
Query: 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRER 283
+LMK C+ + PA+RP ++ LE+++++
Sbjct: 242 KLMKI----CMNEDPAKRPKFDMIVPI------------LEKMQDK 271
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 4e-67
Identities = 84/282 (29%), Positives = 135/282 (47%), Gaps = 20/282 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS 70
F +G+G FG+VY A +K+ +A+KV+ + +++E+ + S R
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P I YG + T++++I+EY G+V +Q DE A + +L +A+ Y H++
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
IHRDIK N+LL G++K+ADFG S SRR GT ++ PE+I+ ++
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMIEGR-MHD 185
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPM-------RVLFIIPRENPPQLDEHFSRLMKEF 243
EK D+WSLG+ E G+PP RV F P + ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDL 237
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPK 285
+S LK P++RP +E+L H +I P + K
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK 279
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 6e-67
Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 39/298 (13%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
E++G+G FG K +E + + +K + + E+ KE+ V+ P + ++ G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+L I EY+ GG++ +I+S +D+ + YLH+ IHRD+
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTIS--------------RRKTFVGTPFWMAPEVI 183
+ N L+ EN +V VADFG++ + + +R T VG P+WMAPE+I
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN------PPQLDEHFS 237
Y+EK D++S GI + E+ D P + F + PP F
Sbjct: 195 NG-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFF 253
Query: 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTP 295
+ C P +RPS +L LE +R + P
Sbjct: 254 PITVR----CCDLDPEKRPSFVKLEHW------------LETLRMHLAGHLPLGPQLE 295
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 2e-66
Identities = 67/288 (23%), Positives = 129/288 (44%), Gaps = 19/288 (6%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCR 69
R+ +G+G F ++ D + + A K++ + E + EIS+
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
++ ++G + +++++E S+ +L + L E LR ++ +YLH
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
IHRD+K N+ L E+ +VK+ DFG++ ++ R+K GTP ++APEV+ G+
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GH 192
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPM-------RVLFIIPRENPPQLDEHFSRLMKE 242
+ + D+WS+G + + G+PP + + IP +H + +
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--------KHINPVAAS 244
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRL-LERIRERPKYPIQ 289
+ L+ P RP+ ELL F + RL + + P++ I
Sbjct: 245 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 292
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 2e-66
Identities = 83/261 (31%), Positives = 128/261 (49%), Gaps = 30/261 (11%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
E++GRG+FG V KA + KDVAIK I ESE E + E+ LS+ P I + Y
Sbjct: 13 EEVVGRGAFGVVCKAKWR--AKDVAIKQI---ESESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYLHNEGK-- 132
G+ L+ + ++MEY GGS+ +++ PL + A + + YLH+
Sbjct: 68 GACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 133 -IHRDIKAANILLTENGDV-KVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQNSEGY 189
IHRD+K N+LL G V K+ DFG + I T G+ WMAPEV + Y
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEG-SNY 180
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLH--PMRVLFIIPR----ENPPQLDEHFSRLMKEF 243
+EK D++S GI + E+ P ++ R+++ + L + LM
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR- 239
Query: 244 VSLCLKKVPAERPSAKELLRH 264
C K P++RPS +E+++
Sbjct: 240 ---CWSKDPSQRPSMEEIVKI 257
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 6e-66
Identities = 66/302 (21%), Positives = 127/302 (42%), Gaps = 18/302 (5%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCR 69
R+ +G+G F ++ D + + A K++ + E + EIS+
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
++ ++G + +++++E S+ +L + L E LR ++ +YLH
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
IHRD+K N+ L E+ +VK+ DFG++ ++ R+K GTP ++APEV+ G+
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GH 218
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPM-------RVLFIIPRENPPQLDEHFSRLMKE 242
+ + D+WS+G + + G+PP + + IP +H + +
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--------KHINPVAAS 270
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAV 302
+ L+ P RP+ ELL F + RL P + + +
Sbjct: 271 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330
Query: 303 GE 304
Sbjct: 331 TV 332
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 3e-65
Identities = 62/273 (22%), Positives = 125/273 (45%), Gaps = 31/273 (11%)
Query: 15 FSSLEL---IGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRS 70
F LE+ IG+G FG VY + +VAI++ID+E +ED+++ ++E+ Q R
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN 129
+ + G+ + L II G ++ +++ LD I ++++ + YLH
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-----FVGTPFWMAPEVIQ 184
+G +H+D+K+ N+ +NG V + DFG+ + + R+ G +APE+I+
Sbjct: 149 KGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 185 NS--------EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-----PRENPPQ 231
+++ +D+++LG E+ E P +++ + P +
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG 267
Query: 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ + S ++ C ERP+ +L+
Sbjct: 268 MGKEISDILLF----CWAFEQEERPTFTKLMDM 296
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-64
Identities = 72/267 (26%), Positives = 126/267 (47%), Gaps = 21/267 (7%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSP 71
F L+G+GSF VY+A +VAIK+ID + ++ +Q E+ + Q + P
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 72 YITEYYGSYLH-QTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN 129
I E Y Y +++++E G + +++ P E + ++ + YLH+
Sbjct: 72 SILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
G +HRD+ +N+LLT N ++K+ADFG++ QL + T GTP +++PE+ S +
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS-AH 189
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPM-------RVLFIIPRENPPQLDEHFSRLMKE 242
++D+WSLG + G PP + +P S K+
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP--------SFLSIEAKD 241
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRN 269
+ L++ PA+R S +L H F+
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFMSR 268
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-63
Identities = 72/269 (26%), Positives = 123/269 (45%), Gaps = 20/269 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS 70
F +G+G FG+VY A +K+ +A+KV+ + E +++EI + S R
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P I Y + + ++++++E+ G + +Q DE A + +L A+ Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
IHRDIK N+L+ G++K+ADFG S RR+T GT ++ PE+I+ ++
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEMIEGK-THD 190
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPM-------RVLFIIPRENPPQLDEHFSRLMKEF 243
EK D+W G+ E G PP V P S K+
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP--------FLSDGSKDL 242
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARK 272
+S L+ P +R K ++ H +++ +
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSR 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 6e-62
Identities = 72/268 (26%), Positives = 135/268 (50%), Gaps = 26/268 (9%)
Query: 15 FSSLEL---IGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRS 70
+ + IG GSFG VYK + + DVA+K++++ + +++ + E+ VL + R
Sbjct: 23 DGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN 129
I + G +L I+ ++ G S+ + + + + I R ++YLH
Sbjct: 80 VNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSE 187
+ IHRD+K+ NI L E+ VK+ DFG++ + +R + + G+ WMAPEVI+ +
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 188 G--YNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFIIPREN--------PPQLDEHF 236
Y+ ++D+++ GI + E+ G+ P ++++ +++ ++ R + +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 237 SRLMKEFVSLCLKKVPAERPSAKELLRH 264
RLM E CLKK ERPS +L
Sbjct: 259 KRLMAE----CLKKKRDERPSFPRILAE 282
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-61
Identities = 54/303 (17%), Positives = 110/303 (36%), Gaps = 45/303 (14%)
Query: 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVL 65
G Q + + +++G+G+ +V++ K+ AIKV + ++ +E VL
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVL 61
Query: 66 SQCRSPYITEYYGSYLHQTK--LWIIMEYMAGGSVADLI---QSGPPLDEMSIACILRDL 120
+ I + + T +IME+ GS+ ++ + L E +LRD+
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGD----VKVADFGVSAQLTRTISRRKTFVGTPF 176
+ + +L G +HR+IK NI+ D K+ DFG + +L + + GT
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEE 180
Query: 177 WMAPEVIQ-------NSEGYNEKADIWSLGITVIEMAKGEPP------------------ 211
++ P++ + + + Y D+WS+G+T A G P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 212 ----------LADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
+ + + L L+ ++ L+ + +
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 262 LRH 264
Sbjct: 301 FAE 303
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 4e-59
Identities = 54/303 (17%), Positives = 110/303 (36%), Gaps = 45/303 (14%)
Query: 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVL 65
G Q + + +++G+G+ +V++ K+ AIKV + ++ +E VL
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVL 61
Query: 66 SQCRSPYITEYYGSYLHQTK--LWIIMEYMAGGSVADLI---QSGPPLDEMSIACILRDL 120
+ I + + T +IME+ GS+ ++ + L E +LRD+
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGD----VKVADFGVSAQLTRTISRRKTFVGTPF 176
+ + +L G +HR+IK NI+ D K+ DFG + +L + + GT
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEE 180
Query: 177 WMAPEVIQ-------NSEGYNEKADIWSLGITVIEMAKGEPP------------------ 211
++ P++ + + + Y D+WS+G+T A G P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 212 ----------LADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
+ + + L L+ ++ L+ + +
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 262 LRH 264
Sbjct: 301 FAE 303
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 6e-59
Identities = 74/340 (21%), Positives = 127/340 (37%), Gaps = 93/340 (27%)
Query: 13 SRFSS----LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
SR+ + ++ +GRG FG V++A +K + + AIK I L E E + +E+ L++
Sbjct: 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 69 RSPYITEYYGSYL-----------------------------HQTKLWIIMEYMAGGSVA 99
P I Y+ ++L + + M S
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 100 DLIQSGPPLDEMSIACI---------LRDLLH----------------------AIEYLH 128
+ + P I L+D ++ A+E+LH
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF------------VGTPF 176
++G +HRD+K +NI T + VKV DFG+ + + + VGT
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-------RVLFIIPRENP 229
+M+PE I + Y+ K DI+SLG+ + E+ L+ R++ +
Sbjct: 242 YMSPEQIHGN-NYSHKVDIFSLGLILFEL---------LYSFSTQMERVRIITDVRNLKF 291
Query: 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269
P L V L P ERP A +++ + N
Sbjct: 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 4e-58
Identities = 77/310 (24%), Positives = 134/310 (43%), Gaps = 50/310 (16%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVID----------------LEESEDEIEDIQKEISV 64
+ +G F + ++ NK A+K + + + +D + E+ +
Sbjct: 39 LNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 65 LSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMS--------IACI 116
++ ++ Y G + +++II EYM S+ + LD+ I CI
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 117 LRDLLHAIEYLHNEGKI-HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175
++ +L++ Y+HNE I HRD+K +NIL+ +NG VK++DFG S + + K GT
Sbjct: 157 IKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGSRGTY 214
Query: 176 FWMAPEVIQNSEGY-NEKADIWSLGITVIEMAKGEPPLADLHPMRVLF------------ 222
+M PE N Y K DIWSLGI + M P + + LF
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPL 274
Query: 223 -------IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPR 275
+ + + S +F+ L L+K PAER ++++ L+H ++ +
Sbjct: 275 DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED- 333
Query: 276 LLERIRERPK 285
L E +E K
Sbjct: 334 LREFSKELYK 343
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 5e-58
Identities = 64/318 (20%), Positives = 121/318 (38%), Gaps = 41/318 (12%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS- 70
R ++ G F VY+A D ++ A+K + E E I +E+ + +
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN-RAIIQEVCFMKKLSGH 85
Query: 71 PYITEYYGSYL-------HQTKLWIIMEYMAGGSVADLI---QSGPPLDEMSIACILRDL 120
P I ++ + ++++ + G + + + +S PL ++ I
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 121 LHAIEYLHNEGK--IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK--------- 169
A++++H + IHRD+K N+LL+ G +K+ DFG + ++
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 170 ---TFVGTPFWMAPEVIQNSEG--YNEKADIWSLGITVIEMAKGEPPLADLHPMRVL--- 221
T TP + PE+I EK DIW+LG + + + P D +R++
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265
Query: 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRF----IRNARKSPRLL 277
+ IP + + + L+ P ER S E++ RN +
Sbjct: 266 YSIP-PHDT-----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319
Query: 278 ERIRERPKYPIQEEPDTP 295
E + + Y P
Sbjct: 320 ELLEQNGGYGSATLSRGP 337
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 1e-57
Identities = 73/334 (21%), Positives = 141/334 (42%), Gaps = 44/334 (13%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
+A++ +++ + S +++G GS G V + VA+K + + D +
Sbjct: 3 IANIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLI----DFCDIALM 57
Query: 61 EISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-------GPPLDEMS 112
EI +L++ P + YY S L+I +E ++ DL++S E +
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 116
Query: 113 IACILRDLLHAIEYLHNEGKIHRDIKAANILLT-------------ENGDVKVADFGVSA 159
+LR + + +LH+ IHRD+K NIL++ EN + ++DFG+
Sbjct: 117 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 160 QL----TRTISRRKTFVGTPFWMAPEVIQNS------EGYNEKADIWSLG-ITVIEMAKG 208
+L + + GT W APE+++ S DI+S+G + ++KG
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 209 EPPLADLHP-----MRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
+ P D + +R +F + D + +S + P +RP+A ++LR
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLH-DRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
Query: 264 HRFIRNARKSPRLLERIRERPKYPIQEEPDTPIN 297
H K L ++ +R + ++ P +
Sbjct: 296 HPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLM 329
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-57
Identities = 68/263 (25%), Positives = 116/263 (44%), Gaps = 16/263 (6%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+G G+FGDV+ ++ + IK I+ + S+ +E I+ EI VL P I + +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPP----LDEMSIACILRDLLHAIEYLHNEGKIH 134
+ ++I+ME GG + + I S L E +A +++ +++A+ Y H++ +H
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 135 RDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
+D+K NIL + +K+ DFG++ GT +MAPEV +
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKRD--VTF 204
Query: 192 KADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVSLC 247
K DIWS G + + G P V P + + +
Sbjct: 205 KCDIWSAGVVMYF-LLTGCLPFTGTSLEEVQQKA-TYKEPNYAVECRPLTPQAVDLLKQM 262
Query: 248 LKKVPAERPSAKELLRHRFIRNA 270
L K P RPSA ++L H + + A
Sbjct: 263 LTKDPERRPSAAQVLHHEWFKQA 285
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-57
Identities = 71/305 (23%), Positives = 126/305 (41%), Gaps = 54/305 (17%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID----LEESEDEIEDIQKEISVLSQCRSPYIT 74
IG+GS+G V A + + AIK+++ + + ++E I+ E+ ++ + P I
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQS------------------------------ 104
Y Y + + ++ME GG + D +
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 105 ----------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT--ENGDVKV 152
E I+ I+R + A+ YLHN+G HRDIK N L + ++ ++K+
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKL 211
Query: 153 ADFGVSAQLTRT----ISRRKTFVGTPFWMAPEVIQ-NSEGYNEKADIWSLGITVIEMAK 207
DFG+S + + T GTP+++APEV+ +E Y K D WS G+ + +
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
Query: 208 GEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
G P ++ + + + S L ++ +S L + ER A L+H
Sbjct: 272 GAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331
Query: 265 RFIRN 269
+I
Sbjct: 332 PWISQ 336
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 6e-57
Identities = 51/284 (17%), Positives = 98/284 (34%), Gaps = 30/284 (10%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELN-----KDVAIKVIDLEESEDEIEDIQKEIS 63
+ L+G G+F VY+A +LN + +KV + E + +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLME 119
Query: 64 VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-----SGPPLDEMSIACILR 118
L ++Y ++L Q ++ E + G++ + I + + +
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 119 DLLHAIEYLHNEGKIHRDIKAANILLT-----------ENGDVKVADFGVSAQLT--RTI 165
+L+ IE +H+ IH DIK N +L + + + D G S +
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP 225
+ T + E++ N + +N + D + + TV M G
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
Query: 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269
P LD + EF + L + +LLR + +
Sbjct: 299 FRRLPHLD-----MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-56
Identities = 71/264 (26%), Positives = 128/264 (48%), Gaps = 12/264 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
+ +G G++G+V DK + + AIK+I S + +E++VL P I + Y
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ + +++ME GG + D I +E+ A I++ +L + YLH +HRD+
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDL 162
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
K N+LL ++ +K+ DFG+SA + K +GT +++APEV++ Y+EK D
Sbjct: 163 KPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRKK--YDEKCD 219
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLKK 250
+WS+G+ + + G PP +L + + D + S K+ + L+
Sbjct: 220 VWSIGVILFILLAGYPPFGGQTDQEILRKV-EKGKYTFDSPEWKNVSEGAKDLIKQMLQF 278
Query: 251 VPAERPSAKELLRHRFIRNARKSP 274
R SA++ L H +I+
Sbjct: 279 DSQRRISAQQALEHPWIKEMCSKK 302
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 7e-56
Identities = 74/265 (27%), Positives = 134/265 (50%), Gaps = 13/265 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPYITEY 76
++G+GSFG+V DK ++ A+KVI + + + E + +E+ +L Q P I +
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
Y + + +++ E GG + D I S E+ A I+R +L I Y+H +HRD
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151
Query: 137 IKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
+K N+LL ++ ++++ DFG+S + + K +GT +++APEV+ + Y+EK
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT--YDEKC 208
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLK 249
D+WS G+ + + G PP + +L + + + S K+ + L
Sbjct: 209 DVWSTGVILYILLSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESAKDLIRKMLT 267
Query: 250 KVPAERPSAKELLRHRFIRNARKSP 274
VP+ R SA++ L H +I+ K
Sbjct: 268 YVPSMRISARDALDHEWIQTYTKEQ 292
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-55
Identities = 71/264 (26%), Positives = 121/264 (45%), Gaps = 14/264 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
IGRGS+G+V A K A K I ED ++ ++EI ++ P I Y
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
++ T ++++ME GG + + + E A I++D+L A+ Y H HRD+K
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 133
Query: 139 AANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
N L + +K+ DFG++A+ +T VGTP++++P+V++ Y + D
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEGL--YGPECDE 190
Query: 196 WSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLKK 250
WS G + + + G PP + V+ I RE E + S + + L K
Sbjct: 191 WSAGVMMYV-LLCGYPPFSAPTDSEVMLKI-REGTFTFPEKDWLNVSPQAESLIRRLLTK 248
Query: 251 VPAERPSAKELLRHRFIRNARKSP 274
P +R ++ + L H + S
Sbjct: 249 SPKQRITSLQALEHEWFEKQLSSS 272
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-55
Identities = 62/264 (23%), Positives = 98/264 (37%), Gaps = 14/264 (5%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT--- 74
E +G G FG V + ++ + VAIK E S E EI ++ + P +
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 75 ---EYYGSYLHQTKLWIIMEYMAGGSVADLI---QSGPPLDEMSIACILRDLLHAIEYLH 128
+ + MEY GG + + ++ L E I +L D+ A+ YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 129 NEGKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
IHRD+K NI+L K+ D G + +L + FVGT ++APE+++
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQ 197
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245
+ Y D WS G E G P RE + + L
Sbjct: 198 -KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKF 256
Query: 246 LCLKKVPAERPSAKELLRHRFIRN 269
+ P R+++
Sbjct: 257 SSVLPTPNHLSGILAGKLERWLQC 280
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-55
Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 20/272 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID----LEESEDEIEDIQKEISVLSQCRSPYIT 74
E+IG+G F V + ++E + A+K++D ED+++E S+ + P+I
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHAIEYLHNE 130
E +Y L+++ E+M G + I +G E + +R +L A+ Y H+
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 131 GKIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSE 187
IHRD+K +LL + VK+ FGV+ QL + VGTP +MAPEV+ E
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV-KRE 208
Query: 188 GYNEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF----SRLMKE 242
Y + D+W G I I ++ G P LF + +++ S K+
Sbjct: 209 PYGKPVDVWGCGVILFILLS-GCLPFYGTKER--LFEGIIKGKYKMNPRQWSHISESAKD 265
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274
V L PAER + E L H +++ +
Sbjct: 266 LVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-55
Identities = 71/259 (27%), Positives = 127/259 (49%), Gaps = 12/259 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
++G+GSFG+V K D+ ++ A+KVI+ + I +E+ +L + P I + +
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ +I+ E GG + D I E A I++ + I Y+H +HRD+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
K NILL ++ D+K+ DFG+S + ++ K +GT +++APEV++ + Y+EK D
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT--YDEKCD 204
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLKK 250
+WS G+ + + G PP + +L + D S K+ + L
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEYDILKRV-ETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
Query: 251 VPAERPSAKELLRHRFIRN 269
P+ R +A + L H +I+
Sbjct: 264 HPSLRITATQCLEHPWIQK 282
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 3e-55
Identities = 70/292 (23%), Positives = 128/292 (43%), Gaps = 55/292 (18%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
LE +G+G +G+V++ ++VA+K+ + + + E+ R I +
Sbjct: 13 LECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFI 68
Query: 78 GSYLH----QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK- 132
S + T+LW+I Y GS+ D +Q LD +S I+ + + +LH E
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 133 -------IHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFVGTPFWMAPE 181
HRD+K+ NIL+ +NG +AD G++ +++ ++ VGT +MAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 182 VIQNS-----EGYNEKADIWSLGITVIEMAKG----------EPPLADLHPMRVLFIIPR 226
V+ + ++ DIW+ G+ + E+A+ +PP D+ P F R
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 227 EN----------PPQLDEH-----FSRLMKEFVSLCLKKVPAERPSAKELLR 263
+ P + ++LMKE C + P+ R +A + +
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE----CWYQNPSARLTALRIKK 295
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 4e-55
Identities = 66/300 (22%), Positives = 134/300 (44%), Gaps = 41/300 (13%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYY 77
+++G G+ V + +++ A+K+I+ + + +E+ +L QC+ + E
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR-SRVFREVEMLYQCQGHRNVLELI 77
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ + + +++ E M GGS+ I +E+ + +++D+ A+++LHN+G HRD+
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRR-------KTFVGTPFWMAPEVIQ--- 184
K NIL + VK+ DF + + + T G+ +MAPEV++
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 185 -NSEGYNEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM-- 240
+ Y+++ D+WSLG I I + G PP + P + F +
Sbjct: 198 EEASIYDKRCDLWSLGVILYI-LLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 241 ----------------KEFVSLCLKKVPAERPSAKELLRHRFIRNARK-----SPRLLER 279
K+ +S L + +R SA ++L+H +++ +P +L+R
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQR 316
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-54
Identities = 64/270 (23%), Positives = 129/270 (47%), Gaps = 13/270 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
E +G+G+F V + K + A K+I+ ++ S + + +++E + + + P I +
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
S ++ +++ + + GG + + I + E + ++ +L +I Y H+ G +HR++
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 131
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
K N+LL + VK+ADFG++ ++ + F GTP +++PEV+ + Y++ D
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVL-KKDPYSKPVD 189
Query: 195 IWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLK 249
IW+ G I I + G PP D R+ I + + K + L
Sbjct: 190 IWACGVILYI-LLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPEWDTVTPEAKSLIDSMLT 247
Query: 250 KVPAERPSAKELLRHRFIRNARKSPRLLER 279
P +R +A + L+ +I N + + R
Sbjct: 248 VNPKKRITADQALKVPWICNRERVASAIHR 277
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-54
Identities = 72/286 (25%), Positives = 130/286 (45%), Gaps = 43/286 (15%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID-------------------------LEESED 53
+ IG+GS+G V A+++ N A+KV+ +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 54 EIEDIQKEISVLSQCRSPYITEYYG--SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEM 111
IE + +EI++L + P + + ++ L+++ E + G V ++ P L E
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSED 137
Query: 112 SIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171
+DL+ IEYLH + IHRDIK +N+L+ E+G +K+ADFGVS + + +
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT 197
Query: 172 VGTPFWMAPEVIQNSE-GYN-EKADIWSLGITVIEMAKGEPPLADLHPMRVL-------F 222
VGTP +MAPE + + ++ + D+W++G+T+ G+ P D M +
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQAL 257
Query: 223 IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268
P + + +K+ ++ L K P R E+ H ++
Sbjct: 258 EFPDQ------PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-54
Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 21/271 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYY 77
+ +G GSF K K+ N+ A+K+I + + QKEI+ L C P I + +
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIIS----KRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ Q +++ME + GG + + I+ E + I+R L+ A+ ++H+ G +HRD+
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDL 132
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
K N+L T +N ++K+ DFG + KT T + APE++ N GY+E D
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGYDESCD 191
Query: 195 IWSLG-ITVIEMAKGEPPLAD------LHPMRVLFIIPRENPPQLDE----HFSRLMKEF 243
+WSLG I M G+ P + ++ + + S+ K+
Sbjct: 192 LWSLGVILYT-MLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSP 274
+ L P +R L + ++++ +
Sbjct: 251 IQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-54
Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 14/260 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
++G+GSFG+V K D+ ++ A+KVI+ + I +E+ +L + P I + +
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ +I+ E GG + D I E A I++ + I Y+H +HRD+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
K NILL ++ D+K+ DFG+S + ++ K +GT +++APEV++ + Y+EK D
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT--YDEKCD 204
Query: 195 IWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLK 249
+WS G I I + G PP + +L + D S K+ + L
Sbjct: 205 VWSAGVILYI-LLSGTPPFYGKNEYDILKRV-ETGKYAFDLPQWRTISDDAKDLIRKMLT 262
Query: 250 KVPAERPSAKELLRHRFIRN 269
P+ R +A + L H +I+
Sbjct: 263 FHPSLRITATQCLEHPWIQK 282
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 1e-53
Identities = 77/283 (27%), Positives = 136/283 (48%), Gaps = 11/283 (3%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
S E++G G FG V+K + +A K+I +D E+++ EISV++Q +
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD-KEEVKNEISVMNQLDHANLI 149
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ Y ++ + + ++MEY+ GG + D +I L E+ ++ + I ++H +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYIL 209
Query: 134 HRDIKAANILLT--ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
H D+K NIL + +K+ DFG++ + + K GTP ++APEV+ N + +
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVV-NYDFVSF 267
Query: 192 KADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVSLC 247
D+WS+G I + + G P + L I DE F S KEF+S
Sbjct: 268 PTDMWSVGVIAYM-LLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQE 290
L K + R SA E L+H ++ + + RL + ++ Q+
Sbjct: 327 LIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSDAQD 369
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-53
Identities = 69/293 (23%), Positives = 119/293 (40%), Gaps = 57/293 (19%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVLSQCRSPYITEY 76
++ IG+G +G+V+ K + VA+KV + +E + EI R I +
Sbjct: 42 VKQIGKGRYGEVWMG--KWRGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGF 96
Query: 77 YGS----YLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ T+L++I +Y GS+ D ++S LD S+ + + + +LH E
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 133 --------IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR----KTFVGTPFWMAP 180
HRD+K+ NIL+ +NG +AD G++ + + T VGT +M P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 181 EVIQ-----NSEGYNEKADIWSLGITVIEMAKG----------EPPLADLHPMRVLF--- 222
EV+ N AD++S G+ + E+A+ + P DL P +
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 223 -----------IIPRE-NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
P + + +LM E C PA R +A + +
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTE----CWAHNPASRLTALRVKK 324
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-53
Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 16/269 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEISVLSQCRSPYI 73
E +G G F V K K K+ A K I E+I++E+++L + R P I
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ + ++T + +I+E ++GG + D + L E L+ +L + YLH++
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIA 130
Query: 134 HRDIKAANILLT----ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
H D+K NI+L N +K+ DFG++ ++ + K GTP ++APE++ N E
Sbjct: 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIV-NYEPL 188
Query: 190 NEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVS 245
+AD+WS+G IT I + G P L I N +E+F S L K+F+
Sbjct: 189 GLEADMWSIGVITYI-LLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIR 247
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSP 274
L K P R + + L H +I+ R+
Sbjct: 248 RLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 2e-53
Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 16/275 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEISVLSQCRSPYI 73
E +G G F V K +K + A K I E+I++E+S+L Q +
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ Y ++T + +I+E ++GG + D + L E ++ +L + YLH +
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIA 137
Query: 134 HRDIKAANILLT----ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
H D+K NI+L +K+ DFG++ ++ K GTP ++APE++ N E
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIV-NYEPL 195
Query: 190 NEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVS 245
+AD+WS+G IT I + G P L I + +E F S L K+F+
Sbjct: 196 GLEADMWSIGVITYI-LLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIR 254
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280
L K +R + +E LRH +I ++ R
Sbjct: 255 KLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRE 289
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-53
Identities = 84/275 (30%), Positives = 131/275 (47%), Gaps = 22/275 (8%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID--------LEESEDEIEDIQKEISVLSQCRS 70
E++GRG V + K K+ A+K+ID EE ++ E KE+ +L +
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 71 -PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
P I + +Y T +++ + M G + D + L E I+R LL I LH
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS--- 186
+HRD+K NILL ++ ++K+ DFG S QL + + GTP ++APE+I+ S
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMND 201
Query: 187 --EGYNEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRL 239
GY ++ D+WS G I + G PP M +L +I N P+ D +S
Sbjct: 202 NHPGYGKEVDMWSTGVIMYT-LLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD-DYSDT 259
Query: 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274
+K+ VS L P +R +A+E L H F +
Sbjct: 260 VKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-53
Identities = 75/275 (27%), Positives = 132/275 (48%), Gaps = 23/275 (8%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID------------LEESEDEIEDIQKEISVLS 66
+G G++G+V +K + + AIKVI + E E+I EIS+L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 67 QCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEY 126
P I + + + + +++ E+ GG + + I + DE A I++ +L I Y
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICY 161
Query: 127 LHNEGKIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI 183
LH +HRDIK NILL ++K+ DFG+S+ ++ + + +GT +++APEV+
Sbjct: 162 LHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVL 220
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRL 239
+ YNEK D+WS G+ + + G PP + ++ + + D + S
Sbjct: 221 KKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV-EKGKYYFDFNDWKNISDE 277
Query: 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274
KE + L L +R +A+E L R+I+ +
Sbjct: 278 AKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNI 312
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-53
Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 18/280 (6%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID-------LEESEDEIEDIQKEISVLSQCRSP 71
+ +G G+ G+V AF+++ K VAI++I D +++ EI +L + P
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
I + + +I++E M GG + D + L E + +L A++YLH G
Sbjct: 201 CIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 259
Query: 132 KIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS-- 186
IHRD+K N+LL+ E+ +K+ DFG S L T S +T GTP ++APEV+ +
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGT 318
Query: 187 EGYNEKADIWSLGITVIEMAKGEPP-LADLHPMRVLFIIPREN---PPQLDEHFSRLMKE 242
GYN D WSLG+ + G PP + + I P++ S +
Sbjct: 319 AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALD 378
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRE 282
V L P R + +E LRH ++++ + + + E
Sbjct: 379 LVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 418
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-53
Identities = 82/282 (29%), Positives = 131/282 (46%), Gaps = 20/282 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID-------LEESEDEIEDIQKEISVLSQCRSP 71
+ +G G+ G+V AF+++ K VAIK+I D +++ EI +L + P
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
I + + +I++E M GG + D + L E + +L A++YLH G
Sbjct: 76 CIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 132 KIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS-- 186
IHRD+K N+LL+ E+ +K+ DFG S L T S +T GTP ++APEV+ +
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGT 193
Query: 187 EGYNEKADIWSLG-ITVIEMAKGEPPL-ADLHPMRVLFIIPR---ENPPQLDEHFSRLMK 241
GYN D WSLG I I G PP + + I P++ S
Sbjct: 194 AGYNRAVDCWSLGVILFI-CLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 252
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRER 283
+ V L P R + +E LRH ++++ + + + E
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 294
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-53
Identities = 63/257 (24%), Positives = 118/257 (45%), Gaps = 10/257 (3%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+ +G G++G+V A ++ + VA+K++D++ + D E+I+KEI + + ++YG
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
++ +EY +GG + D I+ + E L+ + YLH G HRDIK
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRR--KTFVGTPFWMAPEVIQNSEGYN-EKADI 195
N+LL E ++K++DFG++ R GT ++APE+++ ++ E D+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-REFHAEPVDV 191
Query: 196 WSLGITVIEMAKGEPPLADLH-PMRVLFIIPR---ENPPQLDEHFSRLMKEFVSLCLKKV 251
WS GI + M GE P + P + + L +
Sbjct: 192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPLALLHKILVEN 249
Query: 252 PAERPSAKELLRHRFIR 268
P+ R + ++ + R+
Sbjct: 250 PSARITIPDIKKDRWYN 266
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-53
Identities = 66/283 (23%), Positives = 127/283 (44%), Gaps = 14/283 (4%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
++ E +GRG FG V++ + K K + + + ++KEIS+L+ R
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIARHRN 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
I + S+ +L +I E+++G + + + S L+E I + + A+++LH+
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 132 KIHRDIKAANILLT--ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
H DI+ NI+ + +K+ +FG + QL + P + APEV +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVH-QHDVV 180
Query: 190 NEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVS 245
+ D+WSLG + + + G P +++ I +E F S +FV
Sbjct: 181 STATDMWSLGTLVYV-LLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARK--SPRLLERIRERPKY 286
L K R +A E L+H +++ + S +++ ++ R Y
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYY 282
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-53
Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 16/284 (5%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEISVLSQ 67
+ + E +G G F V K +K A K I EDI++E+S+L +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 68 CRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
+ P + + Y ++T + +I+E +AGG + D + L E L+ +L+ + YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 128 HNEGKIHRDIKAANILLT----ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI 183
H+ H D+K NI+L +K+ DFG++ ++ + K GTP ++APE++
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIV 189
Query: 184 QNSEGYNEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRL 239
N E +AD+WS+G IT I + G P L + N DE+F S L
Sbjct: 190 -NYEPLGLEADMWSIGVITYI-LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRER 283
K+F+ L K P +R + ++ L+H +I+ L +
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV 291
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 9e-53
Identities = 68/308 (22%), Positives = 129/308 (41%), Gaps = 10/308 (3%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+ +G G++G+V A ++ + VA+K++D++ + D E+I+KEI + + ++YG
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
++ +EY +GG + D I+ + E L+ + YLH G HRDIK
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRR--KTFVGTPFWMAPEVIQNSEGYN-EKADI 195
N+LL E ++K++DFG++ R GT ++APE+++ ++ E D+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-REFHAEPVDV 191
Query: 196 WSLGITVIEMAKGEPPLADLH-PMRVLF-IIPRE--NPPQLDEHFSRLMKEFVSLCLKKV 251
WS GI + M GE P + ++ P + + L +
Sbjct: 192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPLALLHKILVEN 249
Query: 252 PAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGTVKV 311
P+ R + ++ + R+ K R+ I + +
Sbjct: 250 PSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRT 309
Query: 312 VRDKRSEE 319
S+E
Sbjct: 310 PGSGWSKE 317
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 70/267 (26%), Positives = 127/267 (47%), Gaps = 14/267 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRS-PYITEY 76
+ +GRG F V + K ++ A K + +D +I EI+VL +S P +
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+ Y + +++ +I+EY AGG + L + + E + +++ +L + YLH +H
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVH 154
Query: 135 RDIKAANILL---TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
D+K NILL GD+K+ DFG+S ++ + +GTP ++APE++ N +
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEIL-NYDPITT 212
Query: 192 KADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVSLC 247
D+W++G I + + P I + N +E F S+L +F+
Sbjct: 213 ATDMWNIGIIAYM-LLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSL 271
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSP 274
L K P +RP+A+ L H +++
Sbjct: 272 LVKNPEKRPTAEICLSHSWLQQWDFEN 298
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-52
Identities = 65/265 (24%), Positives = 129/265 (48%), Gaps = 13/265 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
E +G+G+F V + K + A K+I+ ++ S + + +++E + + + P I +
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
S ++ +++ + + GG + + I + E + ++ +L +I Y H+ G +HR++
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 154
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
K N+LL + VK+ADFG++ ++ + F GTP +++PEV++ Y++ D
Sbjct: 155 KPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKD-PYSKPVD 212
Query: 195 IWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRLMKEFVSLCLK 249
IW+ G I I + G PP D R+ I P+ D + K + L
Sbjct: 213 IWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWD-TVTPEAKSLIDSMLT 270
Query: 250 KVPAERPSAKELLRHRFIRNARKSP 274
P +R +A + L+ +I N +
Sbjct: 271 VNPKKRITADQALKVPWICNRERVA 295
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-52
Identities = 62/270 (22%), Positives = 126/270 (46%), Gaps = 12/270 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
E +G+G+F V + ++ A +I+ ++ S + + +++E + + P I +
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
S + ++I + + GG + + I + E + ++ +L A+ + H G +HR++
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNL 136
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
K N+LL + VK+ADFG++ ++ F GTP +++PEV++ Y + D
Sbjct: 137 KPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVD 195
Query: 195 IWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLK 249
+W+ G I I + G PP D R+ I + + K+ ++ L
Sbjct: 196 LWACGVILYILLV-GYPPFWDEDQHRLYQQI-KAGAYDFPSPEWDTVTPEAKDLINKMLT 253
Query: 250 KVPAERPSAKELLRHRFIRNARKSPRLLER 279
P++R +A E L+H +I + + R
Sbjct: 254 INPSKRITAAEALKHPWISHRSTVASCMHR 283
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-52
Identities = 80/291 (27%), Positives = 133/291 (45%), Gaps = 20/291 (6%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-------ESEDEIEDIQKEISVLS 66
++S++ +G G+FG V+ A DKE NK+V +K I E + ++ + EI++LS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 67 QCRSPYITEYYGSYLHQTKLWIIME-YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125
+ I + + +Q ++ME + +G + I P LDE + I R L+ A+
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
YL + IHRDIK NI++ E+ +K+ DFG +A L R TF GT + APEV+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMG 203
Query: 186 SEGYN-EKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLDEHFSRLMKEF 243
Y + ++WSLG+T+ + E P +L + P S+ +
Sbjct: 204 -NPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPY--------LVSKELMSL 254
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDT 294
VS L+ VP R + ++L+ ++ R P
Sbjct: 255 VSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSA 305
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-52
Identities = 76/277 (27%), Positives = 119/277 (42%), Gaps = 37/277 (13%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYY 77
E IG GS+ + K N + A+K+ID D +EI +L + P I
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIID-----KSKRDPTEEIEILLRYGQHPNIITLK 82
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
Y ++++ E M GG + D I E + +L + +EYLH +G +HRD+
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDL 142
Query: 138 KAANILLTENGD----VKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
K +NIL + +++ DFG + QL T T ++APEV+ +GY+
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-ERQGYDAAC 201
Query: 194 DIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE---------------HFS 237
DIWSLG + M G P A+ P + P ++ S
Sbjct: 202 DIWSLGVLLYT-MLTGYTPFANG---------PDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274
K+ VS L P +R +A +LRH +I + + P
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 8e-52
Identities = 76/283 (26%), Positives = 133/283 (46%), Gaps = 19/283 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
F +E++G G+F +V+ + K A+K I + + ++ EI+VL + +
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD-SSLENEIAVLKKIKHEN 67
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I Y T +++M+ ++GG + D I E + +++ +L A++YLH G
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 133 IHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+HRD+K N+L EN + + DFG+S T GTP ++APEV+ + Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVL-AQKPY 184
Query: 190 NEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRLMKEFV 244
++ D WS+G IT I + G PP + ++ I P D S K+F+
Sbjct: 185 SKAVDCWSIGVITYI-LLCGYPPFYEETESKLFEKIKEGYYEFESPFWD-DISESAKDFI 242
Query: 245 SLCLKKVPAERPSAKELLRHRFIRNARKS-----PRLLERIRE 282
L+K P ER + ++ L H +I P + +I++
Sbjct: 243 CHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQIQK 285
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 9e-52
Identities = 65/300 (21%), Positives = 137/300 (45%), Gaps = 13/300 (4%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ LE +G G+FG V++ +K + K I+ D ++ EIS+++Q P
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPK 109
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ + ++ + ++ +I+E+++GG + D + + E + +R ++++H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 132 KIHRDIKAANILLT--ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+H DIK NI+ + VK+ DFG++ +L K T + APE++ + E
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIV-DREPV 227
Query: 190 NEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVS 245
D+W++G + + + G P A + L + R + ++ F S K+F+
Sbjct: 228 GFYTDMWAIGVLGYV-LLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 286
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSP--RLLERIRERPKYPIQEEPDTPINGVRAVG 303
L+K P +R + + L H +++ + R+ + + I+E+ A+G
Sbjct: 287 NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIG 346
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-51
Identities = 77/275 (28%), Positives = 126/275 (45%), Gaps = 16/275 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEISVLSQCRSPYI 73
E +G G F V K +K + A K I E+I++E+S+L Q P I
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ Y ++T + +I+E ++GG + D + L E ++ +L + YLH +
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIA 137
Query: 134 HRDIKAANILLT----ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
H D+K NI+L +K+ DFG++ ++ K GTP ++APE++ N E
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIV-NYEPL 195
Query: 190 NEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVS 245
+AD+WS+G IT I + G P L I + +E F S L K+F+
Sbjct: 196 GLEADMWSIGVITYI-LLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIR 254
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280
L K +R + +E LRH +I ++ R
Sbjct: 255 KLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRE 289
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-51
Identities = 65/292 (22%), Positives = 115/292 (39%), Gaps = 55/292 (18%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
E IG+G FG+V++ K ++VA+K+ E + EI R I +
Sbjct: 47 QESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFR--EAEIYQTVMLRHENILGFI 102
Query: 78 GSYLH----QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK- 132
+ T+LW++ +Y GS+ D + + + + + +LH E
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 133 -------IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR----KTFVGTPFWMAPE 181
HRD+K+ NIL+ +NG +AD G++ + VGT +MAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 182 VIQNSEG-----YNEKADIWSLGITVIEMAKG----------EPPLADLHPMRVLF---- 222
V+ +S ++ADI+++G+ E+A+ + P DL P
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 223 -----------IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
I R + +++M+E C A R +A + +
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRE----CWYANGAARLTALRIKK 329
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-51
Identities = 74/267 (27%), Positives = 131/267 (49%), Gaps = 21/267 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDL-------EESEDEIEDIQKEISVLSQCRS- 70
++IGRG V + + + A+K++++ E+ E+ E ++E +L Q
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P+I SY + ++++ + M G + D + L E I+R LL A+ +LH
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN 219
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS---- 186
+HRD+K NILL +N ++++DFG S L + + GTP ++APE+++ S
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDET 278
Query: 187 -EGYNEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLM 240
GY ++ D+W+ G I +A G PP + +L +I E Q S +
Sbjct: 279 HPGYGKEVDLWACGVILFTLLA-GSPPFWHRRQILMLRMI-MEGQYQFSSPEWDDRSSTV 336
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFI 267
K+ +S L+ P R +A++ L+H F
Sbjct: 337 KDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 179 bits (454), Expect = 4e-51
Identities = 33/300 (11%), Positives = 81/300 (27%), Gaps = 46/300 (15%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEY 76
E + G V+ D E +D A+KV + S E+E + + ++ E
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 77 YGSY--------------------------LHQTKLWIIMEYMAG------GSVADLIQS 104
++M + ++ +
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 105 GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164
+++ + L+ L ++G +H N+ + +G + + D ++
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-- 245
Query: 165 ISRRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPP-------LADLH 216
+R + E + S + + W LG+++ + P +
Sbjct: 246 -TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304
Query: 217 PMRVLFIIPRENPP-QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPR 275
L + ++ +K + L R E + +
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEIS 364
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-50
Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 28/274 (10%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYY 77
+++G G G V + F + + A+K++ + ++E+ Q P+I
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY------DSPKARQEVDHHWQASGGPHIVCIL 88
Query: 78 GSY----LHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG 131
Y + L IIME M GG + IQ E A I+RD+ AI++LH+
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN 148
Query: 132 KIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
HRD+K N+L T ++ +K+ DFG + + T+ + +T TP+++APEV+ E
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVL-GPEK 205
Query: 189 YNEKADIWSLG-ITVIEMAKGEPPLADLHPMRV---LFIIPRENPPQLDE----HFSRLM 240
Y++ D+WSLG I I + G PP + + R S
Sbjct: 206 YDKSCDMWSLGVIMYI-LLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 264
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274
K+ + L LK P ER + + + H +I + P
Sbjct: 265 KQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-50
Identities = 75/283 (26%), Positives = 138/283 (48%), Gaps = 20/283 (7%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEY 76
L+ IG+G+F V A ++VAIK+ID + + ++ + +E+ ++ P I +
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
+ + L++IMEY +GG V D + + + E R ++ A++Y H + +HRD
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRD 139
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN-EKADI 195
+KA N+LL + ++K+ADFG S + T + F G P + APE+ Q + Y+ + D+
Sbjct: 140 LKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQG-KKYDGPEVDV 197
Query: 196 WSLGITVIEMAKGEPPLADLHPM----RVL---FIIPRENPPQLDEHFSRLMKEFVSLCL 248
WSLG+ + + G P + RVL + IP + S + + L
Sbjct: 198 WSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--------FYMSTDCENLLKRFL 249
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEE 291
P +R + +++++ R+I NA L+ E ++
Sbjct: 250 VLNPIKRGTLEQIMKDRWI-NAGHEEDELKPFVEPELDISDQK 291
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-50
Identities = 66/283 (23%), Positives = 124/283 (43%), Gaps = 26/283 (9%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQCRSPYITE 75
+L+G GS+G V + D E A+K++ L + +++KEI +L + R + +
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 76 YYGSYLHQTK--LWIIMEYMAGGSVA--DLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
++ K ++++MEY G D + L+ +EYLH++G
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLEYLHSQG 129
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR--KTFVGTPFWMAPEVIQNSEGY 189
+H+DIK N+LLT G +K++ GV+ L + +T G+P + PE+ + +
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTF 189
Query: 190 N-EKADIWSLGITVIEMAKGEPPLADLHPMRVL-------FIIPRENPPQLDEHFSRLMK 241
+ K DIWS G+T+ + G P + ++ + IP +
Sbjct: 190 SGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP--------GDCGPPLS 241
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERP 284
+ + L+ PA+R S +++ +H + R I P
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSP 284
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 3e-50
Identities = 70/275 (25%), Positives = 127/275 (46%), Gaps = 14/275 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+GRG+ VY+ K K A+KV+ ++ D+ + ++ EI VL + P I +
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDK-KIVRTEIGVLLRLSHPNIIKLKE 115
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
+ T++ +++E + GG + D I E A ++ +L A+ YLH G +HRD+K
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLK 175
Query: 139 AANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
N+L + +K+ADFG+S + KT GTP + APE++ Y + D+
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEIL-RGCAYGPEVDM 233
Query: 196 WSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLKK 250
WS+G IT I + G P D + +F S K+ V +
Sbjct: 234 WSVGIITYILLC-GFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL 292
Query: 251 VPAERPSAKELLRHRFIRNARKSPRLLERIRERPK 285
P +R + + L+H ++ + ++ +++ +
Sbjct: 293 DPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQ 327
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 6e-50
Identities = 70/282 (24%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F +++G GSF V A + +++ AIK+++ E+++ + +E V+S+ P+
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACI-LRDLLHAIEYLHNEG 131
+ Y ++ KL+ + Y G + I+ DE + +++ A+EYLH +G
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-TCTRFYTAEIVSALEYLHGKG 150
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTR--TISRRKTFVGTPFWMAPEVIQNSEGY 189
IHRD+K NILL E+ +++ DFG + L+ +R +FVGT +++PE++ +
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSA 209
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--IIPRENPPQLDEHFSRLMKEFVSLC 247
+ +D+W+LG + ++ G PP + +F II + E F ++ V
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII--KLEYDFPEKFFPKARDLVEKL 266
Query: 248 LKKVPAERP------SAKELLRHRFIRN-------ARKSPRL 276
L +R L H F + + P+L
Sbjct: 267 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 308
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 5e-49
Identities = 72/274 (26%), Positives = 124/274 (45%), Gaps = 27/274 (9%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYY 77
+++G G G V + F+K + A+K++ + ++E+ + + P+I
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVRIV 121
Query: 78 GSY----LHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG 131
Y + L I+ME + GG + IQ E + I++ + AI+YLH+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 181
Query: 132 KIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
HRD+K N+L T N +K+ DFG + + T + T TP+++APEV+ E
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVL-GPEK 239
Query: 189 YNEKADIWSLG-ITVIEMAKGEPPLADLHPMRV---LFIIPRENPPQLDE----HFSRLM 240
Y++ D+WSLG I I + G PP H + + + R + S +
Sbjct: 240 YDKSCDMWSLGVIMYI-LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 298
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274
K + LK P +R + E + H +I + K P
Sbjct: 299 KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 6e-49
Identities = 62/270 (22%), Positives = 117/270 (43%), Gaps = 11/270 (4%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ E +G G+FG V++ ++ + A K + D E ++KEI +S R P
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-KETVRKEIQTMSVLRHPT 215
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ + ++ ++ +I E+M+GG + + + + E +R + + ++H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 132 KIHRDIKAANILLT--ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+H D+K NI+ T + ++K+ DFG++A L K GT + APEV +
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVA-EGKPV 333
Query: 190 NEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVS 245
D+WS+G ++ I + G P + L + + D F S K+F+
Sbjct: 334 GYYTDMWSVGVLSYI-LLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSPR 275
L P R + + L H ++ R
Sbjct: 393 KLLLADPNTRMTIHQALEHPWLTPGNAPGR 422
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-48
Identities = 35/298 (11%), Positives = 85/298 (28%), Gaps = 54/298 (18%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCR------- 69
++G+ +A D+E + + V E + I+ +++E+ L R
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 70 ------------------SPYITEYYGSYLHQT--KLWIIMEYMA------GGSVADLIQ 103
+ + + M G +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 104 SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163
+ L + + ++ + LH+ G +H ++ +I+L + G V + F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL----V 254
Query: 164 TISRRKTFVGTPFWMAPEVIQNSEG----------YNEKADIWSLGITVIEMAKGEPPLA 213
R + + PE+ D W+LG+ + + + P+
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314
Query: 214 DLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271
+ I R + + ++ + L+ +R + + R
Sbjct: 315 KDAALGGSEWIFRSCK-----NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 172 bits (436), Expect = 4e-48
Identities = 40/317 (12%), Positives = 98/317 (30%), Gaps = 45/317 (14%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQ--------- 67
++G+ +A D+E + + V E + I+ +++E+ L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 68 -------------CRSPYITEYYGSYLHQTKLWIIMEYMA-----------GGSVADLIQ 103
+ P + L + +W++ + G +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 104 SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-T 162
+ L + + ++ + LH+ G +H ++ +I+L + G V + F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263
Query: 163 RTISRRKTFVGTPFWMAPEVIQNSEG----YNEKADIWSLGITVIEMAKGEPPLADLHPM 218
+S P A ++ + D W+LG+ + + + P D +
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323
Query: 219 RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278
I R + + ++ + L+ +R + + R
Sbjct: 324 GGSEWIFRSCK-----NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAAL 378
Query: 279 RIRERPKYPIQEEPDTP 295
+ + P +E P
Sbjct: 379 PLYQTDGEPTREGGAPP 395
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 6e-48
Identities = 73/266 (27%), Positives = 127/266 (47%), Gaps = 20/266 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPYITEY 76
+ +G G+FG V + VA+K+++ + S D + I++EI L R P+I +
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
Y T +++MEY++GG + D I ++EM + + +L A++Y H +HRD
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRD 136
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN-EKADI 195
+K N+LL + + K+ADFG+S + +T G+P + APEVI Y + DI
Sbjct: 137 LKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSCGSPNYAAPEVISG-RLYAGPEVDI 194
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVL-------FIIPRENPPQLDEHFSRLMKEFVSLCL 248
WS G+ + + G P D H + F IP + +R + + L
Sbjct: 195 WSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE--------YLNRSVATLLMHML 246
Query: 249 KKVPAERPSAKELLRHRFIRNARKSP 274
+ P +R + K++ H + + S
Sbjct: 247 QVDPLKRATIKDIREHEWFKQDLPSY 272
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 73/297 (24%), Positives = 114/297 (38%), Gaps = 30/297 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID----LEESEDE-IEDIQKEISVLSQ 67
+ + L+G+G FG V+ VAIKVI L S E+++L +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 68 CRS----PYITEYYGSYLHQTKLWIIMEY-MAGGSVADLIQSGPPLDEMSIACILRDLLH 122
+ P + + Q +++E + + D I PL E C ++
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 123 AIEYLHNEGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPE 181
AI++ H+ G +HRDIK NIL+ G K+ DFG A L F GT + PE
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDFDGTRVYSPPE 208
Query: 182 VIQNSEGYN-EKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLDEHFSRL 239
I Y+ A +WSLGI + +M G+ P + P H S
Sbjct: 209 WISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPA--------HVSPD 259
Query: 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPI 296
+ CL P+ RPS +E+L +++ + L P +
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPL------NPSKGGPAPLAWSL 310
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 2e-47
Identities = 66/308 (21%), Positives = 117/308 (37%), Gaps = 58/308 (18%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
LELIGRG +G VYK + VA+KV ++ I +K I +
Sbjct: 9 SLDLDNLKLLELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQNFIN--EKNIYRVPLM 64
Query: 69 RSPYITEYYG-----SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHA 123
I + + + + ++MEY GS+ + D +S + +
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRG 123
Query: 124 IEYLHNEGK---------IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR------ 168
+ YLH E HRD+ + N+L+ +G ++DFG+S +LT R
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 169 --KTFVGTPFWMAPEVIQNS------EGYNEKADIWSLGITVIEMAKG------------ 208
+ VGT +MAPEV++ + E ++ D+++LG+ E+
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 209 -EPPLADLHP-------MRVLFIIPRENPP-----QLDEHFSRLMKEFVSLCLKKVPAER 255
+ M+VL ++ P + + R +KE + C + R
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303
Query: 256 PSAKELLR 263
+A+
Sbjct: 304 LTAQXAEE 311
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-47
Identities = 74/263 (28%), Positives = 129/263 (49%), Gaps = 20/263 (7%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F ++ +G GSFG V KE A+K++D ++ +IE E +L P+
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMS----IACILRDLLHAIEYLH 128
+ + S+ + L+++MEY+AGG + ++ E A I+ EYLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
+ I+RD+K N+L+ + G ++V DFG + ++ R T GTP +APE+I + +G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEALAPEIILS-KG 214
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248
YN+ D W+LG+ + EMA G PP P+++ I + HFS +K+ + L
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKVRFPSHFSSDLKDLLRNLL 273
Query: 249 KKVPAER-----PSAKELLRHRF 266
+ +R ++ H++
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKW 296
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-47
Identities = 58/301 (19%), Positives = 108/301 (35%), Gaps = 55/301 (18%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
LE+ RG FG V+KA N+ VA+K+ + + + E+ L
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKI--FPIQDKQSWQNEYEVYSLPGM 75
Query: 69 RSPYITEYYGS----YLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAI 124
+ I ++ G+ LW+I + GS++D ++ + + I + +
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARGL 134
Query: 125 EYLHNEGK----------IHRDIKAANILLTENGDVKVADFGVSAQL--TRTISRRKTFV 172
YLH + HRDIK+ N+LL N +ADFG++ + ++ V
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 173 GTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKG-----------EPPLADLHP 217
GT +MAPEV++ + + D++++G+ + E+A P +
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254
Query: 218 MRVLF--------------IIPRE-NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
++ ++E C R SA +
Sbjct: 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE----CWDHDAEARLSAGCVG 310
Query: 263 R 263
Sbjct: 311 E 311
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-47
Identities = 70/297 (23%), Positives = 127/297 (42%), Gaps = 24/297 (8%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE--IEDIQKEISVLSQCR 69
R+ ++ +G G VY A D LN VAIK I + E E ++ ++E+ SQ
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
I +++MEY+ G ++++ I+S PL + +L I++ H+
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 130 EGKIHRDIKAANILLTENGDVKVADFG-VSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
+HRDIK NIL+ N +K+ DFG A ++++ +GT + +PE + E
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK-GEA 188
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--------IIPRENPPQLDEHFSRLM 240
+E DI+S+GI + EM GEPP + + + + + + S +
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV- 247
Query: 241 KEFVSLCLKKVPAERP-SAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPI 296
+ +K A R + +E+ + + R E Y + + +
Sbjct: 248 ---ILRATEKDKANRYKTIQEMKDD--LSSVLHENRANE-----DVYELDKMKTIAV 294
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 67/272 (24%), Positives = 108/272 (39%), Gaps = 22/272 (8%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEISVLSQCRS-- 70
L+G G FG VY N VAIK ++ + E+ +L + S
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAG-GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
+ + +I+E + D I L E +L A+ + HN
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 167
Query: 130 EGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
G +HRDIK NIL+ G++K+ DFG A L + F GT + PE I+
Sbjct: 168 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRY-HR 224
Query: 189 YN-EKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLDEHFSRLMKEFVSL 246
Y+ A +WSLGI + +M G+ P +R + S + +
Sbjct: 225 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ--------RVSSECQHLIRW 276
Query: 247 CLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278
CL P++RP+ +E+ H ++++ E
Sbjct: 277 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 308
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 74/273 (27%), Positives = 130/273 (47%), Gaps = 20/273 (7%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L++IGRG+F +V K+ + A+K+++ + E+ ++E VL +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACI-LRDLLHAIEYLHNE 130
IT+ + ++ + L+++MEY GG + L+ G + +A L +++ AI+ +H
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA-EMARFYLAEIVMAIDSVHRL 181
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR-KTFVGTPFWMAPEVIQNSEG- 188
G +HRDIK NILL G +++ADFG +L + R VGTP +++PE++Q G
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 189 -----YNEKADIWSLGITVIEMAKGEPPL--ADLHPM--RVLFIIPRENPPQLDEHFSRL 239
Y + D W+LG+ EM G+ P +++ + P +DE
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEE 301
Query: 240 MKEFVSLCLKKVPAER---PSAKELLRHRFIRN 269
++F+ L P R A + H F
Sbjct: 302 ARDFIQRLLCP-PETRLGRGGAGDFRTHPFFFG 333
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-46
Identities = 70/307 (22%), Positives = 128/307 (41%), Gaps = 40/307 (13%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVLSQCRSPY 72
++ + IG GS+G V+K +++ + VAIK E + I+ I +EI +L Q + P
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + + +L ++ EY + +L + + E + I L A+ + H
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRRKTF---VGTPFWMAPEVIQNSEG 188
IHRD+K NIL+T++ +K+ DFG R + + V T ++ +PE++
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFG----FARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 189 YNEKADIWSLGITVIEMAKGEP--------------------------PLADLHPMRVLF 222
Y D+W++G E+ G P + +
Sbjct: 180 YGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239
Query: 223 IIPRENPPQ-LDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278
IP + L+ F + + L CL P ER + ++LL H + N R+ L
Sbjct: 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE-IEDLA 298
Query: 279 RIRERPK 285
+ ++P
Sbjct: 299 KEHDKPA 305
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-46
Identities = 72/273 (26%), Positives = 125/273 (45%), Gaps = 23/273 (8%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F ++GRG FG+V+ K K A K ++ + + E +L++ S +
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGS----VADLIQSGPPLDEMS----IACILRDLLHAI 124
I ++ +T L ++M M GG + ++ + P E A I+ +
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS----GL 302
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
E+LH I+RD+K N+LL ++G+V+++D G++ +L ++ K + GTP +MAPE++
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPP-LADLHPMRV--LFIIPRENPPQLDEHFSRLMK 241
E Y+ D ++LG+T+ EM P A + L E + FS K
Sbjct: 363 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 242 EFVSLCLKKVPAER-----PSAKELLRHRFIRN 269
+F L+K P +R S L H R+
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 5e-46
Identities = 76/306 (24%), Positives = 142/306 (46%), Gaps = 41/306 (13%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVLSQCRSPY 72
++ +L L+G GS+G V K +K+ + VAIK + + ++ I +EI +L Q R
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEG 131
+ + + +++ E++ ++ D ++ P LD + L +++ I + H+
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRKTF---VGTPFWMAPEVIQNSE 187
IHRDIK NIL++++G VK+ DFG RT++ + + V T ++ APE++
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFG----FARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 188 GYNEKADIWSLGITVIEMAKGEP--------------------------PLADLHPMRVL 221
Y + D+W++G V EM GEP L + +P+
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260
Query: 222 FIIPRENPPQ-LDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRNARKSPRLL 277
+P + L+ + +L + + L CL P +RP ELL H F + + R
Sbjct: 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFS 320
Query: 278 ERIRER 283
+ ++ +
Sbjct: 321 QELQLK 326
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-46
Identities = 68/269 (25%), Positives = 129/269 (47%), Gaps = 22/269 (8%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L IG+GSFG V + K A+K ++ ++ +E+ ++ KE+ ++ P+
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLHAIE 125
+ + S+ + ++++++ + GG DL +Q E + I ++ A++
Sbjct: 77 LVNLWYSFQDEEDMFMVVDLLLGG---DLRYHLQQNVHFKEETVKLFICELVM----ALD 129
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
YL N+ IHRD+K NILL E+G V + DF ++A L R ++ T GT +MAPE+ +
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSS 188
Query: 186 SE--GYNEKADIWSLGITVIEMAKGEPP--LADLHPMRVLFIIPRENPPQLDEHFSRLMK 241
+ GY+ D WSLG+T E+ +G P + + + +S+ M
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMV 248
Query: 242 EFVSLCLKKVPAER-PSAKELLRHRFIRN 269
+ L+ P +R ++ ++ +
Sbjct: 249 SLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-46
Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 25/276 (9%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
E IGRG+FG+V+ + N VA+K D +E +L Q P I
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
G + ++I+ME + GG +++ G L ++ ++ D +EYL ++ IHRD
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT-PF-WMAPEVIQNSEGYNEKAD 194
+ A N L+TE +K++DFG+S + + + P W APE + Y+ ++D
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESD 297
Query: 195 IWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLK 249
+WS GI + E + G P +L + + + P + RLM++ C
Sbjct: 298 VWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQ----CWA 353
Query: 250 KVPAERPSAKELLRHRFIRNARKSPRLLERIRERPK 285
P +RPS + + L+ IR+R +
Sbjct: 354 YEPGQRPSFSTIYQE------------LQSIRKRHR 377
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 8e-46
Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 23/283 (8%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPYITEY 76
E +G GSFG V A + + VA+K I + + D +++EIS L R P+I +
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
Y T + +++EY AGG + D I + E + ++ AIEY H +HRD
Sbjct: 75 YDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRD 133
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN-EKADI 195
+K N+LL +N +VK+ADFG+S + + KT G+P + APEVI + Y + D+
Sbjct: 134 LKPENLLLDDNLNVKIADFGLSN-IMTDGNFLKTSCGSPNYAAPEVING-KLYAGPEVDV 191
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVL-------FIIPRENPPQLDEHFSRLMKEFVSLCL 248
WS GI + M G P D + +++P + S + + +
Sbjct: 192 WSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP--------DFLSPGAQSLIRRMI 243
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEE 291
P +R + +E+ R + P L + E
Sbjct: 244 VADPMQRITIQEIRRDPWFN--VNLPDYLRPMEEVQGSYADSR 284
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 85/295 (28%), Positives = 127/295 (43%), Gaps = 28/295 (9%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+ IG G+FG DK + VA+K I+ + DE ++Q+EI R P I +
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE--NVQREIINHRSLRHPNIVRFKE 83
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
L T L IIMEY +GG + + I + E + LL + Y H+ HRD+K
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLK 143
Query: 139 AANILLTEN--GDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN-EKADI 195
N LL + +K+ DFG S + S+ K+ VGTP ++APEV+ + Y+ + AD+
Sbjct: 144 LENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLR-QEYDGKIADV 201
Query: 196 WSLGITVIEMAKGEPPLADLHPM-----------RVLFIIPRENPPQLDEHFSRLMKEFV 244
WS G+T+ M G P D V + IP D S +
Sbjct: 202 WSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD------DIRISPECCHLI 255
Query: 245 SLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGV 299
S PA R S E+ H + + P L +EP+ P+ +
Sbjct: 256 SRIFVADPATRISIPEIKTHSWFL--KNLPADLMNESNTGSQ--FQEPEQPMQSL 306
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 70/271 (25%), Positives = 136/271 (50%), Gaps = 31/271 (11%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
+ +++IGRG+FG+V K K A+K++ E + +E +++ SP+
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMS---IACILRDLLHAIEYLHN 129
+ + + ++ L+++MEYM GG + +L+ + ++ + A +++ A++ +H+
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA----EVVLALDAIHS 186
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGTPFWMAPEVIQNSEG 188
G IHRD+K N+LL ++G +K+ADFG ++ + + R T VGTP +++PEV+++ G
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 189 ---YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245
Y + D WS+G+ + EM G+ P ++ +S++M S
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYA------------DSLVGT---YSKIMNHKNS 291
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRL 276
L AK L+ F+ + RL
Sbjct: 292 LTFPDDNDISKEAKNLIC-AFLTDREV--RL 319
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 5e-45
Identities = 81/271 (29%), Positives = 133/271 (49%), Gaps = 27/271 (9%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSPY 72
F L+L+G+G+FG V +K + A+K++ ++ ++DE+ E VL R P+
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 73 ITEYYGSYLHQT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLHA 123
+T ++ QT +L +MEY GG +L + E A I+ A
Sbjct: 67 LTALKYAF--QTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIV----SA 117
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI 183
+EYLH+ ++RDIK N++L ++G +K+ DFG+ + + KTF GTP ++APEV+
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243
++ Y D W LG+ + EM G P + LF + + S K
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 244 VSLCLKKVPAER-----PSAKELLRHRFIRN 269
++ LKK P +R AKE++ HRF +
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 6e-45
Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L +G GSFG V+ + + A+KV+ E ++E E +LS P+
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACI-LRDLLHAIEYLHNEG 131
I +G++ ++++IM+Y+ GG + L++ +A ++ A+EYLH++
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN-PVAKFYAAEVCLALEYLHSKD 126
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQL-TRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
I+RD+K NILL +NG +K+ DFG + + T T GTP ++APEV+ YN
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTK-PYN 181
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
+ D WS GI + EM G P D + M+ I + F+ +K+ +S + +
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-LNAELRFPPFFNEDVKDLLSRLITR 240
Query: 251 VPAER-----PSAKELLRHRF 266
++R +++ H +
Sbjct: 241 DLSQRLGNLQNGTEDVKNHPW 261
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 76/278 (27%), Positives = 132/278 (47%), Gaps = 37/278 (13%)
Query: 15 FSSLELIGRGSFGDVY---KAFDKELNKDVAIKVI---DLEESEDEIEDIQKEISVLSQC 68
F L ++G+G +G V+ K K A+KV+ + + + + E ++L +
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 69 RSPYITEYYGSYLH---QT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACI 116
+ P+I + L QT KL++I+EY++GG +L ++ E + +A I
Sbjct: 79 KHPFIVD-----LIYAFQTGGKLYLILEYLSGG---ELFMQLEREGIFMEDTACFYLAEI 130
Query: 117 LRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176
A+ +LH +G I+RD+K NI+L G VK+ DFG+ + + TF GT
Sbjct: 131 S----MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF 236
+MAPE++ G+N D WSLG + +M G PP + + + I + L +
Sbjct: 187 YMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI-LKCKLNLPPYL 244
Query: 237 SRLMKEFVSLCLKKVPAER-----PSAKELLRHRFIRN 269
++ ++ + LK+ A R A E+ H F R+
Sbjct: 245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-44
Identities = 72/283 (25%), Positives = 128/283 (45%), Gaps = 21/283 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPYITEY 76
+ +G G+FG V + VA+K+++ + S D + I++EI L R P+I +
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
Y + ++++MEY++GG + D I LDE + + +L ++Y H +HRD
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRD 141
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN-EKADI 195
+K N+LL + + K+ADFG+S + +T G+P + APEVI Y + DI
Sbjct: 142 LKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSCGSPNYAAPEVISG-RLYAGPEVDI 199
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVL-------FIIPRENPPQLDEHFSRLMKEFVSLCL 248
WS G+ + + G P D H + F P ++ + + + L
Sbjct: 200 WSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP--------QYLNPSVISLLKHML 251
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEE 291
+ P +R + K++ H + + L I +E
Sbjct: 252 QVDPMKRATIKDIREHEWFKQDLPKY-LFPEDPSYSSTMIDDE 293
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-44
Identities = 73/267 (27%), Positives = 126/267 (47%), Gaps = 16/267 (5%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L++IGRG+FG+V K +K A+K+++ E E ++E VL S +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACI-LRDLLHAIEYLHNEG 131
IT + ++ L+++M+Y GG + L+ +A L +++ AI+ +H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR-KTFVGTPFWMAPEVIQNSE--- 187
+HRDIK NIL+ NG +++ADFG +L + + VGTP +++PE++Q E
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 188 -GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--IIPRENPPQLDEHFSRLMKEFV 244
Y + D WSLG+ + EM GE P + + I+ + Q + + +
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHKERFQFPTQVTDVSENAK 314
Query: 245 SLC--LKKVPAER---PSAKELLRHRF 266
L L R ++ +H F
Sbjct: 315 DLIRRLICSREHRLGQNGIEDFKKHPF 341
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-44
Identities = 66/270 (24%), Positives = 117/270 (43%), Gaps = 21/270 (7%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE--IEDIQKEISVLSQCRSPYITE 75
L+GRG GDVY+A D + VA+K++ S D +Q+E + + P++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
+ +L++ M + G +A +++ PL I+R + A++ H G HR
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHR 158
Query: 136 DIKAANILLTENGDVKVADFGV-----SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
D+K NIL++ + + DFG+ +LT+ VGT ++MAPE S
Sbjct: 159 DVKPENILVSADDFAYLVDFGIASATTDEKLTQL----GNTVGTLYYMAPERFSESHA-T 213
Query: 191 EKADIWSLGITVIEMAKGEPP-LADLHPMRVLFIIPRENPPQLDEHFSRLMKEF---VSL 246
+ADI++L + E G PP D + V+ + P+ + F ++
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGD--QLSVMGAHINQAIPRPSTVRPGIPVAFDAVIAR 271
Query: 247 CLKKVPAER-PSAKELLRHRFIRNARKSPR 275
+ K P +R + +L A +
Sbjct: 272 GMAKNPEDRYVTCGDLSAA--AHAALATAD 299
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 9e-44
Identities = 70/292 (23%), Positives = 119/292 (40%), Gaps = 55/292 (18%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYY 77
+++G G G V + F+K + A+K++ + ++E+ + + P+I
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVRIV 77
Query: 78 GSY----LHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG 131
Y + L I+ME + GG + IQ E + I++ + AI+YLH+
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137
Query: 132 KIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
HRD+K N+L T N +K+ DFG A E E
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFG---------------------FAKETTG--EK 174
Query: 189 YNEKADIWSLG-ITVIEMAKGEPPLADLHPMRV---LFIIPRENPPQLDE----HFSRLM 240
Y++ D+WSLG I I + G PP H + + + R + S +
Sbjct: 175 YDKSCDMWSLGVIMYI-LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 233
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP-------RLLERIRERPK 285
K + LK P +R + E + H +I + K P R+L+ +ER +
Sbjct: 234 KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 285
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-43
Identities = 71/270 (26%), Positives = 118/270 (43%), Gaps = 20/270 (7%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F ++G+G FG+V + K A K ++ + E +L + S +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI----QSGPPLDEMSIACI-LRDLLHAIEYL 127
+ +Y + L +++ M GG DL G + A ++ +E L
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGG---DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSE 187
H E ++RD+K NILL ++G ++++D G++ + K VGT +MAPEV++N E
Sbjct: 303 HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKN-E 360
Query: 188 GYNEKADIWSLGITVIEMAKGEPPLAD---LHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244
Y D W+LG + EM G+ P + + +E P + E FS +
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420
Query: 245 SLCLKKVPAER-----PSAKELLRHRFIRN 269
S L K PAER SA+E+ H +
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 27/282 (9%)
Query: 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ F ++++G G+FG VYK +++ VAIK + S ++I E V++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYL 127
+P++ G L T + +I + M G + D + + + + + + YL
Sbjct: 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFVG-TPF-WMAPE 181
+ +HRD+ A N+L+ VK+ DFG L + + G P WMA E
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFG----LAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 182 VIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHF 236
I + Y ++D+WS G+TV E M G P + + I+ + PP
Sbjct: 190 SILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248
Query: 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278
+M++ C RP +E L F + AR R L
Sbjct: 249 YMIMRK----CWMIDADSRPKFRE-LIIEFSKMARDPQRYLV 285
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 36/281 (12%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQ-CRSP 71
F L +IGRGS+ V K+ ++ A+KV+ +L +++I+ +Q E V Q P
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 72 YITEYYGSYLHQT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLH 122
++ + + QT +L+ ++EY+ GG DL +Q L E A I
Sbjct: 71 FLVGLHSCF--QTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEIS----L 121
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
A+ YLH G I+RD+K N+LL G +K+ D+G+ + R TF GTP ++APE+
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 181
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV--------LFIIPRENPPQLDE 234
++ E Y D W+LG+ + EM G P + LF + E ++
Sbjct: 182 LRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 240
Query: 235 HFSRLMKEFVSLCLKKVPAER------PSAKELLRHRFIRN 269
S + L K P ER ++ H F RN
Sbjct: 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-43
Identities = 73/303 (24%), Positives = 132/303 (43%), Gaps = 21/303 (6%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE--IEDIQKEISVLSQCR 69
R+ E++G G +V+ A D ++DVA+KV+ + + D ++E +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 70 SPYITEYY--GSYLHQTKL--WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125
P I Y G +I+MEY+ G ++ D++ + P+ ++ D A+
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGV---SAQLTRTISRRKTFVGTPFWMAPEV 182
+ H G IHRD+K ANI+++ VKV DFG+ A ++++ +GT +++PE
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL--- 239
+ + + ++D++SLG + E+ GEPP P+ V + RE+P L
Sbjct: 191 AR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249
Query: 240 MKEFVSLCLKKVPAERP-SAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPING 298
+ V L K P R +A E+ + PK E + ++
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRAD--LVRVHNGEPPEA-----PKVLTDAERTSLLSS 302
Query: 299 VRA 301
Sbjct: 303 AAG 305
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-43
Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 24/270 (8%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSPY 72
F L+L+G+G+FG V +K + A+K++ ++ ++DE+ E VL R P+
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLHAIE 125
+T S+ +L +MEY GG +L + E A I+ A++
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIV----SALD 262
Query: 126 YLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
YLH+E ++RD+K N++L ++G +K+ DFG+ + + + KTF GTP ++APEV++
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244
+ Y D W LG+ + EM G P + LF + + K +
Sbjct: 323 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLL 380
Query: 245 SLCLKKVPAER----PS-AKELLRHRFIRN 269
S LKK P +R AKE+++HRF
Sbjct: 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 24/268 (8%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQC-RSP 71
F +++G+GSFG V+ A K+ N+ AIK + D+ +D++E E VLS P
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 72 YITEYYGSYLHQT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLH 122
++T + ++ QT L+ +MEY+ GG DL IQS D A I+
Sbjct: 79 FLTHMFCTF--QTKENLFFVMEYLNGG---DLMYHIQSCHKFDLSRATFYAAEII----L 129
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
+++LH++G ++RD+K NILL ++G +K+ADFG+ + ++ TF GTP ++APE+
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
+ + YN D WS G+ + EM G+ P + I R + P + K+
Sbjct: 190 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-RMDNPFYPRWLEKEAKD 247
Query: 243 FVSLCLKKVPAER-PSAKELLRHRFIRN 269
+ + P +R ++ +H R
Sbjct: 248 LLVKLFVREPEKRLGVRGDIRQHPLFRE 275
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 78/279 (27%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQ-CRSP 71
F L +IGRGS+ V K+ ++ A++V+ +L +++I+ +Q E V Q P
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLHAI 124
++ + + +++L+ ++EY+ GG DL +Q L E A I A+
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEIS----LAL 166
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
YLH G I+RD+K N+LL G +K+ D+G+ + R TF GTP ++APE+++
Sbjct: 167 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV--------LFIIPRENPPQLDEHF 236
E Y D W+LG+ + EM G P + LF + E ++
Sbjct: 227 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285
Query: 237 SRLMKEFVSLCLKKVPAER------PSAKELLRHRFIRN 269
S + L K P ER ++ H F RN
Sbjct: 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-42
Identities = 68/267 (25%), Positives = 123/267 (46%), Gaps = 14/267 (5%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS-- 70
FS +IGRG FG+VY + K A+K +D + + E +LS +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 71 -PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
P+I ++ KL I++ M GG + + E + +++ +E++HN
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
++RD+K ANILL E+G V+++D G++ ++ + VGT +MAPEV+Q Y
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAY 368
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPM--RVLFIIPRENPPQLDEHFSRLMKEFVSLC 247
+ AD +SLG + ++ +G P + + +L + FS ++ +
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 428
Query: 248 LKKVPAER-----PSAKELLRHRFIRN 269
L++ R A+E+ F R+
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-42
Identities = 80/273 (29%), Positives = 126/273 (46%), Gaps = 29/273 (10%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRS-P 71
F + ++G+GSFG V A KE A+KV+ D+ +D++E E +LS R+ P
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 72 YITEYYGSYLHQT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLH 122
++T+ + + QT +L+ +ME++ GG DL IQ DE A I+
Sbjct: 85 FLTQLFCCF--QTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEII----S 135
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
A+ +LH++G I+RD+K N+LL G K+ADFG+ + TF GTP ++APE+
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
+Q Y D W++G+ + EM G P LF +
Sbjct: 196 LQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLHEDATG 253
Query: 243 FVSLCLKKVPAER------PSAKELLRHRFIRN 269
+ + K P R +LRH F +
Sbjct: 254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-42
Identities = 80/305 (26%), Positives = 136/305 (44%), Gaps = 28/305 (9%)
Query: 18 LELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+++G G FG+V K +K VAIK + + +E + D E S++ Q P I
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
G + I+ EYM GS+ L + + + +LR + ++YL + G +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEGYN 190
HRD+ A NIL+ N KV+DFG+ L T G W +PE I + +
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FT 228
Query: 191 EKADIWSLGITVIE-MAKGEPPLADLHPMRVLFII--------PRENPPQLDEHFSRLMK 241
+D+WS GI + E M+ GE P ++ V+ + P + P L + +LM
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL--Y--QLML 284
Query: 242 EFVSLCLKKVPAERPSAKELLR--HRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGV 299
+ C +K RP ++++ + IRN S +++ RP + ++ + I
Sbjct: 285 D----CWQKDRNNRPKFEQIVSILDKLIRNP-GSLKIITSAAARPSNLLLDQSNVDITTF 339
Query: 300 RAVGE 304
R G+
Sbjct: 340 RTTGD 344
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 9e-42
Identities = 75/273 (27%), Positives = 132/273 (48%), Gaps = 19/273 (6%)
Query: 15 FSSLELIGRGSFGDVY---KAFDKELNKDVAIKVI---DLEESEDEIEDIQKEISVLSQC 68
F L+++G G++G V+ K + K A+KV+ + + E + E VL
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 69 -RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACI-LRDLLHAIEY 126
+SP++ + ++ +TKL +I++Y+ GG + + E I + +++ A+E+
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE-HEVQIYVGEIVLALEH 174
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVS-AQLTRTISRRKTFVGTPFWMAPEVIQ- 184
LH G I+RDIK NILL NG V + DFG+S + R F GT +MAP++++
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPP---LADLHPMRVLFIIPRENPPQLDEHFSRLMK 241
G+++ D WSLG+ + E+ G P + + + ++ P + S L K
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 294
Query: 242 EFVSLCLKKVPAER-----PSAKELLRHRFIRN 269
+ + L K P +R A E+ H F +
Sbjct: 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 75/304 (24%), Positives = 124/304 (40%), Gaps = 57/304 (18%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ--KEISVLSQCRS 70
++ LE +G G++G VYKA D + + VA+K I L+ +EDE +EIS+L +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLD-AEDEGIPSTAIREISLLKELHH 78
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEY 126
P I + L ++ E+M DL + + L + I L LL + +
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKTF---VGTPFWMAPEV 182
H +HRD+K N+L+ +G +K+ADFG L R +++ V T ++ AP+V
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFG----LARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEP--------------------P----------L 212
+ S+ Y+ DIWS+G EM G+P P L
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250
Query: 213 ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRN 269
+E + L L P +R SA++ + H + ++
Sbjct: 251 PLWKQRT----FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
Query: 270 ARKS 273
Sbjct: 307 LDPQ 310
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 48/295 (16%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ--KEISVLSQCRSP 71
++ LE IG G++G V+KA ++E ++ VA+K + L+ +DE +EI +L + +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHK 61
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYL 127
I + KL ++ E+ DL + LD + L LL + +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKTF---VGTPFWMAPEVI 183
H+ +HRD+K N+L+ NG++K+A+FG L R + + V T ++ P+V+
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFG----LARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPL----ADLHPMRVLFII---PREN-------- 228
++ Y+ D+WS G E+A PL ++ +F + P E
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 229 -----------PPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRN 269
L +L L LK P +R SA+E L+H + +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 76/272 (27%), Positives = 130/272 (47%), Gaps = 28/272 (10%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQ-CRSP 71
F+ L ++G+GSFG V + K ++ A+K++ D+ +D++E E VL+ + P
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 72 YITEYYGSYLHQT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLH 122
++T+ + + QT +L+ +MEY+ GG DL IQ E A I
Sbjct: 82 FLTQLHSCF--QTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIA----I 132
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
+ +L ++G I+RD+K N++L G +K+ADFG+ + KTF GTP ++APE+
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI 192
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
I + Y + D W+ G+ + EM G+ P LF E+ + S+
Sbjct: 193 IAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVA 250
Query: 243 FVSLCLKKVPAER-----PSAKELLRHRFIRN 269
+ K P +R +++ H F R
Sbjct: 251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQ-CRSP 71
F L++IG+GSFG V A K A+KV+ + E + I E +VL + + P
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 72 YITEYYGSYLHQT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLH 122
++ + S+ QT KL+ +++Y+ GG +L +Q E A I
Sbjct: 100 FLVGLHFSF--QTADKLYFVLDYINGG---ELFYHLQRERCFLEPRARFYAAEIA----S 150
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
A+ YLH+ ++RD+K NILL G + + DFG+ + S TF GTP ++APEV
Sbjct: 151 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
+ + Y+ D W LG + EM G PP + + I P QL + + +
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI-LNKPLQLKPNITNSARH 268
Query: 243 FVSLCLKKVPAER----PSAKELLRHRFIRN 269
+ L+K +R E+ H F
Sbjct: 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 37/277 (13%)
Query: 15 FSSLELIGRGSFGDVY---KAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCR 69
F L+++G+GSFG V+ K + + A+KV+ + D + + E +L +
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 84
Query: 70 SPYITEYYGSYLH---QT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACIL 117
P+I + LH QT KL++I++++ GG DL + E +A +
Sbjct: 85 HPFIVK-----LHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELA 136
Query: 118 RDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFW 177
A+++LH+ G I+RD+K NILL E G +K+ DFG+S + + +F GT +
Sbjct: 137 ----LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFS 237
MAPEV+ G+ + AD WS G+ + EM G P + + + + + S
Sbjct: 193 MAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKLGMPQFLS 250
Query: 238 RLMKEFVSLCLKKVPAER-----PSAKELLRHRFIRN 269
+ + + K+ PA R +E+ RH F
Sbjct: 251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 78/328 (23%), Positives = 129/328 (39%), Gaps = 62/328 (18%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE----IEDIQKEISVLSQCR 69
+ L+ +G G++ VYK K + VA+K I LE E I +E+S+L +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLK 58
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIE 125
I + + L ++ EY+ DL Q G ++ ++ L LL +
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRKTF---VGTPFWMAPE 181
Y H + +HRD+K N+L+ E G++K+ADFG L R S KT+ V T ++ P+
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFG----LARAKSIPTKTYDNEVVTLWYRPPD 170
Query: 182 VIQNSEGYNEKADIWSLGITVIEMAKGEP--------------------P---------- 211
++ S Y+ + D+W +G EMA G P P
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 212 LADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIR 268
+ P+ L H RL + L L+ R SA++ ++H F
Sbjct: 231 NEEFKTYN----YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
Query: 269 NARKSPRLLERIRER-PKYPIQEEPDTP 295
+ + L IQ + +
Sbjct: 287 SLGERIHKLPDTTSIFALKEIQLQKEAS 314
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-41
Identities = 60/267 (22%), Positives = 118/267 (44%), Gaps = 32/267 (11%)
Query: 18 LELIGRGSFGDVYKAFDKELNK-------DVAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
E +G+G+F ++K +E+ +V +KV+D + + E + S++S+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFFEAASMMSKLSH 71
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHN 129
++ YG + + ++ E++ GS+ L ++ ++ + + + L A+ +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 130 EGKIHRDIKAANILLT--------ENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAP 180
IH ++ A NILL +K++D G ++ T+ + W+ P
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG----ISITVLPKDILQ-ERIPWVPP 186
Query: 181 EVIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIP---RENPPQLDEHF 236
E I+N + N D WS G T+ E + G+ PL+ L R L + P+ E
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELA 246
Query: 237 SRLMKEFVSLCLKKVPAERPSAKELLR 263
+ L+ C+ P RPS + ++R
Sbjct: 247 N-LINN----CMDYEPDHRPSFRAIIR 268
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 8e-41
Identities = 74/270 (27%), Positives = 128/270 (47%), Gaps = 24/270 (8%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQ-CRSP 71
F+ L ++G+GSFG V + K ++ A+K++ D+ +D++E E VL+ + P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLHAI 124
++T+ + + +L+ +MEY+ GG DL IQ E A I +
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIA----IGL 455
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
+L ++G I+RD+K N++L G +K+ADFG+ + KTF GTP ++APE+I
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 515
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244
+ Y + D W+ G+ + EM G+ P LF E+ + S+
Sbjct: 516 Y-QPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAIC 573
Query: 245 SLCLKKVPAER-----PSAKELLRHRFIRN 269
+ K P +R +++ H F R
Sbjct: 574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 77/294 (26%), Positives = 127/294 (43%), Gaps = 48/294 (16%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ--KEISVLSQCRSP 71
++ LE IG G++G VYKA + + A+K I LE EDE +EIS+L + +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLE-KEDEGIPSTTIREISILKELKHS 60
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYL 127
I + Y + +L ++ E++ DL + L+ ++ L LL+ I Y
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKTF---VGTPFWMAPEVI 183
H+ +HRD+K N+L+ G++K+ADFG L R + + + T ++ AP+V+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFG----LARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------- 224
S+ Y+ DIWS+G EM G P + L I
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 225 ------PRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRN 269
P + L + + L LK P +R +AK+ L H + +
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 76/290 (26%), Positives = 119/290 (41%), Gaps = 20/290 (6%)
Query: 18 LELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
++IG G FG+VYK + VAIK + +E + D E ++ Q I
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
G + II EYM G++ L + + + +LR + ++YL N
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY 168
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEGY 189
+HRD+ A NIL+ N KV+DFG+S L T G W APE I + +
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-F 227
Query: 190 NEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFV 244
+D+WS GI + E M GE P +L V+ I P +LM +
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQ-- 285
Query: 245 SLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDT 294
C ++ A RP ++ + ++P L+ + + P T
Sbjct: 286 --CWQQERARRPKFADI--VSILDKLIRAPDSLKTLADFDPRVSIRLPST 331
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 74/308 (24%), Positives = 121/308 (39%), Gaps = 55/308 (17%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ----KEISVLSQC 68
SR+ + IG G++G VYKA D VA+K + + + +E+++L +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 69 RS---PYITE-----YYGSYLHQTKLWIIMEYMAGGSVADL-----IQSGPPLDEMSIAC 115
+ P + + K+ ++ E++ DL P L +I
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKD 124
Query: 116 ILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF---V 172
++R L +++LH +HRD+K NIL+T G VK+ADFG L R S + V
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG----LARIYSYQMALTPVV 180
Query: 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------- 224
T ++ APEV+ S Y D+WS+G EM + +P L I
Sbjct: 181 VTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 225 ---------------PRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRF 266
P P + + + L L P +R SA L+H +
Sbjct: 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 267 IRNARKSP 274
+ +P
Sbjct: 300 LHKDEGNP 307
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 20/295 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ F ++++G G+FG VYK +++ VAIK + S ++I E V++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYL 127
+P++ G L T + +I + M G + D + + + + + + YL
Sbjct: 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-TPF-WMAPEVIQN 185
+ +HRD+ A N+L+ VK+ DFG++ L G P WMA E I +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 186 SEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLM 240
Y ++D+WS G+TV E M G P + + I+ + PP +M
Sbjct: 194 RI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 252
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTP 295
+ C RP +EL + P+ I+ + + D+
Sbjct: 253 VK----CWMIDADSRPKFREL--IIEFSKMARDPQRYLVIQGDERMHLPSPTDSN 301
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 21/269 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
S + ++ IG G FG V+ + +K VAIK + E ED +E V+ + P
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKT--IREGAMSEEDFIEEAEVMMKLSHPK 64
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ + YG L Q + ++ E+M G ++D L ++ + D+ + YL
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEG 188
IHRD+ A N L+ EN +KV+DFG++ + T GT F W +PEV S
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSFSR- 181
Query: 189 YNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEF 243
Y+ K+D+WS G+ + E ++G+ P + V+ I P H ++M
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH- 240
Query: 244 VSLCLKKVPAERPSAKELLRH--RFIRNA 270
C ++ P +RP+ LLR +
Sbjct: 241 ---CWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 75/316 (23%), Positives = 121/316 (38%), Gaps = 66/316 (20%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ--KEISVLSQCRS 70
S+F LE +G G++ VYK +K VA+K + L+ SE+ +EIS++ + +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD-SEEGT-PSTAIREISLMKELKH 62
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADL---------IQSGPPLDEMSIACILRDLL 121
I Y + KL ++ E+M DL + L+ + LL
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMD----NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKTF---VGTPFW 177
+ + H +HRD+K N+L+ + G +K+ DFG L R TF V T ++
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFG----LARAFGIPVNTFSSEVVTLWY 174
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP--------------------P------ 211
AP+V+ S Y+ DIWS G + EM G+P P
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234
Query: 212 ----LADLHPMRVLF-------IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKE 260
L +P ++ LD + + + L P R SAK+
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN----PDMRLSAKQ 290
Query: 261 LLRHRFIRNARKSPRL 276
L H + +
Sbjct: 291 ALHHPWFAEYYHHASM 306
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 73/286 (25%), Positives = 137/286 (47%), Gaps = 27/286 (9%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ + +G G +G+VY+ K+ + VA+K L+E E+E+ KE +V+ + + P
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
+ + G + +II E+M G++ D ++ + + + + + A+EYL +
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR---RKTFVGTPF---WMAPEVIQ 184
IHRD+ A N L+ EN VKVADFG L+R ++ G F W APE +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFG----LSRLMTGDTYTAH-AGAKFPIKWTAPESLA 185
Query: 185 NSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRL 239
++ ++ K+D+W+ G+ + E G P + +V ++ + E P E L
Sbjct: 186 YNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 244
Query: 240 MKEFVSLCLKKVPAERPSAKELLRH--RFIRNARKSPRLLERIRER 283
M+ C + P++RPS E+ + + + S + + + +R
Sbjct: 245 MRA----CWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 286
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-40
Identities = 63/304 (20%), Positives = 118/304 (38%), Gaps = 25/304 (8%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELN-KDVAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
++ I G G +Y A D+ +N + V +K + + E L++
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH 138
Query: 71 PYITEYY-----GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125
P I + + +I+MEY+ G S+ P+ E L ++L A+
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAE--AIAYLLEILPALS 196
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
YLH+ G ++ D+K NI+LTE +K+ D G +++ GTP + APE+++
Sbjct: 197 YLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRT 251
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245
G DI+++G T+ + P + + E+ P L + S +
Sbjct: 252 --GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----PEDDPVLKTYDS--YGRLLR 302
Query: 246 LCLKKVPAERP-SAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGE 304
+ P +R +A+E+ + + + RP P GV +
Sbjct: 303 RAIDPDPRQRFTTAEEMSAQ--LTGVLREVVAQDTGVPRPGLSTIFSPSRSTFGVDLLVA 360
Query: 305 ASGT 308
+
Sbjct: 361 HTDV 364
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-40
Identities = 72/258 (27%), Positives = 104/258 (40%), Gaps = 24/258 (9%)
Query: 18 LELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
IG G FGDV++ VAIK S+ E +E + Q P+I
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ G +WIIME G + L LD S+ L A+ YL ++ +
Sbjct: 80 KLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 138
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT----PF-WMAPEVIQNSEG 188
HRDI A N+L++ N VK+ DFG L+R + + + P WMAPE I
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFG----LSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 193
Query: 189 YNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEF 243
+ +D+W G+ + E + G P + V+ I PP LM +
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK- 252
Query: 244 VSLCLKKVPAERPSAKEL 261
C P+ RP EL
Sbjct: 253 ---CWAYDPSRRPRFTEL 267
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 67/338 (19%), Positives = 132/338 (39%), Gaps = 74/338 (21%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE---IEDIQKEISVLSQCR 69
S++ L IG+G+FG+V+KA ++ + VA+K + +E +E E I + +EI +L +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKEGFPITAL-REIKILQLLK 74
Query: 70 SPYI--------TEYYGSYLHQTKLWIIMEYM----AGGSVADLIQSGP-PLDEMSIACI 116
+ T+ + ++++ ++ AG L+ + I +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-----LLSNVLVKFTLSEIKRV 129
Query: 117 LRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176
++ LL+ + Y+H +HRD+KAAN+L+T +G +K+ADFG L R S K +
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG----LARAFSLAKNSQPNRY 185
Query: 177 -------WM-APEVIQNSEGYNEKADIWSLGITVIEMAKGEP------------------ 210
W PE++ Y D+W G + EM P
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245
Query: 211 --------PLADLHPMRVLFIIPRENPPQLDEHFSRLMK-----EFVSLCLKKVPAERPS 257
P D + + + + ++ + ++ + + L PA+R
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305
Query: 258 AKELLRHRFIRNA--RKSPRLLERIRERPKYPIQEEPD 293
+ + L H F + + + + +
Sbjct: 306 SDDALNHDFFWSDPMPSDLKGM------LSTHLTSMFE 337
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-40
Identities = 63/272 (23%), Positives = 107/272 (39%), Gaps = 29/272 (10%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
E+IGRG FG VY + + A+K ++ E+ E ++ P +
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 75 EYYG-SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
G + +++ YM G + + + + + ++YL ++
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 149
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTI-------SRRKTFVGTPF-WMAPEVIQ 184
+HRD+ A N +L E VKVADFG L R + KT P WMA E +Q
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 185 NSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRL 239
+ + K+D+WS G+ + E M +G PP D++ + + + P + +
Sbjct: 206 TQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 264
Query: 240 MKEFVSLCLKKVPAERPSAKELLRH--RFIRN 269
M + C RPS EL+
Sbjct: 265 MLK----CWHPKAEMRPSFSELVSRISAIFST 292
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 84/320 (26%), Positives = 130/320 (40%), Gaps = 20/320 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ L+++G G FG V+K + + V IKVI+ + + + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYL 127
+I G + L ++ +Y+ GS+ D + Q L + + + YL
Sbjct: 73 DHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-TPF-WMAPEVIQN 185
G +HR++ A N+LL V+VADFGV+ L + TP WMA E I
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 186 SEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLM 240
+ Y ++D+WS G+TV E M G P A L V ++ + P +M
Sbjct: 192 GK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVM 250
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRE-RPKYPIQEEPDTPINGV 299
+ C RP+ KE L + F R AR PR L RE P EP N
Sbjct: 251 VK----CWMIDENIRPTFKE-LANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKK 305
Query: 300 RAVGEASGTVKVVRDKRSEE 319
E + + D +EE
Sbjct: 306 LEEVELEPELDLDLDLEAEE 325
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-40
Identities = 76/298 (25%), Positives = 125/298 (41%), Gaps = 51/298 (17%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIED------IQKEISVLS 66
R+ L+ +G G F VYKA DK N+ VAIK I L E +D + +EI +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLG-HRSEAKDGINRTAL-REIKLLQ 67
Query: 67 QCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLH 122
+ P I ++ H++ + ++ ++M DL + L I + L
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKTF---VGTPFWM 178
+EYLH +HRD+K N+LL ENG +K+ADFG L ++ + + V T ++
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFG----LAKSFGSPNRAYTHQVVTRWYR 179
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLA---DLHPMRVLF------------- 222
APE++ + Y D+W++G + E+ P L DL + +F
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239
Query: 223 --------IIPRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRN 269
L FS + + L P R +A + L+ ++ N
Sbjct: 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-40
Identities = 75/285 (26%), Positives = 123/285 (43%), Gaps = 39/285 (13%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
L+ IG+G FGDV + VA+K I + + + E SV++Q R
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATA---QAFLAEASVMTQLRHSN 75
Query: 73 ITEYYGSYLHQT-KLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHN 129
+ + G + + L+I+ EYMA GS+ D ++S L + D+ A+EYL
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNS 186
+HRD+ A N+L++E+ KV+DFG LT+ S + W APE ++
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQD--TGKLPVKWTAPEALREK 189
Query: 187 EGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMK 241
+ ++ K+D+WS GI + E + G P + V+ + + + P +MK
Sbjct: 190 K-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 248
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKY 286
C A RPS +L LE I+ +
Sbjct: 249 N----CWHLDAAMRPSFLQLREQ------------LEHIKTHELH 277
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-40
Identities = 71/258 (27%), Positives = 114/258 (44%), Gaps = 17/258 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+G+G FG+V+ VAIK L+ E +E V+ + R
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
+ + Y + ++I+ EYM+ GS+ D ++ G L + + + + Y+
Sbjct: 241 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGY 189
+HRD++AANIL+ EN KVADFG++ + + P W APE +
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-F 358
Query: 190 NEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFV 244
K+D+WS GI + E+ KG P + VL + R PP+ E LM +
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ-- 416
Query: 245 SLCLKKVPAERPSAKELL 262
C +K P ERP+ + L
Sbjct: 417 --CWRKEPEERPTFEYLQ 432
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 60/259 (23%), Positives = 108/259 (41%), Gaps = 21/259 (8%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD---VAIKVI--DLEESEDEIEDIQKEISVLSQCRSPYI 73
E +G GSFG V + + VA+K + D+ + ++D +E++ + +
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
YG L + ++ E GS+ D L + +++ + + YL ++
Sbjct: 84 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 142
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEGY 189
IHRD+ A N+LL VK+ DFG+ L + W APE ++ +
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-F 201
Query: 190 NEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPREN-----PPQLDEHFSRLMKEF 243
+ +D W G+T+ EM G+ P L+ ++L I +E P + +M +
Sbjct: 202 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ- 260
Query: 244 VSLCLKKVPAERPSAKELL 262
C P +RP+ L
Sbjct: 261 ---CWAHKPEDRPTFVALR 276
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 68/283 (24%), Positives = 129/283 (45%), Gaps = 31/283 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ L+ +G G FG V K DVA+K+ ++E ++ +E + + P
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKG-QYDVAVKM--IKEGSMSEDEFFQEAQTMMKLSHPK 64
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ ++YG + ++I+ EY++ G + + L G L+ + + D+ + +L +
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEG 188
IHRD+ A N L+ + VKV+DFG++ + GT F W APEV +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV--GTKFPVKWSAPEVFHYFK- 181
Query: 189 YNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEF 243
Y+ K+D+W+ GI + E + G+ P V+ + + P + ++M
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYS- 240
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKY 286
C ++P +RP+ ++LL +E +RE+ K+
Sbjct: 241 ---CWHELPEKRPTFQQLLSS------------IEPLREKDKH 268
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 21/268 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ L+ +G G FG V + DVAIK+ ++E ++ +E V+
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEK 80
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ + YG Q ++II EYMA G + + L + + + +D+ A+EYL ++
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEG 188
+HRD+ A N L+ + G VKV+DFG+S + G+ F W PEV+ S+
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV--GSKFPVRWSPPEVLMYSK- 197
Query: 189 YNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEF 243
++ K+DIW+ G+ + E + G+ P I + P E +M
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS- 256
Query: 244 VSLCLKKVPAERPSAKELLRH--RFIRN 269
C + ERP+ K LL + +
Sbjct: 257 ---CWHEKADERPTFKILLSNILDVMDE 281
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 79/314 (25%), Positives = 124/314 (39%), Gaps = 70/314 (22%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE------IEDIQKEISVLS 66
R+ + +G G++G+VYKA D N+ VAIK I LE E+E I +E+S+L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE-HEEEGVPGTAI----REVSLLK 88
Query: 67 QCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHA 123
+ + I E H +L +I EY DL + P + I L L++
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLYQLING 144
Query: 124 IEYLHNEGKIHRDIKAANILLT-----ENGDVKVADFGVSAQLTRTISR-RKTF---VGT 174
+ + H+ +HRD+K N+LL+ E +K+ DFG L R + F + T
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG----LARAFGIPIRQFTHEIIT 200
Query: 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP--------------------P--- 211
++ PE++ S Y+ DIWS+ EM P P
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260
Query: 212 -------LADLHPMRVLFIIPRENPPQLDEHFSRLMKE----FVSLCLKKVPAERPSAKE 260
L D P+ L L+ + ++ L+ P +R SAK
Sbjct: 261 TWPGVTALPDWKQSF-----PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315
Query: 261 LLRHRFIRNARKSP 274
L H + + P
Sbjct: 316 ALEHPYFSHNDFDP 329
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 63/270 (23%), Positives = 108/270 (40%), Gaps = 26/270 (9%)
Query: 18 LELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
++G G FG+VY+ +VA+K + + D E E ++ P+I
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ G + WIIME G + L ++ L +++ + A+ YL + +
Sbjct: 77 KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV 135
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT----PF-WMAPEVIQNSEG 188
HRDI NIL+ VK+ DFG L+R I + + P WM+PE I
Sbjct: 136 HRDIAVRNILVASPECVKLGDFG----LSRYIEDEDYYKASVTRLPIKWMSPESINFRR- 190
Query: 189 YNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEF 243
+ +D+W + + E+ G+ P L V+ ++ + P LM
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTR- 249
Query: 244 VSLCLKKVPAERPSAKELLRH--RFIRNAR 271
C P++RP EL+ + +
Sbjct: 250 ---CWDYDPSDRPRFTELVCSLSDVYQMEK 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 69/288 (23%), Positives = 121/288 (42%), Gaps = 46/288 (15%)
Query: 18 LELIGRGSFGDVYKA----FDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
L+ +G+G+FG V + VA+K + +E+ + D ++EI +L + I
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNI 73
Query: 74 TEYYGSYLHQTK--LWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
+Y G + L +IMEY+ GS+ D L + +D + + + +EYL +
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTP-----FWMAPEVI 183
IHRD+ NIL+ VK+ DFG LT+ + + K F V P FW APE +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFG----LTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 184 QNSEGYNEKADIWSLGITVIEM----------------AKGEPPLADLHPMRVLFIIPR- 226
S+ ++ +D+WS G+ + E+ G + ++ ++
Sbjct: 190 TESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
Query: 227 ---ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH--RFIRN 269
P + +M E C +RPS ++L + N
Sbjct: 249 GRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVDQIRDN 292
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-39
Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 39/285 (13%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
L+ IG+G FGDV + VA+K I + + + E SV++Q R
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATA---QAFLAEASVMTQLRHSN 247
Query: 73 ITEYYG-SYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHN 129
+ + G + L+I+ EYMA GS+ D ++S L + D+ A+EYL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNS 186
+HRD+ A N+L++E+ KV+DFG LT+ S + W APE ++
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQD--TGKLPVKWTAPEALREK 361
Query: 187 EGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMK 241
+ ++ K+D+WS GI + E+ G P + V+ + + + P +MK
Sbjct: 362 K-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMK 420
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKY 286
C A RP+ +L LE IR +
Sbjct: 421 N----CWHLDAATRPTFLQLREQ------------LEHIRTHELH 449
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-39
Identities = 62/286 (21%), Positives = 115/286 (40%), Gaps = 44/286 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +G G FG V + VA+K + E + I D++KEI +L I
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 74 TEYYG--SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
+Y G + + +IME++ GS+ + L ++ ++ + ++YL +
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTP-----FWMAPEVI 183
+HRD+ A N+L+ VK+ DFG LT+ I K + V FW APE +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFG----LTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 184 QNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPRENPP-----QLDEHFS 237
S+ + +D+WS G+T+ E + + + + + +
Sbjct: 202 MQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK 260
Query: 238 RL-------------MKEFVSLCLKKVPAERPSAKELLRH--RFIR 268
RL M++ C + P+ R S + L+ ++
Sbjct: 261 RLPCPPNCPDEVYQLMRK----CWEFQPSNRTSFQNLIEGFEALLK 302
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-39
Identities = 70/260 (26%), Positives = 129/260 (49%), Gaps = 15/260 (5%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ + +G G +G+VY+ K+ + VA+K L+E E+E+ KE +V+ + + P
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
+ + G + +II E+M G++ D ++ + + + + + A+EYL +
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGY 189
IHR++ A N L+ EN VKVADFG+S +T P W APE + ++ +
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-F 396
Query: 190 NEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFV 244
+ K+D+W+ G+ + E+A G P + +V ++ + E P E LM+
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA-- 454
Query: 245 SLCLKKVPAERPSAKELLRH 264
C + P++RPS E+ +
Sbjct: 455 --CWQWNPSDRPSFAEIHQA 472
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 9e-39
Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 44/278 (15%)
Query: 18 LELIGRGSFGDVYKA----FDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
L+ +G+G+FG V + VA+K + +E+ + D ++EI +L + I
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNI 104
Query: 74 TEYYGSYLHQTK--LWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
+Y G + L +IMEY+ GS+ D L + +D + + + +EYL +
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTP-----FWMAPEVI 183
IHRD+ NIL+ VK+ DFG LT+ + + K + V P FW APE +
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFG----LTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 184 QNSEGYNEKADIWSLGITVIEM----------------AKGEPPLADLHPMRVLFIIPR- 226
S+ ++ +D+WS G+ + E+ G + ++ ++
Sbjct: 221 TESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279
Query: 227 ---ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
P + +M E C +RPS ++L
Sbjct: 280 GRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDL 313
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 72/275 (26%), Positives = 113/275 (41%), Gaps = 19/275 (6%)
Query: 18 LELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
++IG G G+V + + VAIK + +E + D E S++ Q P I
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
G I+ EYM GS+ L M + +LR + + YL + G +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEGYN 190
HRD+ A N+L+ N KV+DFG+S L T G W APE I ++
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FS 232
Query: 191 EKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVS 245
+D+WS G+ + E +A GE P ++ V+ + P +LM +
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLD--- 289
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280
C K A+RP ++ + +SP L
Sbjct: 290 -CWHKDRAQRPRFSQI--VSVLDALIRSPESLRAT 321
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 33/290 (11%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+E +G G FG+V+ + + VA+K L++ + E +++ Q +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
+ Y + ++II EYM GS+ D +++ G L + + + + ++
Sbjct: 70 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSE 187
IHRD++AANIL+++ K+ADFG++ + + G F W APE I
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAINYGT 186
Query: 188 GYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKE 242
+ K+D+WS GI + E+ G P + V+ + R P E +LM+
Sbjct: 187 -FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEP 292
C K+ P +RP+ L LE + Q +P
Sbjct: 246 ----CWKERPEDRPTFDYLRSV------------LEDFFTATEGQYQPQP 279
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-38
Identities = 72/270 (26%), Positives = 106/270 (39%), Gaps = 26/270 (9%)
Query: 18 LELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
IG G FGDV++ VAIK S+ E +E + Q P+I
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ G +WIIME G + L LD S+ L A+ YL ++ +
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV 513
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT----PF-WMAPEVIQNSEG 188
HRDI A N+L++ N VK+ DFG L+R + + + P WMAPE I
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFG----LSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 568
Query: 189 YNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEF 243
+ +D+W G+ + E+ G P + V+ I PP LM +
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK- 627
Query: 244 VSLCLKKVPAERPSAKELLRH--RFIRNAR 271
C P+ RP EL + +
Sbjct: 628 ---CWAYDPSRRPRFTELKAQLSTILEEEK 654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 60/265 (22%), Positives = 109/265 (41%), Gaps = 29/265 (10%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+IG+G FG VY + ++ AIK + ++E +E ++ P +
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 76 YYG-SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
G + +++ YM G + + + + +EYL + +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTI------SRRKTFVGTPF---WMAPEVIQ 184
HRD+ A N +L E+ VKVADFG L R I S ++ W A E +Q
Sbjct: 147 HRDLAARNCMLDESFTVKVADFG----LARDILDREYYSVQQH-RHARLPVKWTALESLQ 201
Query: 185 NSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRL 239
+ K+D+WS G+ + E + +G PP + P + + + P + ++
Sbjct: 202 TYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQV 260
Query: 240 MKEFVSLCLKKVPAERPSAKELLRH 264
M++ C + PA RP+ + L+
Sbjct: 261 MQQ----CWEADPAVRPTFRVLVGE 281
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 64/257 (24%), Positives = 117/257 (45%), Gaps = 25/257 (9%)
Query: 21 IGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+G G+FG V + + K DVAIKV+ + + E++ +E ++ Q +PYI G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 79 SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ L ++ME GG + L+ + ++A +L + ++YL + +HRD+
Sbjct: 78 VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 136
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTISRR----KTFVGTPF---WMAPEVIQNSEGYN 190
A N+LL K++DFG L++ + + W APE I + ++
Sbjct: 137 AARNVLLVNRHYAKISDFG----LSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FS 191
Query: 191 EKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVS 245
++D+WS G+T+ E ++ G+ P + V+ I + E PP+ LM +
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSD--- 248
Query: 246 LCLKKVPAERPSAKELL 262
C +RP +
Sbjct: 249 -CWIYKWEDRPDFLTVE 264
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 60/254 (23%), Positives = 112/254 (44%), Gaps = 17/254 (6%)
Query: 21 IGRGSFGDVYKAF--DKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYY 77
+G G+FG V K + K++ K VA+K++ E ++ +++ E +V+ Q +PYI
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
G ++ ++ME G + +Q + + +I ++ + ++YL +HRD+
Sbjct: 85 GICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 143
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEGYNEKAD 194
A N+LL K++DFG+S L + K + W APE I + ++ K+D
Sbjct: 144 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSD 202
Query: 195 IWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLK 249
+WS G+ + E + G+ P + V ++ + P LM C
Sbjct: 203 VWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL----CWT 258
Query: 250 KVPAERPSAKELLR 263
RP +
Sbjct: 259 YDVENRPGFAAVEL 272
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-38
Identities = 71/258 (27%), Positives = 114/258 (44%), Gaps = 17/258 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+G+G FG+V+ VAIK L+ E +E V+ + R
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
+ + Y + ++I+ EYM+ GS+ D ++ G L + + + + Y+
Sbjct: 324 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGY 189
+HRD++AANIL+ EN KVADFG++ + + P W APE +
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-F 441
Query: 190 NEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFV 244
K+D+WS GI + E+ KG P + VL + R PP+ E LM +
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ-- 499
Query: 245 SLCLKKVPAERPSAKELL 262
C +K P ERP+ + L
Sbjct: 500 --CWRKEPEERPTFEYLQ 515
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 62/279 (22%), Positives = 108/279 (38%), Gaps = 29/279 (10%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
E+IGRG FG VY + + A+K ++ E+ E ++ P +
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 75 EYYG-SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
G + +++ YM G + + + + + +++L ++
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 213
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTI-------SRRKTFVGTPF-WMAPEVIQ 184
+HRD+ A N +L E VKVADFG L R + KT P WMA E +Q
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 185 NSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRL 239
+ + K+D+WS G+ + E M +G PP D++ + + + P + +
Sbjct: 270 TQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 328
Query: 240 MKEFVSLCLKKVPAERPSAKELLRH--RFIRNARKSPRL 276
M + C RPS EL+ +
Sbjct: 329 MLK----CWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 363
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-38
Identities = 66/283 (23%), Positives = 106/283 (37%), Gaps = 56/283 (19%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +G G FG V N VA+K + + ++EI +L +I
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 74 TEYYG--SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAI------- 124
+Y G L ++MEY+ GS+ D + L LL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIG--------LAQLLLFAQQICEGM 147
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTP-----FW 177
YLH + IHRD+ A N+LL + VK+ DFG L + + + V FW
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG----LAKAVPEGHEYYRVREDGDSPVFW 203
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPP-----Q 231
APE ++ + + +D+WS G+T+ E+ + + L I + +
Sbjct: 204 YAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 232 LDEHFSRL-------------MKEFVSLCLKKVPAERPSAKEL 261
L E RL MK C + + RP+ + L
Sbjct: 263 LLERGERLPRPDKCPAEVYHLMKN----CWETEASFRPTFENL 301
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-38
Identities = 81/306 (26%), Positives = 121/306 (39%), Gaps = 45/306 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ +G G+FG+VY+ + D VA+K + SE + D E ++S+
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLH-AI------E 125
I G L +I+ME MAGG + ++ P + + DLLH A +
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 126 YLHNEGKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTISR----RKTFVGT-PF- 176
YL IHRDI A N LLT G K+ DFG + R I R RK P
Sbjct: 155 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAMLPVK 210
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFII--------PRE 227
WM PE + K D WS G+ + E+ G P VL + P+
Sbjct: 211 WMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN 269
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYP 287
P + R+M + C + P +RP+ + I + P ++ P
Sbjct: 270 CPGPV----YRIMTQ----CWQHQPEDRPNFAII--LERIEYCTQDPDVINTALPIEYGP 319
Query: 288 IQEEPD 293
+ EE +
Sbjct: 320 LVEEEE 325
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-38
Identities = 72/277 (25%), Positives = 118/277 (42%), Gaps = 43/277 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +G+G+FG V L + VA+K + D+ D Q+EI +L S +I
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFI 86
Query: 74 TEYYG--SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
+Y G + L ++MEY+ G + D L + LD + + +EYL +
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTP-----FWMAPEVI 183
+HRD+ A NIL+ VK+ADFG L + + K + V P FW APE +
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFG----LAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 184 QNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPP-----QLDEHFS 237
++ ++ ++D+WS G+ + E+ + + + R+ P +L E
Sbjct: 203 SDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261
Query: 238 RL-------------MKEFVSLCLKKVPAERPSAKEL 261
RL MK C P +RPS L
Sbjct: 262 RLPAPPACPAEVHELMKL----CWAPSPQDRPSFSAL 294
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 78/329 (23%), Positives = 140/329 (42%), Gaps = 61/329 (18%)
Query: 13 SRFSSLELIGRGSFGDVYKAFD-KELNKDVAIKVIDLEESEDE---IEDIQKEISVLSQC 68
++ + IG G++G V+KA D K + VA+K + ++ + +E + I +E++VL
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ-TGEEGMPLSTI-REVAVLRHL 68
Query: 69 RS---PYITE-----YYGSYLHQTKLWIIMEYMAGGSVADLIQ-----SGPPLDEMSIAC 115
+ P + +TKL ++ E++ DL P + +I
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKD 124
Query: 116 ILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF---V 172
++ LL +++LH+ +HRD+K NIL+T +G +K+ADFG L R S + V
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG----LARIYSFQMALTSVV 180
Query: 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------- 224
T ++ APEV+ S Y D+WS+G EM + +P + L I
Sbjct: 181 VTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239
Query: 225 ---------------PRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRHR 265
++ +++ + + + L L K PA+R SA L H
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL-LLKCLTFNPAKRISAYSALSHP 298
Query: 266 FIRNARKSPRLLERIRERPKYPIQEEPDT 294
+ ++ + L+ P E +T
Sbjct: 299 YFQDLERCKENLD--SHLPPSQNTSELNT 325
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-37
Identities = 66/290 (22%), Positives = 120/290 (41%), Gaps = 33/290 (11%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ +G G FG+V+ A + + VA+K ++ +E E +V+ +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDK 244
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
+ + + + ++II E+MA GS+ D ++S G + + + ++
Sbjct: 245 LVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSE 187
IHRD++AANIL++ + K+ADFG++ + + G F W APE I
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWTAPEAINFGS 361
Query: 188 GYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKE 242
+ K+D+WS GI ++E+ G P + V+ + R P E +M
Sbjct: 362 -FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 420
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEP 292
C K P ERP+ + + L+ + +E P
Sbjct: 421 ----CWKNRPEERPTFEYIQSV------------LDDFYTATESQYEEIP 454
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 39/282 (13%), Positives = 87/282 (30%), Gaps = 38/282 (13%)
Query: 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE--IEDIQKEISVLSQC 68
A R+ L G ++A D L++ VA+ +D + + +++ LS+
Sbjct: 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
P + + ++ E++ GGS+ ++ + P ++ L A + H
Sbjct: 89 DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA--IRAMQSLAAAADAAH 146
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
G + + ++ +GDV +A
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYPATMPDAN-------------------------- 180
Query: 189 YNEKADIWSLGITVIEMAKGEPPLAD---LHPMRVLFIIPRENPP---QLDEHFSRLMKE 242
+ DI +G ++ + PL + + P +D +
Sbjct: 181 --PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERP 284
+ ++ R ++ L + +L I E P
Sbjct: 239 VAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAP 280
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 65/276 (23%), Positives = 121/276 (43%), Gaps = 40/276 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD---VAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPYI 73
++G+G FG V +A K+ + VA+K++ + + +IE+ +E + + + P++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 74 TEYYG------SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLH----- 122
+ G + +I+ +M G + + + E L+ L+
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI-GENPFNLPLQTLVRFMVDI 146
Query: 123 --AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFVGTPF 176
+EYL + IHRD+ A N +L E+ V VADFG L+R I R+ +
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG----LSRKIYSGDYYRQG-CASKL 201
Query: 177 ---WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----EN 228
W+A E + ++ Y +D+W+ G+T+ E+ +G+ P A + + + +
Sbjct: 202 PVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ 260
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
PP+ E LM + C P +RPS L
Sbjct: 261 PPECMEEVYDLMYQ----CWSADPKQRPSFTCLRME 292
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-37
Identities = 67/276 (24%), Positives = 115/276 (41%), Gaps = 41/276 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYI 73
+++G G FG V + K+ + VA+K + L+ S+ EIE+ E + + P +
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 74 TEYYG-----SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLH----- 122
G S K +I+ +M G + L+ S I L+ LL
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP--LQTLLKFMVDI 156
Query: 123 --AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFVGTPF 176
+EYL N +HRD+ A N +L ++ V VADFG L++ I R+
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG----LSKKIYSGDYYRQG-RIAKM 211
Query: 177 ---WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----EN 228
W+A E + + Y K+D+W+ G+T+ E+A +G P + + + +
Sbjct: 212 PVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ 270
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
P + +M C + P +RP+ L
Sbjct: 271 PEDCLDELYEIMYS----CWRTDPLDRPTFSVLRLQ 302
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 79/306 (25%), Positives = 120/306 (39%), Gaps = 45/306 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ +G G+FG+VY+ + D VA+K + SE + D E ++S+
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAI-------E 125
I G L +I++E MAGG + ++ P + + DLLH +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 126 YLHNEGKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTISR----RKTFVGT-PF- 176
YL IHRDI A N LLT G K+ DFG + R I R RK P
Sbjct: 196 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRAGYYRKGGCAMLPVK 251
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFII--------PRE 227
WM PE + K D WS G+ + E+ G P VL + P+
Sbjct: 252 WMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN 310
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYP 287
P + R+M + C + P +RP+ + I + P ++ P
Sbjct: 311 CPGPV----YRIMTQ----CWQHQPEDRPNFAII--LERIEYCTQDPDVINTALPIEYGP 360
Query: 288 IQEEPD 293
+ EE +
Sbjct: 361 LVEEEE 366
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 43/277 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+G+GSFG VY+ K + KD VAIK ++ S E + E SV+ + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACIL--RDLLH------- 122
+ G +IME M G + L P + + ++
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFVGT-PF- 176
+ YL+ +HRD+ A N ++ E+ VK+ DFG +TR I RK G P
Sbjct: 150 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVR 205
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVL-FII-------PRE 227
WM+PE +++ + +D+WS G+ + E+A E P L +VL F++ P
Sbjct: 206 WMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 264
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
P L LM+ C + P RPS E++
Sbjct: 265 CPDML----FELMRM----CWQYNPKMRPSFLEIISS 293
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-36
Identities = 65/252 (25%), Positives = 117/252 (46%), Gaps = 17/252 (6%)
Query: 21 IGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+G G+FG V + + K DVAIKV+ + + E++ +E ++ Q +PYI G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 79 SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ L ++ME GG + L+ + ++A +L + ++YL + +HR++
Sbjct: 404 VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEGYNEKAD 194
A N+LL K++DFG+S L S + W APE I + ++ ++D
Sbjct: 463 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSD 521
Query: 195 IWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLK 249
+WS G+T+ E ++ G+ P + V+ I + E PP+ LM + C
Sbjct: 522 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSD----CWI 577
Query: 250 KVPAERPSAKEL 261
+RP +
Sbjct: 578 YKWEDRPDFLTV 589
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 69/298 (23%), Positives = 123/298 (41%), Gaps = 53/298 (17%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCRS 70
+ S +G G++G V A DK + VAIK + +SE + +E+ +L +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 71 PYITEYY------GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLL 121
+ S + +++M +M DL + E I ++ +L
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGL--KFSEEKIQYLVYQML 136
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAP 180
++Y+H+ G +HRD+K N+ + E+ ++K+ DFG L R T +V T ++ AP
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVVTRWYRAP 192
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGE---------------------PPLADLHPM- 218
EVI + YN+ DIWS+G + EM G+ P + +
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252
Query: 219 -----RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRHRFI 267
+ +P+ + F R + L L+K+ +R +A + L H F
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADL-LEKMLELDVDKRLTAAQALTHPFF 309
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 64/280 (22%), Positives = 108/280 (38%), Gaps = 43/280 (15%)
Query: 18 LELIGRGSFGDVYKA-----FDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+E +G FG VYK E + VAIK + + E+ + E + ++ + P
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------LRDLLH- 122
+ G L +I Y + G + + L+ P D S D +H
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 123 AI------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFV 172
EYL + +H+D+ N+L+ + +VK++D G L R + +
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG----LFREVYAADYYKLL-G 188
Query: 173 GTPF---WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR-- 226
+ WMAPE I + ++ +DIWS G+ + E+ G P V+ +I
Sbjct: 189 NSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ 247
Query: 227 --ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
P LM E C + P+ RP K++
Sbjct: 248 VLPCPDDCPAWVYALMIE----CWNEFPSRRPRFKDIHSR 283
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 67/279 (24%), Positives = 117/279 (41%), Gaps = 44/279 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+G G+FG V+ A L+ VA+K + + + +D Q+E +L+ + +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEH 78
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------LRDLLH- 122
I ++YG L ++ EYM G + L GP + L +LH
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 123 ------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFV 172
+ YL ++ +HRD+ N L+ N VK+ DFG ++R + R
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG----MSRDVYSTDYYRVG-G 193
Query: 173 GTPF---WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR-- 226
T WM PE I + + ++D+WS G+ + E+ G+ P L V+ I +
Sbjct: 194 HTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 252
Query: 227 --ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
E P + +M C ++ P +R + KE+ +
Sbjct: 253 VLERPRVCPKEVYDVMLG----CWQREPQQRLNIKEIYK 287
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 74/283 (26%), Positives = 111/283 (39%), Gaps = 45/283 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ-CRSP 71
+ +G G+FG V +A L K VA+K++ E E + E+ VLS
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGS-----------VADLIQSGPPLDEMSIACILRDL 120
I G+ +I EY G S +++ +A L DL
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 121 LH-AI------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
L + +L ++ IHRD+ A NILLT K+ DFG L R I +V
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG----LARDIKNDSNYVV 203
Query: 174 T-----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMR-VLFIIP 225
P WMAPE I N Y ++D+WS GI + E+ G P + +I
Sbjct: 204 KGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262
Query: 226 R----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+P +MK C P +RP+ K++++
Sbjct: 263 EGFRMLSPEHAPAEMYDIMKT----CWDADPLKRPTFKQIVQL 301
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 64/299 (21%), Positives = 122/299 (40%), Gaps = 52/299 (17%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRS 70
R+ +L +G G++G V AFD + VA+K + +S + +E+ +L +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 71 PYITEYY------GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLL 121
+ S ++++ M ADL ++ L + + ++ +L
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQK-LTDDHVQFLIYQIL 142
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAP 180
++Y+H+ IHRD+K +N+ + E+ ++K+ DFG L R + T +V T ++ AP
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTADEMTGYVATRWYRAP 198
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGE---------------------PPLADLHPM- 218
E++ N YN+ DIWS+G + E+ G P L +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 219 -----RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRHRFIR 268
+ + + F V L L+K+ +R +A + L H +
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDL-LEKMLVLDSDKRITAAQALAHAYFA 316
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 50/296 (16%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+G G+FG V+ A L + VA+K + E SE +D Q+E +L+ + +
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQH 104
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI-------LRDLLHAI 124
I ++G L ++ EYM G + L GP ++ L LL
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 125 -------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-----RRKTFV 172
YL +HRD+ N L+ + VK+ DFG ++R I R
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG----MSRDIYSTDYYRVGGRT 220
Query: 173 GTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFII------ 224
P WM PE I + + ++D+WS G+ + E+ G+ P L + I
Sbjct: 221 MLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 279
Query: 225 --PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278
PR PP++ +M+ C ++ P +R S K++ R A+ P L+
Sbjct: 280 ERPRACPPEV----YAIMRG----CWQREPQQRHSIKDVH-ARLQALAQAPPVYLD 326
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 76/305 (24%), Positives = 126/305 (41%), Gaps = 54/305 (17%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
S F L+G G++G V A K + VAIK I+ + +EI +L +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 72 YITEYY-----GSYLHQTKLWIIMEYMAGGSVADLIQ--SGPPLDEMSIACILRDLLHAI 124
I + S+ + +++II E M DL + S L + I + L A+
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM------ 178
+ LH IHRD+K +N+L+ N D+KV DFG++ + + + G M
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 179 ----APEVIQNSEGYNEKADIWSLGITVIEMAKGEP----------------------PL 212
APEV+ S Y+ D+WS G + E+ P
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 213 ADLHPM------RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELL 262
DL + + +P L++ F R+ + + L L+++ PA+R +AKE L
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDL-LQRMLVFDPAKRITAKEAL 304
Query: 263 RHRFI 267
H ++
Sbjct: 305 EHPYL 309
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 87/294 (29%), Positives = 132/294 (44%), Gaps = 48/294 (16%)
Query: 19 ELIGRGSFGDVYKAF--DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CRSPYITE 75
++IG G+FG V KA L D AIK + S+D+ D E+ VL + P I
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------LRDLLH-AI- 124
G+ H+ L++ +EY G++ D L +S + + A + LLH A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 125 -----EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPF- 176
+YL + IHRD+ A NIL+ EN K+ADFG L+R +KT P
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG----LSRGQEVYVKKTMGRLPVR 206
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQ 231
WMA E + S Y +D+WS G+ + E ++ G P + + +P+ E P
Sbjct: 207 WMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 265
Query: 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPK 285
D+ LM++ C ++ P ERPS ++L L R+ E K
Sbjct: 266 CDDEVYDLMRQ----CWREKPYERPSFAQILVS------------LNRMLEERK 303
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 73/282 (25%), Positives = 131/282 (46%), Gaps = 44/282 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVLSQ-CR 69
+ +G G+FG V A ++KD VA+K++ + +E ++ D+ E+ ++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------LRDL 120
I G+ L++I+EY + G++ + L PP E S +DL
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 121 LH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
+ +EYL ++ IHRD+ A N+L+TEN +K+ADFG L R I+ +
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG----LARDINNIDYYKK 215
Query: 174 T-----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR 226
T P WMAPE + + Y ++D+WS G+ + E+ G P + + ++
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 227 ----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ P +M++ C VP++RP+ K+L+
Sbjct: 275 GHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVED 312
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 71/298 (23%), Positives = 121/298 (40%), Gaps = 52/298 (17%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCRS 70
+ + L+ +G G++G V A D VAIK + +SE + +E+ +L R
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 71 PYITEYY------GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLL 121
+ + T +++M +M DL ++ L E I ++ +L
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TDLGKLMKHEK-LGEDRIQFLVYQML 138
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAP 180
+ Y+H G IHRD+K N+ + E+ ++K+ DFG L R T +V T ++ AP
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG----LARQADSEMTGYVVTRWYRAP 194
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGE---------------------PPLADLHPM- 218
EVI N Y + DIWS+G + EM G+ PP + +
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254
Query: 219 -----RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRHRFI 267
+ +P + V+L L+K+ +R +A E L H +
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNL-LEKMLVLDAEQRVTAGEALAHPYF 311
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 75/302 (24%), Positives = 127/302 (42%), Gaps = 56/302 (18%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
G R+++L IG G++G V A+D VAIK I E + + +EI +L + R
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 72 YITEYY-----GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHA 123
I + ++I+ + M DL +++ L I L +L
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQH-LSNDHICYFLYQILRG 140
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-------FVGTPF 176
++Y+H+ +HRD+K +N+LL D+K+ DFG L R +V T +
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG----LARVADPDHDHTGFLTEYVATRW 196
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGE---------------------PPLADL 215
+ APE++ NS+GY + DIWS+G + EM P DL
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 216 HPM------RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRHR 265
+ + L +P +N + F + + L L K+ P +R ++ L H
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL-LDKMLTFNPHKRIEVEQALAHP 315
Query: 266 FI 267
++
Sbjct: 316 YL 317
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 78/318 (24%), Positives = 137/318 (43%), Gaps = 46/318 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVLSQ-CR 69
+ +G G+FG V A L+KD VA+K++ + +E ++ D+ E+ ++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------LRDL 120
I G+ L++I+EY + G++ + L PP E S +DL
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 121 LH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
+ +EYL ++ IHRD+ A N+L+TE+ +K+ADFG L R I +
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG----LARDIHHIDYYKK 249
Query: 174 T-----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR 226
T P WMAPE + + Y ++D+WS G+ + E+ G P + + ++
Sbjct: 250 TTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 308
Query: 227 ----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH--RFIRNARKSPRLLERI 280
+ P +M++ C VP++RP+ K+L+ R +
Sbjct: 309 GHRMDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHH 364
Query: 281 RERPKYPIQEEPDTPING 298
Y I + NG
Sbjct: 365 HHHHDYDIPTTENLYFNG 382
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 59/328 (17%), Positives = 121/328 (36%), Gaps = 78/328 (23%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP- 71
+R+ + +G G F V+ A D N VA+K++ + E + EI +L +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDAD 76
Query: 72 ----------YITEYYGSYLHQTKLW----IIMEYMAGGSVADLIQSGP--PLDEMSIAC 115
+I + + H+ ++ E + G ++ LI+ + + +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 116 ILRDLLHAIEYLHNEGK-IHRDIKAANILLTENGD------VKVADFGVSAQLTRTISRR 168
I + LL ++Y+H IH DIK N+L+ +K+AD G + +
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-- 193
Query: 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP--PLADLHP--------- 217
+ T + +PEV+ + + ADIWS + E+ G+ + H
Sbjct: 194 -NSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251
Query: 218 --MRVLFIIPRE----------------------------------NPPQLDEHFSRLMK 241
+ +L +P + + ++ +
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRN 269
+F+S L+ P +R A L+ H ++++
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 49/287 (17%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ +G G FG V KA L VA+K++ S E+ D+ E +VL Q P+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------------- 116
+ + YG+ L +I+EY GS+ L +S +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 117 -LRDLLH-AI------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168
+ DL+ A +YL +HRD+ A NIL+ E +K++DFG L+R +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG----LSRDVYEE 203
Query: 169 KTFVGT-----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVL 221
++V P WMA E + + Y ++D+WS G+ + E+ G P + P R+
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 222 FIIPR----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
++ E P E RLM + C K+ P +RP ++ +
Sbjct: 263 NLLKTGHRMERPDNCSEEMYRLMLQ----CWKQEPDKRPVFADISKD 305
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 62/292 (21%), Positives = 119/292 (40%), Gaps = 46/292 (15%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
++ ++IG GSFG VY+A + + VAIK + ++ +E+ ++ + I
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 109
Query: 74 TEYY------GSYLHQTKLWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHA 123
G + L ++++Y+ +V + ++ L + + + L +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 124 IEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
+ Y+H+ G HRDIK N+LL + +K+ DFG SA+ +++ + ++ APE+
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGEPNVSYICSRYYRAPEL 227
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEP--------------------P----LADLHPM 218
I + Y D+WS G + E+ G+P P + +++P
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287
Query: 219 RVLFIIPRENPPQLDEHF----SRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
F P+ + F S L+ P R + E H F
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 73/282 (25%), Positives = 129/282 (45%), Gaps = 44/282 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVLSQ-CR 69
+ +G G FG V A ++KD VA+K++ + +E ++ D+ E+ ++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------LRDL 120
I G+ L++I+EY + G++ + L PP E S +DL
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 121 LH-AI------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
+ EYL ++ IHRD+ A N+L+TEN +K+ADFG L R I+ +
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG----LARDINNIDYYKK 261
Query: 174 T-----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR 226
T P WMAPE + + Y ++D+WS G+ + E+ G P + + ++
Sbjct: 262 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 320
Query: 227 ----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ P +M++ C VP++RP+ K+L+
Sbjct: 321 GHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVED 358
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 70/305 (22%), Positives = 114/305 (37%), Gaps = 61/305 (20%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
RF + G+G+FG V +K VAIK + +++ ++Q + L+ P
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQ-IMQDLAVLHHPN 80
Query: 73 ITEYYGSYLHQTK-------LWIIMEYMAGGSVADL-------IQSGPPLDEMSIACILR 118
I + + + L ++MEY+ L + + I L
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 119 DLLHAIEYLHNEGK--IHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRKTFVG-- 173
L+ +I LH HRDIK N+L+ +G +K+ DFG + +S + V
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG----SAKKLSPSEPNVAYI 192
Query: 174 -TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP--------------------P- 211
+ ++ APE+I ++ Y DIWS+G EM GEP P
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 212 ---LADLHPMRVLFIIPRENPPQLDEHFSRLMK-------EFVSLCLKKVPAERPSAKEL 261
L L+P + FS + +S L+ +P ER E
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312
Query: 262 LRHRF 266
L H +
Sbjct: 313 LCHPY 317
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 64/310 (20%), Positives = 109/310 (35%), Gaps = 64/310 (20%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQK---------E 61
S ++ I GS+G V D E VAIK V + + + E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 62 ISVLSQCRSPYITEYYGSYLHQTK-----LWIIMEYMAGGSVADL---IQSG-PPLDEMS 112
I +L+ P I ++H + L+++ E M DL I +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQH 135
Query: 113 IACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-- 170
I + +L + LH G +HRD+ NILL +N D+ + DF L R +
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN----LAREDTADANKT 191
Query: 171 -FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGE-------------------- 209
+V ++ APE++ +G+ + D+WS G + EM +
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251
Query: 210 -PPLADLHPMR-------VLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPS 257
P + D+ + + + L + K+ P R S
Sbjct: 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDL-IAKMLEFNPQRRIS 310
Query: 258 AKELLRHRFI 267
++ LRH +
Sbjct: 311 TEQALRHPYF 320
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 74/311 (23%), Positives = 130/311 (41%), Gaps = 66/311 (21%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED------EI--------ED 57
GSR+ L+ +G G G V+ A D + +K VAIK I L + + EI ++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 58 IQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIA 114
I K +L +T+ GS ++I+ EYM DL ++ GP L E
Sbjct: 70 IVKVFEIL-GPSGSQLTDDVGSLTELNSVYIVQEYME----TDLANVLEQGP-LLEEHAR 123
Query: 115 CILRDLLHAIEYLHNEGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRKT--- 170
+ LL ++Y+H+ +HRD+K AN+ + TE+ +K+ DFG L R + +
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG----LARIMDPHYSHKG 179
Query: 171 ----FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGE----------------- 209
+ T ++ +P ++ + Y + D+W+ G EM G+
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239
Query: 210 ----PPLADLHPM-----RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERP 256
D + + E L + + +E V L+++ P +R
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDF-LEQILTFSPMDRL 298
Query: 257 SAKELLRHRFI 267
+A+E L H ++
Sbjct: 299 TAEEALSHPYM 309
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 75/303 (24%), Positives = 135/303 (44%), Gaps = 67/303 (22%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+++ ++IG GSFG V++A E ++ VAIK + ++ +E+ ++ + P
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-----RFKNRELQIMRIVKHPN 93
Query: 73 ITEYY------GSYLHQTKLWIIMEYMAGGSVADL-------IQSGPPLDEMSIACILRD 119
+ + G + L +++EY+ + + + + I +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 120 LLHAIEYLHNEGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRKTFVG---TP 175
LL ++ Y+H+ G HRDIK N+LL +G +K+ DFG SA + + + V +
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG-SA---KILIAGEPNVSYICSR 205
Query: 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-----------MRVL--- 221
++ APE+I + Y DIWS G + E+ +G+P L P ++VL
Sbjct: 206 YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP----LFPGESGIDQLVEIIKVLGTP 261
Query: 222 --FIIPRENP-------PQLDEH-FSRLMK--------EFVSLCLKKVPAERPSAKELLR 263
I NP PQ+ H FS++ + + +S L+ P+ R +A E L
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 264 HRF 266
H F
Sbjct: 322 HPF 324
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 4e-32
Identities = 67/254 (26%), Positives = 107/254 (42%), Gaps = 53/254 (20%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK---EISVLSQC 68
R+ LIG GS+G V +A+DK + VAIK I ED I D ++ EI++L++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLI-DCKRILREIAILNRL 109
Query: 69 RSPYITEYY-----GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDL 120
++ + +L++++E +D ++ L E+ I +L +L
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVYLTELHIKTLLYNL 165
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM-- 178
L ++Y+H+ G +HRD+K AN L+ ++ VKV DFG L RT+ +
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFG----LARTVDYPENGNSQLPISPR 221
Query: 179 -----------------------------APEVIQNSEGYNEKADIWSLGITVIEMAKGE 209
APE+I E Y E D+WS+G E+
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281
Query: 210 PPLADLHPMR-VLF 222
H R LF
Sbjct: 282 KENVAYHADRGPLF 295
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 74/310 (23%), Positives = 120/310 (38%), Gaps = 65/310 (20%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ IG G+FG V++A L VA+K++ E S D D Q+E +++++ +P
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------------- 116
I + G + ++ EYMA G + + L P
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 117 -LRDLLHAI-------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-- 166
+ L YL +HRD+ N L+ EN VK+ADFG L+R I
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG----LSRNIYSA 227
Query: 167 ---RRKTFVGTPF---WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMR 219
+ WM PE I + Y ++D+W+ G+ + E+ G P +
Sbjct: 228 DYYKADG--NDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284
Query: 220 VLFIIPR----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPR 275
V++ + P LM+ C K+PA+RPS + R
Sbjct: 285 VIYYVRDGNILACPENCPLELYNLMRL----CWSKLPADRPSFCSIHRI----------- 329
Query: 276 LLERIRERPK 285
L+R+ ER +
Sbjct: 330 -LQRMCERAE 338
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 77/247 (31%), Positives = 108/247 (43%), Gaps = 44/247 (17%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCRS 70
+ LIGRGS+G VY A+DK K+VAIK V + E + + I +EI++L++ +S
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 71 PYITEYY-----GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLH 122
YI Y L +L+I++E +DL ++ L E I IL +LL
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIAD----SDLKKLFKTPIFLTEEHIKTILYNLLL 140
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM---- 178
++H G IHRD+K AN LL ++ VKV DFG L RTI+ K
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFG----LARTINSEKDTNIVNDLEENEE 196
Query: 179 ----------------------APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH 216
APE+I E Y + DIWS G E+ +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 217 PMRV-LF 222
R LF
Sbjct: 257 TNRFPLF 263
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 36/300 (12%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-- 69
R+ L++IG+GSFG V KA+D ++++ VA+K++ + +EI +L R
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV--RNEKRFHRQAAEEIRILEHLRKQ 153
Query: 70 ----SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHA 123
+ + ++ + + + E + ++ +LI+ + +L
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 124 IEYLHNEGKIHRDIKAANILLTENG--DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPE 181
++ LH IH D+K NILL + G +KV DFG S + + T++ + F+ APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY---TYIQSRFYRAPE 269
Query: 182 VIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-----------MRVLFIIPR---E 227
VI + Y D+WSLG + E+ G P L P + +L + + +
Sbjct: 270 VILGA-RYGMPIDMWSLGCILAELLTGYP----LLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYP 287
+ S + + R R + P
Sbjct: 325 ASKRAKNFVSS-KGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 68/282 (24%), Positives = 112/282 (39%), Gaps = 44/282 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRS-P 71
+ +GRG+FG V +A ++K VA+K++ + E + E+ +L
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 72 YITEYYGSYLHQTK-LWIIMEYMAGGS---------VADLIQSGPPLDEMSIACILRDLL 121
+ G+ L +I+E+ G+ + P D L L+
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 122 H-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174
+E+L + IHRD+ A NILL+E VK+ DFG L R I + +V
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG----LARDIYKDPDYVRK 207
Query: 175 -----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMR-VLFIIPR 226
P WMAPE I + Y ++D+WS G+ + E+ G P + +
Sbjct: 208 GDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 227 ----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
P + M + C P++RP+ EL+ H
Sbjct: 267 GTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEH 304
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 69/279 (24%), Positives = 118/279 (42%), Gaps = 41/279 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ-CRSP 71
+ +G G+FG V +A L K+ VA+K++ DE E + E+ ++S +
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVAD-------LIQSGPPLDEMSIACILRDLLH-- 122
I G+ H + +I EY G + + ++++ P + RDLLH
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 123 -----AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT--- 174
+ +L ++ IHRD+ A N+LLT K+ DFG L R I ++
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG----LARDIMNDSNYIVKGNA 226
Query: 175 --PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPL-ADLHPMRVLFIIPR--- 226
P WMAPE I + Y ++D+WS GI + E+ G P L + ++
Sbjct: 227 RLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ 285
Query: 227 -ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
P ++ +M+ C P RP+ +++
Sbjct: 286 MAQPAFAPKNIYSIMQA----CWALEPTHRPTFQQICSF 320
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 82/313 (26%), Positives = 128/313 (40%), Gaps = 71/313 (22%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCRS 70
R+ +L+ IG G+ G V A+D L ++VAIK + +++ + +E+ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 71 PYITEYY------GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLL 121
I S ++I+ME M A+L IQ LD ++ +L +L
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQM--ELDHERMSYLLYQML 137
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT---FVGTPFWM 178
I++LH+ G IHRD+K +NI++ + +K+ DFG L RT +V T ++
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAGTSFMMTPYVVTRYYR 193
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGE---------------------PPLADLH- 216
APEVI GY E DIWS+G + EM KG P +
Sbjct: 194 APEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252
Query: 217 ------------------PMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAE 254
LF P P EH + L L K+ ++
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLF--PDVLFPADSEHNKLKASQARDL-LSKMLVIDASK 309
Query: 255 RPSAKELLRHRFI 267
R S E L+H +I
Sbjct: 310 RISVDEALQHPYI 322
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 69/360 (19%), Positives = 127/360 (35%), Gaps = 82/360 (22%)
Query: 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIK----------------------- 44
E + ++S + +G GSFG V + FD E K A+K
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVN 61
Query: 45 VIDL----------EESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94
+I L E + D ++ + + + + L +IMEY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 95 GGSVADL-------IQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL-TE 146
L I+SG + I+ + L A+ ++H+ G HRDIK N+L+ ++
Sbjct: 122 ----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177
Query: 147 NGDVKVADFGVSAQLTRTISRRKTFVG---TPFWMAPEVIQNSEGYNEKADIWSLGITVI 203
+ +K+ DFG + + + V + F+ APE++ + Y D+WS+G
Sbjct: 178 DNTLKLCDFG----SAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 204 EMAKGEP--------------------P----LADLHPMRVLFIIPRENPPQLDEHFSRL 239
E+ G+P P + ++P P +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEG 293
Query: 240 MK----EFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTP 295
+ + L+ P R + E + H F + R S ++ +P + P
Sbjct: 294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYE--SEVKNNSNFPHGVNQNIP 351
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 69/288 (23%), Positives = 110/288 (38%), Gaps = 50/288 (17%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ-CRSP 71
+++G G+FG V A ++K VA+K++ + E E + E+ +++Q
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI-------------- 116
I G+ +++I EY G + + L E I
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 117 -LRDLLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168
DLL +E+L + +HRD+ A N+L+T VK+ DFG L R I
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG----LARDIMSD 225
Query: 169 KTFVGT-----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMR-V 220
+V P WMAPE + Y K+D+WS GI + E+ G P +
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284
Query: 221 LFIIPR----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+I + P E +M+ C +RPS L
Sbjct: 285 YKLIQNGFKMDQPFYATEEIYIIMQS----CWAFDSRKRPSFPNLTSF 328
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 70/339 (20%), Positives = 126/339 (37%), Gaps = 90/339 (26%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELN-KDVAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
+R+ ++ +G G+FG V + D + + VA+K++ + + E + EI VL +
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV--KNVDRYCEAARSEIQVLEHLNT 70
Query: 71 P------YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDL 120
+ + H + I+ E + G S D I+ LD I + +
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLD--HIRKMAYQI 127
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENG-------------------DVKVADFGVSAQL 161
++ +LH+ H D+K NIL ++ D+KV DFG +
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP---- 217
S T V T + APEVI G+++ D+WS+G +IE G + P
Sbjct: 188 DEHHS---TLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFT----VFPTHDS 239
Query: 218 -------MRVLFIIPRE----------------NPPQL--------------------DE 234
R+L +P+ + + +
Sbjct: 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273
+ + + L+ PA+R + +E L+H F +KS
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 75/346 (21%), Positives = 127/346 (36%), Gaps = 72/346 (20%)
Query: 21 IGRGSFGDVYKAFDKEL--NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+GRG++G VYKA K+ +KD A+K I E +EI++L + + P +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI---EGTGISMSACREIALLRELKHPNVISLQK 85
Query: 79 SYLHQT--KLWIIMEY--------MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
+L K+W++ +Y + + + L + +L +L I YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 129 NEGKIHRDIKAANILLT----ENGDVKVADFGVS---AQLTRTISRRKTFVGTPFWM-AP 180
+HRD+K ANIL+ E G VK+AD G + + ++ V T FW AP
Sbjct: 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT-FWYRAP 204
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEP-----------------------------P 211
E++ + Y + DIW++G E+ EP P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 212 -------LADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL------CLKKV----PAE 254
+ + L R N + K V L+K+ P +
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324
Query: 255 RPSAKELLRHRFIRNA--RKSPRLLERIRERPKYPIQEEPDTPING 298
R ++++ ++ + S PK E + G
Sbjct: 325 RITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKG 370
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 58/307 (18%), Positives = 121/307 (39%), Gaps = 59/307 (19%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CRSP 71
+ + +GRG + +V++A + N+ V +K++ + + +I+ +EI +L P
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-KKKIK---REIKILENLRGGP 91
Query: 72 YITEYY---GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
I + +T + D Q L + I + ++L A++Y H
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNN----TDFKQLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 129 NEGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRKTF---VGTPFWMAPEVIQ 184
+ G +HRD+K N+++ E+ +++ D+G L + + V + ++ PE++
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWG----LAEFYHPGQEYNVRVASRYFKGPELLV 203
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPL---AD-----LHPMRVL--------------- 221
+ + Y+ D+WSLG + M + P D + +VL
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263
Query: 222 ------FIIPRENPPQLDEHFSRLMKEFVS-----LCLKKV----PAERPSAKELLRHRF 266
I+ R + + + + VS L K+ R +A+E + H +
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF-LDKLLRYDHQSRLTAREAMEHPY 322
Query: 267 IRNARKS 273
K
Sbjct: 323 FYTVVKD 329
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 84/346 (24%), Positives = 140/346 (40%), Gaps = 72/346 (20%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCRS 70
R+ +L+ IG G+ G V A+D L+++VAIK + +++ + +E+ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 71 PYITEYY------GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLL 121
I + ++++ME M A+L IQ LD ++ +L +L
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQM--ELDHERMSYLLYQML 174
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT---FVGTPFWM 178
I++LH+ G IHRD+K +NI++ + +K+ DFG L RT +V T ++
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAGTSFMMTPYVVTRYYR 230
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGE---------------------PPLADLH- 216
APEVI GY E DIWS+G + EM + + P +
Sbjct: 231 APEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 217 ------------------PMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAE 254
LF P P EH + L L K+ PA+
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLF--PDSLFPADSEHNKLKASQARDL-LSKMLVIDPAK 346
Query: 255 RPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
R S + L+H +I N P +E + +E + I +
Sbjct: 347 RISVDDALQHPYI-NVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 391
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 67/339 (19%), Positives = 120/339 (35%), Gaps = 96/339 (28%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS- 70
+ F + +G G+FG V + K A+KV+ + + E +L + ++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQND 91
Query: 71 ----PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLH 122
I +Y+G +++ + +I E + G S+ ++I G ++ I ++L
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE--DIKLYCIEILK 148
Query: 123 AIEYLHNEGKIHRDIKAANILLTENG-------------------------DVKVADFGV 157
A+ YL H D+K NILL + +K+ DFG
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP 217
+ + + + T + APEVI N G++ +D+WS G + E+ G L
Sbjct: 209 ATFKSDYHG---SIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSL----LFR 260
Query: 218 -----------MRVLFIIPRE--------------------------------------N 228
++ IP+
Sbjct: 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC 320
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
P L +F+ L+ P RPS ELL+H+F+
Sbjct: 321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 64/349 (18%), Positives = 110/349 (31%), Gaps = 86/349 (24%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFD-KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
R+ + +G G+FG V + D VA+K+I E + EI+VL + +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARLEINVLKKIKE 75
Query: 71 P------YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLH 122
+ + I E + G + + ++ P + + L H
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 123 AIEYLHNEGKIHRDIKAANILLTENG-------------------DVKVADFGVSAQLTR 163
A+ +LH H D+K NIL + ++VADFG +
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194
Query: 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP------ 217
+ T V T + PEVI G+ + D+WS+G + E +G L
Sbjct: 195 HHT---TIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFT----LFQTHENRE 246
Query: 218 -----MRVLFIIPR---ENPPQLDEHFS-------------------------------- 237
++L IP + +
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306
Query: 238 -RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPK 285
+ + + L+ PA+R + E L H F R R +
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 76/381 (19%), Positives = 136/381 (35%), Gaps = 116/381 (30%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID--LEESED------EI-------- 55
++ ++ +G+G++G V+K+ D+ + VA+K I + S D EI
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 56 -EDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEM 111
E+I +++L+ R+ + Y ++ +YM DL I++ L+ +
Sbjct: 68 HENI---VNLLNVLRADNDRDVY----------LVFDYME----TDLHAVIRA-NILEPV 109
Query: 112 SIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171
++ L+ I+YLH+ G +HRD+K +NILL VKVADFG L+R+ +
Sbjct: 110 HKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFG----LSRSFVNIRRV 165
Query: 172 VGTPFWM-------------------------APEVIQNSEGYNEKADIWSLGITVIEMA 206
APE++ S Y + D+WSLG + E+
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 207 K---------------------GEPPLADLHP---------MRVLFIIPRENPPQLDEHF 236
P D+ + L + F
Sbjct: 226 CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIF 285
Query: 237 SRLMKEFVSL----------------CLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280
++ + + L+ P +R SA + L+H F+ E
Sbjct: 286 TKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNE--EPN 343
Query: 281 RERP-KYPIQEEPDTPINGVR 300
+ PI + I+ R
Sbjct: 344 CDHIITIPINDNVKHSIDDYR 364
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 78/292 (26%), Positives = 123/292 (42%), Gaps = 55/292 (18%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
E A + F LIG G FG VYK ++ VA+K ES IE+ + EI LS C
Sbjct: 35 EEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRT-PESSQGIEEFETEIETLSFC 92
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVAD----LIQSGPPLD---EMSIACILRDLL 121
R P++ G + ++ +I +YM G++ + + I +
Sbjct: 93 RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC------I 146
Query: 122 HA---IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS---AQLTRT-ISRRKTFV-G 173
A + YLH IHRD+K+ NILL EN K+ DFG+S +L +T +S T V G
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS---TVVKG 203
Query: 174 TPFWMAPEVIQNSEGY------NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE 227
T ++ PE Y EK+D++S G+ + E+ + P ++ +
Sbjct: 204 TLGYIDPE-------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256
Query: 228 NP------------PQLDEHFS-RLMKEFVSL---CLKKVPAERPSAKELLR 263
P L + +++F CL +RPS ++L
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 74/308 (24%), Positives = 126/308 (40%), Gaps = 46/308 (14%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIED-IQKEISVLSQCRS 70
R+ LIG+GSFG V KA+D+ + VAIK+I +++ + Q E+ +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVRLLELMNK 109
Query: 71 P------YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ--SGPPLDEMSIACILRDLLH 122
YI ++ + L ++ E + ++ DL++ + + + +
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 123 AIEYLHNE--GKIHRDIKAANILLTENG--DVKVADFGVSAQLTRTISRRKTFVGTPFWM 178
A+ +L IH D+K NILL +K+ DFG S QL + I ++ + F+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY---QYIQSRFYR 225
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-----------MRVLFIIPR- 226
+PEV+ Y+ D+WSLG ++EM GEP L + VL I P
Sbjct: 226 SPEVLLGM-PYDLAIDMWSLGCILVEMHTGEP----LFSGANEVDQMNKIVEVLGIPPAH 280
Query: 227 --ENPPQLDEHFSRLMKEFVSLCL-------KKVPAERPSAKELLRHRFIRNARKSPRLL 277
+ P+ + F +L +L K P R L R++
Sbjct: 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESG 340
Query: 278 ERIRERPK 285
+ + K
Sbjct: 341 HTVADYLK 348
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 81/293 (27%), Positives = 127/293 (43%), Gaps = 52/293 (17%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ A FS+ ++GRG FG VYK + VA+K + E ++ Q E+ ++S
Sbjct: 26 QVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQTEVEMISMA 84
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVA----DLIQSGPPLD---EMSIAC-ILRDL 120
+ G + T+ ++ YMA GSVA + +S PPLD IA R L
Sbjct: 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGL 144
Query: 121 LHAIEYLHNEGK---IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV----- 172
YLH+ IHRD+KAANILL E + V DFG L + + + T V
Sbjct: 145 ----AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVR 196
Query: 173 GTPFWMAPEVIQNSEGY-NEKADIWSLGITVIEMAKGEPPLADLHPM-----------RV 220
GT +APE + G +EK D++ G+ ++E+ G+ +
Sbjct: 197 GTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 221 LFIIPRENP------PQLDEHFSRL-MKEFV---SLCLKKVPAERPSAKELLR 263
L +E L ++ +++ + LC + P ERP E++R
Sbjct: 255 LL---KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 76/284 (26%), Positives = 118/284 (41%), Gaps = 60/284 (21%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ------KEISVLSQCRSPYI 73
+G G FG VYK + N VA+K + + +I + +EI V+++C+ +
Sbjct: 38 KMGEGGFGVVYKGYVN--NTTVAVKKLA---AMVDITTEELKQQFDQEIKVMAKCQHENL 92
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLI---QSGPPLD---EMSIAC-ILRDLLHAIEY 126
E G L ++ YM GS+ D + PPL IA + +
Sbjct: 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI----NF 148
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT--------ISRRKTFVGTPFWM 178
LH IHRDIK+ANILL E K++DFG L R ++ R VGT +M
Sbjct: 149 LHENHHIHRDIKSANILLDEAFTAKISDFG----LARASEKFAQTVMTSR--IVGTTAYM 202
Query: 179 APEVIQNSEGY-NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE--H 235
APE + G K+DI+S G+ ++E+ G P + + ++L I DE
Sbjct: 203 APEAL---RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE---EIEDEEKT 256
Query: 236 FSRLM---------KEFV------SLCLKKVPAERPSAKELLRH 264
+ S CL + +RP K++ +
Sbjct: 257 IEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-22
Identities = 74/370 (20%), Positives = 126/370 (34%), Gaps = 122/370 (32%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-- 70
R+ + +G G F V+ ++D + K VA+KV+ E E EI +L R+
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIRLLKSVRNSD 94
Query: 71 ------PYITEYYGSYLHQ----TKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILR 118
+ + + T + ++ E + G + I L + I++
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 119 DLLHAIEYLHNEGK-IHRDIKAANILLT-------------------------------- 145
+L ++YLH + + IH DIK NILL+
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 146 -----------------ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
E VK+AD G + + T + + EV+ S G
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNA---CWVHKHFTEDIQTRQYRSLEVLIGS-G 269
Query: 189 YNEKADIWSLGITVIEMAKGEPP---------------LADLHPMRVLFIIPRE------ 227
YN ADIWS E+A G+ +A + + +L +PR+
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALI--IELLGKVPRKLIVAGK 327
Query: 228 ------------------NPPQLDE------HFS----RLMKEFVSLCLKKVPAERPSAK 259
P L E +S +F+ L+ +P +R +A
Sbjct: 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387
Query: 260 ELLRHRFIRN 269
E LRH ++ +
Sbjct: 388 ECLRHPWLNS 397
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 32/228 (14%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-----DEI--------EDI 58
G+++ + IG G FG +Y AF + A V+ +E E E+ +D
Sbjct: 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDC 95
Query: 59 QKEISVLSQCRSPYITEYYGSYLHQTKL----WIIMEYMAGGSVADLIQSGPPLDEMSIA 114
K+ Q I +YGS L + K +++ME + G + + + ++
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVL 154
Query: 115 CILRDLLHAIEYLHNEGKIHRDIKAANILL-TENGD-VKVADFGVSAQLTRTISR----- 167
+ +L +EY+H +H DIKAAN+LL +N D V +AD+G+S + +
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 168 --RKTFVGTPFWMAPEVIQNSEGYNE--KADIWSLGITVIEMAKGEPP 211
RK GT + + + +G ++D+ LG ++ G+ P
Sbjct: 215 NPRKGHNGTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CRS 70
G + IG GSFG +++ + N+ VAIK E + ++ E
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGC 65
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYL 127
I Y ++++ + G S+ DL+ + S+ + +L ++ +
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSI 122
Query: 128 HNEGKIHRDIKAANILL----TENGD-VKVADFGVSAQLTRTISR-------RKTFVGTP 175
H + ++RDIK N L+ ++N + + V DFG+ +++ +K GT
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 176 FWMAPEVIQNSEGYNE--KADIWSLGITVIEMAKGEPP 211
+M+ I G + + D+ +LG + +G P
Sbjct: 183 RYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 25/216 (11%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-S 70
G+R+ IG GSFGD+Y D ++VAIK+ E + + + E + +
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGG 64
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYL 127
I ++ME + G S+ DL + S+ +L ++ IEY+
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYI 121
Query: 128 HNEGKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTISR-------RKTFVGTPFW 177
H++ IHRD+K N L+ V + DFG++ + + K GT +
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 178 MAPEVIQNSEGYNE--KADIWSLGITVIEMAKGEPP 211
+ I G + + D+ SLG ++ G P
Sbjct: 182 AS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 93.8 bits (232), Expect = 4e-21
Identities = 47/329 (14%), Positives = 91/329 (27%), Gaps = 84/329 (25%)
Query: 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-------ESEDEIEDIQKEIS 63
+ E IG G FG+V++ + VAIK+I +E + E+I EI
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 64 VL---------SQCRSPYITEYYGSYLHQ------------------------------T 84
+ R+ + Q
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI-HRDIKAANIL 143
+L+I++E+ GG + +++ + IL L ++ + HRD+ N+L
Sbjct: 136 QLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 144 LTENGDVKVAD-----------FGVSAQLTRTISRRKTFVGTPFWM----APEVIQNSEG 188
L + K+ G+ + R G + ++
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGD 254
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPM----------RVLFIIPRENPPQLDEHFSR 238
Y DI+ L + HP + +
Sbjct: 255 YQ--FDIYRLMKKENNNR-----WGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQ 307
Query: 239 LMKEFVSLCLKKVPAERPSAKELLRHRFI 267
+ ++ + SA +LL +
Sbjct: 308 IKRKIQE--FHRTMLNFSSATDLLCQHSL 334
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 41/237 (17%), Positives = 88/237 (37%), Gaps = 37/237 (15%)
Query: 7 LQEAAGSRFSSLELIGRGSFGDVYKAFD--------KELNKDVAIKV----------IDL 48
L + +G ++ R + G +Y+A + ++K+ +
Sbjct: 36 LTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNF 95
Query: 49 EESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL-WIIMEYMAGGSVADLIQ--SG 105
+ + + K L I G +HQ K ++++ + G S+ +
Sbjct: 96 FQRAAKPLQVNKWKK-LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK 153
Query: 106 PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKV--ADFGVSAQLTR 163
L E S+ + LL A+E+LH +H ++ A NI + +V A +G + +
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 164 TIS-------RRKTFVGTPFWMAPEVIQNSEGYNE--KADIWSLGITVIEMAKGEPP 211
+ R G +++ + +G ++D+ SLG +++ G P
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 48/218 (22%), Positives = 88/218 (40%), Gaps = 27/218 (12%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CRS 70
G F + IG G+FG++ + N+ VAIK LE + + E Q
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYL 127
I + Y +++E + G S+ DL S+ +L L+ +EY+
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYV 121
Query: 128 HNEGKIHRDIKAANILL-----TENGDVKVADFGVSAQLTRTISR-------RKTFVGTP 175
H++ I+RD+K N L+ + + DF ++ + ++ K+ GT
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
Query: 176 FWMAPEVIQNSEGYNE--KADIWSLGITVIEMAKGEPP 211
+M+ I G + + D+ +LG + +G P
Sbjct: 182 RYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 70/329 (21%), Positives = 116/329 (35%), Gaps = 94/329 (28%)
Query: 21 IGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVL---------- 65
+GRG+FG V +A ++K VA+K++ + E + E+ +L
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 66 ------SQCRSPY--ITEY--YG---SYLHQTKLWIIMEYMAGGSVA-----------DL 101
++ P I E+ +G +YL + + G DL
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 102 IQSGPPLDEMSIACI---------------------------LRDLLH-------AIEYL 127
+ + + L L+ +E+L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT-----PF-WMAPE 181
+ IHRD+ A NILL+E VK+ DFG L R I + +V P WMAPE
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFG----LARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 182 VIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR-----ENPPQLDEH 235
I + Y ++D+WS G+ + E + G P + + P
Sbjct: 266 TIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE 324
Query: 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ M + C P++RP+ EL+ H
Sbjct: 325 MYQTMLD----CWHGEPSQRPTFSELVEH 349
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 3e-19
Identities = 47/214 (21%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-S 70
G++F IG GSFG++Y + + N++VAIK+ E + + + E + +
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGG 62
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN 129
I + ++M+ + G S+ DL L ++ + +++ +E++H+
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 130 EGKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTISRR-------KTFVGTPFWMA 179
+ +HRDIK N L+ V + DFG++ + T + + K GT + +
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 180 PEVIQNSEGYNE--KADIWSLGITVIEMAKGEPP 211
+ G + + D+ SLG ++ +G P
Sbjct: 182 ---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 46/236 (19%), Positives = 93/236 (39%), Gaps = 35/236 (14%)
Query: 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIE----- 56
+ + A + + IG+G FG +Y A + +KV + E
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQ 88
Query: 57 -----DIQKEISVLSQCRSPYITEYYGSYLHQTKL----WIIMEYMAGGSVADLIQS-GP 106
+ ++ + + + +Y+GS LH ++IM+ G + + ++
Sbjct: 89 RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK 147
Query: 107 PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL-TENGD-VKVADFGVSAQLTRT 164
++ + +L +EY+H +H DIKA+N+LL +N D V + D+G++ +
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 165 ISR-------RKTFVGTPFWMAPEVIQNSEGYNE--KADIWSLGITVIEMAKGEPP 211
++ GT + + I G + D+ LG +I+ G P
Sbjct: 208 GVHKAYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 7e-08
Identities = 66/506 (13%), Positives = 130/506 (25%), Gaps = 165/506 (32%)
Query: 25 SFGDVYKAFDKELNKDVAIK-VIDLEE---SEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+ D+ F+ + K V D+ + S++EI+ I +S
Sbjct: 17 QYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTL----------R 66
Query: 81 LHQTKLWIIMEYMAGGS---VADLIQSGPP--LDEMSIACILRDLLHA--IEY---LHNE 130
L W ++ V ++++ + + ++ IE L+N+
Sbjct: 67 L----FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 131 GKI-----------HRDIKAANILLTENGDVKV---ADFGVS---AQLTRTISRRKTFVG 173
++ + ++ A + L +V + G + + + +
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDF 182
Query: 174 TPFWM------APEVI---------QNSEGYNEKADIWSLGITVIEMAKGEPPLADL--- 215
FW+ +PE + Q + ++D S I + E L L
Sbjct: 183 KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE--LRRLLKS 240
Query: 216 --HPMRVLFIIPRENPPQLD--------EHF---------SR----------LMKEFVSL 246
+ L + L F +R +SL
Sbjct: 241 KPYE-NCLLV--------LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL 291
Query: 247 CLKKVPAERPSAKELLRHRFI--------RNARK-SPRLLERIRERPKYPIQEEPDTPIN 297
+ K LL +++ R +PR L I E I++ T N
Sbjct: 292 DHHSMTLTPDEVKSLLL-KYLDCRPQDLPREVLTTNPRRLSIIAES----IRDGLATWDN 346
Query: 298 GVRAVGEASGTVKVVRDKRSEETVQVSSQGQT---VRNAGWNFSLSESHGTGTIRTAVK- 353
K V + ++ S R S+ +
Sbjct: 347 -----------WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV--------FPPSAHI 387
Query: 354 PPQV--------REKKPEFSYNQYTPKRTAERSNHGFSAS--------------GSTLHE 391
P + + N+ E+ + S LH
Sbjct: 388 PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR 447
Query: 392 S---PDASPTRYARDSYFDDRQDDYY 414
S P + D D Y+
Sbjct: 448 SIVDHYNIPKTFDSDDLIPPYLDQYF 473
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 577 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.12 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.08 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.74 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.68 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.37 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.25 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.94 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.93 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.8 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.79 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.57 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.45 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.42 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.35 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.33 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.14 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.09 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.73 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.7 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.69 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.24 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.88 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.85 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-62 Score=519.16 Aligned_cols=256 Identities=30% Similarity=0.566 Sum_probs=229.3
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+.+|+.+|++|+|||||+++++|.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999999999999999997665 34557889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||+||+|.++|.. ...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+........
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 183 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccccc
Confidence 9999999999964 34689999999999999999999999999999999999999999999999999988765544455
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
+.+|||.|||||++.+. .|+.++||||||||||||++|.+||...+..+.+..|.....+.++..++.++++||.+||.
T Consensus 184 ~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~ 262 (350)
T 4b9d_A 184 ACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFK 262 (350)
T ss_dssp HHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcc
Confidence 78999999999999875 49999999999999999999999999988887777777777777778899999999999999
Q ss_pred cCCCCCCcHHHHhhcHhhhh
Q 008116 250 KVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 250 ~dP~~RpTa~elL~hpff~~ 269 (577)
+||.+|||+.|||+||||+.
T Consensus 263 ~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 263 RNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp SSGGGSCCHHHHHTSHHHHT
T ss_pred CChhHCcCHHHHhcCHHhhc
Confidence 99999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-62 Score=517.42 Aligned_cols=259 Identities=39% Similarity=0.686 Sum_probs=233.3
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
...|++++.||+|+||+||+|.++.+|+.||||++++.... ..+.+.+|+.+|++|+|||||+++++|.+++.+|||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35799999999999999999999999999999999765432 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
||+||+|.+++.+ +++++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+........+.
T Consensus 152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence 9999999999976 679999999999999999999999999999999999999999999999999999887665666788
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--chhhhhHHHHHHHHHhcc
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--l~~~~s~~l~~lI~~cL~ 249 (577)
+|||.|||||++.+. .|+.++||||||||||||++|.+||...+..+.+..|....++. .+..++.++++||.+||.
T Consensus 231 ~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~ 309 (346)
T 4fih_A 231 VGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 309 (346)
T ss_dssp CSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSC
T ss_pred ccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcC
Confidence 999999999999775 49999999999999999999999999888777766665444333 345789999999999999
Q ss_pred cCCCCCCcHHHHhhcHhhhhccCC
Q 008116 250 KVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 250 ~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
+||.+|||+.|||+||||++....
T Consensus 310 ~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 310 RDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp SSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred CChhHCcCHHHHhcCHhhcCCCCC
Confidence 999999999999999999876543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-62 Score=508.59 Aligned_cols=260 Identities=26% Similarity=0.474 Sum_probs=232.6
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
.++|+++++||+|+||+||+|+++.+|+.||||++++.. .....+.+.+|+.+|++|+|||||+++++|.+++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 357999999999999999999999999999999997543 123467899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc--ccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT--ISR 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~--~~~ 167 (577)
||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+... ...
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999999877533 233
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
..+.||||.|||||++.+. .|+.++|||||||+||+|++|.+||...+.......|....+ .++..+++++++||.+|
T Consensus 191 ~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dli~~l 268 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARDLVEKL 268 (311)
T ss_dssp BCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTCCHHHHHHHHHH
T ss_pred ccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCcccCHHHHHHHHHH
Confidence 4578999999999999876 499999999999999999999999998887776666655443 45678899999999999
Q ss_pred cccCCCCCCcHHH------HhhcHhhhhccCC
Q 008116 248 LKKVPAERPSAKE------LLRHRFIRNARKS 273 (577)
Q Consensus 248 L~~dP~~RpTa~e------lL~hpff~~~~~~ 273 (577)
|.+||.+|||+.| |++||||+.+.+.
T Consensus 269 L~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 269 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred ccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 9999999999987 5889999887653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-61 Score=520.64 Aligned_cols=259 Identities=39% Similarity=0.686 Sum_probs=233.7
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
...|++++.||+|+||.||+|.++.+|+.||||++++.... ..+.+.+|+.+|++|+|||||+++++|.+++.+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 46799999999999999999999999999999999765432 34668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
||+||+|.++++. +++++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+........+.
T Consensus 229 y~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 229 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred CCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence 9999999999976 679999999999999999999999999999999999999999999999999999887665666788
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--chhhhhHHHHHHHHHhcc
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--l~~~~s~~l~~lI~~cL~ 249 (577)
+|||.|||||++.+. .|+.++||||||||||||++|.+||...+..+.+..|....++. .+..++.++++||.+||.
T Consensus 308 ~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~ 386 (423)
T 4fie_A 308 VGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 386 (423)
T ss_dssp EECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred ccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence 999999999999776 49999999999999999999999999888877776665544333 345789999999999999
Q ss_pred cCCCCCCcHHHHhhcHhhhhccCC
Q 008116 250 KVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 250 ~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
+||.+|||+.|||+||||+.....
T Consensus 387 ~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 387 RDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp SSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred CChhHCcCHHHHhcCHHhcCCCCC
Confidence 999999999999999999876443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-61 Score=492.48 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=213.7
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++++.||+|+||+||+|.++.+|+.||||++++... ......+.+|+.+|++|+|||||++++++.+++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999999999999999999976542 233567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
||| +|+|.+++...+++++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+..... ....+
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~ 170 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKT 170 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-CccCC
Confidence 999 7899999988899999999999999999999999999999999999999999999999999999876443 33456
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
.+|||.|||||++.+..+++.++|||||||+||+|++|++||...+.......+.... +.++..+++++++||.+||.+
T Consensus 171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 249 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-YTLPKFLSPGAAGLIKRMLIV 249 (275)
T ss_dssp ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHSCS
T ss_pred eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccC
Confidence 8999999999999887656789999999999999999999998877665555554433 345677899999999999999
Q ss_pred CCCCCCcHHHHhhcHhhhh
Q 008116 251 VPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 251 dP~~RpTa~elL~hpff~~ 269 (577)
||.+|||+.|+|+||||+.
T Consensus 250 dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 250 NPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp SGGGSCCHHHHHHCHHHHT
T ss_pred ChhHCcCHHHHHcCccccc
Confidence 9999999999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-60 Score=487.48 Aligned_cols=257 Identities=28% Similarity=0.493 Sum_probs=222.1
Q ss_pred hhcCCCe-eEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe----
Q 008116 9 EAAGSRF-SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH---- 82 (577)
Q Consensus 9 ~~~~~~f-~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~---- 82 (577)
....++| ++.+.||+|+||+||+|.+..++..||||++.... .....+.+.+|+.+|++|+|||||+++++|.+
T Consensus 21 ~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp ECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred cCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC
Confidence 3445677 77788999999999999999999999999997554 44556789999999999999999999999975
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcc-CCCeeeccccccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTE-NGDVKVADFGVSA 159 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~g--IiHrDIKPeNILld~-~g~vKL~DFGls~ 159 (577)
+..+|||||||+||+|.+++++.+++++..++.|+.||+.||+|||+++ ||||||||+||||+. +|.+||+|||+|+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 3568999999999999999998889999999999999999999999998 999999999999984 7999999999997
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccce-eeccCCCC-CCCchhhhh
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV-LFIIPREN-PPQLDEHFS 237 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~-~~~i~~~~-~~~l~~~~s 237 (577)
.... ....+.+|||.|||||++.+ .|+.++|||||||+||||+||.+||........ ...+.... ++.++..++
T Consensus 181 ~~~~--~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 181 LKRA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp GCCT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred eCCC--CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence 6433 33457899999999999864 499999999999999999999999987654333 33344333 334566778
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
+++++||.+||.+||.+|||+.+||+||||++
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-61 Score=499.89 Aligned_cols=257 Identities=28% Similarity=0.494 Sum_probs=221.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~---~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
++|++++.||+|+||+||+|.+. .+++.||||++++... ......+.+|+.+|++|+|||||+++++|.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999874 4688999999975431 1223467899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
|||||+||+|.++|.+.+++++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.........
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 183 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCC
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998766555556
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
.+.+|||.|||||++.+. .|+.++|||||||+||||++|.+||...+..+....|....+ .++..+++++++||.+||
T Consensus 184 ~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L 261 (304)
T 3ubd_A 184 YSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRMLF 261 (304)
T ss_dssp CSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHc
Confidence 678999999999999876 499999999999999999999999998887777666654443 456778999999999999
Q ss_pred ccCCCCCCc-----HHHHhhcHhhhhcc
Q 008116 249 KKVPAERPS-----AKELLRHRFIRNAR 271 (577)
Q Consensus 249 ~~dP~~RpT-----a~elL~hpff~~~~ 271 (577)
++||.+||| ++||++||||+.+.
T Consensus 262 ~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 262 KRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp CSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 999999998 47999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-59 Score=490.68 Aligned_cols=246 Identities=31% Similarity=0.433 Sum_probs=217.7
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
..|++.+.||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|++|+|||||+++++|.+++.+||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 568999999999999999999999999999999976532 24799999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC-Ceeecccccccccccccc-----
Q 008116 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTIS----- 166 (577)
Q Consensus 93 ~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g-~vKL~DFGls~~~~~~~~----- 166 (577)
|+||+|.++|+..+++++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 99999999998888999999999999999999999999999999999999999987 699999999987643221
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CchhhhhHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEFV 244 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~l~~~~s~~l~~lI 244 (577)
.....+|||.|||||++.+. .|+.++|||||||+||||++|.+||...+.......|....++ .++..+++.+++||
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li 290 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHH
T ss_pred cCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHH
Confidence 12346899999999999876 4999999999999999999999999988877777666555443 35668899999999
Q ss_pred HHhcccCCCCCCcHHHHhhcH
Q 008116 245 SLCLKKVPAERPSAKELLRHR 265 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hp 265 (577)
.+||.+||.+|||+.||++|.
T Consensus 291 ~~~L~~dP~~R~sa~el~~~l 311 (336)
T 4g3f_A 291 QEGLRKEPVHRASAMELRRKV 311 (336)
T ss_dssp HHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHH
Confidence 999999999999999998763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-58 Score=473.65 Aligned_cols=255 Identities=29% Similarity=0.475 Sum_probs=208.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC--------
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-------- 84 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~-------- 84 (577)
++|++++.||+|+||+||+|.++.+|+.||||+++........+.+.+|+.+|++|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 469999999999999999999999999999999987776666788999999999999999999999997644
Q ss_pred ----EEEEEEeccCCCCHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccc
Q 008116 85 ----KLWIIMEYMAGGSVADLIQSGPP---LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (577)
Q Consensus 85 ----~~~LV~Ey~~gGsL~~~l~~~~~---l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGl 157 (577)
.+|||||||++|+|.+++..... .++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 37999999999999999987654 44567899999999999999999999999999999999999999999999
Q ss_pred ccccccccc------------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeecc
Q 008116 158 SAQLTRTIS------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFII 224 (577)
Q Consensus 158 s~~~~~~~~------------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~-~~~~~~i 224 (577)
|+.+..... ...+.+|||.|||||++.+. .|+.++|||||||+||||++ ||..... ...+..+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~ 240 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence 987654321 12346899999999999875 49999999999999999996 7764321 2223333
Q ss_pred CCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 225 ~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.....+......++.+++||.+||++||.+|||+.+||+||||++..
T Consensus 241 ~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 44444455556677889999999999999999999999999998764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=487.08 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=223.0
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe------
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH------ 82 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~------ 82 (577)
.++++|++++.||+|+||+||+|.++.+|+.||||+++... .....+.+.+|+.+|++|+|||||++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 34578999999999999999999999999999999997654 34456788999999999999999999999864
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
.+.+|||||||+ |+|.+++...+++++..++.|++||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 367999999995 6899999888999999999999999999999999999999999999999999999999999998764
Q ss_pred cc----ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------
Q 008116 163 RT----ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------ 226 (577)
Q Consensus 163 ~~----~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------ 226 (577)
.. .....+.+||+.|||||++.+..+|+.++||||||||||||++|.+||...+....+..|..
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 32 22345689999999999998877789999999999999999999999988765544433311
Q ss_pred ---------------CCCCCc---hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 227 ---------------ENPPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 227 ---------------~~~~~l---~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..+..+ ...++.++++||.+||.+||.+|||+.|+|+||||+...
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 011111 124678999999999999999999999999999998653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=463.42 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=222.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
...+|.+.+.||+|+||+||+|.+. .++..||||+++.. .....+.+.+|+.+|++|+|||||+++++|.+++.
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 3468999999999999999999875 45789999999754 44556889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeee
Q 008116 86 LWIIMEYMAGGSVADLIQSG-------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKV 152 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~-------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL 152 (577)
+|||||||++|+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+||||+.++.+||
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999999653 36999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCC
Q 008116 153 ADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENP 229 (577)
Q Consensus 153 ~DFGls~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~ 229 (577)
+|||+|+........ ....+||+.|||||++.+.. |+.++|||||||+||||+| |++||...+..++...+.....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~ 248 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999866443221 22457999999999998764 9999999999999999998 9999999888887777777776
Q ss_pred CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 230 ~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
+..+..++.++.+||.+||.+||.+|||+.+|+ +|+++
T Consensus 249 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~ 286 (299)
T 4asz_A 249 LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN 286 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence 777888999999999999999999999999994 56654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-56 Score=460.74 Aligned_cols=255 Identities=22% Similarity=0.371 Sum_probs=224.5
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~ 83 (577)
+.....+++++.||+|+||+||+|... .+++.||||+++........+.|.+|+.+|++|+|||||+++++|.++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 344568899999999999999999863 467899999997655555567899999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC
Q 008116 84 TKLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~ 147 (577)
+.+|||||||++|+|.++|... ..+++..+..|+.||+.||+|||+++||||||||+||||+.+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 9999999999999999999642 358999999999999999999999999999999999999999
Q ss_pred CCeeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeecc
Q 008116 148 GDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFII 224 (577)
Q Consensus 148 g~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i 224 (577)
+++||+|||+|+.+..... .....+||+.|||||++.+.. |+.++|||||||+||||+| |..||...+..++...+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999987644322 233568999999999998764 9999999999999999998 89999999888888878
Q ss_pred CCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 225 ~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.....++.+..++..+.+|+.+||..||.+|||+.+|+++
T Consensus 261 ~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 261 RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7777777788899999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=461.32 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=215.5
Q ss_pred CCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
..+|.+.+.||+|+||+||+|.+. .++..||||+++.. .....+.|.+|+.+|++|+|||||+++++|.+.+.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357899999999999999999865 46889999999754 445568899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCee
Q 008116 87 WIIMEYMAGGSVADLIQSG---------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~---------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vK 151 (577)
|||||||++|+|.++|+.. +++++.++..|+.||+.||.|||+++||||||||+||||+.++.+|
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEE
Confidence 9999999999999999653 4699999999999999999999999999999999999999999999
Q ss_pred ecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC
Q 008116 152 VADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228 (577)
Q Consensus 152 L~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~ 228 (577)
|+|||+|+.+..... .....+||+.|||||++.+.. |+.++|||||||+||||+| |+.||...+..+.+..+....
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~ 277 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987643322 223468999999999998764 9999999999999999999 999999988877777776666
Q ss_pred CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 229 ~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.+..+..+++++.+||.+||.+||.+|||+.+|+++
T Consensus 278 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 278 ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 667778899999999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=496.81 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=223.7
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-----ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-----~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
-++|+++++||+|+||.||+|.++.+|+.||||++++.. ........+.++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999999999999999996542 222233444557778888999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|||||||+||+|..+|.+.+.|++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~-- 345 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 345 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC--
Confidence 999999999999999988899999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc---eeeccCCCCCCCchhhhhHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR---VLFIIPRENPPQLDEHFSRLMKEF 243 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~---~~~~i~~~~~~~l~~~~s~~l~~l 243 (577)
...+.||||.|||||++.....|+.++||||||||||||++|.+||...+... ....+. .....++..++.++++|
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~-~~~~~~p~~~S~~a~dL 424 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMAVELPDSFSPELRSL 424 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH-HCCCCCCTTSCHHHHHH
T ss_pred CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc-CCCCCCCccCCHHHHHH
Confidence 34578999999999999765569999999999999999999999997644322 112222 23345667899999999
Q ss_pred HHHhcccCCCCCCc-----HHHHhhcHhhhhccC
Q 008116 244 VSLCLKKVPAERPS-----AKELLRHRFIRNARK 272 (577)
Q Consensus 244 I~~cL~~dP~~RpT-----a~elL~hpff~~~~~ 272 (577)
|.+||.+||.+|++ +.+|++||||+.+.+
T Consensus 425 I~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp HHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred HHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 99999999999998 799999999998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=464.42 Aligned_cols=254 Identities=23% Similarity=0.339 Sum_probs=210.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~---~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~ 86 (577)
+.++|++++.||+|+||+||+|.++ .+++.||||.+..... ...+.+|+.+|+.+ +|||||+++++|.+.+++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4678999999999999999999875 4678999999865543 35688999999998 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC-CCeeeccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~-g~vKL~DFGls~~~~~~~ 165 (577)
|||||||+||+|.++++ .+++.+++.|++||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+......
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999999999994 59999999999999999999999999999999999999876 899999999997543211
Q ss_pred ----------------------------cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCc
Q 008116 166 ----------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP 217 (577)
Q Consensus 166 ----------------------------~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~ 217 (577)
....+.+|||.|||||++.+...|+.++||||+|||||+|++|++||...+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1223568999999999998876799999999999999999999999964432
Q ss_pred c-ceeeccC----------------------CCC-------------------------------CCCchhhhhHHHHHH
Q 008116 218 M-RVLFIIP----------------------REN-------------------------------PPQLDEHFSRLMKEF 243 (577)
Q Consensus 218 ~-~~~~~i~----------------------~~~-------------------------------~~~l~~~~s~~l~~l 243 (577)
. ..+..|. ... .......+++++++|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 1 1110000 000 001123568899999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
|.+||+.||.+|||+.|+|+||||+++
T Consensus 333 l~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-55 Score=451.15 Aligned_cols=250 Identities=29% Similarity=0.510 Sum_probs=208.4
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
.++|++.+.||+|+||+||+|.+. ..||||+++... .....+.|.+|+.+|++|+|||||++++++. ++.+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEE
Confidence 468889999999999999999865 359999997554 4556788999999999999999999999875 45689999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc--cc
Q 008116 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SR 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~--~~ 167 (577)
|||++|+|.++|.. ..++++..+..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+...... ..
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 99999999999965 4689999999999999999999999999999999999999999999999999998764322 22
Q ss_pred cccccCCCCCCChhhhhcc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeec-cCCC----CCCCchhhhhHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI-IPRE----NPPQLDEHFSRLM 240 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~--~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~-i~~~----~~~~l~~~~s~~l 240 (577)
..+.+||+.|||||++.+. ..|+.++|||||||+||||+||+.||...+....+.. +... ..+.++..++..+
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l 270 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAM 270 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHH
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHH
Confidence 3457899999999999743 2489999999999999999999999988765443322 2222 1234456789999
Q ss_pred HHHHHHhcccCCCCCCcHHHHhhcH
Q 008116 241 KEFVSLCLKKVPAERPSAKELLRHR 265 (577)
Q Consensus 241 ~~lI~~cL~~dP~~RpTa~elL~hp 265 (577)
++||.+||.+||.+|||+.+|+++.
T Consensus 271 ~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 271 KRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp HHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999999999999999998763
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=483.48 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=229.4
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.++|++++.||+|+||.||+|.++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.+...+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 468999999999999999999999999999999997654 3345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC--CCeeecccccccccccccccc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN--GDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~--g~vKL~DFGls~~~~~~~~~~ 168 (577)
||+||+|.++|.. .+.+++..++.|++||+.||.|||++||+||||||+||||+.+ +.+||+|||+|+.+... ...
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~~~ 313 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSV 313 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-SEE
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-Cce
Confidence 9999999999964 4689999999999999999999999999999999999999854 89999999999877543 334
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchhhhhHHHHHHHH
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVS 245 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s~~l~~lI~ 245 (577)
.+.+||+.|||||++.+. .|+.++|||||||+||+|++|.+||...+..+.+..|.... +......++..+++||.
T Consensus 314 ~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~ 392 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392 (573)
T ss_dssp EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHH
T ss_pred eeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 567999999999999876 48999999999999999999999999888877766665443 33345678999999999
Q ss_pred HhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 246 LCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
+||.+||.+|||+.|+|+||||+...
T Consensus 393 ~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 393 KLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp TTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred HHccCChhHCcCHHHHhcCcCcCCCC
Confidence 99999999999999999999998643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-54 Score=453.33 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=218.6
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC-CceeEeEEEEEeC-C
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQ-T 84 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~t-----g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~H-pnIV~l~~~~~~~-~ 84 (577)
.++|++.+.||+|+||+||+|.+..+ ++.||||.+.........+.+.+|+.+|+++.| ||||+++++|... .
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 46899999999999999999997654 368999999877766677889999999999965 9999999998764 5
Q ss_pred EEEEEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC
Q 008116 85 KLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG 148 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g 148 (577)
.+|||||||++|+|.++|+.. ..+++..+..|+.||+.||+|||+++||||||||+||||+.++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 789999999999999999642 3589999999999999999999999999999999999999999
Q ss_pred Ceeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccce-eecc
Q 008116 149 DVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRV-LFII 224 (577)
Q Consensus 149 ~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~-~~~i 224 (577)
.+||+|||+|+.+..... ...+.+||+.|||||++.+. .|+.++|||||||+||||+| |..||...+.... ...+
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i 301 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 301 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999987644322 23356899999999999876 49999999999999999998 9999988765433 3344
Q ss_pred CCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 225 ~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
..+..+..+..+++++.+||..||..||.+|||+.+|++|
T Consensus 302 ~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 302 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4455566777889999999999999999999999999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=441.20 Aligned_cols=260 Identities=27% Similarity=0.479 Sum_probs=224.8
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~ 87 (577)
..++|+++++||+|+||.||+|.++.+++.||||++.... .......+.+|+.+|+.+ +||||+++++++.+.+.+|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999999999999999997543 223456788999999998 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
||||||+||+|..++.....+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++........
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999999865544445
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
..+.+||+.|+|||++.+.. |+.++|||||||+||+|++|.+||...+.......|..... .++..++..+++||.+|
T Consensus 181 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~l 258 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATGILKSF 258 (353)
T ss_dssp -----CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHH
T ss_pred ccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHH
Confidence 56789999999999998764 89999999999999999999999998877666665544332 34566889999999999
Q ss_pred cccCCCCCCcH------HHHhhcHhhhhccC
Q 008116 248 LKKVPAERPSA------KELLRHRFIRNARK 272 (577)
Q Consensus 248 L~~dP~~RpTa------~elL~hpff~~~~~ 272 (577)
|.+||.+||++ .+|++||||+...+
T Consensus 259 L~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 259 MTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp TCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred hhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 99999999998 99999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=429.89 Aligned_cols=258 Identities=26% Similarity=0.468 Sum_probs=229.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
..++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++...+.+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3478999999999999999999999999999999997654 445567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||||++|+|.+++...+++++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... ....
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~ 171 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLD 171 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CGGG
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-Cccc
Confidence 999999999999988789999999999999999999999999999999999999999999999999999766433 3345
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
..+||+.|+|||++.+...++.++|||||||+||+|++|.+||...+.......+..... .++..++..+.+||.+||.
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~ 250 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKRFLV 250 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHCC
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHCC
Confidence 678999999999998876556899999999999999999999998776655555543332 3455678999999999999
Q ss_pred cCCCCCCcHHHHhhcHhhhhc
Q 008116 250 KVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 250 ~dP~~RpTa~elL~hpff~~~ 270 (577)
.||.+|||+.++|+||||...
T Consensus 251 ~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 251 LNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp SSTTTSCCHHHHTTCTTTTTT
T ss_pred CChhHCcCHHHHhcCHhhcCC
Confidence 999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=431.99 Aligned_cols=259 Identities=30% Similarity=0.513 Sum_probs=229.5
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
-++|+++++||+|+||.||+|.++.+++.||||+++... .......+.+|+.+|+.++||||+++++++.+.+.+|||
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999996542 122456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||||+||+|..++.....+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||++...........
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 163 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCccc
Confidence 99999999999998878899999999999999999999999999999999999999999999999999986544444456
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
+.+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||...+.......+.... ..++..++..+++||.+||.
T Consensus 164 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~ 241 (337)
T 1o6l_A 164 TFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLK 241 (337)
T ss_dssp CCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTC
T ss_pred ccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhh
Confidence 78999999999999775 48999999999999999999999998877655554443332 34556789999999999999
Q ss_pred cCCCCCC-----cHHHHhhcHhhhhccC
Q 008116 250 KVPAERP-----SAKELLRHRFIRNARK 272 (577)
Q Consensus 250 ~dP~~Rp-----Ta~elL~hpff~~~~~ 272 (577)
+||.+|| ++.+|++||||....+
T Consensus 242 ~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 242 KDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp SSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred cCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 9999999 9999999999987653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=444.18 Aligned_cols=260 Identities=28% Similarity=0.490 Sum_probs=223.5
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~L 88 (577)
..+|+++++||+|+||.||+|.++.+++.||||++++... ......+.+|+.+|.++ +|||||+++++|.+...+||
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4689999999999999999999999999999999976542 23346688999999887 89999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
|||||+||+|..++.....+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.........
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~ 210 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 210 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCcc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998655444555
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc--------eeeccCCCCCCCchhhhhHHH
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR--------VLFIIPRENPPQLDEHFSRLM 240 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~--------~~~~i~~~~~~~l~~~~s~~l 240 (577)
.+.+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||....... .+..........++..++..+
T Consensus 211 ~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~ 289 (396)
T 4dc2_A 211 STFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 289 (396)
T ss_dssp CCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred ccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHH
Confidence 678999999999999876 48999999999999999999999996432111 111111122334566789999
Q ss_pred HHHHHHhcccCCCCCCcH------HHHhhcHhhhhccC
Q 008116 241 KEFVSLCLKKVPAERPSA------KELLRHRFIRNARK 272 (577)
Q Consensus 241 ~~lI~~cL~~dP~~RpTa------~elL~hpff~~~~~ 272 (577)
++||.+||.+||.+||++ .+|++||||+.+.+
T Consensus 290 ~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp HHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred HHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 999999999999999985 89999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=419.84 Aligned_cols=262 Identities=43% Similarity=0.771 Sum_probs=229.9
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
....+|++++.||+|+||+||+|.+..+++.||||++...... ..+.+.+|+.++++++||||+++++++...+.+|||
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 3457899999999999999999999999999999998755432 246788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||||++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...........
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 999999999999977 4799999999999999999999999999999999999999999999999999987765555556
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC--CCCCchhhhhHHHHHHHHHh
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--NPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~--~~~~l~~~~s~~l~~lI~~c 247 (577)
..+||+.|+|||++.+.. ++.++|||||||+||+|++|..||...+.......+... .....+..++..+++||.+|
T Consensus 175 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 253 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (297)
T ss_dssp CCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred CccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence 678999999999998764 899999999999999999999999887665444333221 22334567899999999999
Q ss_pred cccCCCCCCcHHHHhhcHhhhhccCCh
Q 008116 248 LKKVPAERPSAKELLRHRFIRNARKSP 274 (577)
Q Consensus 248 L~~dP~~RpTa~elL~hpff~~~~~~~ 274 (577)
|..||.+|||+.++|+||||+......
T Consensus 254 l~~dp~~Rps~~ell~h~~~~~~~~~~ 280 (297)
T 3fxz_A 254 LEMDVEKRGSAKELLQHQFLKIAKPLS 280 (297)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred ccCChhHCcCHHHHhhChhhcccCccc
Confidence 999999999999999999998765443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=433.20 Aligned_cols=261 Identities=28% Similarity=0.512 Sum_probs=229.5
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~ 86 (577)
...++|+++++||+|+||.||+|.++.+++.||||+++.... ......+..|+.+|+.+ +||||+++++++.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 456899999999999999999999999999999999975421 22356788999999987 999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.......
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999986544444
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
...+.+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||...+.......+.... +.++..++..+++||.+
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 251 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVK 251 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred cccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccCHHHHHHHHH
Confidence 45678999999999999875 48999999999999999999999998877666555554333 34556789999999999
Q ss_pred hcccCCCCCCcHH-HHhhcHhhhhccC
Q 008116 247 CLKKVPAERPSAK-ELLRHRFIRNARK 272 (577)
Q Consensus 247 cL~~dP~~RpTa~-elL~hpff~~~~~ 272 (577)
||.+||.+||++. +|++||||+...+
T Consensus 252 lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 252 LFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp HSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred HhcCCHhHcCCChHHHHcCccccCCCH
Confidence 9999999999998 9999999987653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=426.43 Aligned_cols=260 Identities=28% Similarity=0.487 Sum_probs=225.3
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~ 87 (577)
..++|++++.||+|+||.||+|.++.+++.||||++.+.. .......+.+|+.+++++ +|||||++++++.+...+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 3478999999999999999999999999999999997654 344567789999999998 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
||||||++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++........
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence 99999999999999988788999999999999999999999999999999999999999999999999999865444444
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---------ceeeccCCCCCCCchhhhhH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---------RVLFIIPRENPPQLDEHFSR 238 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~---------~~~~~i~~~~~~~l~~~~s~ 238 (577)
..+.+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||...... .....+.. ....++..++.
T Consensus 167 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~s~ 244 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSV 244 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-CCCCCCTTSCH
T ss_pred ccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-CCCCCCCCCCH
Confidence 5577999999999999875 4899999999999999999999999753211 11111221 22345567889
Q ss_pred HHHHHHHHhcccCCCCCCcH------HHHhhcHhhhhccC
Q 008116 239 LMKEFVSLCLKKVPAERPSA------KELLRHRFIRNARK 272 (577)
Q Consensus 239 ~l~~lI~~cL~~dP~~RpTa------~elL~hpff~~~~~ 272 (577)
.+++||.+||.+||.+||++ .+|++||||+...+
T Consensus 245 ~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 245 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 99999999999999999995 89999999987643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=423.70 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=195.7
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC----EEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----KLW 87 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~----~~~ 87 (577)
..+|.+.+.||+|+||+||+|.+ +|+.||||+++.... .......|+..+.+++|||||++++++..++ .+|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 35789999999999999999987 489999999865432 1223345677778899999999999998754 689
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCcccccccceEEEccCCCeeeccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE--------GKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~--------gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
||||||++|+|.++|+. .++++..+..++.|++.||+|||++ +||||||||+||||+.++++||+|||+|+
T Consensus 78 lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999999986 5799999999999999999999987 99999999999999999999999999998
Q ss_pred cccccccc----cccccCCCCCCChhhhhccc-----CCccccchhhHHHHHHHHHhCCCCCCCCCccce----------
Q 008116 160 QLTRTISR----RKTFVGTPFWMAPEVIQNSE-----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRV---------- 220 (577)
Q Consensus 160 ~~~~~~~~----~~~~~GTp~Y~APEvl~~~~-----~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~---------- 220 (577)
........ ....+||+.|||||++.+.. .|+.++|||||||+||||+||.+||........
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76543221 22468999999999997532 267799999999999999999887653322111
Q ss_pred -----eecc-CCCCCCCchh-----hhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 221 -----LFII-PRENPPQLDE-----HFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 221 -----~~~i-~~~~~~~l~~-----~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
...+ .....+.++. ..+..+.+|+.+||..||.+|||+.+|++.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0111 1112223322 345678999999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=428.99 Aligned_cols=261 Identities=27% Similarity=0.442 Sum_probs=229.7
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-----HHHHHHHHHHHHHhCCCCceeEeEEEEEeC
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-----EIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~-----~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~ 83 (577)
..+.++|++.+.||+|+||.||+|.++.+|..||||+++...... ..+.+.+|+.+|++++||||++++++|.+.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 456678999999999999999999999999999999997654321 357789999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC----Ceeeccccccc
Q 008116 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG----DVKVADFGVSA 159 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g----~vKL~DFGls~ 159 (577)
..+|||||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999999998888999999999999999999999999999999999999998776 79999999998
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC---CCchhhh
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP---PQLDEHF 236 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~---~~l~~~~ 236 (577)
.+... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||...+.......+..... +.....+
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (361)
T 2yab_A 168 EIEDG-VEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245 (361)
T ss_dssp ECCTT-CCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred EcCCC-CccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence 76543 234467899999999999765 489999999999999999999999988777666555544332 2234567
Q ss_pred hHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 237 s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
+..+++||.+||.+||.+|||+.++|+||||....
T Consensus 246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 89999999999999999999999999999998643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=430.15 Aligned_cols=262 Identities=26% Similarity=0.449 Sum_probs=229.2
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTK 85 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~ 85 (577)
....++|+++++||+|+||.||+|.++.+++.||||++..... ......+..|+.+|..+ +||||+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 3445799999999999999999999999999999999975431 22356788999999988 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
+|||||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||++.......
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999998654444
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~ 245 (577)
....+.+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||...+.......|.... ..++..++..+++||.
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 253 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICK 253 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHH
T ss_pred cccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHH
Confidence 445578999999999999775 48999999999999999999999999877766555554433 2455678999999999
Q ss_pred HhcccCCCCCC-----cHHHHhhcHhhhhccC
Q 008116 246 LCLKKVPAERP-----SAKELLRHRFIRNARK 272 (577)
Q Consensus 246 ~cL~~dP~~Rp-----Ta~elL~hpff~~~~~ 272 (577)
+||.+||.+|| ++.+|++||||+...+
T Consensus 254 ~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 254 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp HHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 99999999999 5799999999987643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=420.22 Aligned_cols=256 Identities=28% Similarity=0.492 Sum_probs=227.1
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
-++|++++.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+|+.++||||+++++++.+...+|||
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999965431 12356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..... ...
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---~~~ 161 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTY 161 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---CBC
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---ccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999976543 234
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
+.+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||...+.......+.... ..++..++..+++||.+||.
T Consensus 162 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~ 239 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLIT 239 (318)
T ss_dssp CCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTC
T ss_pred cccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhc
Confidence 67899999999999775 48999999999999999999999998877665555544332 23456788999999999999
Q ss_pred cCCCCCC-----cHHHHhhcHhhhhccC
Q 008116 250 KVPAERP-----SAKELLRHRFIRNARK 272 (577)
Q Consensus 250 ~dP~~Rp-----Ta~elL~hpff~~~~~ 272 (577)
+||.+|| ++.+|++||||+...+
T Consensus 240 ~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 240 RDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred cCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 9999999 9999999999987643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=436.78 Aligned_cols=264 Identities=27% Similarity=0.433 Sum_probs=226.3
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
..++|+++++||+|+||+||+|.++.+++.||||++.+... ......+.+|+.+|..++|||||+++++|.+.+.+||
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 35799999999999999999999999999999999965321 1122348899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-
Q 008116 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~- 166 (577)
|||||+||+|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++........
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 9999999999999987 57899999999999999999999999999999999999999999999999999976644322
Q ss_pred ccccccCCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC----CCCCchhhhhH
Q 008116 167 RRKTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----NPPQLDEHFSR 238 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~----~~~~l~~~~s~ 238 (577)
.....+||+.|+|||++.. ...|+.++|||||||+||||++|.+||...+..+....|... ..+.....++.
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 311 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCH
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCH
Confidence 2234689999999999872 335899999999999999999999999988776655555321 22223345889
Q ss_pred HHHHHHHHhcccCCCC--CCcHHHHhhcHhhhhccCCh
Q 008116 239 LMKEFVSLCLKKVPAE--RPSAKELLRHRFIRNARKSP 274 (577)
Q Consensus 239 ~l~~lI~~cL~~dP~~--RpTa~elL~hpff~~~~~~~ 274 (577)
.+++||.+||..+|.+ ||++.+|++||||+...+..
T Consensus 312 ~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 312 NAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp HHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred HHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 9999999999988888 99999999999999886654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=417.69 Aligned_cols=261 Identities=24% Similarity=0.415 Sum_probs=222.3
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
...++|++++.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+++.++|||||++++++.+++..|||
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35689999999999999999999999999999999997665544557789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc--cc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SR 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~--~~ 167 (577)
||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 9999999999999887889999999999999999999999999999999999999999999999999997654322 22
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee--ccCCCCCCCchhhhhHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--IIPRENPPQLDEHFSRLMKEFVS 245 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~--~i~~~~~~~l~~~~s~~l~~lI~ 245 (577)
....+||+.|+|||++.+...++.++|||||||+||+|++|..||.......... .............++..+.+||.
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence 3357899999999999876655889999999999999999999998655432211 12222222334578899999999
Q ss_pred HhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 246 LCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
+||..||.+|||+.+||+||||...
T Consensus 244 ~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 244 KILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHccCChhhCcCHHHHhhChhhccc
Confidence 9999999999999999999999753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=406.05 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=216.3
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++|++++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.++++++||||+++++++.+++.+|||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999976543 3345778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
||.++.+..+....+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 161 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCC
Confidence 99764444444556789999999999999999999999999999999999999999999999999998776554455567
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCC-CccceeeccC------------------C------
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIP------------------R------ 226 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~-~~~~~~~~i~------------------~------ 226 (577)
+||+.|+|||++.+...++.++|||||||++|+|++|..||... +....+..+. .
T Consensus 162 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T 3o0g_A 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred ccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccccc
Confidence 89999999999987666899999999999999999988885432 2211111110 0
Q ss_pred ----CCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 227 ----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 227 ----~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.........++..+++||.+||..||.+|||+.++|+||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 00011223578899999999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=413.84 Aligned_cols=263 Identities=27% Similarity=0.434 Sum_probs=218.6
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
..+.+.++|++++.||+|+||+||+|.+. +++.||||++..... ......+.+|+.+|++++||||+++++++.++..
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 45567799999999999999999999986 489999999975542 2235678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
+|||||||++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999999974 78887765 356999999999999999999999999999999999999999999999999999877554
Q ss_pred ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----CCCC----------
Q 008116 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----ENPP---------- 230 (577)
Q Consensus 165 ~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~----~~~~---------- 230 (577)
.......+||+.|+|||++.+...++.++|||||||++|+|++|.+||........+..+.. ..+.
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 44445678999999999998766689999999999999999999999987655443322210 0000
Q ss_pred ---------------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 231 ---------------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 231 ---------------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.+...++.++.+||.+||..||.+|||+.++|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 01224678899999999999999999999999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=433.54 Aligned_cols=264 Identities=27% Similarity=0.476 Sum_probs=226.1
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
..++|+++++||+|+||.||+|.++.+++.||||++.+... ......+.+|+.+|+.++|||||+++++|.+...+||
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 45789999999999999999999999999999999865321 1122457899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-c
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~ 167 (577)
|||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||++..+..... .
T Consensus 147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence 9999999999999976 5799999999999999999999999999999999999999999999999999977654322 2
Q ss_pred cccccCCCCCCChhhhhcccC---CccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchhhhhHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEG---YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMK 241 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~---~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s~~l~ 241 (577)
..+.+||+.|+|||++.+... |+.++|||||||+||+|++|.+||...+.......|.... ..+....++..++
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 305 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHH
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHH
Confidence 346789999999999976432 7889999999999999999999999887766655554321 1122236789999
Q ss_pred HHHHHhcccCCCC--CCcHHHHhhcHhhhhccCChh
Q 008116 242 EFVSLCLKKVPAE--RPSAKELLRHRFIRNARKSPR 275 (577)
Q Consensus 242 ~lI~~cL~~dP~~--RpTa~elL~hpff~~~~~~~~ 275 (577)
+||.+||..+|.+ ||++.+|++||||+...+...
T Consensus 306 ~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~ 341 (410)
T 3v8s_A 306 NLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE 341 (410)
T ss_dssp HHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred HHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence 9999999999988 999999999999998765443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=421.35 Aligned_cols=258 Identities=28% Similarity=0.406 Sum_probs=226.4
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
...-++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++...+.+
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 4456899999999999999999999999999999999864321 11235789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
||||||+ +|+|.+++...+++++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~ 162 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-N 162 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-B
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-c
Confidence 9999999 7899999987789999999999999999999999999999999999999999999999999999766443 3
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....+||+.|+|||++.+...++.++|||||||+||+|++|..||...........+... ...++..++..+++||.+
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 241 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQSLIRR 241 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-CCCCCTTSCHHHHHHHHT
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCcccCCHHHHHHHHH
Confidence 3456789999999999987664578999999999999999999999887665555554433 234566789999999999
Q ss_pred hcccCCCCCCcHHHHhhcHhhhh
Q 008116 247 CLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~hpff~~ 269 (577)
||..||.+|||+.+|++||||+.
T Consensus 242 ~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 242 MIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp TSCSSGGGSCCHHHHTTCHHHHT
T ss_pred HcCCChhHCcCHHHHHhChhhcc
Confidence 99999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=408.55 Aligned_cols=265 Identities=26% Similarity=0.440 Sum_probs=216.9
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
-++|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.++++++||||+++++++...+.+++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 46899999999999999999999999999999998665433 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|||++++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 99999999999988888999999999999999999999999999999999999999999999999999877655444456
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------------------
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------------ 226 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------------------ 226 (577)
.+||+.|+|||++.+...++.++|||||||++|+|++|.+||...........+..
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence 78999999999998756689999999999999999999999987654332221100
Q ss_pred CCCC---Cc---hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCChhH
Q 008116 227 ENPP---QL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRL 276 (577)
Q Consensus 227 ~~~~---~l---~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~ 276 (577)
..+. .+ ...++..+.+||.+||..||.+|||+.+||+||||++......+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 297 (311)
T 4agu_A 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297 (311)
T ss_dssp CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-----
T ss_pred CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHHH
Confidence 0000 00 13567889999999999999999999999999999987654433
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=421.01 Aligned_cols=258 Identities=24% Similarity=0.457 Sum_probs=226.3
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
.+.++|++.+.||+|+||.||+|.+..++..||||++.... .....+.+.+|+.+|++|+|||||++++++.+.+.+||
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34568999999999999999999999999999999997654 34456789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC---CCeeeccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~---g~vKL~DFGls~~~~~~~ 165 (577)
|||||.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 99999999999999888889999999999999999999999999999999999999865 45999999999776533
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC---CCCCchhhhhHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---NPPQLDEHFSRLMKE 242 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~---~~~~l~~~~s~~l~~ 242 (577)
......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||...+.......+... .+......++..+++
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred cccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 233457899999999999775 4899999999999999999999999887765554444322 223334578999999
Q ss_pred HHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 243 FVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
||.+||..||.+|||+.++|+||||..
T Consensus 264 li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 264 LIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=414.28 Aligned_cols=257 Identities=25% Similarity=0.367 Sum_probs=225.2
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+|+.++||||+++++++.+.+.+|||
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 35789999999999999999999999999999999987543 3456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc--CCCeeecccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE--NGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~--~g~vKL~DFGls~~~~~~~~ 166 (577)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+... .
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~ 158 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-D 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-C
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-C
Confidence 9999999999999764 47999999999999999999999999999999999999987 789999999999876443 2
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC---chhhhhHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ---LDEHFSRLMKEF 243 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~---l~~~~s~~l~~l 243 (577)
.....+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...+.......+....... ....++..+++|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred ccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 33457899999999999775 48899999999999999999999998877665555544333222 234678999999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
|.+||..||.+|||+.++|+||||+..
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=422.76 Aligned_cols=257 Identities=28% Similarity=0.491 Sum_probs=228.6
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
..++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+|+.++||||+++++++.+...+||
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 34789999999999999999999999999999999865431 1235778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++...... .
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---~ 195 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---T 195 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---B
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---c
Confidence 9999999999999988788999999999999999999999999999999999999999999999999999866432 3
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
.+.+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||...+.......+.... ..++..++..+++||.+||
T Consensus 196 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL 273 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp CCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHHHS
T ss_pred ccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHh
Confidence 467899999999999875 48999999999999999999999999877666555554433 3455678999999999999
Q ss_pred ccCCCCCCc-----HHHHhhcHhhhhccC
Q 008116 249 KKVPAERPS-----AKELLRHRFIRNARK 272 (577)
Q Consensus 249 ~~dP~~RpT-----a~elL~hpff~~~~~ 272 (577)
..||.+||+ +.+|++||||....+
T Consensus 274 ~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred hcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 999999998 999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=434.96 Aligned_cols=260 Identities=23% Similarity=0.419 Sum_probs=228.0
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
....++|++++.||+|+||.||+|.+..+|+.||+|++...... ...+.+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 34567899999999999999999999999999999999766533 34577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc---cCCCeeecccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT---ENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld---~~g~vKL~DFGls~~~~~~ 164 (577)
||||||.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++......
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999999998888999999999999999999999999999999999999998 4578999999999877655
Q ss_pred ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchhhhhHHHH
Q 008116 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMK 241 (577)
Q Consensus 165 ~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s~~l~ 241 (577)
.......+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||...+.......+.... +......++..++
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 245 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred CceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 4445567899999999999775 48999999999999999999999998877665555443332 2233356889999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 242 EFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
+||.+||..||.+|||+.++|+||||..
T Consensus 246 ~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 246 DLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 9999999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=434.75 Aligned_cols=259 Identities=29% Similarity=0.514 Sum_probs=218.1
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
.++|+++++||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||++++++|...+.+|||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999999999999999997542 333456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
||||++|+|..++.....+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||++..........
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 306 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 306 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCccc
Confidence 9999999999999887899999999999999999999998 999999999999999999999999999998655544455
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
...+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||...+.......+.... ..++..++..+++||.+||
T Consensus 307 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L 384 (446)
T 4ejn_A 307 KTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLGPEAKSLLSGLL 384 (446)
T ss_dssp CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHc
Confidence 678999999999999775 48999999999999999999999998877655554443332 2345678899999999999
Q ss_pred ccCCCCCC-----cHHHHhhcHhhhhccC
Q 008116 249 KKVPAERP-----SAKELLRHRFIRNARK 272 (577)
Q Consensus 249 ~~dP~~Rp-----Ta~elL~hpff~~~~~ 272 (577)
.+||.+|| ++.+||+||||....+
T Consensus 385 ~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 385 KKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 99999999 9999999999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=419.48 Aligned_cols=261 Identities=32% Similarity=0.570 Sum_probs=220.2
Q ss_pred cCCCeeEEeEEeec--CceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 11 AGSRFSSLELIGRG--SFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 11 ~~~~f~il~~IG~G--sfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
..++|+++++||+| +||.||+|.+..+++.||||++.... .......+.+|+.+|++++|||||++++++...+.+|
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 46799999999999 99999999999999999999997654 3445678889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
||||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999999999764 679999999999999999999999999999999999999999999999999886543221
Q ss_pred c-------ccccccCCCCCCChhhhhcc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC--------
Q 008116 166 S-------RRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP-------- 229 (577)
Q Consensus 166 ~-------~~~~~~GTp~Y~APEvl~~~-~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~-------- 229 (577)
. .....+||+.|+|||++.+. ..|+.++|||||||+||+|++|.+||...+.......+.....
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 1 11234799999999999763 3589999999999999999999999987655443332221111
Q ss_pred -------------------------------------CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 230 -------------------------------------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 230 -------------------------------------~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
...+..++..+++||.+||..||.+|||+.++|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 113345788899999999999999999999999999998764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=416.59 Aligned_cols=261 Identities=27% Similarity=0.470 Sum_probs=216.9
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeccCCC---hHHHHHHHHHHHHHHhCCCCceeEeEEEEEe
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEES---EDEIEDIQKEISVLSQCRSPYITEYYGSYLH 82 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~---~tg~~VAIK~i~~~~~---~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~ 82 (577)
....++|++++.||+|+||.||+|.+. .+++.||||+++.... ......+.+|+.+|++++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 445679999999999999999999985 6899999999976532 2345668899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
.+.+|||||||++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999999887889999999999999999999999999999999999999999999999999987654
Q ss_pred ccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHH
Q 008116 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (577)
Q Consensus 163 ~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~ 242 (577)
.........+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...+.......+.... ..++..++..+++
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~ 250 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNLPPYLTQEARD 250 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCTTSCHHHHH
T ss_pred cCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHH
Confidence 444444567899999999999775 48999999999999999999999998877655554443322 2345568899999
Q ss_pred HHHHhcccCCCCCC-----cHHHHhhcHhhhhcc
Q 008116 243 FVSLCLKKVPAERP-----SAKELLRHRFIRNAR 271 (577)
Q Consensus 243 lI~~cL~~dP~~Rp-----Ta~elL~hpff~~~~ 271 (577)
||.+||..||.+|| ++.++++||||+...
T Consensus 251 li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp HHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred HHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 99999999999999 899999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=408.08 Aligned_cols=258 Identities=28% Similarity=0.470 Sum_probs=215.2
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-------------------------HHHHHHHHHHHH
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-------------------------DEIEDIQKEISV 64 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-------------------------~~~~~i~~Ev~i 64 (577)
...++|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3457999999999999999999999999999999999654321 124568899999
Q ss_pred HHhCCCCceeEeEEEEEe--CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceE
Q 008116 65 LSQCRSPYITEYYGSYLH--QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANI 142 (577)
Q Consensus 65 L~~L~HpnIV~l~~~~~~--~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNI 142 (577)
|++++||||+++++++.+ ...+||||||+++++|.+++.. .++++..++.++.||+.||.|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999987 5689999999999999987643 6899999999999999999999999999999999999
Q ss_pred EEccCCCeeeccccccccccccccccccccCCCCCCChhhhhcccC--CccccchhhHHHHHHHHHhCCCCCCCCCccce
Q 008116 143 LLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG--YNEKADIWSLGITVIEMAKGEPPLADLHPMRV 220 (577)
Q Consensus 143 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~--~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~ 220 (577)
||+.++.+||+|||++.............+||+.|+|||++.+... ++.++|||||||+||+|++|..||........
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 248 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence 9999999999999999876554444456789999999999876432 47789999999999999999999987655433
Q ss_pred eeccCCCC-CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 221 LFIIPREN-PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 221 ~~~i~~~~-~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
...+.... .......++..+++||.+||..||.+|||+.+||+||||.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 33332221 1122345788999999999999999999999999999996
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=404.80 Aligned_cols=267 Identities=63% Similarity=1.090 Sum_probs=238.0
Q ss_pred chhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 6 ~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
.+.......|++++.||+|+||.||+|.+..+++.||||++...........+.+|+.+++++.||||+++++++.....
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 94 (303)
T 3a7i_A 15 NLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK 94 (303)
T ss_dssp TCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 34456667899999999999999999999999999999999876655567889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
+|+||||+++++|.+++.. .++++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 95 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred EEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999999999965 689999999999999999999999999999999999999999999999999998766544
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~ 245 (577)
.......||+.|+|||++.+. .++.++||||||+++|+|++|..||...........+....++.++..++..+.+||.
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 252 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 252 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHH
T ss_pred cccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHH
Confidence 444567899999999999775 4889999999999999999999999887776665555555566667788999999999
Q ss_pred HhcccCCCCCCcHHHHhhcHhhhhccCCh
Q 008116 246 LCLKKVPAERPSAKELLRHRFIRNARKSP 274 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~hpff~~~~~~~ 274 (577)
+||..+|.+|||+.+||+||||.......
T Consensus 253 ~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 281 (303)
T 3a7i_A 253 ACLNKEPSFRPTAKELLKHKFILRNAKKT 281 (303)
T ss_dssp HHCCSSGGGSCCHHHHTTCHHHHHHCCCG
T ss_pred HHcCCChhhCcCHHHHhhChhhhcCCCcc
Confidence 99999999999999999999997665443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=413.10 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=225.7
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-----HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-----~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~ 84 (577)
.+.++|++.+.||+|+||.||+|.+..++..||||++...... ...+.+.+|+.+|++++||||+++++++....
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 4556899999999999999999999999999999999765422 13577899999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC----Ceeecccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG----DVKVADFGVSAQ 160 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g----~vKL~DFGls~~ 160 (577)
.+|||||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999999998888899999999999999999999999999999999999998877 799999999987
Q ss_pred ccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchhhhh
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFS 237 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s 237 (577)
.... ......+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...........+.... +......++
T Consensus 168 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 168 IDFG-NEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp CCTT-SCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred CCCC-CccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 6433 233456899999999999765 48999999999999999999999998776554444333222 222334678
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..+++||.+||..||.+|||+.++|+||||+...
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 9999999999999999999999999999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=403.25 Aligned_cols=255 Identities=28% Similarity=0.500 Sum_probs=211.7
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++|++++.||+|+||.||+|.+ .+++.||||++...... .....+.+|+.++++++||||+++++++...+.+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5899999999999999999998 57899999999755422 224678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|+.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++............
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence 9975 99999875 367999999999999999999999999999999999999999999999999999876544344445
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------------C-----
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------E----- 227 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------------~----- 227 (577)
.+||+.|+|||++.+...++.++|||||||++|+|++|.+||........+..+.. .
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc
Confidence 68999999999997765689999999999999999999999987654332211100 0
Q ss_pred --CCC---CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 228 --NPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 228 --~~~---~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
.+. .+...++..+++||.+||..||.+|||+.++|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 000 112357889999999999999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=426.00 Aligned_cols=260 Identities=29% Similarity=0.447 Sum_probs=220.4
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHH-HHhCCCCceeEeEEEEEeCCEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISV-LSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~i-L~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
..++|+++++||+|+||.||+|.++.+++.||||++.+... ......+.+|..+ ++.++|||||+++++|.+.+.+|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 44689999999999999999999999999999999976542 2334567778777 57789999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
||||||+||+|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++........
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST 195 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence 99999999999999988788999999999999999999999999999999999999999999999999999875544445
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
..+.+||+.|+|||++.+. .|+.++|||||||+||||++|.+||...+.......|... +..++..++..+++||.+|
T Consensus 196 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~l 273 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPNITNSARHLLEGL 273 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-CCCCCSSSCHHHHHHHHHH
T ss_pred cccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHHH
Confidence 5678999999999999875 4899999999999999999999999887766555555433 2344567889999999999
Q ss_pred cccCCCCCCcH----HHHhhcHhhhhccC
Q 008116 248 LKKVPAERPSA----KELLRHRFIRNARK 272 (577)
Q Consensus 248 L~~dP~~RpTa----~elL~hpff~~~~~ 272 (577)
|.+||.+||++ .+|++||||+.+.+
T Consensus 274 L~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 274 LQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp TCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred cccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 99999999986 69999999988754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=413.46 Aligned_cols=260 Identities=27% Similarity=0.459 Sum_probs=207.5
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.++|++++.||+|+||.||+|.+..+++.||||+++..........+.+|+.+|++++|||||++++++..++.+|||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 57899999999999999999999999999999999766544445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 92 YMAGGSVADLIQSG------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 92 y~~gGsL~~~l~~~------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
||+ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 997 6999998642 459999999999999999999999999999999999999999999999999998765444
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC--------------------
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-------------------- 225 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-------------------- 225 (577)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+.
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence 444567899999999999875568999999999999999999999998765433222110
Q ss_pred -----CCCCC--------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 226 -----RENPP--------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 226 -----~~~~~--------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
...+. .....++..+++||.+||..||.+|||+.++|+||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 00000 011246789999999999999999999999999999987543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=414.56 Aligned_cols=264 Identities=27% Similarity=0.432 Sum_probs=212.2
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
.....++|++++.||+|+||+||+|.+..+++.||||++...... .....+.+|+.+|++++||||+++++++..+..+
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 344557999999999999999999999999999999999765432 2346678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc-----cCCCeeeccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT-----ENGDVKVADFGVSAQL 161 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld-----~~g~vKL~DFGls~~~ 161 (577)
|||||||+ |+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+ ..+.+||+|||++...
T Consensus 109 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99999997 59999999888999999999999999999999999999999999999995 4456999999999877
Q ss_pred cccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---------------
Q 008116 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR--------------- 226 (577)
Q Consensus 162 ~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~--------------- 226 (577)
..........+||+.|+|||++.+...++.++|||||||++|+|++|.+||........+..+..
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 55444455678999999999998766689999999999999999999999987655333222110
Q ss_pred -----CC-----CC----CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 227 -----EN-----PP----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 227 -----~~-----~~----~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
.. .. .+...++..+++||.+||..||.+|||+.++|+||||+....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 00 00 012236789999999999999999999999999999987654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=417.55 Aligned_cols=259 Identities=29% Similarity=0.480 Sum_probs=219.3
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC----hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~----~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++|||||++++++...+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 345689999999999999999999999999999999864321 1135778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC---eeecccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD---VKVADFGVS 158 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~---vKL~DFGls 158 (577)
+|||||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999999888743 346899999999999999999999999999999999999987654 999999999
Q ss_pred ccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC---CCchhh
Q 008116 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP---PQLDEH 235 (577)
Q Consensus 159 ~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~---~~l~~~ 235 (577)
.............+||+.|+|||++.+.. |+.++|||||||+||+|++|.+||..... .....+..... +.....
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCCHHHHTT
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCCcccccc
Confidence 87765443345678999999999998754 89999999999999999999999987532 22222222221 122346
Q ss_pred hhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 236 ~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
++..+++||.+||..||.+|||+.++|+||||+..
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 78999999999999999999999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=405.23 Aligned_cols=262 Identities=39% Similarity=0.694 Sum_probs=227.2
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEecc
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
.|+..+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.++++++||||+++++++...+.+||||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 48899999999999999999999999999999975543 23567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccccC
Q 008116 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173 (577)
Q Consensus 94 ~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~G 173 (577)
++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+|
T Consensus 125 ~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 203 (321)
T 2c30_A 125 QGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 203 (321)
T ss_dssp CSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCS
T ss_pred CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccC
Confidence 99999999865 67999999999999999999999999999999999999999999999999999876554444456789
Q ss_pred CCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--chhhhhHHHHHHHHHhcccC
Q 008116 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEFVSLCLKKV 251 (577)
Q Consensus 174 Tp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--l~~~~s~~l~~lI~~cL~~d 251 (577)
|+.|+|||++.+. .++.++|||||||+||+|++|..||...........+....++. ....++..+++||.+||..|
T Consensus 204 t~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 282 (321)
T 2c30_A 204 TPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRD 282 (321)
T ss_dssp CGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSS
T ss_pred CccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCC
Confidence 9999999999765 48999999999999999999999998876655444443333322 23467899999999999999
Q ss_pred CCCCCcHHHHhhcHhhhhccCChhHHH
Q 008116 252 PAERPSAKELLRHRFIRNARKSPRLLE 278 (577)
Q Consensus 252 P~~RpTa~elL~hpff~~~~~~~~~~~ 278 (577)
|.+|||+.+||+||||........+..
T Consensus 283 p~~Rps~~ell~hp~~~~~~~~~~~~~ 309 (321)
T 2c30_A 283 PQERATAQELLDHPFLLQTGLPECLVP 309 (321)
T ss_dssp TTTSCCHHHHHTSGGGGGCCCGGGGHH
T ss_pred hhhCcCHHHHhcChhhccCCCcccchH
Confidence 999999999999999987654443333
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=423.18 Aligned_cols=262 Identities=26% Similarity=0.491 Sum_probs=226.0
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
....++|+++++||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++|||||+++++|.+...+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 344578999999999999999999999999999999986543 122357788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|+|||||.||+|..++.....+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+... .
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~ 169 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-T 169 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-C
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-C
Confidence 999999999999999998889999999999999999999999999999999999999999999999999999876433 3
Q ss_pred ccccccCCCCCCChhhhhcc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccce---eeccCCCCCCCchhhhhHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV---LFIIPRENPPQLDEHFSRLMK 241 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~--~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~---~~~i~~~~~~~l~~~~s~~l~ 241 (577)
...+.+||+.|+|||++... ..|+.++|||||||+||+|++|.+||........ ...+. .....++..++..+.
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~p~~~s~~~~ 248 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-TTVVTYPSAWSQEMV 248 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-HCCCCCCTTSCHHHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-hcccCCCCcCCHHHH
Confidence 34567999999999998642 3488999999999999999999999975433221 11111 123345567889999
Q ss_pred HHHHHhcccCCCCCCc-HHHHhhcHhhhhccC
Q 008116 242 EFVSLCLKKVPAERPS-AKELLRHRFIRNARK 272 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpT-a~elL~hpff~~~~~ 272 (577)
+||.+||.+||.+||+ +.+|+.||||....+
T Consensus 249 ~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 249 SLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp HHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred HHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 9999999999999998 899999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=413.93 Aligned_cols=257 Identities=31% Similarity=0.396 Sum_probs=208.1
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
..++|++++.||+|+||.||+|.+..+++.||||++...... .+.+.+|+.+++.++|||||++++++...+.+||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 458999999999999999999999999999999999754432 256889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC--eeecccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD--VKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~--vKL~DFGls~~~~~~~~~~ 168 (577)
|||++|+|.+++...+++++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++...... ...
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-~~~ 174 (361)
T 3uc3_A 96 EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 174 (361)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-CCC
Confidence 99999999999987788999999999999999999999999999999999999987765 999999998754322 233
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeec----cCC-CCCCCchhhhhHHHHHH
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI----IPR-ENPPQLDEHFSRLMKEF 243 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~----i~~-~~~~~l~~~~s~~l~~l 243 (577)
...+||+.|+|||++.+....+.++|||||||+||+|++|.+||........... +.. .........++..+++|
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 254 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHH
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHH
Confidence 4568999999999998766445559999999999999999999987554322211 111 11112223578999999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
|.+||..||.+|||+.+||+||||...
T Consensus 255 i~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 255 ISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHccCChhHCcCHHHHHhCcchhcC
Confidence 999999999999999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=393.82 Aligned_cols=261 Identities=24% Similarity=0.458 Sum_probs=227.3
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
...++|++++.||+|+||.||+|.+..++..||||++.... .......+.+|+.++++++||||+++++++......|+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 46789999999999999999999999999999999997654 44556788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC---eeeccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTI 165 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~---vKL~DFGls~~~~~~~ 165 (577)
||||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++......
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~- 161 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 161 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-
Confidence 9999999999999987788999999999999999999999999999999999999986655 999999998766543
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC---CCCCchhhhhHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---NPPQLDEHFSRLMKE 242 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~---~~~~l~~~~s~~l~~ 242 (577)
.......||+.|+|||++.+.. ++.++||||||+++|+|++|..||...........+... .+......++..+.+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred ccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 2334568999999999998764 899999999999999999999999887665544433222 222333567899999
Q ss_pred HHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 243 FVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
||.+||..||.+|||+.++|+||||.+...
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 999999999999999999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=416.25 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=218.8
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~ 87 (577)
....++|++++.||+|+||.||+|.++.+++.||||++..... ...+|+.+|.++ .||||+++++++.++..+|
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 3456789999999999999999999999999999999976542 245788888888 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC----CCeeeccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN----GDVKVADFGVSAQLTR 163 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~----g~vKL~DFGls~~~~~ 163 (577)
||||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+... +.+||+|||++.....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999999888899999999999999999999999999999999999998543 3599999999987765
Q ss_pred cccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCC---ccceeeccCCCC---CCCchhhhh
Q 008116 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH---PMRVLFIIPREN---PPQLDEHFS 237 (577)
Q Consensus 164 ~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~---~~~~~~~i~~~~---~~~l~~~~s 237 (577)
......+.+||+.|+|||++.+.. |+.++|||||||+||+|++|.+||.... ..+....+.... +...+..++
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 545555779999999999998754 8899999999999999999999997532 222222332222 222345688
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
..+++||.+||..||.+|||+.++|+||||...
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 999999999999999999999999999999653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=399.37 Aligned_cols=261 Identities=27% Similarity=0.468 Sum_probs=219.1
Q ss_pred chhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 6 ~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
..+....++|++.+.||+|+||.||+|.+..++..||||++.........+.+.+|+.+|++++||||+++++++.+...
T Consensus 15 ~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 15 YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp EESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 35566778999999999999999999999999999999999776655456889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc---cCCCeeecccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT---ENGDVKVADFGVS 158 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld---~~g~vKL~DFGls 158 (577)
+|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999999998843 47899999999999999999999999999999999999994 4578999999999
Q ss_pred ccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC--CCchhhh
Q 008116 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP--PQLDEHF 236 (577)
Q Consensus 159 ~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~--~~l~~~~ 236 (577)
...... ......+||+.|+|||++.. .++.++|||||||+||+|++|..||...........+....+ ......+
T Consensus 175 ~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (285)
T 3is5_A 175 ELFKSD-EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL 251 (285)
T ss_dssp CC-----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCC
T ss_pred eecCCc-ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcC
Confidence 765443 22345689999999999864 488999999999999999999999987765444333322221 1122346
Q ss_pred hHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 237 s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
+..+.+||.+||..||.+|||+.+||+||||++
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 889999999999999999999999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=404.38 Aligned_cols=255 Identities=28% Similarity=0.453 Sum_probs=214.3
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC-------
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT------- 84 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~------- 84 (577)
.++|++++.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+|++++|||||+++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4689999999999999999999999999999999987665556788999999999999999999999986643
Q ss_pred --------------------------------------------------EEEEEEeccCCCCHHHHHHcCCC---CCHH
Q 008116 85 --------------------------------------------------KLWIIMEYMAGGSVADLIQSGPP---LDEM 111 (577)
Q Consensus 85 --------------------------------------------------~~~LV~Ey~~gGsL~~~l~~~~~---l~e~ 111 (577)
.+|+|||||++++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 38999999999999999987543 5666
Q ss_pred HHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc------------cccccccCCCCCCC
Q 008116 112 SIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI------------SRRKTFVGTPFWMA 179 (577)
Q Consensus 112 ~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~------------~~~~~~~GTp~Y~A 179 (577)
.++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 789999999999999999999999999999999999999999999998765432 12234679999999
Q ss_pred hhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHH
Q 008116 180 PEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAK 259 (577)
Q Consensus 180 PEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~ 259 (577)
||++.+. .++.++|||||||++|+|++|..|+.... .....+.....+......++.+.+||.+||.+||.+|||+.
T Consensus 245 PE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 321 (332)
T 3qd2_B 245 PEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321 (332)
T ss_dssp HHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHHHH--HHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred hHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhHHH--HHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence 9999876 48999999999999999999987753321 12222233344445566778899999999999999999999
Q ss_pred HHhhcHhhhh
Q 008116 260 ELLRHRFIRN 269 (577)
Q Consensus 260 elL~hpff~~ 269 (577)
++|+||||++
T Consensus 322 ~~l~~~~f~~ 331 (332)
T 3qd2_B 322 DIIENAIFEN 331 (332)
T ss_dssp HHHHSTTCCC
T ss_pred HHhhchhhhc
Confidence 9999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=425.39 Aligned_cols=261 Identities=28% Similarity=0.424 Sum_probs=202.0
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-----C
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----T 84 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~-----~ 84 (577)
+.++|+++++||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+|++++|||||++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 4578999999999999999999999999999999986543 344567899999999999999999999999543 5
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
.+||||||+ +++|.+++.....+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 799999998 5799999998888999999999999999999999999999999999999999999999999999865422
Q ss_pred c---------------------------cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh----------
Q 008116 165 I---------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK---------- 207 (577)
Q Consensus 165 ~---------------------------~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt---------- 207 (577)
. ......+||++|+|||++.....|+.++||||||||||||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 1 123456899999999987665669999999999999999999
Q ss_pred -CCCCCCCCCccce--------------------e---------------------------eccCCCCCC---Cchhhh
Q 008116 208 -GEPPLADLHPMRV--------------------L---------------------------FIIPRENPP---QLDEHF 236 (577)
Q Consensus 208 -G~~Pf~~~~~~~~--------------------~---------------------------~~i~~~~~~---~l~~~~ 236 (577)
|.++|........ + ..+...... .....+
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 6666654331100 0 000000011 112245
Q ss_pred hHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 237 s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
+..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 789999999999999999999999999999987643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=392.92 Aligned_cols=258 Identities=26% Similarity=0.459 Sum_probs=225.1
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
....++|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.++++++||||+++++++.+...+|+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 34567899999999999999999999999999999998755432 35778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---ccCCCeeeccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL---TENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl---d~~g~vKL~DFGls~~~~~~~ 165 (577)
||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 99999999999999887889999999999999999999999999999999999999 77889999999998766433
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCch---hhhhHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD---EHFSRLMKE 242 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~---~~~s~~l~~ 242 (577)
.......||+.|+|||++.+. ++.++||||||+++|+|++|..||...........+......... ..++..+.+
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence 233456899999999998653 899999999999999999999999887765555444433322222 267899999
Q ss_pred HHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 243 FVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
||.+||..||.+|||+.++|+||||+..
T Consensus 241 li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 241 LIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=425.59 Aligned_cols=262 Identities=27% Similarity=0.443 Sum_probs=223.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
..++|+++++||+|+||.||+|.++.+++.||||++++... ......+.+|+.+|..++||||++++++|.+.+.+||
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 45789999999999999999999999999999999965321 1234558899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-
Q 008116 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~- 166 (577)
|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||++........
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 99999999999999764 4899999999999999999999999999999999999999999999999999987654322
Q ss_pred ccccccCCCCCCChhhhhc------ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC----CCCCchhhh
Q 008116 167 RRKTFVGTPFWMAPEVIQN------SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----NPPQLDEHF 236 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~------~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~----~~~~l~~~~ 236 (577)
.....+||+.|+|||++.. ...|+.++|||||||+||||++|.+||...+..+....|... ..+.+...+
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 298 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CC
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCC
Confidence 2235689999999999973 234899999999999999999999999887766655554331 223344578
Q ss_pred hHHHHHHHHHhcccCCCCC---CcHHHHhhcHhhhhccCC
Q 008116 237 SRLMKEFVSLCLKKVPAER---PSAKELLRHRFIRNARKS 273 (577)
Q Consensus 237 s~~l~~lI~~cL~~dP~~R---pTa~elL~hpff~~~~~~ 273 (577)
+..+++||.+||. +|.+| |++.+|++||||+...+.
T Consensus 299 s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 9999999999999 99998 599999999999987654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=394.47 Aligned_cols=263 Identities=27% Similarity=0.492 Sum_probs=202.4
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~ 84 (577)
......++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++++++||||+++++++.+.+
T Consensus 5 ~~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84 (278)
T ss_dssp HHCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred ccccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence 334455789999999999999999999999999999999864421 122467899999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~ 163 (577)
.+|+||||+++++|.+++... .++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999999999764 6799999999999999999999999999999999999999999999999999987654
Q ss_pred cccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHH
Q 008116 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (577)
Q Consensus 164 ~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~l 243 (577)
........+||+.|+|||++.+. .++.++||||||+++|+|++|..||...........+.... ...+..++..+.+|
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 242 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-YEMPSFLSIEAKDL 242 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC-CCCCTTSCHHHHHH
T ss_pred CCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc-cCCccccCHHHHHH
Confidence 44444467899999999998765 48899999999999999999999998766555444443222 23455678999999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
|.+||..||.+|||+.++|+||||....
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9999999999999999999999997643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=419.19 Aligned_cols=263 Identities=25% Similarity=0.443 Sum_probs=211.1
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCC
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQT 84 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~ 84 (577)
+...+.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.+. |||||++++++...+
T Consensus 3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 45567789999999999999999999999999999999986443 3455678889999999996 999999999998654
Q ss_pred --EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 85 --KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 85 --~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
.+|||||||+ ++|..++.. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred CCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 7999999996 699999976 689999999999999999999999999999999999999999999999999997653
Q ss_pred cc---------------------ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee
Q 008116 163 RT---------------------ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL 221 (577)
Q Consensus 163 ~~---------------------~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~ 221 (577)
.. .......+||++|+|||++.+...|+.++|||||||+||+|++|.+||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 112235689999999999987566999999999999999999999999877654443
Q ss_pred eccCCC--CC-------------------------------CCc-------------hhhhhHHHHHHHHHhcccCCCCC
Q 008116 222 FIIPRE--NP-------------------------------PQL-------------DEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 222 ~~i~~~--~~-------------------------------~~l-------------~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
..|... .| ..+ ...++..+.+||.+||..||.+|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 332100 00 000 01457889999999999999999
Q ss_pred CcHHHHhhcHhhhhcc
Q 008116 256 PSAKELLRHRFIRNAR 271 (577)
Q Consensus 256 pTa~elL~hpff~~~~ 271 (577)
||+.++|+||||....
T Consensus 321 ~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 321 ISANDALKHPFVSIFH 336 (388)
T ss_dssp CCHHHHTTSTTTTTTC
T ss_pred CCHHHHhCCHHHHHhc
Confidence 9999999999998653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=452.18 Aligned_cols=260 Identities=26% Similarity=0.455 Sum_probs=231.6
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~ 87 (577)
..++|+++++||+|+||.||+|.+..+++.||||++++.. .....+.+..|+.+|..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3468999999999999999999999999999999997542 122356788999999988 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
|||||++||+|..++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++........
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 498 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence 99999999999999988789999999999999999999999999999999999999999999999999999865444445
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
..+.+||+.|+|||++.+. .|+.++|||||||+||||++|.+||...+..+....|.... ..++..++.++++||.+|
T Consensus 499 ~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~l 576 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGL 576 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHH
Confidence 5678999999999999775 48999999999999999999999999888777666665544 345667899999999999
Q ss_pred cccCCCCCCcH-----HHHhhcHhhhhccC
Q 008116 248 LKKVPAERPSA-----KELLRHRFIRNARK 272 (577)
Q Consensus 248 L~~dP~~RpTa-----~elL~hpff~~~~~ 272 (577)
|.+||.+||++ .+|++||||+.+.+
T Consensus 577 L~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 577 MTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp SCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred ccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 99999999997 99999999988653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=402.57 Aligned_cols=263 Identities=26% Similarity=0.419 Sum_probs=209.9
Q ss_pred chhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh----HHHHHHHHHHHHHHhC---CCCceeEeEE
Q 008116 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE----DEIEDIQKEISVLSQC---RSPYITEYYG 78 (577)
Q Consensus 6 ~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~----~~~~~i~~Ev~iL~~L---~HpnIV~l~~ 78 (577)
+++....++|++++.||+|+||+||+|.+..+++.||||++...... .....+.+|+.+++.+ .||||+++++
T Consensus 2 p~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp --------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred CCCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 46778889999999999999999999999999999999998644311 1124566788777776 4999999999
Q ss_pred EEEeCC-----EEEEEEeccCCCCHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCee
Q 008116 79 SYLHQT-----KLWIIMEYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (577)
Q Consensus 79 ~~~~~~-----~~~LV~Ey~~gGsL~~~l~~~~~--l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vK 151 (577)
++.... .+++||||+. ++|.+++..... +++..++.++.||+.||+|||++||+||||||+||||+.++.+|
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEE
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEE
Confidence 998765 5899999996 699999987543 99999999999999999999999999999999999999999999
Q ss_pred eccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-----
Q 008116 152 VADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----- 226 (577)
Q Consensus 152 L~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~----- 226 (577)
|+|||++...... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+..
T Consensus 161 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 161 LADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp ECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EeeCccccccCCC-cccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999766433 2334678999999999998764 89999999999999999999999987665433322210
Q ss_pred ------------------CCCC---CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 227 ------------------ENPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 227 ------------------~~~~---~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..+. .+...++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 0000 01235678999999999999999999999999999998653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=394.07 Aligned_cols=258 Identities=31% Similarity=0.515 Sum_probs=221.4
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~--~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
...++|++.+.||+|+||.||+|.+..++..||||++...... .....+.+|+.++++++||||+++++++.+...+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 3457899999999999999999999999999999998644321 22467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
+||||+++++|.+++....++++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--~ 163 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--R 163 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--c
Confidence 99999999999999988788999999999999999999999999999999999999999999999999998654332 2
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
....+||+.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+... ...++..++..+++||.+|
T Consensus 164 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 241 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFVTEGARDLISRL 241 (279)
T ss_dssp ----CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCCCCTTSCHHHHHHHHHH
T ss_pred ccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC-CCCCCCcCCHHHHHHHHHH
Confidence 3456899999999999775 4889999999999999999999999877655544443322 2234556789999999999
Q ss_pred cccCCCCCCcHHHHhhcHhhhhcc
Q 008116 248 LKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 248 L~~dP~~RpTa~elL~hpff~~~~ 271 (577)
|..+|.+|||+.+||+||||....
T Consensus 242 l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 242 LKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp CCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred hccChhhCCCHHHHhhCccccCCc
Confidence 999999999999999999998653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=406.09 Aligned_cols=270 Identities=27% Similarity=0.411 Sum_probs=221.8
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
+.....++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++++++||||+++++++...+.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 344456799999999999999999999999999999999865543 3345667899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
+||||||+++++|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99999999999999998877889999999999999999999999999999999999999999999999999998766554
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-------------------
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------- 226 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------------- 226 (577)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||...........+..
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 4455678999999999998765689999999999999999999999987654332221100
Q ss_pred --CC------CCC---chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCChhH
Q 008116 227 --EN------PPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRL 276 (577)
Q Consensus 227 --~~------~~~---l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~ 276 (577)
.. ... ....++..+.+||.+||..||.+|||+.+||+||||+.......+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 319 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERF 319 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHHHH
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhhhh
Confidence 00 000 112568899999999999999999999999999999875433333
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=390.28 Aligned_cols=261 Identities=24% Similarity=0.399 Sum_probs=225.1
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
..++|++++.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 45789999999999999999999999999999999976665556688999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc--ccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRR 168 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~--~~~ 168 (577)
||+++++|.+++.....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... ...
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 999999999999877789999999999999999999999999999999999999999999999999987654322 223
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee-ec-cCCCCCCCchhhhhHHHHHHHHH
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-FI-IPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~-~~-i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
...+||+.|+|||++.+...++.++||||||+++|+|++|..||......... .. ............++..+.+||.+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHH
Confidence 45689999999999987654578999999999999999999999876543211 11 11112222345688999999999
Q ss_pred hcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 247 CLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
||..||.+|||+.+|++||||+...
T Consensus 245 ~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 245 ILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HCCCCchhCCCHHHHhcCccccChh
Confidence 9999999999999999999998653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=402.85 Aligned_cols=261 Identities=26% Similarity=0.440 Sum_probs=227.4
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-----HHHHHHHHHHHHHhCCCCceeEeEEEEEeC
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-----EIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~-----~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~ 83 (577)
..+.++|++.+.||+|+||.||+|.+..+++.||||++....... ..+.+.+|+.+|+++.||||+++++++...
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 445678999999999999999999999999999999997654221 357799999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC----Ceeeccccccc
Q 008116 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG----DVKVADFGVSA 159 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g----~vKL~DFGls~ 159 (577)
..+|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999999999888899999999999999999999999999999999999999887 79999999997
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC---CCchhhh
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP---PQLDEHF 236 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~---~~l~~~~ 236 (577)
..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+..... +.+...+
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (321)
T 2a2a_A 168 EIEDG-VEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245 (321)
T ss_dssp ECCTT-CCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred ecCcc-ccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhccc
Confidence 76543 223456799999999999765 489999999999999999999999988766555444433322 2233567
Q ss_pred hHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 237 s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
+..+++||.+||..||.+|||+.++|+||||....
T Consensus 246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 89999999999999999999999999999998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=410.04 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=209.5
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEec
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey 92 (577)
++|++++.||+|+||.||+|.+..+++.||||++...........+.+|+.+|++++||||+++++++...+.+||||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 58999999999999999999999999999999997655333333456899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 93 MAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 93 ~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
|. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 160 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccc
Confidence 96 5898888653 569999999999999999999999999999999999999999999999999998765544444567
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----CCC------------------
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----ENP------------------ 229 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~----~~~------------------ 229 (577)
+||+.|+|||++.+...++.++|||||||++|+|++|.+||...+.......+.. ...
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (324)
T 3mtl_A 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240 (324)
T ss_dssp --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCC
T ss_pred cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccc
Confidence 8999999999998766689999999999999999999999987665433322210 000
Q ss_pred -------CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 230 -------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 230 -------~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
......++..+.+||.+||..||.+|||+.++|+||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 001124678899999999999999999999999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=396.21 Aligned_cols=270 Identities=52% Similarity=0.902 Sum_probs=224.8
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
+.+....+|++++.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++++.||||+++++++...+.+
T Consensus 23 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 23 LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp -------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred hhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 55667789999999999999999999999999999999997654 246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~-~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
|+||||+++++|.+++. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999999996 45789999999999999999999999999999999999999999999999999998766544
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CchhhhhHHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEF 243 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~l~~~~s~~l~~l 243 (577)
.......||+.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+....++ ..+..++..+.+|
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 258 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF 258 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred cccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence 444567899999999999775 4899999999999999999999999887655443333222222 2355678999999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhccCChhHHHHh
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~~~~i 280 (577)
|.+||..||.+|||+.++|+||||+.......+...+
T Consensus 259 i~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~~~~~ 295 (314)
T 3com_A 259 VKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLI 295 (314)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGGHHHH
T ss_pred HHHHccCChhhCcCHHHHHhCHHHhcCCcchHHHHHh
Confidence 9999999999999999999999999876554444433
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=428.10 Aligned_cols=259 Identities=25% Similarity=0.425 Sum_probs=228.8
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
....++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+|+.++||||+++++++...+.+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3456899999999999999999999999999999999965431 12356789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|||||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~ 170 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-E 170 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-C
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-c
Confidence 999999999999999988889999999999999999999999999999999999999999999999999999876443 3
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
...+.+||+.|+|||++.+...++.++|||||||+||+|++|.+||...+.......+.... ...+..++..+++||.+
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~ 249 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-FYTPQYLNPSVISLLKH 249 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-CCCCTTCCHHHHHHHHH
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-cCCCccCCHHHHHHHHH
Confidence 34567899999999999876655789999999999999999999998877655555554433 23455678999999999
Q ss_pred hcccCCCCCCcHHHHhhcHhhhh
Q 008116 247 CLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~hpff~~ 269 (577)
||..||.+|||+.+|++||||+.
T Consensus 250 ~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 250 MLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp HTCSSTTTSCCHHHHHTCHHHHT
T ss_pred HcCCCchhCcCHHHHHhCHHhhh
Confidence 99999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=415.70 Aligned_cols=262 Identities=31% Similarity=0.472 Sum_probs=214.1
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-----
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ----- 83 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~----- 83 (577)
.+.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|++++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 35689999999999999999999999999999999997543 344567899999999999999999999999876
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccc
Q 008116 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~ 163 (577)
..+||||||+. ++|.++++....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 57999999995 69999999888899999999999999999999999999999999999999999999999999987643
Q ss_pred ccc----------------------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCC--------
Q 008116 164 TIS----------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLA-------- 213 (577)
Q Consensus 164 ~~~----------------------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~-------- 213 (577)
... .....+||++|+|||++.....|+.++|||||||+||||++|..||.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 321 23567899999999997666669999999999999999998555443
Q ss_pred ---CCCccc-----------------ee---------------------------eccCCCCCCCc---hhhhhHHHHHH
Q 008116 214 ---DLHPMR-----------------VL---------------------------FIIPRENPPQL---DEHFSRLMKEF 243 (577)
Q Consensus 214 ---~~~~~~-----------------~~---------------------------~~i~~~~~~~l---~~~~s~~l~~l 243 (577)
..+... .+ .......+..+ ...++..+.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 221100 00 00000111111 13468899999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
|.+||..||.+|||+.++|+||||+....
T Consensus 342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 99999999999999999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=405.62 Aligned_cols=262 Identities=34% Similarity=0.611 Sum_probs=224.1
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
+.....++|++++.||+|+||.||+|.+..++..||+|++...........+.+|+.+|++++||||+++++++..++.+
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 34556789999999999999999999999999999999998776666678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~-gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
|||||||++++|.+++.....+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++......
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999999999998878899999999999999999999985 9999999999999999999999999998765432
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeec----------------------
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI---------------------- 223 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~---------------------- 223 (577)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp -C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred -cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 23456899999999999875 489999999999999999999999976543221110
Q ss_pred --------------------cCCCCCC-CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 224 --------------------IPRENPP-QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 224 --------------------i~~~~~~-~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
+....++ .....++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 0001111 12234688999999999999999999999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=395.77 Aligned_cols=271 Identities=43% Similarity=0.785 Sum_probs=226.4
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
....++|++++.||+|+||.||+|.+..++..||||++.... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 345689999999999999999999999999999999986543 2345788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
|||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999999999999865 567999999999999999999999999999999999999999999999999998655433333
Q ss_pred cccccCCCCCCChhhhh----cccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CchhhhhHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQ----NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMK 241 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~----~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~l~~~~s~~l~ 241 (577)
....+||+.|+|||++. ....++.++|||||||++|+|++|..||...+.......+....++ ..+..++..+.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHH
Confidence 44568999999999984 2335888999999999999999999999887765544444333322 23567889999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhcHhhhhccCChhHHHHh
Q 008116 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~~~~i 280 (577)
+||.+||..||.+|||+.+|++||||........+.+.+
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~ 292 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELV 292 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHHHHHHH
T ss_pred HHHHHHcccChhhCCCHHHHhcChHHhhhccchhHHHHH
Confidence 999999999999999999999999999887665554443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=389.72 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=219.0
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCC
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~ 84 (577)
+.....++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++..+ +||||+++++++.+.+
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 34455689999999999999999999999999999999997653 233457788999999999 9999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC-------------
Q 008116 85 KLWIIMEYMAGGSVADLIQSG----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN------------- 147 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~----~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~------------- 147 (577)
.+||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999999999753 679999999999999999999999999999999999999844
Q ss_pred ------CCeeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee
Q 008116 148 ------GDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL 221 (577)
Q Consensus 148 ------g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~ 221 (577)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+|+..... .
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~ 237 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---W 237 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---H
T ss_pred cccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---H
Confidence 47999999998776443 2456999999999998765577899999999999999999988755432 2
Q ss_pred eccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 222 ~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
..+.....+.++..++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 2333344455666788999999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=405.72 Aligned_cols=263 Identities=27% Similarity=0.479 Sum_probs=219.4
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC----ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~----~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~ 84 (577)
..+.++|++++.||+|+||.||+|.+..++..||||++.... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 345678999999999999999999999999999999986542 2345678999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHc----------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 008116 85 KLWIIMEYMAGGSVADLIQS----------------------------------------GPPLDEMSIACILRDLLHAI 124 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~----------------------------------------~~~l~e~~i~~il~QLl~aL 124 (577)
.+|||||||++|+|.+++.. ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999999852 11246788999999999999
Q ss_pred HHHHHcCCcccccccceEEEccCC--Ceeecccccccccccccc----ccccccCCCCCCChhhhhcc-cCCccccchhh
Q 008116 125 EYLHNEGKIHRDIKAANILLTENG--DVKVADFGVSAQLTRTIS----RRKTFVGTPFWMAPEVIQNS-EGYNEKADIWS 197 (577)
Q Consensus 125 ~yLHs~gIiHrDIKPeNILld~~g--~vKL~DFGls~~~~~~~~----~~~~~~GTp~Y~APEvl~~~-~~~~~ksDVwS 197 (577)
.|||+++|+||||||+||||+.++ .+||+|||++..+..... .....+||+.|+|||++.+. ..++.++||||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 999999999999999999998776 899999999986543221 12456899999999998652 45889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 198 LGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 198 LGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
|||+||+|++|..||...........+.... +......++..+++||.+||..+|.+||++.++|+||||+...
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 9999999999999998877655444443222 2222345789999999999999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=410.12 Aligned_cols=260 Identities=30% Similarity=0.469 Sum_probs=223.8
Q ss_pred cccchhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-------HHHHHHHHHHHHHHhCCCCceeE
Q 008116 3 DLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-------DEIEDIQKEISVLSQCRSPYITE 75 (577)
Q Consensus 3 ~l~~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-------~~~~~i~~Ev~iL~~L~HpnIV~ 75 (577)
.+..+.....++|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+|++++||||++
T Consensus 14 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 93 (335)
T 3dls_A 14 GLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93 (335)
T ss_dssp HHHHHTTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCC
T ss_pred ccccCCcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEee
Confidence 33445556778999999999999999999999999999999999765421 12346778999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCC-CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecc
Q 008116 76 YYGSYLHQTKLWIIMEYMAGG-SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVAD 154 (577)
Q Consensus 76 l~~~~~~~~~~~LV~Ey~~gG-sL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~D 154 (577)
+++++...+.+++||||+.+| +|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp EEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEee
Confidence 999999999999999999776 9999999888999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchh
Q 008116 155 FGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE 234 (577)
Q Consensus 155 FGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~ 234 (577)
||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||....... ......+.
T Consensus 174 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~~~~~ 245 (335)
T 3dls_A 174 FGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------EAAIHPPY 245 (335)
T ss_dssp CTTCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------TTCCCCSS
T ss_pred cccceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------hhccCCCc
Confidence 9999776543 233457899999999999877645889999999999999999999997643211 11112234
Q ss_pred hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 235 ~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.++..+.+||.+||.+||.+|||+.+||+||||+..
T Consensus 246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 578899999999999999999999999999999764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=392.02 Aligned_cols=260 Identities=24% Similarity=0.462 Sum_probs=229.2
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
....++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.+.||||+++++++...+.+
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 356689999999999999999999999999999999986553 344567889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999987654444
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
......||+.|+|||++.+. .++.++||||||+++|+|++|..||...........+.... ..++..++..+.+||.+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQK 248 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHHHHHH
Confidence 44567899999999999765 48899999999999999999999998776554443333322 24456788999999999
Q ss_pred hcccCCCCCCcHHHHhhcHhhhhc
Q 008116 247 CLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
||..||.+|||+.++++||||...
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HcccChhhCcCHHHHhhChheecC
Confidence 999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=404.91 Aligned_cols=253 Identities=26% Similarity=0.461 Sum_probs=198.5
Q ss_pred CCeeEE---eEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEEE
Q 008116 13 SRFSSL---ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 13 ~~f~il---~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~L 88 (577)
.+|++. +.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+. ||||+++++++.+...+||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 467776 7899999999999999999999999998643 3467789999999996 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC---Ceeeccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKVADFGVSAQLTRTI 165 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g---~vKL~DFGls~~~~~~~ 165 (577)
|||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++.......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 84 VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp EECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred EEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 999999999999999888999999999999999999999999999999999999998765 79999999998765554
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------ceeeccCCCCCC---Cchhh
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-------RVLFIIPRENPP---QLDEH 235 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~-------~~~~~i~~~~~~---~l~~~ 235 (577)
......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||...+.. +....+...... .....
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242 (325)
T ss_dssp --------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHT
T ss_pred CcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccC
Confidence 555567899999999999775 4899999999999999999999999865431 222333333222 22346
Q ss_pred hhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 236 ~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
++..+++||.+||..||.+|||+.+|++||||+..
T Consensus 243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp SCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 78999999999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=407.04 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=206.8
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+|++++||||+++++++.....+|||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 45577999999999999999999999999999999997543 335688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc---CCCeeecccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~---~g~vKL~DFGls~~~~~~~~ 166 (577)
|||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++...... .
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~ 205 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-V 205 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-c
Confidence 999999999999988888999999999999999999999999999999999999975 789999999998765432 2
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-eeeccCCCC---CCCchhhhhHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VLFIIPREN---PPQLDEHFSRLMKE 242 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~-~~~~i~~~~---~~~l~~~~s~~l~~ 242 (577)
.....+||+.|+|||++.+. .++.++|||||||+||+|++|..||....... ....+.... +......++..+++
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 284 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284 (349)
T ss_dssp -------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred ccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHH
Confidence 23457899999999999875 48999999999999999999999998765433 222222221 22334568899999
Q ss_pred HHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 243 FVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
||.+||..||.+|||+.++|+||||....
T Consensus 285 li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 285 LVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99999999999999999999999997643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=425.38 Aligned_cols=259 Identities=29% Similarity=0.546 Sum_probs=227.6
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
.+.++|++.++||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|++++|||||++++++.+...+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 455789999999999999999999999999999999965432 234678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---ccCCCeeecccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL---TENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl---d~~g~vKL~DFGls~~~~~~ 164 (577)
+|||||.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999999999888899999999999999999999999999999999999999 46689999999999776443
Q ss_pred ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchhhhhHHHH
Q 008116 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMK 241 (577)
Q Consensus 165 ~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s~~l~ 241 (577)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||...+.......+.... +......++..++
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 183 -KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp -CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred -cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 23345689999999999976 38999999999999999999999999887766655554332 2233457899999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 242 EFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
+||.+||.++|.+|||+.++|+||||+...
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 999999999999999999999999998653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=425.51 Aligned_cols=261 Identities=28% Similarity=0.513 Sum_probs=225.1
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
+....++|+++++||+|+||+||+|.+..+++.||||++.... .......+.+|+.+|++++|||||++++++.+...+
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 3456689999999999999999999999999999999986432 122357789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc---cCCCeeeccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT---ENGDVKVADFGVSAQLTR 163 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld---~~g~vKL~DFGls~~~~~ 163 (577)
|+|||||.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999999998778899999999999999999999999999999999999995 456799999999976644
Q ss_pred cccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchhhhhHHH
Q 008116 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLM 240 (577)
Q Consensus 164 ~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s~~l 240 (577)
. ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||...+....+..+.... +......++..+
T Consensus 177 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 253 (486)
T 3mwu_A 177 N-TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (486)
T ss_dssp C-----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred C-CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence 3 33346789999999999975 38999999999999999999999998877766555554332 223345789999
Q ss_pred HHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 241 ~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
++||.+||..+|.+|||+.++|+||||+...
T Consensus 254 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 9999999999999999999999999998653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=424.13 Aligned_cols=261 Identities=28% Similarity=0.509 Sum_probs=225.2
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh------------HHHHHHHHHHHHHHhCCCCceeE
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE------------DEIEDIQKEISVLSQCRSPYITE 75 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~------------~~~~~i~~Ev~iL~~L~HpnIV~ 75 (577)
...+.++|++++.||+|+||+||+|.+..++..||||++...... ...+.+.+|+.+|++++|||||+
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 345678999999999999999999999999999999999754321 23567899999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC---Ceee
Q 008116 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKV 152 (577)
Q Consensus 76 l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g---~vKL 152 (577)
+++++.+...+|||||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999999999999998778899999999999999999999999999999999999998775 6999
Q ss_pred ccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--
Q 008116 153 ADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP-- 230 (577)
Q Consensus 153 ~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~-- 230 (577)
+|||++...... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||...+....+..+......
T Consensus 191 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 191 VDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp CCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EECCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999999876543 23346789999999999874 4899999999999999999999999988776666655544322
Q ss_pred -CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 231 -QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 231 -~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.....++..+++||.+||.+||.+|||+.++|+||||+...
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 12346789999999999999999999999999999998654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=413.32 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=222.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
+.++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+|++++|||||++++++.+...+||||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 4568999999999999999999999999999999997554 334467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc--CCCeeeccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE--NGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~--~g~vKL~DFGls~~~~~~~~~ 167 (577)
|||.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+. .+.+||+|||++...... ..
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~ 206 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EI 206 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SC
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-cc
Confidence 999999999999754 47999999999999999999999999999999999999974 478999999999876443 22
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC---CCCCchhhhhHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---NPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~---~~~~l~~~~s~~l~~lI 244 (577)
....+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...+....+..+... .+......++..+++||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp EEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred eeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence 3456899999999999775 4899999999999999999999999887665444433222 22334456889999999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.+||..||.+|||+.++|+||||+..
T Consensus 286 ~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 286 KNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp HTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHcCCChhHCcCHHHHhhCccccCC
Confidence 99999999999999999999999754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=402.25 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=214.3
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----CCceeEeEEEEEe
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----SPYITEYYGSYLH 82 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-----HpnIV~l~~~~~~ 82 (577)
...+.++|++++.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.+. |||||++++++..
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 455678999999999999999999999999999999998642 344567788999999996 9999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc--------------
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-------------- 146 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~-------------- 146 (577)
.+.+||||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 99999999999 999999997643 5999999999999999999999999999999999999975
Q ss_pred -----------CCCeeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCC
Q 008116 147 -----------NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL 215 (577)
Q Consensus 147 -----------~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~ 215 (577)
++.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||+||+|++|.+||...
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 788999999999765432 23568999999999998764 899999999999999999999999876
Q ss_pred CccceeeccCCC---CC------------------------------------------CCchhhhhHHHHHHHHHhccc
Q 008116 216 HPMRVLFIIPRE---NP------------------------------------------PQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 216 ~~~~~~~~i~~~---~~------------------------------------------~~l~~~~s~~l~~lI~~cL~~ 250 (577)
+....+..+... .+ +.+....+..+.+||.+||+.
T Consensus 263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 543322211100 00 001111236788999999999
Q ss_pred CCCCCCcHHHHhhcHhhh
Q 008116 251 VPAERPSAKELLRHRFIR 268 (577)
Q Consensus 251 dP~~RpTa~elL~hpff~ 268 (577)
||.+|||+.+||+||||+
T Consensus 343 dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 343 DPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SGGGSCCHHHHTTSGGGC
T ss_pred ChhhCCCHHHHhcCcccC
Confidence 999999999999999995
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=424.52 Aligned_cols=257 Identities=27% Similarity=0.502 Sum_probs=220.1
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
+.++|++++.||+|+||+||+|.+..++..||||++..... ......+.+|+.+|+.++|||||+++++|.+...+|||
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 34579999999999999999999999999999999976542 22356789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC---CCeeecccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~---g~vKL~DFGls~~~~~~~~ 166 (577)
||||.+|+|.+++....++++..++.++.||+.||.|||++||+||||||+||||+.. +.+||+|||++...... .
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~ 193 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-K 193 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-B
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-c
Confidence 9999999999999877889999999999999999999999999999999999999764 55999999999876543 3
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC---CCchhhhhHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP---PQLDEHFSRLMKEF 243 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~---~~l~~~~s~~l~~l 243 (577)
.....+||+.|+|||++.. .|+.++|||||||++|+|++|.+||...........+..... ......++..+++|
T Consensus 194 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 3446789999999999864 489999999999999999999999998877666555543322 22335688999999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
|.+||..+|.+|||+.++|+||||+..
T Consensus 272 i~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=391.98 Aligned_cols=261 Identities=25% Similarity=0.420 Sum_probs=217.8
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~ 84 (577)
+++...++|++++.||+|+||.||+|.+..++..||||++.... .......+.+|+.++++++||||+++++++..++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 45667889999999999999999999999999999999986543 3455678999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
.+|+||||+++++|.+++...+++++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999999999988789999999999999999999999999999999999999999999999999999776433
Q ss_pred c-cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC----chhhhhHH
Q 008116 165 I-SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ----LDEHFSRL 239 (577)
Q Consensus 165 ~-~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~----l~~~~s~~ 239 (577)
. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.................+. ....++..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp ----------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred cccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 2 2223467999999999998754 8999999999999999999999998876544333332223222 23467899
Q ss_pred HHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 240 MKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 240 l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
+.++|.+||.+||.+||+..+.+.+.|..
T Consensus 244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 244 LSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 99999999999999999666666665543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=387.93 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=217.1
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
....++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++...+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 3456899999999999999999999999999999999865431 12356789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... .
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-~ 165 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-E 165 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC-c
Confidence 999999999999999987788999999999999999999999999999999999999999999999999998776443 2
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....+||+.|+|||++.+....+.++||||||+++|+|++|..||...........+.... ..++..++..+.+||.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~ 244 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYLNRSVATLLMH 244 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-ccCchhcCHHHHHHHHH
Confidence 23356799999999999876545789999999999999999999998766544444333222 23455678899999999
Q ss_pred hcccCCCCCCcHHHHhhcHhhhhc
Q 008116 247 CLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
||..||.+|||+.+|++||||+..
T Consensus 245 ~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 245 MLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HccCChhhCCCHHHHHhChhhccC
Confidence 999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=400.64 Aligned_cols=260 Identities=24% Similarity=0.460 Sum_probs=228.3
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
....+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.+.||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 44578999999999999999999999999999999986543 3445678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
||||||.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 99999999999999988788999999999999999999999999999999999999999999999999999876544444
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
....+||+.|+|||++.+. .++.++|||||||+||+|++|..||...........+.... ..++..++..+.+||.+|
T Consensus 198 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKM 275 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHH
T ss_pred ccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHH
Confidence 4567899999999999775 48899999999999999999999998766544433332222 234556788999999999
Q ss_pred cccCCCCCCcHHHHhhcHhhhhcc
Q 008116 248 LKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 248 L~~dP~~RpTa~elL~hpff~~~~ 271 (577)
|..||.+|||+.+||+||||....
T Consensus 276 l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 276 LQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred ccCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=396.28 Aligned_cols=264 Identities=23% Similarity=0.437 Sum_probs=213.7
Q ss_pred hhhhcCCCeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCC
Q 008116 7 LQEAAGSRFSSL-ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (577)
Q Consensus 7 l~~~~~~~f~il-~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~ 84 (577)
+......+|++. ++||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|+++ +||||+++++++...+
T Consensus 6 ~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp SCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 344567889996 789999999999999999999999999975532 2357789999999995 7999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC---eeeccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD---VKVADFGVSAQL 161 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~---vKL~DFGls~~~ 161 (577)
.+|||||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999999999988788999999999999999999999999999999999999988765 999999998765
Q ss_pred cccc-------cccccccCCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-----------
Q 008116 162 TRTI-------SRRKTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR----------- 219 (577)
Q Consensus 162 ~~~~-------~~~~~~~GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~----------- 219 (577)
.... ......+||+.|+|||++.. ...++.++|||||||++|+|++|.+||.......
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 3221 11234579999999999864 1237889999999999999999999998754322
Q ss_pred ----eeeccCCCCC---CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 220 ----VLFIIPRENP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 220 ----~~~~i~~~~~---~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
....+..... ......++..+++||.+||..||.+|||+.++|+||||+...
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 1111111111 111235788999999999999999999999999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=389.77 Aligned_cols=256 Identities=28% Similarity=0.479 Sum_probs=223.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
..++|++.+.||+|+||.||+|.+..++..||||++..... ......+.+|+.++++++||||+++++++...+.+|+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 34789999999999999999999999999999999864321 1124678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 169 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--RR 169 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--CB
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--cc
Confidence 9999999999999988788999999999999999999999999999999999999999999999999998665432 23
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
...+|++.|+|||++.+. .++.++||||||+++|+|++|..||...........+.... ..++..++..+++||.+||
T Consensus 170 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l 247 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFPPFLSDGSKDLISKLL 247 (284)
T ss_dssp CCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHS
T ss_pred ccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-cCCCCcCCHHHHHHHHHHh
Confidence 456899999999999875 48899999999999999999999998766554444443322 2345567899999999999
Q ss_pred ccCCCCCCcHHHHhhcHhhhhc
Q 008116 249 KKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 249 ~~dP~~RpTa~elL~hpff~~~ 270 (577)
..+|.+||++.+|++||||+..
T Consensus 248 ~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 248 RYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp CSSGGGSCCHHHHHTCHHHHHH
T ss_pred hcCHhhCCCHHHHhhCHHHHhh
Confidence 9999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=387.19 Aligned_cols=254 Identities=28% Similarity=0.498 Sum_probs=218.6
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe----CCEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QTKL 86 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~----~~~~ 86 (577)
+..|++.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+|++++||||+++++++.. ...+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 456899999999999999999999999999999987554 44556789999999999999999999999876 4568
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEc-cCCCeeeccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLT-ENGDVKVADFGVSAQLTR 163 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~g--IiHrDIKPeNILld-~~g~vKL~DFGls~~~~~ 163 (577)
|+||||+++++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999999999999988788999999999999999999999999 99999999999998 789999999999865443
Q ss_pred cccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee-eccCCC-CCCCchhhhhHHHH
Q 008116 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-FIIPRE-NPPQLDEHFSRLMK 241 (577)
Q Consensus 164 ~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~-~~i~~~-~~~~l~~~~s~~l~ 241 (577)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||......... ..+... .+..++..++..+.
T Consensus 185 ~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 260 (290)
T 1t4h_A 185 S--FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260 (290)
T ss_dssp T--SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred c--ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHH
Confidence 2 2335689999999998864 3899999999999999999999999875443322 222222 23345566778999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 242 EFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
+||.+||..||.+|||+.+||+||||++
T Consensus 261 ~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=416.86 Aligned_cols=265 Identities=29% Similarity=0.495 Sum_probs=212.7
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-------hHHHHHHHHHHHHHHhCCCCceeEeEEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------EDEIEDIQKEISVLSQCRSPYITEYYGSYL 81 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-------~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~ 81 (577)
....++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|++++|||||++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4556899999999999999999999999999999999865431 122345789999999999999999999975
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC---Ceeecccccc
Q 008116 82 HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKVADFGVS 158 (577)
Q Consensus 82 ~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g---~vKL~DFGls 158 (577)
.+.+|||||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+..+ .+||+|||++
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred -cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 566899999999999999998888999999999999999999999999999999999999997544 5999999999
Q ss_pred ccccccccccccccCCCCCCChhhhhc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee-eccCCCCCC---Cc
Q 008116 159 AQLTRTISRRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-FIIPRENPP---QL 232 (577)
Q Consensus 159 ~~~~~~~~~~~~~~GTp~Y~APEvl~~--~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~-~~i~~~~~~---~l 232 (577)
...... ......+||+.|+|||++.+ ...|+.++|||||||+||+|++|.+||........+ ..+...... ..
T Consensus 290 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 290 KILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp TSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred eecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 876543 33346789999999999853 345888999999999999999999999865443222 222222222 22
Q ss_pred hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCChh
Q 008116 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPR 275 (577)
Q Consensus 233 ~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~~~ 275 (577)
...++..+.+||.+||..||.+|||+.++|+||||+.......
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~ 411 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 411 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHHH
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHHH
Confidence 3467899999999999999999999999999999987544333
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=404.33 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=221.8
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-----C
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----T 84 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~-----~ 84 (577)
.++++|++++.||+|+||.||+|.+..++..||||++...........+.+|+.+|++++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34579999999999999999999999999999999998666666678899999999999999999999999765 3
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
.+|+||||+. |+|.++++. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 6899999996 599999976 57999999999999999999999999999999999999999999999999999766543
Q ss_pred ccc---cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---------------
Q 008116 165 ISR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR--------------- 226 (577)
Q Consensus 165 ~~~---~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~--------------- 226 (577)
... ....+||+.|+|||++.+...++.++|||||||+||+|++|.+||...+....+..+..
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 221 23468999999999987766689999999999999999999999987765544333210
Q ss_pred ------------CCCCC---chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 227 ------------ENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 227 ------------~~~~~---l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
..... +...++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 00111 113467889999999999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=422.28 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=208.7
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-----
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ----- 83 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~----- 83 (577)
.+.++|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+|+.++|||||++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 44689999999999999999999999999999999997543 344567889999999999999999999999754
Q ss_pred -CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 84 -TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 84 -~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
..+|||||||++ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 468999999965 5777764 359999999999999999999999999999999999999999999999999998664
Q ss_pred ccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC---------------
Q 008116 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--------------- 227 (577)
Q Consensus 163 ~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~--------------- 227 (577)
.. ......+||+.|+|||++.+. .|+.++|||||||+||+|++|++||...+....+..|...
T Consensus 216 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 216 TS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp -C-CCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred CC-cccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 32 234567999999999999876 4999999999999999999999999876543332222100
Q ss_pred -----------CCCCc---------------hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 228 -----------NPPQL---------------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 228 -----------~~~~l---------------~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
....+ ....+..+++||.+||..||.+|||+.|+|+||||...
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 00000 11226789999999999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=396.53 Aligned_cols=264 Identities=45% Similarity=0.835 Sum_probs=199.5
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
....++|++.+.||+|+||.||+|.+..+++.||||++...........+.+|+.++++++||||+++++++...+.+|+
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34568999999999999999999999989999999998766544556778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccc
Q 008116 89 IMEYMAGGSVADLIQS--------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~--------~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999999963 45699999999999999999999999999999999999999999999999999876
Q ss_pred ccccc-----cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC-----
Q 008116 161 LTRTI-----SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP----- 230 (577)
Q Consensus 161 ~~~~~-----~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~----- 230 (577)
..... .......||+.|+|||++.....++.++|||||||+||+|++|..||................++
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence 54321 11234679999999999876445889999999999999999999999887655443322222211
Q ss_pred ----CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 231 ----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 231 ----~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
.....++..+.+||.+||..||.+|||+.+|++||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp ----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 123457789999999999999999999999999999987644
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=388.56 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=221.4
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-----HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-----~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
+.++|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 456899999999999999999999999999999998765422 135789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC----Ceeeccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG----DVKVADFGVSAQL 161 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g----~vKL~DFGls~~~ 161 (577)
+|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999999998778899999999999999999999999999999999999998876 7999999998766
Q ss_pred cccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC---CCchhhhhH
Q 008116 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP---PQLDEHFSR 238 (577)
Q Consensus 162 ~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~---~~l~~~~s~ 238 (577)
... .......||+.|+|||++.+. .++.++||||||+++|+|++|..||...........+..... ......++.
T Consensus 163 ~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 163 EAG-NEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp C---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred cCC-CcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 443 223456799999999999765 489999999999999999999999988766554444333222 223346788
Q ss_pred HHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 239 LMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 239 ~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.+.+||.+||..||.+|||+.++|+||||+...
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 999999999999999999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=402.08 Aligned_cols=260 Identities=42% Similarity=0.778 Sum_probs=223.1
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
...|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|++++|||||++++++..++..|||
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 3569999999999999999999999999999999976532 33457789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~-~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
||||. |+|.+++. ...++++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----
Confidence 99997 67888774 4578999999999999999999999999999999999999999999999999998765432
Q ss_pred ccccCCCCCCChhhhhc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-CCCCchhhhhHHHHHHHH
Q 008116 169 KTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRLMKEFVS 245 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~--~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~-~~~~l~~~~s~~l~~lI~ 245 (577)
...+||+.|+|||++.. ...++.++|||||||+||+|++|.+||...+....+..+... .+......++..+++||.
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 287 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 287 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 35689999999999853 335889999999999999999999999887665444333322 233334578899999999
Q ss_pred HhcccCCCCCCcHHHHhhcHhhhhccCChhH
Q 008116 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRL 276 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~hpff~~~~~~~~~ 276 (577)
+||..+|.+|||+.+||+||||.........
T Consensus 288 ~~l~~dP~~Rps~~~ll~h~~~~~~~~~~~~ 318 (348)
T 1u5q_A 288 SCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 318 (348)
T ss_dssp HHTCSSGGGSCCHHHHTTCHHHHSCCCTTHH
T ss_pred HHcccChhhCcCHHHHhhChhhhccCCcchh
Confidence 9999999999999999999999876554433
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=394.55 Aligned_cols=261 Identities=46% Similarity=0.855 Sum_probs=216.4
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEe------
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH------ 82 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~------ 82 (577)
...++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++++ .||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 457899999999999999999999999999999999975543 236788999999999 89999999999987
Q ss_pred CCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
...+||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 56899999999999999999753 5799999999999999999999999999999999999999999999999999887
Q ss_pred ccccccccccccCCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCchhh
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDEH 235 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~l~~~ 235 (577)
...........+||+.|+|||++.. ...++.++|||||||+||+|++|..||...+.......+.... +......
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 2x7f_A 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 258 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSC
T ss_pred cCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccc
Confidence 6544444456789999999999862 2348889999999999999999999998876655444443322 2223456
Q ss_pred hhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 236 ~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
++..+.+||.+||..||.+||++.+||+||||+....
T Consensus 259 ~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred cCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 7899999999999999999999999999999987654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=388.28 Aligned_cols=258 Identities=32% Similarity=0.526 Sum_probs=224.3
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe--CCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~--~~~~~L 88 (577)
.++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999999999999999997654 34456789999999999999999999998864 568999
Q ss_pred EEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcC-----CcccccccceEEEccCCCeeeccccccc
Q 008116 89 IMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEG-----KIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~g-----IiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999999964 345999999999999999999999999 9999999999999999999999999997
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHH
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL 239 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~ 239 (577)
.............||+.|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+.....+.++..++..
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHH
Confidence 7654433334568999999999998754 889999999999999999999999987765555555555555666778999
Q ss_pred HHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 240 l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
+.+||.+||..+|.+||++.+||+|+|+...
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 9999999999999999999999999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=387.39 Aligned_cols=259 Identities=31% Similarity=0.514 Sum_probs=203.5
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHH-HHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIE-DIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~-~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
...++|++++.||+|+||.||+|.+..+++.||||++.......... .+.++..+++.+.||||+++++++..++..||
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 45679999999999999999999999999999999997665444333 34455556888899999999999999999999
Q ss_pred EEeccCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEccCCCeeeccccccccccc
Q 008116 89 IMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~----~~~~l~e~~i~~il~QLl~aL~yLHs~-gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~ 163 (577)
||||++ |+|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 999997 58877764 357899999999999999999999998 999999999999999999999999999977654
Q ss_pred cccccccccCCCCCCChhhh---hcccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceee-ccCCCCCCCchhhhhH
Q 008116 164 TISRRKTFVGTPFWMAPEVI---QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLF-IIPRENPPQLDEHFSR 238 (577)
Q Consensus 164 ~~~~~~~~~GTp~Y~APEvl---~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~-~~~~~-~i~~~~~~~l~~~~s~ 238 (577)
. .......||+.|+|||++ .....++.++|||||||++|+|++|..||..... ..... .+....+......++.
T Consensus 163 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (290)
T 3fme_A 163 D-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA 241 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCH
T ss_pred c-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCH
Confidence 3 222345799999999997 2334588999999999999999999999976332 22221 2222233333456889
Q ss_pred HHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 239 LMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 239 ~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.+.+||.+||..+|.+|||+.++++||||+..
T Consensus 242 ~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 242 EFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 99999999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=397.82 Aligned_cols=262 Identities=26% Similarity=0.451 Sum_probs=217.5
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC-
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT- 84 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~- 84 (577)
...+.++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 86 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence 3456789999999999999999999999999999999997653 3345678899999999999999999999987654
Q ss_pred ---EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 85 ---KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 85 ---~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
..|||||||++++|.+++...+++++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 45999999999999999988788999999999999999999999999999999999999999999999999999766
Q ss_pred ccccc---ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC---chhh
Q 008116 162 TRTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ---LDEH 235 (577)
Q Consensus 162 ~~~~~---~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~---l~~~ 235 (577)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+....+.. ....
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ---------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred cccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 43321 22346799999999999876 48999999999999999999999998876655443333222222 1235
Q ss_pred hhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 236 ~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
++..+.+||.+||.+||.+||++.++|.|+|++..
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 78999999999999999999999999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=398.18 Aligned_cols=258 Identities=26% Similarity=0.486 Sum_probs=212.9
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCC--CceeEeEEEEEeCCE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRS--PYITEYYGSYLHQTK 85 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~H--pnIV~l~~~~~~~~~ 85 (577)
...+.+|++++.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+|+++.| |||+++++++..+..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 345788999999999999999999885 58899999997654 34456789999999999976 999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
+|||||+ .+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 9999995 5889999999888999999999999999999999999999999999999997 6789999999998764432
Q ss_pred c--ccccccCCCCCCChhhhhc----------ccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-cee-eccCCCCCCC
Q 008116 166 S--RRKTFVGTPFWMAPEVIQN----------SEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVL-FIIPRENPPQ 231 (577)
Q Consensus 166 ~--~~~~~~GTp~Y~APEvl~~----------~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~-~~~-~~i~~~~~~~ 231 (577)
. .....+||+.|+|||++.+ ...++.++|||||||+||+|++|..||...... ... ..+.......
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 2 1235689999999999864 134888999999999999999999999764332 111 1122223334
Q ss_pred chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 232 l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
++...+..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 45556788999999999999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=408.95 Aligned_cols=252 Identities=27% Similarity=0.449 Sum_probs=205.7
Q ss_pred cCCCeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHh-CCCCceeEeEEEEEe----CC
Q 008116 11 AGSRFSSL-ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CRSPYITEYYGSYLH----QT 84 (577)
Q Consensus 11 ~~~~f~il-~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~-L~HpnIV~l~~~~~~----~~ 84 (577)
..++|.++ ++||+|+||+||+|.+..+++.||||++... ..+.+|+.++.+ ++||||++++++|.. ..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 34678887 7999999999999999999999999998632 457788988754 589999999999876 56
Q ss_pred EEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc---CCCeeeccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVSA 159 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~---~g~vKL~DFGls~ 159 (577)
.+|||||||+||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 799999999999999999864 35999999999999999999999999999999999999987 7889999999998
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee----eccCC---CCCCCc
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL----FIIPR---ENPPQL 232 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~----~~i~~---~~~~~l 232 (577)
..... ....+.+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||...+..... ..+.. ..+...
T Consensus 213 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 213 ETTSH-NSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp ECC------------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred ccCCC-CccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 65432 233467899999999999765 4899999999999999999999999876543221 11111 112222
Q ss_pred hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 233 ~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
...++..+++||.+||..||.+|||+.+||+||||...
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 35688999999999999999999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=391.95 Aligned_cols=258 Identities=27% Similarity=0.460 Sum_probs=222.0
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
...++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++++++||||+++++++.....+|+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 456789999999999999999999999999999999975432 2346688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---ccCCCeeecccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL---TENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl---d~~g~vKL~DFGls~~~~~~~~ 166 (577)
|||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9999999999999877889999999999999999999999999999999999999 67889999999998754332
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchhhhhHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEF 243 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s~~l~~l 243 (577)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.... +......++..+.+|
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 241 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 23456799999999999765 48999999999999999999999998876554444333222 223445788999999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
|.+||..||.+|||+.++|+||||....
T Consensus 242 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 242 ICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 9999999999999999999999998643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=393.30 Aligned_cols=258 Identities=21% Similarity=0.351 Sum_probs=216.3
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC--E
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT--K 85 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~--~ 85 (577)
+....++|++.++||+|+||.||+|.+..+++.||||++.........+.+.+|+.+|++++||||+++++++.... .
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 34567899999999999999999999999999999999976554445677889999999999999999999998765 7
Q ss_pred EEEEEeccCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE----ccCCCeeecccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL----TENGDVKVADFGVS 158 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~---~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl----d~~g~vKL~DFGls 158 (577)
+|||||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||| +..+.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 899999999999999997643 39999999999999999999999999999999999999 77788999999999
Q ss_pred ccccccccccccccCCCCCCChhhhhc-------ccCCccccchhhHHHHHHHHHhCCCCCCCCCccce----eeccCC-
Q 008116 159 AQLTRTISRRKTFVGTPFWMAPEVIQN-------SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV----LFIIPR- 226 (577)
Q Consensus 159 ~~~~~~~~~~~~~~GTp~Y~APEvl~~-------~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~----~~~i~~- 226 (577)
...... ......+||+.|+|||++.. ...++.++|||||||+||+|++|..||........ ...+..
T Consensus 164 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 164 RELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp EECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred eecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 876543 23345689999999999863 24588999999999999999999999975432111 111100
Q ss_pred -----------------------CCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHh
Q 008116 227 -----------------------ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266 (577)
Q Consensus 227 -----------------------~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpf 266 (577)
.....+...++..+.+||.+||..||.+|||+.|+|+||-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 1112345678889999999999999999999999999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=406.66 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=215.0
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC--
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-- 84 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~-- 84 (577)
...+.++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|++++||||+++++++....
T Consensus 20 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 20 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 99 (367)
T ss_dssp EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred eeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence 3455789999999999999999999999999999999986543 3445678899999999999999999999998753
Q ss_pred ----EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccc
Q 008116 85 ----KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 85 ----~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
.+||||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 100 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 8899999987 6799999999999999999999999999999999999999999999999999976
Q ss_pred ccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--------------
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------------- 226 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~-------------- 226 (577)
... .....+||++|+|||++.+...++.++|||||||++|+|++|.+||...+....+..|..
T Consensus 178 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 178 ADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp CCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 543 234578999999999998755699999999999999999999999987665333222210
Q ss_pred ----------------CCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 227 ----------------ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 227 ----------------~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.....+...++..+.+||.+||..||.+|||+.++|+||||....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 001112235688999999999999999999999999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=428.31 Aligned_cols=261 Identities=25% Similarity=0.429 Sum_probs=224.6
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~--~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
....+|+++++||+|+||.||+|.++.+|+.||||++.+.... .....+.+|+.+|++++|||||+++++|.+...+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 3457899999999999999999999999999999999654321 23567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSG----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~----~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~ 163 (577)
||||||+||+|..++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||++..+..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999999753 4699999999999999999999999999999999999999999999999999987655
Q ss_pred cccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----ceeeccCCCCCCCchhhhhHH
Q 008116 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM----RVLFIIPRENPPQLDEHFSRL 239 (577)
Q Consensus 164 ~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~----~~~~~i~~~~~~~l~~~~s~~ 239 (577)
........+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||...... .....+.. ....++..++..
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-~~~~~p~~~s~~ 419 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAVTYPDKFSPA 419 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-CCCCCCTTSCHH
T ss_pred CCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-cccCCCcccCHH
Confidence 44444557999999999999875 5899999999999999999999999875432 12222221 223455678999
Q ss_pred HHHHHHHhcccCCCCCCc-----HHHHhhcHhhhhccC
Q 008116 240 MKEFVSLCLKKVPAERPS-----AKELLRHRFIRNARK 272 (577)
Q Consensus 240 l~~lI~~cL~~dP~~RpT-----a~elL~hpff~~~~~ 272 (577)
+++||.+||.+||.+||+ +.+|++||||+...+
T Consensus 420 ~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp HHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred HHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 999999999999999995 589999999998653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=395.89 Aligned_cols=263 Identities=30% Similarity=0.518 Sum_probs=217.0
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-------hHHHHHHHHHHHHHHhCCCCceeEeEEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------EDEIEDIQKEISVLSQCRSPYITEYYGSYL 81 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-------~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~ 81 (577)
..+.++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 4566799999999999999999999999999999999865431 122346889999999999999999999987
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC---eeecccccc
Q 008116 82 HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD---VKVADFGVS 158 (577)
Q Consensus 82 ~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~---vKL~DFGls 158 (577)
.+. +|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 655 8999999999999999988889999999999999999999999999999999999999987654 999999998
Q ss_pred ccccccccccccccCCCCCCChhhhhc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee-eccCCCC---CCCc
Q 008116 159 AQLTRTISRRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-FIIPREN---PPQL 232 (577)
Q Consensus 159 ~~~~~~~~~~~~~~GTp~Y~APEvl~~--~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~-~~i~~~~---~~~l 232 (577)
...... ......+||+.|+|||++.. ...++.++|||||||++|+|++|..||........+ ..+.... .+..
T Consensus 165 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 165 KILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp EECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred eecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 766432 22235689999999999742 345889999999999999999999999865543222 2222222 2223
Q ss_pred hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCC
Q 008116 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 233 ~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
...++..+.+||.+||..||.+||++.++|+||||+.....
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 284 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHH
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHH
Confidence 34678999999999999999999999999999999875443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=402.60 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=213.1
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH----HHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED----EIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~----~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
...++|++++.||+|+||.||+|.+..+|+.||||++....... ....+.+|+.++++++||||+++++++.....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34689999999999999999999999999999999987543211 12467899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
+|+||||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999999975 898888653 46999999999999999999999999999999999999999999999999999877655
Q ss_pred ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------------
Q 008116 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------ 226 (577)
Q Consensus 165 ~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------------ 226 (577)
.......+||+.|+|||++.+...++.++|||||||+||+|++|.+||...+....+..+..
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 44455678999999999997766689999999999999999999999987654333222110
Q ss_pred ----CCCCC-----chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 227 ----ENPPQ-----LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 227 ----~~~~~-----l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
...+. +...++..+++||.+||..||.+|||+.|+|+||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 00000 113567899999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=394.31 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=209.5
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~ 87 (577)
...++|+++++||+|+||+||+|.+..+++.||||++.... ..........|+..+.++ .||||++++++|..++.+|
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 34478999999999999999999999999999999986543 233344555666666555 9999999999999999999
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|||||| +++|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++...... .
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~ 211 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-G 211 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-C
Confidence 999999 6789888864 457999999999999999999999999999999999999999999999999998766433 2
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....+||+.|+|||++.+ .++.++|||||||+||+|++|..||........+ .....++.++..++..+.+||.+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~ 287 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL--RQGYLPPEFTAGLSSELRSVLVM 287 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH--TTTCCCHHHHTTSCHHHHHHHHH
T ss_pred CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH--hccCCCcccccCCCHHHHHHHHH
Confidence 3345679999999999875 4899999999999999999997766543322111 11222334556788999999999
Q ss_pred hcccCCCCCCcHHHHhhcHhhhh
Q 008116 247 CLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~hpff~~ 269 (577)
||.+||.+|||+.+||+||||++
T Consensus 288 ~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 288 MLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=431.76 Aligned_cols=260 Identities=27% Similarity=0.420 Sum_probs=223.9
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
...++|+++++||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 345789999999999999999999999999999999965421 123466889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
||||||+||+|.+++...+ .+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++..+...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~- 339 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG- 339 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC-
Confidence 9999999999999997644 4999999999999999999999999999999999999999999999999999876433
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc----eeeccCCCCCCCchhhhhHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR----VLFIIPRENPPQLDEHFSRLMK 241 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~----~~~~i~~~~~~~l~~~~s~~l~ 241 (577)
......+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||....... ....+ ...+..++..++..++
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i-~~~~~~~p~~~s~~~~ 417 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVPEEYSERFSPQAR 417 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH-HHCCCCCCTTSCHHHH
T ss_pred ccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh-hcccccCCccCCHHHH
Confidence 223456899999999999875 48999999999999999999999998754321 11112 1233445567899999
Q ss_pred HHHHHhcccCCCCCC-----cHHHHhhcHhhhhccC
Q 008116 242 EFVSLCLKKVPAERP-----SAKELLRHRFIRNARK 272 (577)
Q Consensus 242 ~lI~~cL~~dP~~Rp-----Ta~elL~hpff~~~~~ 272 (577)
+||.+||.+||.+|| ++.+|++||||+...+
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 999999999999999 8999999999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=392.88 Aligned_cols=252 Identities=29% Similarity=0.524 Sum_probs=209.9
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
.....+|++.+.||+|+||+||+|.+ ++..||||++.... .......+.+|+.+|++++||||+++++++.....+|
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 34457999999999999999999987 48899999997654 3445678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEccCCCeeecccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPP---LDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~---l~e~~i~~il~QLl~aL~yLHs~g--IiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
||||||++|+|.+++..... +++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||++....
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999999987553 999999999999999999999999 9999999999999999999999999997655
Q ss_pred ccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-CCCCCCchhhhhHHHH
Q 008116 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMK 241 (577)
Q Consensus 163 ~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-~~~~~~l~~~~s~~l~ 241 (577)
.........+||+.|+|||++.+.. ++.++|||||||+||+|++|..||...+.......+. ......++..++..+.
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 269 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269 (309)
T ss_dssp -----------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred ccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 4433345678999999999998764 8999999999999999999999999877665544432 2334456677899999
Q ss_pred HHHHHhcccCCCCCCcHHHHhh
Q 008116 242 EFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~ 263 (577)
+||.+||..+|.+|||+.+|++
T Consensus 270 ~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 270 AIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999997
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=385.39 Aligned_cols=261 Identities=30% Similarity=0.502 Sum_probs=223.9
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--------hHHHHHHHHHHHHHHhCC-CCceeEeEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--------EDEIEDIQKEISVLSQCR-SPYITEYYGS 79 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--------~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~ 79 (577)
....++|++.+.||+|+||.||+|.+..+++.||||+++.... ....+.+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 4456899999999999999999999999999999999975531 123467889999999995 9999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccc
Q 008116 80 YLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 80 ~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
+.....+||||||+++++|.+++.....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999999999999887889999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccccCCCCCCChhhhhc-----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCC
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQN-----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQ 231 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~-----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~ 231 (577)
..... ......+||+.|+|||++.+ ...++.++||||||+++|+|++|..||...+.......+.... +..
T Consensus 173 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 173 QLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp ECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred hcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 66433 23345689999999999862 3347889999999999999999999998776544443332222 222
Q ss_pred chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 232 l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 335688999999999999999999999999999999865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=401.95 Aligned_cols=262 Identities=23% Similarity=0.412 Sum_probs=214.7
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEe-------
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLH------- 82 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~------- 82 (577)
..++|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+|++++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 447999999999999999999999999999999998655422 224567899999999999999999999987
Q ss_pred -CCEEEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccc
Q 008116 83 -QTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 83 -~~~~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
.+.+|||||||++ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 4578999999975 77777754 36799999999999999999999999999999999999999999999999999976
Q ss_pred cccc----ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---CCCCC---
Q 008116 161 LTRT----ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---RENPP--- 230 (577)
Q Consensus 161 ~~~~----~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~---~~~~~--- 230 (577)
+... .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||...........+. ...++
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 5422 1223456899999999999876668999999999999999999999998765433222111 00000
Q ss_pred --------------------Cchh-----hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCC
Q 008116 231 --------------------QLDE-----HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 231 --------------------~l~~-----~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
.+.. ..+..+++||.+||..||.+|||+.++|+||||+.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 0111 126779999999999999999999999999999875443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=400.86 Aligned_cols=256 Identities=27% Similarity=0.421 Sum_probs=206.7
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC----
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT---- 84 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~---- 84 (577)
...++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 45689999999999999999999999999999999997543 3445678899999999999999999999998765
Q ss_pred --EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 85 --KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 85 --~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
.+|||||||. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 7899999996 57888886 459999999999999999999999999999999999999999999999999997654
Q ss_pred ccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC------------
Q 008116 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP------------ 230 (577)
Q Consensus 163 ~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~------------ 230 (577)
.. ......+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+......
T Consensus 179 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 179 TS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp ------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred cc-cccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 32 223456899999999999875 4899999999999999999999999876654333222111000
Q ss_pred -----------------------------CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 231 -----------------------------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 231 -----------------------------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
......+..+++||.+||..||.+|||+.++|+||||...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 0012236789999999999999999999999999999854
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=407.29 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=215.6
Q ss_pred CCCeeE--EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 12 GSRFSS--LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 12 ~~~f~i--l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
...|.+ .++||+|+||.||+|.+..+|..||||++.... ....+.+.+|+.+|++++|||||++++++...+.+|||
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 344555 678999999999999999999999999997654 33457899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE--ccCCCeeecccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL--TENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl--d~~g~vKL~DFGls~~~~~~~~ 166 (577)
||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+... .
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-E 243 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-C
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-c
Confidence 9999999999988653 579999999999999999999999999999999999999 45678999999999876443 2
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchhhhhHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEF 243 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s~~l~~l 243 (577)
.....+||+.|+|||++... .++.++|||||||+||+|++|..||...+....+..+.... +......++..+++|
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 322 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF 322 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred ccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence 33456899999999999765 48999999999999999999999998877655544443222 223335678999999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
|.+||..||.+|||+.++|+||||....
T Consensus 323 i~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 323 ISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 9999999999999999999999998764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=400.92 Aligned_cols=258 Identities=27% Similarity=0.509 Sum_probs=222.1
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-------hHHHHHHHHHHHHHHhC-CCCceeEeEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------EDEIEDIQKEISVLSQC-RSPYITEYYGSYL 81 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-------~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~ 81 (577)
...++|++.+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+++++ .||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 344689999999999999999999999999999999875431 12246678999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 82 HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 82 ~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
.....||||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 99999999999999999999987788999999999999999999999999999999999999999999999999998876
Q ss_pred cccccccccccCCCCCCChhhhhcc-----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC---ch
Q 008116 162 TRTISRRKTFVGTPFWMAPEVIQNS-----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ---LD 233 (577)
Q Consensus 162 ~~~~~~~~~~~GTp~Y~APEvl~~~-----~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~---l~ 233 (577)
... ......+||+.|+|||++.+. ..++.++|||||||+||+|++|..||...........+....... ..
T Consensus 251 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 251 EPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 543 233467899999999998642 247889999999999999999999998776554444443322211 22
Q ss_pred hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 234 ~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
..++..+.+||.+||..||.+|||+.++|+||||+
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 35688899999999999999999999999999996
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=404.40 Aligned_cols=256 Identities=25% Similarity=0.486 Sum_probs=212.9
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCC--CCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR--SPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~--HpnIV~l~~~~~~~~~~~L 88 (577)
+.+|++++.||+|+||.||+|.+.. ++.||||++.... .......+.+|+.+|++|. |||||++++++..+..+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 4569999999999999999999875 8999999997654 3455688999999999996 5999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc--
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-- 166 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-- 166 (577)
||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+.....
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 999 55889999999888999999999999999999999999999999999999995 58999999999987643322
Q ss_pred ccccccCCCCCCChhhhhcc----------cCCccccchhhHHHHHHHHHhCCCCCCCCCcc-ceeeccC-CCCCCCchh
Q 008116 167 RRKTFVGTPFWMAPEVIQNS----------EGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFIIP-RENPPQLDE 234 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~----------~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~-~~~~~i~-~~~~~~l~~ 234 (577)
.....+||+.|+|||++.+. ..|+.++||||||||||+|++|.+||...... ..+..+. ......++.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence 12356899999999998751 24889999999999999999999999865332 2222221 122223444
Q ss_pred hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 235 ~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
..+..+++||.+||..||.+|||+.+||+||||+..
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 557889999999999999999999999999999753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=405.44 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=225.9
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEE-----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAF-----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL 81 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~-----~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~ 81 (577)
+......+|++++.||+|+||.||+|. +..++..||||+++..........+.+|+.++++++|||||++++++.
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 445556899999999999999999999 455788999999976666666778999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC---Cee
Q 008116 82 HQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVK 151 (577)
Q Consensus 82 ~~~~~~LV~Ey~~gGsL~~~l~~~-------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g---~vK 151 (577)
.....|||||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++ .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 999999999999999999999753 3589999999999999999999999999999999999999655 599
Q ss_pred eccccccccccccc--cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC
Q 008116 152 VADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228 (577)
Q Consensus 152 L~DFGls~~~~~~~--~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~ 228 (577)
|+|||++..+.... .......||+.|+|||++.+. .++.++|||||||+||+|++ |.+||...........+....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999997653322 222356789999999999776 48999999999999999998 999999888777776666666
Q ss_pred CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 229 ~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
....+..++..+.+||.+||..+|.+|||+.+|+++.++.
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 5666678899999999999999999999999999997664
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=407.41 Aligned_cols=255 Identities=25% Similarity=0.436 Sum_probs=211.4
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe-------
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH------- 82 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~------- 82 (577)
....+|++++.||+|+||.||+|.+..+|+.||||++.... ....+|+.+|+.++|||||+++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45689999999999999999999999999999999986543 223479999999999999999999854
Q ss_pred -------------------------------CCEEEEEEeccCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHH
Q 008116 83 -------------------------------QTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYL 127 (577)
Q Consensus 83 -------------------------------~~~~~LV~Ey~~gGsL~~~l~----~~~~l~e~~i~~il~QLl~aL~yL 127 (577)
...++||||||+ |+|.+.+. ....+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334899999997 57776664 467899999999999999999999
Q ss_pred HHcCCcccccccceEEEc-cCCCeeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHH
Q 008116 128 HNEGKIHRDIKAANILLT-ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA 206 (577)
Q Consensus 128 Hs~gIiHrDIKPeNILld-~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLl 206 (577)
|++||+||||||+||||+ .++.+||+|||++..+... ......+||+.|+|||++.+...++.++|||||||++|+|+
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 999999999999999998 6789999999999866443 23346789999999999987666899999999999999999
Q ss_pred hCCCCCCCCCccceeeccCC------------------------CCCC----CchhhhhHHHHHHHHHhcccCCCCCCcH
Q 008116 207 KGEPPLADLHPMRVLFIIPR------------------------ENPP----QLDEHFSRLMKEFVSLCLKKVPAERPSA 258 (577)
Q Consensus 207 tG~~Pf~~~~~~~~~~~i~~------------------------~~~~----~l~~~~s~~l~~lI~~cL~~dP~~RpTa 258 (577)
+|.+||...+....+..+.. .... .++..++..+.+||.+||..||.+|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 99999987665433322210 0000 1234578889999999999999999999
Q ss_pred HHHhhcHhhhhcc
Q 008116 259 KELLRHRFIRNAR 271 (577)
Q Consensus 259 ~elL~hpff~~~~ 271 (577)
.++|+||||+..+
T Consensus 317 ~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 317 YEAMAHPFFDHLR 329 (383)
T ss_dssp HHHHTSGGGHHHH
T ss_pred HHHhcCHHHHHHH
Confidence 9999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=410.24 Aligned_cols=250 Identities=13% Similarity=0.160 Sum_probs=206.1
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHH---HHHHhCCCCceeEeE-------EE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEI---SVLSQCRSPYITEYY-------GS 79 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev---~iL~~L~HpnIV~l~-------~~ 79 (577)
..+|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+ .+|++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999999999999999997542 334567899999 455556899999998 77
Q ss_pred EEeCC-----------------EEEEEEeccCCCCHHHHHHcCCCCCH-------HHHHHHHHHHHHHHHHHHHcCCccc
Q 008116 80 YLHQT-----------------KLWIIMEYMAGGSVADLIQSGPPLDE-------MSIACILRDLLHAIEYLHNEGKIHR 135 (577)
Q Consensus 80 ~~~~~-----------------~~~LV~Ey~~gGsL~~~l~~~~~l~e-------~~i~~il~QLl~aL~yLHs~gIiHr 135 (577)
+...+ ..||||||| +|+|.+++...+.+++ ..++.|+.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 66553 289999999 6899999976554555 7888899999999999999999999
Q ss_pred ccccceEEEccCCCeeeccccccccccccccccccccCCCCCCChhhhhcc----------cCCccccchhhHHHHHHHH
Q 008116 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS----------EGYNEKADIWSLGITVIEM 205 (577)
Q Consensus 136 DIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~----------~~~~~ksDVwSLGviLyeL 205 (577)
||||+||||+.++.+||+|||++..... .....+| +.|+|||++.+. ..|+.++|||||||+||+|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 9999999999999999999999976432 3345678 999999999875 2489999999999999999
Q ss_pred HhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 206 AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 206 ltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
++|..||...........+.... ..++..+++||.+||..||.+|||+.++|+||||+...
T Consensus 307 ltg~~Pf~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWIFRSC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHSSCCC------CCSGGGGSSC-----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHCCCCCcccccccchhhhhhhc-----cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 99999998776555444443221 35678999999999999999999999999999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=395.88 Aligned_cols=263 Identities=25% Similarity=0.460 Sum_probs=221.9
Q ss_pred hhhcCCCeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCC
Q 008116 8 QEAAGSRFSSL-ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (577)
Q Consensus 8 ~~~~~~~f~il-~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~ 84 (577)
.+.+.++|.+. +.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.+ .||||+++++++....
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 45667789998 899999999999999999999999999976442 23357789999999999 5799999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc---CCCeeeccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVSA 159 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~---~g~vKL~DFGls~ 159 (577)
.+|||||||.+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 99999999999999999854 367999999999999999999999999999999999999987 7899999999998
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---CCCCCCchhhh
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---RENPPQLDEHF 236 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~---~~~~~~l~~~~ 236 (577)
..... ......+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+. ...+......+
T Consensus 183 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 260 (327)
T 3lm5_A 183 KIGHA-CELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260 (327)
T ss_dssp EC----------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred ccCCc-cccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhccc
Confidence 76543 223456899999999999765 48999999999999999999999998876654433332 22333444578
Q ss_pred hHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 237 s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
+..+++||.+||..||.+|||+.+||+||||+....
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 899999999999999999999999999999987643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=403.22 Aligned_cols=259 Identities=29% Similarity=0.490 Sum_probs=217.5
Q ss_pred CCeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeccCCC---hHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEES---EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTK 85 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~---~tg~~VAIK~i~~~~~---~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~ 85 (577)
++|++++.||+|+||.||+|.+. .+++.||||+++.... ......+.+|+.+|+++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 69999999999999999999984 5799999999864321 12235677899999999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
+|||||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 213 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCC
Confidence 99999999999999999877889999999999999999999999999999999999999999999999999997654322
Q ss_pred -cccccccCCCCCCChhhhhcc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---CCCCCCchhhhhHHH
Q 008116 166 -SRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---RENPPQLDEHFSRLM 240 (577)
Q Consensus 166 -~~~~~~~GTp~Y~APEvl~~~-~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~---~~~~~~l~~~~s~~l 240 (577)
......+||+.|+|||++.+. ..++.++|||||||+||+|++|..||...........+. ....+.++..++..+
T Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
T 1vzo_A 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 293 (355)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHH
Confidence 223456899999999999753 347889999999999999999999997554322211110 112334556788999
Q ss_pred HHHHHHhcccCCCCCC-----cHHHHhhcHhhhhcc
Q 008116 241 KEFVSLCLKKVPAERP-----SAKELLRHRFIRNAR 271 (577)
Q Consensus 241 ~~lI~~cL~~dP~~Rp-----Ta~elL~hpff~~~~ 271 (577)
++||.+||.+||.+|| ++.+|++||||....
T Consensus 294 ~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 9999999999999999 999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=402.03 Aligned_cols=253 Identities=23% Similarity=0.441 Sum_probs=222.0
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEc-------CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEe
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDK-------ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH 82 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~-------~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~ 82 (577)
...+|++.+.||+|+||.||+|.+. .++..||||+++..........+.+|+.+|+++ +|||||++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3478999999999999999999874 345679999998766666778899999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE 146 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~ 146 (577)
.+.+|||||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence 999999999999999999997643 4889999999999999999999999999999999999999
Q ss_pred CCCeeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeec
Q 008116 147 NGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFI 223 (577)
Q Consensus 147 ~g~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~ 223 (577)
++.+||+|||++..+..... ......||+.|+|||++.+. .|+.++|||||||+||||++ |..||......+....
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~ 317 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999986643321 12335678899999999875 48999999999999999999 9999998877766666
Q ss_pred cCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 224 i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+.....+..+..++..+.+||.+||..+|.+||++.+|+++
T Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 318 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66665666677889999999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=395.57 Aligned_cols=263 Identities=27% Similarity=0.397 Sum_probs=220.2
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC---
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--- 83 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~--- 83 (577)
+...+.++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 44567899999999999999999999999999999999997666666677889999999999999999999988764
Q ss_pred --CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 84 --TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 84 --~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
..+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 67999999996 699999976 67999999999999999999999999999999999999999999999999999766
Q ss_pred ccccc----------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc-------
Q 008116 162 TRTIS----------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------- 224 (577)
Q Consensus 162 ~~~~~----------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i------- 224 (577)
..... .....+||+.|+|||++.....++.++|||||||+||+|++|.+||...+....+..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 43211 1223579999999999876556899999999999999999999999876532221111
Q ss_pred ---------------------CCCCCC---CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 225 ---------------------PRENPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 225 ---------------------~~~~~~---~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
...... .....++..+.+||.+||..||.+|||+.+||+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 000001 11235788999999999999999999999999999998653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=387.06 Aligned_cols=261 Identities=26% Similarity=0.450 Sum_probs=212.9
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEE------
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL------ 81 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~------ 81 (577)
...+.++|++++.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 456789999999999999999999999999999999998754 3455678899999999999999999999873
Q ss_pred --------eCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc-cCCCeee
Q 008116 82 --------HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT-ENGDVKV 152 (577)
Q Consensus 82 --------~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld-~~g~vKL 152 (577)
....+|+||||+. |+|.+++.. +++++..++.++.||+.||+|||++||+||||||+||||+ .++.+||
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 4468999999997 699999965 6799999999999999999999999999999999999997 5679999
Q ss_pred ccccccccccccc---cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC
Q 008116 153 ADFGVSAQLTRTI---SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP 229 (577)
Q Consensus 153 ~DFGls~~~~~~~---~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~ 229 (577)
+|||++....... .......||+.|+|||++.....++.++|||||||++|+|++|..||...+.......+....+
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998664321 2223457899999999987655689999999999999999999999987765433322211100
Q ss_pred --------------------------C---CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 230 --------------------------P---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 230 --------------------------~---~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
. .+...++..+++||.+||..||.+|||+.++|+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 0 11235788999999999999999999999999999998653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=392.52 Aligned_cols=255 Identities=29% Similarity=0.475 Sum_probs=223.6
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~ 83 (577)
....++|++++.||+|+||.||+|.+. .+++.||||+++..........+.+|+.++++++||||+++++++...
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345589999999999999999999987 455899999998766666678899999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccccc
Q 008116 84 TKLWIIMEYMAGGSVADLIQSG------------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKA 139 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~------------------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKP 139 (577)
+.+|||||||++|+|.+++... .++++..++.++.||+.||.|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 9999999999999999999763 5799999999999999999999999999999999
Q ss_pred ceEEEccCCCeeeccccccccccccc--cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCC
Q 008116 140 ANILLTENGDVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLH 216 (577)
Q Consensus 140 eNILld~~g~vKL~DFGls~~~~~~~--~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~ 216 (577)
+||||+.++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 99999999999999999997654322 1223457899999999998764 8999999999999999999 999999887
Q ss_pred ccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 217 PMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 217 ~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.......+.......++..++..+.+||.+||..+|.+||++.+|+++
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 282 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 766666666666666677889999999999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=387.71 Aligned_cols=253 Identities=21% Similarity=0.390 Sum_probs=213.4
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEe--CCEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLH--QTKLW 87 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~--~~~~~ 87 (577)
..++|++++.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+|+++. ||||+++++++.. ....+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 3578999999999999999999999999999999986432 367899999999996 9999999999988 66899
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC-Ceeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g-~vKL~DFGls~~~~~~~~ 166 (577)
+||||+.+++|.++++. +++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++...... .
T Consensus 110 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~ 185 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-Q 185 (330)
T ss_dssp EEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-C
T ss_pred EEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-C
Confidence 99999999999999854 89999999999999999999999999999999999999776 8999999999765433 2
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-ceeecc----------------CCC--
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFII----------------PRE-- 227 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~-~~~~~i----------------~~~-- 227 (577)
.....+||+.|+|||++.+...++.++|||||||+||+|++|..||...... ..+..+ ...
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 3345689999999999987566899999999999999999999999543221 000000 000
Q ss_pred ------------------CCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 228 ------------------NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 228 ------------------~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
........++..+++||.+||..||.+|||+.+||+||||+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 01112234789999999999999999999999999999998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=384.71 Aligned_cols=264 Identities=27% Similarity=0.504 Sum_probs=226.6
Q ss_pred cchhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC
Q 008116 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (577)
Q Consensus 5 ~~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~ 83 (577)
...+....++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (287)
T ss_dssp HHHTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhHHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence 3467778889999999999999999999999999999999986543 223457889999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC---CCeeecccccccc
Q 008116 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSAQ 160 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~---g~vKL~DFGls~~ 160 (577)
..+|+||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++..
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999999999999777889999999999999999999999999999999999999754 4699999999876
Q ss_pred ccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchhhhh
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFS 237 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s 237 (577)
.... .......||+.|+|||++.+. ++.++||||||+++|+|++|..||...+.......+.... +......++
T Consensus 174 ~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 2wei_A 174 FQQN-TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (287)
T ss_dssp BCCC-SSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred ecCC-CccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence 6433 223345789999999998753 8899999999999999999999998876655444433222 112234678
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..+.+||.+||..+|.+|||+.++|+||||+...
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 9999999999999999999999999999998653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=387.41 Aligned_cols=262 Identities=26% Similarity=0.427 Sum_probs=218.6
Q ss_pred ccchhhhcCCCeeEEeEEeecCceEEEEEEE-cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCC------ceeEe
Q 008116 4 LAGLQEAAGSRFSSLELIGRGSFGDVYKAFD-KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP------YITEY 76 (577)
Q Consensus 4 l~~l~~~~~~~f~il~~IG~GsfG~Vy~a~~-~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~Hp------nIV~l 76 (577)
+...++...++|++++.||+|+||.||+|.+ ..+++.||||+++.. ....+.+.+|+.+++.+.|+ +|+++
T Consensus 5 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 5 ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp TCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred eeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 3456777889999999999999999999998 567899999998643 34457788999999988665 49999
Q ss_pred EEEEEeCCEEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc--------
Q 008116 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-------- 146 (577)
Q Consensus 77 ~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~-------- 146 (577)
++++...+.+||||||+ +++|.+++.... ++++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 899999997654 6899999999999999999999999999999999999987
Q ss_pred -----------CCCeeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCC
Q 008116 147 -----------NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL 215 (577)
Q Consensus 147 -----------~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~ 215 (577)
++.+||+|||++..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CccccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 66899999999876433 23456899999999999875 4899999999999999999999999876
Q ss_pred CccceeeccC---CCCC----------------------------------------CCchhhhhHHHHHHHHHhcccCC
Q 008116 216 HPMRVLFIIP---RENP----------------------------------------PQLDEHFSRLMKEFVSLCLKKVP 252 (577)
Q Consensus 216 ~~~~~~~~i~---~~~~----------------------------------------~~l~~~~s~~l~~lI~~cL~~dP 252 (577)
+.......+. ...+ .......+..+.+||.+||..||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 5433221110 0000 00122346789999999999999
Q ss_pred CCCCcHHHHhhcHhhhhccC
Q 008116 253 AERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 253 ~~RpTa~elL~hpff~~~~~ 272 (577)
.+|||+.+||+||||+..+.
T Consensus 318 ~~Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 318 AKRITLREALKHPFFDLLKK 337 (339)
T ss_dssp TTSCCHHHHTTSGGGGGGGC
T ss_pred ccccCHHHHhcCHHHHHHhc
Confidence 99999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=392.60 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=220.1
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~---~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
..++|++.+.||+|+||.||+|.+..++. .||||++.........+.+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 45789999999999999999999986554 599999987666667788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
||||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 999999999999999654 6899999999999999999999999999999999999999999999999999987654322
Q ss_pred cc---ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHH
Q 008116 167 RR---KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (577)
Q Consensus 167 ~~---~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~ 242 (577)
.. ....+|+.|+|||++.+.. ++.++|||||||+||+|++ |..||...........+........+..++..+.+
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 285 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQ 285 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHH
Confidence 21 2235678899999997654 8999999999999999999 99999988877776666666555666788999999
Q ss_pred HHHHhcccCCCCCCcHHHHhh
Q 008116 243 FVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~ 263 (577)
||..||..||.+|||+.+|++
T Consensus 286 li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 286 LMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999996
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=404.98 Aligned_cols=261 Identities=21% Similarity=0.397 Sum_probs=203.0
Q ss_pred chhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-
Q 008116 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ- 83 (577)
Q Consensus 6 ~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~- 83 (577)
+..-.+.++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 22 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 22 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp TEEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CcccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 334456789999999999999999999999999999999986543 344567888999999999999999999999754
Q ss_pred -----CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccc
Q 008116 84 -----TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (577)
Q Consensus 84 -----~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls 158 (577)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 5689999999 7899999876 68999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-------------
Q 008116 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP------------- 225 (577)
Q Consensus 159 ~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~------------- 225 (577)
...... ....+||+.|+|||++.+...++.++|||||||+||+|++|.+||...+....+..+.
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 180 RHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 765432 3457899999999999875568999999999999999999999998766543322211
Q ss_pred --------------CCCCCCc---hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 226 --------------RENPPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 226 --------------~~~~~~l---~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
......+ ...++..+.+||.+||..||.+|||+.++|+||||....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0011111 124578899999999999999999999999999998653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=385.82 Aligned_cols=255 Identities=26% Similarity=0.447 Sum_probs=224.0
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~ 83 (577)
.....+|++.+.||+|+||.||+|.+. .++..||||++.........+.+.+|+.+|++++||||+++++++...
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 345679999999999999999999883 456899999998766666778899999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCccccccc
Q 008116 84 TKLWIIMEYMAGGSVADLIQSGP------------------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKA 139 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~~------------------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKP 139 (577)
+.+|+||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 99999999999999999997643 389999999999999999999999999999999
Q ss_pred ceEEEccCCCeeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCC
Q 008116 140 ANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLH 216 (577)
Q Consensus 140 eNILld~~g~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~ 216 (577)
+||||+.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999876643322 123456788999999998754 8999999999999999999 999999887
Q ss_pred ccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 217 PMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 217 ~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.......+........+..++..+.+||.+||..||.+||++.+|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 258 PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 776666665555566677889999999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=385.54 Aligned_cols=251 Identities=27% Similarity=0.448 Sum_probs=212.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
..++|++.++||+|+||+||+|.+..++..||||++... .......+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 357999999999999999999999999999999998543 4556688999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc--
Q 008116 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-- 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~-- 167 (577)
|||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99999999999976 578999999999999999999999999999999999999999999999999999765433221
Q ss_pred ------------cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC--CCCCCCch
Q 008116 168 ------------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP--RENPPQLD 233 (577)
Q Consensus 168 ------------~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~--~~~~~~l~ 233 (577)
....+||+.|+|||++.+. .++.++|||||||+||+|++|..||............. .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCC
T ss_pred ccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCC
Confidence 1156899999999999875 48999999999999999999999997654432211110 00011123
Q ss_pred hhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 234 ~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
..++..+.+||.+||..||.+|||+.+|++
T Consensus 246 ~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 456788999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=395.25 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=216.9
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEE-----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEe
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAF-----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH 82 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~-----~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~ 82 (577)
....++|++.+.||+|+||.||+|. +..+++.||||+++........+.+.+|+.+|+++ +|||||++++++..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 3456899999999999999999998 55667899999998766666678899999999999 89999999999987
Q ss_pred CC-EEEEEEeccCCCCHHHHHHcCCC------------------------------------------------------
Q 008116 83 QT-KLWIIMEYMAGGSVADLIQSGPP------------------------------------------------------ 107 (577)
Q Consensus 83 ~~-~~~LV~Ey~~gGsL~~~l~~~~~------------------------------------------------------ 107 (577)
.+ .+|+|||||.+|+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 55 48999999999999999976432
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc--ccccccC
Q 008116 108 ------------LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVG 173 (577)
Q Consensus 108 ------------l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~--~~~~~~G 173 (577)
+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... ......|
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 89999999999999999999999999999999999999999999999999976543221 2234678
Q ss_pred CCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCcccee-eccCCCCCCCchhhhhHHHHHHHHHhcccC
Q 008116 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL-FIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (577)
Q Consensus 174 Tp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~-~~i~~~~~~~l~~~~s~~l~~lI~~cL~~d 251 (577)
|+.|+|||++.+. .++.++|||||||+||+|++ |.+||......... ..+........+..++..+.+||..||..+
T Consensus 258 t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 336 (359)
T 3vhe_A 258 PLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 336 (359)
T ss_dssp CGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 9999999999875 48999999999999999998 99999876543322 222233344555678899999999999999
Q ss_pred CCCCCcHHHHhhc
Q 008116 252 PAERPSAKELLRH 264 (577)
Q Consensus 252 P~~RpTa~elL~h 264 (577)
|.+|||+.+|++|
T Consensus 337 P~~Rps~~ell~~ 349 (359)
T 3vhe_A 337 PSQRPTFSELVEH 349 (359)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCCCHHHHHHH
Confidence 9999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=388.53 Aligned_cols=260 Identities=23% Similarity=0.408 Sum_probs=201.7
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~---~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
...++|++.+.||+|+||.||+|.+..++. .||||++.... .....+.+.+|+.++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345789999999999999999999887765 89999987553 33456789999999999999999999999988765
Q ss_pred E------EEEEeccCCCCHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeec
Q 008116 86 L------WIIMEYMAGGSVADLIQSG------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (577)
Q Consensus 86 ~------~LV~Ey~~gGsL~~~l~~~------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~ 153 (577)
. |+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 5 9999999999999999542 269999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCC
Q 008116 154 DFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPP 230 (577)
Q Consensus 154 DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~ 230 (577)
|||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++ |.+||...........+......
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 258 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL 258 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred eccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC
Confidence 9999976643321 11234578899999999876 48999999999999999999 99999988877766666655555
Q ss_pred CchhhhhHHHHHHHHHhcccCCCCCCc-------HHHHhhcHhhhhc
Q 008116 231 QLDEHFSRLMKEFVSLCLKKVPAERPS-------AKELLRHRFIRNA 270 (577)
Q Consensus 231 ~l~~~~s~~l~~lI~~cL~~dP~~RpT-------a~elL~hpff~~~ 270 (577)
..+..++..+.+||.+||..||.+||| +.+++.|+|+...
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 259 KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 666778899999999999999999999 6666777777654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=405.25 Aligned_cols=255 Identities=29% Similarity=0.497 Sum_probs=212.5
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC------CCCceeEeEEEEEe
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC------RSPYITEYYGSYLH 82 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L------~HpnIV~l~~~~~~ 82 (577)
+.+..+|+++++||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+ .||||+++++++..
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 45677899999999999999999999999999999999643 33456778888888877 57899999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC--eeecccccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD--VKVADFGVS 158 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~--vKL~DFGls 158 (577)
...+||||||+. ++|.+++... ..+++..++.|+.||+.||+|||+++||||||||+||||+.++. +||+|||++
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999999995 6999998764 35999999999999999999999999999999999999999887 999999998
Q ss_pred ccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------
Q 008116 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------ 226 (577)
Q Consensus 159 ~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------ 226 (577)
..... ...+.+||+.|+|||++.+.. |+.++|||||||+||+|++|.+||...+....+..+..
T Consensus 250 ~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 250 CYEHQ---RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp EETTC---CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eecCC---cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 65432 234678999999999998764 89999999999999999999999987654322211100
Q ss_pred -----------CC----------------------------CC-------CchhhhhHHHHHHHHHhcccCCCCCCcHHH
Q 008116 227 -----------EN----------------------------PP-------QLDEHFSRLMKEFVSLCLKKVPAERPSAKE 260 (577)
Q Consensus 227 -----------~~----------------------------~~-------~l~~~~s~~l~~lI~~cL~~dP~~RpTa~e 260 (577)
.. ++ .+....+..+.+||.+||..||.+|||+.|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 00 00 011123678999999999999999999999
Q ss_pred HhhcHhhhhc
Q 008116 261 LLRHRFIRNA 270 (577)
Q Consensus 261 lL~hpff~~~ 270 (577)
+|+||||+..
T Consensus 406 ~L~Hpw~~~~ 415 (429)
T 3kvw_A 406 ALRHPWLRRR 415 (429)
T ss_dssp HHTSTTTC--
T ss_pred HhCChhhccC
Confidence 9999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=397.67 Aligned_cols=255 Identities=13% Similarity=0.123 Sum_probs=195.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhC--CCCceeEeE-------EEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQC--RSPYITEYY-------GSYL 81 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L--~HpnIV~l~-------~~~~ 81 (577)
..|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 459999999999999999999999999999999987653 33456778886555544 699988765 4554
Q ss_pred eC-----------------CEEEEEEeccCCCCHHHHHHcC-CCCCHHHH------HHHHHHHHHHHHHHHHcCCccccc
Q 008116 82 HQ-----------------TKLWIIMEYMAGGSVADLIQSG-PPLDEMSI------ACILRDLLHAIEYLHNEGKIHRDI 137 (577)
Q Consensus 82 ~~-----------------~~~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i------~~il~QLl~aL~yLHs~gIiHrDI 137 (577)
.. ..+|||||||+ |+|.+++... ..+++..+ ..++.||+.||+|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 33 34899999998 8999999752 34455555 677799999999999999999999
Q ss_pred ccceEEEccCCCeeeccccccccccccccccccccCCCCCCChhhhhc-ccCCccccchhhHHHHHHHHHhCCCCCCCCC
Q 008116 138 KAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN-SEGYNEKADIWSLGITVIEMAKGEPPLADLH 216 (577)
Q Consensus 138 KPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~-~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~ 216 (577)
||+||||+.++.+||+|||++...... .....||+.|+|||++.+ ...|+.++|||||||+||+|++|.+||....
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 999999999999999999999866432 124567799999999975 1348999999999999999999999998764
Q ss_pred ccce--eec---cC-C--CCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 217 PMRV--LFI---IP-R--ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 217 ~~~~--~~~---i~-~--~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
+... ... .. . .........++..+++||.+||..||.+|||+.++|+||||+...
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 3211 111 00 0 111122246789999999999999999999999999999998764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=381.17 Aligned_cols=255 Identities=33% Similarity=0.568 Sum_probs=211.5
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 16 ~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
....+||+|+||.||+|.+..++..||||.+..... ...+.+.+|+.+++.++||||+++++++...+.+++||||+++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp SSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 334499999999999999999999999999976542 3457789999999999999999999999999999999999999
Q ss_pred CCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc-CCCeeeccccccccccccccccccc
Q 008116 96 GSVADLIQSG---PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 96 GsL~~~l~~~---~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~-~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||||+. ++.+||+|||++.............
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 183 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF 183 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCC
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccccc
Confidence 9999999754 35679999999999999999999999999999999999987 8999999999998765443334466
Q ss_pred cCCCCCCChhhhhcc-cCCccccchhhHHHHHHHHHhCCCCCCCCCcccee--eccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 172 VGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL--FIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~-~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~--~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
.||+.|+|||++.+. ..++.++||||||+++|+|++|..||......... ........+.++..++..+.+||.+||
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 263 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 263 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTT
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHc
Confidence 899999999998754 23788999999999999999999999754332111 111112334456678899999999999
Q ss_pred ccCCCCCCcHHHHhhcHhhhhcc
Q 008116 249 KKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 249 ~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..||.+||++.++|+||||+...
T Consensus 264 ~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 264 EPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp CSSTTTSCCHHHHHTSGGGCC--
T ss_pred cCChhhCCCHHHHhcChhhhhcc
Confidence 99999999999999999998654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=397.35 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=214.1
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE-
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL- 86 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~- 86 (577)
-.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++......
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 345689999999999999999999999999999999997654 334467889999999999999999999999877654
Q ss_pred -----EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 87 -----WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 87 -----~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred cceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999996 68988874 45999999999999999999999999999999999999999999999999999765
Q ss_pred cccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC----------------
Q 008116 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---------------- 225 (577)
Q Consensus 162 ~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~---------------- 225 (577)
... ....+||+.|+|||++.+...++.++|||||||+||+|++|..||...+....+..+.
T Consensus 195 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 195 DAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred ccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 432 3456899999999999875568999999999999999999999998765433222221
Q ss_pred -----------CCCCC---CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 226 -----------RENPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 226 -----------~~~~~---~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..... .+...++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 00011 11234688999999999999999999999999999998654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=378.74 Aligned_cols=259 Identities=31% Similarity=0.577 Sum_probs=210.0
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe--------
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-------- 82 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~-------- 82 (577)
..++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 346899999999999999999999999999999998643 3456788999999999999999999998865
Q ss_pred -----CCEEEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccc
Q 008116 83 -----QTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFG 156 (577)
Q Consensus 83 -----~~~~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFG 156 (577)
...+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 4578999999999999999975 3468899999999999999999999999999999999999999999999999
Q ss_pred cccccccc--------------ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCC-cccee
Q 008116 157 VSAQLTRT--------------ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVL 221 (577)
Q Consensus 157 ls~~~~~~--------------~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~-~~~~~ 221 (577)
++...... .......+||+.|+|||++.+...++.++|||||||++|+|++ ||.... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 98765422 1122356799999999999865568999999999999999998 554321 11111
Q ss_pred ec---cCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCCh
Q 008116 222 FI---IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274 (577)
Q Consensus 222 ~~---i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~~ 274 (577)
.. .....++.+....+..+++||.+||..||.+|||+.+||+||||.......
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 294 (303)
T 1zy4_A 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE 294 (303)
T ss_dssp HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHH
T ss_pred HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHH
Confidence 11 122234455667788899999999999999999999999999997654433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=378.86 Aligned_cols=254 Identities=27% Similarity=0.393 Sum_probs=210.7
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
....++|++.+.||+|+||.||+|.+..+ +..||||++.........+.+.+|+.++++++||||+++++++ .++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCc
Confidence 44568999999999999999999998654 4579999987766666678899999999999999999999997 4567
Q ss_pred EEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 89999999999999999754 47999999999999999999999999999999999999999999999999999776443
Q ss_pred cc-ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHH
Q 008116 165 IS-RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (577)
Q Consensus 165 ~~-~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~ 242 (577)
.. ......+|+.|+|||++... .++.++|||||||++|+|++ |.+||...........+.......++..++..+.+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 248 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 248 (281)
T ss_dssp ---------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 21 12234678899999999765 48999999999999999996 99999988777666666655555667788999999
Q ss_pred HHHHhcccCCCCCCcHHHHhhc
Q 008116 243 FVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~h 264 (577)
||.+||..+|.+|||+.+|+++
T Consensus 249 li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 249 LMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=393.15 Aligned_cols=255 Identities=26% Similarity=0.421 Sum_probs=211.5
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC--------CCceeEeEE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR--------SPYITEYYG 78 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~--------HpnIV~l~~ 78 (577)
+++...++|++++.||+|+||+||+|.+..+++.||||++... ....+.+.+|+.+|+.+. ||||+++++
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 5566789999999999999999999999999999999998643 345677899999999985 788999999
Q ss_pred EEE----eCCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEccCC---
Q 008116 79 SYL----HQTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENG--- 148 (577)
Q Consensus 79 ~~~----~~~~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~-gIiHrDIKPeNILld~~g--- 148 (577)
++. ....+||||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 998 456899999999 56666666443 5799999999999999999999998 999999999999998765
Q ss_pred ----------------------------------------------CeeeccccccccccccccccccccCCCCCCChhh
Q 008116 149 ----------------------------------------------DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182 (577)
Q Consensus 149 ----------------------------------------------~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEv 182 (577)
.+||+|||++...... ....+||+.|+|||+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence 7999999999776432 345689999999999
Q ss_pred hhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee------c-------------------------------cC
Q 008116 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF------I-------------------------------IP 225 (577)
Q Consensus 183 l~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~------~-------------------------------i~ 225 (577)
+.+.. ++.++|||||||+||+|++|.+||...+...... . +.
T Consensus 265 ~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 265 LIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 98764 8999999999999999999999997654322110 0 00
Q ss_pred CCCC----------CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 226 RENP----------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 226 ~~~~----------~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
...+ ...+...+..+.+||.+||..||.+|||+.+||+||||+
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0000 012345677899999999999999999999999999996
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=374.51 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=219.2
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
...+|++++.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.++++++||||+++++++.+...+|+||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 34789999999999999999999874 778999999755432 367899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-ccc
Q 008116 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRR 168 (577)
Q Consensus 91 Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~-~~~ 168 (577)
||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 99999999999965 4569999999999999999999999999999999999999999999999999997654332 122
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
....||+.|+|||++.+.. ++.++||||||+++|+|++ |.+||...........+........+..++..+.+||.+|
T Consensus 165 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 243 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 243 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred cCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHH
Confidence 3456788899999997654 8999999999999999999 9999998877766666666555566677889999999999
Q ss_pred cccCCCCCCcHHHHhhc
Q 008116 248 LKKVPAERPSAKELLRH 264 (577)
Q Consensus 248 L~~dP~~RpTa~elL~h 264 (577)
|..+|.+|||+.++++|
T Consensus 244 l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 244 WRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCcccCcCHHHHHHH
Confidence 99999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=405.88 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=208.0
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC------CE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------TK 85 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~------~~ 85 (577)
..+|+++++||+|+||.||+|.+..+++.||||++.... ....+|+.+|++|+|||||+++++|... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 347999999999999999999999999999999986543 2235799999999999999999988542 24
Q ss_pred EEEEEeccCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC-CCeeecccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQ 160 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~----~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~-g~vKL~DFGls~~ 160 (577)
++|||||+.+ +|..++. ....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 7899999975 6666553 35789999999999999999999999999999999999999965 5789999999987
Q ss_pred ccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--------------
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------------- 226 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~-------------- 226 (577)
+... ......+||+.|+|||++.+...|+.++|||||||+||||++|.+||...+....+..+..
T Consensus 207 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 207 LVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred cccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 6443 2334578999999999997765699999999999999999999999987654332222110
Q ss_pred -----CCCCC---------chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 227 -----ENPPQ---------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 227 -----~~~~~---------l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
...+. +...++.++++||.+||..||.+|||+.++|+||||....
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 00000 1234678999999999999999999999999999998653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=382.05 Aligned_cols=259 Identities=24% Similarity=0.432 Sum_probs=215.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC---ChHHHHHHHHHHHHHHhCCCCceeEeEEEEE--eCCE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQCRSPYITEYYGSYL--HQTK 85 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~---~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~--~~~~ 85 (577)
+.++|++.+.||+|+||.||+|.+..++..||||++.... .......+.+|+.++++++||||+++++++. ....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4579999999999999999999999999999999996543 1234578999999999999999999999984 4557
Q ss_pred EEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~ 163 (577)
+|||||||.++ |.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999876 7777754 46799999999999999999999999999999999999999999999999999876543
Q ss_pred c--ccccccccCCCCCCChhhhhccc-CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHH
Q 008116 164 T--ISRRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240 (577)
Q Consensus 164 ~--~~~~~~~~GTp~Y~APEvl~~~~-~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l 240 (577)
. ........||+.|+|||++.+.. .++.++|||||||++|+|++|..||...+.......+.... ..++..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~l 240 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCGPPL 240 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CCCCSSSCHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CCCCCccCHHH
Confidence 2 12223567999999999987533 24679999999999999999999998876554444443322 23455678999
Q ss_pred HHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 241 ~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.+||.+||..||.+|||+.+|++||||+...
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 9999999999999999999999999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=393.54 Aligned_cols=260 Identities=27% Similarity=0.463 Sum_probs=219.5
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh----------------HHHHHHHHHHHHHHhCCCC
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE----------------DEIEDIQKEISVLSQCRSP 71 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~----------------~~~~~i~~Ev~iL~~L~Hp 71 (577)
.....++|++++.||+|+||.||+|.+ +++.||||++...... .....+.+|+.++++++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 344568999999999999999999999 7999999998643211 1127889999999999999
Q ss_pred ceeEeEEEEEeCCEEEEEEeccCCCCHHHH------HHc--CCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceE
Q 008116 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADL------IQS--GPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANI 142 (577)
Q Consensus 72 nIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~------l~~--~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNI 142 (577)
||+++++++...+.+|+||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 655 5789999999999999999999999 9999999999999
Q ss_pred EEccCCCeeeccccccccccccccccccccCCCCCCChhhhhcccCCcc-ccchhhHHHHHHHHHhCCCCCCCCCc-cce
Q 008116 143 LLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE-KADIWSLGITVIEMAKGEPPLADLHP-MRV 220 (577)
Q Consensus 143 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~-ksDVwSLGviLyeLltG~~Pf~~~~~-~~~ 220 (577)
||+.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||..... ...
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 9999999999999998776443 3345689999999999987634665 99999999999999999999987655 333
Q ss_pred eeccCCCCCCC------------------chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 221 LFIIPRENPPQ------------------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 221 ~~~i~~~~~~~------------------l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
...+....... ....++..+.+||.+||..||.+|||+.++|+||||....
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 33332222111 1156789999999999999999999999999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=393.20 Aligned_cols=264 Identities=24% Similarity=0.400 Sum_probs=209.5
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC----------hHHHHHHHHHHHHHHhCCCCceeEe
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES----------EDEIEDIQKEISVLSQCRSPYITEY 76 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~----------~~~~~~i~~Ev~iL~~L~HpnIV~l 76 (577)
-...+.++|++.+.||+|+||.||+|.+.. +..||||++..... ....+.+.+|+.+|++++||||+++
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp HHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred HHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 345677999999999999999999999865 89999999854322 2235789999999999999999999
Q ss_pred EEEEEe-----CCEEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCe
Q 008116 77 YGSYLH-----QTKLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDV 150 (577)
Q Consensus 77 ~~~~~~-----~~~~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~v 150 (577)
++++.. ...+||||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 173 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDI 173 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCE
Confidence 999854 337899999997 6888887653 479999999999999999999999999999999999999999999
Q ss_pred eeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-----
Q 008116 151 KVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP----- 225 (577)
Q Consensus 151 KL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~----- 225 (577)
||+|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||...........+.
T Consensus 174 kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 174 TICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp EECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999999755433 233456899999999999875568999999999999999999999998765433222110
Q ss_pred ----------------------CCCCC----CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCC
Q 008116 226 ----------------------RENPP----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (577)
Q Consensus 226 ----------------------~~~~~----~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~ 273 (577)
...+. .....++..+.+||.+||..||.+|||+.++|+||||+.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 00111 1123457889999999999999999999999999999886543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=392.30 Aligned_cols=258 Identities=25% Similarity=0.382 Sum_probs=201.2
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC-----
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----- 84 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~----- 84 (577)
...++|++.+.||+|+||.||+|.+..++..||||++..... ......+|+..++.++||||++++++|....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 345789999999999999999999999999999998854432 2245677888889999999999999997643
Q ss_pred --EEEEEEeccCCCCHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHH--HcCCcccccccceEEEcc-CCCeeeccc
Q 008116 85 --KLWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHAIEYLH--NEGKIHRDIKAANILLTE-NGDVKVADF 155 (577)
Q Consensus 85 --~~~LV~Ey~~gGsL~~~l----~~~~~l~e~~i~~il~QLl~aL~yLH--s~gIiHrDIKPeNILld~-~g~vKL~DF 155 (577)
.+||||||+.+ +|...+ .....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 38999999976 554433 35678999999999999999999999 999999999999999996 899999999
Q ss_pred cccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC--------
Q 008116 156 GVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-------- 227 (577)
Q Consensus 156 Gls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~-------- 227 (577)
|++...... ......+||+.|+|||++.+...++.++|||||||+||+|++|.+||...+....+..+...
T Consensus 177 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 177 GSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp TTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 999876543 23345689999999999977666899999999999999999999999876654333222110
Q ss_pred ----------------CC-------CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 228 ----------------NP-------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 228 ----------------~~-------~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.. +.....++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 00 011112568899999999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=393.93 Aligned_cols=254 Identities=24% Similarity=0.449 Sum_probs=223.4
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCC-------CcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKEL-------NKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYL 81 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~t-------g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~ 81 (577)
...++|++.+.||+|+||.||+|.+..+ +..||||++...........+.+|+.+++++ +|||||++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 4457999999999999999999997543 3579999998777777778899999999999 9999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc
Q 008116 82 HQTKLWIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT 145 (577)
Q Consensus 82 ~~~~~~LV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld 145 (577)
.++.+|||||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 9999999999999999999997643 499999999999999999999999999999999999999
Q ss_pred cCCCeeeccccccccccccc--cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceee
Q 008116 146 ENGDVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLF 222 (577)
Q Consensus 146 ~~g~vKL~DFGls~~~~~~~--~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~ 222 (577)
.++.+||+|||++....... .......||+.|+|||++.+. .++.++|||||||+||+|++ |..||..........
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999998664332 122345678999999999875 48999999999999999999 999999887766666
Q ss_pred ccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 223 IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 223 ~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.+........+..++..+.+||.+||..+|.+|||+.+|+++
T Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 305 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 666555556667789999999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=386.29 Aligned_cols=264 Identities=25% Similarity=0.406 Sum_probs=222.8
Q ss_pred ccchhhhcCCCeeEEeEEeecCceEEEEEE-----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEE
Q 008116 4 LAGLQEAAGSRFSSLELIGRGSFGDVYKAF-----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78 (577)
Q Consensus 4 l~~l~~~~~~~f~il~~IG~GsfG~Vy~a~-----~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~ 78 (577)
+..+.+...++|++++.||+|+||.||+|. +..++..||||++...........+.+|+.++++++||||+++++
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 21 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp GGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 345666778999999999999999999998 556788999999976666666778999999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC---C
Q 008116 79 SYLHQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---G 148 (577)
Q Consensus 79 ~~~~~~~~~LV~Ey~~gGsL~~~l~~~-------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~---g 148 (577)
++.....+|||||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+ .
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 999999999999999999999999764 348999999999999999999999999999999999999844 4
Q ss_pred Ceeeccccccccccccc--cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccC
Q 008116 149 DVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIP 225 (577)
Q Consensus 149 ~vKL~DFGls~~~~~~~--~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~ 225 (577)
.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||+||+|++ |..||...........+.
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 69999999987653322 1223457899999999997754 8999999999999999998 999998877666655555
Q ss_pred CCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 226 ~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
.......+..++..+.+||.+||..+|.+||++.+|++|.|+.
T Consensus 260 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 5555556677889999999999999999999999999998764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=382.01 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=213.2
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEc-CCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhC---CCCceeEeEEEEE---
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDK-ELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQC---RSPYITEYYGSYL--- 81 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~-~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L---~HpnIV~l~~~~~--- 81 (577)
...++|++++.||+|+||.||+|.+. .+++.||||++...... .....+.+|+.+++.+ .||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34589999999999999999999995 67899999998654321 1123456777777766 8999999999987
Q ss_pred --eCCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccc
Q 008116 82 --HQTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (577)
Q Consensus 82 --~~~~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGl 157 (577)
....+++||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 4568999999997 6999999764 3599999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-----------
Q 008116 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------- 226 (577)
Q Consensus 158 s~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~----------- 226 (577)
+...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||........+..+..
T Consensus 167 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 167 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CCCCCGG-GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred cccccCC-CCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 8766433 2334568999999999997754 89999999999999999999999987654332211110
Q ss_pred ---------------CCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 227 ---------------ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 227 ---------------~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
.....+...++..+++||.+||..||.+|||+.++|+||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 0011123457889999999999999999999999999999987654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=385.66 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=210.8
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcE----EEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~----VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
....+|+++++||+|+||+||+|.+..++.. ||+|.+...........+.+|+.++++++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 4457899999999999999999999877765 57787765444455678999999999999999999999998755
Q ss_pred EEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
.++|+||+.+|+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 7899999999999999976 467999999999999999999999999999999999999999999999999999876443
Q ss_pred ccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHH
Q 008116 165 ISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (577)
Q Consensus 165 ~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~ 241 (577)
... .....||+.|+|||++.+. .++.++|||||||++|+|++ |..||...........+........+..++..+.
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 249 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHH
T ss_pred cccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 222 1234578899999999876 48999999999999999999 9999998877666666655555556667889999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhc
Q 008116 242 EFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+||.+||..+|.+||++.+|+++
T Consensus 250 ~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 250 MIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=372.21 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=218.4
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
...++|++++.||+|+||.||+|.+. ++..||||++...... ...+.+|+.++++++||||+++++++.....+|+|
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 45679999999999999999999876 4778999999755432 36689999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-c
Q 008116 90 MEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~ 167 (577)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999999999764 4599999999999999999999999999999999999999999999999999876543321 1
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....||+.|+|||++.+.. ++.++||||||+++|+|++ |..||...........+........+..++..+.+||..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYS 240 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHH
Confidence 22345677899999997754 8999999999999999999 999998887766666666555555666788999999999
Q ss_pred hcccCCCCCCcHHHHhhc
Q 008116 247 CLKKVPAERPSAKELLRH 264 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~h 264 (577)
||..+|.+|||+.+++++
T Consensus 241 ~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 241 CWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHH
Confidence 999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=402.44 Aligned_cols=258 Identities=25% Similarity=0.420 Sum_probs=208.8
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC---
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT--- 84 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~--- 84 (577)
......+|+++++||+|+||.||+|.+..++. ||||.+.... ....+|+.+|+.++|||||+++++|....
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc-----chHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 34455689999999999999999999987665 8888775433 12347999999999999999999996543
Q ss_pred ---EEEEEEeccCCCCHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc-cCCCeeeccccc
Q 008116 85 ---KLWIIMEYMAGGSVADLI---QSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT-ENGDVKVADFGV 157 (577)
Q Consensus 85 ---~~~LV~Ey~~gGsL~~~l---~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld-~~g~vKL~DFGl 157 (577)
.+|||||||.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+
T Consensus 109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 389999999765433332 2357899999999999999999999999999999999999999 789999999999
Q ss_pred cccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-----------
Q 008116 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------- 226 (577)
Q Consensus 158 s~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~----------- 226 (577)
++..... ......+||+.|+|||++.+...|+.++|||||||+||+|++|.+||...+....+..+..
T Consensus 189 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 189 AKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9876433 2334678999999999998766699999999999999999999999987664333222110
Q ss_pred -------------CCCCC----chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 227 -------------ENPPQ----LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 227 -------------~~~~~----l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
..+.. ++..++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 01111 12346789999999999999999999999999999987643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=388.35 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=213.4
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE---
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK--- 85 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~--- 85 (577)
.+..+|.+.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 45689999999999999999999999999999999997644 33446788999999999999999999999987654
Q ss_pred ---EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 86 ---LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 86 ---~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred ceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 599999996 68988874 359999999999999999999999999999999999999999999999999987654
Q ss_pred ccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc------------------
Q 008116 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------ 224 (577)
Q Consensus 163 ~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i------------------ 224 (577)
.. ....+||+.|+|||++.+...++.++|||||||+||+|++|..||...+....+..+
T Consensus 178 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 178 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred CC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 32 335689999999999987556899999999999999999999999876543222111
Q ss_pred ---------C---CCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 225 ---------P---RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 225 ---------~---~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
. ......+...++..+.+||.+||..||.+|||+.++|+||||....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0 0111223346789999999999999999999999999999998653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=374.51 Aligned_cols=251 Identities=26% Similarity=0.384 Sum_probs=216.5
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
....+|++++.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.++++++||||+++++++.....+|+|
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 34568999999999999999999887 5778999999755432 36688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-c
Q 008116 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~ 167 (577)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 999999999999976 56799999999999999999999999999999999999999999999999999976643321 1
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....||+.|+|||++.+.. ++.++||||||+++|+|++ |..||...........+........+..++..+.+||..
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 256 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 256 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHH
Confidence 22345788899999998764 8999999999999999998 999999887766666666555555666778999999999
Q ss_pred hcccCCCCCCcHHHHhhc
Q 008116 247 CLKKVPAERPSAKELLRH 264 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~h 264 (577)
||..+|.+|||+.+|++|
T Consensus 257 ~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 257 CWHEKADERPTFKILLSN 274 (283)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCChhHCcCHHHHHHH
Confidence 999999999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=397.02 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=220.4
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.++|++.+.||+|+||.||+|.+..+++.||||+++..........+.+|+.+|++++|||||++++++...+.+|||||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 46899999999999999999999999999999999766555566778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc--
Q 008116 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR-- 168 (577)
Q Consensus 92 y~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~-- 168 (577)
||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 99999999999753 469999999999999999999999999999999999999999999999999987643321111
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
....+++.|+|||++.... ++.++|||||||+||||++ |..||...........+........+..++..+.+||.+|
T Consensus 273 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQC 351 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 1234577899999998654 8999999999999999998 9999998877666656655555566777899999999999
Q ss_pred cccCCCCCCcHHHHhhc
Q 008116 248 LKKVPAERPSAKELLRH 264 (577)
Q Consensus 248 L~~dP~~RpTa~elL~h 264 (577)
|..||.+|||+.+|++.
T Consensus 352 l~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 352 WAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCCchhCcCHHHHHHH
Confidence 99999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=380.50 Aligned_cols=261 Identities=34% Similarity=0.602 Sum_probs=198.6
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHH-HHHhCCCCceeEeEEEEEeCCEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEIS-VLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~-iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
....++|++++.||+|+||.||+|.+..+++.||||++...........+.+|+. +++.++||||+++++++...+..|
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 3456899999999999999999999999999999999987665555566667776 677789999999999999999999
Q ss_pred EEEeccCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEccCCCeeeccccccccc
Q 008116 88 IIMEYMAGGSVADLIQS-----GPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~-----~~~l~e~~i~~il~QLl~aL~yLHs~-gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
|||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++...
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99999975 88888753 57899999999999999999999999 9999999999999999999999999999776
Q ss_pred cccccccccccCCCCCCChhhhh---cccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccCCCCCCCc----h
Q 008116 162 TRTISRRKTFVGTPFWMAPEVIQ---NSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQL----D 233 (577)
Q Consensus 162 ~~~~~~~~~~~GTp~Y~APEvl~---~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~-~~~~~~i~~~~~~~l----~ 233 (577)
.... ......||+.|+|||++. ....++.++|||||||+||+|++|..||..... ......+....++.+ .
T Consensus 177 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3aln_A 177 VDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSS
T ss_pred cccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccc
Confidence 4432 223457999999999984 223488999999999999999999999986542 222333333333322 2
Q ss_pred hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 234 ~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..++..+.+||..||..||.+|||+.+|++||||....
T Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 35789999999999999999999999999999997653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=384.02 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=213.7
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCC-cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCc------eeEeEEE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELN-KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY------ITEYYGS 79 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg-~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~Hpn------IV~l~~~ 79 (577)
+++...++|++++.||+|+||.||+|.+..++ ..||||+++.. ......+.+|+.+++++.|++ |+.++++
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 56677899999999999999999999998777 68999998643 344577889999999987655 9999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE-------------
Q 008116 80 YLHQTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL------------- 144 (577)
Q Consensus 80 ~~~~~~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl------------- 144 (577)
+...+.+||||||+ +++|.+++... .++++..++.++.||+.||.|||++||+||||||+||||
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999999 66777777543 479999999999999999999999999999999999999
Q ss_pred ------ccCCCeeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc
Q 008116 145 ------TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM 218 (577)
Q Consensus 145 ------d~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~ 218 (577)
+.++.+||+|||++..... .....+||+.|+|||++.+. .++.++|||||||+||+|++|.+||......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5678999999999876433 23456899999999999875 4899999999999999999999999876543
Q ss_pred ceeeccC---CCCCC----------------------------------------CchhhhhHHHHHHHHHhcccCCCCC
Q 008116 219 RVLFIIP---RENPP----------------------------------------QLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 219 ~~~~~i~---~~~~~----------------------------------------~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
.....+. ...+. ......+..+.+||.+||..||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 3221110 00000 0011235689999999999999999
Q ss_pred CcHHHHhhcHhhhhcc
Q 008116 256 PSAKELLRHRFIRNAR 271 (577)
Q Consensus 256 pTa~elL~hpff~~~~ 271 (577)
||+.++|+||||....
T Consensus 326 pt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 326 ITLAEALLHPFFAGLT 341 (355)
T ss_dssp CCHHHHTTSGGGGGCC
T ss_pred cCHHHHhcChhhcCCC
Confidence 9999999999999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=381.07 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=222.2
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~ 83 (577)
....++|++.+.||+|+||.||+|.+. .++..||||++...........+.+|+.++++++||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 445679999999999999999999876 457889999998766666677899999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeec
Q 008116 84 TKLWIIMEYMAGGSVADLIQSG----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~----------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~ 153 (577)
...|+||||+++|+|.+++... .++++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 9999999999999999999642 467999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCC
Q 008116 154 DFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPP 230 (577)
Q Consensus 154 DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~ 230 (577)
|||++........ ......||+.|+|||++.+.. ++.++|||||||+||+|++ |..||...........+......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 259 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC
Confidence 9999876543321 122446789999999998754 8999999999999999999 89999887766655555555555
Q ss_pred CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 231 ~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
..+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5667788999999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=382.12 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=215.2
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEE--EEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDV--AIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~V--AIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~L 88 (577)
.++|++.+.||+|+||.||+|.+..++..+ |||.+...........+.+|+.+|+++ +||||+++++++...+.+||
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 478999999999999999999999888865 999987655555567899999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeee
Q 008116 89 IMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKV 152 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL 152 (577)
||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEE
Confidence 999999999999997643 7999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCC
Q 008116 153 ADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQ 231 (577)
Q Consensus 153 ~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~ 231 (577)
+|||++...... .......+++.|+|||++.+. .++.++|||||||+||+|++ |..||...........+.......
T Consensus 184 ~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 261 (327)
T 1fvr_A 184 ADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 261 (327)
T ss_dssp CCTTCEESSCEE-CCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred cccCcCcccccc-ccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCC
Confidence 999998754322 222345678999999999765 48899999999999999998 999998887766666665555555
Q ss_pred chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 232 l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 262 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 262 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 566788999999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=386.92 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=214.2
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcE----EEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~----VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
..+|++++.||+|+||.||+|.+..++.. ||+|.+...........+.+|+.++++++||||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 57899999999999999999999888776 77777754443333456788999999999999999999886 56689
Q ss_pred EEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
+||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999999999764 5799999999999999999999999999999999999999999999999999987644322
Q ss_pred --ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHH
Q 008116 167 --RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (577)
Q Consensus 167 --~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~l 243 (577)
......||+.|+|||++.+.. ++.++|||||||+||+|++ |..||...........+........+..++..+.+|
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMV 249 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHH
T ss_pred cccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHH
Confidence 223457888999999998764 8999999999999999999 999999877766666665555555666778889999
Q ss_pred HHHhcccCCCCCCcHHHHhhc
Q 008116 244 VSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~h 264 (577)
|.+||..+|.+||++.+|+++
T Consensus 250 i~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 250 MVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=383.83 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=213.4
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeC
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ 83 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~ 83 (577)
...++|++.+.||+|+||.||+|.+ ..++..||||++...........+.+|+.+|+++ .||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457899999999999999999997 3456789999997655445567899999999999 899999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Q 008116 84 TKLWIIMEYMAGGSVADLIQSGP-----------------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAA 140 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~~-----------------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPe 140 (577)
+.+|||||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 99999999999999999997643 3799999999999999999999999999999999
Q ss_pred eEEEccCCCeeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCc
Q 008116 141 NILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHP 217 (577)
Q Consensus 141 NILld~~g~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~ 217 (577)
||||+.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||+||+|++ |..||.....
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 99999999999999999976644322 122456789999999997754 8999999999999999998 9999987765
Q ss_pred cceee-ccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcH
Q 008116 218 MRVLF-IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHR 265 (577)
Q Consensus 218 ~~~~~-~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hp 265 (577)
..... .+........+..++..+.+||.+||..||.+|||+.+|++|.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 281 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 43322 2233334445566789999999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=386.47 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=218.8
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-----HHHHHHHHHHHHHhCC--CCceeEeEEE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-----EIEDIQKEISVLSQCR--SPYITEYYGS 79 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~-----~~~~i~~Ev~iL~~L~--HpnIV~l~~~ 79 (577)
......++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+|+.+++++. ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 34567789999999999999999999999999999999997553211 2245678999999995 5999999999
Q ss_pred EEeCCEEEEEEeccCC-CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc-cCCCeeeccccc
Q 008116 80 YLHQTKLWIIMEYMAG-GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT-ENGDVKVADFGV 157 (577)
Q Consensus 80 ~~~~~~~~LV~Ey~~g-GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld-~~g~vKL~DFGl 157 (577)
+...+.+++||||+.+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999999976 89999998878999999999999999999999999999999999999999 678999999999
Q ss_pred cccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhh
Q 008116 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFS 237 (577)
Q Consensus 158 s~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s 237 (577)
+...... ......||+.|+|||++.+...++.++|||||||+||+|++|..||....... . ....++..++
T Consensus 197 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~-~~~~~~~~~~ 267 (320)
T 3a99_A 197 GALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII------R-GQVFFRQRVS 267 (320)
T ss_dssp CEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH------H-CCCCCSSCCC
T ss_pred ccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh------c-ccccccccCC
Confidence 8776532 23356799999999999876655788999999999999999999997543210 0 1122344678
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
..+.+||.+||..||.+|||+.+|++||||+....
T Consensus 268 ~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 89999999999999999999999999999987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=373.12 Aligned_cols=252 Identities=26% Similarity=0.464 Sum_probs=222.7
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
....+|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+.++++++||||+++++++.+...+|+|
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 456789999999999999999999999999999999975433 457889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-
Q 008116 90 MEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~- 166 (577)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 999999999999976 34599999999999999999999999999999999999999999999999999987653321
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~ 245 (577)
......||+.|+|||++.+.. ++.++||||||+++|+|++ |.+||...+.......+........+..++..+.+||.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 223456788999999998764 8999999999999999999 99999988776666666555555666788999999999
Q ss_pred HhcccCCCCCCcHHHHhhc
Q 008116 246 LCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~h 264 (577)
.||..||.+|||+.++++.
T Consensus 247 ~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 247 ACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCChhhCcCHHHHHHH
Confidence 9999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=390.31 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=211.3
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CC-----ceeEeEEEE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SP-----YITEYYGSY 80 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-Hp-----nIV~l~~~~ 80 (577)
......++|++++.||+|+||+||+|.+..+++.||||+++.. ......+.+|+.+++.+. |+ +|+++++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 3455678999999999999999999999999999999999643 334577888999998884 55 499999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH--HcCCcccccccceEEEc--cCCCeeecc
Q 008116 81 LHQTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLH--NEGKIHRDIKAANILLT--ENGDVKVAD 154 (577)
Q Consensus 81 ~~~~~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLH--s~gIiHrDIKPeNILld--~~g~vKL~D 154 (577)
...+.+||||||+. ++|.+++... ..+++..++.++.||+.||.||| ..||+||||||+||||+ .++.+||+|
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999995 5999999764 46999999999999999999999 57999999999999995 468899999
Q ss_pred ccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--------
Q 008116 155 FGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------- 226 (577)
Q Consensus 155 FGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~-------- 226 (577)
||++..... .....+||+.|+|||++.+.. ++.++|||||||+||+|++|.+||...+....+..+..
T Consensus 205 FG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (382)
T 2vx3_A 205 FGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280 (382)
T ss_dssp CTTCEETTC---CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred ccCceeccc---ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999987643 234578999999999998764 89999999999999999999999987654332221110
Q ss_pred -----------------C--------------CCC---Cch---------------------hhhhHHHHHHHHHhcccC
Q 008116 227 -----------------E--------------NPP---QLD---------------------EHFSRLMKEFVSLCLKKV 251 (577)
Q Consensus 227 -----------------~--------------~~~---~l~---------------------~~~s~~l~~lI~~cL~~d 251 (577)
. .++ .+. ......+++||.+||..|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 0 000 000 011247899999999999
Q ss_pred CCCCCcHHHHhhcHhhhhc
Q 008116 252 PAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 252 P~~RpTa~elL~hpff~~~ 270 (577)
|.+|||+.++|+||||+..
T Consensus 361 P~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 361 PKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTTSCCHHHHTTSGGGCC-
T ss_pred hhhCCCHHHHhcCcccccC
Confidence 9999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=382.28 Aligned_cols=255 Identities=23% Similarity=0.443 Sum_probs=219.7
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEc-------CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDK-------ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSY 80 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~-------~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~ 80 (577)
....++|++.+.||+|+||.||+|.+. .++..||||++...........+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 345689999999999999999999985 457789999998776666778899999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE
Q 008116 81 LHQTKLWIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL 144 (577)
Q Consensus 81 ~~~~~~~LV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl 144 (577)
...+.+||||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 99999999999999999999997643 38999999999999999999999999999999999999
Q ss_pred ccCCCeeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCcccee
Q 008116 145 TENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL 221 (577)
Q Consensus 145 d~~g~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~ 221 (577)
+.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||+||+|++ |..||.........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 9999999999999976643321 122346788999999997754 8999999999999999999 99999887765555
Q ss_pred eccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 222 ~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
..+........+..++..+.+||.+||..+|.+|||+.+|+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5454444445566788999999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=376.52 Aligned_cols=255 Identities=23% Similarity=0.423 Sum_probs=209.1
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~ 83 (577)
.+....+|++++.||+|+||.||+|. +..+++.||||++... .....+.+.+|+.+|++++||||+++++++...
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 44567899999999999999999998 5678999999998744 345567899999999999999999999998653
Q ss_pred --CEEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccc
Q 008116 84 --TKLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 84 --~~~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
..+|||||||++|+|.+++... .++++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 5689999999999999999764 3599999999999999999999999999999999999999999999999999987
Q ss_pred ccccccc---cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----------------cee
Q 008116 161 LTRTISR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM----------------RVL 221 (577)
Q Consensus 161 ~~~~~~~---~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~----------------~~~ 221 (577)
....... .....|++.|+|||++.+.. ++.++|||||||++|+|++|..||...... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 6443211 22345788899999998764 899999999999999999999998643211 111
Q ss_pred eccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 222 ~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
..+........+..++..+.+||..||..+|.+|||+.+|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1222233344566788999999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=376.07 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=216.8
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeC
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ 83 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~ 83 (577)
...++|++.+.||+|+||.||+|.+ ..++..||||++.........+.+.+|+.+|+++ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3457999999999999999999985 4567899999998766666678899999999999 999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc
Q 008116 84 TKLWIIMEYMAGGSVADLIQSGP------------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT 145 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~~------------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld 145 (577)
+..|+|||||++|+|.+++.... ++++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 99999999999999999997643 489999999999999999999999999999999999999
Q ss_pred cCCCeeeccccccccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceee
Q 008116 146 ENGDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLF 222 (577)
Q Consensus 146 ~~g~vKL~DFGls~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~ 222 (577)
.++.+||+|||++......... .....||+.|+|||++.+. .++.++|||||||+||+|++ |..||..........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 9999999999999776543221 2245678899999999775 48999999999999999998 999998765433222
Q ss_pred c-cCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 223 I-IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 223 ~-i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
. +........+..++..+.+||.+||..||.+|||+.+|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 2 22222333445678999999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=370.99 Aligned_cols=253 Identities=24% Similarity=0.416 Sum_probs=219.5
Q ss_pred cCCCeeEEe-EEeecCceEEEEEEEc--CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 11 AGSRFSSLE-LIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 11 ~~~~f~il~-~IG~GsfG~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
..++|.+++ .||+|+||.||+|.+. .++..||||++.........+.+.+|+.++++++||||+++++++ ..+.+|
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 346788887 9999999999999864 467889999998776666778899999999999999999999999 556799
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 99999999999999964 35799999999999999999999999999999999999999999999999999977643322
Q ss_pred c---cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHH
Q 008116 167 R---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (577)
Q Consensus 167 ~---~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~ 242 (577)
. .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||...........+.....+.++..++..+.+
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 244 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 244 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHH
Confidence 1 22345789999999997654 8999999999999999998 99999887776666666555556667788999999
Q ss_pred HHHHhcccCCCCCCcHHHHhhcH
Q 008116 243 FVSLCLKKVPAERPSAKELLRHR 265 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~hp 265 (577)
||..||..+|.+||++.+|+++.
T Consensus 245 li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 245 LMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999999999873
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=382.46 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=187.2
Q ss_pred hhcCCCeeEEe-EEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe----C
Q 008116 9 EAAGSRFSSLE-LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH----Q 83 (577)
Q Consensus 9 ~~~~~~f~il~-~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~----~ 83 (577)
..+.++|++++ +||+|+||.||+|.+..+++.||||++.... .........++.+.||||+++++++.. .
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 45678999965 6999999999999999999999999986431 222233344667799999999999986 4
Q ss_pred CEEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc---CCCeeecccccc
Q 008116 84 TKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVS 158 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~---~g~vKL~DFGls 158 (577)
..+|||||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 56899999999999999997653 6999999999999999999999999999999999999976 455999999998
Q ss_pred ccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee----eccC---CCCCCC
Q 008116 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL----FIIP---RENPPQ 231 (577)
Q Consensus 159 ~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~----~~i~---~~~~~~ 231 (577)
...... .....+||+.|+|||++... .++.++|||||||+||+|++|..||......... ..+. ...+..
T Consensus 179 ~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 179 KETTQN--ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp EEC------------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred eecccc--ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 765432 23456899999999998665 4889999999999999999999999765543321 1111 111222
Q ss_pred chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 232 l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
....++..+++||.+||..||.+|||+.++|+||||+..
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 335678999999999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=371.78 Aligned_cols=254 Identities=19% Similarity=0.276 Sum_probs=212.3
Q ss_pred chhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCC
Q 008116 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (577)
Q Consensus 6 ~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~ 84 (577)
+......++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+ +||||+++++++....
T Consensus 3 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 3 GQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp ---CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 3455678999999999999999999999999999999999865432 24578899999999 8999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC-----eeecccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD-----VKVADFGVS 158 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~-----vKL~DFGls 158 (577)
..|+||||+ +++|.+++... .++++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 99999999764 46999999999999999999999999999999999999987765 999999999
Q ss_pred cccccccc-------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee---eccCC--
Q 008116 159 AQLTRTIS-------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---FIIPR-- 226 (577)
Q Consensus 159 ~~~~~~~~-------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~---~~i~~-- 226 (577)
........ .....+||+.|+|||++.+.. ++.++|||||||+||+|++|..||......... ..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 87654322 123567999999999997754 899999999999999999999999875432211 11110
Q ss_pred --CCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 227 --ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 227 --~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
...+.+...++..+.+||..||..+|.+||++.+|++.
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11112233678999999999999999999999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=382.95 Aligned_cols=248 Identities=22% Similarity=0.322 Sum_probs=209.2
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~L 88 (577)
.++++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.++++| +||||+++++++......||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 457899999999999999999999999999999999875542 24578999999999 99999999999999999999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC-----eeecccccccccc
Q 008116 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD-----VKVADFGVSAQLT 162 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~-----vKL~DFGls~~~~ 162 (577)
||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||++..+.
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999 9999999976 478999999999999999999999999999999999999998887 9999999998764
Q ss_pred ccccc-------cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee---eccCCC---CC
Q 008116 163 RTISR-------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---FIIPRE---NP 229 (577)
Q Consensus 163 ~~~~~-------~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~---~~i~~~---~~ 229 (577)
..... ....+||+.|+|||++.+.. ++.++|||||||+||+|++|..||......... ..+... .+
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 43221 24578999999999998754 899999999999999999999999876543221 111100 01
Q ss_pred -CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 230 -PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 230 -~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
..+...++ .+.+||..||..+|.+||++.+|++
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 01112345 8999999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=393.18 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=193.2
Q ss_pred hcCCCeeEE-eEEeecCceEEEEEEEc--CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe--CC
Q 008116 10 AAGSRFSSL-ELIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QT 84 (577)
Q Consensus 10 ~~~~~f~il-~~IG~GsfG~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~--~~ 84 (577)
.+.+.|++. ++||+|+||.||+|.+. .+++.||||++...... ..+.+|+.+|++|+|||||+++++|.. ..
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 344567774 47999999999999966 56889999999755432 467899999999999999999999965 67
Q ss_pred EEEEEEeccCCCCHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE----ccCCCee
Q 008116 85 KLWIIMEYMAGGSVADLIQS---------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL----TENGDVK 151 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~---------~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl----d~~g~vK 151 (577)
.+||||||+. ++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+|
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 8999999996 588888752 1259999999999999999999999999999999999999 6778999
Q ss_pred eccccccccccccc---cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc---------
Q 008116 152 VADFGVSAQLTRTI---SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR--------- 219 (577)
Q Consensus 152 L~DFGls~~~~~~~---~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~--------- 219 (577)
|+|||++..+.... ......+||+.|+|||++.+...|+.++||||||||||+|++|.+||.......
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99999998765322 223457899999999999876668999999999999999999999997543310
Q ss_pred eeecc---CCCCCCC---------------------------c-------hhhhhHHHHHHHHHhcccCCCCCCcHHHHh
Q 008116 220 VLFII---PRENPPQ---------------------------L-------DEHFSRLMKEFVSLCLKKVPAERPSAKELL 262 (577)
Q Consensus 220 ~~~~i---~~~~~~~---------------------------l-------~~~~s~~l~~lI~~cL~~dP~~RpTa~elL 262 (577)
.+..+ ....+.. + ....+..+.+||.+||..||.+|||+.++|
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000 0000000 0 001167789999999999999999999999
Q ss_pred hcHhhhhc
Q 008116 263 RHRFIRNA 270 (577)
Q Consensus 263 ~hpff~~~ 270 (577)
+||||...
T Consensus 333 ~hp~f~~~ 340 (405)
T 3rgf_A 333 QDPYFLED 340 (405)
T ss_dssp TSGGGTSS
T ss_pred cChhhccC
Confidence 99999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=392.28 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=206.9
Q ss_pred CCCeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~---~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
..+|++.+.||+|+||.||+|.+. .++..||||+++..........+.+|+.+|++++||||+++++++.....+||
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 458999999999999999999886 46778999999876666667889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 99999999999999764 47999999999999999999999999999999999999999999999999999876543222
Q ss_pred c---ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHH
Q 008116 168 R---KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (577)
Q Consensus 168 ~---~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~l 243 (577)
. ....+++.|+|||++.+.. ++.++|||||||+||||++ |..||...........+........+..++..+.+|
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 282 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL 282 (373)
T ss_dssp ----------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHH
T ss_pred ceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHH
Confidence 1 1234578899999998754 8999999999999999998 999998887766555554444344455778999999
Q ss_pred HHHhcccCCCCCCcHHHHhh
Q 008116 244 VSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~ 263 (577)
|..||..+|.+||++.+|++
T Consensus 283 i~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 283 MLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=374.03 Aligned_cols=259 Identities=32% Similarity=0.571 Sum_probs=198.8
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHH-HHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIED-IQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~-i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
..++|++++.||+|+||.||+|.+..+++.||||++........... +..+..+++.++||||+++++++...+.+|||
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 34689999999999999999999999999999999987665444334 44555678888999999999999999999999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~-gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
|||+ ++.+..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....... .
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 180 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-A 180 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-c
Confidence 9999 5666666643 57899999999999999999999995 99999999999999999999999999987664432 2
Q ss_pred cccccCCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccCCCCCCCch--hhhhHHH
Q 008116 168 RKTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLD--EHFSRLM 240 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~-~~~~~~i~~~~~~~l~--~~~s~~l 240 (577)
.....||+.|+|||++.. ...++.++|||||||+||+|++|..||..... ......+....++.++ ..++..+
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDF 260 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHH
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHH
Confidence 335679999999999852 33478899999999999999999999986432 2223333222332222 3578999
Q ss_pred HHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 241 ~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.+||.+||..||.+||++.+||+||||+...
T Consensus 261 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 261 QSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 9999999999999999999999999998653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=366.64 Aligned_cols=249 Identities=27% Similarity=0.528 Sum_probs=203.1
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC---hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES---EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~---~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
...++|++.+.||+|+||.||+|.+. +..||||++..... ....+.+.+|+.+++.++||||+++++++..++.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 34679999999999999999999985 88999999865432 22357789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcc--------CCCeeeccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG---KIHRDIKAANILLTE--------NGDVKVADF 155 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~g---IiHrDIKPeNILld~--------~g~vKL~DF 155 (577)
|+||||+++++|.+++.. .++++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999999864 68999999999999999999999999 899999999999986 678999999
Q ss_pred cccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-CCCCCCchh
Q 008116 156 GVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDE 234 (577)
Q Consensus 156 Gls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-~~~~~~l~~ 234 (577)
|++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+. .......+.
T Consensus 161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (271)
T 3dtc_A 161 GLAREWHRTT--KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCT
T ss_pred Cccccccccc--ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCc
Confidence 9997664432 2356899999999999875 48999999999999999999999998876554443332 223344566
Q ss_pred hhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 235 ~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.++..+.+||.+||..+|.+|||+.+++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 788999999999999999999999999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=380.03 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=212.6
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEE----EEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDV----AIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~V----AIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
....+|+++++||+|+||.||+|.+..++..| |+|.+...........+.+|+.++++++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 44689999999999999999999998887755 6676654444445678999999999999999999999998765
Q ss_pred EEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
.++|+||+.+|+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 8899999999999999975 467999999999999999999999999999999999999999999999999999876433
Q ss_pred ccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHH
Q 008116 165 ISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (577)
Q Consensus 165 ~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~ 241 (577)
... .....||+.|+|||++.+. .++.++|||||||+||+|++ |.+||...........+........+..++..+.
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 249 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 249 (327)
T ss_dssp ---------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHH
T ss_pred cccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 222 2234578899999999876 48999999999999999999 9999998877766666666665566677899999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhc
Q 008116 242 EFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+||.+||..+|.+||++.+|++.
T Consensus 250 ~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 250 MIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=364.56 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=217.2
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..+|++++.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.++++++||||+++++++...+.+|+|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 468999999999999999999987 5788999999765432 3678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-cccc
Q 008116 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRRK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~-~~~~ 169 (577)
|+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99999999999764 569999999999999999999999999999999999999999999999999987654321 1122
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
...|++.|+|||++.+.. ++.++||||||+++|+|++ |.+||...........+........+..++..+.+||.+||
T Consensus 164 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l 242 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 242 (267)
T ss_dssp STTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHc
Confidence 456788999999997654 8999999999999999999 99999887766666556555555556678899999999999
Q ss_pred ccCCCCCCcHHHHhhc
Q 008116 249 KKVPAERPSAKELLRH 264 (577)
Q Consensus 249 ~~dP~~RpTa~elL~h 264 (577)
..+|.+||++.+++++
T Consensus 243 ~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 243 RERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=370.30 Aligned_cols=257 Identities=30% Similarity=0.527 Sum_probs=204.1
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~ 84 (577)
+.....++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++...+
T Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 26 MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105 (310)
T ss_dssp GTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 33445678999999999999999999999999999999997533 3445678899999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
.+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999999863 56799999999999999999999999999999999999999999999999999877
Q ss_pred ccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--ceeeccCCCC-CCCchhhhh
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM--RVLFIIPREN-PPQLDEHFS 237 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~--~~~~~i~~~~-~~~l~~~~s 237 (577)
............|++.|+|||++.+. .++.++||||||+++|+|++|..||...... .....+.... ++.....++
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264 (310)
T ss_dssp -------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSC
T ss_pred ecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccC
Confidence 65544344456899999999999765 4899999999999999999999999754321 1222222222 222335688
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
..+.+||.+||..||.+|||+.+|+++
T Consensus 265 ~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 265 EELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=373.65 Aligned_cols=258 Identities=26% Similarity=0.493 Sum_probs=211.0
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCC--CCceeEeEEEEEeCCEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR--SPYITEYYGSYLHQTKL 86 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~--HpnIV~l~~~~~~~~~~ 86 (577)
..+.+|++++.||+|+||.||+|.+.. ++.||||++.... .......+.+|+.+++++. ||||+++++++.....+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 345789999999999999999999864 8899999997654 3455688999999999996 59999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
||||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++........
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC------
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccc
Confidence 99999 55889999998888999999999999999999999999999999999999996 48999999999987643322
Q ss_pred --ccccccCCCCCCChhhhhcc----------cCCccccchhhHHHHHHHHHhCCCCCCCCCcc-ceee-ccCCCCCCCc
Q 008116 167 --RRKTFVGTPFWMAPEVIQNS----------EGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLF-IIPRENPPQL 232 (577)
Q Consensus 167 --~~~~~~GTp~Y~APEvl~~~----------~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~-~~~~-~i~~~~~~~l 232 (577)
.....+||+.|+|||++.+. ..++.++|||||||+||+|++|..||...... .... .+.......+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC
Confidence 12345799999999998651 34788999999999999999999999765332 1111 1122222334
Q ss_pred hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 233 ~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
+...+..+.+||.+||..||.+||++.+||+||||+..
T Consensus 262 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 45567899999999999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=374.16 Aligned_cols=254 Identities=21% Similarity=0.383 Sum_probs=210.4
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ- 83 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~- 83 (577)
......|++++.||+|+||.||+|. +..+++.||||++...........+.+|+.+|++++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 3345679999999999999999998 56789999999997665555568899999999999999999999999876
Q ss_pred -CEEEEEEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 84 -TKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 84 -~~~~LV~Ey~~gGsL~~~l~-~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
..+|+||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 67899999999999999994 4567999999999999999999999999999999999999999999999999999876
Q ss_pred ccccc---ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCC---------------ccceeec
Q 008116 162 TRTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH---------------PMRVLFI 223 (577)
Q Consensus 162 ~~~~~---~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~---------------~~~~~~~ 223 (577)
..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..|+.... .......
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 54322 223457889999999998764 8899999999999999999999864321 0111122
Q ss_pred cCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 224 i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
+........+..++..+.+||.+||..||.+|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2233344456678899999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=376.16 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=216.0
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEe
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH 82 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~ 82 (577)
....++|++.+.||+|+||.||+|.+ ..+++.||||++...........+.+|+.+++++ +||||+++++++..
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 34567999999999999999999985 4567899999998776666677899999999999 79999999999877
Q ss_pred CC-EEEEEEeccCCCCHHHHHHcCCC----------------CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc
Q 008116 83 QT-KLWIIMEYMAGGSVADLIQSGPP----------------LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT 145 (577)
Q Consensus 83 ~~-~~~LV~Ey~~gGsL~~~l~~~~~----------------l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld 145 (577)
.+ .+|+|||||++++|.+++..... +++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 54 59999999999999999976543 89999999999999999999999999999999999999
Q ss_pred cCCCeeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCcccee-
Q 008116 146 ENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL- 221 (577)
Q Consensus 146 ~~g~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~- 221 (577)
.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.........
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 999999999999976643322 123457899999999997754 8999999999999999998 99999876543322
Q ss_pred eccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 222 ~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
..+........+..++..+.+||..||..+|.+|||+.+|++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222233344456678999999999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=367.92 Aligned_cols=251 Identities=24% Similarity=0.403 Sum_probs=214.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE-EE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL-WI 88 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~---~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~-~L 88 (577)
-.|++.++||+|+||.||+|.+..++. .||||.+.........+.+.+|+.++++++||||+++++++...+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 356777999999999999999765544 79999998766666778899999999999999999999999876655 99
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc--
Q 008116 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-- 165 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~-- 165 (577)
||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 9999999999999976 4678999999999999999999999999999999999999999999999999997654321
Q ss_pred --cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHH
Q 008116 166 --SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (577)
Q Consensus 166 --~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~ 242 (577)
.......||+.|+|||++.+.. ++.++|||||||++|+|++ |.+||...+.......+........+..++..+.+
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 259 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ 259 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHH
Confidence 1223457889999999997754 8999999999999999999 55566666666655555555555666778899999
Q ss_pred HHHHhcccCCCCCCcHHHHhhc
Q 008116 243 FVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~h 264 (577)
||..||..+|.+|||+.++++.
T Consensus 260 li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 260 VMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999973
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=379.94 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=208.0
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-----HHHHHHHHHHHHHHhC----CCCceeEeEE
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-----DEIEDIQKEISVLSQC----RSPYITEYYG 78 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-----~~~~~i~~Ev~iL~~L----~HpnIV~l~~ 78 (577)
.....++|++.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++++ .||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 355678999999999999999999999999999999999655421 1234456799999998 8999999999
Q ss_pred EEEeCCEEEEEEec-cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc-cCCCeeecccc
Q 008116 79 SYLHQTKLWIIMEY-MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT-ENGDVKVADFG 156 (577)
Q Consensus 79 ~~~~~~~~~LV~Ey-~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld-~~g~vKL~DFG 156 (577)
++...+..++|||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999999999999 78999999998878899999999999999999999999999999999999999 78999999999
Q ss_pred ccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhh
Q 008116 157 VSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF 236 (577)
Q Consensus 157 ls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~ 236 (577)
++...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||...... .. ....++..+
T Consensus 186 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~-----~~~~~~~~~ 256 (312)
T 2iwi_A 186 SGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--LE-----AELHFPAHV 256 (312)
T ss_dssp SCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--HH-----TCCCCCTTS
T ss_pred hhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH--hh-----hccCCcccC
Confidence 98776543 2345679999999999987654566899999999999999999999754221 10 112334567
Q ss_pred hHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 237 s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
+..+.+||.+||..+|.+|||+.++|+||||+...
T Consensus 257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 88999999999999999999999999999998653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=369.23 Aligned_cols=254 Identities=22% Similarity=0.384 Sum_probs=214.9
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcC---CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKE---LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~---tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
....++|++.+.||+|+||.||+|.+.. ++..||||++.........+.+.+|+.++++++||||+++++++.. +.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 3456799999999999999999998653 3456999999877666677889999999999999999999999865 45
Q ss_pred EEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
.|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 6899999999999999965 356999999999999999999999999999999999999999999999999999766443
Q ss_pred cc-ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHH
Q 008116 165 IS-RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (577)
Q Consensus 165 ~~-~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~ 242 (577)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++ |..||...........+........+..++..+.+
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 245 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT 245 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred cccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 21 12345678899999999765 48999999999999999998 99999877666555555444444556678899999
Q ss_pred HHHHhcccCCCCCCcHHHHhhc
Q 008116 243 FVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~h 264 (577)
||.+||..+|.+||++.+|+++
T Consensus 246 li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 246 LMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=372.74 Aligned_cols=249 Identities=24% Similarity=0.427 Sum_probs=209.1
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCC-------cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELN-------KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL 81 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg-------~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~ 81 (577)
....++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 345679999999999999999999998777 479999986543 334578999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC--------eee
Q 008116 82 HQTKLWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD--------VKV 152 (577)
Q Consensus 82 ~~~~~~LV~Ey~~gGsL~~~l~~~~~-l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~--------vKL 152 (577)
..+..|||||||++|+|.+++..... +++..++.++.||+.||.|||++||+||||||+||||+.++. +||
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999999999976544 999999999999999999999999999999999999998887 999
Q ss_pred ccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhC-CCCCCCCCccceeeccCCCCCCC
Q 008116 153 ADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPPQ 231 (577)
Q Consensus 153 ~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG-~~Pf~~~~~~~~~~~i~~~~~~~ 231 (577)
+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++| .+||............. ....
T Consensus 163 ~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~--~~~~ 236 (289)
T 4fvq_A 163 SDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE--DRHQ 236 (289)
T ss_dssp CCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--TTCC
T ss_pred ccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh--ccCC
Confidence 999998655332 2456899999999998755689999999999999999995 55555544332222221 1223
Q ss_pred chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 232 l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
++..++..+.+||.+||..||.+|||+.++++|
T Consensus 237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 334456789999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=370.48 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=215.4
Q ss_pred CCCeeEEe-EEeecCceEEEEEEE--cCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 12 GSRFSSLE-LIGRGSFGDVYKAFD--KELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 12 ~~~f~il~-~IG~GsfG~Vy~a~~--~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
..+|++.+ .||+|+||.||+|.+ ..+++.||||++..... ....+.+.+|+.++++++||||+++++++ ..+.+|
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46899999 999999999999954 56788999999975542 33467899999999999999999999998 667889
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999998766433221
Q ss_pred ---cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHH
Q 008116 168 ---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (577)
Q Consensus 168 ---~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~l 243 (577)
.....|++.|+|||++.+.. ++.++||||||+++|+|++ |..||...........+.....+.++..++..+.+|
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 252 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 12345678999999997654 8899999999999999999 999999887766666665555566677889999999
Q ss_pred HHHhcccCCCCCCcHHHHhhc
Q 008116 244 VSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~h 264 (577)
|.+||..||.+||++.+|++.
T Consensus 253 i~~~l~~dp~~Rps~~~l~~~ 273 (291)
T 1xbb_A 253 MNLCWTYDVENRPGFAAVELR 273 (291)
T ss_dssp HHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=377.76 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=213.4
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCC----cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELN----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg----~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
....+|++.+.||+|+||.||+|.+..++ ..||||++...........+.+|+.++++++||||+++++++...+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 34578999999999999999999887553 46999999876666666789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
+||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999999754 67999999999999999999999999999999999999999999999999999876543
Q ss_pred cccc---ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHH
Q 008116 165 ISRR---KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240 (577)
Q Consensus 165 ~~~~---~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l 240 (577)
.... ....+|+.|+|||++.+. .++.++|||||||+||+|++ |..||...........+........+..++..+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l 279 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 279 (333)
T ss_dssp ----------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred cccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHH
Confidence 2211 123568899999999765 48999999999999999998 999998877766665555554445566788999
Q ss_pred HHHHHHhcccCCCCCCcHHHHhhc
Q 008116 241 KEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 241 ~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.+||.+||..+|.+||++.+|+++
T Consensus 280 ~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 280 YQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=368.54 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=214.7
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEE-eCCEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL-HQTKL 86 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~-~~~~~ 86 (577)
...+|++.++||+|+||.||+|.+..+ ...||||.+.........+.+.+|+.++++++||||+++++++. .++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 346899999999999999999987543 34689999987666667788999999999999999999999864 45688
Q ss_pred EEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 999999999999999975 4568999999999999999999999999999999999999999999999999997664322
Q ss_pred c----ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHH
Q 008116 166 S----RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240 (577)
Q Consensus 166 ~----~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l 240 (577)
. ......||+.|+|||++.+.. ++.++||||||+++|+|++ |.+||...+.......+........+..++..+
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 261 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 261 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHH
T ss_pred hhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHH
Confidence 1 123456788999999997764 8999999999999999999 777887776666555555555555667788999
Q ss_pred HHHHHHhcccCCCCCCcHHHHhhc
Q 008116 241 KEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 241 ~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.+||.+||..+|.+|||+.+|++.
T Consensus 262 ~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 262 YEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999973
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=379.29 Aligned_cols=256 Identities=28% Similarity=0.420 Sum_probs=210.1
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
....++|++.+.||+|+||.||+|.+. +++.||||++...........+.+|+.+++++.||||+++++++......+|
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 456789999999999999999999754 5899999999765543334468999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEccCCCeeeccccccccc
Q 008116 89 IMEYMAGGSVADLIQSG----PPLDEMSIACILRDLLHAIEYLHNE---GKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~----~~l~e~~i~~il~QLl~aL~yLHs~---gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
|||||.+|+|.+++... .++++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 99999999999999764 3499999999999999999999999 9999999999999999999999999999866
Q ss_pred cccccc-cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCC-----Ccc------------ceeec
Q 008116 162 TRTISR-RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL-----HPM------------RVLFI 223 (577)
Q Consensus 162 ~~~~~~-~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~-----~~~------------~~~~~ 223 (577)
...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||... ... .....
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred CcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence 433222 23456999999999997764 899999999999999999999999521 000 00000
Q ss_pred -cCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHh
Q 008116 224 -IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266 (577)
Q Consensus 224 -i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpf 266 (577)
.............+..+.+||..||..+|.+|||+.+|++|..
T Consensus 264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 1111122344566788999999999999999999999998743
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=363.34 Aligned_cols=248 Identities=19% Similarity=0.363 Sum_probs=212.7
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC--CEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKL 86 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~--~~~ 86 (577)
...++|++++.||+|+||.||+|.+. +..||||++.... .....+.+.+|+.++++++||||+++++++... ..+
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 34578999999999999999999986 8899999997654 345567899999999999999999999999887 788
Q ss_pred EEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEccCCCeeecccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~g--IiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999999998754 5899999999999999999999999 9999999999999999999999998865432
Q ss_pred ccccccccccCCCCCCChhhhhcccC--CccccchhhHHHHHHHHHhCCCCCCCCCccceeecc-CCCCCCCchhhhhHH
Q 008116 163 RTISRRKTFVGTPFWMAPEVIQNSEG--YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-PRENPPQLDEHFSRL 239 (577)
Q Consensus 163 ~~~~~~~~~~GTp~Y~APEvl~~~~~--~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i-~~~~~~~l~~~~s~~ 239 (577)
. ...+||+.|+|||++.+... ++.++|||||||++|+|++|..||...........+ .....+.++..++..
T Consensus 165 ~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 165 S-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp C-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred c-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2 24578999999999976431 333799999999999999999999887665443332 233445566778999
Q ss_pred HHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 240 MKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 240 l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+.+||.+||..||.+|||+.++++.
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999963
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=366.91 Aligned_cols=253 Identities=28% Similarity=0.479 Sum_probs=212.7
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHH------HHHHHHHHHHHHhCCCCceeEeEEEE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE------IEDIQKEISVLSQCRSPYITEYYGSY 80 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~------~~~i~~Ev~iL~~L~HpnIV~l~~~~ 80 (577)
+.....++|++.+.||+|+||.||+|.+..+++.||||++........ .+.+.+|+.++++++||||+++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 445667899999999999999999999999999999999865442211 26789999999999999999999998
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEccCCC-----eee
Q 008116 81 LHQTKLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGD-----VKV 152 (577)
Q Consensus 81 ~~~~~~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~g--IiHrDIKPeNILld~~g~-----vKL 152 (577)
.+.. ++||||+++|+|.+++... .++++..++.++.||+.||.|||++| |+||||||+||||+.++. +||
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7655 7999999999999888653 57999999999999999999999999 999999999999988776 999
Q ss_pred ccccccccccccccccccccCCCCCCChhhhhc-ccCCccccchhhHHHHHHHHHhCCCCCCCCCccce--eec-cCCCC
Q 008116 153 ADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN-SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV--LFI-IPREN 228 (577)
Q Consensus 153 ~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~-~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~--~~~-i~~~~ 228 (577)
+|||++..... ......||+.|+|||++.. ...++.++|||||||++|+|++|..||........ ... .....
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 99999875443 2335689999999999842 23478899999999999999999999987654332 111 12233
Q ss_pred CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 229 ~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.+.++..++..+.+||.+||..||.+|||+.+|++.
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 445667889999999999999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=372.28 Aligned_cols=253 Identities=23% Similarity=0.397 Sum_probs=208.4
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcC---CCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC--
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKE---LNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-- 84 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~---tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~-- 84 (577)
..++|++.+.||+|+||.||+|.+.. ++..||||++.... .......+.+|+.++++++||||+++++++....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 35789999999999999999998765 55689999997654 3445678999999999999999999999998755
Q ss_pred ---EEEEEEeccCCCCHHHHHH------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccc
Q 008116 85 ---KLWIIMEYMAGGSVADLIQ------SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADF 155 (577)
Q Consensus 85 ---~~~LV~Ey~~gGsL~~~l~------~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DF 155 (577)
..|+||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 3599999999999999984 3467999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCc
Q 008116 156 GVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQL 232 (577)
Q Consensus 156 Gls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l 232 (577)
|++........ ......+++.|+|||++.+. .++.++|||||||+||+|++ |.+||...........+.....+..
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 270 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ 270 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred CcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCC
Confidence 99876643321 12235678899999999775 48999999999999999999 9999988877666666655555666
Q ss_pred hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 233 ~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+..++..+.+||.+||..+|.+|||+.+|+++
T Consensus 271 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 271 PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77889999999999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=372.62 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=205.7
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
....++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++..++.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 344579999999999999999999999999999999997553 233457889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~- 165 (577)
|+||||+++++|.+++....++++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999987664432
Q ss_pred cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCchhhhhHHHHHH
Q 008116 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSRLMKEF 243 (577)
Q Consensus 166 ~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~--~~~l~~~~s~~l~~l 243 (577)
.......||+.|+|||++.+. .++.++||||||+++|+|++|..||...........+.... +...+..++..+.+|
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred ccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 222356799999999999765 48899999999999999999999998765432222222222 123345678899999
Q ss_pred HHHhcccCCCCCC-cHHHHhh
Q 008116 244 VSLCLKKVPAERP-SAKELLR 263 (577)
Q Consensus 244 I~~cL~~dP~~Rp-Ta~elL~ 263 (577)
|.+||..||.+|| ++.++++
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999 8888875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=379.19 Aligned_cols=254 Identities=23% Similarity=0.372 Sum_probs=208.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----------CCceeEeEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----------SPYITEYYGS 79 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-----------HpnIV~l~~~ 79 (577)
..++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++++. ||||++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 357999999999999999999999999999999998643 334567889999999886 8999999999
Q ss_pred EEeCC----EEEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcc------
Q 008116 80 YLHQT----KLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTE------ 146 (577)
Q Consensus 80 ~~~~~----~~~LV~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~-gIiHrDIKPeNILld~------ 146 (577)
+...+ .+++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||||+.
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 98754 789999999 8999999975 35699999999999999999999998 9999999999999953
Q ss_pred CCCeeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee-----
Q 008116 147 NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL----- 221 (577)
Q Consensus 147 ~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~----- 221 (577)
.+.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||+||+|++|..||.........
T Consensus 174 ~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 347999999999766432 33568999999999998764 899999999999999999999999754421100
Q ss_pred --------------------------------eccCCCC----------CCCchhhhhHHHHHHHHHhcccCCCCCCcHH
Q 008116 222 --------------------------------FIIPREN----------PPQLDEHFSRLMKEFVSLCLKKVPAERPSAK 259 (577)
Q Consensus 222 --------------------------------~~i~~~~----------~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~ 259 (577)
..+.... ...++..++..+.+||.+||..||.+|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 0000000 1123356778999999999999999999999
Q ss_pred HHhhcHhhhhcc
Q 008116 260 ELLRHRFIRNAR 271 (577)
Q Consensus 260 elL~hpff~~~~ 271 (577)
+||+||||+...
T Consensus 330 ell~hp~f~~~~ 341 (373)
T 1q8y_A 330 GLVNHPWLKDTL 341 (373)
T ss_dssp HHHTCGGGTTCT
T ss_pred HHhhChhhhccc
Confidence 999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=391.42 Aligned_cols=256 Identities=21% Similarity=0.360 Sum_probs=213.5
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC--E
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT--K 85 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~--~ 85 (577)
+....++|++.++||+|+||.||+|.+..+++.||||++...........+.+|+.+|++++||||+++++++.... .
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 44567899999999999999999999999999999999976554445677889999999999999999999998765 7
Q ss_pred EEEEEeccCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE----ccCCCeeecccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL----TENGDVKVADFGVS 158 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~---~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl----d~~g~vKL~DFGls 158 (577)
+|||||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||| +..+.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999996532 39999999999999999999999999999999999999 67778999999999
Q ss_pred ccccccccccccccCCCCCCChhhhhcc-------cCCccccchhhHHHHHHHHHhCCCCCCCCCcc----ceeeccCCC
Q 008116 159 AQLTRTISRRKTFVGTPFWMAPEVIQNS-------EGYNEKADIWSLGITVIEMAKGEPPLADLHPM----RVLFIIPRE 227 (577)
Q Consensus 159 ~~~~~~~~~~~~~~GTp~Y~APEvl~~~-------~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~----~~~~~i~~~ 227 (577)
...... ......+||+.|+|||++... ..++.++|||||||++|+|++|..||...... .....+...
T Consensus 164 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 164 RELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp EECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred eEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 876543 233456899999999998641 34788999999999999999999999643321 111111111
Q ss_pred ------------------------CCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 228 ------------------------NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 228 ------------------------~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
....+...++..+.+||.+||..||.+||++.+++++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 1123346778899999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=377.17 Aligned_cols=253 Identities=27% Similarity=0.400 Sum_probs=213.5
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
...++|++.+.||+|+||.||+|.+. ++..||||++.... ....+.+.+|+.++++++||||+++++++...+.+|+|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 35689999999999999999999965 68999999986553 33467899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSG----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~----~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
|||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999998653 258999999999999999999999999999999999999999999999999987654322
Q ss_pred c--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc----------------CCC
Q 008116 166 S--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII----------------PRE 227 (577)
Q Consensus 166 ~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i----------------~~~ 227 (577)
. ......||+.|+|||++.+.. ++.++|||||||+||+|++|..||....+......+ ...
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred ccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence 1 123456999999999997764 899999999999999999999999865543322111 111
Q ss_pred CCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcH
Q 008116 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHR 265 (577)
Q Consensus 228 ~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hp 265 (577)
....+...++..+.+||.+||..||.+|||+.+++++.
T Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 12234556788999999999999999999999999873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=366.74 Aligned_cols=251 Identities=25% Similarity=0.477 Sum_probs=202.3
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHh--CCCCceeEeEEEEEe--
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ--CRSPYITEYYGSYLH-- 82 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~--L~HpnIV~l~~~~~~-- 82 (577)
+.....++|++++.||+|+||+||+|.+ +++.||||++... ....+.+|.+++.. ++||||+++++++..
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 4566789999999999999999999987 5899999998643 23555667777766 799999999998765
Q ss_pred --CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCcccccccceEEEccCCCeee
Q 008116 83 --QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH--------NEGKIHRDIKAANILLTENGDVKV 152 (577)
Q Consensus 83 --~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLH--------s~gIiHrDIKPeNILld~~g~vKL 152 (577)
...+||||||+++|+|.++++. ..+++..++.++.||+.||.||| +++|+||||||+||||+.++.+||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3468999999999999999965 67999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccccccc----cccccCCCCCCChhhhhccc-----CCccccchhhHHHHHHHHHhC----------CCCCC
Q 008116 153 ADFGVSAQLTRTISR----RKTFVGTPFWMAPEVIQNSE-----GYNEKADIWSLGITVIEMAKG----------EPPLA 213 (577)
Q Consensus 153 ~DFGls~~~~~~~~~----~~~~~GTp~Y~APEvl~~~~-----~~~~ksDVwSLGviLyeLltG----------~~Pf~ 213 (577)
+|||++......... ....+||+.|+|||++.+.. .++.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999998765443222 23458999999999997652 245789999999999999999 88886
Q ss_pred CCCcccee----ec-c-CCCCCCC-----chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 214 DLHPMRVL----FI-I-PRENPPQ-----LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 214 ~~~~~~~~----~~-i-~~~~~~~-----l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
........ .. + .....+. ....++..+.+||.+||..||.+|||+.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 64332211 00 1 1111112 233567889999999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=367.75 Aligned_cols=252 Identities=27% Similarity=0.488 Sum_probs=214.0
Q ss_pred chhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe---
Q 008116 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--- 82 (577)
Q Consensus 6 ~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~--- 82 (577)
.+......+|++++.||+|+||.||+|.+..+++.||||++.... ..+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp CCCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 356677889999999999999999999999999999999997553 356789999999999999999998865
Q ss_pred -------------CCEEEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC
Q 008116 83 -------------QTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (577)
Q Consensus 83 -------------~~~~~LV~Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~ 147 (577)
...+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 4568999999999999999964 3679999999999999999999999999999999999999999
Q ss_pred CCeeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC
Q 008116 148 GDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE 227 (577)
Q Consensus 148 g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~ 227 (577)
+.+||+|||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ....+..
T Consensus 159 ~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~~~~~- 233 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKND-GKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETSK--FFTDLRD- 233 (284)
T ss_dssp TEEEECCCTTCEESSCC-SCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--HHHHHHT-
T ss_pred CCEEECcchhheecccc-ccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHHH--HHHHhhc-
Confidence 99999999998776543 223456799999999999875 489999999999999999999998753211 1111111
Q ss_pred CCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 228 ~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
..++..++..+++||.+||..||.+|||+.++++|.+...
T Consensus 234 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 --GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1223457788999999999999999999999999976643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=375.79 Aligned_cols=254 Identities=22% Similarity=0.391 Sum_probs=215.6
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCc-----EEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeC
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNK-----DVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ 83 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~-----~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~ 83 (577)
...++|++.+.||+|+||.||+|.+..++. .||||.+.........+.+.+|+.+|+++ +||||+++++++...
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 446789999999999999999999977664 79999998776666778899999999999 899999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC
Q 008116 84 TKLWIIMEYMAGGSVADLIQS--------------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD 149 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~--------------~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~ 149 (577)
+.+|||||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence 999999999999999999964 346899999999999999999999999999999999999999999
Q ss_pred eeeccccccccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeecc-C
Q 008116 150 VKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFII-P 225 (577)
Q Consensus 150 vKL~DFGls~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i-~ 225 (577)
+||+|||++......... .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||...........+ .
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 281 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence 999999999866433221 22356788999999998754 8999999999999999998 99999876543332222 1
Q ss_pred CCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 226 ~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.......+..++..+.+||..||..+|.+|||+.+|+++
T Consensus 282 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 282 DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 222333445678899999999999999999999999974
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=375.68 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=203.1
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC----EEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----KLW 87 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~----~~~ 87 (577)
..+|+++++||+|+||.||+|.+. ++.||||++.... .......+|+.+|++++|||||++++++.... .+|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 468999999999999999999876 7999999986543 23355667999999999999999999998743 579
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc----------CCcccccccceEEEccCCCeeeccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE----------GKIHRDIKAANILLTENGDVKVADFGV 157 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~----------gIiHrDIKPeNILld~~g~vKL~DFGl 157 (577)
||||||++|+|.++++. ..+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 99 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 99999999999999977 5699999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccc--ccccccCCCCCCChhhhhcc----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceee---------
Q 008116 158 SAQLTRTIS--RRKTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--------- 222 (577)
Q Consensus 158 s~~~~~~~~--~~~~~~GTp~Y~APEvl~~~----~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~--------- 222 (577)
+..+..... .....+||+.|+|||++.+. ..++.++|||||||+||+|++|..||..........
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 976654322 22346899999999999763 236678999999999999999999997643321110
Q ss_pred -------c-cCCCCCCCch-----hhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 223 -------I-IPRENPPQLD-----EHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 223 -------~-i~~~~~~~l~-----~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
. ......+.+. ...+..+.+||.+||..||.+|||+.+|++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 0111112221 1345679999999999999999999999974
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=371.56 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=207.4
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe----CCE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QTK 85 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~----~~~ 85 (577)
...++|++++.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 4467999999999999999999999999999999998654 34456788999999999999999999999873 347
Q ss_pred EEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
+|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 8999999999999999865 578999999999999999999999999999999999999999999999999998765
Q ss_pred ccccc---------ccccccCCCCCCChhhhhccc--CCccccchhhHHHHHHHHHhCCCCCCCCCc--cceeeccCCCC
Q 008116 162 TRTIS---------RRKTFVGTPFWMAPEVIQNSE--GYNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPREN 228 (577)
Q Consensus 162 ~~~~~---------~~~~~~GTp~Y~APEvl~~~~--~~~~ksDVwSLGviLyeLltG~~Pf~~~~~--~~~~~~i~~~~ 228 (577)
..... ......||+.|+|||++.... .++.++|||||||++|+|++|..||..... ......+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 32211 112356899999999986532 267899999999999999999999954211 11111111122
Q ss_pred CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 229 ~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.......++..+.+||.+||..||.+|||+.+|+++
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 222334678999999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=390.70 Aligned_cols=243 Identities=28% Similarity=0.450 Sum_probs=213.2
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC-EEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-KLWIIM 90 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~-~~~LV~ 90 (577)
..+|++++.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|++++|||||++++++.... .+||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 468999999999999999999886 7899999997554 3467899999999999999999999987765 799999
Q ss_pred eccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 168 (577)
|||++|+|.+++...+ .+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++...... .
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 343 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---Q 343 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---c
Confidence 9999999999997643 3799999999999999999999999999999999999999999999999998754322 2
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
....+++.|+|||++.+. .++.++|||||||+||||++ |..||......+....+........+..++..+.+||.+|
T Consensus 344 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 422 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNC 422 (450)
T ss_dssp ---CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence 234678999999999875 48999999999999999998 9999998877777666666666666778899999999999
Q ss_pred cccCCCCCCcHHHHhh
Q 008116 248 LKKVPAERPSAKELLR 263 (577)
Q Consensus 248 L~~dP~~RpTa~elL~ 263 (577)
|..||.+|||+.+|++
T Consensus 423 l~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 423 WHLDAATRPTFLQLRE 438 (450)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCChhHCcCHHHHHH
Confidence 9999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=373.77 Aligned_cols=251 Identities=26% Similarity=0.457 Sum_probs=211.9
Q ss_pred CCCeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEE--eCCE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL--HQTK 85 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~--~~~~ 85 (577)
..+|++++.||+|+||.||+|. +..++..||||++... .....+.+.+|+.++++++||||+++++++. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 4799999999999999999998 5678999999999754 3445677999999999999999999999887 4567
Q ss_pred EEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
+||||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 9999999999999999975 457999999999999999999999999999999999999999999999999999866433
Q ss_pred cc---ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---------------ceeeccCC
Q 008116 165 IS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---------------RVLFIIPR 226 (577)
Q Consensus 165 ~~---~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~---------------~~~~~i~~ 226 (577)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... .....+..
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 22 123456889999999997764 899999999999999999999998643221 11112222
Q ss_pred CCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 227 ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 227 ~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
......+..++..+.+||.+||..||.+|||+.+|+++
T Consensus 260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33344556788999999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=362.24 Aligned_cols=250 Identities=24% Similarity=0.442 Sum_probs=214.3
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
....++|++++.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.+|++++||||+++++++. .+..|+
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 345679999999999999999999976 467899999865442 2467899999999999999999999886 456899
Q ss_pred EEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999999999653 2799999999999999999999999999999999999999999999999999977643321
Q ss_pred -ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHH
Q 008116 167 -RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 167 -~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI 244 (577)
......|++.|+|||++.+.. ++.++||||||+++|+|++ |..||...........+........+..++..+.+||
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 243 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHH
Confidence 122346788999999997654 8899999999999999999 9999988776665555555555555667889999999
Q ss_pred HHhcccCCCCCCcHHHHhh
Q 008116 245 SLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~ 263 (577)
.+||..+|.+|||+.+|++
T Consensus 244 ~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 244 RLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHhccChhhCCCHHHHHH
Confidence 9999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=365.12 Aligned_cols=254 Identities=28% Similarity=0.510 Sum_probs=201.0
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
..+...++|++.+.||+|+||.||+|.+.. .||||+++... .....+.+.+|+.+|++++||||+++++++ ....
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 456678899999999999999999997653 59999997655 345568899999999999999999999954 5667
Q ss_pred EEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
+++|||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 8999999999999999954 467999999999999999999999999999999999999999999999999998765432
Q ss_pred --ccccccccCCCCCCChhhhhc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc-C----CCCCCCchhh
Q 008116 165 --ISRRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-P----RENPPQLDEH 235 (577)
Q Consensus 165 --~~~~~~~~GTp~Y~APEvl~~--~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i-~----~~~~~~l~~~ 235 (577)
........||+.|+|||++.. ...++.++|||||||++|+|++|..||...........+ . ......+...
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 122234679999999999862 234788999999999999999999999876543322211 1 1122234457
Q ss_pred hhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 236 ~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
++..+.+||.+||..+|.+|||+.+|++.
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 78999999999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=363.07 Aligned_cols=245 Identities=28% Similarity=0.445 Sum_probs=206.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-CEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-TKLWII 89 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~-~~~~LV 89 (577)
..++|++++.||+|+||.||+|.+. +..||||++.... ..+.+.+|+.++++++||||+++++++... +.+|+|
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 3478999999999999999999875 8899999986543 457789999999999999999999987654 478999
Q ss_pred EeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
|||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 99999999999997643 3899999999999999999999999999999999999999999999999998765432
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....+++.|+|||++.+. .++.++||||||+++|+|++ |..||...........+........+..++..+.+||.+
T Consensus 171 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 249 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 249 (278)
T ss_dssp -----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence 2245689999999999765 48999999999999999998 999999887766666666655566677889999999999
Q ss_pred hcccCCCCCCcHHHHhhc
Q 008116 247 CLKKVPAERPSAKELLRH 264 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~h 264 (577)
||..||.+|||+.++++.
T Consensus 250 ~l~~~p~~Rps~~~l~~~ 267 (278)
T 1byg_A 250 CWHLDAAMRPSFLQLREQ 267 (278)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HhcCChhhCCCHHHHHHH
Confidence 999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=397.67 Aligned_cols=249 Identities=26% Similarity=0.468 Sum_probs=219.6
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..+|++.+.||+|+||.||+|.+..++..||||+++.... ..+.+.+|+.+|++++|||||++++++.....+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 4579999999999999999999999999999999975543 35779999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-cc
Q 008116 92 YMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (577)
Q Consensus 92 y~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~~ 168 (577)
||.+|+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++........ ..
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 9999999999975 35699999999999999999999999999999999999999999999999999987643221 12
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
....+++.|+|||++.... ++.++|||||||+||||++ |..||...+.......+........+..++..+.+||.+|
T Consensus 377 ~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 455 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 455 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 2345678899999998754 8999999999999999999 9999998877766666666555566778899999999999
Q ss_pred cccCCCCCCcHHHHhh
Q 008116 248 LKKVPAERPSAKELLR 263 (577)
Q Consensus 248 L~~dP~~RpTa~elL~ 263 (577)
|..+|.+|||+.+|++
T Consensus 456 l~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 456 WQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCcChhHCcCHHHHHH
Confidence 9999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=390.20 Aligned_cols=264 Identities=24% Similarity=0.358 Sum_probs=203.7
Q ss_pred ccccchhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEE
Q 008116 2 ADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSY 80 (577)
Q Consensus 2 ~~l~~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~ 80 (577)
..++.+.....+.|.+.++||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+|+++ +|||||++++++
T Consensus 4 ~~~p~~~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~ 78 (434)
T 2rio_A 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSE 78 (434)
T ss_dssp ----CCSCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccccchhhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEE
Confidence 4567788888899999999999999999875 44579999999986532 35678999999986 899999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHcCCCC-------CHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC------
Q 008116 81 LHQTKLWIIMEYMAGGSVADLIQSGPPL-------DEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN------ 147 (577)
Q Consensus 81 ~~~~~~~LV~Ey~~gGsL~~~l~~~~~l-------~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~------ 147 (577)
.++..+|||||||. |+|.+++...... ++..++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 79 ~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~ 157 (434)
T 2rio_A 79 TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTAD 157 (434)
T ss_dssp ECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSC
T ss_pred ecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccc
Confidence 99999999999995 6999999765433 233457899999999999999999999999999999754
Q ss_pred -------CCeeeccccccccccccccc----cccccCCCCCCChhhhhc------ccCCccccchhhHHHHHHHHHh-CC
Q 008116 148 -------GDVKVADFGVSAQLTRTISR----RKTFVGTPFWMAPEVIQN------SEGYNEKADIWSLGITVIEMAK-GE 209 (577)
Q Consensus 148 -------g~vKL~DFGls~~~~~~~~~----~~~~~GTp~Y~APEvl~~------~~~~~~ksDVwSLGviLyeLlt-G~ 209 (577)
+.+||+|||++......... ....+||+.|+|||++.+ ...++.++|||||||+||+|++ |.
T Consensus 158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~ 237 (434)
T 2rio_A 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237 (434)
T ss_dssp CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence 47999999999876543221 234689999999999965 2358899999999999999999 99
Q ss_pred CCCCCCCcccee--eccCC-CC-CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 210 PPLADLHPMRVL--FIIPR-EN-PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 210 ~Pf~~~~~~~~~--~~i~~-~~-~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.||......... ..... .. .......++..+++||.+||..||.+|||+.+||+||||+...
T Consensus 238 ~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~~ 303 (434)
T 2rio_A 238 HPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKS 303 (434)
T ss_dssp CTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCHH
T ss_pred CCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCcH
Confidence 999765432211 11100 01 1112346788999999999999999999999999999997643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=363.09 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=201.5
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEE-EeCCE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY-LHQTK 85 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~-~~~~~ 85 (577)
+...++++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.|++++..+..+ .....
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 445678999999999999999999999999999999998754432 24578899999999887766665544 67788
Q ss_pred EEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---ccCCCeeeccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL---TENGDVKVADFGVSAQL 161 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl---d~~g~vKL~DFGls~~~ 161 (577)
.+|||||+ +++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99999999 9999999974 4679999999999999999999999999999999999999 78899999999999876
Q ss_pred ccccc-------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---C----C
Q 008116 162 TRTIS-------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---R----E 227 (577)
Q Consensus 162 ~~~~~-------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~---~----~ 227 (577)
..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+. . .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 54322 123568999999999998764 8999999999999999999999998765432221111 0 0
Q ss_pred CCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 228 ~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
....+...++..+.+||..||..+|.+|||+.+|++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 011122456889999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=372.51 Aligned_cols=252 Identities=22% Similarity=0.390 Sum_probs=211.2
Q ss_pred hcCCCe-eEEeEEeecCceEEEEEEE----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe--
Q 008116 10 AAGSRF-SSLELIGRGSFGDVYKAFD----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-- 82 (577)
Q Consensus 10 ~~~~~f-~il~~IG~GsfG~Vy~a~~----~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~-- 82 (577)
.+.++| ++++.||+|+||.||++.. ..+++.||||++...........+.+|+.+|++++||||+++++++.+
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 355666 9999999999999988753 457899999999877666677889999999999999999999999988
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
...+||||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred CceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 4689999999999999999976 459999999999999999999999999999999999999999999999999998765
Q ss_pred cccc---ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---------------ceeecc
Q 008116 163 RTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---------------RVLFII 224 (577)
Q Consensus 163 ~~~~---~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~---------------~~~~~i 224 (577)
.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... .....+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 4321 123456889999999998764 889999999999999999999998653211 111122
Q ss_pred CCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 225 ~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
........+..++..+.+||..||..+|.+|||+.+|++
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 233344456678899999999999999999999999996
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=362.14 Aligned_cols=252 Identities=21% Similarity=0.324 Sum_probs=207.1
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEE-EeCCE
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY-LHQTK 85 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~-~~~~~ 85 (577)
+...++++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.+.|++++..+..+ .....
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence 3445789999999999999999999999999999999998655432 4588999999999887766555544 66788
Q ss_pred EEEEEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---ccCCCeeeccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL---TENGDVKVADFGVSAQL 161 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~-~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl---d~~g~vKL~DFGls~~~ 161 (577)
.|+||||+ +++|.+++. ...++++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99999999 999999997 35679999999999999999999999999999999999999 47889999999999876
Q ss_pred ccccc-------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee---eccCC----C
Q 008116 162 TRTIS-------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---FIIPR----E 227 (577)
Q Consensus 162 ~~~~~-------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~---~~i~~----~ 227 (577)
..... ......||+.|+|||++.+.. ++.++|||||||+||+|++|..||......... ..+.. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 54322 123568999999999998764 899999999999999999999999875432211 11110 0
Q ss_pred CCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 228 ~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
....+...++..+.+||..||..+|.+|||+.+|++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 111123457889999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=378.55 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=202.5
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcC---CCcEEEEEEeccCCChHH----------HHHHHHHHHHHHhCCCCce
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKE---LNKDVAIKVIDLEESEDE----------IEDIQKEISVLSQCRSPYI 73 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~---tg~~VAIK~i~~~~~~~~----------~~~i~~Ev~iL~~L~HpnI 73 (577)
+.+...++|++.+.||+|+||.||+|.+.. ++..||||++........ ...+.+|+.+++.+.||||
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp EECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred eccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence 344566899999999999999999999987 788999999876543211 1236678899999999999
Q ss_pred eEeEEEEEe----CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC-
Q 008116 74 TEYYGSYLH----QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG- 148 (577)
Q Consensus 74 V~l~~~~~~----~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g- 148 (577)
+++++++.. ...+||||||| +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 999999988 77899999999 999999998777899999999999999999999999999999999999999877
Q ss_pred -Ceeecccccccccccccc-------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-
Q 008116 149 -DVKVADFGVSAQLTRTIS-------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR- 219 (577)
Q Consensus 149 -~vKL~DFGls~~~~~~~~-------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~- 219 (577)
.+||+|||++..+..... .....+||+.|+|||++.+. .++.++|||||||+||+|++|..||.......
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999976643221 11356899999999999876 48999999999999999999999996432111
Q ss_pred eeecc----CCCCCCCch-----hhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 220 VLFII----PRENPPQLD-----EHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 220 ~~~~i----~~~~~~~l~-----~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
..... ....+..+. ..++..+.+||..||..+|.+||++.+|++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11110 111111111 157789999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=373.87 Aligned_cols=244 Identities=19% Similarity=0.217 Sum_probs=200.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEE-----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCceeEeEEEEEe
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAF-----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGSYLH 82 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~-----~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~---HpnIV~l~~~~~~ 82 (577)
...+|++.+.||+|+||.||+|. +..+++.||||++.... ...+.+|+.+++.+. |+||+++++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 45789999999999999999994 67789999999996543 356788888888886 8999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc-----------
Q 008116 83 QTKLWIIMEYMAGGSVADLIQS-----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE----------- 146 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~-----~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~----------- 146 (577)
.+..|||||||++|+|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999999963 567999999999999999999999999999999999999998
Q ss_pred CCCeeeccccccccccc--cccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc
Q 008116 147 NGDVKVADFGVSAQLTR--TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII 224 (577)
Q Consensus 147 ~g~vKL~DFGls~~~~~--~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i 224 (577)
++.+||+|||++..+.. ........+||+.|+|||++.+.. |+.++|||||||+||+|++|..||............
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 297 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECS
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCceeech
Confidence 89999999999976532 223344678999999999998765 899999999999999999999999654332221111
Q ss_pred CCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 225 ~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.. ... ..+..+.+|+..||..+|.+|++..+.|.+
T Consensus 298 --~~-~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 298 --LF-RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp --CC-TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred --hc-ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 11 111 236778999999999999999665554444
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=382.75 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=206.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe-CCEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTKLWI 88 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~-~~~~~L 88 (577)
..|++.++||+|+||.||+|.+..+ +..||||.++..........+.+|+.+|++++||||+++++++.. ++..|+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 3588999999999999999987543 346899998766666677889999999999999999999998754 568899
Q ss_pred EEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-
Q 008116 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~- 166 (577)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999999764 4689999999999999999999999999999999999999999999999999976543211
Q ss_pred ---ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHH
Q 008116 167 ---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (577)
Q Consensus 167 ---~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~ 242 (577)
......||+.|+|||++.+. .++.++|||||||+||+|++ |.+||...+.......+........+..++..+.+
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~ 327 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 327 (373)
T ss_dssp ---------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11234678899999999875 48999999999999999999 78889887766655555555555556678899999
Q ss_pred HHHHhcccCCCCCCcHHHHhhc
Q 008116 243 FVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 243 lI~~cL~~dP~~RpTa~elL~h 264 (577)
||.+||..+|.+|||+.+|+++
T Consensus 328 li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 328 VMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=389.60 Aligned_cols=248 Identities=24% Similarity=0.403 Sum_probs=214.3
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
...+|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|++++|||||++++++. .+.+||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 45689999999999999999999864 67899999975432 3578999999999999999999999986 66789999
Q ss_pred eccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-c
Q 008116 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~ 167 (577)
|||.+|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||++........ .
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 999999999999753 3789999999999999999999999999999999999999999999999999987643221 1
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....+++.|+|||++.... ++.++|||||||+||||++ |..||......+....+........+..++..+.+||.+
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 420 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 420 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred cCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 22345678899999997654 8999999999999999999 999999887766666555555555567789999999999
Q ss_pred hcccCCCCCCcHHHHhh
Q 008116 247 CLKKVPAERPSAKELLR 263 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~ 263 (577)
||..||.+|||+.+|+.
T Consensus 421 cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 421 CWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HccCChhHCcCHHHHHH
Confidence 99999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=366.86 Aligned_cols=251 Identities=23% Similarity=0.385 Sum_probs=189.4
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEE-------
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYL------- 81 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~------- 81 (577)
....+|++.++||+|+||.||+|.+..+++.||||++... .......+.+|+.+++++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 3456899999999999999999999999999999998544 3445677899999999995 999999999994
Q ss_pred -eCCEEEEEEeccCCCCHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEccCCCeeeccc
Q 008116 82 -HQTKLWIIMEYMAGGSVADLIQS---GPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKVADF 155 (577)
Q Consensus 82 -~~~~~~LV~Ey~~gGsL~~~l~~---~~~l~e~~i~~il~QLl~aL~yLHs~g--IiHrDIKPeNILld~~g~vKL~DF 155 (577)
....+++||||+. |+|.+++.. .+++++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 3446899999995 799988854 567999999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccc------------ccccccCCCCCCChhhhh--cccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee
Q 008116 156 GVSAQLTRTIS------------RRKTFVGTPFWMAPEVIQ--NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL 221 (577)
Q Consensus 156 Gls~~~~~~~~------------~~~~~~GTp~Y~APEvl~--~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~ 221 (577)
|++........ .....+||+.|+|||++. ....++.++|||||||+||+|++|..||.........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence 99977643221 112457999999999983 2234788999999999999999999999876544333
Q ss_pred eccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcH
Q 008116 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHR 265 (577)
Q Consensus 222 ~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hp 265 (577)
.... .......++..+.+||.+||..+|.+|||+.++++|.
T Consensus 263 ~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 263 NGKY---SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ---C---CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cCcc---cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 2221 1222344567789999999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=379.07 Aligned_cols=253 Identities=18% Similarity=0.262 Sum_probs=201.3
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeccCCChH--H--------HHHHHHHHHHHHhCCCCce
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESED--E--------IEDIQKEISVLSQCRSPYI 73 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~~~~t-----g~~VAIK~i~~~~~~~--~--------~~~i~~Ev~iL~~L~HpnI 73 (577)
+...++|++.+.||+|+||.||+|.+..+ ++.||||++....... . ...+..|+..++.+.||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 34567999999999999999999998764 5889999986554210 0 1223456667788899999
Q ss_pred eEeEEEEEeC----CEEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc--c
Q 008116 74 TEYYGSYLHQ----TKLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT--E 146 (577)
Q Consensus 74 V~l~~~~~~~----~~~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld--~ 146 (577)
+++++++... ..+||||||| +++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+ .
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 9999998774 4689999999 99999999765 6899999999999999999999999999999999999999 8
Q ss_pred CCCeeeccccccccccccccc-------cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc
Q 008116 147 NGDVKVADFGVSAQLTRTISR-------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR 219 (577)
Q Consensus 147 ~g~vKL~DFGls~~~~~~~~~-------~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~ 219 (577)
++.+||+|||++..+...... ....+||+.|+|||++.+.. ++.++|||||||+||+|++|..||.......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 899999999999766433211 13456999999999998764 8999999999999999999999998543221
Q ss_pred eeec-cCCCCCCCc---------hhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 220 VLFI-IPRENPPQL---------DEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 220 ~~~~-i~~~~~~~l---------~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
.... ........+ ...++..+.+||..||..+|.+||++.+|++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1110 000000011 1345789999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=363.74 Aligned_cols=250 Identities=27% Similarity=0.452 Sum_probs=200.0
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC--CCCceeEeEEEEEeC-
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC--RSPYITEYYGSYLHQ- 83 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L--~HpnIV~l~~~~~~~- 83 (577)
+.....++|++++.||+|+||.||+|.+. ++.||||++.... .....+|.+++..+ +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 34556679999999999999999999886 8999999985432 24445566666554 899999999999887
Q ss_pred ---CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCcccccccceEEEccCCCeee
Q 008116 84 ---TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE--------GKIHRDIKAANILLTENGDVKV 152 (577)
Q Consensus 84 ---~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~--------gIiHrDIKPeNILld~~g~vKL 152 (577)
..+|||||||++|+|.++++. ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999976 5799999999999999999999999 9999999999999999999999
Q ss_pred ccccccccccccccc----cccccCCCCCCChhhhhcccCCcc------ccchhhHHHHHHHHHhC----------CCCC
Q 008116 153 ADFGVSAQLTRTISR----RKTFVGTPFWMAPEVIQNSEGYNE------KADIWSLGITVIEMAKG----------EPPL 212 (577)
Q Consensus 153 ~DFGls~~~~~~~~~----~~~~~GTp~Y~APEvl~~~~~~~~------ksDVwSLGviLyeLltG----------~~Pf 212 (577)
+|||++..+...... ....+||+.|+|||++.+.. +.. ++|||||||+||+|++| ..||
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 999999766443222 12468999999999997654 333 38999999999999999 6677
Q ss_pred CCCCcccee-----ecc-CCCCCCCc-----hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 213 ADLHPMRVL-----FII-PRENPPQL-----DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 213 ~~~~~~~~~-----~~i-~~~~~~~l-----~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
......... ..+ .....+.+ ...++..+.+||.+||..||.+|||+.+|++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 654332111 001 11111222 23678889999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=357.71 Aligned_cols=234 Identities=26% Similarity=0.426 Sum_probs=194.0
Q ss_pred hhcCCCeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHH-HhCCCCceeEeEEEEEe----
Q 008116 9 EAAGSRFSSL-ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVL-SQCRSPYITEYYGSYLH---- 82 (577)
Q Consensus 9 ~~~~~~f~il-~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL-~~L~HpnIV~l~~~~~~---- 82 (577)
....++|.++ ++||+|+||.||+|.+..+++.||||++... ..+.+|+.++ +.+.||||+++++++..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 3455788888 7899999999999999999999999998642 4577899988 55699999999999987
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc---CCCeeeccccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGV 157 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~~--~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~---~g~vKL~DFGl 157 (577)
...+|||||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 678999999999999999997643 6999999999999999999999999999999999999998 78899999999
Q ss_pred cccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeec----cCCCCCC---
Q 008116 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI----IPRENPP--- 230 (577)
Q Consensus 158 s~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~----i~~~~~~--- 230 (577)
+..... ..++.++|||||||+||+|++|.+||........... +......
T Consensus 167 a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 167 AKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp CEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred cccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 754321 2377899999999999999999999977654332211 1111111
Q ss_pred CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 231 ~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.....++..+.+||.+||..||.+|||+.++|+||||....
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 11246789999999999999999999999999999998653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=364.40 Aligned_cols=243 Identities=30% Similarity=0.557 Sum_probs=200.7
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
-.++|++.+.||+|+||.||+|.+. ++.||||++... ...+.+.+|+.+|++++||||+++++++. +..||||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~ 78 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVM 78 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEE
Confidence 3578999999999999999999875 789999998643 24577899999999999999999999876 4479999
Q ss_pred eccCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEccCCC-eeeccccccccccc
Q 008116 91 EYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHN---EGKIHRDIKAANILLTENGD-VKVADFGVSAQLTR 163 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~---~l~e~~i~~il~QLl~aL~yLHs---~gIiHrDIKPeNILld~~g~-vKL~DFGls~~~~~ 163 (577)
||+++|+|.+++.... .+++..++.++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999999998654 47899999999999999999999 89999999999999998886 79999999876543
Q ss_pred cccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc--eeeccCCCCCCCchhhhhHHHH
Q 008116 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR--VLFIIPRENPPQLDEHFSRLMK 241 (577)
Q Consensus 164 ~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~--~~~~i~~~~~~~l~~~~s~~l~ 241 (577)
. .....||+.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+.....+.+...++..+.
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
T 2eva_A 159 H---MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234 (307)
T ss_dssp ---------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHH
T ss_pred c---cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHH
Confidence 2 2345799999999999875 48999999999999999999999998654322 2222333444555667889999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhc
Q 008116 242 EFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+||.+||..+|.+|||+.+|+++
T Consensus 235 ~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=398.05 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=212.4
Q ss_pred CCeeEEe-EEeecCceEEEEEEEc--CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 13 SRFSSLE-LIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 13 ~~f~il~-~IG~GsfG~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
.++.+.+ .||+|+||.||+|.+. .++..||||+++........+.+.+|+.+|++++|||||++++++.. +.+|||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4566666 8999999999999875 35667999999766555567889999999999999999999999876 569999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-
Q 008116 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~- 167 (577)
||||.+|+|.+++.. ...+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||++..+......
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 999999999999964 356999999999999999999999999999999999999999999999999999876433221
Q ss_pred --cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHH
Q 008116 168 --RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 168 --~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI 244 (577)
.....+++.|+|||++... .++.++|||||||+||||++ |..||...+..+....+........+..++..+.+||
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 572 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALM 572 (613)
T ss_dssp --------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 1223467899999999765 48999999999999999998 9999999887777777776666667778999999999
Q ss_pred HHhcccCCCCCCcHHHHhh
Q 008116 245 SLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~ 263 (577)
..||..+|.+||++.+|++
T Consensus 573 ~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 573 SDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHTTCSSTTTSCCHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHH
Confidence 9999999999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=357.42 Aligned_cols=243 Identities=30% Similarity=0.489 Sum_probs=204.1
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCC---ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccC
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~---~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~ 94 (577)
.+.||+|+||.||+|.+ ++..||||++.... .....+.+.+|+.++++++||||+++++++...+.+|+||||++
T Consensus 36 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 113 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113 (307)
T ss_dssp CCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred CCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecC
Confidence 38999999999999986 48899999986532 23446789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc--ccc
Q 008116 95 GGSVADLIQS---GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRK 169 (577)
Q Consensus 95 gGsL~~~l~~---~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~--~~~ 169 (577)
+++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ ...
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 193 (307)
T 2nru_A 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193 (307)
T ss_dssp TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECS
T ss_pred CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccccc
Confidence 9999999963 45799999999999999999999999999999999999999999999999999876543221 123
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC--------------CCCCCCchhh
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP--------------RENPPQLDEH 235 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~--------------~~~~~~l~~~ 235 (577)
..+||+.|+|||++.+. ++.++|||||||++|+|++|.+||...........+. .......+..
T Consensus 194 ~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (307)
T 2nru_A 194 RIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST 271 (307)
T ss_dssp SCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHH
T ss_pred ccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchH
Confidence 45799999999998753 7889999999999999999999998765433222110 1112233456
Q ss_pred hhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 236 ~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
++..+.+||.+||..+|.+|||+.+|+++
T Consensus 272 ~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 272 SVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 77889999999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=385.43 Aligned_cols=248 Identities=26% Similarity=0.419 Sum_probs=210.1
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
...+|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|++++||||+++++++.. +.+||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 34689999999999999999999875 46799999975442 24678999999999999999999999865 6789999
Q ss_pred eccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-c
Q 008116 91 EYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~ 167 (577)
|||++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||++........ .
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 99999999999964 35699999999999999999999999999999999999999999999999999976643211 1
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....+++.|+|||++.... ++.++|||||||+||+|++ |..||......+....+........+..++..+.+||.+
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 416 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 416 (452)
T ss_dssp -----CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 22345788999999998754 8999999999999999999 999999887776666666665556667889999999999
Q ss_pred hcccCCCCCCcHHHHhh
Q 008116 247 CLKKVPAERPSAKELLR 263 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~ 263 (577)
||..+|.+|||+.+|++
T Consensus 417 cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 417 CWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=385.12 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=202.3
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
..+|.+.++||+|+||+||. ....+++.||||++..... ..+.+|+.+|+++ +|||||++++++.+...+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 45799999999999999764 3445789999999865432 2357899999999 8999999999999999999999
Q ss_pred eccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc---C--CCeeecccccccccccc
Q 008116 91 EYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---N--GDVKVADFGVSAQLTRT 164 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~---~--g~vKL~DFGls~~~~~~ 164 (577)
|||. |+|.+++... ..+.+..++.++.||+.||.|||++||+||||||+||||+. + ..+||+|||++..+...
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9995 6999999764 34666677899999999999999999999999999999953 2 35789999999876533
Q ss_pred c---cccccccCCCCCCChhhhhc--ccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCC--CCchhhh
Q 008116 165 I---SRRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENP--PQLDEHF 236 (577)
Q Consensus 165 ~---~~~~~~~GTp~Y~APEvl~~--~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~--~~l~~~~ 236 (577)
. ......+||+.|+|||++.+ ...++.++|||||||+||+|++ |.+||...........+..... .......
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence 2 22345689999999999874 2346779999999999999999 9999976544332222211111 1123356
Q ss_pred hHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccCChhHHH
Q 008116 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278 (577)
Q Consensus 237 s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~~~~~~~ 278 (577)
+..+++||.+||..||.+|||+.+||+||||+...+....+.
T Consensus 257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~~~~~~~ 298 (432)
T 3p23_A 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQ 298 (432)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHHHHHHHH
T ss_pred cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHHHHHHHH
Confidence 777999999999999999999999999999987654333333
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=359.23 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=203.2
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcC-CC--cEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKE-LN--KDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~-tg--~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
...+|++++.||+|+||.||+|.+.. ++ ..||||+++... .....+.+.+|+.++++++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 45799999999999999999998643 33 369999986543 2345678999999999999999999999998765
Q ss_pred EEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
.++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 8999999999999999965 357999999999999999999999999999999999999999999999999998776433
Q ss_pred ccc---cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCC-CCCCchhhhhHH
Q 008116 165 ISR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRL 239 (577)
Q Consensus 165 ~~~---~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~l~~~~s~~ 239 (577)
... .....||+.|+|||++.+.. ++.++||||||+++|+|++ |..||...+.......+... .....+..++..
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred ccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHH
Confidence 221 22356788999999997754 8899999999999999999 99999887766555444332 233445678899
Q ss_pred HHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 240 MKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 240 l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+.+||.+||..+|.+|||+.+|+++
T Consensus 254 l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 254 IYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999999973
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=363.20 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=194.1
Q ss_pred CccccchhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHH--HHhCCCCceeEeEE
Q 008116 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISV--LSQCRSPYITEYYG 78 (577)
Q Consensus 1 ~~~l~~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~i--L~~L~HpnIV~l~~ 78 (577)
|+..........++|++++.||+|+||.||+|.+ +++.||||++.... ...+..|..+ +..+.||||+++++
T Consensus 1 m~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~ 74 (336)
T 3g2f_A 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIV 74 (336)
T ss_dssp --------CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred CCCcccCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhhee
Confidence 3334444555678999999999999999999976 58999999996543 2333444444 55689999999998
Q ss_pred EEEe-----CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCcccccccceEEE
Q 008116 79 SYLH-----QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE---------GKIHRDIKAANILL 144 (577)
Q Consensus 79 ~~~~-----~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~---------gIiHrDIKPeNILl 144 (577)
.+.. ...+|||||||++|+|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+||||
T Consensus 75 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill 153 (336)
T 3g2f_A 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV 153 (336)
T ss_dssp EEEEECTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred cccccccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE
Confidence 6643 2367999999999999999976 4569999999999999999999999 99999999999999
Q ss_pred ccCCCeeeccccccccccccc--------cccccccCCCCCCChhhhhcc------cCCccccchhhHHHHHHHHHhCCC
Q 008116 145 TENGDVKVADFGVSAQLTRTI--------SRRKTFVGTPFWMAPEVIQNS------EGYNEKADIWSLGITVIEMAKGEP 210 (577)
Q Consensus 145 d~~g~vKL~DFGls~~~~~~~--------~~~~~~~GTp~Y~APEvl~~~------~~~~~ksDVwSLGviLyeLltG~~ 210 (577)
+.++.+||+|||++..+.... ......+||+.|+|||++.+. ..++.++|||||||+||+|++|..
T Consensus 154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~ 233 (336)
T 3g2f_A 154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233 (336)
T ss_dssp CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence 999999999999997654321 112345799999999999762 236678999999999999999977
Q ss_pred CCCCCCccceeecc-------------------CCCCCCCch------hhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 211 PLADLHPMRVLFII-------------------PRENPPQLD------EHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 211 Pf~~~~~~~~~~~i-------------------~~~~~~~l~------~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
||............ .....+.++ ..++..+.+||.+||..||.+|||+.+|++.
T Consensus 234 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp GGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 76433221111000 011111221 2356789999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=371.00 Aligned_cols=247 Identities=17% Similarity=0.298 Sum_probs=203.9
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCC--------CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeE------
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKEL--------NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE------ 75 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~t--------g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~------ 75 (577)
..+++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+++++.||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3468999999999999999999999874 889999998754 45789999999999999887
Q ss_pred ---------eEEEEEe-CCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEE
Q 008116 76 ---------YYGSYLH-QTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANIL 143 (577)
Q Consensus 76 ---------l~~~~~~-~~~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNIL 143 (577)
+++++.. +..+||||||| +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777776 77899999999 99999999875 78999999999999999999999999999999999999
Q ss_pred EccCC--Ceeecccccccccccccc-------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCC
Q 008116 144 LTENG--DVKVADFGVSAQLTRTIS-------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD 214 (577)
Q Consensus 144 ld~~g--~vKL~DFGls~~~~~~~~-------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~ 214 (577)
|+.++ .+||+|||++..+..... ......||+.|+|||++.+. .++.++|||||||+||+|++|..||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99988 899999999976654321 11345899999999999875 489999999999999999999999987
Q ss_pred CCcc-cee-eccC--CCCCCCc------hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 215 LHPM-RVL-FIIP--RENPPQL------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 215 ~~~~-~~~-~~i~--~~~~~~l------~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.... ... ..+. ...+..+ ...++..+.+||.+||..||.+||++.+|++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 5421 111 1110 0111111 12468999999999999999999999999873
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=397.57 Aligned_cols=244 Identities=24% Similarity=0.414 Sum_probs=210.2
Q ss_pred eEEeecCceEEEEEEE--cCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFD--KELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~--~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
+.||+|+||.||+|.+ ..+++.||||+++... .....+.+.+|+.+|++++|||||++++++.. +.++||||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999965 4567899999997543 23346789999999999999999999999864 568999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc---ccccc
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR---RKTFV 172 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~---~~~~~ 172 (577)
|+|.+++.....+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++..+...... .....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 533 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence 999999998889999999999999999999999999999999999999999999999999999876433221 22345
Q ss_pred CCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccC
Q 008116 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (577)
Q Consensus 173 GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~d 251 (577)
||+.|+|||++.+. .++.++|||||||+||||++ |..||......+....+.......++..++..+.+||..||..|
T Consensus 534 ~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~d 612 (635)
T 4fl3_A 534 WPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD 612 (635)
T ss_dssp -CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 78899999999775 48999999999999999998 99999998887777777766666777889999999999999999
Q ss_pred CCCCCcHHHHhhc
Q 008116 252 PAERPSAKELLRH 264 (577)
Q Consensus 252 P~~RpTa~elL~h 264 (577)
|.+||++.+|++.
T Consensus 613 P~~RPs~~~l~~~ 625 (635)
T 4fl3_A 613 VENRPGFAAVELR 625 (635)
T ss_dssp TTTSCCHHHHHHH
T ss_pred HhHCcCHHHHHHH
Confidence 9999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=363.03 Aligned_cols=253 Identities=23% Similarity=0.425 Sum_probs=209.5
Q ss_pred hhcCCCeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC
Q 008116 9 EAAGSRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (577)
Q Consensus 9 ~~~~~~f~il~~IG~GsfG~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~ 84 (577)
.....+|++++.||+|+||.||+|. +..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 3445689999999999999999998 46689999999997543 345678999999999999999999999987654
Q ss_pred --EEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 85 --KLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 85 --~~~LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
.++|||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 789999999999999999764 56999999999999999999999999999999999999999999999999999876
Q ss_pred cccccc---cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCc----------c------ceee
Q 008116 162 TRTISR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP----------M------RVLF 222 (577)
Q Consensus 162 ~~~~~~---~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~----------~------~~~~ 222 (577)
...... .....+++.|+|||++.+.. ++.++|||||||+||+|++|..||..... . ....
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 443221 12346788899999998754 88999999999999999999999864210 0 0111
Q ss_pred ccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 223 IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 223 ~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
.+........+..++..+.+||.+||..+|.+|||+.+|++
T Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 12222233445678899999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=358.41 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=205.8
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHh--CCCCceeEeEEEEEeCC-
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ--CRSPYITEYYGSYLHQT- 84 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~--L~HpnIV~l~~~~~~~~- 84 (577)
.....++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|+.+++. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 4456689999999999999999999884 899999998643 34567889999987 78999999999998876
Q ss_pred ---EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCcccccccceEEEccCCCeeec
Q 008116 85 ---KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH--------NEGKIHRDIKAANILLTENGDVKVA 153 (577)
Q Consensus 85 ---~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLH--------s~gIiHrDIKPeNILld~~g~vKL~ 153 (577)
.+|+||||+++|+|.+++.. .++++..++.++.||+.||.||| +++|+||||||+||||+.++.+||+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 89999999999999999976 57999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccc----ccccccCCCCCCChhhhhcccC-----CccccchhhHHHHHHHHHhC----------CCCCCC
Q 008116 154 DFGVSAQLTRTIS----RRKTFVGTPFWMAPEVIQNSEG-----YNEKADIWSLGITVIEMAKG----------EPPLAD 214 (577)
Q Consensus 154 DFGls~~~~~~~~----~~~~~~GTp~Y~APEvl~~~~~-----~~~ksDVwSLGviLyeLltG----------~~Pf~~ 214 (577)
|||++........ .....+||+.|+|||++.+... ++.++|||||||+||+|++| ..||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 9999976654322 1234589999999999876421 33689999999999999999 788876
Q ss_pred CCccc-----eeecc-CCCCCCCch-----hhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 215 LHPMR-----VLFII-PRENPPQLD-----EHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 215 ~~~~~-----~~~~i-~~~~~~~l~-----~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
..... ....+ .....+.++ ..++..+.+||.+||..||.+|||+.+|++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 53321 11111 111222222 2566789999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=389.24 Aligned_cols=248 Identities=26% Similarity=0.424 Sum_probs=214.6
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
..++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|++|+|||||++++++.. +.+||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 35689999999999999999999875 46799999976543 24678999999999999999999999865 6789999
Q ss_pred eccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc-cc
Q 008116 91 EYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SR 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~-~~ 167 (577)
|||.+|+|.+++.. ...+++..++.|+.||+.||.|||+++||||||||+||||+.++.+||+|||++..+.... ..
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 99999999999964 3569999999999999999999999999999999999999999999999999998664321 11
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....+++.|+|||++.... ++.++|||||||+||||++ |..||......+....+........+..++..+.+||.+
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 499 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 499 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 22345778899999998754 8999999999999999999 999999887766666666555555667889999999999
Q ss_pred hcccCCCCCCcHHHHhh
Q 008116 247 CLKKVPAERPSAKELLR 263 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~ 263 (577)
||..+|.+|||+.+|++
T Consensus 500 cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 500 CWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcCCChhHCcCHHHHHH
Confidence 99999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=382.43 Aligned_cols=249 Identities=21% Similarity=0.336 Sum_probs=208.4
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC-CceeEeEEEEEeCCEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~H-pnIV~l~~~~~~~~~~~L 88 (577)
.+.++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.|.| ++|+.+..++......||
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 4678999999999999999999999999999999998655432 357899999999976 666777777788889999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---ccCCCeeecccccccccccc
Q 008116 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL---TENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILl---d~~g~vKL~DFGls~~~~~~ 164 (577)
||||| +++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||++..+...
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999 9999999974 5689999999999999999999999999999999999999 57899999999999876543
Q ss_pred ccc-------cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc---C----CCCCC
Q 008116 165 ISR-------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII---P----RENPP 230 (577)
Q Consensus 165 ~~~-------~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i---~----~~~~~ 230 (577)
... ....+||+.|+|||++.+.. ++.++||||||||||+|++|..||...........+ . .....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 221 12568999999999998764 899999999999999999999999876542211111 1 01111
Q ss_pred CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 231 ~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
.+...++.++.+||..||..+|.+||++.+|++
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 233567889999999999999999999999876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=374.56 Aligned_cols=249 Identities=14% Similarity=0.178 Sum_probs=198.5
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHHHHHHHHHHHhCCC-Cce----------------
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKEISVLSQCRS-PYI---------------- 73 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~--~~~~~i~~Ev~iL~~L~H-pnI---------------- 73 (577)
..|++.++||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.+.| +|+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3588899999999999999999999999999998744432 236789999999999976 211
Q ss_pred -----eEeEEEEEe-----CCEEEEEEeccCCCCHHHHHHc-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccc
Q 008116 74 -----TEYYGSYLH-----QTKLWIIMEYMAGGSVADLIQS-------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136 (577)
Q Consensus 74 -----V~l~~~~~~-----~~~~~LV~Ey~~gGsL~~~l~~-------~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrD 136 (577)
..++.++.. ...++++|+++ +++|.+++.. ..++++..+..++.||+.||+|||++||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 111111111 12467788877 6899999841 34578889999999999999999999999999
Q ss_pred cccceEEEccCCCeeeccccccccccccccccccccCCCCCCChhhhh---------cccCCccccchhhHHHHHHHHHh
Q 008116 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ---------NSEGYNEKADIWSLGITVIEMAK 207 (577)
Q Consensus 137 IKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~---------~~~~~~~ksDVwSLGviLyeLlt 207 (577)
|||+||||+.++.+||+|||+++..... ....+| +.|+|||++. ....|+.++|||||||+||+|++
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 9999999999999999999998765433 345688 9999999984 22347889999999999999999
Q ss_pred CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 208 GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 208 G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
|+.||...+.......+.... ..++..+++||.+||..||.+||++.++|+||||+...
T Consensus 313 g~~Pf~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWIFRSC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp SSCCCCTTGGGSCSGGGGSSC-----CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCCCCCCcchhhhHHHHHhhc-----ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence 999998876655544443322 24678999999999999999999999999999998764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=400.04 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=212.2
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe----
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH---- 82 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~---- 82 (577)
+.....++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+|+.+|++++||||+++++++..
T Consensus 8 ~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ---------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 4445568999999999999999999999999999999999776666667889999999999999999999998765
Q ss_pred --CCEEEEEEeccCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC---eeecc
Q 008116 83 --QTKLWIIMEYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD---VKVAD 154 (577)
Q Consensus 83 --~~~~~LV~Ey~~gGsL~~~l~~~~---~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~---vKL~D 154 (577)
++..|||||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 667899999999999999997643 6999999999999999999999999999999999999997765 99999
Q ss_pred ccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccc--------------e
Q 008116 155 FGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR--------------V 220 (577)
Q Consensus 155 FGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~--------------~ 220 (577)
||++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||....... .
T Consensus 168 FG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 168 LGYAKELDQG-ELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred cccccccccc-cccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 9999876443 233457899999999999765 48999999999999999999999996431100 0
Q ss_pred eecc---------CCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 221 LFII---------PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 221 ~~~i---------~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.... ....+..+...++..+.+||..||..||.+|||+.++|+||||...
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 0000 0011223455688999999999999999999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=363.06 Aligned_cols=250 Identities=24% Similarity=0.445 Sum_probs=206.1
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
...++|++.+.||+|+||.||+|.+.. .||||++..... ....+.+.+|+.++++++||||+++++++.....+++
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 446899999999999999999998864 499999875432 2234567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc---
Q 008116 89 IMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT--- 164 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~-~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~--- 164 (577)
||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 999999999999997644 799999999999999999999999999999999999998 679999999997654321
Q ss_pred --ccccccccCCCCCCChhhhhc--------ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc-h
Q 008116 165 --ISRRKTFVGTPFWMAPEVIQN--------SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-D 233 (577)
Q Consensus 165 --~~~~~~~~GTp~Y~APEvl~~--------~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l-~ 233 (577)
........||+.|+|||++.. ...++.++|||||||++|+|++|..||...........+.....+.. .
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 265 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ 265 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCC
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCc
Confidence 112234569999999999864 23478899999999999999999999988766555444433333222 3
Q ss_pred hhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 234 ~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
..++..+.+||.+||..+|.+|||+.+|++
T Consensus 266 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 266 IGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp SSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 357888999999999999999999999996
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=372.95 Aligned_cols=242 Identities=21% Similarity=0.285 Sum_probs=197.0
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-------hHHHHHHHHHHHHHHhCC---------CCceeE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------EDEIEDIQKEISVLSQCR---------SPYITE 75 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-------~~~~~~i~~Ev~iL~~L~---------HpnIV~ 75 (577)
.++|++++.||+|+||+||+|.+ +|+.||||++..... ....+.+.+|+.+|+.++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 47899999999999999999998 589999999976532 223477889999999885 888888
Q ss_pred eEEEEE------------------------------eCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHH
Q 008116 76 YYGSYL------------------------------HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125 (577)
Q Consensus 76 l~~~~~------------------------------~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~ 125 (577)
+++++. ....+|||||||++|+|.+.+.+ ..+++..++.|+.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 777653 26789999999999977776644 67899999999999999999
Q ss_pred HHH-HcCCcccccccceEEEccCC--------------------CeeeccccccccccccccccccccCCCCCCChhhhh
Q 008116 126 YLH-NEGKIHRDIKAANILLTENG--------------------DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184 (577)
Q Consensus 126 yLH-s~gIiHrDIKPeNILld~~g--------------------~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~ 184 (577)
||| ++||+||||||+||||+.++ .+||+|||+|+..... ..+||+.|+|||++.
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhc
Confidence 999 99999999999999999887 8999999999876532 458999999999998
Q ss_pred cccCCccccchhhHHHH-HHHHHhCCCCCCCCCc----c-ceeec--cCCCCCCCchhhhhHHHHHHHHHhcccCCCCCC
Q 008116 185 NSEGYNEKADIWSLGIT-VIEMAKGEPPLADLHP----M-RVLFI--IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERP 256 (577)
Q Consensus 185 ~~~~~~~ksDVwSLGvi-LyeLltG~~Pf~~~~~----~-~~~~~--i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~Rp 256 (577)
+.. +.++||||||++ .+++++|..||..... . ..... ............++..+++||.+||.+|
T Consensus 251 g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----- 323 (336)
T 2vuw_A 251 GDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----- 323 (336)
T ss_dssp CCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred CCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence 653 889999998777 7889999999954210 0 00101 1111223345678999999999999976
Q ss_pred cHHHHh-hcHhhh
Q 008116 257 SAKELL-RHRFIR 268 (577)
Q Consensus 257 Ta~elL-~hpff~ 268 (577)
|+.++| +||||+
T Consensus 324 sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 SATDLLCQHSLFK 336 (336)
T ss_dssp SHHHHHHHCGGGC
T ss_pred CHHHHHhcCCCcC
Confidence 999999 999994
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=392.14 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=215.4
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
..++|++.+.||+|+||.||+|.+..+ +..||||.+.........+.+.+|+.+|++++|||||++++++. ++.+|
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 346899999999999999999998643 46799999876666666788999999999999999999999984 56689
Q ss_pred EEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
||||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 999999999999999754 4799999999999999999999999999999999999999999999999999987643321
Q ss_pred -ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHH
Q 008116 167 -RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 167 -~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI 244 (577)
......||+.|+|||++.+. .++.++|||||||+||||++ |.+||...........+.......++..++..+.+||
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 625 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 625 (656)
T ss_dssp -------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred eeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHH
Confidence 12234678899999999765 48999999999999999997 9999998877666666655555566778899999999
Q ss_pred HHhcccCCCCCCcHHHHhhc
Q 008116 245 SLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~h 264 (577)
.+||..||.+|||+.+|++.
T Consensus 626 ~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 626 TKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=389.54 Aligned_cols=247 Identities=21% Similarity=0.321 Sum_probs=208.9
Q ss_pred hhhcCCCeeEEeEEeecCceEEEEEEEcC-CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE-
Q 008116 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK- 85 (577)
Q Consensus 8 ~~~~~~~f~il~~IG~GsfG~Vy~a~~~~-tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~- 85 (577)
++.+.++|++++.||+|+||.||+|.+.. +++.||||++...........+.+|+.+|++++|||||++++++...+.
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 44567899999999999999999999976 7899999998766556667788999999999999999999999987655
Q ss_pred ----EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccc
Q 008116 86 ----LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 86 ----~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~ 161 (577)
+|||||||+|++|.+++.. ++++..++.|+.||+.||.|||++|||||||||+||||+.+ .+||+|||++...
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999998754 79999999999999999999999999999999999999875 8999999999776
Q ss_pred cccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHH
Q 008116 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (577)
Q Consensus 162 ~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~ 241 (577)
... ...+||+.|+|||++.+. ++.++|||||||+||+|++|.+||...... .+. .......++..+.
T Consensus 232 ~~~----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----~~~---~~~~~~~~~~~l~ 298 (681)
T 2pzi_A 232 NSF----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----GLP---EDDPVLKTYDSYG 298 (681)
T ss_dssp TCC----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----SCC---TTCHHHHHCHHHH
T ss_pred ccC----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----ccc---ccccccccCHHHH
Confidence 433 456899999999998764 588999999999999999999998753211 111 1112234578899
Q ss_pred HHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 242 EFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
+||.+||.+||.+||+..+++.|+|+.-.
T Consensus 299 ~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 299 RLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 99999999999999999999999988643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=343.21 Aligned_cols=224 Identities=18% Similarity=0.234 Sum_probs=192.5
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++++.||||+++++++..++.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 567899999999999999999999999999999999976543 445678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
||||||+|++|.++++. + ....++..|+.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999999965 3 4566788999999999999999999999999999999999999998543
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee---ccCCCCCC---CchhhhhHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF---IIPRENPP---QLDEHFSRLMK 241 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~---~i~~~~~~---~l~~~~s~~l~ 241 (577)
|++| ++.++|||||||+||+|++|..||...+....+. ......++ .+...++..+.
T Consensus 175 ---------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 ---------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp ---------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred ---------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence 3332 6789999999999999999999999876654332 22222222 22346889999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhc
Q 008116 242 EFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+||.+||.+||.+| |+.++++.
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHcccCCccC-CHHHHHHH
Confidence 99999999999999 99999974
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=334.63 Aligned_cols=231 Identities=16% Similarity=0.182 Sum_probs=165.8
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeccCC---------ChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEE
Q 008116 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEE---------SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 20 ~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~---------~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV 89 (577)
.++.|++|.+..+.....|+.||||++.+.. .....+.+.+|+++|+++ .|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4677888888888887889999999996542 123456799999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||||+|++|.++|...+++++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+..........
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~ 397 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT 397 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence 9999999999999998899875 4789999999999999999999999999999999999999999988766555566
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
+.+||+.|||||++.+. +...+|+||+|+++++|+++..||... +. ..++. ...+..++..++.
T Consensus 398 t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~~~~~--------l~-~~~~~-----~~~~~~l~~~l~~ 461 (569)
T 4azs_A 398 NLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSNWLYA--------VW-QEPVE-----RWNFVLLLALFEK 461 (569)
T ss_dssp HHHHHHHHHHHHHC-------------------CCCCTTHHHHHHH--------HH-TSCGG-----GCSHHHHHHHHHT
T ss_pred CceechhhccHHHhCCC--CCCcccccccccchhhhccccchhHHH--------hh-cCCCC-----CCcHHHHHHHHhC
Confidence 78999999999999764 677899999999999988776554210 00 00100 0124556677788
Q ss_pred cCCCCCCcHHHHhhcHhhhh
Q 008116 250 KVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 250 ~dP~~RpTa~elL~hpff~~ 269 (577)
.+|..||.......++|...
T Consensus 462 ~~~~~~~~~~~~~~~~~~~~ 481 (569)
T 4azs_A 462 KAKLPSAEQQRGATEQWIIA 481 (569)
T ss_dssp GGGSCCGGGSSCCHHHHHHH
T ss_pred CCCCCCCChhhhccchhHHH
Confidence 88888988888878887753
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-29 Score=275.99 Aligned_cols=185 Identities=22% Similarity=0.286 Sum_probs=146.9
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--h-----HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--E-----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~-----~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
..++||+|+||.||+|. ..+..+++|....... . ...+.+.+|+.+|++++||||+++..++...+..|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 35689999999999994 4478899998644321 1 1245689999999999999999666666677788999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc--
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-- 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~-- 167 (577)
||||++++|.+++.. +..++.||+.||.|||++||+||||||+||||+. .+||+|||+++........
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 999999999999865 6689999999999999999999999999999998 9999999999877543221
Q ss_pred -----cccccCCCCCCChhhhhcc-cCCccccchhhHHHHHHHHHhCCCCCC
Q 008116 168 -----RKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLA 213 (577)
Q Consensus 168 -----~~~~~GTp~Y~APEvl~~~-~~~~~ksDVwSLGviLyeLltG~~Pf~ 213 (577)
..+.+||+.|||||++... ..|+..+|+|+..+-.++.+.+..+|.
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2367899999999999751 237888999999999999888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=227.55 Aligned_cols=160 Identities=18% Similarity=0.244 Sum_probs=125.6
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-----------------HHHHHHHHHHHHHHhCCCCcee
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-----------------DEIEDIQKEISVLSQCRSPYIT 74 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-----------------~~~~~i~~Ev~iL~~L~HpnIV 74 (577)
+..|.+.+.||+|+||.||+|.+ .+|+.||||+++..... .....+.+|+.+|++++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 34455669999999999999999 78999999999643321 13567899999999998 4 5
Q ss_pred EeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecc
Q 008116 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVAD 154 (577)
Q Consensus 75 ~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~D 154 (577)
++++++.. +..|+|||||+|++|.+ +.. .....++.||+.||.|||++||+||||||+||||+ ++.+||+|
T Consensus 165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 165 AVPKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp SSCCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred CcCeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 55555433 45699999999999998 421 23557999999999999999999999999999999 99999999
Q ss_pred ccccccccccccccccccCCCCCCChhhhhcc---------cCCccccchhh
Q 008116 155 FGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS---------EGYNEKADIWS 197 (577)
Q Consensus 155 FGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~---------~~~~~ksDVwS 197 (577)
||++.. +..++|||++... ..|+..+|+|.
T Consensus 236 FG~a~~-------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 236 FPQSVE-------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CTTCEE-------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCCCeE-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999753 4457899987531 12556667765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-21 Score=197.34 Aligned_cols=140 Identities=22% Similarity=0.311 Sum_probs=111.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcE--EEEEEeccCCCh-----------------------HHHHHHHHHHHHHHh
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKD--VAIKVIDLEESE-----------------------DEIEDIQKEISVLSQ 67 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~--VAIK~i~~~~~~-----------------------~~~~~i~~Ev~iL~~ 67 (577)
.-|++.+.||+|+||.||+|.+..+|+. ||||+++..... .....+.+|+.+|+.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3478999999999999999999778989 999997543211 112367899999999
Q ss_pred CCCCce--eEeEEEEEeCCEEEEEEeccCC-C----CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCccccccc
Q 008116 68 CRSPYI--TEYYGSYLHQTKLWIIMEYMAG-G----SVADLIQSGPPLDEMSIACILRDLLHAIEYLH-NEGKIHRDIKA 139 (577)
Q Consensus 68 L~HpnI--V~l~~~~~~~~~~~LV~Ey~~g-G----sL~~~l~~~~~l~e~~i~~il~QLl~aL~yLH-s~gIiHrDIKP 139 (577)
|.|++| +.++++ ...+|||||+.+ | +|.+++.. +++..+..++.||+.||.||| .+||+||||||
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 987754 344432 346899999942 3 78777533 345678899999999999999 99999999999
Q ss_pred ceEEEccCCCeeeccccccccc
Q 008116 140 ANILLTENGDVKVADFGVSAQL 161 (577)
Q Consensus 140 eNILld~~g~vKL~DFGls~~~ 161 (577)
+||||+. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999988 9999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=6.5e-18 Score=179.88 Aligned_cols=139 Identities=20% Similarity=0.194 Sum_probs=102.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC----------------hHH---HH--HHHHHHHHHHhCCCC
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES----------------EDE---IE--DIQKEISVLSQCRSP 71 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~----------------~~~---~~--~i~~Ev~iL~~L~Hp 71 (577)
.-|++...||.|+||.||+|.+. +|+.||||+++.... ... .. ...+|...|.+|.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 35999999999999999999985 599999998753210 000 01 124677888888555
Q ss_pred ceeEeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCC--
Q 008116 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD-- 149 (577)
Q Consensus 72 nIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~-- 149 (577)
+|....-+.... .+|||||++|++|..+.. ...+..++.||+.+|.|||.+|||||||||.||||+.+|.
T Consensus 174 gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 174 GFPVPEPIAQSR--HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp TCSCCCEEEEET--TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCCCeeeeccC--ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 443222111222 379999999999876532 2245678899999999999999999999999999988763
Q ss_pred --------eeecccccccc
Q 008116 150 --------VKVADFGVSAQ 160 (577)
Q Consensus 150 --------vKL~DFGls~~ 160 (577)
+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 89999996543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=1.7e-13 Score=136.14 Aligned_cols=141 Identities=18% Similarity=0.167 Sum_probs=113.3
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV 89 (577)
.-..|++...++.|+.+.||++... +..|++|+...... .....+.+|+.+|+.| .+..++++++++...+..|+|
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 3456999999999999999999754 67899999864221 1124588999999998 467788999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN---------------------------------------- 129 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs---------------------------------------- 129 (577)
|||++|.+|.+.+. +......++.++..+|..||.
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999987641 122344778899999999998
Q ss_pred -------------------cCCcccccccceEEEccCCCeeeccccccc
Q 008116 130 -------------------EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 130 -------------------~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876556799999763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=2.1e-12 Score=126.86 Aligned_cols=142 Identities=14% Similarity=0.076 Sum_probs=104.0
Q ss_pred cchhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCc--eeEeEEEEEe
Q 008116 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY--ITEYYGSYLH 82 (577)
Q Consensus 5 ~~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~Hpn--IV~l~~~~~~ 82 (577)
+.........|.+..+.+.|..+.||++.. .+|..|+||+.... ....+.+|+.+++.+.+.+ ++++++++..
T Consensus 12 p~~l~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~ 86 (264)
T 1nd4_A 12 PAAWVERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTE 86 (264)
T ss_dssp CGGGTTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred CHHHHHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC
Confidence 333344455677766555677799999954 45778999997543 1245788999999885434 5668888888
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC-------------------------------
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG------------------------------- 131 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~g------------------------------- 131 (577)
++..|+||||++|.+|. .. .... ..++.+++..|..||...
T Consensus 87 ~~~~~~v~e~i~G~~l~--~~---~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 87 AGRDWLLLGEVPGQDLL--SS---HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp SSCEEEEEECCSSEETT--TS---CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CCCCEEEEEecCCcccC--cC---cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 88899999999998884 21 1222 256667777777777643
Q ss_pred ---------------------------CcccccccceEEEccCCCeeeccccccc
Q 008116 132 ---------------------------KIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 132 ---------------------------IiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876666799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.6e-11 Score=128.15 Aligned_cols=142 Identities=16% Similarity=0.259 Sum_probs=107.9
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEec--cCCChHHHHHHHHHHHHHHhCC--CCceeEeEEEEEeC---CEEE
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVID--LEESEDEIEDIQKEISVLSQCR--SPYITEYYGSYLHQ---TKLW 87 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~--~~~~~~~~~~i~~Ev~iL~~L~--HpnIV~l~~~~~~~---~~~~ 87 (577)
...++.|+.|.++.||++... +..+++|+.. ..........+.+|+.+++.|. +..+++++.++.+. +..|
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 445788999999999998765 4678899875 3321122356889999999996 45688888888766 4589
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-------------------------------------- 129 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs-------------------------------------- 129 (577)
+||||++|..|.+.. ...++......++.+++..|..||.
T Consensus 118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999998875421 2347788888999999999999997
Q ss_pred --------------------cCCcccccccceEEEccCCC--eeecccccccc
Q 008116 130 --------------------EGKIHRDIKAANILLTENGD--VKVADFGVSAQ 160 (577)
Q Consensus 130 --------------------~gIiHrDIKPeNILld~~g~--vKL~DFGls~~ 160 (577)
..++|+|++|.|||++.++. +.|+||+++..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987753 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.12 E-value=7.1e-11 Score=120.39 Aligned_cols=182 Identities=20% Similarity=0.230 Sum_probs=123.5
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCc--eeEeEEEEEeCC---EEEEEE
Q 008116 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPY--ITEYYGSYLHQT---KLWIIM 90 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~Hpn--IV~l~~~~~~~~---~~~LV~ 90 (577)
.++.|+.|.+..||++ +..+++|+.... .....+.+|+.+|+.+ .+.. +++++....... ..|+||
T Consensus 24 ~i~~~~~G~~n~v~~v-----~~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 24 TIEISGEGNDCIAYEI-----NRDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCCEEEECSSEEEEES-----TTSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eeEecCCCCcceEEEE-----CCEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3567999999999987 256899986422 3457789999999887 3332 345554433333 348999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN----------------------------------------- 129 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs----------------------------------------- 129 (577)
||++|.+|..... ..++..+...++.+++..|..||.
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999998876433 347777888888899888888886
Q ss_pred -----------------cCCcccccccceEEEcc--CCCeeeccccccccccccccccccccCCCCC---CChhhhhc--
Q 008116 130 -----------------EGKIHRDIKAANILLTE--NGDVKVADFGVSAQLTRTISRRKTFVGTPFW---MAPEVIQN-- 185 (577)
Q Consensus 130 -----------------~gIiHrDIKPeNILld~--~g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y---~APEvl~~-- 185 (577)
..++|+|++|.|||++. .+.+.|+||+.+....... .......+ ..|+.+..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~----Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN----DFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH----HHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH----HHHHHHhhccccCHHHHHHHH
Confidence 13699999999999988 4568899999875432110 00111111 23332110
Q ss_pred --cc---------CCccccchhhHHHHHHHHHhCCCCC
Q 008116 186 --SE---------GYNEKADIWSLGITVIEMAKGEPPL 212 (577)
Q Consensus 186 --~~---------~~~~ksDVwSLGviLyeLltG~~Pf 212 (577)
.. ......+.|+++.++|.+.+|.++|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 0122358999999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=6.1e-08 Score=96.25 Aligned_cols=133 Identities=16% Similarity=0.169 Sum_probs=98.2
Q ss_pred EEeecCce-EEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEEEEEeccCCCC
Q 008116 20 LIGRGSFG-DVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEYMAGGS 97 (577)
Q Consensus 20 ~IG~GsfG-~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~LV~Ey~~gGs 97 (577)
.+..|..+ .||+......+..+++|+-+.. ....+.+|+.+|+.|. +--|.+++.++.+.+..|+|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 34445444 7999887777888999986532 3466889999999883 3336788888899999999999999998
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------------
Q 008116 98 VADLIQSGPPLDEMSIACILRDLLHAIEYLHNE----------------------------------------------- 130 (577)
Q Consensus 98 L~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~----------------------------------------------- 130 (577)
+.+..... ......+..++...|.-||..
T Consensus 107 ~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 107 AFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 88766431 122334556666666666640
Q ss_pred -----------CCcccccccceEEEccCCCeeecccccccc
Q 008116 131 -----------GKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 131 -----------gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 168999999999999877778999998643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=1.9e-07 Score=95.58 Aligned_cols=134 Identities=19% Similarity=0.176 Sum_probs=96.0
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCC---ceeEeEEEEE-eCCEEEEEEec
Q 008116 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP---YITEYYGSYL-HQTKLWIIMEY 92 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~Hp---nIV~l~~~~~-~~~~~~LV~Ey 92 (577)
-++.++.|....||+. +..++||+.. .......+.+|+.+|+.|.+. .|.+++.+.. ..+..|+||||
T Consensus 23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV-----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp CEEEEEECSSEEEEEE-----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeeecCCCcceeEEEE-----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 3567899999999998 5678999852 233457889999999999642 3556666654 34567899999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc------------------------------------------
Q 008116 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE------------------------------------------ 130 (577)
Q Consensus 93 ~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~------------------------------------------ 130 (577)
++|.+|....- ..++......++.++...|..||..
T Consensus 95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99988876422 2345555555556666666555532
Q ss_pred ------------------CCcccccccceEEEcc---CCC-eeecccccccc
Q 008116 131 ------------------GKIHRDIKAANILLTE---NGD-VKVADFGVSAQ 160 (577)
Q Consensus 131 ------------------gIiHrDIKPeNILld~---~g~-vKL~DFGls~~ 160 (577)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 455 48999997654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=5.8e-07 Score=94.79 Aligned_cols=79 Identities=20% Similarity=0.233 Sum_probs=51.7
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC------hHHHHHHHHHHHHHHhCC-C-Cc-eeEeEEEEEeCCEE
Q 008116 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES------EDEIEDIQKEISVLSQCR-S-PY-ITEYYGSYLHQTKL 86 (577)
Q Consensus 16 ~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~------~~~~~~i~~Ev~iL~~L~-H-pn-IV~l~~~~~~~~~~ 86 (577)
..++.||.|.++.||++.....++.|+||....... ......+..|+.+|+.+. + |. +++++.+ +.+..
T Consensus 33 ~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 33 LTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp CEEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred eEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 346789999999999997766678899998643211 012345678999998873 2 33 4455543 44556
Q ss_pred EEEEeccCCC
Q 008116 87 WIIMEYMAGG 96 (577)
Q Consensus 87 ~LV~Ey~~gG 96 (577)
++||||+++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.28 E-value=7.3e-06 Score=83.42 Aligned_cols=137 Identities=21% Similarity=0.258 Sum_probs=80.0
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----CCceeEeE-E--EEEeCCEEE
Q 008116 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----SPYITEYY-G--SYLHQTKLW 87 (577)
Q Consensus 16 ~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-----HpnIV~l~-~--~~~~~~~~~ 87 (577)
.-++.|+.|..+.||++... +..+++|+.... . ..+..|+.+++.|. .|.++... + +....+..|
T Consensus 35 ~~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~--~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 35 EKIDVIQGNQMALVWKVHTD--SGAVCLKRIHRP--E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp CEEEECC----CEEEEEEET--TEEEEEEEECSC--H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred EEeeeccccccCcEEEEEeC--CCCEEEEecCCC--H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 34566777888999998764 345899998642 2 33445555555442 34444311 1 123567889
Q ss_pred EEEeccCCCCHH-----------HHH---H---cCC--C---------CCHHH---------------------------
Q 008116 88 IIMEYMAGGSVA-----------DLI---Q---SGP--P---------LDEMS--------------------------- 112 (577)
Q Consensus 88 LV~Ey~~gGsL~-----------~~l---~---~~~--~---------l~e~~--------------------------- 112 (577)
+||||++|.++. ..+ + ... + ..+..
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986542 111 1 111 1 01110
Q ss_pred ----HHHHHHHHHHHHHHHHH-------------cCCcccccccceEEEccCCCeeeccccccc
Q 008116 113 ----IACILRDLLHAIEYLHN-------------EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 113 ----i~~il~QLl~aL~yLHs-------------~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
+..++.++..++.+|+. ..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234445666653 479999999999999888899999999753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=5.4e-07 Score=93.33 Aligned_cols=85 Identities=8% Similarity=0.074 Sum_probs=57.3
Q ss_pred eeEEeEE-eecCceEEEEEEEc--C----CCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCC-C--CceeEeEEEEEe
Q 008116 15 FSSLELI-GRGSFGDVYKAFDK--E----LNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCR-S--PYITEYYGSYLH 82 (577)
Q Consensus 15 f~il~~I-G~GsfG~Vy~a~~~--~----tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~-H--pnIV~l~~~~~~ 82 (577)
...++.| +.|....+|++... . ++..+++|....... ......+.+|+.+|+.|. + -.+.+++.++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4556788 88999999988653 1 156789998643220 000145778888888873 3 356778877665
Q ss_pred C---CEEEEEEeccCCCCHH
Q 008116 83 Q---TKLWIIMEYMAGGSVA 99 (577)
Q Consensus 83 ~---~~~~LV~Ey~~gGsL~ 99 (577)
. +..|+||||++|..|.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3568999999886643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.94 E-value=5.6e-05 Score=77.86 Aligned_cols=78 Identities=15% Similarity=0.150 Sum_probs=62.1
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCceeEeEEEEEeCCEEEEEEe
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~---HpnIV~l~~~~~~~~~~~LV~E 91 (577)
-.-++.|+.|.+..+|+... .+..++||+.... ....+..|+..|+.|. ...+++++.+....+..|+|||
T Consensus 38 i~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 34567899999999999875 3678899987533 2466889999998883 3568888888888889999999
Q ss_pred ccCCCCH
Q 008116 92 YMAGGSV 98 (577)
Q Consensus 92 y~~gGsL 98 (577)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.93 E-value=2.5e-05 Score=83.16 Aligned_cols=76 Identities=18% Similarity=0.152 Sum_probs=46.4
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEecc-----CCC-h--HHHHHHHHHHHHHH-hCCCCceeEeEEEEEeCCEE
Q 008116 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL-----EES-E--DEIEDIQKEISVLS-QCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 16 ~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~-----~~~-~--~~~~~i~~Ev~iL~-~L~HpnIV~l~~~~~~~~~~ 86 (577)
..++.||.|..+.||++.. .+..|+||.... ... . .....+..|+..+. ......+++++.+. .+..
T Consensus 37 ~~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~ 112 (420)
T 2pyw_A 37 LVIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMA 112 (420)
T ss_dssp CEEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTT
T ss_pred eEEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCcc
Confidence 4577899999999999954 467899994321 100 0 01123333433332 22234566777664 5667
Q ss_pred EEEEecc-CC
Q 008116 87 WIIMEYM-AG 95 (577)
Q Consensus 87 ~LV~Ey~-~g 95 (577)
++||||+ +|
T Consensus 113 ~lv~e~l~~g 122 (420)
T 2pyw_A 113 LIGMRYLEPP 122 (420)
T ss_dssp EEEECCCCTT
T ss_pred EEEEeecCCc
Confidence 9999999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00011 Score=73.76 Aligned_cols=86 Identities=13% Similarity=0.071 Sum_probs=61.0
Q ss_pred hhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-C--CceeEeEEEEEeC
Q 008116 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-S--PYITEYYGSYLHQ 83 (577)
Q Consensus 7 l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-H--pnIV~l~~~~~~~ 83 (577)
+....+.+...++.+|.|..+.||++... +|+.|++|+....... ....+..|+..|+.|. . --+++++++ ..
T Consensus 9 ~~~l~G~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~ 84 (288)
T 3f7w_A 9 VTELTGREVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD 84 (288)
T ss_dssp HHHHHCCCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET
T ss_pred HHHhcCCCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC
Confidence 45566788999999999999999999764 5889999986533211 1245788999998873 2 124455543 22
Q ss_pred CEEEEEEeccCCCCH
Q 008116 84 TKLWIIMEYMAGGSV 98 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL 98 (577)
-++||||+.++..
T Consensus 85 --~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 --RTLAMEWVDERPP 97 (288)
T ss_dssp --TEEEEECCCCCCC
T ss_pred --ceEEEEeecccCC
Confidence 3789999987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.79 E-value=3.7e-05 Score=77.82 Aligned_cols=132 Identities=13% Similarity=0.125 Sum_probs=75.4
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCce-eEeEEEEEeCCEEEEEEecc-CC
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIMEYM-AG 95 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnI-V~l~~~~~~~~~~~LV~Ey~-~g 95 (577)
++.|+.|....+|++ ..|++|+...... ......+|+.+++.+..-++ .+++.. +.+.-++|+||+ +|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE--EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 788999999999999 4689998754211 11223568887777632222 455544 344457899999 66
Q ss_pred CCHHH---------------HH---Hc-CCCC----C-HHHHHHHHHH--------------HHHHHHHHH----H----
Q 008116 96 GSVAD---------------LI---QS-GPPL----D-EMSIACILRD--------------LLHAIEYLH----N---- 129 (577)
Q Consensus 96 GsL~~---------------~l---~~-~~~l----~-e~~i~~il~Q--------------Ll~aL~yLH----s---- 129 (577)
.+|.. .+ +. ...+ . ...+..+... +...+..|. .
T Consensus 93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 54421 01 11 1111 1 1122222111 111122221 1
Q ss_pred cCCcccccccceEEEccCCCeeecccccccc
Q 008116 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (577)
Q Consensus 130 ~gIiHrDIKPeNILld~~g~vKL~DFGls~~ 160 (577)
..++|+|+.|.||| ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 13799999999999 5567889999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00042 Score=67.77 Aligned_cols=136 Identities=16% Similarity=0.163 Sum_probs=92.4
Q ss_pred CCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeeccccccccccccccccccccC
Q 008116 96 GSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173 (577)
Q Consensus 96 GsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~G 173 (577)
-+|.++|+. +.+++|+++|.++.|.+.+|.-+-. ..-..+=+.|..|+|..+|.|-+.+ +.+. ..
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~ 99 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AG 99 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cc
Confidence 379999964 6899999999999999999877622 2222344567999999999987763 2110 12
Q ss_pred CCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc---
Q 008116 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK--- 250 (577)
Q Consensus 174 Tp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~--- 250 (577)
...+.+||... ...+.+.=|||||+++|.-+--..| +.....+|+.|..||..|..-
T Consensus 100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~------------------e~eE~eLS~~LE~LL~~Mt~~~~d 159 (229)
T 2yle_A 100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK------------------ENEERELSPPLEQLIDHMANTVEA 159 (229)
T ss_dssp -------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC------------------TTEEECCCHHHHHHHHHHTTCCC-
T ss_pred ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC------------------cccchhhCHHHHHHHHHHHhcccc
Confidence 23467888763 2356788999999999999853322 233446789999999999755
Q ss_pred ----------------------CCCCCCcHHHHhhc
Q 008116 251 ----------------------VPAERPSAKELLRH 264 (577)
Q Consensus 251 ----------------------dP~~RpTa~elL~h 264 (577)
.+..|++.++||+.
T Consensus 160 ~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~ 195 (229)
T 2yle_A 160 DGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL 195 (229)
T ss_dssp -------------------CCSCCCCCCSHHHHHHH
T ss_pred cccccccccccccccccccccccccCcCCHHHHHHH
Confidence 24678899998863
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00014 Score=74.42 Aligned_cols=137 Identities=16% Similarity=0.183 Sum_probs=72.3
Q ss_pred EEeEEeecCceE-EEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-C-CceeEeEEEEEeCCEEEEEEecc
Q 008116 17 SLELIGRGSFGD-VYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-S-PYITEYYGSYLHQTKLWIIMEYM 93 (577)
Q Consensus 17 il~~IG~GsfG~-Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-H-pnIV~l~~~~~~~~~~~LV~Ey~ 93 (577)
-++.|+.|.... +|+... .++..+++|....... ..+..|+.+++.|. + -.+++++.+....+ ++|||++
T Consensus 22 ~~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 22 NRTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp EECC--------CCEEEEC-TTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eeeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 355676665554 666643 2256778886543211 23456777777663 2 23556666533333 7899999
Q ss_pred CCCCHHHHHHcC--------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHH
Q 008116 94 AGGSVADLIQSG--------------------------PPLDEMSIA-------CIL-------------RDLLHAIEYL 127 (577)
Q Consensus 94 ~gGsL~~~l~~~--------------------------~~l~e~~i~-------~il-------------~QLl~aL~yL 127 (577)
.+..+.+.+... ..+...... .+. ..+...++.|
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 776665433210 112221111 000 0111223333
Q ss_pred H------HcCCcccccccceEEEccC----CCeeecccccccc
Q 008116 128 H------NEGKIHRDIKAANILLTEN----GDVKVADFGVSAQ 160 (577)
Q Consensus 128 H------s~gIiHrDIKPeNILld~~----g~vKL~DFGls~~ 160 (577)
. ...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1 2368999999999999874 6789999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0017 Score=65.78 Aligned_cols=141 Identities=13% Similarity=0.192 Sum_probs=80.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----CCceeEeE-E--EEEeCCE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----SPYITEYY-G--SYLHQTK 85 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-----HpnIV~l~-~--~~~~~~~ 85 (577)
...-++.|+.|....+|++... +..+++|+...... ...+..|+.+++.|. -|.++... + +....+.
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES--SCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred cceEeeccCCCcccceEEEEeC--CccEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 3445677888999999998754 23688998865211 234566777777662 23333211 1 1223567
Q ss_pred EEEEEeccCCCCHH-----------HHH---Hc---C--CC----CCHHHHHHH---------------HHHHHHHHHHH
Q 008116 86 LWIIMEYMAGGSVA-----------DLI---QS---G--PP----LDEMSIACI---------------LRDLLHAIEYL 127 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~-----------~~l---~~---~--~~----l~e~~i~~i---------------l~QLl~aL~yL 127 (577)
.+++|+|++|..+. ..+ +. . .+ ......... ...+...+++|
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 89999999886531 111 10 0 01 111111110 01134455566
Q ss_pred HH-------cCCcccccccceEEEccCCCeeeccccccc
Q 008116 128 HN-------EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 128 Hs-------~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
+. .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 53 368999999999999877656899999764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00051 Score=69.79 Aligned_cols=76 Identities=16% Similarity=0.120 Sum_probs=48.1
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-C-CceeEeEEE-----EEeCCEEEEEE
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-S-PYITEYYGS-----YLHQTKLWIIM 90 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-H-pnIV~l~~~-----~~~~~~~~LV~ 90 (577)
+..|+ |....||++... +|+.+++|....... ....+..|+.+++.|. + -.+++++.. ...++..++||
T Consensus 31 ~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp CEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred EEeec-CcccceEEEEcC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 34566 888899987543 466799999863321 1345677888887763 1 123444332 23356778999
Q ss_pred eccCCCC
Q 008116 91 EYMAGGS 97 (577)
Q Consensus 91 Ey~~gGs 97 (577)
+|++|..
T Consensus 107 ~~i~G~~ 113 (328)
T 1zyl_A 107 PSVGGRQ 113 (328)
T ss_dssp ECCCCEE
T ss_pred EecCCCC
Confidence 9998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00033 Score=74.10 Aligned_cols=136 Identities=13% Similarity=0.187 Sum_probs=83.1
Q ss_pred EeEEeecCceEEEEEEEcC-------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEEEE
Q 008116 18 LELIGRGSFGDVYKAFDKE-------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~-------tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~LV 89 (577)
++.|..|-...+|++.... .+..|++|+.... ......+.+|..+++.|. +.-..++++.+.. .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 4667778888999997642 3578999985321 112355678999998883 3334666666543 299
Q ss_pred EeccCCCCHH--------------HHHH---c-----CCCC--CHHHHHHHHHHHHH-------------------HHHH
Q 008116 90 MEYMAGGSVA--------------DLIQ---S-----GPPL--DEMSIACILRDLLH-------------------AIEY 126 (577)
Q Consensus 90 ~Ey~~gGsL~--------------~~l~---~-----~~~l--~e~~i~~il~QLl~-------------------aL~y 126 (577)
|||++|.+|. ..|. . ..+. -+.++..|+.++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 9999886542 1111 1 1112 24566666655432 2334
Q ss_pred HHH--------cCCcccccccceEEEccC----CCeeeccccccc
Q 008116 127 LHN--------EGKIHRDIKAANILLTEN----GDVKVADFGVSA 159 (577)
Q Consensus 127 LHs--------~gIiHrDIKPeNILld~~----g~vKL~DFGls~ 159 (577)
|.. ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 432 248999999999999876 789999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0005 Score=73.70 Aligned_cols=74 Identities=15% Similarity=0.139 Sum_probs=50.5
Q ss_pred EEeEEeecCceEEEEEEEcC-------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEEE
Q 008116 17 SLELIGRGSFGDVYKAFDKE-------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~-------tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~L 88 (577)
.++.|+.|....||++.... .+..|++|+...... ...+..|+.+++.|. +.-.+++++.+. + .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~ 149 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR 149 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence 46788999999999997653 257899998743222 134557999988884 323366776553 2 38
Q ss_pred EEeccCCCC
Q 008116 89 IMEYMAGGS 97 (577)
Q Consensus 89 V~Ey~~gGs 97 (577)
|+||++|.+
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999998643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00058 Score=70.97 Aligned_cols=76 Identities=16% Similarity=0.214 Sum_probs=45.6
Q ss_pred EEeEEeecCceEEEEEEEcC--------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCc-eeEeEEEEEeCCEEE
Q 008116 17 SLELIGRGSFGDVYKAFDKE--------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQTKLW 87 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~--------tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~Hpn-IV~l~~~~~~~~~~~ 87 (577)
.++.|+.|....+|++.... .+..|++|+..... ........|+.+++.|...+ ++++++.+ .+ +
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~ 110 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--G 110 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec--CC--c
Confidence 46678888889999997653 13688999864321 11123467888888774223 44666544 22 7
Q ss_pred EEEeccCCCCH
Q 008116 88 IIMEYMAGGSV 98 (577)
Q Consensus 88 LV~Ey~~gGsL 98 (577)
+||||++|.+|
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0031 Score=65.10 Aligned_cols=73 Identities=12% Similarity=0.019 Sum_probs=45.5
Q ss_pred EEeEEeec--CceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCceeEeEEE------EEeCCE
Q 008116 17 SLELIGRG--SFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGS------YLHQTK 85 (577)
Q Consensus 17 il~~IG~G--sfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~---HpnIV~l~~~------~~~~~~ 85 (577)
.++.|..| ....||++... .| .+++|+...... ..|+.+++.|. -|+|++++.. ....+.
T Consensus 25 ~~~~l~~G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~-------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~ 95 (339)
T 3i1a_A 25 TAQFIQGGADTNAFAYQADSE-SK-SYFIKLKYGYHD-------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHF 95 (339)
T ss_dssp EEEEETTTSCSSCEEEEEECS-SC-EEEEEEEECSSC-------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSE
T ss_pred eeEEeeccCccccceEEEEeC-CC-CEEEEEecCccc-------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCE
Confidence 45566433 36899999754 34 899998765432 34555555552 2334444432 234678
Q ss_pred EEEEEeccCCCCH
Q 008116 86 LWIIMEYMAGGSV 98 (577)
Q Consensus 86 ~~LV~Ey~~gGsL 98 (577)
.++||+|++|..+
T Consensus 96 ~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 96 KIIAYPFIHAPNG 108 (339)
T ss_dssp EEEEEECCCCCBT
T ss_pred EEEEEeccCCCcC
Confidence 8999999998765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0039 Score=67.42 Aligned_cols=76 Identities=18% Similarity=0.219 Sum_probs=49.4
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCce-eEeEEEEEeCCEEEEEEeccCC
Q 008116 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnI-V~l~~~~~~~~~~~LV~Ey~~g 95 (577)
.++.|+.|-...+|++.....+..|++|+..... . ..-...+|..+|+.|...+| +++++.+. + .+||||++|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4678889999999999876545789999874321 1 11112688999998854344 56777662 2 259999987
Q ss_pred CCH
Q 008116 96 GSV 98 (577)
Q Consensus 96 GsL 98 (577)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.69 E-value=0.029 Score=60.01 Aligned_cols=76 Identities=11% Similarity=0.131 Sum_probs=49.4
Q ss_pred EEeEEeecCceEEEEEEEcCC-------CcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEEE
Q 008116 17 SLELIGRGSFGDVYKAFDKEL-------NKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~t-------g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~L 88 (577)
-++.|..|-...+|++..... +..|++|+..... . ..-...+|..+++.|. +.-.+++++.+ .+ ++
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~ 147 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-G-KFYDSKVELDVFRYLSNINIAPNIIADF--PE--GR 147 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-c-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CE
Confidence 456777888899999987521 5789999864321 1 1123467888888873 33345566533 23 78
Q ss_pred EEeccCCCCH
Q 008116 89 IMEYMAGGSV 98 (577)
Q Consensus 89 V~Ey~~gGsL 98 (577)
||||++|.+|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.24 E-value=0.13 Score=54.13 Aligned_cols=29 Identities=34% Similarity=0.478 Sum_probs=24.2
Q ss_pred CcccccccceEEE------ccCCCeeecccccccc
Q 008116 132 KIHRDIKAANILL------TENGDVKVADFGVSAQ 160 (577)
Q Consensus 132 IiHrDIKPeNILl------d~~g~vKL~DFGls~~ 160 (577)
++|+|+.+.|||+ +.++.++|+||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 3456799999988743
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.88 E-value=0.85 Score=44.13 Aligned_cols=116 Identities=11% Similarity=0.094 Sum_probs=79.8
Q ss_pred CCCceeEeEEEEEeCCEEEEEEeccC-CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC
Q 008116 69 RSPYITEYYGSYLHQTKLWIIMEYMA-GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (577)
Q Consensus 69 ~HpnIV~l~~~~~~~~~~~LV~Ey~~-gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~ 147 (577)
.||+++.+ .+-.+++.+.|.++.-. +-++.. + ..++....+.++.+|+....+++ .-+|--|+|+||+++.+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRD 115 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCC
Confidence 68999987 56677788888777764 334444 3 33788888999999988775543 34777899999999999
Q ss_pred CCeeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCC
Q 008116 148 GDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD 214 (577)
Q Consensus 148 g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~ 214 (577)
+.+++.=.|+-..+. |.=+.+|-+ +-.+=|++..+++++..|..
T Consensus 116 ~~p~i~~RGik~~l~------------P~~~~ee~f-----------L~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 116 GLPIAKTRGLQNVVD------------PLPVSEAEF-----------LTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp SCEEESCCEETTTBS------------CCCCCHHHH-----------HHHHHHHHHHHHCTTCCHHH
T ss_pred CCEEEEEccCccCCC------------CCCCCHHHH-----------HHHHHHHHHHHHcCCCCHHH
Confidence 999998777532211 111122222 22466788899999888754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.85 E-value=2.2 Score=41.41 Aligned_cols=116 Identities=13% Similarity=0.112 Sum_probs=77.1
Q ss_pred CCCceeEeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHH-HHHHcCCcccccccceEEEccC
Q 008116 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE-YLHNEGKIHRDIKAANILLTEN 147 (577)
Q Consensus 69 ~HpnIV~l~~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~-yLHs~gIiHrDIKPeNILld~~ 147 (577)
.||++ -..+-.+++.+.|.++.-+++.=+..++ .++....+.++.+|+.... ++ ..-+|--|+|+||+++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 68888 3344477888888888764443333443 3788888888888877665 44 345777889999999999
Q ss_pred CCeeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCC
Q 008116 148 GDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD 214 (577)
Q Consensus 148 g~vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~ 214 (577)
+.++|.=.|+-..+ .|.=+.+|-+. -.+=|++..++.++..|..
T Consensus 121 ~~p~i~hRGi~~~l------------pP~e~~ee~fl-----------~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 121 LEPFFLHVGVKESL------------PPDEWDDERLL-----------REVKATVLALTEGEYRFDE 164 (219)
T ss_dssp CCEEESCCEETTTB------------SSCSCCHHHHH-----------HHHHHHHHHHTTCSSCHHH
T ss_pred CcEEEEEcCCcccC------------CCCCCCHHHHH-----------HHHHHHHHHHHcCCCCHHH
Confidence 99999887763221 11112233222 2466788888888777643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 577 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-90 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-89 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-88 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-85 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-84 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-82 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-81 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-80 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-79 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-78 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-77 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-76 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-76 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-75 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-74 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-73 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-72 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-71 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-71 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-71 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-70 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-70 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-69 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-69 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-69 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-68 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-68 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-68 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-67 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-67 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-66 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-66 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-66 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-66 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-65 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-64 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-63 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-63 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-63 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-62 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-62 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-61 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-61 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-61 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-60 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-59 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-59 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-58 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-56 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-55 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-53 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-39 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-25 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 276 bits (708), Expect = 8e-90
Identities = 118/268 (44%), Positives = 169/268 (63%), Gaps = 8/268 (2%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ + +G G+FG VYKA +KE + A KVID + SE+E+ED EI +L+ C P I
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNI 71
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ ++ ++ LWI++E+ AGG+V ++ + PL E I + + L A+ YLH+
Sbjct: 72 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 131
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ----NSEG 188
IHRD+KA NIL T +GD+K+ADFGVSA+ TRTI RR +F+GTP+WMAPEV+
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSL 246
Y+ KAD+WSLGIT+IEMA+ EPP +L+PMRVL I + PP L +S K+F+
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 251
Query: 247 CLKKVPAERPSAKELLRHRFIRNARKSP 274
CL+K R + +LL+H F+ P
Sbjct: 252 CLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 277 bits (709), Expect = 1e-89
Identities = 113/290 (38%), Positives = 167/290 (57%), Gaps = 10/290 (3%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRS 70
FS L IG GSFG VY A D ++ VAIK + +S ++ +DI KE+ L + R
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P +Y G YL + W++MEY G + L PL E+ IA + L + YLH+
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ--NSEG 188
IHRD+KA NILL+E G VK+ DFG + ++ +FVGTP+WMAPEVI +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFVGTPYWMAPEVILAMDEGQ 190
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-DEHFSRLMKEFVSLC 247
Y+ K D+WSLGIT IE+A+ +PPL +++ M L+ I + P L H+S + FV C
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPIN 297
L+K+P +RP+++ LL+HRF+ R +++ I +R K ++E +
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI-QRTKDAVRELDNLQYR 299
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 272 bits (697), Expect = 4e-88
Identities = 115/271 (42%), Positives = 170/271 (62%), Gaps = 5/271 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+++ E IG+G+ G VY A D ++VAI+ ++L++ + E I EI V+ + ++P I
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-ELIINEILVMRENKNPNI 79
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
Y SYL +LW++MEY+AGGS+ D++ DE IA + R+ L A+E+LH+ I
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQVI 138
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIK+ NILL +G VK+ DFG AQ+T S+R T VGTP+WMAPEV+ + Y K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKV 197
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGI IEM +GEPP + +P+R L++I P+L E S + ++F++ CL
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 252 PAERPSAKELLRHRFIRNARKSPRLLERIRE 282
+R SAKELL+H+F++ A+ L I
Sbjct: 258 VEKRGSAKELLQHQFLKIAKPLSSLTPLIAA 288
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 265 bits (678), Expect = 1e-85
Identities = 65/259 (25%), Positives = 123/259 (47%), Gaps = 4/259 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ ++ +G G++G+V A ++ + VA+K++D++ + D E+I+KEI + +
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
++YG ++ +EY +GG + D I+ + E L+ + YLH G
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRR--KTFVGTPFWMAPEVIQNSEGYNE 191
HRDIK N+LL E ++K++DFG++ R GT ++APE+++ E + E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLK 249
D+WS GI + M GE P + +E L+ + + L
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 245
Query: 250 KVPAERPSAKELLRHRFIR 268
+ P+ R + ++ + R+
Sbjct: 246 ENPSARITIPDIKKDRWYN 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (667), Expect = 5e-84
Identities = 82/265 (30%), Positives = 129/265 (48%), Gaps = 13/265 (4%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYI 73
+ L IG GS+G K K K + K +D +E E + + E+++L + + P I
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 74 TEYYGSYLHQT--KLWIIMEYMAGGSVADLIQSG----PPLDEMSIACILRDLLHAIEYL 127
YY + +T L+I+MEY GG +A +I G LDE + ++ L A++
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 128 HNEGK-----IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
H +HRD+K AN+ L +VK+ DFG++ L S K FVGTP++M+PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
+ YNEK+DIWSLG + E+ PP + I ++ +S + E
Sbjct: 186 MNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNE 244
Query: 243 FVSLCLKKVPAERPSAKELLRHRFI 267
++ L RPS +E+L + I
Sbjct: 245 IITRMLNLKDYHRPSVEEILENPLI 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (657), Expect = 1e-82
Identities = 81/258 (31%), Positives = 133/258 (51%), Gaps = 6/258 (2%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE--IEDIQKEISVLSQCRS 70
F +G+G FG+VY A +K+ +A+KV+ + E +++E+ + S R
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P I YG + T++++I+EY G+V +Q DE A + +L +A+ Y H++
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
IHRDIK N+LL G++K+ADFG S + RR T GT ++ PE+I+ ++
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEG-RMHD 182
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
EK D+WSLG+ E G+PP I R + + ++ +S LK
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-FPDFVTEGARDLISRLLKH 241
Query: 251 VPAERPSAKELLRHRFIR 268
P++RP +E+L H +I
Sbjct: 242 NPSQRPMLREVLEHPWIT 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 254 bits (651), Expect = 5e-81
Identities = 92/305 (30%), Positives = 148/305 (48%), Gaps = 47/305 (15%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
F + +G G+ G V+K K +A K+I LE I +E+ VL +C SPYI
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+YG++ ++ I ME+M GGS+ +++ + E + + ++ + YL + KI
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 134 -HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
HRD+K +NIL+ G++K+ DFGVS QL + +FVGT +M+PE +Q Y+ +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-THYSVQ 183
Query: 193 ADIWSLGITVIEMAKGEPPLAD-------------------------------------- 214
+DIWS+G++++EMA G P+
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 215 ----LHPMRVLFIIPRENPPQLDEH-FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269
+ +L I E PP+L FS ++FV+ CL K PAER K+L+ H FI+
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
Query: 270 ARKSP 274
+
Sbjct: 304 SDAEE 308
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (645), Expect = 1e-80
Identities = 73/266 (27%), Positives = 131/266 (49%), Gaps = 15/266 (5%)
Query: 14 RFSSLEL-IGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSP 71
RF ++ IGRGSF VYK D E +VA + + ++ E + ++E +L + P
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 72 YITEYYGSYLHQTK----LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
I +Y S+ K + ++ E M G++ ++ + + R +L +++L
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 128 HNEGK--IHRDIKAANILLT-ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
H IHRD+K NI +T G VK+ D G++ + + K +GTP +MAPE+ +
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPEMYE 186
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--IIPRENPPQLDEHFSRLMKE 242
Y+E D+++ G+ ++EMA E P ++ ++ + P D+ +KE
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIR 268
+ C+++ ER S K+LL H F +
Sbjct: 245 IIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 248 bits (633), Expect = 8e-79
Identities = 81/272 (29%), Positives = 132/272 (48%), Gaps = 18/272 (6%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL--------EESEDEIEDIQKEISVL 65
+ E++GRG V + K K+ A+K+ID+ EE ++ E KE+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 66 SQCRS-PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAI 124
+ P I + +Y T +++ + M G + D + L E I+R LL I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
LH +HRD+K NILL ++ ++K+ DFG S QL + + GTP ++APE+I+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIE 182
Query: 185 NSE-----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHF 236
S GY ++ D+WS G+ + + G PP M +L +I N + +
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242
Query: 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268
S +K+ VS L P +R +A+E L H F +
Sbjct: 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 248 bits (635), Expect = 1e-78
Identities = 76/279 (27%), Positives = 139/279 (49%), Gaps = 9/279 (3%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +++G G+F +V A DK K VAIK I + E + ++ EI+VL + + P I
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 69
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
Y L++IM+ ++GG + D I E + ++ +L A++YLH+ G +
Sbjct: 70 VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 134 HRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
HRD+K N+L E+ + ++DFG+S S T GTP ++APEV+ + Y+
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQ-KPYS 187
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLC 247
+ D WS+G+ + G PP D + ++ I + + S K+F+
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 247
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSPRLLER-IRERPK 285
++K P +R + ++ L+H +I + + + + E+ K
Sbjct: 248 MEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIK 286
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (625), Expect = 1e-77
Identities = 70/263 (26%), Positives = 135/263 (51%), Gaps = 15/263 (5%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSP 71
+ + + IG GSFG VYK + + DVA+K++++ + +++ + E+ VL + R
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNE 130
I + G Y +L I+ ++ G S+ + + + + I R ++YLH +
Sbjct: 65 NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTR--TISRRKTFVGTPFWMAPEVI--QNS 186
IHRD+K+ NI L E+ VK+ DFG++ +R + + G+ WMAPEVI Q+
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-----PRENPPQLDEHFSRLMK 241
Y+ ++D+++ GI + E+ G+ P ++++ + + + ++ + + MK
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 242 EFVSLCLKKVPAERPSAKELLRH 264
++ CLKK ERP ++L
Sbjct: 244 RLMAECLKKKRDERPLFPQILAS 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (620), Expect = 1e-76
Identities = 64/260 (24%), Positives = 127/260 (48%), Gaps = 6/260 (2%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSP 71
F +++G GSF V A + +++ AIK+++ E+++ + +E V+S+ P
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ + Y ++ KL+ + Y G + I+ DE +++ A+EYLH +G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTR--TISRRKTFVGTPFWMAPEVIQNSEGY 189
IHRD+K NILL E+ +++ DFG + L+ +R +FVGT +++PE++ +
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSA 187
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249
+ +D+W+LG + ++ G PP + + I + E F ++ V L
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-IKLEYDFPEKFFPKARDLVEKLLV 246
Query: 250 KVPAERPSAKELLRHRFIRN 269
+R +E+ + ++
Sbjct: 247 LDATKRLGCEEMEGYGPLKA 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 244 bits (623), Expect = 2e-76
Identities = 68/329 (20%), Positives = 134/329 (40%), Gaps = 15/329 (4%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ E +G G+FG V++ ++ + A K + E + E ++KEI +S R P +
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTL 85
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ ++ ++ +I E+M+GG + + + + E +R + + ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 133 IHRDIKAANILLT--ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
+H D+K NI+ T + ++K+ DFG++A L K GT + APEV + +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEG-KPVG 203
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLC 247
D+WS+G+ + G P + L + + S K+F+
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 263
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASG 307
L P R + + L H ++ P +I I++ T + G
Sbjct: 264 LLADPNTRMTIHQALEHPWLTPGNA-PGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLG 322
Query: 308 TVKVVRDKRSEETVQVSSQGQTVRNAGWN 336
+ R + Q ++R+A W+
Sbjct: 323 RISNYSSLR-----KHRPQEYSIRDAFWD 346
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 240 bits (613), Expect = 6e-75
Identities = 64/291 (21%), Positives = 131/291 (45%), Gaps = 15/291 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ LE +G G+FG V++ +K + K I+ D+ ++ EIS+++Q P +
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK-YTVKNEISIMNQLHHPKL 88
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ ++ + ++ +I+E+++GG + D I + + E + +R ++++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 133 IHRDIKAANILL--TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
+H DIK NI+ + VK+ DFG++ +L K T + APE++ E
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDR-EPVG 206
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLC 247
D+W++G+ + G P A + L + R + S K+F+
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSPR------LLERIRERPKYPIQEEP 292
L+K P +R + + L H +++ + +IR++ K + P
Sbjct: 267 LQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWP 317
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (607), Expect = 2e-74
Identities = 70/305 (22%), Positives = 137/305 (44%), Gaps = 12/305 (3%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
++ E +GRG FG V++ + K K + ++ ++ + ++KEIS+L+ R I
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHRNI 63
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ S+ +L +I E+++G + + I + L+E I + + A+++LH+
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 133 IHRDIKAANILLT--ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
H DI+ NI+ + +K+ +FG + QL + P + APEV Q+ + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQH-DVVS 181
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLC 247
D+WSLG V + G P +++ I + + S +FV
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241
Query: 248 LKKVPAERPSAKELLRHRFIRNA--RKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEA 305
L K R +A E L+H +++ R S +++ ++ R Y + D + A
Sbjct: 242 LVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISC 301
Query: 306 SGTVK 310
G ++
Sbjct: 302 GGAIR 306
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 7e-73
Identities = 73/260 (28%), Positives = 133/260 (51%), Gaps = 6/260 (2%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLS-QCRS 70
F +++G+GSFG V+ A K+ N+ AIK + + +D++E E VLS
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P++T + ++ + L+ +MEY+ GG + IQS D +++ +++LH++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
G ++RD+K NILL ++G +K+ADFG+ + ++ TF GTP ++APE++ + YN
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYN 181
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
D WS G+ + EM G+ P + I R + P + K+ + +
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-RMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 251 VPAERPSAK-ELLRHRFIRN 269
P +R + ++ +H R
Sbjct: 241 EPEKRLGVRGDIRQHPLFRE 260
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 2e-72
Identities = 75/291 (25%), Positives = 138/291 (47%), Gaps = 15/291 (5%)
Query: 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE-----IEDIQKEI 62
QE + + E +G G F V K +K A K I ++ EDI++E+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 63 SVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLH 122
S+L + + P + + Y ++T + +I+E +AGG + D + L E L+ +L+
Sbjct: 65 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGD----VKVADFGVSAQLTRTISRRKTFVGTPFWM 178
+ YLH+ H D+K NI+L + +K+ DFG++ ++ + K GTP ++
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFV 183
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEH 235
APE++ N E +AD+WS+G+ + G P L + N + +
Sbjct: 184 APEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKY 286
S L K+F+ L K P +R + ++ L+H +I+ + + + L P++
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP-KDTQQALSSAWSHPQF 292
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 2e-71
Identities = 72/273 (26%), Positives = 124/273 (45%), Gaps = 25/273 (9%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
L+ IG+G FGDV + VA+K I ++ + E SV++Q R
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSN 61
Query: 73 ITEYYGSYLHQ-TKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHN 129
+ + G + + L+I+ EYMA GS+ D ++S L + D+ A+EYL
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+HRD+ A N+L++E+ KV+DFG++ + + S + T W APE ++ + +
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS---STQDTGKLPVKWTAPEALRE-KKF 177
Query: 190 NEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248
+ K+D+WS GI + E+ + G P + V+ + + + + E + C
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPRLLERIR 281
A RPS +L LE I+
Sbjct: 238 HLDAAMRPSFLQLREQ------------LEHIK 258
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 5e-71
Identities = 67/286 (23%), Positives = 114/286 (39%), Gaps = 31/286 (10%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDL----EESEDEIEDIQKEISVLSQCRSPYI 73
L+ +G G F VYKA DK N+ VAIK I L E + +EI +L + P I
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
++ H++ + ++ ++M + + L I + L +EYLH +
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRD+K N+LL ENG +K+ADFG++ V T ++ APE++ + Y
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFII---------------------------PR 226
D+W++G + E+ P L + L I P
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 227 ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272
+ + + + P R +A + L+ ++ N
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 8e-71
Identities = 64/262 (24%), Positives = 115/262 (43%), Gaps = 12/262 (4%)
Query: 21 IGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+G G+FG V + + K DVAIKV+ + + E++ +E ++ Q +PYI G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
L ++ME GG + + + ++A +L + ++YL + +HRD+
Sbjct: 77 -VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135
Query: 138 KAANILLTENGDVKVADFGVSAQLTR---TISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
A N+LL K++DFG+S L + R W APE I ++ ++D
Sbjct: 136 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSD 194
Query: 195 IWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPA 253
+WS G+T+ E + G+ P + V+ I + + + +S C
Sbjct: 195 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWE 254
Query: 254 ERPSAKEL---LRHRFIRNARK 272
+RP + +R + A K
Sbjct: 255 DRPDFLTVEQRMRACYYSLASK 276
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 2e-70
Identities = 61/256 (23%), Positives = 112/256 (43%), Gaps = 12/256 (4%)
Query: 21 IGRGSFGDVYKAF--DKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPYITEYY 77
+G G+FG V K + K++ K VA+K++ E +++ E +V+ Q +PYI
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
G ++ME G + +Q + + +I ++ + ++YL +HRD+
Sbjct: 75 G-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 138 KAANILLTENGDVKVADFGVSAQLT---RTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
A N+LL K++DFG+S L + W APE I ++ K+D
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSD 192
Query: 195 IWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPA 253
+WS G+ + E + G+ P + V ++ + R M + ++LC
Sbjct: 193 VWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVE 252
Query: 254 ERPSAKEL---LRHRF 266
RP + LR+ +
Sbjct: 253 NRPGFAAVELRLRNYY 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 5e-70
Identities = 82/288 (28%), Positives = 140/288 (48%), Gaps = 11/288 (3%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPY 72
F L+L+G+G+FG V +K + A+K++ E ++DE+ E VL R P+
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+T ++ +L +MEY GG + + E +++ A+EYLH+
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
++RDIK N++L ++G +K+ DFG+ + + KTF GTP ++APEV+++ Y
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRA 185
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252
D W LG+ + EM G P + R+ +I + S K ++ LKK P
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-LMEEIRFPRTLSPEAKSLLAGLLKKDP 244
Query: 253 AERPS-----AKELLRHRFIRNARKSPRLLERIRERPKYP-IQEEPDT 294
+R AKE++ HRF + ++++ P P + E DT
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLSINWQ-DVVQKKLLPPFKPQVTSEVDT 291
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 226 bits (577), Expect = 2e-69
Identities = 71/292 (24%), Positives = 134/292 (45%), Gaps = 15/292 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEISVLSQC 68
FS +IGRG FG+VY + K A+K +D +++ E + + +S++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
P+I ++ KL I++ M GG + + E + +++ +E++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
N ++RD+K ANILL E+G V+++D G++ ++ + VGT +MAPEV+Q
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVA 182
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPRENPPQLDEHFSRLMKEFVSL 246
Y+ AD +SLG + ++ +G P + + +L + FS ++ +
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 242
Query: 247 CLKKVPAERPS-----AKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPD 293
L++ R A+E+ F R+ + + P P + E +
Sbjct: 243 LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ-MVFLQKYPPPLIPPRGEVN 293
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 224 bits (571), Expect = 4e-69
Identities = 80/289 (27%), Positives = 138/289 (47%), Gaps = 15/289 (5%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPY 72
F L +G GSFG V+ + + A+KV+ E ++E E +LS P+
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I +G++ ++++IM+Y+ GG + L++ ++ A+EYLH++
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
I+RD+K NILL +NG +K+ DFG + + T GTP ++APEV+ + YN+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVST-KPYNKS 181
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252
D WS GI + EM G P D + M+ I + F+ +K+ +S + +
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-LNAELRFPPFFNEDVKDLLSRLITRDL 240
Query: 253 AER-----PSAKELLRHRFIRNARKSPRLLERIRERPKYP--IQEEPDT 294
++R +++ H + + +LL R E P P Q + DT
Sbjct: 241 SQRLGNLQNGTEDVKNHPWFKEVVWE-KLLSRNIETPYEPPIQQGQGDT 288
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 7e-69
Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 7/253 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ L+ +G G FG V + DVAIK+I ++ + +E V+ +
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED--EFIEEAKVMMNLSHEKLV 62
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ YG Q ++II EYMA G + + ++ + + +D+ A+EYL ++ +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQNSEGYNEK 192
HRD+ A N L+ + G VKV+DFG+S + W PEV+ ++ K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSK 181
Query: 193 ADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251
+DIW+ G+ + E+ + G+ P I + S + + C +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 241
Query: 252 PAERPSAKELLRH 264
ERP+ K LL +
Sbjct: 242 ADERPTFKILLSN 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 222 bits (566), Expect = 8e-69
Identities = 75/302 (24%), Positives = 127/302 (42%), Gaps = 45/302 (14%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQ 67
+ + IG G+FG V++A L VA+K++ E S D D Q+E +++++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 68 CRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS----------------------- 104
+P I + G + ++ EYMA G + + ++S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 105 -GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-- 161
PPL CI R + + YL +HRD+ N L+ EN VK+ADFG+S +
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRV 220
WM PE I Y ++D+W+ G+ + E+ + G P + V
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 221 LFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280
++ + N E+ + + LC K+PA+RPS + R+L+R+
Sbjct: 252 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH------------RILQRM 299
Query: 281 RE 282
E
Sbjct: 300 CE 301
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 221 bits (565), Expect = 2e-68
Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 13/274 (4%)
Query: 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISV 64
+E S ++IG G FG+V K K VAIK + +E + D E S+
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 65 LSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL-IQSGPPLDEMSIACILRDLLHA 123
+ Q P + G T + II E+M GS+ Q+ + + +LR +
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-----TRTISRRKTFVGTPFWM 178
++YL + +HRD+ A NIL+ N KV+DFG+S L T + W
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFS 237
APE IQ + +D+WS GI + E+ + GE P D+ V+ I ++
Sbjct: 201 APEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259
Query: 238 RLMKEFVSLCLKKVPAERPSAKELLRH--RFIRN 269
+ + + C +K RP +++ + IRN
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 2e-68
Identities = 71/273 (26%), Positives = 123/273 (45%), Gaps = 19/273 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
S + ++ IG G FG V+ + VAIK I +E D +E V+ + P
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE--DFIEEAEVMMKLSHPK 61
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPL-DEMSIACILRDLLHAIEYLHNEG 131
+ + YG L Q + ++ E+M G ++D +++ L ++ + D+ + YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTR-TISRRKTFVGTPFWMAPEVIQNSEGYN 190
IHRD+ A N L+ EN +KV+DFG++ + + W +PEV S Y+
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYS 180
Query: 191 EKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249
K+D+WS G+ + E+ ++G+ P + V+ I S + + ++ C K
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK 240
Query: 250 KVPAERPSAKELLRHRFIRNARKSPRLLERIRE 282
+ P +RP+ LLR L I E
Sbjct: 241 ERPEDRPAFSRLLRQ------------LAEIAE 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 5e-68
Identities = 76/296 (25%), Positives = 135/296 (45%), Gaps = 32/296 (10%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CRSPYITEYY 77
+++G G G V + F+K + A+K++ + ++E+ + + + P+I
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVRIV 71
Query: 78 GSY----LHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG 131
Y + L I+ME + GG + IQ E + I++ + AI+YLH+
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 132 KIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
HRD+K N+L T N +K+ DFG + + T + T TP+++APEV+ E
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVL-GPEK 189
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------ENPPQLDEHFSRLMK 241
Y++ D+WSLG+ + + G PP H + + + E P S +K
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 249
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARKSP-------RLLERIRERPKYPIQE 290
+ LK P +R + E + H +I + K P R+L+ +ER + +E
Sbjct: 250 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 305
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 7e-68
Identities = 70/275 (25%), Positives = 114/275 (41%), Gaps = 18/275 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIE-----DIQKEISVLSQ 67
S++ L+G G FG VY N VAIK ++ + D E + E+ +L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 68 CRSPY--ITEYYGSYLHQTKLWIIMEYMAGGS-VADLIQSGPPLDEMSIACILRDLLHAI 124
S + + + +I+E + D I L E +L A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 125 EYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI 183
+ HN G +HRDIK NIL+ N G++K+ DFG A L T F GT + PE I
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWI 181
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243
+ + A +WSLGI + +M G+ P + + S +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------IRGQVFFRQRVSSECQHL 234
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278
+ CL P++RP+ +E+ H ++++ E
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 218 bits (557), Expect = 1e-67
Identities = 72/267 (26%), Positives = 129/267 (48%), Gaps = 13/267 (4%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSP 71
R+ E++G G +V+ A D L++DVA+KV+ DL ++E + P
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 72 YITEYYGSYLHQTK----LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
I Y + +T +I+MEY+ G ++ D++ + P+ ++ D A+ +
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQL---TRTISRRKTFVGTPFWMAPEVIQ 184
H G IHRD+K ANI+++ VKV DFG++ + ++++ +GT +++PE +
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMK 241
+ + ++D++SLG + E+ GEPP P+ V + RE+ P E S +
Sbjct: 188 G-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIR 268
V L K P R +R +R
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 3e-67
Identities = 79/322 (24%), Positives = 130/322 (40%), Gaps = 40/322 (12%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
G R+++L IG G++G V A+D VAIK I E + + +EI +L + R
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 72 YITEYYGSYLHQT----KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
I T K ++ ++ G + L+++ L I L +L ++Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT---RTISRRKTFVGTPFWMAPEVIQ 184
H+ +HRD+K +N+LL D+K+ DFG++ +V T ++ APE++
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------------------- 224
NS+GY + DIWS+G + EM P H + L I
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 225 -------PRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRNARKSP 274
P +N + F + + L L P +R ++ L H ++
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305
Query: 275 RLLERIRERPKYPIQEEPDTPI 296
E I E P E D P
Sbjct: 306 D--EPIAEAPFKFDMELDDLPK 325
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 8e-67
Identities = 72/279 (25%), Positives = 112/279 (40%), Gaps = 20/279 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCR 69
R IG G FGDV++ VAIK S+ E +E + Q
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLH 128
P+I + G + + +WIIME G + +Q LD S+ L A+ YL
Sbjct: 67 HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQNSE 187
++ +HRDI A N+L++ N VK+ DFG+S + + + + WMAPE I N
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 184
Query: 188 GYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246
+ +D+W G+ + E+ G P + V+ I + + + ++
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 244
Query: 247 CLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPK 285
C P+ RP EL L I E K
Sbjct: 245 CWAYDPSRRPRFTELKAQ------------LSTILEEEK 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-66
Identities = 61/255 (23%), Positives = 113/255 (44%), Gaps = 9/255 (3%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+E +G G FG+V+ + + VA+K + + + E +++ Q +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQR 69
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNE 130
+ Y + Q ++II EYM GS+ D + SG L + + + + ++
Sbjct: 70 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQNSEGY 189
IHRD++AANIL+++ K+ADFG++ + + W APE I +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTF 187
Query: 190 NEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248
K+D+WS GI + E+ G P + V+ + R ++ + + + LC
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247
Query: 249 KKVPAERPSAKELLR 263
K+ P +RP+ L
Sbjct: 248 KERPEDRPTFDYLRS 262
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 3e-66
Identities = 60/285 (21%), Positives = 110/285 (38%), Gaps = 34/285 (11%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ 67
+++G G+FG V A ++K VA+K++ + E E + E+ +++Q
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 68 CRS-PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS---------------------- 104
S I G+ +++I EY G + + ++S
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 105 -GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT- 162
L + C + +E+L + +HRD+ A N+L+T VK+ DFG++ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 163 -RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRV 220
R WMAPE + Y K+D+WS GI + E+ + G P +
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 221 LF-IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ +I + + + + C +RPS L
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 215 bits (548), Expect = 3e-66
Identities = 71/284 (25%), Positives = 122/284 (42%), Gaps = 30/284 (10%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
++ LE IG G++G VYKA + + A+K I LE E E +EIS+L + +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I + Y + +L ++ E++ L L+ ++ L LL+ I Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
+HRD+K N+L+ G++K+ADFG++ + + + T ++ AP+V+ S+ Y+
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFII---------------------------- 224
DIWS+G EM G P + L I
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268
+ + +S LK P +R +AK+ L H + +
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 5e-66
Identities = 65/263 (24%), Positives = 115/263 (43%), Gaps = 11/263 (4%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+G+G FG+V+ + VAIK + E +E V+ + R
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 73
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNE 130
+ + Y + + ++I+ EYM+ GS+ D + ++G L + + + + Y+
Sbjct: 74 LVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGTPFWMAPEVIQNSEGY 189
+HRD++AANIL+ EN KVADFG++ + + R+ W APE +
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRF 191
Query: 190 NEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248
K+D+WS GI + E+ KG P + VL + R + + + C
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 251
Query: 249 KKVPAERPSAKELLR--HRFIRN 269
+K P ERP+ + L + +
Sbjct: 252 RKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 7e-66
Identities = 70/279 (25%), Positives = 116/279 (41%), Gaps = 12/279 (4%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQC 68
S + ++IG G FG+VYK K + VAIK + +E + D E ++ Q
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL-IQSGPPLDEMSIACILRDLLHAIEYL 127
I G + II EYM G++ + + + +LR + ++YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF---VGTPFWMAPEVIQ 184
N +HRD+ A NIL+ N KV+DFG+S L T W APE I
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 185 NSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243
+ +D+WS GI + E+ GE P +L V+ I + +
Sbjct: 187 Y-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRE 282
+ C ++ A RP +++ + ++P L+ + +
Sbjct: 246 MMQCWQQERARRPKFADIV--SILDKLIRAPDSLKTLAD 282
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-65
Identities = 73/299 (24%), Positives = 128/299 (42%), Gaps = 34/299 (11%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-R 69
+ ++IG G+FG V KA K+ L D AIK + S+D+ D E+ VL +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----------------SGPPLDEMSI 113
P I G+ H+ L++ +EY G++ D ++ + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 114 ACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
D+ ++YL + IHRD+ A NIL+ EN K+ADFG+ ++ ++
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL-SRGQEVYVKKTMGRL 188
Query: 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQL 232
WMA E + N Y +D+WS G+ + E+ + G P + + +P+ +
Sbjct: 189 PVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEE 291
+ + + + C ++ P ERPS ++L L R+ E K +
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS------------LNRMLEERKTYVNTT 294
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (541), Expect = 3e-65
Identities = 67/274 (24%), Positives = 132/274 (48%), Gaps = 9/274 (3%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ + +G G +G+VY+ K+ + VA+K + E E+E+ KE +V+ + + P
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 74
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ--SGPPLDEMSIACILRDLLHAIEYLHNE 130
+ + G + +II E+M G++ D ++ + + + + + + A+EYL +
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV-GTPFWMAPEVIQNSEGY 189
IHRD+ A N L+ EN VKVADFG+S +T W APE + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKF 193
Query: 190 NEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248
+ K+D+W+ G+ + E+A G P + +V ++ ++ + E + E + C
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253
Query: 249 KKVPAERPSAKELLR--HRFIRNARKSPRLLERI 280
+ P++RPS E+ + + + S + + +
Sbjct: 254 QWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 287
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 6e-64
Identities = 73/289 (25%), Positives = 122/289 (42%), Gaps = 30/289 (10%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
F +E IG G++G VYKA +K + VA+K I L+ E+E +EIS+L + P
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADL-IQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
I + + KL+++ E++ + + + I L LL + + H+
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
+HRD+K N+L+ G +K+ADFG++ + V T ++ APE++ + Y+
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFII--------------------------- 224
DIWSLG EM + LF I
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 225 -PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272
R++ ++ + +S L P +R SAK L H F ++ K
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 7e-64
Identities = 58/256 (22%), Positives = 109/256 (42%), Gaps = 11/256 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
E+IGRG FG VY + + A+K ++ E+ E ++ P +
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 76 YYGSYLH-QTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
G L + +++ YM G + + I+ + + +++L ++ +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQL----TRTISRRKTFVGTPFWMAPEVIQNSEGY 189
HRD+ A N +L E VKVADFG++ + ++ + WMA E +Q + +
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKF 211
Query: 190 NEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248
K+D+WS G+ + E+ +G PP D++ + + + E+ + E + C
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 271
Query: 249 KKVPAERPSAKELLRH 264
RPS EL+
Sbjct: 272 HPKAEMRPSFSELVSR 287
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-63
Identities = 59/290 (20%), Positives = 110/290 (37%), Gaps = 20/290 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
F ++++G G+FG VYK + VAIK + S ++I E V++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P++ G L T I G + + + + + + + YL +
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT--FVGTPFWMAPEVIQNSEG 188
+HRD+ A N+L+ VK+ DFG++ L WMA E I +
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RI 189
Query: 189 YNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247
Y ++D+WS G+TV E+ G P + + I+ + + + + C
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPIN 297
RP +EL+ ++ P+ + + D ++
Sbjct: 250 WMIDADSRPKFRELIIE------------FSKMARDPQRYLVIQGDERMH 287
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-63
Identities = 64/301 (21%), Positives = 120/301 (39%), Gaps = 44/301 (14%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSP 71
S++ L IG+G+FG+V+KA ++ + VA+K + +E E E +EI +L +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 72 YITEYYGSYLHQT--------KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHA 123
+ + ++++ ++ L I +++ LL+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT----ISRRKTFVGTPFWMA 179
+ Y+H +HRD+KAAN+L+T +G +K+ADFG++ + +R V T ++
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------PRENPPQL 232
PE++ Y D+W G + EM P + L +I E P +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 233 DEH------------------------FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268
D + + + L PA+R + + L H F
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309
Query: 269 N 269
+
Sbjct: 310 S 310
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-63
Identities = 59/260 (22%), Positives = 110/260 (42%), Gaps = 13/260 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKD---VAIKVI--DLEESEDEIEDIQKEISVLSQC 68
LE +G GSFG V + + VA+K + D+ + ++D +E++ +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYL 127
+ YG L + ++ E GS+ D ++ +++ + + YL
Sbjct: 69 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR---TISRRKTFVGTPFWMAPEVIQ 184
++ IHRD+ A N+LL VK+ DFG+ L + ++ W APE ++
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 185 NSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENP-PQLDEHFSRLMKE 242
++ +D W G+T+ EM G+ P L+ ++L I +E E + +
Sbjct: 188 T-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246
Query: 243 FVSLCLKKVPAERPSAKELL 262
+ C P +RP+ L
Sbjct: 247 VMVQCWAHKPEDRPTFVALR 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-63
Identities = 64/270 (23%), Positives = 118/270 (43%), Gaps = 19/270 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ 67
+ + +G+GSFG VY+ K + KD VAIK ++ S E + E SV+ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 68 CRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----------SGPPLDEMSIACIL 117
++ G +IME M G + ++ P + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 118 RDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT--FVGTP 175
++ + YL+ +HRD+ A N ++ E+ VK+ DFG++ + T RK +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDE 234
WM+PE +++ + +D+WS G+ + E+A E P L +VL + +
Sbjct: 200 RWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258
Query: 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ ++ E + +C + P RPS E++
Sbjct: 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (524), Expect = 6e-62
Identities = 79/289 (27%), Positives = 137/289 (47%), Gaps = 14/289 (4%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSP 71
+F ++ +G GSFG V KE A+K++D ++ +IE E +L P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
++ + S+ + L+++MEY+AGG + ++ E ++ EYLH+
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
I+RD+K N+L+ + G ++V DFG + R R T GTP +APE+I + +GYN+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEIILS-KGYNK 217
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251
D W+LG+ + EMA G PP P+++ I + HFS +K+ + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-GKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 252 PAER-----PSAKELLRHRFIRNARKSPRLLERIRERPKYP-IQEEPDT 294
+R ++ H++ + +R E P P + DT
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFATTDWI-AIYQRKVEAPFIPKFKGPGDT 324
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (519), Expect = 8e-62
Identities = 52/279 (18%), Positives = 100/279 (35%), Gaps = 25/279 (8%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
G+R+ IG GSFGD+Y D ++VAIK+ ++ ++ E + +
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL---HIESKIYKMMQGG 62
Query: 72 -YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
I ++ME + ++ + ++ IEY+H++
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 131 GKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTIS-------RRKTFVGTPFWMAP 180
IHRD+K N L+ V + DFG++ + + K GT + +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-------PPQLD 233
+ + D+ SLG ++ G P L R + L
Sbjct: 183 NTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 234 EHFSRLMKEFVSLCLKKVPAERPSA---KELLRHRFIRN 269
+ + +++ C ++P ++L R+ F R
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-61
Identities = 66/288 (22%), Positives = 124/288 (43%), Gaps = 30/288 (10%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
++ LE IG G++G V+KA ++E ++ VA+K + L+ + E +EI +L + +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I + KL ++ E+ LD + L LL + + H+
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
+HRD+K N+L+ NG++K+A+FG++ + V T ++ P+V+ ++ Y+
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 193 ADIWSLGITVIEMAKGEPPLADLHP--------MRVLFIIPRENPPQLDE---------- 234
D+WS G E+A PL + R+L E P + +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 235 -----------HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271
+ ++ + LK P +R SA+E L+H + +
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (513), Expect = 6e-61
Identities = 65/279 (23%), Positives = 128/279 (45%), Gaps = 28/279 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVL 65
R + +G G+FG V A L+KD VA+K++ + +E ++ D+ E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 66 SQC-RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP----------------L 108
+ I G+ L++I+EY + G++ + +Q+ P L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 109 DEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168
+ + +EYL ++ IHRD+ A N+L+TE+ +K+ADFG++ + +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 169 KTFV--GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIP 225
KT WMAPE + + Y ++D+WS G+ + E+ G P + + ++
Sbjct: 193 KTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ + + + + C VP++RP+ K+L+
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 201 bits (511), Expect = 9e-61
Identities = 51/301 (16%), Positives = 98/301 (32%), Gaps = 34/301 (11%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
G + IG GSFG +++ + N+ VAIK ++ D + +L+ C
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGI 63
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
Y+G ++++ + L G ++A + +L ++ +H +
Sbjct: 64 PNVYYFGQ--EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 132 KIHRDIKAANILLTE-----NGDVKVADFGVSAQLTRTIS-------RRKTFVGTPFWMA 179
++RDIK N L+ + V DFG+ ++ +K GT +M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------PRENPPQL 232
+ + D+ +LG + +G P L +L
Sbjct: 182 INTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEP 292
F +++ P L L ++ ER E
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQ------------GLFSKVLERLNTTEDENF 288
Query: 293 D 293
D
Sbjct: 289 D 289
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 4e-60
Identities = 71/296 (23%), Positives = 129/296 (43%), Gaps = 39/296 (13%)
Query: 14 RFSSLELIGRGSFGDVYKAFD-KELNKDVAIKVIDLEESEDEIE-DIQKEISV---LSQC 68
++ + IG G++G V+KA D K + VA+K + ++ E+ + +E++V L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 69 RSPYITEYYGSYL-----HQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLH 122
P + + +TKL ++ E++ L + P + +I ++ LL
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
+++LH+ +HRD+K NIL+T +G +K+ADFG A++ + V T ++ APEV
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG-LARIYSFQMALTSVVVTLWYRAPEV 186
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------ 224
+ S Y D+WS+G EM + +P + L I
Sbjct: 187 LLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 225 --------PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272
+ + L K+ + CL PA+R SA L H + ++ +
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 7e-60
Identities = 67/279 (24%), Positives = 113/279 (40%), Gaps = 29/279 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ 67
+R S + +G G+FG V +A L K VA+K++ E E + E+ VLS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 68 C-RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS------------------GPPL 108
I G+ +I EY G + + ++ L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 109 DEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168
D + + + +L ++ IHRD+ A NILLT K+ DFG++ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 169 KT--FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIP 225
WMAPE I N Y ++D+WS GI + E+ + G P + + +
Sbjct: 203 VKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 226 REN-PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
+E EH M + + C P +RP+ K++++
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-59
Identities = 84/310 (27%), Positives = 143/310 (46%), Gaps = 19/310 (6%)
Query: 2 ADLAGLQEAAG-SRFSSLELIGRGSFGDVYKAFD---KELNKDVAIKVID---LEESEDE 54
A+L G E G F L+++G G++G V+ + K A+KV+ + +
Sbjct: 12 ANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 71
Query: 55 IEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSI 113
E + E VL R SP++ + ++ +TKL +I++Y+ GG + + E +
Sbjct: 72 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV 131
Query: 114 ACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT-RTISRRKTFV 172
+ +++ A+E+LH G I+RDIK NILL NG V + DFG+S + R F
Sbjct: 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 191
Query: 173 GTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---EN 228
GT +MAP++++ + G+++ D WSLG+ + E+ G P I R ++
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPS-----AKELLRHRFIRNARKSPRLLERIRER 283
P + S L K+ + L K P +R A E+ H F + L +
Sbjct: 252 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD-DLAAKKVPA 310
Query: 284 PKYPIQEEPD 293
P P+ +
Sbjct: 311 PFKPVIRDEL 320
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 4e-59
Identities = 65/310 (20%), Positives = 118/310 (38%), Gaps = 44/310 (14%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
++ ++IG GSFG VY+A + + VAIK + ++ +E+ ++ + I
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 75
Query: 74 TEYYGSYLHQTK------LWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAI 124
+ + L ++++Y+ ++ L + + + L ++
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 EYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI 183
Y+H+ G HRDIK N+LL + +K+ DFG + QL R +++ + ++ APE+I
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 194
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------- 224
+ Y D+WS G + E+ G+P + L I
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 225 PRENPPQLDEH---------FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPR 275
PQ+ H S L+ P R + E H F R
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 314
Query: 276 LLERIRERPK 285
L R+ P
Sbjct: 315 KLPNGRDTPA 324
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-58
Identities = 71/316 (22%), Positives = 127/316 (40%), Gaps = 46/316 (14%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSP 71
+ + L+ +G G++G V A D VAIK + +SE + +E+ +L R
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 72 YITEYYGSYLHQ------TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125
+ + T +++M +M G + L++ L E I ++ +L +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK-LGEDRIQFLVYQMLKGLR 135
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
Y+H G IHRD+K N+ + E+ ++K+ DFG++ Q S +V T ++ APEVI N
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVILN 192
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII--------------------- 224
Y + DIWS+G + EM G+ + L I
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 225 ---------PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPR 275
+++ + + S L + L +R +A E L H + + +
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT-- 310
Query: 276 LLERIRERPKYPIQEE 291
E + KY +
Sbjct: 311 --EDEPQVQKYDDSFD 324
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 191 bits (487), Expect = 7e-57
Identities = 55/300 (18%), Positives = 115/300 (38%), Gaps = 49/300 (16%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPY 72
+ + +GRG + +V++A + N+ V +K++ + + I++EI +L R P
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGPN 91
Query: 73 ITEYYGSYLHQTK--LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
I ++ E++ L Q L + I + ++L A++Y H+
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM 148
Query: 131 GKIHRDIKAANILLT-ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
G +HRD+K N+++ E+ +++ D+G+ A+ V + ++ PE++ + + Y
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 190 NEKADIWSLGITVIEMAKGEPPL------------------------------------- 212
+ D+WSLG + M + P
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267
Query: 213 ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272
D+ R + S +F+ L+ R +A+E + H + K
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-56
Identities = 61/279 (21%), Positives = 115/279 (41%), Gaps = 28/279 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ 67
R + +GRG+FG V +A ++K VA+K++ + E + E+ +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 68 CRSPYITEYYGSYLHQT--KLWIIMEYMAGGSVADLIQS----------------GPPLD 109
+ L +I+E+ G+++ ++S L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 110 EMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR--TISR 167
+ C + +E+L + IHRD+ A NILL+E VK+ DFG++ + + R
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLF-IIP 225
+ WMAPE I + Y ++D+WS G+ + E+ P + +
Sbjct: 193 KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ ++ + M + + C P++RP+ EL+ H
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-55
Identities = 60/320 (18%), Positives = 126/320 (39%), Gaps = 45/320 (14%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRS 70
R+ +L +G G++G V AFD + VA+K + +S + +E+ +L +
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 71 PYITEYYGSYLHQTKLW-----IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125
+ + L ++ ++ G + ++++ L + + ++ +L ++
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLK 135
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
Y+H+ IHRD+K +N+ + E+ ++K+ DFG++ +V T ++ APE++ N
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLN 192
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII--------------------- 224
YN+ DIWS+G + E+ G + L +I
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 225 ---------PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK--- 272
P+ N + + L + + L +R +A + L H +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312
Query: 273 --SPRLLERIRERPKYPIQE 290
++ E I E
Sbjct: 313 EPVADPYDQSFESRDLLIDE 332
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 5e-55
Identities = 61/308 (19%), Positives = 119/308 (38%), Gaps = 59/308 (19%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
E IG+G FG+V++ + ++VA+K+ E + EI R I +
Sbjct: 8 QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFR--EAEIYQTVMLRHENILGFI 63
Query: 78 GSY----LHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK- 132
+ T+LW++ +Y GS+ D + + + + + +LH E
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 133 -------IHRDIKAANILLTENGDVKVADFGVSAQL----TRTISRRKTFVGTPFWMAPE 181
HRD+K+ NIL+ +NG +AD G++ + VGT +MAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 182 VIQNSEG-----YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF 236
V+ +S ++ADI+++G+ E+A+ ++ + + P ++E
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 237 ---------------------SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPR 275
R+M + + C A R +A + +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT----------- 291
Query: 276 LLERIRER 283
L ++ ++
Sbjct: 292 -LSQLSQQ 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 5e-53
Identities = 72/332 (21%), Positives = 137/332 (41%), Gaps = 60/332 (18%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
R+ +L+ IG G+ G V A+D L+++VAIK + +++ + +E+ ++
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 73 ITEYYGSYLHQ------TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEY 126
I + Q ++++ME M + LD ++ +L +L I++
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKH 134
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
LH+ G IHRD+K +NI++ + +K+ DFG+ A+ T +V T ++ APEVI
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILG- 192
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM------ 240
GY E DIWS+G + EM + + + + + E +L
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 241 -----------------------------------KEFVSLCLKKVPAERPSAKELLRHR 265
++ +S L PA+R S + L+H
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 266 FIRNARK-------SPRLLERIRERPKYPIQE 290
+I P++ ++ + ++ I+E
Sbjct: 313 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEE 344
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (364), Expect = 5e-39
Identities = 59/345 (17%), Positives = 122/345 (35%), Gaps = 78/345 (22%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+R+ + +G G F V+ A D N VA+K++ ++ E + EI +L +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT--EAAEDEIKLLQRVNDAD 70
Query: 73 ITE-------------YYGSYLHQTKLWIIMEYMAGGSVADLI---QSGPPLDEMSIACI 116
T+ + ++ + ++M + G + + + + I
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 117 LRDLLHAIEYLHNEGKI-HRDIKAANILLTENG------DVKVADFGVSAQLTRTISRRK 169
+ LL ++Y+H I H DIK N+L+ +K+AD G +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYT 187
Query: 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPP---------LADLHPMRV 220
+ T + +PEV+ + + ADIWS + E+ G+ D +
Sbjct: 188 NSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 221 LFIIPRENPP--------------------------------------QLDEHFSRLMKE 242
+ + E P + + ++ + +
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYP 287
F+S L+ P +R A L+ H ++++ + R+ +R Y
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEI--RVPDRELYG 349
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 100 bits (250), Expect = 4e-25
Identities = 30/205 (14%), Positives = 71/205 (34%), Gaps = 38/205 (18%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE-----------------IEDIQKE 61
+L+G G V+ + ++ + +K + + + I + E
Sbjct: 6 KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 62 ISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLL 121
L + + + + Y + ++ME + + + + +L +L
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELY-------RVRVENPDEVLDMIL 113
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPE 181
+ ++ G +H D+ N+L++E G + + DF S ++ R
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWRE------ILERDVR 166
Query: 182 VIQN--SEGYNEKADIWSLGITVIE 204
I S Y + DI S +++
Sbjct: 167 NIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 577 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.66 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.1 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.94 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.93 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.75 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-60 Score=482.76 Aligned_cols=258 Identities=24% Similarity=0.420 Sum_probs=222.5
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
-++|++++.||+|+||+||+|.++.+|+.||||+++........+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46899999999999999999999999999999999876655556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc--cccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRRK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~--~~~~ 169 (577)
||++|+|.+++.....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.... ....
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 99999999999888899999999999999999999999999999999999999999999999999998765432 2234
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc--CCCCCCCchhhhhHHHHHHHHHh
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII--PRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i--~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
..+||+.|||||++.+..+++.++|||||||+||+|++|.+||............ ...........++..+++||.+|
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 243 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 243 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHH
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHH
Confidence 6789999999999988765678899999999999999999999765543322221 22222333457899999999999
Q ss_pred cccCCCCCCcHHHHhhcHhhhh
Q 008116 248 LKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 248 L~~dP~~RpTa~elL~hpff~~ 269 (577)
|.+||.+|||+.|+|+||||++
T Consensus 244 L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 244 LVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp SCSSTTTSCCHHHHTTCTTTTC
T ss_pred cCCChhHCcCHHHHhcCHhhCc
Confidence 9999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-60 Score=484.04 Aligned_cols=261 Identities=43% Similarity=0.775 Sum_probs=231.5
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..+|++++.||+|+||+||+|.++.+|+.||||++...... ..+.+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 46899999999999999999999999999999999765433 34678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
||+||+|.+++.+ .++++..++.|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..........
T Consensus 98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred ecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence 9999999999876 579999999999999999999999999999999999999999999999999998876555555677
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCchhhhhHHHHHHHHHhcc
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~--~~~l~~~~s~~l~~lI~~cL~ 249 (577)
+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||...+....+..+.... ....+..++..+++||.+||.
T Consensus 177 ~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 255 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255 (293)
T ss_dssp CSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred ccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence 899999999999875 48999999999999999999999998877665554443322 234467889999999999999
Q ss_pred cCCCCCCcHHHHhhcHhhhhccCChh
Q 008116 250 KVPAERPSAKELLRHRFIRNARKSPR 275 (577)
Q Consensus 250 ~dP~~RpTa~elL~hpff~~~~~~~~ 275 (577)
+||.+|||+.|+|+||||+.....+.
T Consensus 256 ~dP~~R~s~~eil~Hp~~~~~~~~~~ 281 (293)
T d1yhwa1 256 MDVEKRGSAKELLQHQFLKIAKPLSS 281 (293)
T ss_dssp SSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred CChhHCcCHHHHhcCHhhCCCCCCCc
Confidence 99999999999999999986554443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-60 Score=475.93 Aligned_cols=253 Identities=32% Similarity=0.533 Sum_probs=227.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++++.||+|+||+||+|.++.+++.||||++.+... ......+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999865431 223567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|||++|+|.+++...+++++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|...... ....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--~~~~ 163 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTT 163 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--CCEE
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--cccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999766433 3346
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
.+||+.|||||++.+. .|+.++|||||||+||+|++|.+||...+.......+.... +.++..+++++++||.+||.+
T Consensus 164 ~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 241 (263)
T d2j4za1 164 LCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKH 241 (263)
T ss_dssp TTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHTCS
T ss_pred cCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHccC
Confidence 7899999999999876 48999999999999999999999999887766666665444 345677899999999999999
Q ss_pred CCCCCCcHHHHhhcHhhhh
Q 008116 251 VPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 251 dP~~RpTa~elL~hpff~~ 269 (577)
||.+|||+.|||+||||..
T Consensus 242 dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 242 NPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp SGGGSCCHHHHHTCHHHHH
T ss_pred CHhHCcCHHHHHcCcCcCC
Confidence 9999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-59 Score=477.11 Aligned_cols=258 Identities=45% Similarity=0.788 Sum_probs=230.2
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.+.|++++.||+|+||+||+|.++.++..||||+++... ....+.+.+|+.+|++|+|||||++++++.+++.+|||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 357999999999999999999999999999999997654 3345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
||++|+|.+++.+ ..++++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+..........+
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 9999999999754 567999999999999999999999999999999999999999999999999999877655445557
Q ss_pred ccCCCCCCChhhhhc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CchhhhhHHHHHHH
Q 008116 171 FVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEFV 244 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~l~~~~s~~l~~lI 244 (577)
.+||+.|||||++.. ...|+.++|||||||+||+|++|.+||...+..+.+..+....++ ..+..++.++++||
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li 249 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence 899999999999852 334889999999999999999999999998887777666555443 33568899999999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.+||++||.+|||+.|||+||||+..
T Consensus 250 ~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 250 KKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-59 Score=473.83 Aligned_cols=255 Identities=32% Similarity=0.532 Sum_probs=216.9
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe--CCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~--~~~~~L 88 (577)
.++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++++|||||++++++.+ +..+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 468999999999999999999999999999999997665 44556789999999999999999999999965 456899
Q ss_pred EEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcC-----CcccccccceEEEccCCCeeeccccccc
Q 008116 89 IMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEG-----KIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~----~~~l~e~~i~~il~QLl~aL~yLHs~g-----IiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
|||||++|+|.+++.. ...+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999853 568999999999999999999999876 9999999999999999999999999998
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHH
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL 239 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~ 239 (577)
.+..........+|||.|||||++.+. .|+.++|||||||+||||++|.+||...+..+....+.....+.++..++++
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 241 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 241 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 876554555678999999999999775 4899999999999999999999999988877776666666666677889999
Q ss_pred HHHHHHHhcccCCCCCCcHHHHhhcHhh
Q 008116 240 MKEFVSLCLKKVPAERPSAKELLRHRFI 267 (577)
Q Consensus 240 l~~lI~~cL~~dP~~RpTa~elL~hpff 267 (577)
+++||.+||.+||.+|||+.|||+|||+
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-59 Score=482.66 Aligned_cols=258 Identities=34% Similarity=0.624 Sum_probs=222.4
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
..++|++++.||+|+||+||+|.+..+|+.||||+++..........+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46789999999999999999999999999999999987665556688999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+.+... ...
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~~ 161 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN 161 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--TC-
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--ccc
Confidence 999999999999888899999999999999999999997 59999999999999999999999999999876442 334
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee---------------------------
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--------------------------- 222 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~--------------------------- 222 (577)
+.+||+.|||||++.+.. |+.++|||||||+||||++|+.||...+......
T Consensus 162 ~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp --CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred cccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 679999999999998864 9999999999999999999999997654321100
Q ss_pred ---------------ccCCCCCCCch-hhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 223 ---------------IIPRENPPQLD-EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 223 ---------------~i~~~~~~~l~-~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.+....++.++ ..++.++++||.+||..||.+|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 00011112222 24678999999999999999999999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-58 Score=481.66 Aligned_cols=257 Identities=30% Similarity=0.525 Sum_probs=233.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|+++++||+|+||.||+|+++.+|+.||||++++.. .......+.+|+.+|++++|||||+++++|.+.+.+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999999999999999997543 1234677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|||+||+|..++...+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...........
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~ 164 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCC
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCccccc
Confidence 99999999999998899999999999999999999999999999999999999999999999999999877655555667
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
.+|||.|||||++.+. .|+.++|||||||+||||++|++||...+.......+.... ..++..++.++++||.+||++
T Consensus 165 ~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~ 242 (337)
T d1o6la_ 165 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKK 242 (337)
T ss_dssp CEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCS
T ss_pred ceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHhhccC
Confidence 8999999999999876 48999999999999999999999999888766665555443 456678999999999999999
Q ss_pred CCCCCCc-----HHHHhhcHhhhhcc
Q 008116 251 VPAERPS-----AKELLRHRFIRNAR 271 (577)
Q Consensus 251 dP~~RpT-----a~elL~hpff~~~~ 271 (577)
||.+|++ +.+|++||||+...
T Consensus 243 dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 243 DPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred CchhhcccccccHHHHHcCcccccCC
Confidence 9999994 89999999998764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-58 Score=478.23 Aligned_cols=259 Identities=29% Similarity=0.466 Sum_probs=211.8
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
.+.+.|+++++||+|+||+||+|.++.+++.||||++...........+.+|+.+|++++|||||++++++.+++.+|||
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45677999999999999999999999999999999998766555556788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc---cCCCeeecccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld---~~g~vKL~DFGls~~~~~~~~ 166 (577)
||||+||+|.+++...+++++..++.++.||+.||.|||++|||||||||+|||+. .++.+||+|||+|+..... .
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~ 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-S 164 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-C
Confidence 99999999999999888999999999999999999999999999999999999995 4689999999999866433 3
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchhhhhHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEF 243 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s~~l~~l 243 (577)
...+.+||+.|||||++.+. .|+.++|||||||+||+|++|.+||...........+.... +......+++.+++|
T Consensus 165 ~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp --------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred eeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence 34567899999999999876 48999999999999999999999999877666555554433 223446789999999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
|.+||.+||.+|||+.|+|+||||+..
T Consensus 244 i~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 244 IRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-58 Score=463.01 Aligned_cols=256 Identities=28% Similarity=0.493 Sum_probs=221.2
Q ss_pred hhcCCCe-eEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe----
Q 008116 9 EAAGSRF-SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH---- 82 (577)
Q Consensus 9 ~~~~~~f-~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~---- 82 (577)
....++| ++.+.||+|+||+||+|.+..++..||||++.... .....+.+.+|+++|++++|||||+++++|.+
T Consensus 4 ~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 83 (270)
T d1t4ha_ 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83 (270)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred cCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc
Confidence 3445677 67788999999999999999999999999987654 45556789999999999999999999999875
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEc-cCCCeeeccccccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLT-ENGDVKVADFGVSA 159 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~g--IiHrDIKPeNILld-~~g~vKL~DFGls~ 159 (577)
+..+|||||||++|+|.+++.+...+++..++.|+.||+.||+|||+++ ||||||||+||||+ .++.+||+|||+|+
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 4568999999999999999988889999999999999999999999998 99999999999997 47899999999997
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccce-eeccCCCC-CCCchhhhh
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV-LFIIPREN-PPQLDEHFS 237 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~-~~~i~~~~-~~~l~~~~s 237 (577)
..... ...+.+|||.|||||++.+ .|+.++|||||||+||+|++|.+||........ ...+.... ++.++..++
T Consensus 164 ~~~~~--~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 164 LKRAS--FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp GCCTT--SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred eccCC--ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence 64332 3346789999999999865 389999999999999999999999987654333 33343333 334566778
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
+++++||.+||.+||++|||+.|||+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-58 Score=472.89 Aligned_cols=259 Identities=41% Similarity=0.750 Sum_probs=228.4
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
...|++++.||+|+||+||+|.+..+++.||||++..... ....+.+.+|+.+|++|+|||||+++++|.+++.+|||
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 3469999999999999999999999999999999976543 34457789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||||.+|+|..++....++++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|..... ..
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~ 169 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----AN 169 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BC
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----CC
Confidence 99999999988888778999999999999999999999999999999999999999999999999999976543 24
Q ss_pred cccCCCCCCChhhhhcc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCchhhhhHHHHHHHHH
Q 008116 170 TFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~--~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~l~~~~s~~l~~lI~~ 246 (577)
..+||+.|||||++.+. ..|+.++|||||||+||||++|.+||...+....+..+.... +...+..+++.+++||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 57899999999998642 348899999999999999999999999887766555554433 333455789999999999
Q ss_pred hcccCCCCCCcHHHHhhcHhhhhccCCh
Q 008116 247 CLKKVPAERPSAKELLRHRFIRNARKSP 274 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~hpff~~~~~~~ 274 (577)
||.+||.+|||+.+||+||||.......
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~~~~~~~ 277 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVLRERPPT 277 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred HCcCChhHCcCHHHHHhCHHhcCCCCch
Confidence 9999999999999999999998654443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-58 Score=473.19 Aligned_cols=259 Identities=26% Similarity=0.479 Sum_probs=227.0
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
.++|+++++||+|+||+||+|.++.+|+.||||++.+.. .....+.+.+|+.+|++++|||||+++++|.+++.+|||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 357999999999999999999999999999999996543 123457799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc--cc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SR 167 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~--~~ 167 (577)
||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... ..
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999998765332 23
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
..+.+||+.|||||++.+.. |+.++|||||||+||+|++|.+||...+.......|....+ .++..+++.+++||.+|
T Consensus 167 ~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~ 244 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKL 244 (288)
T ss_dssp ---CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-CCCTTCCHHHHHHHHTT
T ss_pred cccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC-CCCccCCHHHHHHHHHH
Confidence 34578999999999998764 89999999999999999999999998877766666655443 45677899999999999
Q ss_pred cccCCCCCCcHHH------HhhcHhhhhccC
Q 008116 248 LKKVPAERPSAKE------LLRHRFIRNARK 272 (577)
Q Consensus 248 L~~dP~~RpTa~e------lL~hpff~~~~~ 272 (577)
|++||.+|||+.| |++||||+.+.+
T Consensus 245 L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 245 LVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred ccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 9999999999987 578899987654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=464.43 Aligned_cols=260 Identities=27% Similarity=0.443 Sum_probs=228.8
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-----HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-----~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~ 84 (577)
.+.++|++++.||+|+||+||+|.++.+|+.||||++++.... ...+.+.+|+.+|++|+|||||+++++|.+.+
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 3567899999999999999999999999999999999755421 23578999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC----Ceeecccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG----DVKVADFGVSAQ 160 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g----~vKL~DFGls~~ 160 (577)
.+|||||||+||+|.++|...+++++..++.++.||+.||.|||+++||||||||+||||+.++ .+||+|||+|..
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999999998878999999999999999999999999999999999999998776 599999999987
Q ss_pred ccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC---CCchhhhh
Q 008116 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP---PQLDEHFS 237 (577)
Q Consensus 161 ~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~---~~l~~~~s 237 (577)
.... ....+.+||+.|+|||++.+. .|+.++|||||||+||+|++|..||...+..+....+..... ...+..++
T Consensus 167 ~~~~-~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 167 IDFG-NEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp CTTS-CBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred cCCC-ccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 6543 334467899999999999875 489999999999999999999999998877766655554433 23345788
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..+++||.+||.+||.+|||+.++|+||||+...
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999999998653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.2e-57 Score=467.87 Aligned_cols=255 Identities=28% Similarity=0.502 Sum_probs=228.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
.+|++++.||+|+||+||+|.++.+|+.||||+++.... ....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 579999999999999999999999999999999965431 223578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
|||+||+|..++.....+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..... ..+
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~~~ 160 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYT 160 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---BCC
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---ccc
Confidence 99999999999999899999999999999999999999999999999999999999999999999999876433 346
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
.+||+.|||||++.+. .|+.++|||||||+||+|++|.+||...+..+....+..... .++..++..++++|.+||.+
T Consensus 161 ~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~ 238 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLITR 238 (316)
T ss_dssp CCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCS
T ss_pred ccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhh
Confidence 7999999999999875 489999999999999999999999998877766666544432 45567889999999999999
Q ss_pred CCCCCC-----cHHHHhhcHhhhhccC
Q 008116 251 VPAERP-----SAKELLRHRFIRNARK 272 (577)
Q Consensus 251 dP~~Rp-----Ta~elL~hpff~~~~~ 272 (577)
||.+|+ |+++||+||||+.+.+
T Consensus 239 dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 239 DLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred CHHhccccchhhHHHHHcCcccccCCH
Confidence 999996 9999999999988743
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-56 Score=471.24 Aligned_cols=257 Identities=23% Similarity=0.380 Sum_probs=226.8
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
+-++|++++.||+|+||.||+|.++.+|+.||||++.... ....+.+.+|+.+|++|+|||||+++++|.+++.+||||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3468999999999999999999999999999999997554 344678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc--CCCeeeccccccccccccccc
Q 008116 91 EYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE--NGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~-~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~--~g~vKL~DFGls~~~~~~~~~ 167 (577)
|||+||+|.+++. ..+++++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+|+.+... ..
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~ 181 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QS 181 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-SC
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-cc
Confidence 9999999999985 4567999999999999999999999999999999999999964 578999999999876543 33
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchhhhhHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFV 244 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s~~l~~lI 244 (577)
..+.+||+.|||||++.+.. |+.++|||||||+||+|++|.+||...+..+.+..|.... +......++..+++||
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 260 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHH
T ss_pred cceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 45679999999999998764 8999999999999999999999999887766665554332 3334467899999999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
.+||.+||.+|||++|||+||||+..
T Consensus 261 ~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 261 RKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-57 Score=469.04 Aligned_cols=257 Identities=28% Similarity=0.535 Sum_probs=229.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHH-hCCCCceeEeEEEEEeCCEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLS-QCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~-~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
.+|+++++||+|+||+||+|.++.+++.||||++++.. .....+.+.+|+.++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999999999999999996543 1223456677777765 68999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||||++|+|.+++.....+++..++.++.||+.||+|||+++||||||||+|||++.++++||+|||+++..........
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~ 161 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 161 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999987765555556
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~ 249 (577)
..+||+.|+|||++.+.. |+.++|||||||+||+|++|+.||...+.......+.... +.++..++..+++||.+||.
T Consensus 162 ~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 162 TFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFV 239 (320)
T ss_dssp CCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSC
T ss_pred ccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHhcc
Confidence 679999999999998764 8999999999999999999999999888777666665444 35667889999999999999
Q ss_pred cCCCCCCcHH-HHhhcHhhhhcc
Q 008116 250 KVPAERPSAK-ELLRHRFIRNAR 271 (577)
Q Consensus 250 ~dP~~RpTa~-elL~hpff~~~~ 271 (577)
+||.+||++. +|++||||+...
T Consensus 240 ~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 240 REPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp SSGGGSBTTBSCGGGSGGGTTCC
T ss_pred cCCCCCcCHHHHHHhCchhccCC
Confidence 9999999995 899999998764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-56 Score=471.52 Aligned_cols=259 Identities=26% Similarity=0.419 Sum_probs=223.7
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-----hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-----~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
-++|+++++||+|+||.||+|.++.+|+.||||++.+... .........|+.+++.++|||||+++++|.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 3689999999999999999999999999999999864321 11223334557788888999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
|||||||+||+|.++|.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-- 160 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 160 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS--
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC--
Confidence 999999999999999988889999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee--eccCCCCCCCchhhhhHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL--FIIPRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~--~~i~~~~~~~l~~~~s~~l~~lI 244 (577)
.....+||+.|||||++.....|+.++|||||||+||+|++|.+||......... .......+..++..+++.+++||
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 240 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHH
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHH
Confidence 3346789999999999976666999999999999999999999999876543322 22223344556678899999999
Q ss_pred HHhcccCCCCCCc-----HHHHhhcHhhhhccC
Q 008116 245 SLCLKKVPAERPS-----AKELLRHRFIRNARK 272 (577)
Q Consensus 245 ~~cL~~dP~~RpT-----a~elL~hpff~~~~~ 272 (577)
.+||.+||.+||| |++|++||||+++.+
T Consensus 241 ~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp HHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred HHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 9999999999999 799999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-56 Score=470.72 Aligned_cols=256 Identities=23% Similarity=0.401 Sum_probs=226.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
+.++|++++.||+|+||+||+|.+..+|+.||||+++... ......+.+|+.+|++|+|||||+++++|.+++.+||||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999999999999999999999999997654 334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc--cCCCeeeccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT--ENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld--~~g~vKL~DFGls~~~~~~~~~ 167 (577)
|||+||+|.+++... .++++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|..+... ..
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~~ 184 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EI 184 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SC
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-Cc
Confidence 999999999987654 4799999999999999999999999999999999999997 5689999999999877543 33
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchhhhhHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFV 244 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~~~s~~l~~lI 244 (577)
..+.+||+.|||||++.+. .|+.++|||||||+||+|++|.+||...+....+..+.... +......++.++++||
T Consensus 185 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp EEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred eeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 4567899999999999876 49999999999999999999999999887766665554332 3344567899999999
Q ss_pred HHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 245 SLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
.+||.+||.+|||+.|||+||||+.
T Consensus 264 ~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHccCChhHCcCHHHHhcCHhhCC
Confidence 9999999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-56 Score=470.58 Aligned_cols=254 Identities=28% Similarity=0.507 Sum_probs=228.3
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
++|++++.||+|+||.||+|.++.+|+.||||++.+... ....+.+.+|+.+|+.++|||||++++++.+...+|+||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 589999999999999999999999999999999865431 223577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
||+.+|+|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+... ..+
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---~~~ 197 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TWT 197 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---BCC
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---ccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999876532 346
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhccc
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~ 250 (577)
.+||+.|||||++.+. .|+.++|||||||+||+|++|.+||...+.......|....+ ..+..+++++.+||.+||.+
T Consensus 198 ~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~ 275 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHHHSCS
T ss_pred ccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHHhhh
Confidence 7899999999999875 489999999999999999999999998877666666554433 44567899999999999999
Q ss_pred CCCCCC-----cHHHHhhcHhhhhcc
Q 008116 251 VPAERP-----SAKELLRHRFIRNAR 271 (577)
Q Consensus 251 dP~~Rp-----Ta~elL~hpff~~~~ 271 (577)
||.+|+ |+.+||+||||+...
T Consensus 276 dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 276 DLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred CHHhccccccccHHHHHcCccccCCC
Confidence 999994 999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=458.34 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=216.5
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH----HHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED----EIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 16 ~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~----~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
+.+++||+|+||+||+|.++.+|+.||||+++...... ....+.+|+.+|++++|||||++++++..++.+|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 46899999999999999999999999999997554221 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
||.++++..++.....+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~ 160 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence 99998888888777889999999999999999999999999999999999999999999999999998876655555677
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------------CCC
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------------------ENP 229 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~----------------------~~~ 229 (577)
+||+.|+|||++.....|+.++|||||||+||||++|.+||...+..+.+..|.. ...
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240 (299)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence 9999999999998766789999999999999999999999987655443322110 000
Q ss_pred CC-----chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 230 PQ-----LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 230 ~~-----l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
+. +...++..+++||.+||+.||.+||||.|+|+||||++.
T Consensus 241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 00 112467899999999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-55 Score=448.76 Aligned_cols=257 Identities=30% Similarity=0.514 Sum_probs=226.6
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--------hHHHHHHHHHHHHHHhCC-CCceeEeEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--------EDEIEDIQKEISVLSQCR-SPYITEYYGSYLH 82 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~--------~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~ 82 (577)
.++|++++.||+|+||+||+|.+..+|+.||||++++... ....+.+.+|+.+|++|. |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4799999999999999999999999999999999976542 123456889999999996 9999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
++.+|||||||++|+|.++|+..+++++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999998775
Q ss_pred ccccccccccCCCCCCChhhhhc-----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCchh
Q 008116 163 RTISRRKTFVGTPFWMAPEVIQN-----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDE 234 (577)
Q Consensus 163 ~~~~~~~~~~GTp~Y~APEvl~~-----~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~l~~ 234 (577)
.. ......+||+.|+|||++.+ ...++.++|||||||+||+|++|++||...+.......+.... +.....
T Consensus 162 ~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (277)
T d1phka_ 162 PG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240 (277)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred CC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 43 23345789999999999863 2347889999999999999999999999887766555444332 233445
Q ss_pred hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 235 ~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
.+|+++++||.+||++||.+|||+.|||+||||+.
T Consensus 241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 78999999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-56 Score=459.12 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=225.7
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
.+-++|++++.||+|+||+||+|+++.+++.||||+++.... ....+.+|+.+|++++|||||+++++|.+++.+|||
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 456899999999999999999999999999999999976542 335688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC--CCeeecccccccccccccc
Q 008116 90 MEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN--GDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~~-~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~--g~vKL~DFGls~~~~~~~~ 166 (577)
||||+||+|.++|...+ ++++.+++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||++...... .
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~ 158 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-D 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-C
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-C
Confidence 99999999999997654 79999999999999999999999999999999999999854 57999999999876443 3
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC---CchhhhhHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP---QLDEHFSRLMKEF 243 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~---~l~~~~s~~l~~l 243 (577)
...+.+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||...+.......|...... .....++.++++|
T Consensus 159 ~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred cccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 34467899999999999776 4899999999999999999999999988877666666543322 2234688999999
Q ss_pred HHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 244 VSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
|.+||.+||.+|||+.|+|+||||+.
T Consensus 238 i~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcCHhhcc
Confidence 99999999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=448.30 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=217.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.+|++++.||+|+||+||+|.+..+|+.||||+++..... .....+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999999999999999999755422 235788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccccccc
Q 008116 92 YMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (577)
Q Consensus 92 y~~gGsL~~~l~-~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 170 (577)
||.++.+..... ....+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~ 161 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence 996554444433 3467999999999999999999999999999999999999999999999999999887666556667
Q ss_pred ccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC------------------CC-----
Q 008116 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP------------------RE----- 227 (577)
Q Consensus 171 ~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~------------------~~----- 227 (577)
.+||+.|+|||++....+++.++|||||||++|+|++|+.||...+....+..+. ..
T Consensus 162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241 (298)
T ss_dssp CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSC
T ss_pred ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccc
Confidence 7999999999998887777899999999999999999999998765433222110 00
Q ss_pred --CCCC---chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 228 --NPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 228 --~~~~---l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.... ....++.++++||.+||++||.+|||+.|||+||||++..
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 0000 1124678899999999999999999999999999998763
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=445.12 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=217.6
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-----HHHHHHHHHHHHHHhCC--CCceeEeEEEEEeC
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-----DEIEDIQKEISVLSQCR--SPYITEYYGSYLHQ 83 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-----~~~~~i~~Ev~iL~~L~--HpnIV~l~~~~~~~ 83 (577)
+.++|++.++||+|+||+||+|.+..+|+.||||+++..... .....+.+|+.+|++++ |||||++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 468999999999999999999999999999999999754321 11234678999999986 89999999999999
Q ss_pred CEEEEEEeccCC-CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC-CCeeeccccccccc
Q 008116 84 TKLWIIMEYMAG-GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQL 161 (577)
Q Consensus 84 ~~~~LV~Ey~~g-GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~-g~vKL~DFGls~~~ 161 (577)
+.+|+||||+.+ ++|.+++.....+++..++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||+|+..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999976 6888998887899999999999999999999999999999999999999854 79999999999765
Q ss_pred cccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCchhhhhHHHH
Q 008116 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (577)
Q Consensus 162 ~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~ 241 (577)
... ...+.+||+.|+|||++.+..+++.++|||||||+||+|++|..||...+. +.. ....++..+|.+++
T Consensus 162 ~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~-~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 162 KDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR-GQVFFRQRVSSECQ 232 (273)
T ss_dssp CSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-CCCCCSSCCCHHHH
T ss_pred ccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhh-cccCCCCCCCHHHH
Confidence 432 345678999999999998776677889999999999999999999976432 111 11234456889999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 242 EFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
+||.+||.+||.+|||+.|+|+||||++..
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 999999999999999999999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=451.86 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=213.2
Q ss_pred cCCCeeEEe-EEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEe----CC
Q 008116 11 AGSRFSSLE-LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH----QT 84 (577)
Q Consensus 11 ~~~~f~il~-~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~----~~ 84 (577)
+-++|+++. +||+|+||+||+|.+..+++.||||+++.. ..+.+|+.++.++ +|||||+++++|.+ +.
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 346899985 699999999999999999999999998643 5578899987654 89999999999976 46
Q ss_pred EEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc---CCCeeeccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVSA 159 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~---~g~vKL~DFGls~ 159 (577)
.+|||||||+||+|.++|... .++++.+++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 799999999999999999764 47999999999999999999999999999999999999985 4679999999998
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee----ccCCC---CCCCc
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF----IIPRE---NPPQL 232 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~----~i~~~---~~~~l 232 (577)
..... ......+||+.|||||++.+.. |+.++|||||||+||+|++|.+||...+...... .+... .+...
T Consensus 163 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 163 ETTSH-NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp ECCCC-CCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eccCC-CccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 76543 3345678999999999998764 9999999999999999999999998765443322 22211 12233
Q ss_pred hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 233 ~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
...+++++++||.+||++||.+|||+.|||+||||...
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 45789999999999999999999999999999999753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-54 Score=440.18 Aligned_cols=256 Identities=28% Similarity=0.475 Sum_probs=216.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++|++++.||+|+||+||+|.++ +|+.||||+++.... ....+.+.+|+.+|++++|||||+++++|..++..|++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 58999999999999999999986 689999999976543 2235789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
|+.++.|..+....+.+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||++.............
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence 99888888888878899999999999999999999999999999999999999999999999999998776554455567
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC------------------C-------
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP------------------R------- 226 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~------------------~------- 226 (577)
+|++.|+|||++.+...++.++|||||||+||||++|++||...+..+.+..+. .
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccc
Confidence 899999999999877778999999999999999999999998765433221110 0
Q ss_pred CCC---CCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 227 ENP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 227 ~~~---~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
..+ ......++..+++||.+||++||.+|||+.|||+||||++
T Consensus 241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 000 1123356789999999999999999999999999999974
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-54 Score=441.70 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=213.1
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~---~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
..+|++.++||+|+||+||+|.++.+++ .||||.+.........+.+.+|+.+|++|+|||||++++++..++.+||
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 4689999999999999999999987664 6899998777677777889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~ 167 (577)
|||||++|+|.+++.. .+.+++..+..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+++.+......
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 9999999999998876 457999999999999999999999999999999999999999999999999999876543221
Q ss_pred -----cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHH
Q 008116 168 -----RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (577)
Q Consensus 168 -----~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~ 241 (577)
.....||+.|||||++.+. .|+.++|||||||+||||+| |.+||......+....+.....+..+..++..+.
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 263 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263 (299)
T ss_dssp -----------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHH
Confidence 1124689999999999876 48999999999999999998 8999999888777777776666667778899999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhc
Q 008116 242 EFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+||.+||..||.+|||+.+|+++
T Consensus 264 ~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 264 QLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-54 Score=436.89 Aligned_cols=254 Identities=24% Similarity=0.431 Sum_probs=222.8
Q ss_pred CCeeEEeE-EeecCceEEEEEEEcC--CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 13 SRFSSLEL-IGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 13 ~~f~il~~-IG~GsfG~Vy~a~~~~--tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
.+|.+.+. ||+|+||+||+|.++. ++..||||+++........+.+.+|+.+|++++|||||++++++.. +.+|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 57888885 9999999999998754 4558999999877667777889999999999999999999999865 468999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc--
Q 008116 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-- 166 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-- 166 (577)
||||++|+|.+++.. ...+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+++.+.....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 999999999999754 46799999999999999999999999999999999999999999999999999987654322
Q ss_pred -ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHH
Q 008116 167 -RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (577)
Q Consensus 167 -~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI 244 (577)
.....+||+.|||||++.... |+.++|||||||+||||+| |.+||...+..+....+..+..+.++..++.++.+||
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 245 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALM 245 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 123457899999999998764 8999999999999999998 9999998887777777777777777888999999999
Q ss_pred HHhcccCCCCCCcHHHH---hhcHhhh
Q 008116 245 SLCLKKVPAERPSAKEL---LRHRFIR 268 (577)
Q Consensus 245 ~~cL~~dP~~RpTa~el---L~hpff~ 268 (577)
.+||..+|.+|||+.+| |+|+|+.
T Consensus 246 ~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 246 SDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999988 5677764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-54 Score=439.50 Aligned_cols=255 Identities=25% Similarity=0.431 Sum_probs=220.2
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
..++|++.+.||+|+||+||+|.+..+++.||||+++.... ..+.+.+|+.+|++|+|||||+++++|.+++.+||||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34689999999999999999999999999999999875543 3467999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-
Q 008116 91 EYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~- 167 (577)
|||++|+|.+++.. ...+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+........
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 99999999999965 367899999999999999999999999999999999999999999999999999876543222
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCC-CCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPL-ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf-~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....||+.|+|||++.+.. |+.++|||||||+||||++|..|| ...+.......+.....+..+..++..+++||.+
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 251 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred eccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHH
Confidence 22346899999999998764 899999999999999999966654 4555544445555566667778899999999999
Q ss_pred hcccCCCCCCcHHHHhhcHhhhhc
Q 008116 247 CLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
||..||.+|||+.+|++ +|...
T Consensus 252 cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 252 CWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp HTCSSGGGSCCHHHHHH--HHHHT
T ss_pred HcCCCHhHCcCHHHHHH--HHHHH
Confidence 99999999999999975 45444
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-54 Score=435.48 Aligned_cols=248 Identities=24% Similarity=0.422 Sum_probs=213.4
Q ss_pred eEEeecCceEEEEEEEc--CCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEeccCC
Q 008116 19 ELIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (577)
Q Consensus 19 ~~IG~GsfG~Vy~a~~~--~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~Ey~~g 95 (577)
+.||+|+||+||+|.+. .+++.||||+++... .....+.+.+|+.+|++++|||||++++++.. +.+|||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999864 456789999996543 23345789999999999999999999999865 457899999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc---ccccc
Q 008116 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR---RKTFV 172 (577)
Q Consensus 96 GsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~---~~~~~ 172 (577)
|+|.+++....++++..+..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+++.+...... .....
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 999999998889999999999999999999999999999999999999999999999999999876433222 22457
Q ss_pred CCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhcccC
Q 008116 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (577)
Q Consensus 173 GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~d 251 (577)
||+.|||||++.+.. |+.++|||||||+||||++ |.+||...+..+....+.....+.++..++..+++||.+||..|
T Consensus 172 gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~d 250 (277)
T d1xbba_ 172 WPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD 250 (277)
T ss_dssp CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCC
Confidence 999999999998764 8999999999999999997 89999998887777777777777778889999999999999999
Q ss_pred CCCCCcHHHHh---hcHhhh
Q 008116 252 PAERPSAKELL---RHRFIR 268 (577)
Q Consensus 252 P~~RpTa~elL---~hpff~ 268 (577)
|.+|||+.+|+ +|+|+.
T Consensus 251 p~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 251 VENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp TTTSCCHHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHhhCHHhh
Confidence 99999999984 566654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-53 Score=432.55 Aligned_cols=258 Identities=27% Similarity=0.473 Sum_probs=214.1
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC---
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT--- 84 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~--- 84 (577)
.+.++|++++.||+|+||+||+|.+..+|+.||||+++... .......+.+|+.+|+.++|||||++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 45789999999999999999999999999999999997654 3445678999999999999999999999998654
Q ss_pred -EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccc
Q 008116 85 -KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (577)
Q Consensus 85 -~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~ 163 (577)
.+|||||||+|++|.+++...+++++.+++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||++.....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 4899999999999999998888999999999999999999999999999999999999999999999999999865533
Q ss_pred cc---cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC---Cchhhhh
Q 008116 164 TI---SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP---QLDEHFS 237 (577)
Q Consensus 164 ~~---~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~~~~~---~l~~~~s 237 (577)
.. ......+||+.|||||++.+. .|+.++|||||||+||+|++|.+||...+..+....+....+. .....+|
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ---------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred ccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 22 223457899999999999875 4899999999999999999999999988776655544433322 2345688
Q ss_pred HHHHHHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 238 ~~l~~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
..+++||.+||.+||.+||+..+.|.|+|++
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 9999999999999999999544445567664
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=429.31 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=208.8
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
..+|++++.||+|+||+||+|.+. ++..||||+++..... .+.+.+|+.+|++++|||||++++++..++.+|||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 368999999999999999999986 4678999999765432 3678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-cc
Q 008116 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~-~~ 169 (577)
||++|+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++........ ..
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999999998654 67899999999999999999999999999999999999999999999999999876543222 23
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
...||+.|+|||++.+.. |+.++|||||||+||||+| |.+||...+..+....+.....+..+..++..+.+||..||
T Consensus 161 ~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 239 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239 (263)
T ss_dssp ----CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred ceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHc
Confidence 467999999999998764 9999999999999999999 57777776666666666666666667788999999999999
Q ss_pred ccCCCCCCcHHHHhhc
Q 008116 249 KKVPAERPSAKELLRH 264 (577)
Q Consensus 249 ~~dP~~RpTa~elL~h 264 (577)
..||.+|||+++|++|
T Consensus 240 ~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 240 KERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCCHhHCcCHHHHHHH
Confidence 9999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=433.72 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=211.7
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCC-CcEEEEEEeccCCCh-HHHHHHHHHHHHHHhC---CCCceeEeEEEEEe---
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKEL-NKDVAIKVIDLEESE-DEIEDIQKEISVLSQC---RSPYITEYYGSYLH--- 82 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~t-g~~VAIK~i~~~~~~-~~~~~i~~Ev~iL~~L---~HpnIV~l~~~~~~--- 82 (577)
..++|++++.||+|+||+||+|++..+ ++.||||+++..... .....+.+|+.+|+.| +|||||+++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 357999999999999999999999765 678999998654322 1223466778777765 79999999999864
Q ss_pred --CCEEEEEEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccc
Q 008116 83 --QTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 83 --~~~~~LV~Ey~~gGsL~~~l~-~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
...+|++||||.++.+..... ....+++..++.++.||+.||+|||+++||||||||+|||++..+.+||+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 347899999998887765543 34679999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC--------------
Q 008116 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-------------- 225 (577)
Q Consensus 160 ~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~-------------- 225 (577)
..... ......+||+.|+|||++.+.. |+.++|||||||+||||++|.+||...+..+.+..+.
T Consensus 165 ~~~~~-~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 165 IYSFQ-MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCCGG-GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hhccc-ccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 65433 3445678999999999998764 9999999999999999999999998765543322210
Q ss_pred ------------CCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 226 ------------RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 226 ------------~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
......+...++..+++||.+||.+||.+|||+.|+|+||||+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 0001122345788999999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=430.04 Aligned_cols=254 Identities=24% Similarity=0.429 Sum_probs=218.9
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~ 90 (577)
..++|++++.||+|+||+||+|.++ ++..||||+++.... ..+.+.+|+.+|++++|||||++++++. ++.+||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~ 86 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEE
Confidence 3468999999999999999999986 578899999975443 2467999999999999999999999875 45679999
Q ss_pred eccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-c
Q 008116 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (577)
Q Consensus 91 Ey~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~ 167 (577)
|||++|+|.+++... .++++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+..... .
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999999987542 3699999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhC-CCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHH
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG-~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~ 246 (577)
.....||+.|||||++.+.. |+.++|||||||+||||+|| .+||...+..+....+.....+..+..++..+.+||.+
T Consensus 167 ~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 245 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHH
Confidence 33467999999999998764 89999999999999999995 55666666666666666666667778899999999999
Q ss_pred hcccCCCCCCcHHHHhh--cHhhhh
Q 008116 247 CLKKVPAERPSAKELLR--HRFIRN 269 (577)
Q Consensus 247 cL~~dP~~RpTa~elL~--hpff~~ 269 (577)
||..||++|||+.+|++ |+||..
T Consensus 246 cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 246 CWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999999999998 788863
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=440.85 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=214.5
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCc-----EEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNK-----DVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTK 85 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~-----~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~ 85 (577)
.++|++.++||+|+||+||+|.+..+++ .||||.+...........+.+|+.+|+++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3689999999999999999999876543 69999987665555567889999999998 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceE
Q 008116 86 LWIIMEYMAGGSVADLIQSG-----------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANI 142 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~-----------------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNI 142 (577)
+|||||||++|+|.++|+.. ..+++..++.|+.||+.||+|||+++||||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 99999999999999999653 3589999999999999999999999999999999999
Q ss_pred EEccCCCeeeccccccccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccc
Q 008116 143 LLTENGDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMR 219 (577)
Q Consensus 143 Lld~~g~vKL~DFGls~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~ 219 (577)
|++.++.+||+|||+|+........ ..+.+||+.|||||++.+.. |+.++|||||||+||||++ |.+||...+...
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876543322 23567899999999998764 9999999999999999997 899998876655
Q ss_pred eeec-cCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 220 VLFI-IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 220 ~~~~-i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.+.. +.....+..+..+++.+++||.+||..||.+|||+++|++|
T Consensus 275 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4433 33444556677889999999999999999999999999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=430.86 Aligned_cols=250 Identities=28% Similarity=0.517 Sum_probs=207.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV 89 (577)
..++|++.+.||+|+||+||+|... ..||||+++... .....+.+.+|+.+|++++|||||++++++. ...+|||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv 81 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV 81 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence 3578999999999999999999754 359999997554 3456788999999999999999999999864 4568999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc--c
Q 008116 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--S 166 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~--~ 166 (577)
||||++|+|.+++.. ..++++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+...... .
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 999999999999965 4679999999999999999999999999999999999999999999999999997764332 2
Q ss_pred ccccccCCCCCCChhhhhcc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc-CCCC-C---CCchhhhhHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-PREN-P---PQLDEHFSRL 239 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~--~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i-~~~~-~---~~l~~~~s~~ 239 (577)
.....+||+.|||||++.+. ..|+.++|||||||+||||+||..||...+....+..+ .... + ..++..+++.
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 241 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence 23456899999999998643 24789999999999999999999999887654433222 2211 1 2345578899
Q ss_pred HHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 240 MKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 240 l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+++||.+||..||.+|||+.+|+++
T Consensus 242 l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 242 MKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-53 Score=439.44 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=214.7
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC----
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT---- 84 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~---- 84 (577)
.+.++|++++.||+|+||+||+|.+..+|+.||||+++... .....+.+.+|+.+|++++|||||+++++|...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 46789999999999999999999999999999999997654 3445678999999999999999999999998755
Q ss_pred --EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 85 --KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 85 --~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
.+||||||| +.+|..+++. .++++..++.+++||+.||.|||++|||||||||+|||++.++.+||+|||+|....
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 579999999 6788888765 689999999999999999999999999999999999999999999999999997664
Q ss_pred ccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc------------------
Q 008116 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------ 224 (577)
Q Consensus 163 ~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i------------------ 224 (577)
. .....+||+.|+|||++.+...++.++|||||||+||+|++|.+||...+....+..+
T Consensus 173 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 173 S---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp S---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred C---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 3 3346789999999999987667899999999999999999999999876543222111
Q ss_pred ------------CCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 225 ------------PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 225 ------------~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
.......+...+++.+++||.+||..||.+|||+.|||+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 11111122345688999999999999999999999999999998764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=422.71 Aligned_cols=258 Identities=25% Similarity=0.402 Sum_probs=223.5
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
++|++++.||+|+||+||+|.+..+++.||||+++.... ......+.+|+.+|+.++|||||+++++|.....+++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 589999999999999999999999999999999976553 3456889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (577)
Q Consensus 92 y~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 171 (577)
++.+++|..++...+.+++..++.++.|++.||+|||++|||||||||+||||+.++.+||+|||++.............
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~ 161 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceee
Confidence 99999999999888999999999999999999999999999999999999999999999999999998876655555566
Q ss_pred cCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeecc--------------------------
Q 008116 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFII-------------------------- 224 (577)
Q Consensus 172 ~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~-~~~~~~i-------------------------- 224 (577)
.+++.|+|||++.....++.++|||||||++|+|++|..||..... .+....+
T Consensus 162 ~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T d1unla_ 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred ccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccc
Confidence 7899999999998776689999999999999999999999743322 1111110
Q ss_pred --CCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 225 --PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 225 --~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
...........++..+.+||.+||++||.+||||+|||+||||++.
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 0011122334678899999999999999999999999999999764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=422.91 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=212.5
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~L 88 (577)
.++|++.+.||+|+||.||+|.+..+ +..||||.++........+.+.+|+.+|++++|||||++++++. ++.+||
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 46899999999999999999998654 35689999877666667788999999999999999999999985 567899
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-
Q 008116 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~- 166 (577)
|||||++|+|.+++.. ..++++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+.+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence 9999999999998754 56799999999999999999999999999999999999999999999999999987654322
Q ss_pred ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHH
Q 008116 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (577)
Q Consensus 167 ~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~ 245 (577)
......||+.|+|||++.+. .|+.++|||||||+||||++ |.+||...+..+....+.....+.++..++..+++||.
T Consensus 165 ~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 243 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243 (273)
T ss_dssp ------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 22345789999999999876 48999999999999999997 89999998888887777777777778889999999999
Q ss_pred HhcccCCCCCCcHHHHhhc
Q 008116 246 LCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 246 ~cL~~dP~~RpTa~elL~h 264 (577)
+||..||.+|||+.+|++|
T Consensus 244 ~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 244 KCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-52 Score=423.24 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=212.4
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCC----cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELN----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg----~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
..+.|++.++||+|+||.||+|.+..++ ..||||+++..........+.+|+.+|++++|||||++++++.+...+
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 3578999999999999999999987654 479999998776666677899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 87 WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
++|||||.+++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+....
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 999999999999998865 4679999999999999999999999999999999999999999999999999998764432
Q ss_pred cc---cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhC-CCCCCCCCccceeeccCCCCCCCchhhhhHHHH
Q 008116 166 SR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (577)
Q Consensus 166 ~~---~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG-~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~ 241 (577)
.. .....||+.|||||++.+. .|+.++|||||||+||||++| .+||......+....+.....+..+..++..+.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 243 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243 (283)
T ss_dssp ---------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred ccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHH
Confidence 22 1235689999999999876 499999999999999999995 555666666666666666666667778899999
Q ss_pred HHHHHhcccCCCCCCcHHHHhh
Q 008116 242 EFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~ 263 (577)
+||..||..+|.+|||+.+|++
T Consensus 244 ~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 244 QLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999999987
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=422.23 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=222.6
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.++|+++++||+|+||+||+|.++ ++..||||+++..... .+.+.+|+.++++++|||||+++++|.+++.+|+|||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 368999999999999999999985 6889999999865433 3678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc-cc
Q 008116 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~-~~ 169 (577)
||++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...... ..
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 9999999999754 467999999999999999999999999999999999999999999999999999766443222 22
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
...||+.|+|||++.+.. |+.++|||||||++|||+| |+.||...+..+....+.....+..+..++..+++||.+||
T Consensus 160 ~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 238 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238 (258)
T ss_dssp CSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred ccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHc
Confidence 467899999999998765 8999999999999999998 89999998888777777776666777888999999999999
Q ss_pred ccCCCCCCcHHHHhhc
Q 008116 249 KKVPAERPSAKELLRH 264 (577)
Q Consensus 249 ~~dP~~RpTa~elL~h 264 (577)
..||.+|||+.+||+|
T Consensus 239 ~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 239 HEKADERPTFKILLSN 254 (258)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCCHhHCcCHHHHHHH
Confidence 9999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=436.19 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=214.9
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC----E
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----K 85 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~----~ 85 (577)
.++.+|++++.||+|+||+||+|.+..+|+.||||+++........+.+.+|+.+|++|+|||||++++++.... .
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 356899999999999999999999999999999999987766667788999999999999999999999997653 2
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccc
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~ 165 (577)
.+++++|+.+|+|.++++. .++++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++.......
T Consensus 85 ~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred eEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 3444555669999999976 579999999999999999999999999999999999999999999999999997664432
Q ss_pred c---ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeec-------------------
Q 008116 166 S---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI------------------- 223 (577)
Q Consensus 166 ~---~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~------------------- 223 (577)
. .....+||+.|+|||++.....|+.++||||+||++|+|++|.+||...+.......
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 2 234568999999999987766789999999999999999999999976553221111
Q ss_pred --------cCCCCCCC---chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 224 --------IPRENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 224 --------i~~~~~~~---l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
+....... +...++..+++||.+||+.||.+|||+.++|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 11111111 123567889999999999999999999999999999855
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=431.72 Aligned_cols=258 Identities=23% Similarity=0.400 Sum_probs=211.8
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCceeEeEEEEEe--------
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLH-------- 82 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~-------- 82 (577)
-++|++++.||+|+||+||+|++..+|+.||||++..... ......+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4899999999999999999999999999999999866543 2345678899999999999999999999865
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~ 162 (577)
+..+|+|||||.++.+..+......+++..++.+++||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 34689999999888777776667889999999999999999999999999999999999999999999999999997654
Q ss_pred ccc----cccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-------------
Q 008116 163 RTI----SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP------------- 225 (577)
Q Consensus 163 ~~~----~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~------------- 225 (577)
... ......+||+.|+|||++.+...|+.++|||||||+||+|++|++||...+.......+.
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 321 223356899999999999877679999999999999999999999998655433221110
Q ss_pred -------------CCCCCCchh-----hhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhh
Q 008116 226 -------------RENPPQLDE-----HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (577)
Q Consensus 226 -------------~~~~~~l~~-----~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~ 269 (577)
......+.. ..+..+++||.+||++||++|||+.|||+||||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 000111111 23567899999999999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=437.20 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=209.3
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC------CEEE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------TKLW 87 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~------~~~~ 87 (577)
+|+.+++||+|+||+||+|++..+|+.||||++..... .+.+|+.+|++|+|||||+++++|... .++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 79999999999999999999999999999999976542 235799999999999999999998643 3589
Q ss_pred EEEeccCCCCHHHH---HHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC-Ceeeccccccccccc
Q 008116 88 IIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTR 163 (577)
Q Consensus 88 LV~Ey~~gGsL~~~---l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g-~vKL~DFGls~~~~~ 163 (577)
||||||+++.+..+ ......+++..++.|++||+.||+|||++||+||||||+||||+.++ .+||+|||++..+..
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 99999976643333 24567899999999999999999999999999999999999999775 899999999987654
Q ss_pred cccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC------------------
Q 008116 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP------------------ 225 (577)
Q Consensus 164 ~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~------------------ 225 (577)
. ....+.+||+.|+|||++.+...|+.++|||||||++|||++|++||...+....+..+.
T Consensus 176 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 176 G-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp T-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred C-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 3 334567899999999998876679999999999999999999999998765433322211
Q ss_pred ------CCCCC----CchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhcc
Q 008116 226 ------RENPP----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (577)
Q Consensus 226 ------~~~~~----~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~ 271 (577)
..... .....+++++.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00000 11235688999999999999999999999999999998753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.7e-52 Score=427.38 Aligned_cols=253 Identities=21% Similarity=0.382 Sum_probs=213.0
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeC--CEEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQ--TKLWI 88 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~--~~~~L 88 (577)
.++|+++++||+|+||+||+|+++.+|+.||||+++... .+.+.+|+.+|+++. ||||++++++|... ..+|+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 368999999999999999999999999999999997543 367889999999995 99999999999854 56999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC-Ceeeccccccccccccccc
Q 008116 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISR 167 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g-~vKL~DFGls~~~~~~~~~ 167 (577)
|||||.+++|..+. ..+++..++.+++||+.||+|||++|||||||||+||||+.++ .+||+|||+|...... ..
T Consensus 110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~~ 185 (328)
T d3bqca1 110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QE 185 (328)
T ss_dssp EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-CC
T ss_pred EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-Cc
Confidence 99999999998764 5699999999999999999999999999999999999998765 6999999999876543 33
Q ss_pred cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccce-e-------------------------
Q 008116 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV-L------------------------- 221 (577)
Q Consensus 168 ~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~-~------------------------- 221 (577)
....+||+.|+|||++.+...|+.++|||||||++|+|++|..||........ .
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 265 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCc
Confidence 45678999999999998777789999999999999999999999976543110 0
Q ss_pred --eccC-CC--------CCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhccC
Q 008116 222 --FIIP-RE--------NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (577)
Q Consensus 222 --~~i~-~~--------~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~~~ 272 (577)
..+. .. ........+++++++||.+||.+||.+|||++|||+||||+.+.+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred ccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0000 00 011123457889999999999999999999999999999987643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-52 Score=427.13 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=213.3
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
..+|+++++||+|+||+||+|.+..+|+ .||||.++........+.+.+|+.+|++++|||||+++++|.++ ..+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 3579999999999999999999987776 58888886555555568899999999999999999999999765 567
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
++|||+.+|+|.+++.. ...+++..++.|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+.......
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 88899999999988765 46899999999999999999999999999999999999999999999999999987654332
Q ss_pred cc--ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHH
Q 008116 167 RR--KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (577)
Q Consensus 167 ~~--~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~l 243 (577)
.. ....||+.|||||++.+.. |+.++|||||||+||||+| |.+||...+..+....+..+..+..+..++..+.+|
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~l 245 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 245 (317)
T ss_dssp --------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHH
T ss_pred cccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 22 2356899999999998764 9999999999999999998 899999887777666666666666777889999999
Q ss_pred HHHhcccCCCCCCcHHHHhhcH
Q 008116 244 VSLCLKKVPAERPSAKELLRHR 265 (577)
Q Consensus 244 I~~cL~~dP~~RpTa~elL~hp 265 (577)
|.+||..||.+|||+.+|+.|.
T Consensus 246 i~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 246 MVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCChhhCcCHHHHHHHH
Confidence 9999999999999999999983
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=432.23 Aligned_cols=259 Identities=29% Similarity=0.512 Sum_probs=222.0
Q ss_pred CCeeEEeEEeecCceEEEEEEE---cCCCcEEEEEEeccCC---ChHHHHHHHHHHHHHHhCCC-CceeEeEEEEEeCCE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFD---KELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQTK 85 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~---~~tg~~VAIK~i~~~~---~~~~~~~i~~Ev~iL~~L~H-pnIV~l~~~~~~~~~ 85 (577)
.+|++++.||+|+||+||+|.+ +.+|+.||||++++.. .....+.+.+|+.+|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999987 4578999999986543 11234668899999999965 899999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc-
Q 008116 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT- 164 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~- 164 (577)
+|+|||||.+|+|.+++...+.+++..++.++.||+.||.|||+++||||||||+||||+.+|.+||+|||++..+...
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~ 183 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccc
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999999866433
Q ss_pred ccccccccCCCCCCChhhhhccc-CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---CCCCCchhhhhHHH
Q 008116 165 ISRRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---ENPPQLDEHFSRLM 240 (577)
Q Consensus 165 ~~~~~~~~GTp~Y~APEvl~~~~-~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~---~~~~~l~~~~s~~l 240 (577)
.....+..|++.|+|||++.+.. +++.++|||||||+||+|++|..||...+.......+.. ...+.++..++..+
T Consensus 184 ~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 263 (322)
T d1vzoa_ 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263 (322)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHH
Confidence 33345678999999999997643 477899999999999999999999987766554433322 23345566789999
Q ss_pred HHHHHHhcccCCCCCC-----cHHHHhhcHhhhhcc
Q 008116 241 KEFVSLCLKKVPAERP-----SAKELLRHRFIRNAR 271 (577)
Q Consensus 241 ~~lI~~cL~~dP~~Rp-----Ta~elL~hpff~~~~ 271 (577)
.+||.+||.+||.+|| |++|||+||||+...
T Consensus 264 ~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 9999999999999999 589999999998764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-51 Score=421.46 Aligned_cols=252 Identities=28% Similarity=0.466 Sum_probs=223.4
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~ 85 (577)
..++|++++.||+|+||+||+|.++ .++..||||+++........+.+.+|+.+|++++||||+++++++...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3568999999999999999999875 35678999999877777677889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccce
Q 008116 86 LWIIMEYMAGGSVADLIQSG------------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAAN 141 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~------------------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeN 141 (577)
+++|||||++|+|.+++... ..+++..+..|+.||+.||+|||+++||||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 99999999999999999642 248899999999999999999999999999999999
Q ss_pred EEEccCCCeeeccccccccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCC-CCCCCCCcc
Q 008116 142 ILLTENGDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGE-PPLADLHPM 218 (577)
Q Consensus 142 ILld~~g~vKL~DFGls~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~-~Pf~~~~~~ 218 (577)
|||+.++++||+|||+|+.+...... ..+.+||+.|+|||++.+.. |+.++|||||||+||||++|. +||...+..
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 99999999999999999866443222 23567999999999998764 999999999999999999985 789988888
Q ss_pred ceeeccCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 219 RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 219 ~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
+....+.....+..+..++.++.+||..||+.+|.+|||+.||++
T Consensus 250 e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 250 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888777777788889999999999999999999999999965
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=420.93 Aligned_cols=250 Identities=27% Similarity=0.429 Sum_probs=216.5
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcE--EEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCEEEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKD--VAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~--VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~~~LV 89 (577)
++|++.++||+|+||+||+|.++.++.. ||||.++........+.+.+|+.+|+++ +|||||+++++|.+++.+|||
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6899999999999999999999888764 6778876555555667899999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeec
Q 008116 90 MEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (577)
Q Consensus 90 ~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~ 153 (577)
||||++|+|.++|+.. ..+++..+..++.||+.||.|||+++||||||||+|||++.++.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 9999999999999653 579999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCC-CCCCCCCccceeeccCCCCCCCc
Q 008116 154 DFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGE-PPLADLHPMRVLFIIPRENPPQL 232 (577)
Q Consensus 154 DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~-~Pf~~~~~~~~~~~i~~~~~~~l 232 (577)
|||+++...... ......||+.|+|||.+.... |+.++|||||||+||||++|. +||...+..+....+.....+..
T Consensus 170 DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~ 247 (309)
T d1fvra_ 170 DFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247 (309)
T ss_dssp CTTCEESSCEEC-CC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCC
T ss_pred cccccccccccc-cccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 999997654332 223567999999999998764 899999999999999999965 67888887777777777666777
Q ss_pred hhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 233 ~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
+..+++++++||.+||..||++|||+.+|++|
T Consensus 248 ~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 78899999999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=418.22 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=211.1
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEEEEEe
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~LV~E 91 (577)
.++|++.+.||+|+||+||+|.+..+ ..||||+++..... .+.+.+|+.+|++++|||||++++++. ++.+|+|||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEE
Confidence 46899999999999999999998764 57999999755432 367999999999999999999999985 456899999
Q ss_pred ccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc-cc
Q 008116 92 YMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (577)
Q Consensus 92 y~~gGsL~~~l~~--~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~-~~ 168 (577)
||++|+|..++.. ...+++..+..++.||+.||+|||+++|+||||||+||||+.++++||+|||+++....... ..
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 9999999998853 35799999999999999999999999999999999999999999999999999976643322 22
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhC-CCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG-~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
....||+.|+|||++.... ++.++|||||||+||||++| .+||......+.+..+.....+..+..++..+++||.+|
T Consensus 172 ~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 250 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250 (285)
T ss_dssp ----CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHH
Confidence 3467999999999998764 89999999999999999995 555566666666666666666667788999999999999
Q ss_pred cccCCCCCCcHHHHhh--cHhhhh
Q 008116 248 LKKVPAERPSAKELLR--HRFIRN 269 (577)
Q Consensus 248 L~~dP~~RpTa~elL~--hpff~~ 269 (577)
|+.||++||++.+|+. ++||..
T Consensus 251 l~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 251 WRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cccCHhHCcCHHHHHHHHhhhhcC
Confidence 9999999999999987 666653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=429.54 Aligned_cols=256 Identities=21% Similarity=0.391 Sum_probs=212.7
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeC-----C
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----T 84 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~-----~ 84 (577)
+.++|++++.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+|++|+|||||++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3679999999999999999999999999999999997654 334567789999999999999999999999643 3
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccc
Q 008116 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~ 164 (577)
..++||+|+.+|+|.+++.. .++++..++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 44666777889999999965 6799999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------------
Q 008116 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------ 226 (577)
Q Consensus 165 ~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~------------------ 226 (577)
...+.+||+.|+|||++.+...++.++|||||||+||+|++|.+||...+.......+..
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 234678999999999988777789999999999999999999999986654322221110
Q ss_pred ---------CCCCC---chhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 227 ---------ENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 227 ---------~~~~~---l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
..... ....++..+++||.+||..||.+|||+.|||+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00001 112467899999999999999999999999999999865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=417.61 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=205.4
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeC-C
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ-T 84 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~-~ 84 (577)
.++|++.+.||+|+||.||+|.+.. +++.||||+++..........+.+|+.++.++ +|||||.+++++... .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 4689999999999999999999754 45789999998766666677888888888887 789999999988764 4
Q ss_pred EEEEEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCC
Q 008116 85 KLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG 148 (577)
Q Consensus 85 ~~~LV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g 148 (577)
.+|+|||||++|+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+||||+.++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence 689999999999999999642 3589999999999999999999999999999999999999999
Q ss_pred Ceeecccccccccccccc--ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhC-CCCCCCCCcccee-ecc
Q 008116 149 DVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVL-FII 224 (577)
Q Consensus 149 ~vKL~DFGls~~~~~~~~--~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG-~~Pf~~~~~~~~~-~~i 224 (577)
++||+|||+|+....... .....+||+.|||||++.+. .|+.++|||||||+||||++| .+||........+ ..+
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~ 250 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999986644322 23356899999999999876 489999999999999999986 5678766544333 333
Q ss_pred CCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 225 ~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.....+..+..+++.+++||.+||..||.+|||+.+|++|
T Consensus 251 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4445556677889999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=408.36 Aligned_cols=243 Identities=28% Similarity=0.460 Sum_probs=208.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe-CCEEEEEEe
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTKLWIIME 91 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~-~~~~~LV~E 91 (577)
++|++++.||+|+||.||+|.++ |..||||+++... ..+.+.+|+.+|++++|||||++++++.+ .+.+|||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 57999999999999999999985 7899999996543 34678999999999999999999999865 456899999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccccc
Q 008116 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (577)
Q Consensus 92 y~~gGsL~~~l~~~--~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 169 (577)
||++|+|.+++... ..+++..++.|+.||+.||.|||+++|+||||||+|||++.++.+||+|||++...... ..
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---~~ 158 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QD 158 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC---Cc
Confidence 99999999999643 35899999999999999999999999999999999999999999999999999765432 23
Q ss_pred cccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCchhhhhHHHHHHHHHhc
Q 008116 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (577)
Q Consensus 170 ~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~cL 248 (577)
...+|+.|+|||++.+.. ++.++|||||||++|||++ |.+||...+..+....+.....+.++..+++.+++||.+||
T Consensus 159 ~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl 237 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237 (262)
T ss_dssp ---CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 567899999999998764 8999999999999999998 79999888888877888777777788889999999999999
Q ss_pred ccCCCCCCcHHHHhhc
Q 008116 249 KKVPAERPSAKELLRH 264 (577)
Q Consensus 249 ~~dP~~RpTa~elL~h 264 (577)
..||.+|||+.+|+++
T Consensus 238 ~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 238 HLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred ccCHhHCcCHHHHHHH
Confidence 9999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=423.21 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=202.3
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe------C
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH------Q 83 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~------~ 83 (577)
+.++|+++++||+|+||+||+|.++.+|+.||||+++... .......+.+|+.+|++++|||||+++++|.. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 3478999999999999999999999999999999997654 34456778999999999999999999999964 3
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccc
Q 008116 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (577)
Q Consensus 84 ~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~ 163 (577)
..+|+|||||.++ |...+ ...+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 6899999999765 44444 35699999999999999999999999999999999999999999999999999876654
Q ss_pred cccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC------------------
Q 008116 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP------------------ 225 (577)
Q Consensus 164 ~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~------------------ 225 (577)
. ......+||+.|+|||++.+. .++.++||||+||++|+|++|++||...+.......+.
T Consensus 172 ~-~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 172 S-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp ----------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred c-cccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 3 334467899999999999876 58999999999999999999999997654322211110
Q ss_pred -----------------------CCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhhcHhhhhc
Q 008116 226 -----------------------RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (577)
Q Consensus 226 -----------------------~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~hpff~~~ 270 (577)
..........++.++++||.+||.+||.+||||+|||+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 000001123467889999999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=413.98 Aligned_cols=252 Identities=24% Similarity=0.452 Sum_probs=218.8
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCC-------cEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEe
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELN-------KDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH 82 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg-------~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~ 82 (577)
..++|++.+.||+|+||.||+|.+..++ ..||||+++..........+.+|+.++.++ +|||||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3579999999999999999999876554 479999998777777778899999999988 89999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc
Q 008116 83 QTKLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE 146 (577)
Q Consensus 83 ~~~~~LV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~ 146 (577)
+..+|+|||||++|+|.++|... ..+++..+..++.||+.||.|||+++||||||||+|||++.
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence 99999999999999999999643 35899999999999999999999999999999999999999
Q ss_pred CCCeeeccccccccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeec
Q 008116 147 NGDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFI 223 (577)
Q Consensus 147 ~g~vKL~DFGls~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~ 223 (577)
++.+||+|||++......... ....+||+.|+|||++.+. .|+.++|||||||+||||++ |.+||...+.......
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 999999999999876543222 2346799999999999876 49999999999999999998 7999998887777667
Q ss_pred cCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 224 i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
+.....+..+..+++.+++||.+||++||.+|||+.+|++
T Consensus 250 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 7666667777889999999999999999999999999997
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=411.63 Aligned_cols=252 Identities=24% Similarity=0.404 Sum_probs=222.6
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~ 86 (577)
.++|++.+.||+|+||+||+|.+.. ++..||||+++..........+.+|+.++++++|||||++++++..++.+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 4799999999999999999998752 35789999998776666677899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccc
Q 008116 87 WIIMEYMAGGSVADLIQSG----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFG 156 (577)
Q Consensus 87 ~LV~Ey~~gGsL~~~l~~~----------~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFG 156 (577)
++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||||+.++++||+|||
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecc
Confidence 9999999999999998531 357899999999999999999999999999999999999999999999999
Q ss_pred ccccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhC-CCCCCCCCccceeeccCCCCCCCch
Q 008116 157 VSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPPQLD 233 (577)
Q Consensus 157 ls~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG-~~Pf~~~~~~~~~~~i~~~~~~~l~ 233 (577)
+++.+...... ....+||+.|+|||.+.+.. ++.++|||||||+||||++| .+||...+..+.+..+.....+..+
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p 257 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred cceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 99866443222 23457899999999998764 88999999999999999998 5889888887777777776666777
Q ss_pred hhhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 234 ~~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
..++..+.+||.+||+.+|.+|||+.+|+++
T Consensus 258 ~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8899999999999999999999999999973
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=406.30 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=205.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcC-CC--cEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCCEEE
Q 008116 13 SRFSSLELIGRGSFGDVYKAFDKE-LN--KDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (577)
Q Consensus 13 ~~f~il~~IG~GsfG~Vy~a~~~~-tg--~~VAIK~i~~~~--~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~~~~ 87 (577)
.+|++++.||+|+||.||+|.+.. ++ ..||||+++... .....+.+.+|+.+|++++|||||++++++.+ ..++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 579999999999999999998643 33 478999987543 33456789999999999999999999999965 4678
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeecccccccccccccc
Q 008116 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~-~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~ 166 (577)
+|||||++|+|.+++.. .+.+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 99999999999988754 46799999999999999999999999999999999999999999999999999987644322
Q ss_pred c---cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCC-CCCCchhhhhHHHH
Q 008116 167 R---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRLMK 241 (577)
Q Consensus 167 ~---~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~l~~~~s~~l~ 241 (577)
. .....|++.|+|||++.+. .++.++|||||||++|||++ |.+||...+..+....+... ..+..+..++..++
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 245 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred cceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHH
Confidence 1 2234678899999999876 49999999999999999998 89999988887776666443 34455678899999
Q ss_pred HHHHHhcccCCCCCCcHHHHhhcHhhh
Q 008116 242 EFVSLCLKKVPAERPSAKELLRHRFIR 268 (577)
Q Consensus 242 ~lI~~cL~~dP~~RpTa~elL~hpff~ 268 (577)
+||.+||..||.+|||+.+|++ +|+
T Consensus 246 ~li~~cl~~dp~~RPt~~ei~~--~L~ 270 (273)
T d1u46a_ 246 NVMVQCWAHKPEDRPTFVALRD--FLL 270 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH--HHH
Confidence 9999999999999999999974 454
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=406.40 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=217.1
Q ss_pred CCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCceeEeEEEEEeCCE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTK 85 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L-~HpnIV~l~~~~~~~~~ 85 (577)
.++|++.++||+|+||.||+|.+. .+++.||||+++..........+.+|+.+++++ +|||||++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 479999999999999999999863 467799999998777777778899999999999 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccC
Q 008116 86 LWIIMEYMAGGSVADLIQSGP------------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~~l~~~~------------------~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~ 147 (577)
+|||||||++|+|.+++.... .+++..+..|+.||+.||+|||+++||||||||+|||++.+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccccc
Confidence 999999999999999996532 58999999999999999999999999999999999999999
Q ss_pred CCeeeccccccccccccccc--cccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeec-
Q 008116 148 GDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFI- 223 (577)
Q Consensus 148 g~vKL~DFGls~~~~~~~~~--~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLlt-G~~Pf~~~~~~~~~~~- 223 (577)
+.+||+|||+++........ ....+||+.|+|||++... .++.++|||||||+||||+| |.+||...+....+..
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~ 260 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999876543222 2346899999999999875 48999999999999999998 6666766665444333
Q ss_pred cCCCCCCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 224 i~~~~~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
+.....+..+..++..+.+||.+||..||.+|||+.+|++
T Consensus 261 i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3344455566778999999999999999999999999996
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=402.52 Aligned_cols=246 Identities=22% Similarity=0.359 Sum_probs=208.2
Q ss_pred EeEEeecCceEEEEEEEcCCC---cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEe-CCEEEEEEecc
Q 008116 18 LELIGRGSFGDVYKAFDKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTKLWIIMEYM 93 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~-~~~~~LV~Ey~ 93 (577)
.++||+|+||+||+|.+..++ ..||||.++........+.+.+|+.+|++|+|||||++++++.. +..+++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 578999999999999986543 36999999876677778899999999999999999999999876 56899999999
Q ss_pred CCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccccccccccccc----c
Q 008116 94 AGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----R 168 (577)
Q Consensus 94 ~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGls~~~~~~~~~----~ 168 (577)
++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||||+.++.+||+|||+++........ .
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 191 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceec
Confidence 999999998753 46788899999999999999999999999999999999999999999999999876443221 1
Q ss_pred ccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCC-CCccceeeccCCCCCCCchhhhhHHHHHHHHHh
Q 008116 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD-LHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (577)
Q Consensus 169 ~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~-~~~~~~~~~i~~~~~~~l~~~~s~~l~~lI~~c 247 (577)
....||+.|+|||++.... ++.++||||||++||||++|..||.. .+.......+..+..+..+..++..+.+||.+|
T Consensus 192 ~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~c 270 (311)
T d1r0pa_ 192 TGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 270 (311)
T ss_dssp TCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHH
Confidence 2357899999999998764 89999999999999999997776654 344445555555566666778899999999999
Q ss_pred cccCCCCCCcHHHHhhc
Q 008116 248 LKKVPAERPSAKELLRH 264 (577)
Q Consensus 248 L~~dP~~RpTa~elL~h 264 (577)
|..||.+||++.||++|
T Consensus 271 l~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 271 WHPKAEMRPSFSELVSR 287 (311)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHH
Confidence 99999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-48 Score=396.10 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=203.5
Q ss_pred cCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCc-eeEeEEEEEeCCEEEEE
Q 008116 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQTKLWII 89 (577)
Q Consensus 11 ~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~Hpn-IV~l~~~~~~~~~~~LV 89 (577)
++++|++++.||+|+||.||+|.+..+|+.||||++...... ..+.+|+++++++.|++ |+.++.++..++..++|
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 568999999999999999999999999999999998765422 45788999999997665 55666777888899999
Q ss_pred EeccCCCCHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc---CCCeeeccccccccccccc
Q 008116 90 MEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVSAQLTRTI 165 (577)
Q Consensus 90 ~Ey~~gGsL~~~l-~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~---~g~vKL~DFGls~~~~~~~ 165 (577)
|||| +++|...+ .....+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.+....
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9999 55666655 44578999999999999999999999999999999999999864 4579999999998765432
Q ss_pred c-------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-------CCCCC
Q 008116 166 S-------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------ENPPQ 231 (577)
Q Consensus 166 ~-------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~i~~-------~~~~~ 231 (577)
. ...+.+||+.|||||++.+.. |+.++|||||||++|||++|..||...........+.. ...+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 1 223568999999999998764 89999999999999999999999987655443332211 11112
Q ss_pred chhhhhHHHHHHHHHhcccCCCCCCcHHHH---hhcHhhhh
Q 008116 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKEL---LRHRFIRN 269 (577)
Q Consensus 232 l~~~~s~~l~~lI~~cL~~dP~~RpTa~el---L~hpff~~ 269 (577)
+...+|+++.+||..||..+|.+||++.+| |+|+|.+.
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 334678999999999999999999998755 56666543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.1e-47 Score=387.81 Aligned_cols=249 Identities=19% Similarity=0.268 Sum_probs=208.1
Q ss_pred hcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC-CceeEeEEEEEeCCEEEE
Q 008116 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 10 ~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~H-pnIV~l~~~~~~~~~~~L 88 (577)
.++++|++++.||+|+||+||+|++..+|+.||||+++.... ...+.+|+.+++.|.| +||+.+++++..+...|+
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 467899999999999999999999999999999999865542 2457889999999965 999999999999999999
Q ss_pred EEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcc-----CCCeeecccccccccc
Q 008116 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-----NGDVKVADFGVSAQLT 162 (577)
Q Consensus 89 V~Ey~~gGsL~~~l~~~-~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~-----~g~vKL~DFGls~~~~ 162 (577)
||||| +++|.+++... ..+++..+..++.|++.||+|||++|||||||||+||||+. .+.+||+|||+|+.+.
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 78999998654 57999999999999999999999999999999999999974 5789999999998764
Q ss_pred cccc-------ccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeec---cC----CCC
Q 008116 163 RTIS-------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI---IP----REN 228 (577)
Q Consensus 163 ~~~~-------~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~~---i~----~~~ 228 (577)
.... ...+.+||+.|||||++.+. .++.++|||||||++|||++|..||........... +. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 3321 22356899999999999875 499999999999999999999999986544322111 11 011
Q ss_pred CCCchhhhhHHHHHHHHHhcccCCCCCCcHHHHhh
Q 008116 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (577)
Q Consensus 229 ~~~l~~~~s~~l~~lI~~cL~~dP~~RpTa~elL~ 263 (577)
+..+...+|+++.+|+..|+..+|.+||+++.|.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 12233467889999999999999999999887754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=388.75 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=195.0
Q ss_pred CCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCceeEeEEEEEeCC----EEE
Q 008116 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----KLW 87 (577)
Q Consensus 12 ~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~HpnIV~l~~~~~~~~----~~~ 87 (577)
...|.+.+.||+|+||.||+|++ +|+.||||+++.... .......|+..+++++|||||++++++.+.+ .+|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 35789999999999999999986 489999999865432 1222345666667889999999999998754 689
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------cCCcccccccceEEEccCCCeeeccccccc
Q 008116 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN--------EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 88 LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs--------~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
||||||++|+|.++|++ .++++..++.++.|++.||.|||. +|||||||||+||||+.++.+||+|||++.
T Consensus 78 lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999999987 579999999999999999999996 599999999999999999999999999998
Q ss_pred ccccccc----ccccccCCCCCCChhhhhccc-----CCccccchhhHHHHHHHHHhCCCCCCCCCccceee--------
Q 008116 160 QLTRTIS----RRKTFVGTPFWMAPEVIQNSE-----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-------- 222 (577)
Q Consensus 160 ~~~~~~~----~~~~~~GTp~Y~APEvl~~~~-----~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~~-------- 222 (577)
....... .....+||+.|+|||++.+.. .++.++|||||||+||||+||.+||..........
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 7654322 223568999999999987532 25778999999999999999998875432211110
Q ss_pred -------cc-CCCCCCCchh-----hhhHHHHHHHHHhcccCCCCCCcHHHHhhc
Q 008116 223 -------II-PRENPPQLDE-----HFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (577)
Q Consensus 223 -------~i-~~~~~~~l~~-----~~s~~l~~lI~~cL~~dP~~RpTa~elL~h 264 (577)
.+ .....+.++. .....+.+|+.+||..||.+|||+.||+++
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00 0111122222 344679999999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.9e-44 Score=372.59 Aligned_cols=258 Identities=22% Similarity=0.341 Sum_probs=200.6
Q ss_pred hhhhcC-CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----------CCcee
Q 008116 7 LQEAAG-SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----------SPYIT 74 (577)
Q Consensus 7 l~~~~~-~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-----------HpnIV 74 (577)
+++.+. ++|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+|+.+. |||||
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 344443 57999999999999999999999999999999997543 23467788999988875 57899
Q ss_pred EeEEEEEe--CCEEEEEEeccCCCCHHHH-H--HcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEccCC
Q 008116 75 EYYGSYLH--QTKLWIIMEYMAGGSVADL-I--QSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENG 148 (577)
Q Consensus 75 ~l~~~~~~--~~~~~LV~Ey~~gGsL~~~-l--~~~~~l~e~~i~~il~QLl~aL~yLHs-~gIiHrDIKPeNILld~~g 148 (577)
++++++.. ....+++|+++..+.+... . .....+++..++.++.||+.||+|||+ +||+||||||+||||+.++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163 (362)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence 99998865 3566777776655443222 2 335689999999999999999999998 8999999999999998765
Q ss_pred C------eeeccccccccccccccccccccCCCCCCChhhhhcccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee-
Q 008116 149 D------VKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL- 221 (577)
Q Consensus 149 ~------vKL~DFGls~~~~~~~~~~~~~~GTp~Y~APEvl~~~~~~~~ksDVwSLGviLyeLltG~~Pf~~~~~~~~~- 221 (577)
. ++|+|||.+..... .....+||+.|+|||++... .|+.++|||||||++++|++|+.||.........
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cccccceeeEeeccccccccc---ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 3 99999999876543 23467899999999999876 4899999999999999999999999754321100
Q ss_pred ------------------------------------eccCCCC----------CCCchhhhhHHHHHHHHHhcccCCCCC
Q 008116 222 ------------------------------------FIIPREN----------PPQLDEHFSRLMKEFVSLCLKKVPAER 255 (577)
Q Consensus 222 ------------------------------------~~i~~~~----------~~~l~~~~s~~l~~lI~~cL~~dP~~R 255 (577)
..+.... ........+..+++||.+||..||.+|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 0000000 111234567889999999999999999
Q ss_pred CcHHHHhhcHhhhhc
Q 008116 256 PSAKELLRHRFIRNA 270 (577)
Q Consensus 256 pTa~elL~hpff~~~ 270 (577)
|||+|||+||||++.
T Consensus 320 pta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 320 ADAGGLVNHPWLKDT 334 (362)
T ss_dssp BCHHHHHTCGGGTTC
T ss_pred cCHHHHhcCcccCCC
Confidence 999999999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=2.6e-25 Score=211.25 Aligned_cols=165 Identities=16% Similarity=0.226 Sum_probs=123.0
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-----------------hHHHHHHHHHHHHHHhCCCCceeEeE
Q 008116 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-----------------EDEIEDIQKEISVLSQCRSPYITEYY 77 (577)
Q Consensus 15 f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-----------------~~~~~~i~~Ev~iL~~L~HpnIV~l~ 77 (577)
+.+.+.||+|+||+||+|.+. +|+.||||+++.... ......+.+|+..+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457899999999999999985 689999998753211 01123456789999999999999988
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEccCCCeeeccccc
Q 008116 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (577)
Q Consensus 78 ~~~~~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs~gIiHrDIKPeNILld~~g~vKL~DFGl 157 (577)
++. . .+|+|||+++..+.+ +++..+..++.||+.+|.|||++||+||||||+||||+++ .++|+|||+
T Consensus 81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 653 2 279999998865543 4555677899999999999999999999999999999865 589999999
Q ss_pred cccccccccccccccCCCCCCC------hhhhhcccCCccccchhhHHHHH
Q 008116 158 SAQLTRTISRRKTFVGTPFWMA------PEVIQNSEGYNEKADIWSLGITV 202 (577)
Q Consensus 158 s~~~~~~~~~~~~~~GTp~Y~A------PEvl~~~~~~~~ksDVwSLGviL 202 (577)
|.....+.... |.. .+.+. ..|+.++|+||+.--+
T Consensus 149 a~~~~~~~~~~--------~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 149 SVEVGEEGWRE--------ILERDVRNIITYFS--RTYRTEKDINSAIDRI 189 (191)
T ss_dssp CEETTSTTHHH--------HHHHHHHHHHHHHH--HHHCCCCCHHHHHHHH
T ss_pred cccCCCCCcHH--------HHHHHHHHHHHHHc--CCCCCcccHHHHHHHH
Confidence 87654332211 111 12222 2488899999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.66 E-value=2.4e-08 Score=96.29 Aligned_cols=149 Identities=17% Similarity=0.152 Sum_probs=101.4
Q ss_pred cccchhhhcCCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEE
Q 008116 3 DLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYL 81 (577)
Q Consensus 3 ~l~~l~~~~~~~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~ 81 (577)
+|.+........|++++..+.++.+.||+... .+..++||........ ....+.+|+.++..|. +--+.+++.+..
T Consensus 4 ~~~~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~ 80 (263)
T d1j7la_ 4 RISPELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp SSCHHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred ccCHHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEe
Confidence 44555555567888888877777789998853 4667788887543211 2245778888888773 333677788888
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------
Q 008116 82 HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-------------------------------- 129 (577)
Q Consensus 82 ~~~~~~LV~Ey~~gGsL~~~l~~~~~l~e~~i~~il~QLl~aL~yLHs-------------------------------- 129 (577)
.++..|+||++++|.++...... ......++.++...|..||+
T Consensus 81 ~~~~~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 81 HDGWSNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred cCCceEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 88999999999999888665421 11122233344444444442
Q ss_pred ---------------------c------CCcccccccceEEEccCCCeeeccccccc
Q 008116 130 ---------------------E------GKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 130 ---------------------~------gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
. .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 26899999999999876666799999764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.10 E-value=2.1e-06 Score=81.88 Aligned_cols=75 Identities=12% Similarity=0.105 Sum_probs=52.5
Q ss_pred EEeecC-ceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC--CCceeEeEEEEEeCCEEEEEEeccCCC
Q 008116 20 LIGRGS-FGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR--SPYITEYYGSYLHQTKLWIIMEYMAGG 96 (577)
Q Consensus 20 ~IG~Gs-fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~--HpnIV~l~~~~~~~~~~~LV~Ey~~gG 96 (577)
.+..|. -+.||+.... .+..+++|...... ...+..|+..|+.|. .-.+.+++.+..+++..|+||+|++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 344444 4689988754 46678899865443 234678888888773 233677788888888999999999886
Q ss_pred CHH
Q 008116 97 SVA 99 (577)
Q Consensus 97 sL~ 99 (577)
++.
T Consensus 92 ~~~ 94 (255)
T d1nd4a_ 92 DLL 94 (255)
T ss_dssp ETT
T ss_pred ccc
Confidence 653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.10 E-value=2.3e-06 Score=88.27 Aligned_cols=78 Identities=19% Similarity=0.204 Sum_probs=51.1
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeccC------CChHHHHHHHHHHHHHHhC-CC--CceeEeEEEEEeCCEEEE
Q 008116 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLE------ESEDEIEDIQKEISVLSQC-RS--PYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 18 l~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~------~~~~~~~~i~~Ev~iL~~L-~H--pnIV~l~~~~~~~~~~~L 88 (577)
.+.||.|....||++.+..+++.|+||.-... .......+...|+..|+.+ .+ ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56789999999999998877889999975321 1111234567788888876 22 345566644 4556689
Q ss_pred EEeccCCCC
Q 008116 89 IMEYMAGGS 97 (577)
Q Consensus 89 V~Ey~~gGs 97 (577)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.94 E-value=0.0014 Score=64.66 Aligned_cols=68 Identities=16% Similarity=0.137 Sum_probs=44.1
Q ss_pred ceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC-----CceeEeE--EEEEeCCEEEEEEeccCCC
Q 008116 26 FGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-----PYITEYY--GSYLHQTKLWIIMEYMAGG 96 (577)
Q Consensus 26 fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~H-----pnIV~l~--~~~~~~~~~~LV~Ey~~gG 96 (577)
--.||++... +|..|++|+.+.... ..+++..|...|..|.. |..+..- ..+..++..+.+++++.|.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 4589999764 588899999764432 23667788888877632 2112211 1334567789999999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.93 E-value=0.0013 Score=66.68 Aligned_cols=75 Identities=15% Similarity=0.144 Sum_probs=51.9
Q ss_pred EEeEEeecCceEEEEEEEcC-------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCceeEeEEEEEeCCEEEE
Q 008116 17 SLELIGRGSFGDVYKAFDKE-------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWI 88 (577)
Q Consensus 17 il~~IG~GsfG~Vy~a~~~~-------tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-HpnIV~l~~~~~~~~~~~L 88 (577)
.++.|+.|-.-.+|++.... .+..|.+++.-.... .....+|..+++.+. +.-.+++++++.. ++
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 45789999999999998653 245688888652222 234668999999884 4444577777642 68
Q ss_pred EEeccCCCCH
Q 008116 89 IMEYMAGGSV 98 (577)
Q Consensus 89 V~Ey~~gGsL 98 (577)
|+||++|..|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.75 E-value=0.0027 Score=61.81 Aligned_cols=141 Identities=11% Similarity=0.142 Sum_probs=74.9
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----CCceeEeEE---EEEeCCE
Q 008116 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----SPYITEYYG---SYLHQTK 85 (577)
Q Consensus 14 ~f~il~~IG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~i~~Ev~iL~~L~-----HpnIV~l~~---~~~~~~~ 85 (577)
....++.|..|---+.|+..... ..|++|++..... ...+..|+.+|..|. .|..+...+ +......
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~--g~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~ 93 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 93 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESS--CCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred CceEeecCCCCcccCeEEEEECC--CcEEEEEcCCCCC---HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecc
Confidence 45556667788888999987653 3589999854322 234555666666653 233332211 2233556
Q ss_pred EEEEEeccCCCCHHH-----------HH---H---cC------CCCCHH------------------HHHHHHHHHHHHH
Q 008116 86 LWIIMEYMAGGSVAD-----------LI---Q---SG------PPLDEM------------------SIACILRDLLHAI 124 (577)
Q Consensus 86 ~~LV~Ey~~gGsL~~-----------~l---~---~~------~~l~e~------------------~i~~il~QLl~aL 124 (577)
.+.++.++.+..... .+ . .. ...... .+...+..+...+
T Consensus 94 ~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 173 (316)
T d2ppqa1 94 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 173 (316)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred cceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhh
Confidence 677777776643211 00 0 00 000111 1111122222222
Q ss_pred HHHH----HcCCcccccccceEEEccCCCeeeccccccc
Q 008116 125 EYLH----NEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (577)
Q Consensus 125 ~yLH----s~gIiHrDIKPeNILld~~g~vKL~DFGls~ 159 (577)
.-.+ ..|+||+|+.++|||++.+...-|+||+.++
T Consensus 174 ~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 174 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 2222 1379999999999999988777899999864
|